<?xml version="1.0"?>
<!DOCTYPE FILE SYSTEM "cfc-2.dtd">
<FILE>

<RECORD>
<PAPERNUM>PN78001</PAPERNUM>

<RECORDNUM>00782 </RECORDNUM>
<MEDLINENUM>78231664</MEDLINENUM>
<AUTHORS><AUTHOR>Mei-Liu-H</AUTHOR></AUTHORS>
<TITLE>Reactive neuroaxonal dystrophy in children.  Clinical pathological
correlation.</TITLE>
<SOURCE>Acta-Neuropathol (Berl). 1978 Jun 30. 42(3). P 237-41.</SOURCE>
<MAJORSUBJ><TOPIC>BRAIN-DISEASES: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AUTOPSY</TOPIC><TOPIC>BILE-DUCTS: ab</TOPIC><TOPIC>BRAIN-DISEASES: ci, et</TOPIC><TOPIC>BRAIN-STEM: pa</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEART-FAILURE-CONGESTIVE: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KIDNEY-FAILURE-CHRONIC: co</TOPIC><TOPIC>NUTRITION-DISORDERS: co</TOPIC><TOPIC>SPINAL-CORD: pa</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>VINCRISTINE: ae</TOPIC></MINORSUBJ>
<ABSTRACT>The aim of the present study was to determine the frequency and
etioloical factors of neuroaxonal dystrophy (N.D.) in brainstem and
spinal cord of children with various non-neurological diseases.  The
materials used in this study consisted of 266 consecutive autopsies
from 1974-1976 and an additional 13 cases from previous years.  By
far, the most common cause of N.D. in children was chemotherapeutic
drugs, particularly vincristine, used for the treatment of malignant
tumors.  Approximately 90% of these children developed N.D. and the
changes ranged from mild to severe.  Approximately two-thirds of
children with cystic fibrosis, congestive heart failure and chronic
renal failure developed N.D. and the changes were mostly mild.  Only
one-third of patients with congenital biliary atresia and
malnutrition developed N.D. and the changes were always mild.  The
frequency and severity of N.D. increased in patients who had
prolonged clinical courses; no N.D. was seen in patients who died
from acute cases such as trauma, acute infection, intoxication,
acute renal failure or prematurity.  This type of N.D. may be
considered as reactive to a wide variety of injurious factors such
as drug toxicity, malnutrition, chronic hypoxia and chronic renal
failure, either alone or in combination.  In contrast to previous
reports of a low incidence of N.D. in children, there has been a
sharp increase in recent years due to the advent of chemotherapy.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERARD-BADIER M" publication="ACTA NEUROPATH (BERL)" d1="28" d2="261" d3="974"/>
<CITE num="002" author="BORISY GG" publication="J CELL BIOL" d1="34" d2="525" d3="967"/>
<CITE num="003" author="BRANNON W" publication="ACTA NEUROPATH (BERL)" d1="9" d2="1" d3="967"/>
<CITE num="004" author="CHOU SM" publication="ACTA NEUROPATH (BERL)" d1="3" d2="428" d3="964"/>
<CITE num="005" author="FUJISAWA K" publication="ACTA NEUROPATH (BERL)" d1="8" d2="255" d3="967"/>
<CITE num="006" author="JELLINGER K" publication="GERMAN MEDICAL MONTHLY BD" d1="13" d2="341" d3="968"/>
<CITE num="007" author="LAMPERT P" publication="J NEUROPATH EXP NEUROL" d1="23" d2="60" d3="964"/>
<CITE num="008" author="LIU HM" publication="ACTA NEUROPATH (BERL)" d1="37" d2="207" d3="977"/>
<CITE num="009" author="LIU HM" publication="NEUROLOGY (MINN)" d1="24" d2="547" d3="974"/>
<CITE num="010" author="LUI HM" publication="ACTA NEUROPATH (BERL)" d1="27" d2="201" d3="974"/>
<CITE num="011" author="MARTIN JJ" publication="EUR NEUROL" d1="8" d2="239" d3="972"/>
<CITE num="012" author="PENTSCHEW A" publication="ACTA NEUROPATH (BERL)" d1="1" d2="313" d3="962"/>
<CITE num="013" author="SEITELBERGER F" publication="ACTA NEUROPATH (BERL) SUPPL" d1="5" d2="17" d3="971"/>
<CITE num="014" author="SEITELBERGER F" publication="PROC CONG NEUROPATH 1ST" d1="3" d2="323" d3="952"/>
<CITE num="015" author="SUNG JH" publication="J NEUROPATH EXP NEUROL" d1="25" d2="341" d3="966"/>
<CITE num="016" author="SUNG JH" publication="J NEUROPATH EXP NEUROL" d1="25" d2="341" d3="966"/>
<CITE num="017" author="WISNIEWSKI H" publication="J CELL BIOL" d1="38" d2="224" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78002</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CARDI J             BR" publication="AIN                          1" d1="02" d2="27 9" d3="9"/>
<CITE num="2" author="GRAFE MR" publication="J NEUROPATHOL EXP NEUROL" d1="39" d2="555" d3="980"/>
<CITE num="3" author="SUNG JH" publication="J NEUROPATHOL EXP NEUROL" d1="39" d2="584" d3="980"/>
<CITE num="4" author="SUNG JH" publication="J NEUROPATHOL EXP NEUROL" d1="40" d2="37" d3="981"/>
<CITE num="5" author="TOMIWA K" publication="J NEUROL" d1="229" d2="267" d3="983"/>
<CITE num="6" author="ROBAIN  O" publication="J NEUROL NEUROSURG PSYCHIAT" d1="47" d2="65" d3="984"/>
<CITE num="7" author="WISNIEWSKI KE" publication="ACTA NEUROPATH (BERL)" d1="66" d2="68" d3="985"/>
</CITATIONS>
<RECORDNUM>00783 </RECORDNUM>
<MEDLINENUM>78120444</MEDLINENUM>
<AUTHORS><AUTHOR>Kraemer-R</AUTHOR><AUTHOR>Rudeberg-A</AUTHOR><AUTHOR>Hadorn-B</AUTHOR><AUTHOR>Rossi-E</AUTHOR></AUTHORS>
<TITLE>Relative underweight in cystic fibrosis and its prognostic value.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1978 Jan. 67(1). P 33-7.</SOURCE>
<MAJORSUBJ><TOPIC>BODY-WEIGHT</TOPIC><TOPIC>CYSTIC-FIBROSIS: mo</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PROGNOSIS</TOPIC></MINORSUBJ>
<ABSTRACT>On the basis of observations in 117 children with cystic fibrosis,
seen from January 1956 to June 1976, it is demonstrated that the
relative underweight (weight loss corrected for height) is most
pronounced in children with predominantly pulmonary sypmtoms. The
degree of underweight closely correlates inversely with survival.
Because of its prognostic value, it is recommended that this clinical
parameter be included in the checkups which are periodically carried
out on children suffering from cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="COOPERMAN EM" publication="CAN MED ASSOC J" d1="105" d2="580" d3="971"/>
<CITE num="002" author="CUTLER SJ" publication="J CHRON DIS" d1="8" d2="699" d3="958"/>
<CITE num="003" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="004" author="FRIOLET B" publication="THER UMSCH" d1="31" d2="578" d3="974"/>
<CITE num="005" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="006" author="HADORN B" publication="SCHWEIZ RUNDSCHAU MED" d1="14" d2="454" d3="973"/>
<CITE num="007" author="HOGGER GP" publication="HELV PAEDIATR ACTA" d1="30" d2="151" d3="975"/>
<CITE num="008" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="009" author="KERREBIJN KF" publication="PROC INT CF CONG 7TH" d1="" d2="" d3="976"/>
<CITE num="010" author="KRAEMER R" publication="SCHWEIZ MED WOCHENSCHR" d1="107" d2="271" d3="977"/>
<CITE num="011" author="KRAEMER R" publication="HELV PAEDIATR ACTA" d1="32" d2="107" d3="977"/>
<CITE num="012" author="LAPEY A" publication="J PEDIATR" d1="84" d2="328" d3="974"/>
<CITE num="013" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="014" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="015" author="SHWACHMAN H" publication="HOSP PRACT" d1="9" d2="143" d3="974"/>
<CITE num="016" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="017" author="SPROUL A" publication="J PEDIATR" d1="65" d2="664" d3="964"/>
<CITE num="018" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="019" author="TANNER JM" publication="ARCH DIS CHILD" d1="41" d2="454" d3="966"/>
<CITE num="020" author="WARWICK WJ" publication="J CHRON DIS" d1="28" d2="609" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78003</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NTAGNESE PAD        AM" publication="J MED" d1="66" d2="21 9" d3="9"/>
<CITE num="2" author="KRAEMER R" publication="SCHWEIZ MED WOCHENSCHR" d1="109" d2="39" d3="979"/>
<CITE num="3" author="KARP RJ" publication="CLIN CHEST MED" d1="1" d2="375" d3="980"/>
<CITE num="4" author="COATES AL" publication="ACTA PAEDIATR SCAND" d1="69" d2="353" d3="980"/>
<CITE num="5" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="6" author="GOW R" publication="LANCET" d1="2" d2="1071" d3="981"/>
<CITE num="7" author="BELL L" publication="J CAN DIET ASSOC" d1="42" d2="62" d3="981"/>
<CITE num="8" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="9" author="MILLER M" publication="AM J CLIN NUTR" d1="36" d2="492" d3="982"/>
<CITE num="10" author="PARSONS HG" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="44" d3="983"/>
<CITE num="11" author="SHEPHERD RW" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="439" d3="983"/>
<CITE num="12" author="GIUNTA A" publication="RIV ITAL PEDIATR" d1="9" d2="171" d3="983"/>
<CITE num="13" author="POSSELT HG" publication="ATEMWEGS LUNGENKRANKH" d1="10" d2="345" d3="984"/>
<CITE num="14" author="HOLT TL" publication="IRCS MED SCI BIOCHEM" d1="12" d2="370" d3="984"/>
<CITE num="15" author="WELLS AL" publication="J FOOD NUTR" d1="41" d2="65" d3="984"/>
<CITE num="16" author="BERTRAND JM" publication="J PEDIATR" d1="104" d2="41" d3="984"/>
<CITE num="17" author="MANSELL AL" publication="J PEDIATR" d1="104" d2="700" d3="984"/>
<CITE num="18" author="CANCIANI M" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="735" d3="985"/>
<CITE num="19" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="20" author="MISCHLER EH" publication="SEM RESPIR MED" d1="6" d2="271" d3="985"/>
<CITE num="21" author="GRAHAM N" publication="CLIN RADIOL" d1="36" d2="199" d3="985"/>
<CITE num="22" author="HOLT TL" publication="AM J CLIN NUTR" d1="41" d2="1061" d3="985"/>
<CITE num="23" author="SCHRODER R" publication="SCHWEIZ MED WOCHENSCHR" d1="115" d2="828" d3="985"/>
<CITE num="24" author="WILSON DO" publication="AM REV RESPIR DIS" d1="132" d2="1347" d3="985"/>
<CITE num="25" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="26" author="HUGHES RL" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="42" d3="985"/>
<CITE num="27" author="NEIJENS HJ" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="38" d3="985"/>
<CITE num="28" author="ANON" publication="LANCET" d1="1" d2="249" d3="986"/>
<CITE num="29" author="LEVY L" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="97" d3="986"/>
<CITE num="30" author="SOUTTER VL" publication="CLIN GASTROENTEROL" d1="15" d2="137" d3="986"/>
<CITE num="31" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
<CITE num="32" author="OLOUGHLIN E" publication="AM J CLIN NUTR" d1="43" d2="732" d3="986"/>
<CITE num="33" author="MOORE MC" publication="AM J CLIN NUTR" d1="44" d2="33" d3="986"/>
<CITE num="34" author="MAHANEY MC" publication="HUM BIOL" d1="58" d2="445" d3="986"/>
<CITE num="35" author="SCHAAD UB" publication="ACTA PAEDIATR SCAND" d1="75" d2="128" d3="986"/>
<CITE num="36" author="DODGE JA" publication="J ROY SOC MED" d1="79" d2="27" d3="986"/>
<CITE num="37" author="MARCOTTE JE" publication="CHEST" d1="90" d2="375" d3="986"/>
<CITE num="38" author="SHEPHERD RW" publication="J PEDIATR" d1="109" d2="788" d3="986"/>
<CITE num="39" author="STEAD RJ" publication="CLIN ENDOCRINOL" d1="26" d2="187" d3="987"/>
<CITE num="40" author="GUELPA G" publication="SCHWEIZ MED WOCHENSCHR" d1="117" d2="168" d3="987"/>
</CITATIONS>
<RECORDNUM>00784 </RECORDNUM>
<MEDLINENUM>78231746</MEDLINENUM>
<AUTHORS><AUTHOR>Nielsen-H-E</AUTHOR><AUTHOR>Lundh-S</AUTHOR><AUTHOR>Jacobsen-S-V</AUTHOR><AUTHOR>Hoiby-N</AUTHOR></AUTHORS>
<TITLE>Hypergammaglobulinemic purpura in cystic fibrosis.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1978 Jul. 67(4). P 443-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PURPURA-HYPERGLOBULINEMIC: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HAEMOPHILUS-INFECTIONS: co</TOPIC><TOPIC>HAEMOPHILUS-INFLUENZAE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LEG</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PNEUMONIA: co</TOPIC><TOPIC>PURPURA-HYPERGLOBULINEMIC: bl, im</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MINORSUBJ>
<ABSTRACT>Four patients are presented aged 14 to 20 years with cystic fibrosis
and recurrent purpura of the legs. They have polyclonal increase of
Ig but no intermediate complexes demonstrable by ultracentrifugation.
The 4 patients differ from other patients with cystic fibrosis by a
rapid deterioration of the clinical condition after the establishment
of permanent pulmonary infection, and also by their proneness to
Haemophilus influenzae infections. The clinical and laboratory
findings are compatible with the diagnosis of Waldenstrom's
hypergammaglobulinemic purpura. The heterogeneity of this syndrome is
discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="BR MED J" d1="1" d2="7" d3="973"/>
<CITE num="002" author="CAPRA JD" publication="MEDICINE (BALTIMORE)" d1="50" d2="125" d3="971"/>
<CITE num="003" author="CARR RD" publication="ARCH DERMATOL" d1="94" d2="536" d3="966"/>
<CITE num="004" author="DANES BS" publication="CLIN GENET" d1="8" d2="85" d3="975"/>
<CITE num="005" author="FARRELL C" publication="SCAND J IMMUNOL" d1="4" d2="673" d3="975"/>
<CITE num="006" author="HOIGNE R" publication="IN: DUKES NG" d1="" d2="551" d3="975"/>
<CITE num="007" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="008" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="009" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="010" author="JACOBS JC" publication="J PEDIATR" d1="87" d2="91" d3="975"/>
<CITE num="011" author="JOHNSON KJ" publication="J CLIN INVEST" d1="54" d2="349" d3="974"/>
<CITE num="012" author="KATTAMIS C" publication="HELV PAEDIATR ACTA" d1="25" d2="421" d3="970"/>
<CITE num="013" author="KYLE RA" publication="MEDICINE (BALTIMORE)" d1="50" d2="113" d3="971"/>
<CITE num="014" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="015" author="SCHWARTZ HJ" publication="JAMA" d1="187" d2="230" d3="964"/>
<CITE num="016" author="STRAUSS WG" publication="N ENGL J MED" d1="260" d2="857" d3="959"/>
<CITE num="017" author="WALDENSTROM JG" publication="NORD MED" d1="20" d2="2288" d3="943"/>
<CITE num="018" author="WALDENSTROM JG" publication="ACTA MED SCAND SUPPL" d1="142" d2="931" d3="952"/>
<CITE num="019" author="WALDENSTROM JG" publication="MONOCLONAL AND POLYCLONAL HYP" d1="" d2="" d3="968"/>
<CITE num="020" author="WIDMER U" publication="MINERVA PEDIATR" d1="27" d2="104" d3="975"/>
<CITE num="021" author="ZAHARIA L" publication="ACTA MED SCAND" d1="199" d2="429" d3="976"/>
<CITE num="022" author="ZAVALA DC" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="450" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78004</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TER NA              J" publication="PEDIATR" d1="95" d2="97 9" d3="9"/>
<CITE num="2" author="CELADA A" publication="HELV PAEDIATR ACTA" d1="35" d2="569" d3="980"/>
<CITE num="3" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="4" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="5" author="SCHIDLOW DV" publication="ARCH DIS CHILD" d1="59" d2="377" d3="984"/>
<CITE num="6" author="CIRIELLO MM" publication="HAEMATOLOGICA" d1="69" d2="435" d3="984"/>
<CITE num="7" author="PRESSLER T" publication="ACTA PAEDIATR SCAND" d1="73" d2="541" d3="984"/>
<CITE num="8" author="SUMMERS GD" publication="BR J RHEUMATOL" d1="25" d2="393" d3="986"/>
<CITE num="9" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
<CITE num="10" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
</CITATIONS>
<RECORDNUM>00785 </RECORDNUM>
<MEDLINENUM>78120454</MEDLINENUM>
<AUTHORS><AUTHOR>Roomans-G-M</AUTHOR><AUTHOR>Afzelius-B-A</AUTHOR><AUTHOR>Kollberg-H</AUTHOR><AUTHOR>Forslind-B</AUTHOR></AUTHORS>
<TITLE>Electrolytes in nails analysed by X-ray microanalysis in electron
microscopy.  Considerations on a new method for the diagnosis of
cystic fibrosis.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1978 Jan. 67(1). P 89-94.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ELECTROLYTES: an</TOPIC><TOPIC>NAILS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>EVALUATION-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>MICROSCOPY-ELECTRON</TOPIC><TOPIC>SODIUM: an</TOPIC><TOPIC>ELECTRON-PROBE-MICROANALYSIS</TOPIC></MINORSUBJ>
<ABSTRACT>Patients with cystic fibrosis (CF) have an increased concentration of
sodium in their nails. Hitherto, only neutron activation analysis has
been considered for the diagnosis of cystic fibrosis by analysis of
electrolytes in nails. It has been thoroughly tested methodologically
and clinically. However, the intrinsic advantages of X-ray
microanalysis and the results obtained in this study suggest that
this method, after further testing, may be a useful diagnostic acid
for cystic fibrosis. In comparison with neutron activation analysis,
X-ray microanalysis has the advantage of simultaneously giving the
concentrations of several elements and may be accessible at any
hospital with an electron microscope fitted with the necessary
equipment. Nails of CF-patients are here shown to have increased
concentrations of Na, K and Cl, which will make the diagnosis of
cystic fibrosis more reliable. The possibility of using sulphur as a
reference element may eliminate the weighing procedure necessary in
neutron activation analysis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERG T" publication="NORTHERN PEDIATR CONG 15" d1="" d2="" d3="967"/>
<CITE num="002" author="CHANDLER JA" publication="J MICROSC" d1="106" d2="291" d3="976"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="004" author="FITE LE" publication="PROC INT CONF MOD TRENDS" d1="" d2="147" d3="968"/>
<CITE num="005" author="FORSLIND B" publication="ACTA DERM VENEREOL (STOCKH)" d1="50" d2="161" d3="970"/>
<CITE num="006" author="FORSLIND B" publication="J INVEST DERMATOL" d1="67" d2="273" d3="976"/>
<CITE num="007" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="008" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="009" author="HALL TA" publication="MICROSCOPIC BIOL CELL" d1="22" d2="271" d3="975"/>
<CITE num="010" author="HARRISON WW" publication="CLIN CHIM ACTA" d1="36" d2="483" d3="972"/>
<CITE num="011" author="HEIN W" publication="MIKROCHIM ACTA WIEN SUPPL" d1="5" d2="1" d3="974"/>
<CITE num="012" author="HEINTZ PH" publication="THESIS" d1="" d2="" d3="967"/>
<CITE num="013" author="JOHNSON GF" publication="PEDIATRICS" d1="47" d2="88" d3="971"/>
<CITE num="014" author="KANABROCKI E" publication="J NUCL MED" d1="9" d2="478" d3="968"/>
<CITE num="015" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="63" d2="411" d3="974"/>
<CITE num="016" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="63" d2="405" d3="974"/>
<CITE num="017" author="KOPITO L" publication="N ENGL J MED" d1="272" d2="504" d3="965"/>
<CITE num="018" author="MORGAN AJ" publication="J MICROSC" d1="104" d2="271" d3="975"/>
<CITE num="019" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78005</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EPHAN U             MO" publication="NOGR PAEDIATR" d1="10" d2="41 9" d3="9"/>
<CITE num="2" author="GHADIALLY FN" publication="PATHOLOGY" d1="11" d2="95" d3="979"/>
<CITE num="3" author="KUYPERS GAJ" publication="HISTOCHEMISTRY" d1="69" d2="145" d3="980"/>
<CITE num="4" author="DAVID H" publication="BIOL ZENTRALBL" d1="101" d2="715" d3="982"/>
<CITE num="5" author="FORSLIND B" publication="SCANN ELECTRON MICROSC" d1="1982" d2="1715" d3="982"/>
<CITE num="6" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1982" d2="229" d3="982"/>
<CITE num="7" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="8" author="ROOMANS GM" publication="ANN NY ACAD SCI" d1="428" d2="121" d3="984"/>
<CITE num="9" author="FORSLIND B" publication="SCANN ELECTRON MICROSC" d1="1984" d2="183" d3="984"/>
<CITE num="10" author="CHAPMAN AL" publication="EUR J RESPIR DIS" d1="66" d2="218" d3="985"/>
<CITE num="11" author="BAKER D" publication="SCANN ELECTRON MICROSC" d1="1985" d2="659" d3="985"/>
<CITE num="12" author="DJALDETTI M" publication="CLIN SCI" d1="72" d2="669" d3="987"/>
<CITE num="13" author="DJALDETTI M" publication="DERMATOLOGICA" d1="174" d2="114" d3="987"/>
</CITATIONS>
<RECORDNUM>00786 </RECORDNUM>
<MEDLINENUM>79018054</MEDLINENUM>
<AUTHORS><AUTHOR>Hosli-P</AUTHOR><AUTHOR>Kollberg-H</AUTHOR><AUTHOR>Vogt-E</AUTHOR></AUTHORS>
<TITLE>Reliable diagnosis of the major type of cystic fibrosis with
fibroblast cultures.  A double blind study.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1978 Sep. 67(5). P 617-20.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>GLYCOPROTEINS: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ALKALINE-PHOSPHATASE: me</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>DOUBLE-BLIND-METHOD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOPROTERENOL: du</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>SKIN: en</TOPIC><TOPIC>THEOPHYLLINE: du</TOPIC></MINORSUBJ>
<ABSTRACT>A double blind study has been carried out to demonstrate that the
most common type of cystic fibrosis (CF) can be reliably diagnosed
with skin-derived fibroblast cultures. Alkaline phosphatase (AIP)
activity has been measured in 6 normal controls, 12 CF-heterozygotes
and 6 CF-homozygotes before and after stimulation with Tamm-Horsfall-
glycoprotein (THP), isoproterenol and theophyline ("THP-induction
test"). The mean AIP-activities after THP-induction were 8.8, 12.7
and 34.6 for the three different genotypes respectively. There was no
overlap between the values of CF-homozygotes on the one hand, and the
values of CF-heterozygotes and normal controls on the other hand. All
24 specimens were correctly diagnosed in the present double blind
study, indicating the very high degree of reliability of the THP-
induction test in the detection of the predominant type of cystic
fibrosis with fibroblast cultures. Normal controls and CF-
heterozygotes could not be discriminated on an individual basis, but
as a group the CF-heterozygotes displayed higher AIP-values.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARTMAN J" publication="J PEDIATR" d1="76" d2="430" d3="970"/>
<CITE num="002" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="003" author="FARRELL PM" publication="PROC SOC EXP BIOL MED" d1="149" d2="340" d3="975"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="HICKMAN S" publication="BIOCHEM BIOPHYS RES COMMUN" d1="49" d2="992" d3="972"/>
<CITE num="006" author="HOSLI P" publication="TISSUE CULTIVATION ON PLASTIC" d1="" d2="" d3="972"/>
<CITE num="007" author="HOSLI P" publication="IN: MOTULSKY AG" d1="" d2="226" d3="974"/>
<CITE num="008" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="009" author="HOSLI P" publication="ADV EXP MED BIOL" d1="68" d2="1" d3="976"/>
<CITE num="010" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
<CITE num="011" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="013" author="HOSLI P" publication="HUM GENET" d1="41" d2="169" d3="978"/>
<CITE num="015" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="63" d2="411" d3="974"/>
<CITE num="016" author="LIGHTBODY J" publication="LANCET" d1="1" d2="451" d3="971"/>
<CITE num="017" author="MATALON R" publication="BIOCHEM BIOPHYS RES COMMUN" d1="33" d2="954" d3="968"/>
<CITE num="018" author="PALLAVICINI JC" publication="J PEDIATR" d1="77" d2="280" d3="970"/>
<CITE num="019" author="WARWICK WJ" publication="PEDIATRICS" d1="34" d2="621" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78006</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HONEY MJ            CL" publication="IN PERINATOL" d1="6" d2="55 9" d3="9"/>
<CITE num="2" author="DISANTAGNESE PA" publication="MONOGR PAEDIATR" d1="10" d2="66" d3="979"/>
<CITE num="3" author="CAREY WF" publication="AUST J EXP BIOL MED SCI" d1="57" d2="225" d3="979"/>
<CITE num="4" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="5" author="CHASE HP" publication="METABOLISM" d1="29" d2="365" d3="980"/>
<CITE num="6" author="FASTH A" publication="ACTA PAEDIATR SCAND" d1="69" d2="189" d3="980"/>
<CITE num="7" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="8" author="CEDER O" publication="ULTRASTRUCTURAL PATHOL" d1="4" d2="305" d3="983"/>
<CITE num="9" author="KHALID BAK" publication="CLIN ENDOCRINOL" d1="18" d2="407" d3="983"/>
<CITE num="10" author="CEDER O" publication="CLIN GENET" d1="23" d2="298" d3="983"/>
<CITE num="11" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="12" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
</CITATIONS>
<RECORDNUM>00787 </RECORDNUM>
<MEDLINENUM>79018052</MEDLINENUM>
<AUTHORS><AUTHOR>Katznelson-D</AUTHOR></AUTHORS>
<TITLE>Increased intracranial pressure in cystic fibrosis.</TITLE>
<SOURCE>Acta-Paediatr-Scand. 1978 Sep. 67(5). P 607-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PSEUDOTUMOR-CEREBRI: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: co, et</TOPIC><TOPIC>VENOUS-PRESSURE</TOPIC></MINORSUBJ>
<ABSTRACT>Three cystic fibrosis infants with severe respiratory distress had
increased intracranial pressure (with bulging fontanels) which
cleared parri passu with improvement in the chest condition. It is
proposed that the intracranial hypertension is a result of raised
venous pressure, itself secondary to the intrathoracic obstruction to
venous return, consequent on the bronchial obstructive disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRAY PF" publication="AM J DIS CHILD" d1="126" d2="78" d3="973"/>
<CITE num="002" author="DEES SC" publication="PEDIATRICS" d1="23" d2="1143" d3="959"/>
<CITE num="003" author="FIELDS JP" publication="J PEDIATR" d1="58" d2="74" d3="961"/>
<CITE num="004" author="JOHNSTON I" publication="BRAIN" d1="97" d2="289" d3="974"/>
<CITE num="005" author="JOHNSTON I" publication="BRAIN" d1="97" d2="301" d3="974"/>
<CITE num="006" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="007" author="MARIE J" publication="AM J DIS CHILD" d1="87" d2="731" d3="954"/>
<CITE num="008" author="SHWACHMAN H" publication="IN: KENDIG EL JR" d1="1" d2="524" d3="972"/>
<CITE num="009" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78007</PAPERNUM>
<CITATIONS>
<CITE num="1" author="USSIG LM            AC" publication="TA PAEDIATR SCAND" d1="68" d2="15 9" d3="9"/>
<CITE num="2" author="MAGAZZU G" publication="RIV ITAL PEDIATR" d1="7" d2="73" d3="981"/>
<CITE num="3" author="ROACH ES" publication="PEDIATRICS" d1="68" d2="300" d3="981"/>
<CITE num="4" author="PALMER EA" publication="J TOXICOL CUTAN OCUL TOXICOL" d1="1" d2="181" d3="982"/>
</CITATIONS>
<RECORDNUM>00788 </RECORDNUM>
<MEDLINENUM>78141570</MEDLINENUM>
<AUTHORS><AUTHOR>Matsuo-T</AUTHOR><AUTHOR>Ikeda-T</AUTHOR><AUTHOR>Mori-Y</AUTHOR><AUTHOR>Nonaka-M</AUTHOR><AUTHOR>Fujiwara-H</AUTHOR><AUTHOR>Yun-K</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis of the pancreas in a human fetus.</TITLE>
<SOURCE>Acta-Pathol-Jpn. 1978 Jan. 28(1). P 77-82.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: em</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GESTATIONAL-AGE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREAS: pa</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<ABSTRACT>Postmortem examination of a 26 week old (postmenstrual) human fetus
delivered by Cesarean section revealed meconium ileus and many
swollen mucus-secreting cells in the gastro-intestinal mucosa. The
pancreas showed extensive fibrosis, acinar destruction and dilatation
of ducts containing eosinophilic casts. Mucous glands of the lungs
also revealed mucous cells swollen and distended with their secretory
products. The patient is believed to have cystic fibrosis of the
pancreas, suggesting that the pathologic manifestations of the
disease may begin early in fetal life.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78008</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="002" author="BAUMANN T" publication="HELV PAEDIATR ACTA SUPPL 8" d1="13" d2="1" d3="958"/>
<CITE num="003" author="BOYER PH" publication="PEDIATRICS" d1="16" d2="778" d3="955"/>
<CITE num="004" author="JOHANSEN PG" publication="LANCET" d1="1" d2="455" d3="968"/>
<CITE num="005" author="KEENE MFL" publication="LANCET" d1="1" d2="767" d3="929"/>
<CITE num="006" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="007" author="MARKS BL" publication="LANCET" d1="1" d2="365" d3="960"/>
<CITE num="008" author="WARKANY J" publication="CONGENITAL MALFORMATIONS NOTE" d1="" d2="732" d3="971"/>
</REFERENCES>
<RECORDNUM>00789 </RECORDNUM>
<MEDLINENUM>78141584</MEDLINENUM>
<AUTHORS><AUTHOR>Rolla-G</AUTHOR><AUTHOR>Melsen-B</AUTHOR><AUTHOR>Sonju-T</AUTHOR></AUTHORS>
<TITLE>Is sulphated blood-group substance in pancreas a factor in cystic
fibrosis?.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [A]. 1978 Jan. 86(1). P 83-6.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-GROUPS</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GLYCOPROTEINS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>AUTORADIOGRAPHY</TOPIC><TOPIC>CALCIUM: bl</TOPIC><TOPIC>CERCOPITHECUS</TOPIC><TOPIC>MACACA-FASCICULARIS</TOPIC><TOPIC>ANTHROPOIDEA</TOPIC><TOPIC>PANCREAS: me</TOPIC><TOPIC>SULFATES: me</TOPIC></MINORSUBJ>
<ABSTRACT>The present study showed that the pancreas of two monkey species
contained sulphated blood-group substance. Such strongly anionic
molecules are known to bind calcium, and their solutions form gels in
the presence of cations. It is suggested that such a mechanism may be
involved in cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="002" author="HAUG A" publication="ACTA CHEM SCAND" d1="24" d2="843" d3="970"/>
<CITE num="003" author="KOPITO LE" publication="PEDIATR RES" d1="10" d2="742" d3="976"/>
<CITE num="004" author="LAMB D" publication="BR J DIS CHEST" d1="66" d2="239" d3="972"/>
<CITE num="005" author="LUDWIG H" publication="SCAND J IMMUNOL" d1="6" d2="724" d3="977"/>
<CITE num="006" author="ROLLA G" publication="ARCH ORAL BIOL" d1="20" d2="341" d3="975"/>
<CITE num="007" author="SMIDSROD O" publication="CHEM SOC FARADAY DISC" d1="57" d2="263" d3="974"/>
<CITE num="008" author="SZULMAN AE" publication="J EXP MED" d1="111" d2="785" d3="960"/>
<CITE num="009" author="SONJU T" publication="ACTA PATH MICROBIOL SCAND" d1="79" d2="95" d3="971"/>
<CITE num="010" author="SONJU T" publication="ARCH ORAL BIOL" d1="19" d2="897" d3="974"/>
<CITE num="011" author="SONJU T" publication="CARIES RES" d1="8" d2="113" d3="974"/>
<CITE num="012" author="SONJU T" publication="ACTA PATH MICROBIOL SCAND" d1="83" d2="215" d3="975"/>
<CITE num="013" author="WATKINS WM" publication="IN: GOTTSCHALK A" d1="" d2="830" d3="972"/>
<CITE num="014" author="WEISS A" publication="KOLLOID ZEITSCHRIFT" d1="158" d2="22" d3="958"/>
<CITE num="015" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="016" author="YOSIZAWA Z" publication="IN: GOTTSCHALK A" d1="5" d2="1000" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78009</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHALSEN H           MO" publication="NOGR PAEDIATR" d1="10" d2="48 9" d3="9"/>
</CITATIONS>
<RECORDNUM>00790 </RECORDNUM>
<MEDLINENUM>79038683</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Nielsen-H</AUTHOR><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Glikmann-G</AUTHOR><AUTHOR>Svehag-S-E</AUTHOR></AUTHORS>
<TITLE>Immune complexes in the sputum of patients with cystic fibrosis
suffering from chronic Pseudomonas aeruginosa lung infection.</TITLE>
<SOURCE>Acta-Pathol-Microbiol-Scand [C]. 1978 Feb. 86(1). P 37-40.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIGEN-ANTIBODY-COMPLEX</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PNEUMONIA: co</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co</TOPIC><TOPIC>SPUTUM: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>COMPLEMENT-FIXATION-TESTS</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGG</TOPIC><TOPIC>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PNEUMONIA: im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: im</TOPIC><TOPIC>RHEUMATOID-FACTOR</TOPIC></MINORSUBJ>
<ABSTRACT>12 cystic fibrosis (CF) patients chronically infected with mucoid P.
aeruginosa and presenting multiple precipitins in serum against this
bacterium and 12 patients without P. aeruginosa infection were
examined for occurrence of soluble immune complexes in their sputum
sol phase by a complement consumption assay and a solid phase
rheumatoid factor binding assay. The correlation between the results
obtained in the two assays was significant (r = 0.625, p less than
0.01). The patients chronically infected with P. aeruginosa showed a
significantly (p less than 0.01) higher frequency of immune complex
activity in their sputum sol phase, as compared to the patients
without P. aeruginosa lung infection. These findings point to the
possibility that chronic lung infection with mucoid P. aeruginosa in
CF may be an immune complex disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="002" author="COCHRANE CG" publication="IN: ZWEIFACH BW" d1="3" d2="85" d3="974"/>
<CITE num="003" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="004" author="GALLIN JI" publication="IN: KIRKPATRICK CH" d1="" d2="161" d3="976"/>
<CITE num="005" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="HIRSCHHORN R" publication="IN: ZWEIFACH BW" d1="1" d2="259" d3="974"/>
<CITE num="008" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="009" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="010" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="011" author="HOIBY N" publication="ACTA PAEDIATR SCAND" d1="63" d2="843" d3="974"/>
<CITE num="012" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="433" d3="975"/>
<CITE num="013" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="459" d3="975"/>
<CITE num="014" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="015" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="016" author="LEBER PD" publication="IN: ZWEIFACH BW" d1="3" d2="401" d3="974"/>
<CITE num="017" author="NIELSEN H" publication="ACTA PATH MICROBIOL SCAND (C)" d1="84" d2="261" d3="976"/>
<CITE num="018" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="469" d3="975"/>
<CITE num="019" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="85" d2="57" d3="977"/>
<CITE num="020" author="STALENHEIM G" publication="IMMUNOCHEMISTRY" d1="10" d2="501" d3="973"/>
<CITE num="021" author="THORELL JI" publication="BIOCHIM BIOPHYS ACTA" d1="251" d2="363" d3="971"/>
<CITE num="022" author="THUESEN-PEDERSEN J" publication="DAN MED BULL" d1="21" d2="12" d3="974"/>
<CITE num="023" author="TURK JL" publication="BOLL IST SIEROTER MILAN SUPPL" d1="53" d2="208" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78010</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            MO" publication="NOGR PAEDIATR" d1="10" d2="31 9" d3="9"/>
<CITE num="2" author="STRAUSS RG" publication="HELV PAEDIATR ACTA" d1="34" d2="429" d3="979"/>
<CITE num="3" author="HOIBY N" publication="ACTA PAEDIATR SCAND" d1="68" d2="495" d3="979"/>
<CITE num="4" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="87" d2="229" d3="979"/>
<CITE num="5" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="87" d2="1" d3="979"/>
<CITE num="6" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (B)" d1="87" d2="345" d3="979"/>
<CITE num="7" author="BERDISCHEWSKY M" publication="PEDIATR RES" d1="14" d2="830" d3="980"/>
<CITE num="8" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="9" author="SKOV PS" publication="ALLERGY" d1="35" d2="23" d3="980"/>
<CITE num="10" author="MATTHEWS WJ" publication="N ENGL J MED" d1="302" d2="245" d3="980"/>
<CITE num="11" author="SORENSEN RU" publication="PEDIATR RES" d1="15" d2="14" d3="981"/>
<CITE num="12" author="CHURCH JA" publication="CHEST" d1="80" d2="405" d3="981"/>
<CITE num="13" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="14" author="DANIELE RP" publication="AM REV RESPIR DIS" d1="124" d2="738" d3="981"/>
<CITE num="15" author="PERMIN H" publication="ALLERGY" d1="37" d2="93" d3="982"/>
<CITE num="16" author="MOSS RB" publication="CLIN EXP IMMUNOL" d1="47" d2="301" d3="982"/>
<CITE num="17" author="PITCHERWILMOTT RW" publication="ARCH DIS CHILD" d1="57" d2="577" d3="982"/>
<CITE num="18" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="19" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="20" author="ANON" publication="LANCET" d1="2" d2="257" d3="983"/>
<CITE num="21" author="SCHILLER NL" publication="PEDIATR RES" d1="17" d2="747" d3="983"/>
<CITE num="22" author="DORING G" publication="INFECT IMMUN" d1="42" d2="197" d3="983"/>
<CITE num="23" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND" d1="72" d2="283" d3="983"/>
<CITE num="24" author="SPEERT DP" publication="PEDIATR RES" d1="18" d2="431" d3="984"/>
<CITE num="25" author="DORING G" publication="ACTA PATH MICROB IMMU SCA (C)" d1="92" d2="307" d3="984"/>
<CITE num="26" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="27" author="MISCHLER EH" publication="SEM RESPIR MED" d1="6" d2="271" d3="985"/>
<CITE num="28" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
<CITE num="29" author="WOODS DE" publication="J INFECT DIS" d1="151" d2="581" d3="985"/>
<CITE num="30" author="KHARAZMI A" publication="EUR J CLIN INVEST" d1="16" d2="143" d3="986"/>
<CITE num="31" author="HOIBY N" publication="ANNU REV MICROBIOL" d1="40" d2="29" d3="986"/>
<CITE num="32" author="PIEDRA P" publication="J PEDIATR" d1="108" d2="817" d3="986"/>
<CITE num="33" author="MOSS RB" publication="AM REV RESPIR DIS" d1="133" d2="648" d3="986"/>
<CITE num="34" author="DASGUPTA MK" publication="J CLIN IMMUNOL" d1="7" d2="51" d3="987"/>
</CITATIONS>
<RECORDNUM>00791 </RECORDNUM>
<MEDLINENUM>79121553</MEDLINENUM>
<AUTHORS><AUTHOR>Lebenthal-E</AUTHOR></AUTHORS>
<TITLE>Pancreatic function and disease in infancy and childhood.</TITLE>
<SOURCE>Adv-Pediatr. 1978. 25. P 223-61. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>PANCREAS: ph</TOPIC><TOPIC>PANCREATIC-DISEASES: pp</TOPIC><TOPIC>PANCREATITIS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>DIGESTION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PANCREAS: ab, en</TOPIC><TOPIC>PANCREATIC-DISEASES: dt, en</TOPIC><TOPIC>PANCREATIC-NEOPLASMS: pp</TOPIC><TOPIC>PANCREATITIS: th</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>STARCH</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<EXTRACT>Normal development of the pancreas is of great importance in the
neonate and infant.  This review evaluates the development of
exocrine pancreatic function, the hormonal control of this function,
the interrelationship of pancreatic enzymes and pancreatic adaptation
to food.  The functional changes that occur in different disease
processes of the pancreas affecting the infant will also be
discussed.  Since the treatment of pancreatic exocrine insufficiency
with orally administered pancreatic enzymes in children is often more
difficult than expected, the practical approach to enzyme treatment
will be discussed.  The morphological development and congenital
malformations of the pancreas, tumors of the pancreas, the normal
function of the exocrine pancreas, the development of the exocrine
pancreatic function, developmental aspects of amylase activity and
starch digestion, dietary adaptation of the exocrine pancreas,
pancreatic function tests, pancreatic insufficiency, cystic fibrosis,
Shwachman syndrome, isolated pancreatic enzyme deficiencies, the
treatment of exocrine pancreatic insufficiency, pancreatitis in
childhood, and the treatment of acute pancreatitis are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ABRUZZO JL" publication="ANN SURG" d1="147" d2="921" d3="958"/>
<CITE num="002" author="ADAMS JT" publication="SURGERY" d1="63" d2="877" d3="968"/>
<CITE num="003" author="AKERS DR" publication="SURGERY" d1="71" d2="817" d3="972"/>
<CITE num="004" author="ALLAN BJ" publication="ARCH BIOCHEM BIOPHYS" d1="136" d2="529" d3="970"/>
<CITE num="005" author="ANTONOWICZ I" publication="GASTROENTEROLOGY" d1="72" d2="1299" d3="977"/>
<CITE num="006" author="ANDERSON TA" publication="J LAB CLIN MED" d1="79" d2="31" d3="972"/>
<CITE num="007" author="APPEL MF" publication="ARCH SURG" d1="108" d2="63" d3="974"/>
<CITE num="008" author="AREY LB" publication="DEVELOPMENTAL ANATOMY 7TH ED" d1="" d2="" d3="965"/>
<CITE num="009" author="AURICCHIO S" publication="PEDIATRICS" d1="39" d2="853" d3="967"/>
<CITE num="010" author="AURICCHIO S" publication="PEDIATRICS" d1="35" d2="944" d3="965"/>
<CITE num="011" author="BABKIN BP" publication="SECRETORY MECHANISMS OF THE D" d1="" d2="54" d3="950"/>
<CITE num="012" author="BACHRACH WH" publication="GASTROENTEROLOGY" d1="63" d2="890" d3="972"/>
<CITE num="013" author="BALZER E" publication="Z GASTROENTEROL" d1="5" d2="239" d3="967"/>
<CITE num="014" author="BANKS PA" publication="GASTROENTEROLOGY" d1="61" d2="382" d3="971"/>
<CITE num="015" author="BARBERO GJ" publication="AM J DIS CHILD" d1="112" d2="536" d3="966"/>
<CITE num="016" author="BARBEZAT GO" publication="PEDIATRICS" d1="42" d2="77" d3="968"/>
<CITE num="017" author="BARTHOLOMEW C" publication="BR MED J" d1="1" d2="666" d3="970"/>
<CITE num="018" author="BECKER WF" publication="ANN SURG" d1="163" d2="892" d3="966"/>
<CITE num="019" author="BEN ABDELJLIL A" publication="BIOCHEM BIOPHYS RES COMMUN" d1="10" d2="112" d3="963"/>
<CITE num="020" author="BENZONANA G" publication="BIOCHIM BIOPHYS ACTA" d1="105" d2="121" d3="965"/>
<CITE num="021" author="BERK JE" publication="JAMA" d1="199" d2="98" d3="967"/>
<CITE num="022" author="BISHOP RP" publication="AM J GASTROENTEROL" d1="49" d2="112" d3="968"/>
<CITE num="023" author="BLAINEY JD" publication="CLIN SCI" d1="32" d2="377" d3="967"/>
<CITE num="024" author="BLOCK MB" publication="N ENGL J MED" d1="282" d2="380" d3="970"/>
<CITE num="025" author="BLUMENTHAL HT" publication="ANN SURG" d1="27" d2="533" d3="961"/>
<CITE num="026" author="BODIAN M" publication="ACTA PAEDIATR SCAND" d1="53" d2="282" d3="964"/>
<CITE num="027" author="BONIN A" publication="J PEDIATR" d1="83" d2="594" d3="973"/>
<CITE num="028" author="BORGSTROM B" publication="BIOCHIM BIOPHYS ACTA" d1="242" d2="509" d3="971"/>
<CITE num="029" author="BROOKS FP" publication="N ENGL J MED" d1="286" d2="300" d3="972"/>
<CITE num="030" author="BUNNELL CE" publication="J PEDIATR" d1="80" d2="465" d3="972"/>
<CITE num="031" author="CAREY MC" publication="GUT" d1="9" d2="700" d3="968"/>
<CITE num="032" author="CASTLEMAN B" publication="N ENGL J MED" d1="286" d2="1353" d3="972"/>
<CITE num="033" author="CHRISTOPHE J" publication="GUT" d1="7" d2="298" d3="966"/>
<CITE num="034" author="CHRISTOPHE J" publication="HORM METAB RES" d1="3" d2="393" d3="971"/>
<CITE num="035" author="COMFORT MW" publication="GASTROENTEROLOGY" d1="21" d2="54" d3="952"/>
<CITE num="036" author="CORNET E" publication="J CHIR (PARIS)" d1="84" d2="527" d3="962"/>
<CITE num="037" author="COTTON PB" publication="LANCET" d1="1" d2="53" d3="972"/>
<CITE num="038" author="DAGORN JC" publication="GASTROENTEROLOGY" d1="73" d2="42" d3="977"/>
<CITE num="039" author="DELACHAUME-SALEM E" publication="BIOL GASTROENTEROL" d1="2" d2="135" d3="970"/>
<CITE num="040" author="DESNUELLE P" publication="CIBA FOUND SYMP" d1="" d2="90" d3="962"/>
<CITE num="041" author="DEVIZIA B" publication="J PEDIATR" d1="86" d2="50" d3="975"/>
<CITE num="042" author="DIMAGNO EP" publication="N ENGL J MED" d1="296" d2="1318" d3="977"/>
<CITE num="043" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="15" d2="683" d3="955"/>
<CITE num="044" author="DI SANTAGNESE PA" publication="ACTA PAEDIATR SCAND" d1="63" d2="163" d3="974"/>
<CITE num="045" author="DIVINCENTI FC" publication="J TRAUMA" d1="8" d2="1004" d3="968"/>
<CITE num="046" author="DREILING DA" publication="GASTROENTEROLOGY" d1="30" d2="382" d3="956"/>
<CITE num="047" author="DOLAN RV" publication="ARCH SURG" d1="109" d2="762" d3="974"/>
<CITE num="048" author="DONOWITZ M" publication="J PEDIATR" d1="87" d2="241" d3="975"/>
<CITE num="049" author="DRUMMEY GD" publication="N ENGL J MED" d1="264" d2="85" d3="961"/>
<CITE num="050" author="ANON" publication="LANCET" d1="1" d2="205" d3="975"/>
<CITE num="051" author="ELLIOTT GB" publication="CAN J SURG" d1="11" d2="357" d3="968"/>
<CITE num="052" author="ERLANGER BF" publication="ARCH BIOCHEM BIOPHYS" d1="95" d2="271" d3="961"/>
<CITE num="053" author="FARMER RG" publication="AM J MED" d1="54" d2="161" d3="973"/>
<CITE num="054" author="FELDMAN M" publication="JAMA" d1="148" d2="893" d3="952"/>
<CITE num="055" author="FOMON SJ" publication="AM J CLIN NUTR" d1="28" d2="1299" d3="970"/>
<CITE num="056" author="FRABLE WJ" publication="CANCER" d1="27" d2="667" d3="971"/>
<CITE num="057" author="FREDRICKSON DS" publication="IN: STANBURY JB" d1="" d2="545" d3="972"/>
<CITE num="058" author="FREDRICKSON DS" publication="N ENGL J MED" d1="276" d2="34" d3="967"/>
<CITE num="059" author="FREY C" publication="PEDIATRICS" d1="32" d2="93" d3="963"/>
<CITE num="060" author="FRINGLE EM" publication="PROC R SOC MED" d1="61" d2="776" d3="968"/>
<CITE num="061" author="FRUCHT DA" publication="AM J DIS CHILD" d1="92" d2="182" d3="956"/>
<CITE num="062" author="GEOKAS MC" publication="CALIF MED" d1="117" d2="1" d3="972"/>
<CITE num="063" author="GIBBS GE" publication="PEDIATRICS" d1="5" d2="941" d3="950"/>
<CITE num="064" author="GIEDION A" publication="FORTSCHR GEB ROENTG NUKL" d1="108" d2="51" d3="968"/>
<CITE num="065" author="YOUNGS G" publication="GUT" d1="13" d2="154" d3="972"/>
<CITE num="066" author="GERATZ JD" publication="AM J PHYSIOL" d1="219" d2="705" d3="970"/>
<CITE num="067" author="GO VLW" publication="J CLIN INVEST" d1="49" d2="1558" d3="970"/>
<CITE num="068" author="GOULD BS" publication="AM J DIS CHILD" d1="91" d2="584" d3="956"/>
<CITE num="069" author="GRACES L" publication="PEDIATRICS" d1="41" d2="789" d3="968"/>
<CITE num="070" author="GRAHAM DY" publication="N ENGL J MED" d1="296" d2="1314" d3="977"/>
<CITE num="071" author="GREENBERGER NJ" publication="MEDICINE (BALTIMORE)" d1="45" d2="161" d3="966"/>
<CITE num="072" author="GROSFELD J" publication="ARCH SURG" d1="101" d2="370" d3="970"/>
<CITE num="073" author="GROSS JB" publication="AM J MED" d1="33" d2="358" d3="962"/>
<CITE num="074" author="GROSS RE" publication="SURGERY OF INFANCY AND CHILDH" d1="" d2="" d3="953"/>
<CITE num="075" author="GRYBOSKI J" publication="MAJ PROB CLIN PEDIATR" d1="13" d2="450" d3="975"/>
<CITE num="076" author="GUNDERSEN AE" publication="J PEDIATR SURG" d1="4" d2="478" d3="969"/>
<CITE num="077" author="HADORN B" publication="IN: ANDERSON CM" d1="" d2="289" d3="975"/>
<CITE num="078" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
<CITE num="079" author="HADORN B" publication="LANCET" d1="1" d2="812" d3="969"/>
<CITE num="080" author="HADORN B" publication="J PEDIATR" d1="73" d2="39" d3="968"/>
<CITE num="081" author="HAYS D" publication="ANN SURG" d1="153" d2="103" d3="961"/>
<CITE num="082" author="HENDREN WH" publication="ARCH DIS CHILD" d1="40" d2="132" d3="965"/>
<CITE num="083" author="HUDSON E" publication="ARCH INTERN MED" d1="125" d2="314" d3="970"/>
<CITE num="084" author="HONG SS" publication="AM J PHYSIOL" d1="191" d2="71" d3="957"/>
<CITE num="085" author="HOWARD JM" publication="ANN SURG" d1="165" d2="293" d3="967"/>
<CITE num="086" author="HOWARD F" publication="BR J NUTR" d1="17" d2="281" d3="963"/>
<CITE num="087" author="JACKSON CE" publication="AM J MED" d1="43" d2="727" d3="967"/>
<CITE num="088" author="JAMIESON JD" publication="J CELL BIOL" d1="34" d2="597" d3="967"/>
<CITE num="089" author="JANOWITZ HD" publication="ANN INTERN MED" d1="74" d2="444" d3="971"/>
<CITE num="090" author="JODL J" publication="ACTA PAEDIATR SCAND" d1="64" d2="619" d3="975"/>
<CITE num="091" author="JOHNSON WC" publication="ANN SURG" d1="9" d2="562" d3="970"/>
<CITE num="092" author="JORDAN SC" publication="J PEDIATR" d1="91" d2="211" d3="977"/>
<CITE num="093" author="KARJOO M" publication="ARCH DIS CHILD" d1="48" d2="143" d3="973"/>
<CITE num="094" author="KATTWINKEL J" publication="PEDIATRICS" d1="51" d2="55" d3="973"/>
<CITE num="095" author="KAWANISHI H" publication="N ENGL J MED" d1="289" d2="357" d3="973"/>
<CITE num="096" author="KEENE MFL" publication="LANCET" d1="1" d2="767" d3="929"/>
<CITE num="097" author="KELLER PJ" publication="J BIOL CHEM" d1="242" d2="281" d3="967"/>
<CITE num="098" author="KIESSWETTER WB" publication="SURGERY" d1="36" d2="146" d3="954"/>
<CITE num="099" author="KILMAN JW" publication="SURGERY" d1="55" d2="455" d3="964"/>
<CITE num="100" author="KLEIN B" publication="CLIN CHEM" d1="16" d2="32" d3="970"/>
<CITE num="101" author="KLEITSCH WP" publication="ARCH SURG" d1="71" d2="795" d3="955"/>
<CITE num="102" author="KONIJN AM" publication="AM J PHYSIOL" d1="218" d2="1113" d3="970"/>
<CITE num="103" author="KLUMPP TG" publication="AM J DIS CHILD" d1="40" d2="1215" d3="930"/>
<CITE num="104" author="KREJS GJ" publication="AM J DIG DIS" d1="22" d2="280" d3="977"/>
<CITE num="105" author="KUNITZ M" publication="J GEN PHYSIOL" d1="22" d2="429" d3="939"/>
<CITE num="106" author="LAGERLOF HO" publication="ACTA MED SCAND SUPPL" d1="128" d2="1" d3="942"/>
<CITE num="107" author="LEBENTHAL E" publication="PEDIATRICS" d1="56" d2="585" d3="975"/>
<CITE num="108" author="LEBENTHAL E" publication="GASTROENTEROLOGY" d1="70" d2="508" d3="976"/>
<CITE num="109" author="LEBENTHAL E" publication="BIOCHIM BIOPHYS ACTA" d1="497" d2="558" d3="977"/>
<CITE num="110" author="LIEBERMAN J" publication="GASTROENTEROLOGY" d1="50" d2="183" d3="966"/>
<CITE num="111" author="LIECHTY RD" publication="JAMA" d1="230" d2="1538" d3="974"/>
<CITE num="112" author="LILLIBRIDGE CB" publication="J PEDIATR" d1="82" d2="279" d3="973"/>
<CITE num="113" author="LIESTYNA JA" publication="AM J DIS CHILD" d1="107" d2="644" d3="964"/>
<CITE num="114" author="LIEBOW C" publication="SCIENCE" d1="189" d2="472" d3="975"/>
<CITE num="115" author="LIFTON LJ" publication="JAMA" d1="229" d2="47" d3="974"/>
<CITE num="116" author="LINDBERG T" publication="ACTA PAEDIATR SCAND" d1="63" d2="805" d3="974"/>
<CITE num="117" author="LONG WB" publication="GASTROENTEROLOGY" d1="71" d2="589" d3="976"/>
<CITE num="118" author="LOUVARD D" publication="BIOCHIM BIOPHYS ACTA" d1="309" d2="127" d3="973"/>
<CITE num="119" author="LOWE CU" publication="AM J DIS CHILD" d1="82" d2="459" d3="951"/>
<CITE num="120" author="LUNDH G" publication="GASTROENTEROLOGY" d1="42" d2="275" d3="962"/>
<CITE num="121" author="LYMAN RL" publication="J NUTR" d1="79" d2="28" d3="963"/>
<CITE num="122" author="MACGREGOR IL" publication="GASTROENTEROLOGY" d1="72" d2="195" d3="977"/>
<CITE num="123" author="MALAISSE-LAGAE F" publication="SCIENCE" d1="190" d2="795" d3="975"/>
<CITE num="124" author="MALLARD RE" publication="J PEDIATR" d1="91" d2="445" d3="977"/>
<CITE num="125" author="MALONE JI" publication="J PEDIATR" d1="85" d2="825" d3="974"/>
<CITE num="126" author="MARCHIS-MOUREN G" publication="ARCH BIOCHEM BIOPHYS" d1="83" d2="309" d3="959"/>
<CITE num="127" author="MARDH PA" publication="BR MED J" d1="2" d2="240" d3="973"/>
<CITE num="128" author="MARTIN DU PAN R" publication="INT Z VITAMINFORSCH" d1="1" d2="67" d3="971"/>
<CITE num="129" author="MARTINEZ W" publication="ANN SURG" d1="147" d2="1" d3="958"/>
<CITE num="130" author="MATSUMOTO Y" publication="SURGERY" d1="76" d2="827" d3="974"/>
<CITE num="131" author="MCELROY R" publication="AM J MED" d1="52" d2="228" d3="972"/>
<CITE num="132" author="MOORE JG" publication="AM J DIG DIS" d1="16" d2="97" d3="971"/>
<CITE num="133" author="MORENS DM" publication="AM J DIS CHILD" d1="128" d2="401" d3="974"/>
<CITE num="134" author="MOYNAN RW" publication="J PEDIATR" d1="65" d2="711" d3="964"/>
<CITE num="135" author="NAGEL W" publication="PHYSIOL CHEM" d1="340" d2="1" d3="965"/>
<CITE num="136" author="NEELEY WA" publication="ANN SURG" d1="173" d2="657" d3="971"/>
<CITE num="137" author="NORDSTROM C" publication="BIOCHIM BIOPHYS ACTA" d1="242" d2="209" d3="971"/>
<CITE num="138" author="NORMAN A" publication="ACTA PAEDIATR SCAND" d1="61" d2="571" d3="972"/>
<CITE num="139" author="NORTHRUP WF" publication="SURGERY" d1="71" d2="27" d3="972"/>
<CITE num="140" author="OTHERSON HB" publication="J TRAUMA" d1="8" d2="535" d3="968"/>
<CITE num="141" author="PALADE GE" publication="IN: DE REUCK AVS" d1="" d2="" d3="962"/>
<CITE num="142" author="PALADE GE" publication="SCIENCE" d1="189" d2="347" d3="975"/>
<CITE num="143" author="PATTEN BM" publication="HUMAN EMBRYOLOGY" d1="" d2="" d3="968"/>
<CITE num="144" author="PAVLOV JP" publication="ARBEIT DER VERDEUUNGSDRUS" d1="" d2="48" d3="898"/>
<CITE num="145" author="PERRIER CV" publication="GASTROENTEROLOGY" d1="44" d2="493" d3="963"/>
<CITE num="146" author="PETERSEN H" publication="SCAND J GASTROENTEROL" d1="5" d2="555" d3="970"/>
<CITE num="147" author="PRATT CB" publication="J PEDIATR" d1="77" d2="474" d3="970"/>
<CITE num="148" author="REETSMA K" publication="SURGERY" d1="42" d2="22" d3="957"/>
<CITE num="149" author="REGAN PT" publication="GASTROENTEROLOGY" d1="72" d2="A95" d3="977"/>
<CITE num="150" author="RICKHAM PP" publication="ARCH DIS CHILD" d1="29" d2="80" d3="954"/>
<CITE num="151" author="RICOUR C" publication="ACTA PAEDIATR SCAND" d1="63" d2="168" d3="974"/>
<CITE num="152" author="RIEMENSCHNEIDER TA" publication="PEDIATRICS" d1="41" d2="428" d3="968"/>
<CITE num="153" author="ROBINSON MJ" publication="PEDIATRICS" d1="48" d2="232" d3="971"/>
<CITE num="154" author="ROSSI E" publication="HELV PAEDIATR ACTA" d1="8" d2="530" d3="953"/>
<CITE num="155" author="ROTHMAN SS" publication="NATURE" d1="213" d2="460" d3="967"/>
<CITE num="156" author="ROTHMAN SS" publication="AM J PHYSIOL" d1="217" d2="504" d3="969"/>
<CITE num="157" author="ROTHMAN SS" publication="SCIENCE" d1="190" d2="747" d3="975"/>
<CITE num="158" author="SAID SI" publication="N ENGL J MED" d1="293" d2="155" d3="975"/>
<CITE num="159" author="SALMAN AJ" publication="PROC SOC EXP BIOL MED" d1="126" d2="694" d3="967"/>
<CITE num="160" author="SAUNDERS JHB" publication="BR MED J" d1="1" d2="418" d3="977"/>
<CITE num="161" author="SCHMIDT H" publication="CLIN ORTHOP" d1="69" d2="135" d3="970"/>
<CITE num="162" author="SHANKLIN DR" publication="N ENGL J MED" d1="266" d2="1097" d3="962"/>
<CITE num="163" author="SHELDON W" publication="ARCH DIS CHILD" d1="39" d2="268" d3="964"/>
<CITE num="164" author="SHMERLING DH" publication="HELV PAEDIATR ACTA" d1="24" d2="547" d3="969"/>
<CITE num="165" author="SHWACHMAN H" publication="J PEDIATR" d1="63" d2="835" d3="963"/>
<CITE num="166" author="SHWACHMAN H" publication="J PEDIATR" d1="65" d2="645" d3="964"/>
<CITE num="167" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="92" d2="347" d3="956"/>
<CITE num="168" author="SHWACHMAN H" publication="IN: SLEISENGER MH" d1="" d2="1206" d3="973"/>
<CITE num="169" author="SHWACHMAN H" publication="BIRTH DEF ORIG ART SER" d1="8" d2="46" d3="972"/>
<CITE num="170" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="171" author="SHWACHMAN H" publication="ADV PEDIATR" d1="7" d2="249" d3="955"/>
<CITE num="172" author="SIBERT JR" publication="GUT" d1="16" d2="81" d3="975"/>
<CITE num="173" author="SIBERT JR" publication="GUT" d1="16" d2="81" d3="975"/>
<CITE num="174" author="SIBERT JR" publication="ARCH DIS CHILD" d1="50" d2="443" d3="975"/>
<CITE num="175" author="SKUDE G" publication="ACTA PAEDIATR SCAND" d1="65" d2="145" d3="976"/>
<CITE num="176" author="SNOOK JT" publication="J NUTR" d1="87" d2="297" d3="965"/>
<CITE num="177" author="SNOOK JT" publication="AM J PHYSIOL" d1="221" d2="1383" d3="971"/>
<CITE num="178" author="SOLOMON AK" publication="FED PROC" d1="11" d2="722" d3="952"/>
<CITE num="179" author="STOVER SL" publication="J PEDIATR" d1="73" d2="235" d3="968"/>
<CITE num="180" author="SWAN DC" publication="LANCET" d1="1" d2="60" d3="966"/>
<CITE num="181" author="TACHIBANA T" publication="JAPAN J OBSTET GYNECOL" d1="10" d2="27" d3="927"/>
<CITE num="182" author="TACHIBANA T" publication="JAPAN J OBSTET GYNECOL" d1="10" d2="40" d3="927"/>
<CITE num="183" author="TACHIBANA T" publication="JAPAN J OBSTET GYNECOL" d1="11" d2="92" d3="928"/>
<CITE num="184" author="TAUSSIG LM" publication="PEDIATRICS" d1="54" d2="229" d3="974"/>
<CITE num="185" author="THEODORIDES T" publication="J CHIR (PARIS)" d1="87" d2="445" d3="964"/>
<CITE num="186" author="UDALL JN" publication="J PEDIATR" d1="88" d2="819" d3="976"/>
<CITE num="187" author="URSING B" publication="BR MED J" d1="3" d2="524" d3="973"/>
<CITE num="188" author="WALTERS RL" publication="AM J SURG" d1="3" d2="364" d3="966"/>
<CITE num="189" author="WARSHAW AL" publication="N ENGL J MED" d1="292" d2="325" d3="975"/>
<CITE num="190" author="WEIJERS HA" publication="ACTA PAEDIATR SCAND" d1="42" d2="24" d3="953"/>
<CITE num="191" author="WELCH KJ" publication="TRAUMATIC LESIONS OF ABDOMEN" d1="6" d2="" d3="962"/>
<CITE num="192" author="WEITZMAN JJ" publication="SURGERY" d1="57" d2="309" d3="965"/>
<CITE num="193" author="WERNER B" publication="ACTA PAEDIATR SCAND SUPPL 6" d1="35" d2="1" d3="948"/>
<CITE num="194" author="WHALEN J" publication="AM J SURG" d1="121" d2="16" d3="971"/>
<CITE num="195" author="WHITE TT" publication="AM J SURG" d1="129" d2="132" d3="970"/>
<CITE num="196" author="WITTE CL" publication="JAMA" d1="203" d2="1068" d3="968"/>
<CITE num="197" author="WOLF RO" publication="OBSTET GYNECOL" d1="41" d2="337" d3="973"/>
<CITE num="198" author="WOODLEY JF" publication="GUT" d1="13" d2="900" d3="972"/>
<CITE num="199" author="WORMSLEY KG" publication="GASTROENTEROLOGY" d1="1" d2="27" d3="972"/>
<CITE num="200" author="WORMSLEY KG" publication="GUT" d1="13" d2="398" d3="972"/>
<CITE num="201" author="WORNING H" publication="SCAND J GASTROENTEROL" d1="1" d2="268" d3="966"/>
<CITE num="202" author="WRIGHT E" publication="SURGERY" d1="69" d2="389" d3="971"/>
<CITE num="203" author="ZOPPI G" publication="ACTA PAEDIATR SCAND" d1="59" d2="692" d3="970"/>
<CITE num="204" author="ZOPPI G" publication="PEDIATR RES" d1="6" d2="880" d3="972"/>
<CITE num="205" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78011</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BENTHAL E           PE" publication="DIATR RES" d1="14" d2="56 9" d3="0"/>
<CITE num="2" author="LEBENTHAL E" publication="J PEDIATR" d1="97" d2="389" d3="980"/>
<CITE num="3" author="LEBENTHAL E" publication="PEDIATR RES" d1="15" d2="1240" d3="981"/>
<CITE num="4" author="CARREL O" publication="HELV PAEDIATR ACTA" d1="36" d2="405" d3="981"/>
<CITE num="5" author="LEBENTHAL E" publication="AM J GASTROENTEROL" d1="75" d2="436" d3="981"/>
<CITE num="6" author="ANON" publication="J AM DIET ASSOC" d1="78" d2="443" d3="981"/>
<CITE num="7" author="ANDERSEN DW" publication="PEDIATR RES" d1="16" d2="304" d3="982"/>
<CITE num="8" author="BOWLING SA" publication="AM J MED TECHNOLOGY" d1="48" d2="25" d3="982"/>
<CITE num="9" author="RANDOLPH VS" publication="AM J MED TECHNOLOGY" d1="48" d2="15" d3="982"/>
<CITE num="10" author="ADRIAENSSENS K" publication="ARCH DIS CHILD" d1="57" d2="553" d3="982"/>
<CITE num="11" author="LONGNECKER DS" publication="AM J PATHOL" d1="107" d2="103" d3="982"/>
<CITE num="12" author="SVENDSEN LS" publication="ACTA VET SCAND SUPPL 78" d1="1982" d2="1" d3="982"/>
<CITE num="13" author="LEBENTHAL E" publication="J PEDIATR" d1="102" d2="1" d3="983"/>
<CITE num="14" author="ANDERSEN DW" publication="J NUTR" d1="113" d2="430" d3="983"/>
<CITE num="15" author="COURTOIS P" publication="ANN BIOL CLIN" d1="43" d2="127" d3="985"/>
<CITE num="16" author="STEGINK LD" publication="METABOLISM" d1="35" d2="519" d3="986"/>
<CITE num="17" author="ANDERSEN DW" publication="J NUTR" d1="117" d2="274" d3="987"/>
</CITATIONS>
<RECORDNUM>00792 </RECORDNUM>
<MEDLINENUM>79038961</MEDLINENUM>
<AUTHORS><AUTHOR>Griscom-N-T</AUTHOR></AUTHORS>
<TITLE>Total body opacification.</TITLE>
<SOURCE>AJR. 1978 Nov. 131(5). P 919-25. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>IODIZED-OILS: du</TOPIC><TOPIC>RADIOGRAPHY: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ABSCESS: ra</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ASCITES: ra</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMMON-BILE-DUCT: ab</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>CYSTS: ra</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: ra</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: cn, ra</TOPIC><TOPIC>IODIZED-OILS: ad, ae</TOPIC><TOPIC>LIVER-DISEASES: ra</TOPIC><TOPIC>DIATRIZOATE-MEGLUMINE: du</TOPIC><TOPIC>RADIOGRAPHY: ae</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>TECHNOLOGY-RADIOLOGIC</TOPIC><TOPIC>URETERAL-OBSTRUCTION: ra</TOPIC></MINORSUBJ>
<ABSTRACT>Total body opacification is the phenomenon whereby introduction of
iodinated contrast material into the blood stream renders structures
differentially radiopaque according to their blood supply.  The term
implies the physiology: it is the whole body which is opacified, in
proportion to the iodine in its plasma and extravascular
extracellular fluid at the time of the radiograph.  To the density
inherent in the tissue before injection is added the opacity of the
iodine circulating through and transuding into it.  Just as tissues,
even those of "water density," have minor intrinsic differences in
x-ray absorption, so they may also have minor differences in blood
flow and transudation into the extracellular fluid; the combination
of these minor differences often makes the invisible visible.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALFIDI R" publication="AM J ROENTG RAD THER NUCL MED" d1="124" d2="199" d3="975"/>
<CITE num="002" author="NEW PFJ" publication="RADIOLOGY" d1="110" d2="109" d3="974"/>
<CITE num="003" author="MATEGRANO VC" publication="RADIOLOGY" d1="125" d2="135" d3="977"/>
<CITE num="004" author="BIRNHOLZ JC" publication="RADIOLOGY" d1="105" d2="303" d3="972"/>
<CITE num="005" author="PHILLIPS JC" publication="RADIOLOGY" d1="112" d2="17" d3="974"/>
<CITE num="006" author="IMRAY TJ" publication="AM J ROENTG RAD THER NUCL MED" d1="125" d2="60" d3="975"/>
<CITE num="007" author="WIRTANEN GW" publication="RADIOLOGY" d1="108" d2="51" d3="973"/>
<CITE num="008" author="HEGEDUS V" publication="INVEST RADIOL" d1="9" d2="56" d3="974"/>
<CITE num="009" author="KORMANO M" publication="RADIOLOGY" d1="121" d2="379" d3="976"/>
<CITE num="010" author="GOODING CA" publication="RADIOLOGY" d1="102" d2="77" d3="972"/>
<CITE num="011" author="MESSINA AV" publication="RADIOLOGY" d1="120" d2="345" d3="976"/>
<CITE num="012" author="SHANSER JD" publication="RADIOL SOC NORTH AM ANNU MTG" d1="" d2="" d3="977"/>
<CITE num="013" author="LACHMAN RS" publication="PEDIATR RADIOL" d1="3" d2="117" d3="975"/>
<CITE num="014" author="YOUNG LW" publication="ANN RADIOL (PARIS)" d1="17" d2="391" d3="974"/>
<CITE num="015" author="MONCADA R" publication="AM J ROENTGENOL" d1="129" d2="583" d3="977"/>
<CITE num="016" author="MARTIN DJ" publication="BR J RADIOL" d1="45" d2="185" d3="972"/>
<CITE num="017" author="EFFMANN EL" publication="RADIOL SOC NORTH AM ANNU MTG" d1="" d2="" d3="975"/>
<CITE num="018" author="GRISCOM NT" publication="AM J ROENTG RAD THER NUCL MED" d1="93" d2="447" d3="965"/>
<CITE num="019" author="RABINOWITZ JG" publication="J CAN ASSOC RADIOL" d1="24" d2="226" d3="973"/>
<CITE num="020" author="FELLOWS KE" publication="RADIOL CLIN NORTH AM" d1="10" d2="349" d3="972"/>
<CITE num="021" author="ROSENFIELD N" publication="RADIOLOGY" d1="114" d2="113" d3="975"/>
<CITE num="022" author="KURLANDER GJ" publication="RADIOLOGY" d1="89" d2="1075" d3="967"/>
<CITE num="023" author="BERDON WE" publication="AM J ROENTG RAD THER NUCL MED" d1="118" d2="18" d3="973"/>
<CITE num="024" author="ROBINSON AE" publication="RADIOLOGY" d1="122" d2="749" d3="977"/>
<CITE num="025" author="ANON" publication="N ENGL J MED" d1="295" d2="608" d3="976"/>
<CITE num="026" author="CROWE JE" publication="AM J ROENTGENOL" d1="130" d2="167" d3="978"/>
<CITE num="027" author="LEAPE LL" publication="PEDIATRICS" d1="47" d2="101" d3="971"/>
<CITE num="028" author="MEYERS MA" publication="RADIOLOGY" d1="117" d2="539" d3="975"/>
<CITE num="029" author="GENEREUX GP" publication="J CAN ASSOC RADIOL" d1="21" d2="242" d3="970"/>
<CITE num="030" author="MONCADA R" publication="AM J ROENTGENOL" d1="129" d2="583" d3="977"/>
<CITE num="031" author="MORIN ME" publication="RADIOLOGY" d1="121" d2="307" d3="976"/>
<CITE num="032" author="BALIKIAN JP" publication="AM J ROENTG RAD THER NUCL MED" d1="122" d2="692" d3="974"/>
<CITE num="033" author="HATFIELD PM" publication="AM J ROENTG RAD THER NUCL MED" d1="119" d2="687" d3="973"/>
<CITE num="034" author="LOVE L" publication="AM J ROENTG RAD THER NUCL MED" d1="122" d2="299" d3="974"/>
<CITE num="035" author="LILIENFELD RM" publication="J UROL" d1="115" d2="123" d3="976"/>
<CITE num="036" author="MITTY HA" publication="AM J ROENTG RAD THER NUCL MED" d1="115" d2="630" d3="972"/>
<CITE num="037" author="SMITH AM" publication="AM J ROENTG RAD THER NUCL MED" d1="104" d2="389" d3="968"/>
<CITE num="038" author="KURTI DJ" publication="AM J ROENTG RAD THER NUCL MED" d1="119" d2="576" d3="973"/>
<CITE num="039" author="RABUSHKA SE" publication="RADIOLOGY" d1="109" d2="549" d3="973"/>
<CITE num="040" author="MORGAN H" publication="RADIOLOGY" d1="97" d2="301" d3="970"/>
<CITE num="041" author="BRILL PW" publication="AM J ROENTGENOL" d1="127" d2="289" d3="976"/>
<CITE num="042" author="STANLEY P" publication="PEDIATR RADIOL" d1="5" d2="58" d3="976"/>
<CITE num="043" author="BALSYS R" publication="INVEST RADIOL ABSTR" d1="12" d2="393" d3="977"/>
<CITE num="044" author="BARBARIC ZL" publication="RADIOLOGY" d1="123" d2="587" d3="977"/>
<CITE num="045" author="BENTON C" publication="RADIOLOGY" d1="104" d2="61" d3="972"/>
<CITE num="046" author="GRISCOM NT" publication="J PEDIATR SURG" d1="1" d2="76" d3="966"/>
<CITE num="047" author="DUNBAR JS" publication="RADIOL CLIN NORTH AM" d1="10" d2="367" d3="972"/>
<CITE num="048" author="WITTEN DM" publication="AM J ROENTG RAD THER NUCL MED" d1="119" d2="832" d3="973"/>
<CITE num="049" author="MARTIN DJ" publication="RADIOL CLIN NORTH AM" d1="13" d2="359" d3="975"/>
<CITE num="050" author="TALNER LB" publication="CONTRIB NEPHROL" d1="5" d2="3" d3="977"/>
<CITE num="051" author="STANDEN JR" publication="AM J ROENTG RAD THER NUCL MED" d1="93" d2="473" d3="965"/>
<CITE num="052" author="ANSELL G" publication="BR J RADIOL" d1="43" d2="395" d3="970"/>
<CITE num="053" author="DOUST BD" publication="RADIOLOGY" d1="104" d2="557" d3="972"/>
<CITE num="054" author="MOREAU JF" publication="RADIOLOGY" d1="115" d2="329" d3="975"/>
<CITE num="055" author="ELKIN M" publication="RADIOLOGY" d1="116" d2="259" d3="975"/>
<CITE num="056" author="DUNBAR JS" publication="AM J ROENTG RAD THER NUCL MED" d1="110" d2="520" d3="970"/>
<CITE num="057" author="GRISCOM NT" publication="RADIOLOGY" d1="106" d2="385" d3="973"/>
<CITE num="058" author="OCONNOR JF" publication="AM J ROENTG RAD THER NUCL MED" d1="90" d2="63" d3="963"/>
<CITE num="059" author="HOLT JF" publication="YEARBOOK OF RADIOLOGY" d1="" d2="" d3="965"/>
<CITE num="060" author="GOODING CA" publication="AM J ROENTG RAD THER NUCL MED" d1="123" d2="802" d3="975"/>
<CITE num="061" author="MCALISTER W" publication="SOC PEDIATR RADIOL ANNU MTG" d1="" d2="" d3="978"/>
<CITE num="062" author="BORRA S" publication="N ENGL J MED" d1="284" d2="592" d3="971"/>
<CITE num="063" author="BERGMAN LA" publication="N ENGL J MED" d1="279" d2="1277" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78012</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EMIN BJ             AM" publication="J ROENTGENOL                1" d1="32" d2="57 9" d3="9"/>
<CITE num="2" author="MAHMUD F" publication="AM J ROENTGENOL" d1="133" d2="1180" d3="979"/>
<CITE num="3" author="DEAN PB" publication="INVEST RADIOL" d1="15" d2="S164" d3="980"/>
<CITE num="4" author="AUSTIN RM" publication="CLIN RADIOL" d1="31" d2="697" d3="980"/>
<CITE num="5" author="KATZBERG RW" publication="RADIOLOGY" d1="134" d2="297" d3="980"/>
<CITE num="6" author="MORIN ME" publication="CRC CRIT REV DIAGN IMAGING" d1="15" d2="237" d3="981"/>
<CITE num="7" author="NEWHOUSE JH" publication="AM J ROENTGENOL" d1="136" d2="463" d3="981"/>
<CITE num="8" author="AXIOTIS CA" publication="J CLIN GASTROENTEROL" d1="5" d2="541" d3="983"/>
<CITE num="9" author="MINDELZUN RE" publication="SEM ROENTGENOL" d1="19" d2="259" d3="984"/>
</CITATIONS>
<RECORDNUM>00793 </RECORDNUM>
<MEDLINENUM>78253890</MEDLINENUM>
<AUTHORS><AUTHOR>Strauss-A</AUTHOR><AUTHOR>Mendes-E</AUTHOR></AUTHORS>
<TITLE>Exocrine disorder in asthmatics: demonstration of high sweat
chloride levels in chronic patients and their relatives.</TITLE>
<SOURCE>Allergol-Immunopathol (Madr). 1978 Jan-Feb. 6(1). P 19-24.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: pp</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ASTHMA: et, fg</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>RESPIRATORY-HYPERSENSITIVITY: et</TOPIC></MINORSUBJ>
<ABSTRACT>In 87 patients with svere chronic asthma, the sweat chloride (Cl)
level was determined, and increased concentrations were found in 12
(13.7%).  In 76% of the relatives of these patients increased sweat
Cl levels were also found.  The authors give data of their clinical
and allergy study and conclude that 13.7% of the patients under
investigation had clinical characteristics of asthma, allergy and a
functional exocrine disorder.  The exocrinopathy may be an important
factor in the pathophysiology of certain types of asthma.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78013</PAPERNUM>
<REFERENCES>
<CITE num="001" author="CAPLIN I" publication="ANN ALLERGY" d1="31" d2="320" d3="973"/>
<CITE num="002" author="ANON" publication="IN: PORTER R" d1="38" d2="174" d3="971"/>
<CITE num="003" author="COUNAHAN R" publication="ARCH DIS CHILD" d1="50" d2="477" d3="975"/>
<CITE num="004" author="FIGUEIRA F" publication="REV PAUL MED" d1="51" d2="99" d3="967"/>
<CITE num="005" author="KOPITO L" publication="PEDIATRICS" d1="43" d2="794" d3="969"/>
<CITE num="006" author="MEARNS MB" publication="LANCET" d1="1" d2="538" d3="967"/>
<CITE num="007" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="008" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="009" author="STRAUSS A" publication="J PEDIATR RIO DE JANEIRO" d1="35" d2="12" d3="970"/>
<CITE num="010" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="011" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>
<RECORDNUM>00794 </RECORDNUM>
<MEDLINENUM>78142110</MEDLINENUM>
<AUTHORS><AUTHOR>Jacob-R-A</AUTHOR><AUTHOR>Sandstead-H-H</AUTHOR><AUTHOR>Solomons-N-W</AUTHOR><AUTHOR>Rieger-C</AUTHOR><AUTHOR>Rothberg-R</AUTHOR></AUTHORS>
<TITLE>Zinc status and vitamin A transport in cystic fibrosis.</TITLE>
<SOURCE>Am-J-Clin-Nutr. 1978 Apr. 31(4). P 638-44.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>VITAMIN-A: me</TOPIC><TOPIC>ZINC: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>HAIR: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RETINOL-BINDING-PROTEINS: bl</TOPIC><TOPIC>SERUM-ALBUMIN: me</TOPIC></MINORSUBJ>
<ABSTRACT>Zinc status and the retinol transport system were examined in 18
retinol supplemented cystic fibrosis (CF) patients and 40 age-matched
controls. Plasma vitamin A was significantly lower in the CF group as
compared to the controls and correlated positively with plasma
retinol-binding protein (RBP) in both the CF and control groups.
Plasma zinc of the CF group was not significantly lower than controls
whereas hair zinc was. Plasma zinc was positively correlated with
plasma RBP, vitamin A, and albumin in the CF group but not in the
controls. Plasma concentrations of vitamin A, RBP, albumin, and zinc
decreased with age in the CF group but not in the controls. The data
support previous suggestions that low plasma vitamin A levels in CF
are due to defects in the retinol transport system. The zinc status
of the CF groups as a whole was judged to be low-normal however a
subgroup of CF patients were in the marginal to deficient category.
This subgroup also had lower levels of plasma vitamin A and RBP. The
data suggest that zinc may be a contributing factor in the low plasma
vitamin A/RBP levels of CF patients with marginal or deficient zinc
status.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="J PEDIATR" d1="15" d2="763" d3="939"/>
<CITE num="002" author="KANAI MA" publication="J CLIN INVEST" d1="47" d2="2025" d3="968"/>
<CITE num="003" author="SMITH FR" publication="J CLIN INVEST" d1="49" d2="1754" d3="970"/>
<CITE num="004" author="UNDERWOOD BA" publication="PEDIATR RES" d1="6" d2="26" d3="972"/>
<CITE num="005" author="SMITH FR" publication="J LAB CLIN MED" d1="80" d2="423" d3="972"/>
<CITE num="006" author="SMITH JC JR" publication="SCIENCE" d1="181" d2="954" d3="973"/>
<CITE num="007" author="SMITH JE" publication="J LAB CLIN MED" d1="84" d2="692" d3="974"/>
<CITE num="008" author="HALSTED JA" publication="LANCET" d1="1" d2="322" d3="970"/>
<CITE num="009" author="BROWN ED" publication="J NUTR" d1="106" d2="563" d3="976"/>
<CITE num="010" author="SMITH JC JR" publication="J NUTR" d1="106" d2="569" d3="976"/>
<CITE num="011" author="HUBER AM" publication="J NUTR" d1="105" d2="1486" d3="975"/>
<CITE num="012" author="CARNEY SM" publication="J NUTR" d1="106" d2="1773" d3="976"/>
<CITE num="013" author="SINHA SN" publication="AM J CLIN PATHOL" d1="54" d2="570" d3="970"/>
<CITE num="014" author="NEELD JB" publication="J NUTR" d1="79" d2="454" d3="963"/>
<CITE num="015" author="KLEVAY LM" publication="AM J CLIN NUTR" d1="23" d2="284" d3="970"/>
<CITE num="016" author="PALIN HD" publication="PEDIATR RES ABST 343" d1="10" d2="358" d3="976"/>
<CITE num="017" author="KNOEPFLE G" publication="Z KINDERHEILK" d1="119" d2="279" d3="975"/>
<CITE num="018" author="HENKIN RI" publication="AM J MED SCI" d1="264" d2="401" d3="972"/>
<CITE num="019" author="KIRCHGESSNER M" publication="IN: PRASAD AS" d1="1" d2="189" d3="976"/>
<CITE num="020" author="MORRISON SA" publication="AM J CLIN NUTR" d1="30" d2="612" d3="977"/>
<CITE num="021" author="BEISEL WR" publication="ANN INTERN MED" d1="67" d2="744" d3="967"/>
<CITE num="022" author="PEKAREK RS" publication="PROC SOC EXP BIOL MED" d1="138" d2="728" d3="971"/>
<CITE num="023" author="SANDSTEAD HH" publication="IN: PRASAD AS" d1="" d2="33" d3="976"/>
<CITE num="024" author="BEISEL WR" publication="IN: PRASAD AS" d1="1" d2="87" d3="976"/>
<CITE num="025" author="HALSTED JA" publication="GASTROENTEROLOGY" d1="67" d2="193" d3="974"/>
<CITE num="026" author="MUTO Y" publication="J BIOL CHEM" d1="247" d2="2542" d3="972"/>
<CITE num="027" author="SMITH FR" publication="AM J CLIN NUTR" d1="26" d2="973" d3="973"/>
<CITE num="028" author="SMITH FR" publication="AM J CLIN NUTR" d1="26" d2="982" d3="973"/>
<CITE num="029" author="SMITH FR" publication="J CLIN INVEST" d1="50" d2="2426" d3="971"/>
<CITE num="030" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="031" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="032" author="STERLING K" publication="J CLIN INVEST" d1="30" d2="1238" d3="951"/>
<CITE num="033" author="PITTMAN FE" publication="AM J DIS CHILD" d1="108" d2="360" d3="964"/>
<CITE num="034" author="STROBER W" publication="PEDIATRICS" d1="43" d2="416" d3="969"/>
<CITE num="035" author="GIROUX EL" publication="BIOINORG CHEM" d1="5" d2="211" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78014</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LIN D               AM" publication="J CLIN NUTR" d1="32" d2="53 9" d3="9"/>
<CITE num="2" author="PEKAREK RS" publication="AM J CLIN NUTR" d1="32" d2="1466" d3="979"/>
<CITE num="3" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="32" d2="856" d3="979"/>
<CITE num="4" author="ATUKORALA S" publication="BR J CANCER" d1="40" d2="927" d3="979"/>
<CITE num="5" author="CHASE HP" publication="J PEDIATR" d1="95" d2="337" d3="979"/>
<CITE num="6" author="CASPER RC" publication="AM J CLIN NUTR" d1="33" d2="1801" d3="980"/>
<CITE num="7" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="33" d2="2031" d3="980"/>
<CITE num="8" author="MAGAZZU G" publication="RIV ITAL PEDIATR" d1="7" d2="73" d3="981"/>
<CITE num="9" author="ANDREWS WS" publication="J PEDIATR SURG" d1="16" d2="284" d3="981"/>
<CITE num="10" author="HOOPER PL" publication="AM J CLIN NUTR" d1="34" d2="970" d3="981"/>
<CITE num="11" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="12" author="GORDON EF" publication="J PEDIATR" d1="99" d2="341" d3="981"/>
<CITE num="13" author="HANSEN MA" publication="ANNU REV NUTRITION" d1="2" d2="151" d3="982"/>
<CITE num="14" author="MIKHAIL MM" publication="EUR J CLIN INVEST" d1="12" d2="345" d3="982"/>
<CITE num="15" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="35" d2="1048" d3="982"/>
<CITE num="16" author="SOLOMONS NW" publication="J AM DIET ASSOC" d1="80" d2="115" d3="982"/>
<CITE num="17" author="DELUCA F" publication="EUR J PEDIATR" d1="138" d2="327" d3="982"/>
<CITE num="18" author="VANDERHOOF JA" publication="DIG DIS SCI" d1="28" d2="300" d3="983"/>
<CITE num="19" author="HANSEN RC" publication="ARCH DERMATOL" d1="119" d2="51" d3="983"/>
<CITE num="20" author="BALY DL" publication="AM J CLIN NUTR" d1="40" d2="199" d3="984"/>
<CITE num="21" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="22" author="DELVES HT" publication="CLIN ENDOCRINOL METAB" d1="14" d2="725" d3="985"/>
<CITE num="23" author="VANWOUWE JP" publication="SCI TOTAL ENVIRON" d1="42" d2="149" d3="985"/>
<CITE num="24" author="RASMUSSEN M" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="397" d3="986"/>
</CITATIONS>
<RECORDNUM>00795 </RECORDNUM>
<MEDLINENUM>78208255</MEDLINENUM>
<AUTHORS><AUTHOR>Finley-P-R</AUTHOR><AUTHOR>Dye-J-A</AUTHOR><AUTHOR>Lichti-D-A</AUTHOR><AUTHOR>Byers-J-M-3d</AUTHOR><AUTHOR>Williams-R-J</AUTHOR></AUTHORS>
<TITLE>A modified ion-selective electrode method for measurement of
chloride in sweat.</TITLE>
<SOURCE>Am-J-Clin-Pathol. 1978 Jun. 69(6). P 615-8.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>ELECTRODES: is</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<ABSTRACT>A modified method of analysis of sweat chloride concentration with an
ion-selective electrode is presented. The original method of sweat
chloride analysis proposed by the Orion Research Corporation
(Cambridge, Massachusetts 02139) is inadequate because it produces
erratic and misleading results. The modified method was compared with
the reference quantitative method of Gibson and Cooke. In the
modified method, individual electrode pads are cut and placed in the
electrodes rather than using the pads supplied by the company;
pilocarpine nitrate (2,000 mg/l) is used in place of pilocarpine HCl
(640 mg/l); sodium bicarbonate as the weak electrolyte is used
instead of K2SO4. A 10-minute period for sweat accumulation is
employed rather than a zero-time collection as in the original Orion
method. The modification has been studied for reproducibility in
individuals, reproducibility between right and left arm in
individuals; it has been compared extensively with the quantitative
method of Gibson and Cooke, both in normal individuals and in
patients with cystic fibrosis. There is excellent agreement between
the modified method and the quantitative reference method. There
appears to be a slight bias toward higher concentrations of chloride
from the right arm compared with the left arm, but this difference is
not medically significant.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78015</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BOWMAN BH" publication="N ENGL J MED" d1="294" d2="937" d3="976"/>
<CITE num="002" author="BRIMBLECOMBE FSW" publication="LANCET" d1="2" d2="1428" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="AM J MED" d1="15" d2="777" d3="953"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="IBBOTT FA" publication="STANDARD METH CLIN CHEM" d1="5" d2="101" d3="965"/>
<CITE num="006" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="007" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="008" author="ROSENLUND ML" publication="CRC CRIT REV CLIN LAB SCI" d1="3" d2="257" d3="972"/>
<CITE num="009" author="SHWACHMAN H" publication="ANN NY ACAD SCI" d1="93" d2="600" d3="962"/>
<CITE num="010" author="SHWACHMAN H" publication="MOD PROBL PEDIATR" d1="10" d2="158" d3="967"/>
<CITE num="011" author="SZABO L" publication="CLIN CHEM" d1="19" d2="727" d3="973"/>
<CITE num="012" author="WARWICK WJ" publication="CF CLUB ABST" d1="16" d2="58" d3="975"/>
</REFERENCES>
<RECORDNUM>00796 </RECORDNUM>
<MEDLINENUM>78121163</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenstein-B-J</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis presenting with the meconium plug syndrome.</TITLE>
<SOURCE>Am-J-Dis-Child. 1978 Feb. 132(2). P 167-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: di</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: di</TOPIC><TOPIC>MECONIUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, ra</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: et, ra</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et, ra</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MEGACOLON: co, di</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<ABSTRACT>The meconium plug syndrome (MPS) is a common cause of low intestinal
obstruction in newborn infants. Usually, it is benign and not
associated with other intestinal dysfunction. We describe the cases
of three infants in whom there was intestinal obstruction consistent
with the MPS and in which cystic fibrosis (CF) was later documented.
We suggest that there is an association between the MPS and CF, and
that the condition of all infants with the MPS be evaluated for the
possibility of both Hirschsprung's disease and CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CLATWORTHY HW" publication="SURGERY" d1="39" d2="131" d3="956"/>
<CITE num="002" author="ELLIS DG" publication="J PEDIATR SURG" d1="1" d2="54" d3="966"/>
<CITE num="003" author="SWISCHUK LE" publication="AM J ROENTG RAD THER NUCL MED" d1="103" d2="339" d3="968"/>
<CITE num="004" author="MIKITY VG" publication="RADIOLOGY" d1="88" d2="740" d3="967"/>
<CITE num="005" author="GILLIS DA" publication="CAN MED ASSOC J" d1="92" d2="225" d3="965"/>
<CITE num="006" author="GROSSMAN H" publication="AM J ROENTG RAD THER NUCL MED" d1="97" d2="227" d3="966"/>
<CITE num="007" author="EMERY JL" publication="ARCH DIS CHILD" d1="32" d2="17" d3="957"/>
<CITE num="008" author="CHING NPH" publication="ARCH SURG" d1="90" d2="65" d3="965"/>
<CITE num="009" author="SOKAL MM" publication="N ENGL J MED" d1="286" d2="823" d3="972"/>
<CITE num="010" author="BRUNS WT" publication="AM J DIS CHILD" d1="131" d2="71" d3="977"/>
<CITE num="011" author="POOLE CA" publication="J PEDIATR SURG" d1="11" d2="1011" d3="976"/>
<CITE num="012" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="013" author="DOLAN TF JR" publication="J PEDIATR SURG" d1="9" d2="821" d3="974"/>
<CITE num="014" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78016</PAPERNUM>
<CITATIONS>
<CITE num="1" author="N J                 PE" publication="DIATRICS" d1="66" d2="66 9" d3="0"/>
<CITE num="2" author="ROSENSTEIN BJ" publication="AM J DIS CHILD" d1="134" d2="72" d3="980"/>
<CITE num="3" author="STARSHAK RJ" publication="GASTROINTEST RADIOL" d1="6" d2="75" d3="981"/>
<CITE num="4" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="5" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="6" author="MULLER F" publication="PRENAT DIAGN" d1="5" d2="109" d3="985"/>
<CITE num="7" author="ABRAMSON SJ" publication="SEM ROENTGENOL" d1="22" d2="97" d3="987"/>
<CITE num="8" author="HALL SL" publication="CLIN PEDIATR" d1="26" d2="191" d3="987"/>
</CITATIONS>
<RECORDNUM>00797 </RECORDNUM>
<MEDLINENUM>78121196</MEDLINENUM>
<AUTHORS><AUTHOR>Gunn-T</AUTHOR><AUTHOR>Belmonte-M-M</AUTHOR><AUTHOR>Colle-E</AUTHOR><AUTHOR>Dupont-C</AUTHOR></AUTHORS>
<TITLE>Edema as the presenting symptom of cystic fibrosis: difficulties in
diagnosis.</TITLE>
<SOURCE>Am-J-Dis-Child. 1978 Mar. 132(3). P 317-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>EDEMA: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPOPROTEINEMIA: et</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SWEAT: an</TOPIC></MINORSUBJ>
<EXTRACT>Hypoproteinemia and edema may develop in infants with cystic fibrosis
whatever their diet although prior ingestion of soy bean formula
appears to be a predisposing factor, and a negative sweat chloride
test may be present in a CF child during the hypoproteinemic phase of
the illness.  The diagnosis cannot be excluded until a negative test
with adequate secretion of sweat is obtained after edema and
hypoproteinemia have resolved.</EXTRACT>
<REFERENCES>
<CITE num="001" author="FLEISHER DS" publication="J PEDIATR" d1="64" d2="341" d3="964"/>
<CITE num="002" author="MULNE A" publication="PEDIATR RES ABST 342" d1="10" d2="358" d3="976"/>
<CITE num="003" author="BILLE BSV" publication="ACTA PAEDIATR SCAND" d1="44" d2="435" d3="955"/>
<CITE num="004" author="GOLDMAN AS" publication="J PEDIATR" d1="59" d2="301" d3="961"/>
<CITE num="005" author="ANDERSON C" publication="MED J AUST" d1="2" d2="195" d3="966"/>
<CITE num="006" author="MASI M" publication="INT ANESTHESIOL CLIN" d1="53" d2="55" d3="971"/>
<CITE num="007" author="MACLEAN WC JR" publication="J PEDIATR" d1="83" d2="86" d3="973"/>
<CITE num="008" author="LEE PA" publication="JAMA" d1="228" d2="585" d3="974"/>
<CITE num="009" author="VLACHOS P" publication="J PEDIATR" d1="84" d2="926" d3="974"/>
<CITE num="010" author="DOLAN TF JR" publication="CLIN PEDIATR" d1="9" d2="295" d3="970"/>
<CITE num="011" author="LOCK J" publication="J PEDIATR" d1="84" d2="912" d3="974"/>
<CITE num="012" author="PAXSON CL JR" publication="JAMA" d1="230" d2="1257" d3="974"/>
<CITE num="013" author="BASS HN" publication="PEDIATRICS" d1="59" d2="126" d3="977"/>
<CITE num="014" author="SHAHIDI NT" publication="J PEDIATR" d1="59" d2="533" d3="961"/>
<CITE num="015" author="ROGER R" publication="J PEDIATR" d1="86" d2="264" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78017</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ELSEN OH            J" publication="PEDIATR GASTROENTEROL NUTR" d1="1" d2="55 9" d3="2"/>
<CITE num="2" author="TURKEL SB" publication="CLIN PERINATOL" d1="9" d2="613" d3="982"/>
<CITE num="3" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="4" author="CHRISTOFFEL KS" publication="J PEDIATR" d1="107" d2="231" d3="985"/>
</CITATIONS>
<RECORDNUM>00798 </RECORDNUM>
<MEDLINENUM>79059455</MEDLINENUM>
<AUTHORS><AUTHOR>Townes-P-L</AUTHOR><AUTHOR>Kopelman-A-E</AUTHOR></AUTHORS>
<TITLE>Meconium plug syndrome, cystic fibrosis, and exocrine pancreatic
deficiency [letter].</TITLE>
<SOURCE>Am-J-Dis-Child. 1978 Oct. 132(10). P 1043-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et</TOPIC><TOPIC>MECONIUM</TOPIC><TOPIC>PANCREATIC-DISEASES: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<EXTRACT>We have observed severe meconium plug syndrome (MPS) in a newborn
infant who was found during the neonatal period to have extensive
exocrine pancreatic deficiency.  Cystic fibrosis was excluded by
several sweat chloride tests.  Our observation of MPS in a patient
with exocrine pancreatic deficiency suggests that the MPS observed in
the CF patients reported by Rosenstein is probably caused by
pancreatic deficiency.  The frequent occurrence of meconium ileus
(MI) in CF and the rarity of MPS in CF is curious, since they may be
different manifestations of the same pathologic process.
Conceivably, MPS may occur with total absence of pancreatic enzymes
(as in our patient and in a few patients with CF).  Low levels of
enzymes in CF may limit expression to meconium ileus.  We wish to
suggest the evaluation of exocrine pancreatic function in these
patients even if CF has been excluded by sweat tests. - There is
conflicting, albeit fragmentary, data suggesting that exocrine
pancreatic deficiency may not be the sole cause of meconium
obstruction in CF.  Several investigators have suggested that MI may
be the result of abnormal protein and mucoprotein secretions by the
intestinal goblet cells and not from lack of pancreatic enzymes
alone.  While these observations suggest that exocrine pancreatic
deficiency may not play a major role in all instance of meconium
obstruction, it is important to note that there may be little
correlation between the histologic appearance of the pancreas and
exocrine function.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="001" author="ROSENSTEIN BJ" publication="AM J DIS CHILD" d1="132" d2="167" d3="978"/>
<CITE num="002" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="002" author="GROSSMAN H" publication="AM J ROENTG RAD THER NUCL MED" d1="97" d2="227" d3="966"/>
<CITE num="003" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78018</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SENSTEIN BJ         AM" publication="J DIS CHILD                 1" d1="34" d2="72 9" d3="0"/>
</CITATIONS>
<RECORDNUM>00799 </RECORDNUM>
<MEDLINENUM>78208347</MEDLINENUM>
<AUTHORS><AUTHOR>Spiro-R-K</AUTHOR><AUTHOR>Landman-M-E</AUTHOR></AUTHORS>
<TITLE>Meconium ileus equivalent.</TITLE>
<SOURCE>Am-J-Gastroenterol. 1978 Mar. 69(3 Pt 1). P 302-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLCYSTEINE: tu</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FECES-IMPACTED: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ILEUM: pa, ra</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: pa</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MECONIUM</TOPIC><TOPIC>RESPIRATION-ARTIFICIAL</TOPIC></MINORSUBJ>
<ABSTRACT>A case of meconium ileus equivalent in a 30-year old man is
presented. The pathology and therapy for the condition are discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HUNTON DB" publication="GASTROENTEROLOGY" d1="50" d2="99" d3="966"/>
<CITE num="002" author="DAVIDSON M" publication="HOSP PRACT" d1="2" d2="47" d3="976"/>
<CITE num="003" author="JENSEN KG" publication="ACTA PAEDIATR SCAND" d1="51" d2="344" d3="962"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="ANN INTERN MED" d1="50" d2="1321" d3="959"/>
<CITE num="005" author="QUINLAN MF" publication="AUSTRALAS ANN MED" d1="16" d2="84" d3="967"/>
<CITE num="006" author="SIGLER RM" publication="MAYO CLIN PROC" d1="40" d2="477" d3="965"/>
<CITE num="007" author="ROWE MI" publication="AM J SURG" d1="125" d2="185" d3="973"/>
<CITE num="008" author="SCHILLER M" publication="AM J SURG" d1="122" d2="22" d3="971"/>
<CITE num="009" author="BROWN PM" publication="N ENGL J MED" d1="263" d2="544" d3="960"/>
<CITE num="010" author="NANKIN P" publication="AM J SURG" d1="123" d2="609" d3="972"/>
<CITE num="011" author="LILLIBRIDGE CB" publication="J PEDIATR" d1="71" d2="887" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78019</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BACHNIK NF          SU" publication="RG GYNECOL OBSTET            1" d1="52" d2="37 9" d3="1"/>
<CITE num="2" author="ROSENBERG E" publication="KLIN PAEDIATR" d1="195" d2="323" d3="983"/>
<CITE num="3" author="RUBINSTEIN S" publication="PEDIATRICS" d1="78" d2="473" d3="986"/>
</CITATIONS>
<RECORDNUM>00800 </RECORDNUM>
<MEDLINENUM>78184587</MEDLINENUM>
<AUTHORS><AUTHOR>Parry-M-F</AUTHOR><AUTHOR>Neu-H-C</AUTHOR></AUTHORS>
<TITLE>A comparative study of ticarcillin plus tobramycin versus
carbenicillin plus gentamicin for the treatment of serious
infections due to gram-negative bacilli.</TITLE>
<SOURCE>Am-J-Med. 1978 Jun. 64(6). P 961-6.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>CARBENICILLIN: tu</TOPIC><TOPIC>GENTAMICINS: tu</TOPIC><TOPIC>GRAM-NEGATIVE-AEROBIC-BACTERIA: de</TOPIC><TOPIC>PENICILLINS: tu</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>TICARCILLIN: tu</TOPIC><TOPIC>TOBRAMYCIN: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KIDNEY-FUNCTION-TESTS</TOPIC><TOPIC>KIDNEY: de</TOPIC><TOPIC>PNEUMONIA: dt</TOPIC><TOPIC>SEPTICEMIA: dt</TOPIC></MINORSUBJ>
<ABSTRACT>The combination of ticarcillin plus tobramycin (TT) or carbenicillin
plus gentamicin (CG) was used to treat 82 patients with severe
systemic gram-negative infection in a prospective, randomized study.
Pseudomonas aeruginosa was the primary pathogen in 7 (93 per cent) of
these patients. Patients treated with TT responded more frequently
(92 per cent or 37 of 40) than patients treated with CG (71 per cent
or 30 of 42) (p is less than 0.05). This difference was primarily due
to a greater response to TT in patients with pulmonary infections (93
per cent versus 68 per cent) and infections due to Pseudomonas (92
per cent versus 70 per cent). Severity of underlying disease was also
an important determinant of response. Except for a greater incidence
of hepatotoxicity with CG (23 per cent versus 3 per cent; p is less
than 0.02), there was no difference in toxicity, colonization with
drug-resistant microorganisms or superinfection between the two
treatment groups. The combination of TT appears to be superior to CG
for the treatment of pulmonary infections due to Pseudomonas
aeruginosa.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDRIOLE VT" publication="J INFECT DIS" d1="129" d2="124" d3="974"/>
<CITE num="002" author="LUMISH RM" publication="J INFECT DIS" d1="133" d2="538" d3="976"/>
<CITE num="003" author="SCOTT RE" publication="ANTIMICROB AGENTS CHEMOTHER" d1="10" d2="646" d3="976"/>
<CITE num="004" author="MYEROWITZ RL" publication="J INFECT DIS" d1="124" d2="239" d3="971"/>
<CITE num="005" author="MCCABE WR" publication="BULL NY ACAD MED" d1="51" d2="1084" d3="975"/>
<CITE num="006" author="KLASTERSKY J" publication="J INFECT DIS" d1="129" d2="187" d3="974"/>
<CITE num="007" author="KLASTERSKY J" publication="ANTIMICROB AGENTS CHEMOTHER" d1="7" d2="640" d3="975"/>
<CITE num="008" author="PARRY MF" publication="J PEDIATR" d1="90" d2="144" d3="977"/>
<CITE num="009" author="FELD R" publication="J INFECT DIS" d1="135" d2="61" d3="977"/>
<CITE num="010" author="SMITH CR" publication="N ENGL J MED" d1="296" d2="349" d3="977"/>
<CITE num="011" author="NEU HC" publication="ANTIMICROB AGENTS CHEMOTHER" d1="10" d2="385" d3="970"/>
<CITE num="012" author="NEU HC" publication="J INFECT DIS SUPPL" d1="134" d2="3" d3="976"/>
<CITE num="013" author="NEU HC" publication="ANTIMICROB AGENTS CHEMOTHER" d1="8" d2="457" d3="975"/>
<CITE num="014" author="PARRY MF" publication="J INFECT DIS" d1="133" d2="46" d3="976"/>
<CITE num="015" author="MCHENRY MC" publication="ANN INTERN MED" d1="74" d2="192" d3="971"/>
<CITE num="016" author="BAUER AW" publication="AM J CLIN PATHOL" d1="45" d2="493" d3="966"/>
<CITE num="017" author="NEU HC" publication="APPL MICROBIOL" d1="21" d2="66" d3="971"/>
<CITE num="018" author="FU KP" publication="ANTIMICROB AGENTS CHEMOTHER" d1="10" d2="511" d3="976"/>
<CITE num="019" author="PARRY MF" publication="ANTIMICROB AGENTS CHEMOTHER" d1="9" d2="625" d3="976"/>
<CITE num="020" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="021" author="PARRY MF" publication="J INFECT DIS SUPPL" d1="134" d2="194" d3="976"/>
<CITE num="022" author="HEWITT WL" publication="POSTGRAD MED J SUPPL 7" d1="50" d2="55" d3="974"/>
<CITE num="023" author="LIPNER HI" publication="J LAB CLIN MED" d1="86" d2="183" d3="975"/>
<CITE num="024" author="BROWN CH 3RD" publication="N ENGL J MED" d1="291" d2="265" d3="974"/>
<CITE num="025" author="PARRY MF" publication="J INFECT DIS" d1="134" d2="476" d3="976"/>
<CITE num="026" author="LAU WK" publication="AM J MED" d1="62" d2="959" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78020</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EWART C             DR" publication="UG INTEL CLIN PHARM" d1="13" d2="92 9" d3="9"/>
<CITE num="2" author="MEYER M" publication="CAN J MICROBIOL" d1="25" d2="1232" d3="979"/>
<CITE num="3" author="HOPEFL AW" publication="AM J HOSP PHARM" d1="36" d2="178" d3="979"/>
<CITE num="4" author="CHOW M" publication="CONN MED" d1="43" d2="25" d3="979"/>
<CITE num="5" author="PANCOAST SJ" publication="AM J MED" d1="67" d2="747" d3="979"/>
<CITE num="6" author="ANDRIOLE VT" publication="J LAB CLIN MED" d1="94" d2="196" d3="979"/>
<CITE num="7" author="PENNINGTON JE" publication="J INFECT DIS" d1="140" d2="881" d3="979"/>
<CITE num="8" author="NEU HC" publication="INFECTION" d1="8" d2="S 62" d3="980"/>
<CITE num="9" author="KOHLER RB" publication="J CLIN MICROBIOL" d1="12" d2="39" d3="980"/>
<CITE num="10" author="BROGDEN RN" publication="DRUGS" d1="20" d2="325" d3="980"/>
<CITE num="11" author="SORKNESS R" publication="AM J HOSP PHARM" d1="37" d2="555" d3="980"/>
<CITE num="12" author="YOUNG LS" publication="J ANTIMICROB CHEMOTHER" d1="8" d2="121" d3="981"/>
<CITE num="13" author="BELL WE" publication="ANN NEUROL" d1="9" d2="313" d3="981"/>
<CITE num="14" author="HOPEFL AW" publication="DRUG INTEL CLIN PHARM" d1="15" d2="697" d3="981"/>
<CITE num="15" author="ELLIS PP" publication="CAN J OPHTHALMOL" d1="16" d2="79" d3="981"/>
<CITE num="16" author="MOZZANA R" publication="HAEMATOLOGICA" d1="66" d2="634" d3="981"/>
<CITE num="17" author="BRINKER KR" publication="J LAB CLIN MED" d1="98" d2="292" d3="981"/>
<CITE num="18" author="HYATT AC" publication="J PEDIATR" d1="99" d2="307" d3="981"/>
<CITE num="19" author="ELIOPOULOS GM" publication="REV INFECT DIS" d1="4" d2="282" d3="982"/>
<CITE num="20" author="BELL WE" publication="SEM PERINATOL" d1="6" d2="1" d3="982"/>
<CITE num="21" author="PARRY MF" publication="J ANTIMICROB CHEMOTHER" d1="9" d2="273" d3="982"/>
<CITE num="22" author="PENNINGTON JE" publication="ANTIMICROB AGENTS CHEMOTHER" d1="22" d2="406" d3="982"/>
<CITE num="23" author="ABRAMOWITZ PW" publication="AM J HOSP PHARM" d1="39" d2="1176" d3="982"/>
<CITE num="24" author="TENENBAUM MJ" publication="MED CLIN NORTH AM" d1="66" d2="17" d3="982"/>
<CITE num="25" author="GRAFT DF" publication="J PEDIATR" d1="100" d2="497" d3="982"/>
<CITE num="26" author="KOHLER RB" publication="ARCH INTERN MED" d1="142" d2="1335" d3="982"/>
<CITE num="27" author="BODEY GP" publication="REV INFECT DIS" d1="5" d2="279" d3="983"/>
<CITE num="28" author="SAVOIA D" publication="DRUGS UNDER EXP CLIN RES" d1="9" d2="143" d3="983"/>
<CITE num="29" author="CHIN NX" publication="J ANTIMICROB CHEMOTHER" d1="11" d2="33" d3="983"/>
<CITE num="30" author="SRINIVASAN S" publication="INFECTION" d1="11" d2="291" d3="983"/>
<CITE num="31" author="BINT AJ" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="115" d3="983"/>
<CITE num="32" author="GASPARETTO A" publication="J ANTIMICROB CHEMOTHER" d1="12" d2="171" d3="983"/>
<CITE num="33" author="SHLAES DM" publication="PEDIATR CLIN NORTH AM" d1="30" d2="121" d3="983"/>
<CITE num="34" author="KAHLMETER G" publication="J ANTIMICROB CHEMOTHER" d1="13" d2="9" d3="984"/>
<CITE num="35" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="36" author="ENG RHK" publication="INT J DERMATOL" d1="23" d2="153" d3="984"/>
<CITE num="37" author="YOUNG LS" publication="AM J MED" d1="76" d2="61" d3="984"/>
<CITE num="38" author="MOORE RD" publication="AM J MED" d1="77" d2="657" d3="984"/>
<CITE num="39" author="SCULLY BE" publication="ARCH INTERN MED" d1="144" d2="57" d3="984"/>
<CITE num="40" author="ACAR JF" publication="REV INFECT DIS" d1="7" d2="S513" d3="985"/>
<CITE num="41" author="LEVISON ME" publication="REV INFECT DIS" d1="7" d2="S656" d3="985"/>
<CITE num="42" author="SCULLY BE" publication="REV INFECT DIS" d1="7" d2="S669" d3="985"/>
<CITE num="43" author="CONE LA" publication="ANTIMICROB AGENTS CHEMOTHER" d1="28" d2="33" d3="985"/>
<CITE num="44" author="BALTCH AL" publication="AM J MED" d1="79" d2="8" d3="985"/>
<CITE num="45" author="WILSON CB" publication="J PEDIATR" d1="106" d2="1049" d3="985"/>
<CITE num="46" author="HANNO P" publication="UROL CLIN NORTH AM" d1="13" d2="577" d3="986"/>
<CITE num="47" author="ARPI M" publication="CHEMOTHERAPY" d1="32" d2="68" d3="986"/>
<CITE num="48" author="EVANS DA" publication="AM J MED" d1="80" d2="39" d3="986"/>
</CITATIONS>
<RECORDNUM>00801 </RECORDNUM>
<MEDLINENUM>78254310</MEDLINENUM>
<AUTHORS><AUTHOR>Knox-G-E</AUTHOR><AUTHOR>Palmer-M-D</AUTHOR><AUTHOR>Huddleston-J-F</AUTHOR></AUTHORS>
<TITLE>Fetal cystic fibrosis presenting as dystocia due to midgut volvulus
with lethal perforation.</TITLE>
<SOURCE>Am-J-Obstet-Gynecol. 1978 Jul 15. 131(6). P 698-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DYSTOCIA: di</TOPIC><TOPIC>FETAL-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>DYSTOCIA: et</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: co</TOPIC><TOPIC>PERITONITIS: co, et</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>RUPTURE-SPONTANEOUS</TOPIC></MINORSUBJ>
<EXTRACT>Fetal or neonatal volvulus is a rare event and is usually associated
with an anatomic defect.  Massive abdominal distension secondary to a
ruptured or unruptured volvulus has never been reported as a cause of
obstructed labor.  The present report documents such a case,
secondary to chemical peritonitis resulting from a ruptured midgut
volvulus.  This case demonstrates an unusual presentation of presumed
cystic fibrosis with meconium ileus and volvulus which led to
ischemic infarction and perforation of the small bowel.  This case
likewise emphasizes the need to consider the presence of other fetal
anomalies, such as omphalocele or gastroschisis, when the usual
maneuvers fail to relieve shoulder dystocia.</EXTRACT>
<REFERENCES>
<CITE num="001" author="KRASNA IH" publication="J PEDIATR SURG" d1="8" d2="615" d3="973"/>
<CITE num="002" author="SROUJI MN" publication="J PEDIATR SURG" d1="9" d2="779" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78021</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ALEV J              J" publication="MED GENET" d1="20" d2="29 9" d3="3"/>
</CITATIONS>
<RECORDNUM>00802 </RECORDNUM>
<MEDLINENUM>78078929</MEDLINENUM>
<AUTHORS><AUTHOR>Davis-S-D</AUTHOR><AUTHOR>Bruns-W-T</AUTHOR></AUTHORS>
<TITLE>Effects of sputum from patients with cystic fibrosis on the activity
in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1978 Jan. 117(1). P 176-8.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: pd</TOPIC><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: de</TOPIC><TOPIC>SPUTUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBENICILLIN: pd</TOPIC><TOPIC>GENTAMICINS: pd</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MICROBIAL-SENSITIVITY-TESTS</TOPIC><TOPIC>NEOMYCIN: pd</TOPIC><TOPIC>POLYMYXIN-B: pd</TOPIC><TOPIC>TOBRAMYCIN: pd</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>By in vitro tests on 12 strains of Pseudomonas aeruginosa, sputum
from patients with cystic fibrosis sharply increased the minimal
bactericidal concentrations of polymyxin B and neomycin. Sputum had a
lesser effect on tests with gentamicin and tobramycin and essentially
none on tests with carbenicillin.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="NEWTON BA" publication="NATURE" d1="172" d2="160" d3="953"/>
<CITE num="002" author="NEWTON BA" publication="J GEN MICROBIOL" d1="10" d2="491" d3="954"/>
<CITE num="003" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="004" author="POTTER JL" publication="PEDIATRICS" d1="36" d2="714" d3="965"/>
<CITE num="005" author="GARROD LP" publication="J CLIN PATHOL" d1="22" d2="534" d3="969"/>
<CITE num="006" author="SAGGERS BA" publication="J CLIN PATHOL" d1="23" d2="266" d3="970"/>
<CITE num="007" author="KUNIN CM" publication="J INFECT DIS" d1="121" d2="55" d3="970"/>
<CITE num="008" author="DAVIS SD" publication="J INFECT DIS" d1="123" d2="392" d3="971"/>
<CITE num="009" author="DAVIS SD" publication="J INFECT DIS" d1="124" d2="610" d3="971"/>
<CITE num="010" author="CHEN CH" publication="ANTIMICROB AGENTS CHEMOTHER" d1="2" d2="331" d3="972"/>
<CITE num="011" author="DAVIS SD" publication="APPL MICROBIOL" d1="23" d2="775" d3="972"/>
<CITE num="012" author="DAVIS SD" publication="ANTIMICROB AGENTS CHEMOTHER" d1="1" d2="466" d3="972"/>
<CITE num="013" author="DAVIS SD" publication="CHEMOTHERAPY" d1="19" d2="243" d3="973"/>
<CITE num="014" author="DIENSTAG J" publication="ANTIMICROB AGENTS CHEMOTHER" d1="1" d2="41" d3="972"/>
<CITE num="015" author="ZIMELIS VM" publication="J INFECT DIS" d1="127" d2="663" d3="973"/>
<CITE num="016" author="BRYANT RE" publication="ANTIMICROB AGENTS CHEMOTHER" d1="6" d2="702" d3="974"/>
<CITE num="017" author="D AMATO RF" publication="ANTIMICROB AGENTS CHEMOTHER" d1="7" d2="596" d3="975"/>
<CITE num="018" author="LENNETTE EH" publication="MANUAL OF CLINICAL MICROBIOLO" d1="" d2="" d3="974"/>
<CITE num="019" author="RELLER LD" publication="J INFECT DIS" d1="130" d2="454" d3="974"/>
<CITE num="020" author="HUANG NN" publication="GUIDE TO DRUG THERAPY IN PATI" d1="" d2="" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78022</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EXANDER MR          CH" publication="EST" d1="75" d2="75 9" d3="9"/>
<CITE num="2" author="VAUDAUX P" publication="J ANTIMICROB CHEMOTHER" d1="8" d2="17" d3="981"/>
<CITE num="3" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="4" author="MAXWELL D" publication="J ANTIMICROB CHEMOTHER" d1="11" d2="203" d3="983"/>
<CITE num="5" author="STACK BHR" publication="THORAX" d1="40" d2="358" d3="985"/>
<CITE num="6" author="MENDELMAN PM" publication="AM REV RESPIR DIS" d1="132" d2="761" d3="985"/>
<CITE num="7" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
</CITATIONS>
<RECORDNUM>00803 </RECORDNUM>
<MEDLINENUM>78164287</MEDLINENUM>
<AUTHORS><AUTHOR>Lemen-R-J</AUTHOR><AUTHOR>Gates-A-J</AUTHOR><AUTHOR>Mathe-A-A</AUTHOR><AUTHOR>Waring-W-W</AUTHOR><AUTHOR>Hyman-A-L</AUTHOR><AUTHOR>Kadowitz-P-D</AUTHOR></AUTHORS>
<TITLE>Relationships among digital clubbing, disease severity, and serum
prostaglandins F2alpha and E concentrations in cystic fibrosis
patients.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1978 Apr. 117(4). P 639-46.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: et</TOPIC><TOPIC>PROSTAGLANDINS-E: bl</TOPIC><TOPIC>PROSTAGLANDINS-F: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl, co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OSTEOARTHROPATHY-SECONDARY-HYPERTROPHIC: bl</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>VITAL-CAPACITY</TOPIC></MINORSUBJ>
<ABSTRACT>Nine patients with cystic fibrosis but without digital clubbing
(Group A) were matched, prospectively, by sex and approximate age to
9 cystic fibrosis patients with digital clubbing (Group B) and to 9
normal persons (control subjects). Patients in Group B had
significantly (P less than 0.05) lower clinical scores and forced
vital capacity than did those in Group A, indicating more severe
pulmonary disease in the former; however, other spirometer tests of
pulmonary function revealed no differences between Groups A and B.
The degree of digital clubbing had significant (P less than 0.05)
linear relationships to forced vital capacity (r = -0.73) and
clinical scores (r = 0.853) for Groups A and B. Plasma concentrations
of prostaglandins F2alpha and E were significantly increased (P less
than 0.05) in both Group A (X +/- SE, 0.48 +/- 0.03 and 0.87 +/- 0.10
ng per ml, respectively) and Group B (X +/- SE, 0.68 +/- 0.04 and
1.81 +/- 0.16 ng per ml, respectively) compared to the control group
(X +/- SE, 0.14 +/- 0.01 and 0.39 +/- 0.02 ng per ml, respectively).
Group B had significantly larger concentrations than did Group A;
however, plasma concentrations of prostaglandin 15-keto-13, 14-
dihydro metabolite were not different in Groups A and B, and were
significantly smaller than in the control group. These studies
suggest that the degree of digital clubbing in cystic fibrosis is
related to the severity of the pulmonary involvement and that the
prostaglandin system may play an important role in this disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BIGLER FC" publication="AM J PATHOL" d1="34" d2="237" d3="958"/>
<CITE num="002" author="LOVELL RRH" publication="CLIN SCI" d1="9" d2="299" d3="950"/>
<CITE num="003" author="DEGOWIN EL" publication="BEDSIDE DIAGNOSTIC EXAMINATIO" d1="" d2="546" d3="965"/>
<CITE num="004" author="MELLINS RB" publication="CIRCULATION" d1="33" d2="143" d3="966"/>
<CITE num="005" author="WIERMAN WH" publication="JAMA" d1="155" d2="1459" d3="954"/>
<CITE num="006" author="WARING WW" publication="AM REV RESPIR DIS" d1="104" d2="166" d3="971"/>
<CITE num="007" author="MAUER EF" publication="AM HEART J" d1="34" d2="852" d3="947"/>
<CITE num="008" author="TURNER-WARWICK M" publication="THORAX" d1="18" d2="238" d3="963"/>
<CITE num="009" author="MCLAUGHLIN GE" publication="ANN INTERN MED" d1="67" d2="579" d3="967"/>
<CITE num="010" author="BASHOUR FA" publication="J LAB CLIN MED" d1="58" d2="613" d3="961"/>
<CITE num="011" author="GREEN K" publication="LANCET" d1="2" d2="1419" d3="974"/>
<CITE num="012" author="MATHE AA" publication="IN: RAMSWELL PW" d1="3" d2="169" d3="977"/>
<CITE num="013" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="014" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="015" author="LEMEN RG" publication="IN: KENDIG EL JR" d1="" d2="166" d3="977"/>
<CITE num="016" author="LEVINE L" publication="ADV BIOL SCI" d1="9" d2="71" d3="973"/>
<CITE num="017" author="MATHE AA" publication="ACTA PHYSIOL SCAND SUPPL 98" d1="441" d2="155" d3="976"/>
<CITE num="018" author="MATHE AA" publication="BIOCHEM PHARMACOL" d1="26" d2="181" d3="977"/>
<CITE num="019" author="SNEDECOR GW" publication="STATISTICAL METHODS" d1="" d2="" d3="967"/>
<CITE num="020" author="REID L" publication="MOD PROBL PEDIATR" d1="10" d2="195" d3="967"/>
<CITE num="021" author="ZUELZER WW" publication="PEDIATRICS" d1="4" d2="53" d3="949"/>
<CITE num="022" author="BEIER FR" publication="AM REV RESPIR DIS" d1="94" d2="430" d3="966"/>
<CITE num="023" author="COOK CD" publication="PEDIATRICS" d1="24" d2="181" d3="959"/>
<CITE num="024" author="SIEGLER RL" publication="J PEDIATR" d1="81" d2="734" d3="977"/>
<CITE num="025" author="FERREIRA SH" publication="NATURE" d1="216" d2="868" d3="967"/>
<CITE num="026" author="BOWDEN DH" publication="AM J MED" d1="38" d2="226" d3="965"/>
<CITE num="027" author="ROSENTHAL A" publication="PEDIATRICS" d1="59" d2="588" d3="977"/>
<CITE num="028" author="LIEBERMAN J" publication="ANN INTERN MED" d1="82" d2="806" d3="975"/>
<CITE num="029" author="HALL GH" publication="J APPL PHYSIOL" d1="21" d2="923" d3="966"/>
<CITE num="030" author="SAMUELSSON B" publication="ANNU REV BIOCHEM" d1="898" d2="669" d3="975"/>
<CITE num="031" author="NAKANO J" publication="PROC SOC EXP BIOL MED" d1="144" d2="506" d3="973"/>
<CITE num="032" author="HABBOUSHE C" publication="PEDIATRICS" d1="48" d2="973" d3="971"/>
<CITE num="033" author="SAID SI" publication="FED PROC" d1="32" d2="1972" d3="973"/>
<CITE num="034" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="035" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
<CITE num="036" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="037" author="ELLIOTT RB" publication="PEDIATR RES" d1="7" d2="427" d3="973"/>
<CITE num="038" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="039" author="BAKHLE YS" publication="PHYSIOL REV" d1="54" d2="1007" d3="974"/>
<CITE num="040" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="109" d2="743" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78023</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DGE JA              LA" publication="NCET" d1="2" d2="75 9" d3="8"/>
<CITE num="2" author="SCHRIJEN F" publication="CLIN SCI MOL MED" d1="55" d2="485" d3="978"/>
<CITE num="3" author="LLOYDSTILL JD" publication="PEDIATRICS" d1="64" d2="50" d3="979"/>
<CITE num="4" author="GIRI SN" publication="J PHARMACOL METHODS" d1="4" d2="335" d3="980"/>
<CITE num="5" author="GIRI SN" publication="ENVIRON RES" d1="21" d2="467" d3="980"/>
<CITE num="6" author="CHANDLER DB" publication="PROSTAGLANDINS MED" d1="7" d2="571" d3="981"/>
<CITE num="7" author="METZ SA" publication="METABOLISM" d1="30" d2="299" d3="981"/>
<CITE num="8" author="GODARD P" publication="RESPIRATION" d1="42" d2="43" d3="981"/>
<CITE num="9" author="SHNEERSON JM" publication="BR J DIS CHEST" d1="75" d2="75" d3="981"/>
<CITE num="10" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="11" author="MARTINEZLAVIN M" publication="ARTHRITIS RHEUM" d1="25" d2="1186" d3="982"/>
<CITE num="12" author="LAVI Y" publication="J THORAC CARDIOVASC SURG" d1="84" d2="373" d3="982"/>
<CITE num="13" author="CHANDLER DB" publication="PROSTAGLANDINS LEUKOTR MED" d1="11" d2="11" d3="983"/>
<CITE num="14" author="MOON MA" publication="PROSTAGLANDINS" d1="25" d2="615" d3="983"/>
<CITE num="15" author="HANSEN RC" publication="ARCH DERMATOL" d1="119" d2="51" d3="983"/>
<CITE num="16" author="CHANDLER DB" publication="AM REV RESPIR DIS" d1="128" d2="71" d3="983"/>
<CITE num="17" author="ANDERSON CM" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="15" d3="984"/>
<CITE num="18" author="DAVIS PB" publication="J LAB CLIN MED" d1="104" d2="203" d3="984"/>
<CITE num="19" author="RUSSI EW" publication="BR MED J" d1="288" d2="1160" d3="984"/>
<CITE num="20" author="SPRINCE  NL" publication="N ENGL J MED" d1="310" d2="375" d3="984"/>
<CITE num="21" author="GIRI SN" publication="EXP LUNG RES" d1="9" d2="119" d3="985"/>
<CITE num="22" author="CHANDLER DB" publication="PROSTAGLANDINS LEUKOTR MED" d1="19" d2="139" d3="985"/>
<CITE num="23" author="LEUNG FW" publication="WEST J MED" d1="142" d2="345" d3="985"/>
<CITE num="24" author="MATUCCICERINIC M" publication="J RHEUMATOL" d1="13" d2="834" d3="986"/>
<CITE num="25" author="MISCHLER EH" publication="PEDIATR RES" d1="20" d2="36" d3="986"/>
<CITE num="26" author="PITTSTUCKER TJ" publication="ARCH DIS CHILD" d1="61" d2="576" d3="986"/>
<CITE num="27" author="BENDVOLD E" publication="J REPROD FERTIL" d1="78" d2="311" d3="986"/>
<CITE num="28" author="OZAKI T" publication="J APPL PHYSIOL" d1="62" d2="219" d3="987"/>
</CITATIONS>
<RECORDNUM>00804 </RECORDNUM>
<MEDLINENUM>78185256</MEDLINENUM>
<AUTHORS><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Wood-R-E</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Matthews-L-W</AUTHOR><AUTHOR>Tucker-A-S</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR></AUTHORS>
<TITLE>Treatment and prognosis of massive hemoptysis in cystic fibrosis.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1978 May. 117(5). P 825-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEMOPTYSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>BLOOD-TRANSFUSION</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>DRAINAGE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEMOPTYSIS: et, mo</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OHIO</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>RECURRENCE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>VITAMIN-K: tu</TOPIC></MINORSUBJ>
<ABSTRACT>Massive hemoptysis (volume of expectorated blood &gt; 300 ml in 24
hours) occurred in 38 (5 per cent) of 728 patients with cystic
fibrosis.  Twenty-two of the patients were in the midst of a
relatively long-lasting flare-up of pulmonary infection.  There was
no other consistent precipitating event.  All but 7 of the patients
were admitted after the initial episode and were treated with
parenteral antimicrobial drugs.  Postural drainage was resumed as
rapidly as possible after cessation of acute bleeding.  Vitamin K
was administered to all patients.  Volumes of expectorated blood
were as large as 2,500 ml with the initial episode.  Blood pressure
changes occurred in 4 patients.  Five patients received blood
transfusions.  Bleeding stopped without surgical intervention in all
patients, usually within 4 days.  The 38 patients had a total of 85
episodes of bleeding.  No surgical treatment was undertaken at this
center.  One patient underwent a lobectomoy at another hospital but
continued to bleed postoperatively.  Ten patients died (mean
survival after hemoptysis, 2.5 years; range, 3 months to 6 years).
This survival rate is comparable to that of another group of
patients with equally severe lung disease who had never bled
profusely.  The other 28 patients remain alive from 7 months to 20
years after their initial episode.  Our dat suggest that massive
hemoptysis complicating cystic fibrosis may not be as ominous an
event as has been believed in the past.  Because of the tendency of
most patients to stop bleeding without aggressive surgical
intervention, future studies of new therapeutic measures for massive
hemoptysis must have appropriate untreated control patients who
receive only medical management.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="002" author="LEVITSKY S" publication="JAMA" d1="213" d2="125" d3="970"/>
<CITE num="003" author="FELLOWS KE" publication="RADIOLOGY" d1="114" d2="551" d3="975"/>
<CITE num="004" author="ORES CN" publication="AM REV RESPIR DIS" d1="99" d2="790" d3="969"/>
<CITE num="005" author="KHAW K-T" publication="CF CLUB ABST" d1="" d2="" d3="977"/>
<CITE num="006" author="REMY J" publication="RADIOLOGY" d1="122" d2="33" d3="977"/>
<CITE num="007" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="008" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="009" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="010" author="MACK JF" publication="BR J RADIOL" d1="38" d2="422" d3="965"/>
<CITE num="011" author="SAW EC" publication="CHEST" d1="70" d2="589" d3="976"/>
<CITE num="012" author="SAHEBJAMI H" publication="CHEST" d1="69" d2="131" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78024</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MY J                NO" publication="UV PRESSE MED" d1="7" d2="06 9" d3="8"/>
<CITE num="2" author="FINK RJ" publication="CHEST" d1="74" d2="643" d3="978"/>
<CITE num="3" author="WOOD RE" publication="SOUTH MED J" d1="72" d2="189" d3="979"/>
<CITE num="4" author="MARACHE P" publication="ANN RADIOL (PARIS)" d1="23" d2="337" d3="980"/>
<CITE num="5" author="FAIRFAX AJ" publication="BR J DIS CHEST" d1="74" d2="345" d3="980"/>
<CITE num="6" author="TOM LWC" publication="ANN OTOL RHINOL LARYNGOL" d1="89" d2="419" d3="980"/>
<CITE num="7" author="FRIEDMAN PJ" publication="AM J ROENTGENOL" d1="136" d2="1131" d3="981"/>
<CITE num="8" author="TABACHNIK NF" publication="SURG GYNECOL OBSTET" d1="152" d2="837" d3="981"/>
<CITE num="9" author="MAGEE G" publication="LUNG" d1="160" d2="165" d3="982"/>
<CITE num="10" author="MARMON L" publication="J PEDIATR SURG" d1="18" d2="811" d3="983"/>
<CITE num="11" author="PORTER DK" publication="J THORAC CARDIOVASC SURG" d1="86" d2="409" d3="983"/>
<CITE num="12" author="BOBROWITZ ID" publication="ARCH INTERN MED" d1="143" d2="1343" d3="983"/>
<CITE num="13" author="PORTER DK" publication="ARCH INTERN MED" d1="143" d2="287" d3="983"/>
<CITE num="14" author="DAVIS PB" publication="CHEST" d1="85" d2="802" d3="984"/>
<CITE num="15" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="16" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="17" author="TAFRESHI M" publication="NY STATE J MED" d1="85" d2="38" d3="985"/>
</CITATIONS>
<RECORDNUM>00805 </RECORDNUM>
<MEDLINENUM>78122210</MEDLINENUM>
<AUTHORS><AUTHOR>Lopez-Vidriero-M-T</AUTHOR><AUTHOR>Reid-L</AUTHOR></AUTHORS>
<TITLE>Chemical markers of mucous and serum glycoproteins and their
relation to viscosity in mucoid and purulent sputum from various
hypersecretory diseases.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1978 Mar. 117(3). P 465-77.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-DISEASES: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>GLYCOPROTEINS: an</TOPIC><TOPIC>MUCUS: an</TOPIC><TOPIC>SPUTUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ASTHMA: me</TOPIC><TOPIC>BRONCHIECTASIS: me</TOPIC><TOPIC>BRONCHITIS: me</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FUCOSE: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SIALOGLYCOPROTEINS: an</TOPIC><TOPIC>VISCOSITY</TOPIC></MINORSUBJ>
<ABSTRACT>Mucus and serum are always present in sputum. The concentrations of
their markers were measured in mucoid and purulent sputum from
patients with chronic bronchitis, asthma, cystic fibrosis, or
bronchiectasis. Differences in the concentrations of both mucous and
serum glycoproteins were greater among different macroscopic types of
sputum than among diseases for the same macroscopic type. Comparison
between diseases showed that sputum from patients with asthma had the
widest variation in concentrations of markers of mucous glycoprotein
and dry macromolecular weight. When the astham group was further
analyzed, it became apparent that patients with extrinsic asthma
without chronic bronchitis represented a homogeneous group, whereas
those with intrinsic asthma, with or without chronic bronchitis, were
responsible for the wide variation. The concentrations of markers of
mucous and serum glycoproteins in a sputum sample were correlated
with the apparent viscosity of the sputum to establish the relative
contribution of the glycoproteins to the viscosity of sputum. In
mucoid sputum, the mucous glycoprotein was most important in
determining the viscosity, whereas when in infected sputum, both
mucous and serum components contributed to the viscosity.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DEGAND P" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="199" d3="973"/>
<CITE num="002" author="BOAT TF" publication="IN: DULFANO MJ" d1="" d2="243" d3="973"/>
<CITE num="003" author="ROBERTS GP" publication="EUR J BIOCHEM" d1="50" d2="265" d3="974"/>
<CITE num="004" author="CREETH JM" publication="BIOCHEM J" d1="167" d2="557" d3="977"/>
<CITE num="005" author="BROGAN TD" publication="THORAX" d1="26" d2="418" d3="971"/>
<CITE num="006" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="007" author="SPIRO SG" publication="J CLIN PATHOL" d1="28" d2="60" d3="975"/>
<CITE num="008" author="KEAL EE" publication="POSTGRAD MED J" d1="47" d2="171" d3="971"/>
<CITE num="009" author="LOPEZ-VIDRIERO MT" publication="THORAX" d1="28" d2="401" d3="973"/>
<CITE num="010" author="PUCHELLE E" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="237" d3="973"/>
<CITE num="011" author="ROBERTS GP" publication="ARCH BIOCHEM BIOPHYS" d1="173" d2="528" d3="976"/>
<CITE num="012" author="LITT M" publication="BIORHEOLOGY" d1="11" d2="111" d3="974"/>
<CITE num="013" author="MARRIOTT C" publication="BIORHEOLOGY" d1="11" d2="119" d3="974"/>
<CITE num="014" author="MARRIOTT C" publication="BIORHEOLOGY" d1="11" d2="129" d3="974"/>
<CITE num="015" author="LITT M" publication="BIORHEOLOGY" d1="13" d2="37" d3="976"/>
<CITE num="016" author="CHEN TM" publication="BIORHEOLOGY" d1="13" d2="211" d3="976"/>
<CITE num="017" author="FORBES J" publication="LANCET" d1="2" d2="767" d3="957"/>
<CITE num="018" author="MUNIES R" publication="J PHARM SCI" d1="57" d2="824" d3="968"/>
<CITE num="019" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="97" d2="654" d3="968"/>
<CITE num="020" author="DAVIS SS" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="47" d3="973"/>
<CITE num="021" author="ANON" publication="LANCET" d1="2" d2="775" d3="965"/>
<CITE num="022" author="PORTER R" publication="CIBA FOUND STUDY GROUP 38" d1="" d2="" d3="971"/>
<CITE num="023" author="ANDERSON CM" publication="MED J AUST" d1="1" d2="419" d3="958"/>
<CITE num="024" author="CHARMAN J" publication="BIORHEOLOGY" d1="9" d2="185" d3="972"/>
<CITE num="025" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
<CITE num="026" author="GIBBONS MN" publication="ANALYST" d1="80" d2="268" d3="955"/>
<CITE num="027" author="ANTONOPOULOS CA" publication="ACTA CHEM SCAND" d1="16" d2="1521" d3="962"/>
<CITE num="028" author="DAS I" publication="FED EUR BIOCHEM SOC 9TH MTG" d1="" d2="438" d3="974"/>
<CITE num="029" author="PALMER KNV" publication="BR J DIS CHEST" d1="64" d2="185" d3="970"/>
<CITE num="031" author="LAMB D" publication="HISTOCHEM J" d1="4" d2="91" d3="972"/>
<CITE num="032" author="JONES R" publication="HISTOCHEM J" d1="5" d2="19" d3="973"/>
<CITE num="033" author="LAMB D" publication="THESIS" d1="" d2="" d3="969"/>
<CITE num="034" author="KEAL EE" publication="THESIS" d1="" d2="" d3="970"/>
<CITE num="035" author="LAMB D" publication="J PATHOL" d1="98" d2="213" d3="969"/>
<CITE num="036" author="LAMB D" publication="BR J DIS CHEST" d1="66" d2="239" d3="972"/>
<CITE num="037" author="JONES R" publication="J PATHOL" d1="116" d2="1" d3="975"/>
<CITE num="038" author="JONES R" publication="PROC INT SYMP ON MUCUS I" d1="" d2="397" d3="976"/>
<CITE num="039" author="MCCARTHY C" publication="Q J EXP PHYSIOL" d1="49" d2="85" d3="964"/>
<CITE num="040" author="LAMB D" publication="J PATHOL BACTERIOL" d1="96" d2="87" d3="968"/>
<CITE num="041" author="JONES R" publication="BR MED J" d1="2" d2="142" d3="972"/>
<CITE num="042" author="JONES R" publication="BR J EXP PATHOL" d1="54" d2="229" d3="973"/>
<CITE num="043" author="MATTHEWS LW" publication="AM REV RESPIR DIS" d1="88" d2="199" d3="963"/>
<CITE num="044" author="DENNIS EG" publication="J ALLERGY" d1="35" d2="464" d3="964"/>
<CITE num="045" author="SCHULTZE HE" publication="MOLECULAR BIOL OF HUMAN PROTE" d1="1" d2="" d3="966"/>
<CITE num="046" author="HOUSTON JC" publication="THORAX" d1="8" d2="207" d3="953"/>
<CITE num="047" author="KEAL EE" publication="IN: STEIN M" d1="" d2="223" d3="975"/>
<CITE num="048" author="EARLE BV" publication="THORAX" d1="8" d2="195" d3="953"/>
<CITE num="049" author="GLYNN AA" publication="THORAX" d1="15" d2="142" d3="960"/>
<CITE num="050" author="GORDON WI" publication="PROC SYMP NATURE OF ASTHMA" d1="" d2="25" d3="964"/>
<CITE num="051" author="VIDAL J" publication="COLLOQ INT PATHOL THORAC LILL" d1="" d2="69" d3="968"/>
<CITE num="052" author="DUNNILL MS" publication="IN: STEIN M" d1="" d2="213" d3="975"/>
<CITE num="053" author="TURIAF J" publication="J FRANC MED CHIR THORAC" d1="12" d2="290" d3="958"/>
<CITE num="054" author="GIBBONS RA" publication="BIOCHEM J" d1="73" d2="209" d3="959"/>
<CITE num="055" author="GIBBONS RA" publication="BIOCHEM J" d1="73" d2="209" d3="959"/>
<CITE num="056" author="PUCHELLE E" publication="BIORHEOLOGY" d1="12" d2="219" d3="975"/>
<CITE num="057" author="MEYER FA" publication="BIORHEOLOGY" d1="13" d2="49" d3="976"/>
<CITE num="058" author="KEAL EE" publication="THORAX" d1="27" d2="643" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78025</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PEZVIDRIERO MT      TH" publication="ORAX" d1="34" d2="12 9" d3="9"/>
<CITE num="2" author="WANNER A" publication="AM J MED" d1="67" d2="477" d3="979"/>
<CITE num="3" author="LOPEZVIDRIERO MT" publication="SCAND J RESPIR DIS" d1="1979" d2="33" d3="979"/>
<CITE num="4" author="SHIMURA S" publication="BIORHEOLOGY" d1="17" d2="363" d3="980"/>
<CITE num="5" author="BATTISTA SP" publication="ARCH ENVIRON HEALTH" d1="35" d2="239" d3="980"/>
<CITE num="6" author="REID LM" publication="ENVIRON HEALTH PERSPECT" d1="35" d2="113" d3="980"/>
<CITE num="7" author="KING M" publication="FED PROC" d1="39" d2="3080" d3="980"/>
<CITE num="8" author="KING M" publication="EUR J RESPIR DIS" d1="61" d2="39" d3="980"/>
<CITE num="9" author="LOPEZVIDRIERO MT" publication="EUR J RESPIR DIS" d1="61" d2="21" d3="980"/>
<CITE num="10" author="LOPEZVIDRIERO MT" publication="J COMP PATHOL" d1="90" d2="415" d3="980"/>
<CITE num="11" author="KING M" publication="PEDIATR RES" d1="15" d2="120" d3="981"/>
<CITE num="12" author="PUCHELLE E" publication="BIORHEOLOGY" d1="18" d2="659" d3="981"/>
<CITE num="13" author="BAUER E" publication="RES COMMUN CHEM PATH PHARM" d1="34" d2="547" d3="981"/>
<CITE num="14" author="MIRRAKHIMOV MM" publication="TER ARKH" d1="53" d2="110" d3="981"/>
<CITE num="15" author="SNYDER CE" publication="CARBOHYD RES" d1="105" d2="87" d3="982"/>
<CITE num="16" author="MORRIS JB" publication="ANAL BIOCHEM" d1="121" d2="129" d3="982"/>
<CITE num="17" author="REID L" publication="ADV EXP MED BIOL" d1="144" d2="369" d3="982"/>
<CITE num="18" author="REID L" publication="EXP LUNG RES" d1="4" d2="157" d3="983"/>
<CITE num="19" author="HARBITZ O" publication="EUR J RESPIR DIS" d1="65" d2="512" d3="984"/>
<CITE num="20" author="MORETTI M" publication="EUR J RESPIR DIS" d1="65" d2="365" d3="984"/>
<CITE num="21" author="STELANDER M" publication="EUR J RESPIR DIS" d1="65" d2="5" d3="984"/>
<CITE num="22" author="GREENSTONE M" publication="BR J DIS CHEST" d1="79" d2="9" d3="985"/>
<CITE num="23" author="BROWN DT" publication="ANN OTOL RHINOL LARYNGOL" d1="94" d2="3" d3="985"/>
<CITE num="24" author="BROFELDT S" publication="AM REV RESPIR DIS" d1="133" d2="1138" d3="986"/>
<CITE num="25" author="MORETTI M" publication="THORAX" d1="42" d2="229" d3="987"/>
<CITE num="26" author="ROGERS DF" publication="CLIN SCI" d1="72" d2="629" d3="987"/>
</CITATIONS>
<RECORDNUM>00806 </RECORDNUM>
<MEDLINENUM>79101945</MEDLINENUM>
<AUTHORS><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Orenstein-D-M</AUTHOR><AUTHOR>Wood-R-E</AUTHOR><AUTHOR>Matthews-L-W</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR></AUTHORS>
<TITLE>Treatment and prognosis of lobar and segmental atelectasis in cystic
fibrosis.</TITLE>
<SOURCE>Am-Rev-Respir-Dis. 1978 Nov. 118(5). P 821-6.</SOURCE>
<MAJORSUBJ><TOPIC>ATELECTASIS: et</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ATELECTASIS: di, th</TOPIC><TOPIC>BRONCHOSCOPY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Lobar atelectasis occurred in 30 (4.1 per cent) and segmental
atelectasis occurred in 6 (0.8 per cent) of 728 patients with cystic
fibrosis. The right lung was involved in all 11 patients less than 5
years of age and in 18 of 26 episodes in 19 older patients. Five of
the younger patients died within 5 years of the initial episode.
Bronchoscopy (with or without local lavage) performed in addition to
intensified medical therapy did not appear to improve the outcome.
Future studies of therapeutic measures (including bronchoscopy) for
treatment of atelectasis complicating cystic fibrosis must include
appropriate control patients who receive only medical therapy.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="178" d3="953"/>
<CITE num="002" author="LLOYD-STILL JD" publication="PEDIATRICS" d1="53" d2="678" d3="974"/>
<CITE num="003" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="004" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="976"/>
<CITE num="005" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="006" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="963"/>
<CITE num="007" author="JAY SJ" publication="N ENGL J MED" d1="293" d2="798" d3="975"/>
<CITE num="008" author="FOX HM" publication="AM REV RESPIR DIS" d1="108" d2="469" d3="973"/>
<CITE num="009" author="ABDULMAJID OA" publication="THORAX" d1="31" d2="635" d3="976"/>
<CITE num="010" author="WELLONS HA" publication="AM J DIS CHILD" d1="130" d2="301" d3="976"/>
<CITE num="011" author="DEES SC" publication="JAMA" d1="197" d2="8" d3="966"/>
<CITE num="012" author="LIU PV" publication="HOSP PRACT" d1="11" d2="139" d3="976"/>
<CITE num="013" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="014" author="BEDROSSIAN CWM" publication="HUM PATHOL" d1="7" d2="195" d3="976"/>
<CITE num="015" author="HOLSCLAW DS" publication="CLIN PEDIATR" d1="9" d2="346" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78026</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DDING GJ            PE" publication="DIATR CLIN NORTH AM" d1="31" d2="91 9" d3="4"/>
<CITE num="2" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="3" author="LESTER LA" publication="SEM RESPIR MED" d1="6" d2="285" d3="985"/>
<CITE num="4" author="REDDING GJ" publication="PEDIATR RES" d1="19" d2="552" d3="985"/>
<CITE num="5" author="NUSSBAUM E" publication="CLIN PEDIATR" d1="24" d2="379" d3="985"/>
<CITE num="6" author="ABMAN SH" publication="J PEDIATR" d1="107" d2="933" d3="985"/>
<CITE num="7" author="SHERMAN JM" publication="PEDIATR PULMONOL" d1="2" d2="244" d3="986"/>
<CITE num="8" author="TOMASHEFSKI JF" publication="AM REV RESPIR DIS" d1="133" d2="535" d3="986"/>
</CITATIONS>
<RECORDNUM>00807 </RECORDNUM>
<MEDLINENUM>79081157</MEDLINENUM>
<AUTHORS><AUTHOR>Brackenridge-C-J</AUTHOR></AUTHORS>
<TITLE>The seasonal variation of births of offspring from couples
heterozygous for cystic fibrosis.</TITLE>
<SOURCE>Ann-Hum-Genet. 1978 Oct. 42(2). P 197-201.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>SEASONS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AUSTRALIA</TOPIC><TOPIC>BIRTH-RATE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FERTILITY</TOPIC><TOPIC>GENES</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>STATISTICS</TOPIC><TOPIC>TEMPERATURE</TOPIC></MINORSUBJ>
<ABSTRACT>To test whether the month of birth of patients with cystic fibrosis
(CF) is seasonally distributed as reported in a Dutch survey,
published Australian data were examined and no difference in the
monthly variation was found between births of CF patients and their
unaffected sibs. When the two groups were combined and analysed by
periodic regression using successively higher Fourier terms, a
significant fit to the observed frequencies was obtained with a
bimodal curve. Possession of a single CF gene seems therefore
sufficient for expression of the cyclic variation. In substantial
agreement with the Dutch series, maximum frequencies were found to
occur in March or April and in September. It is suggested that one or
both parents may be subject to variable fertility mediated by a
temperature-dependent mechanism. The relevance of a periodic
fertility pattern in preserving the CF gene in the population by
selective heterozygote advantage is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BLISS CI" publication="STATISTICS IN BIOLOGY" d1="2" d2="219" d3="970"/>
<CITE num="002" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="004" author="EDWARDS JH" publication="ANN HUM GENET" d1="25" d2="89" d3="961"/>
<CITE num="005" author="FROGGATT P" publication="BR J PREV SOC MED" d1="25" d2="119" d3="971"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="GUMBEL EJ" publication="J AM STATIST ASSOC" d1="49" d2="267" d3="954"/>
<CITE num="008" author="KESSLER WR" publication="PEDIATRICS" d1="8" d2="648" d3="951"/>
<CITE num="009" author="LOWE CU" publication="AM J DIS CHILD" d1="78" d2="349" d3="949"/>
<CITE num="010" author="MIETTINEN OS" publication="BR HEART J" d1="32" d2="103" d3="970"/>
<CITE num="011" author="PIKE MC" publication="BR MED J" d1="2" d2="395" d3="967"/>
<CITE num="012" author="SHWACHMAN H" publication="N ENGL J MED" d1="255" d2="999" d3="956"/>
<CITE num="013" author="TEN KATE LP" publication="INT J EPIDEMIOL" d1="6" d2="23" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78027</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ACKENRIDGE CJ       AM" publication="J MED GENET" d1="5" d2="03 9" d3="0"/>
<CITE num="2" author="BRACKENRIDGE CJ" publication="AM J MED GENET" d1="5" d2="295" d3="980"/>
<CITE num="3" author="ROMEO G" publication="RIV ITAL PEDIATR" d1="7" d2="201" d3="981"/>
<CITE num="4" author="DAVID TJ" publication="J MED GENET" d1="18" d2="299" d3="981"/>
<CITE num="5" author="PASSARGE E" publication="EUR J PEDIATR" d1="143" d2="54" d3="984"/>
<CITE num="6" author="MITCHELL RJ" publication="HUM BIOL" d1="57" d2="213" d3="985"/>
</CITATIONS>
<RECORDNUM>00808 </RECORDNUM>
<MEDLINENUM>78078968</MEDLINENUM>
<AUTHORS><AUTHOR>Andrews-C</AUTHOR><AUTHOR>Mango-M</AUTHOR><AUTHOR>Venuto-R-C</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in adults [letter].</TITLE>
<SOURCE>Ann-Intern-Med. 1978 Jan. 88(1). P 128-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HEAT-EXHAUSTION: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPONATREMIA: et</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>An adult male was recently discovered to have cystic fibrosis after a
unique clinical presentation not mentioned in the review article.
This patient with recurrent episodes of heat exhaustion and
hyponatremia had no extraordinary source of Na+ loss other than his
sweat.  This case represents an important new presentation of cystic
fibrosis.  Most internists view this disease as one seen only in
chronically ill children.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78028</PAPERNUM>
<REFERENCES>
<CITE num="001" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="002" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="003" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>
<RECORDNUM>00809 </RECORDNUM>
<MEDLINENUM>79061093</MEDLINENUM>
<AUTHORS><AUTHOR>Schaad-U</AUTHOR><AUTHOR>Kraemer-R</AUTHOR><AUTHOR>Gaze-H</AUTHOR><AUTHOR>Hadorn-B</AUTHOR></AUTHORS>
<TITLE>One-hour blood-xylose in cystic fibrosis.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Sep. 53(9). P 756-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>XYLOSE: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>One-hour blood-xylose concentrations after an oral xylose load were
measured in children with cystic fibrosis (CF) and healthy controls.
The mean of the 1-hour blood-xylose values was significantly
increased in the group with CF. The finding confirms an earlier
observation by Rolles et al. (1973). Its significance is not at
present understood but it suggests that small intestinal function
should be further investigated in CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="COLOMBO JP" publication="IN: RICHTERICH R" d1="" d2="462" d3="978"/>
<CITE num="002" author="GIBBONS ISE" publication="ARCH DIS CHILD" d1="44" d2="63" d3="969"/>
<CITE num="003" author="ROE JH" publication="J BIOL CHEM" d1="173" d2="507" d3="948"/>
<CITE num="004" author="ROLLES CJ" publication="LANCET" d1="2" d2="1043" d3="973"/>
<CITE num="005" author="SCHAAD U" publication="ARCH DIS CHILD" d1="53" d2="420" d3="978"/>
<CITE num="006" author="SCHAAD U" publication="HELV PAEDIATR ACTA" d1="30" d2="331" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78029</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ASE LL              GA" publication="STROENTEROLOGY" d1="88" d2="78 9" d3="5"/>
<CITE num="2" author="PENNY DJ" publication="ARCH DIS CHILD" d1="61" d2="1127" d3="986"/>
<CITE num="3" author="LECLERCQFOUCART J" publication="J PEDIATR GASTROENTEROL NUTR" d1="6" d2="66" d3="987"/>
</CITATIONS>
<RECORDNUM>00810 </RECORDNUM>
<MEDLINENUM>79061100</MEDLINENUM>
<AUTHORS><AUTHOR>Ahuja-A-S</AUTHOR><AUTHOR>Mann-N-M</AUTHOR></AUTHORS>
<TITLE>Cimetidine in cystic fibrosis [letter].</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Sep. 53(9). P 766.</SOURCE>
<MAJORSUBJ><TOPIC>CIMETIDINE: tu</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>GUANIDINES: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FATS: an</TOPIC><TOPIC>FECES: an</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>A pilot study has examined the effect of cimetidine on steatorrhea in
children with pancreatic insufficiency due to CF who were receiving
pancreatic supplements.  Administration of cimetidine with pancreatic
supplements reduced the faecal fat excretion in 4 out of 5 children,
in 3 cases by more than 50%.  In Case 4 steatorrhea increased on
cimetidine but without any symptoms and we have no explanation for
it.  None of the children had any side effects from the drug.
Further studies are needed to determine the indications of cimetidine
in the dietary management of CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HEIZER WD" publication="BULL JOHNS HOPKINS HOSP" d1="116" d2="261" d3="965"/>
<CITE num="002" author="KATTWINKEL J" publication="PEDIATRICS" d1="50" d2="133" d3="972"/>
<CITE num="003" author="REGAN PT" publication="GASTROENTEROLOGY" d1="72" d2="A95" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78030</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HONI M              HE" publication="LV PAEDIATR ACTA" d1="36" d2="59 9" d3="1"/>
<CITE num="2" author="BELL L" publication="J CAN DIET ASSOC" d1="42" d2="62" d3="981"/>
</CITATIONS>
<RECORDNUM>00811 </RECORDNUM>
<MEDLINENUM>78164870</MEDLINENUM>
<AUTHORS><AUTHOR>Smalley-C-A</AUTHOR><AUTHOR>Addy-D-P</AUTHOR><AUTHOR>Anderson-C-M</AUTHOR></AUTHORS>
<TITLE>Limitations of the sweat test [letter].</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Apr. 53(4). P 351-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>SODIUM: an</TOPIC></MINORSUBJ>
<EXTRACT>We are in agreement with Schwarz et al. when they state that the
sweat test has some limitations in the diagnosis of cystic fibrosis
(CF) and that the diagnosis is not justified on the basis of an
abnormal sweat test unless there is other supporting evidence of the
disease.  In our experience a much greater problem of sweat test
accuracy occurs in hospitals where the test is carried out on a very
much smaller number of patients and where the laboratory has a much
lesser degree of experience than that of the authors.  We have had a
significant number of patients referred to our regional children's
hospital who have had abnormal sweat electrolyte measurements
elsewhere, but unequivocally normal measurements when repeated by a
laboratory carrying out a large number of tests.  We have not needed
to go to the extent of serial collections of sweat and of giving
spironolactone as have the authors.  If we obtain a test within the
'grey area' on repeated occasions, we carefully seek other evidence
of the disease, particularly evidence of pancreatic disease. - We do
not advocate the general use of spironolactone: the merit of this
drug in our experiments on certain patients was merely to support our
suspicion of temporary hyperaldosteronism, a condition which might
have led to erroneous conclusions in the absence of K or Cl
determinations.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78031</PAPERNUM>
<REFERENCES>
<CITE num="001" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="52" d2="870" d3="977"/>
<CITE num="002" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="003" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
</REFERENCES>
<RECORDNUM>00812 </RECORDNUM>
<MEDLINENUM>79040865</MEDLINENUM>
<AUTHORS><AUTHOR>Turner-M-W</AUTHOR><AUTHOR>Warner-J-O</AUTHOR><AUTHOR>Stokes-C-R</AUTHOR></AUTHORS>
<TITLE>Immunological studies in cystic fibrosis.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Aug. 53(8). P 631-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HLA-ANTIGENS: an</TOPIC><TOPIC>IGE: an</TOPIC><TOPIC>IMMUNOGLOBULINS: an</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>RESPIRATORY-HYPERSENSITIVITY: co, im</TOPIC></MINORSUBJ>
<ABSTRACT>Evidence is presented to support the concept that much of the
allergy in cystic fibrosis (CF) is IgE mediated.  Total IgE levels
were higher in allergic than in nonallergic CF patients.  Levels
were also higher in those patients who had had the greatest number
of chest infections in the preceding 12 months.  IgE antibody levels
to Dermatophagoides pteronyssinus, Timothy grass pollen, and
Aspergillus fumigatus were higher in those with positive results
from skin tests to these allergens.  The serum IgG, IgM, and IgA
levels of allergic and nonallergic CF patients did not differ but
the overall mean values for IgG and iGM were higher than those
reported for healthy British children.  The highest levels tended to
be present in patients with the greatest number of recent major
chest infections and the difference was significant for IgG.  16
patients had IgA levels &gt;2 SD below the reported means for
age-matched controls and 11 of these were nonallergic.  IgA levels
were also higher in patients who had recently experienced major
chest infections.  45 of the patients were tissue types for HLA A
and B antigens but no significant clinical associations with single
antigens were observed.  The antigen phenotype A1 + B8 was more
common in patients with multiple allergic symptoms than in those
with a single allergy or merely a positive result from a skin test.
Nonsignificant increases of W19 in patients with frequent infections
and of A2 in patients presenting with meconium ileus were also
noted.  The data presented do not permit a choice to be made between
the alternative concepts of allergy as a primary abnormality in CF,
and allergy arising secondary to infection.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="002" author="COOMBS RRA" publication="IN: GELL PGH" d1="" d2="761" d3="975"/>
<CITE num="003" author="FAHEY JL" publication="J IMMUNOL" d1="94" d2="84" d3="965"/>
<CITE num="004" author="GEBHARD RL" publication="LANCET" d1="2" d2="760" d3="973"/>
<CITE num="005" author="HOBBS JR" publication="ASSOC CLIN PATHOLOGISTS BROAD" d1="" d2="1" d3="970"/>
<CITE num="006" author="KAISER GI" publication="HLA AND DISEASE" d1="" d2="252" d3="976"/>
<CITE num="007" author="ANON" publication="LANCET" d1="2" d2="1291" d3="975"/>
<CITE num="008" author="MACKAY IR" publication="LANCET" d1="2" d2="793" d3="972"/>
<CITE num="009" author="MCNEISH AS" publication="LANCET" d1="1" d2="668" d3="973"/>
<CITE num="010" author="MEARNS MB" publication="LANCET" d1="1" d2="538" d3="967"/>
<CITE num="011" author="MICKEY MR" publication="TISSUE ANTIGENS" d1="1" d2="57" d3="971"/>
<CITE num="012" author="MITTAL KK" publication="TRANSPLANTATION" d1="6" d2="913" d3="968"/>
<CITE num="013" author="NELSON SD" publication="TISSUE ANTIGENS" d1="4" d2="361" d3="974"/>
<CITE num="014" author="NYE L" publication="CLIN ALLERGY" d1="5" d2="13" d3="975"/>
<CITE num="015" author="PARISH WE" publication="LANCET" d1="2" d2="591" d3="970"/>
<CITE num="016" author="PIRSKANEN R" publication="ANN CLIN RES" d1="4" d2="304" d3="972"/>
<CITE num="017" author="POLYMENIDIS Z" publication="LANCET" d1="2" d2="1452" d3="973"/>
<CITE num="018" author="SHAKIB F" publication="CLIN ALLERGY" d1="6" d2="237" d3="976"/>
<CITE num="019" author="SOOTHILL JF" publication="CLIN ALLERGY" d1="6" d2="305" d3="976"/>
<CITE num="020" author="STANWORTH DR" publication="CLIN ALLERGY" d1="3" d2="37" d3="973"/>
<CITE num="021" author="SVEJGAARD A" publication="TRANSPLANT REV" d1="22" d2="3" d3="975"/>
<CITE num="022" author="TAYLOR B" publication="LANCET" d1="2" d2="111" d3="973"/>
<CITE num="023" author="TURNER MW" publication="CLIN EXP IMMUNOL" d1="27" d2="43" d3="977"/>
<CITE num="024" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="025" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="026" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="027" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="028" author="WEEKE B" publication="DAN MED BULL" d1="23" d2="155" d3="976"/>
<CITE num="029" author="WIDE L" publication="LANCET" d1="2" d2="1105" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78032</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NASPEREN PP         AU" publication="ST PAEDIATR J" d1="16" d2="53 9" d3="0"/>
<CITE num="2" author="ORMEROD LP" publication="THORAX" d1="35" d2="768" d3="980"/>
<CITE num="3" author="BRUETON MJ" publication="ARCH DIS CHILD" d1="55" d2="348" d3="980"/>
<CITE num="4" author="HARPER TB" publication="LUNG" d1="157" d2="219" d3="980"/>
<CITE num="5" author="DINWIDDIE R" publication="PRACTITIONER" d1="224" d2="291" d3="980"/>
<CITE num="6" author="MATTHEWS WJ" publication="N ENGL J MED" d1="302" d2="245" d3="980"/>
<CITE num="7" author="REEN DJ" publication="CLIN ALLERGY" d1="11" d2="571" d3="981"/>
<CITE num="8" author="PITCHERWILMOTT RW" publication="ARCH DIS CHILD" d1="57" d2="577" d3="982"/>
<CITE num="9" author="VOSS MJ" publication="J ALLERGY CLIN IMMUNOL" d1="69" d2="536" d3="982"/>
<CITE num="10" author="GUIDOTTI TL" publication="AM J MED SCI" d1="283" d2="157" d3="982"/>
<CITE num="11" author="ANON" publication="LANCET" d1="2" d2="257" d3="983"/>
<CITE num="12" author="AUERBACH HS" publication="LANCET" d1="2" d2="686" d3="985"/>
<CITE num="13" author="MOSS RB" publication="MONOGR ALLERGY" d1="19" d2="202" d3="986"/>
<CITE num="14" author="FERGUSON A" publication="HUM NUTR CLIN NUTR" d1="40C" d2="255" d3="986"/>
<CITE num="15" author="CANNY GJ" publication="THORAX" d1="41" d2="221" d3="986"/>
<CITE num="16" author="FICK RB" publication="AM REV RESPIR DIS" d1="133" d2="418" d3="986"/>
<CITE num="17" author="DASGUPTA MK" publication="J CLIN IMMUNOL" d1="7" d2="51" d3="987"/>
<CITE num="18" author="MOSS RB" publication="CHEST" d1="91" d2="522" d3="987"/>
</CITATIONS>
<RECORDNUM>00813 </RECORDNUM>
<MEDLINENUM>79081404</MEDLINENUM>
<AUTHORS><AUTHOR>Yassa-J-G</AUTHOR><AUTHOR>Prosser-R</AUTHOR><AUTHOR>Dodge-J-A</AUTHOR></AUTHORS>
<TITLE>Effects of an artificial diet on growth of patients with cystic
fibrosis.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Oct. 53(10). P 777-83.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC><TOPIC>FOOD-FORMULATED</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AGE-DETERMINATION-BY-SKELETON</TOPIC><TOPIC>BODY-HEIGHT</TOPIC><TOPIC>BODY-WEIGHT</TOPIC><TOPIC>CEPHALOMETRY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SKINFOLD-THICKNESS</TOPIC></MINORSUBJ>
<ABSTRACT>The effects of an artificial diet on growth were examined in a
controlled trial on 43 patients with cystic fibrosis. 28 patients
received the diet for 12 months. Comparison was made between their
growth before, during, and after dietary treatment. Growth changes
were also assessed in 15 other patients who received a conventional
diet. Artificial dietary treatment led to some improvement in height,
weight, subscapular skinfold thickness, and a disproportionate
advance of bone age for the group as a whole. Only 10 (36%) patients
had a 'clinically' significant improvement in height, weight, or both-
-i.e. more than 0.5 standard deviation score. Greatest improvements
were in young and mildly affected patients. It is proposed that the
future use of such an unpleasant and expensive diet should be
restricted to a few selected cases, rather than given as routine
treatment.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALLAN JD" publication="AM J DIS CHILD" d1="126" d2="22" d3="973"/>
<CITE num="002" author="BERRY HK" publication="AM J DIS CHILD" d1="129" d2="165" d3="975"/>
<CITE num="003" author="CLARKE CW" publication="Q J MED" d1="17" d2="358" d3="924"/>
<CITE num="004" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="005" author="HARPER MH" publication="MED J AUST" d1="2" d2="663" d3="930"/>
<CITE num="006" author="LOBER CW" publication="AM J DIS CHILD" d1="129" d2="1239" d3="975"/>
<CITE num="007" author="PASSINI F" publication="DTSCH MED WSCHR" d1="45" d2="851" d3="919"/>
<CITE num="008" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="009" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="010" author="SPROUL A" publication="J PEDIATR" d1="65" d2="664" d3="964"/>
<CITE num="011" author="TANNER JM" publication="IN: FORFAR JO" d1="" d2="270" d3="973"/>
<CITE num="012" author="TANNER JM" publication="ARCH DIS CHILD" d1="50" d2="142" d3="975"/>
<CITE num="013" author="TANNER JM" publication="ASSESSMENT OF SKELETAL MATURI" d1="" d2="" d3="975"/>
<CITE num="014" author="TANNER JM" publication="ARCH DIS CHILD" d1="41" d2="454" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78033</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ASE HP              J" publication="PEDIATR" d1="95" d2="37 9" d3="9"/>
<CITE num="2" author="KASPER H" publication="LEBER MAGEN DARM" d1="10" d2="269" d3="980"/>
<CITE num="3" author="KORETZ RL" publication="GASTROENTEROLOGY" d1="78" d2="393" d3="980"/>
<CITE num="4" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="5" author="MILLER M" publication="AM J CLIN NUTR" d1="36" d2="492" d3="982"/>
<CITE num="6" author="PENCHARZ PB" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="400" d3="983"/>
<CITE num="7" author="SHEPHERD RW" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="439" d3="983"/>
<CITE num="8" author="BERTRAND JM" publication="J PEDIATR" d1="104" d2="41" d3="984"/>
<CITE num="9" author="MANSELL AL" publication="J PEDIATR" d1="104" d2="700" d3="984"/>
<CITE num="10" author="CANCIANI M" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="735" d3="985"/>
<CITE num="11" author="HEINE W" publication="Z KLIN MED" d1="40" d2="181" d3="985"/>
<CITE num="12" author="HOLT TL" publication="AM J CLIN NUTR" d1="41" d2="1061" d3="985"/>
<CITE num="13" author="RUSSELL RI" publication="PROC NUTR SOC" d1="44" d2="87" d3="985"/>
<CITE num="14" author="MEARNS MB" publication="ARCH DIS CHILD" d1="60" d2="272" d3="985"/>
<CITE num="15" author="CHALMERS DM" publication="ACTA PAEDIATR SCAND" d1="74" d2="114" d3="985"/>
<CITE num="16" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="17" author="NEIJENS HJ" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="38" d3="985"/>
<CITE num="18" author="LESTER LA" publication="J PARENT ENTERAL NUTR" d1="10" d2="289" d3="986"/>
<CITE num="19" author="SOUTTER VL" publication="CLIN GASTROENTEROL" d1="15" d2="137" d3="986"/>
<CITE num="20" author="FERGUSON A" publication="HUM NUTR CLIN NUTR" d1="40C" d2="255" d3="986"/>
<CITE num="21" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
<CITE num="22" author="OLOUGHLIN E" publication="AM J CLIN NUTR" d1="43" d2="732" d3="986"/>
<CITE num="23" author="MOORE MC" publication="AM J CLIN NUTR" d1="44" d2="33" d3="986"/>
<CITE num="24" author="GOODCHILD MC" publication="J ROY SOC MED" d1="79" d2="32" d3="986"/>
</CITATIONS>
<RECORDNUM>00814 </RECORDNUM>
<MEDLINENUM>78122876</MEDLINENUM>
<AUTHORS><AUTHOR>Godfrey-S</AUTHOR><AUTHOR>Mearns-M</AUTHOR><AUTHOR>Howlett-G</AUTHOR></AUTHORS>
<TITLE>Serial lung function studies in cystic fibrosis in the first 5 years
of life.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Jan. 53(1). P 83-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC></MINORSUBJ>
<ABSTRACT>Lung mechanics were studied in 8 infants with cystic fibrosis at 6
months of life and radiosotopic lung function was measured in 5 of
them at 5 years of age. The children who were initially asymptomatic
had normal lung mechanics in infancy but the 2 restudied later had
abnormal radioisotopic lung function. The symptomatic children showed
abnormalities in infancy and more marked changes later. It is
concluded that the lungs in cystic fibrosis are probably normal
initially and that damage occurs later even in the absence of
symptoms.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="002" author="HOWLETT G" publication="ARCH DIS CHILD" d1="47" d2="707" d3="972"/>
<CITE num="003" author="LAMARRE A" publication="PEDIATRICS" d1="50" d2="291" d3="972"/>
<CITE num="004" author="PHELAN PD" publication="ARCH DIS CHILD" d1="44" d2="393" d3="969"/>
<CITE num="005" author="RONCHETTI R" publication="ARCH DIS CHILD" d1="50" d2="595" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78034</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AEMER R             HE" publication="LV PAEDIATR ACTA" d1="34" d2="17 9" d3="9"/>
<CITE num="2" author="PEDERZINI F" publication="RIV ITAL PEDIATR" d1="9" d2="445" d3="983"/>
<CITE num="3" author="GODFREY S" publication="PEDIATRICS" d1="72" d2="517" d3="983"/>
<CITE num="4" author="TEPPER RS" publication="AM REV RESPIR DIS" d1="135" d2="1075" d3="987"/>
</CITATIONS>
<RECORDNUM>00815 </RECORDNUM>
<MEDLINENUM>79040866</MEDLINENUM>
<AUTHORS><AUTHOR>Sacher-M</AUTHOR><AUTHOR>Kobsa-A</AUTHOR><AUTHOR>Shmerling-D-H</AUTHOR></AUTHORS>
<TITLE>PABA screening test for exocrine pancreatic function in infants and
children.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Aug. 53(8). P 639-41.</SOURCE>
<MAJORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: du</TOPIC><TOPIC>AMINOBENZOIC-ACIDS: du</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PANCREAS: ph</TOPIC><TOPIC>PANCREATIC-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: ur</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHYMOTRYPSIN: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>PANCREATIC-DISEASES: et, ur</TOPIC></MINORSUBJ>
<ABSTRACT>P-Amino-benzoic acid (PABA) is split specifically by pancreatic
chymotrypsin from the synthetic tripeptide N-benzoyl-L-tyrosyl-PABA.
The urinary excretion of absorbed PABA serves as an index for
exocrine pancreatic function. The peptide (0.015 g/kg) was
administered orally to 20 controls (aged between 5 months and 16
years), 6 patients with exocrine pancreatic insufficiency caused by
cystic fibrosis (CF), and 9 newborn infants. In the controls the mean
6-hour PABA recovery was 58.5% (+/- 11.2 SD). Recovery in patients
with CF was lower (P less than 0.001) with no overlap. In newborn
infants the mean 6-hour PABA recovery was 23.4 (+/- 17.7 SD);
overlapping in 3 instances with the results in CF patients. This
simple, noninvasive test thus appears promising and merits further
investigation in younger infants, especially newborns.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARVANITAKIS C" publication="LANCET" d1="1" d2="663" d3="976"/>
<CITE num="002" author="GYR K" publication="GUT" d1="17" d2="27" d3="976"/>
<CITE num="003" author="GYR K" publication="GASTROENTEROLOGY" d1="68" d2="488" d3="975"/>
<CITE num="004" author="HADORN B" publication="J PEDIATR" d1="73" d2="39" d3="968"/>
<CITE num="005" author="HAVERBACK BJ" publication="GASTROENTEROLOGY" d1="44" d2="588" d3="963"/>
<CITE num="006" author="IMONDI AR" publication="GUT" d1="13" d2="726" d3="972"/>
<CITE num="007" author="SMITH HW" publication="J CLIN INVEST" d1="24" d2="388" d3="945"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78035</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ONDI AR             BI" publication="OCHEM MED" d1="22" d2="98 9" d3="9"/>
<CITE num="2" author="SACHER M" publication="J PEDIATR" d1="94" d2="159" d3="979"/>
<CITE num="3" author="WALLER SL" publication="AUST NZ J MED" d1="10" d2="351" d3="980"/>
<CITE num="4" author="LANKISCH PG" publication="DTSCH MED WSCHR" d1="105" d2="1418" d3="980"/>
<CITE num="5" author="LANG C" publication="SCHWEIZ MED WOCHENSCHR" d1="110" d2="522" d3="980"/>
<CITE num="6" author="DOCKTER G" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="732" d3="980"/>
<CITE num="7" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="746" d3="980"/>
<CITE num="8" author="OSSWALD P" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="340" d3="980"/>
<CITE num="9" author="HOEK FJ" publication="GUT" d1="22" d2="8" d3="981"/>
<CITE num="10" author="LANKISCH PG" publication="HEPATOGASTROENTEROLOGY" d1="28" d2="333" d3="981"/>
<CITE num="11" author="LANG C" publication="BR J SURG" d1="68" d2="771" d3="981"/>
<CITE num="12" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="13" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="14" author="LIBEER JC" publication="CLIN CHIM ACTA" d1="115" d2="119" d3="981"/>
<CITE num="15" author="DOCKTER G" publication="EUR J PEDIATR" d1="135" d2="277" d3="981"/>
<CITE num="16" author="KAI H" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="445" d3="982"/>
<CITE num="17" author="LANKISCH PG" publication="GUT" d1="23" d2="777" d3="982"/>
<CITE num="18" author="LENTZE MJ" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="S252" d3="983"/>
<CITE num="19" author="RYAN ME" publication="CLIN GASTROENTEROL" d1="12" d2="533" d3="983"/>
<CITE num="20" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="2" d2="249" d3="984"/>
<CITE num="21" author="SATO M" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="415" d3="984"/>
<CITE num="22" author="TOSKES PP" publication="PHARMACOTHERAPY" d1="4" d2="74" d3="984"/>
<CITE num="23" author="LANKISCH PG" publication="CLIN GASTROENTEROL" d1="13" d2="717" d3="984"/>
<CITE num="24" author="SCHONI M" publication="PEDIATR RES" d1="18" d2="66" d3="984"/>
<CITE num="25" author="HUBBARD VS" publication="DIG DIS SCI" d1="29" d2="881" d3="984"/>
<CITE num="26" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="27" author="GILLARD BK" publication="AM J DIS CHILD" d1="138" d2="577" d3="984"/>
<CITE num="28" author="BELLENTANI S" publication="EUR J PEDIATR" d1="143" d2="145" d3="984"/>
<CITE num="29" author="SCOTTA MS" publication="CLIN BIOCHEM" d1="18" d2="233" d3="985"/>
<CITE num="30" author="MEE AS" publication="GUT" d1="26" d2="1257" d3="985"/>
<CITE num="31" author="RIEU D" publication="ANN PEDIATR (PARIS)" d1="32" d2="205" d3="985"/>
<CITE num="32" author="NIEDERAU C" publication="GASTROENTEROLOGY" d1="88" d2="1973" d3="985"/>
<CITE num="33" author="HEYMAN MB" publication="GASTROENTEROLOGY" d1="89" d2="685" d3="985"/>
<CITE num="34" author="WEIZMAN Z" publication="GASTROENTEROLOGY" d1="89" d2="596" d3="985"/>
<CITE num="35" author="GHARBO SA" publication="ANAL BIOCHEM" d1="148" d2="228" d3="985"/>
<CITE num="36" author="SCHARPE S" publication="CLIN CHEM" d1="33" d2="5" d3="987"/>
<CITE num="37" author="SARLES J" publication="ARCH FR PEDIATR" d1="44" d2="311" d3="987"/>
</CITATIONS>
<RECORDNUM>00816 </RECORDNUM>
<MEDLINENUM>78255586</MEDLINENUM>
<AUTHORS><AUTHOR>Smalley-C-A</AUTHOR><AUTHOR>Brown-G-A</AUTHOR><AUTHOR>Parkes-M-E</AUTHOR><AUTHOR>Tease-H</AUTHOR><AUTHOR>Brookes-V</AUTHOR><AUTHOR>Anderson-C-M</AUTHOR></AUTHORS>
<TITLE>Reduction of bile acid loss in cystic fibrosis by dietary means.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Jun. 53(6). P 477-82.</SOURCE>
<MAJORSUBJ><TOPIC>BILE-ACIDS-AND-SALTS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: dh</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, me</TOPIC><TOPIC>FECES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREATIN: tu</TOPIC><TOPIC>CELIAC-DISEASE: dh, et</TOPIC><TOPIC>TRIGLYCERIDES: tu</TOPIC></MINORSUBJ>
<ABSTRACT>On a 'normal' diet increased faecal bile acid excretion was found in
14 of 16 children with cystic fibrosis who had steatorrhoea, but
excretion was normal in 2 such children without steatorrhoea. The 16
children with steatorrhoea took 3 regimens of diet and therapy: a
'normal' diet with pancreatic enzyme supplements, a diet of reduced
long-chain triglycerides with added medium-chain triglycerides, and
the same diet with added pancreatic enzyme supplements. On each of
these three regimens steatorrhoea and faecal bile acid loss were
significantly less than on no treatment, with the lowest excretions
occurring on the diet of reduced long-chain triglycerides with added
medium-chain triglycerides and pancreatic enzyme supplements.
Although a reduction in steatorrhoea was nearly always accompanied by
a decrease in bile acid excretion, the initial bile acid loss was
very variable and could not be predicted for any given degree of
steatorrhoea. This suggests that at least one other factor, possibly
liver disease or bile acid pool size, influences bile acid loss in
the faeces.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="MOD PROBL PEDIATR" d1="10" d2="326" d3="967"/>
<CITE num="002" author="ANDERSON CM" publication="LANCET" d1="1" d2="836" d3="952"/>
<CITE num="003" author="ANSANELLI V" publication="FRACASTORO (VERONA)" d1="63" d2="637" d3="970"/>
<CITE num="004" author="BAGHERI SA" publication="GASTROENTEROLOGY" d1="66" d2="878" d3="974"/>
<CITE num="005" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="007" author="FOSBROOKE AS" publication="CLIN CHIM ACTA" d1="20" d2="517" d3="968"/>
<CITE num="008" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="009" author="GRACEY M" publication="ARCH DIS CHILD" d1="45" d2="445" d3="970"/>
<CITE num="010" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
<CITE num="011" author="HOFMANN AF" publication="IN: SENIOR JR" d1="" d2="9" d3="968"/>
<CITE num="012" author="IWATA T" publication="J BIOCHEM (TOKYO)" d1="56" d2="424" d3="964"/>
<CITE num="013" author="LEYLAND FC" publication="ARCH DIS CHILD" d1="44" d2="170" d3="969"/>
<CITE num="014" author="MURPHY GM" publication="IN: ANDERSON CM" d1="" d2="667" d3="975"/>
<CITE num="015" author="REDINGER RN" publication="GASTROENTEROLOGY" d1="64" d2="610" d3="973"/>
<CITE num="016" author="ROLLER RJ" publication="GASTROENTEROLOGY" d1="72" d2="661" d3="977"/>
<CITE num="017" author="SHERR HP" publication="AM J CLIN NUTR" d1="27" d2="1369" d3="974"/>
<CITE num="018" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="019" author="TYSON KRT" publication="J PEDIATR SURG" d1="3" d2="271" d3="968"/>
<CITE num="020" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="021" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="67" d2="835" d3="974"/>
<CITE num="022" author="WEBER AM" publication="CLIN CHIM ACTA" d1="39" d2="524" d3="972"/>
<CITE num="023" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="024" author="WEBER AM" publication="GASTROENTEROLOGY" d1="68" d2="1066" d3="975"/>
<CITE num="025" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="026" author="WEBSTER R" publication="ARCH DIS CHILD" d1="28" d2="343" d3="953"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78036</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ARKEY BJ            MO" publication="NOGR PAEDIATR" d1="10" d2="12 9" d3="9"/>
<CITE num="2" author="JONAS A" publication="J PEDIATR" d1="95" d2="366" d3="979"/>
<CITE num="3" author="BALISTRERI WF" publication="J PEDIATR" d1="96" d2="582" d3="980"/>
<CITE num="4" author="COLOMBO C" publication="RIV ITAL PEDIATR" d1="8" d2="77" d3="982"/>
<CITE num="5" author="BALISTRERI WF" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="105" d3="983"/>
<CITE num="6" author="ISENBERG JN" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="447" d3="983"/>
<CITE num="7" author="COLOMBO C" publication="DIG DIS SCI" d1="28" d2="306" d3="983"/>
<CITE num="8" author="COLOMBO C" publication="J PEDIATR GASTROENTEROL NUTR" d1="3" d2="556" d3="984"/>
<CITE num="9" author="SETCHELL KDR" publication="CLIN CHIM ACTA" d1="151" d2="101" d3="985"/>
<CITE num="10" author="WEBER AM" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="9" d3="985"/>
<CITE num="11" author="LEROY C" publication="DIG DIS SCI" d1="31" d2="911" d3="986"/>
</CITATIONS>
<RECORDNUM>00817 </RECORDNUM>
<MEDLINENUM>78255587</MEDLINENUM>
<AUTHORS><AUTHOR>Bray-P-T</AUTHOR><AUTHOR>Clark-G-C</AUTHOR><AUTHOR>Moody-G-J</AUTHOR><AUTHOR>Thomas-G</AUTHOR><AUTHOR>Thomas-J-D</AUTHOR></AUTHORS>
<TITLE>Sweat testing for cystic fibrosis.  Diagnostic screening with a
combination chloride ion-selective electrode.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Jun. 53(6). P 483-6.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ELECTRODES</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC></MINORSUBJ>
<ABSTRACT>Screening of sweat chloride in newborn infants with the Orion Skin
Chloride Measuring System and incorporating some procedural
innovations is described. The results indicate that while diagnostic
screening for cystic fibrosis can be readily undertaken, the test
with the chloride ion-selective electrode is best left at least to
the second day of life or later because of insufficient sweating in
very young babies. Measurements on 2 babies with cystic fibrosis are
also discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARMSTRONG D" publication="ORION RES INC NEWSLETTER" d1="3" d2="28" d3="971"/>
<CITE num="002" author="BRAY PT" publication="PERSPECTIVE OF SODIUM AND CHL" d1="" d2="" d3="975"/>
<CITE num="003" author="BRAY PT" publication="CLIN CHIM ACTA" d1="77" d2="69" d3="977"/>
<CITE num="004" author="BRAY PT" publication="CLIN CHIM ACTA" d1="80" d2="333" d3="977"/>
<CITE num="005" author="CHERIAN AG" publication="CLIN CHEM" d1="17" d2="652" d3="971"/>
<CITE num="006" author="GIBSON LE" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="007" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="008" author="GURSON CT" publication="HELV PAEDIATR ACTA" d1="28" d2="165" d3="973"/>
<CITE num="009" author="KOPITO L" publication="PEDIATRICS" d1="43" d2="794" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78037</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AY PT               AR" publication="CH DIS CHILD" d1="53" d2="18 9" d3="8"/>
<CITE num="2" author="LITTLEWOOD JM" publication="ARCH DIS CHILD" d1="61" d2="1041" d3="986"/>
<CITE num="3" author="BECK R" publication="ACTA PAEDIATR SCAND" d1="75" d2="639" d3="986"/>
</CITATIONS>
<RECORDNUM>00818 </RECORDNUM>
<MEDLINENUM>79081443</MEDLINENUM>
<AUTHORS><AUTHOR>Griffiths-A-D</AUTHOR><AUTHOR>Bull-F-E</AUTHOR></AUTHORS>
<TITLE>Sweat testing for cystic fibrosis [letter].</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Nov. 53(11). P 918.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MASS-SCREENING</TOPIC></MINORSUBJ>
<EXTRACT>Bray et al. conclude that the mass screening of newborn babies with
chloride ion-selective electrodes is a feasible method for the
diagnosis of cystic fibrosis; they also suggest that this procedure
might be used in conjunction with meconium analysis to reduce the
incidence of false positive results.  In 1972 we reported the details
of a child with proved cystic fibrosis in whom raised sweat sodium
but normal sweat chloride levels were obtained during treatment with
cloxacillin.  Attention was drawn to the implication of the finding
with regard to screening procedures, and the suggestion was made
that, in at least some children with cystic fibrosis, the cloxacillin
radical might replace the chloride ion in the sweat.  When mass
screening for cystic fibrosis is to be undertaken using methods based
on the estimation of sweat chloride levels, it is therefore prudent
to inquire whether the infant is receiving medication from any source
and, if so, to interpret the results with caution. - These are
instances of false-negative sweat chloride readings, but there is no
evidence yet from our 1205 tests of any negative cystic fibrosis
sweat chloride; the statistical chance of this is in any case small.
These several cases suggest a need for a systematic investigation of
the effect of medication on sweat ion levels in general as well as in
cystic fibrosis cases.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78038</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BRAY PT" publication="PERSPECTIVE OF SODIUM AND CHL" d1="" d2="" d3="975"/>
<CITE num="002" author="BRAY PT" publication="ARCH DIS CHILD" d1="53" d2="483" d3="978"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="9" d3="975"/>
<CITE num="004" author="GRIFFITHS AD" publication="ARCH DIS CHILD" d1="47" d2="132" d3="972"/>
</REFERENCES>
<RECORDNUM>00819 </RECORDNUM>
<MEDLINENUM>79081430</MEDLINENUM>
<AUTHORS><AUTHOR>Silverman-M</AUTHOR><AUTHOR>Hobbs-F-D</AUTHOR><AUTHOR>Gordon-I-R</AUTHOR><AUTHOR>Carswell-F</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis, atopy, and airways lability.</TITLE>
<SOURCE>Arch-Dis-Child. 1978 Nov. 53(11). P 873-7.</SOURCE>
<MAJORSUBJ><TOPIC>AIRWAY-OBSTRUCTION: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HYPERSENSITIVITY-IMMEDIATE: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>ALLERGENS</TOPIC><TOPIC>ASPERGILLUS-FUMIGATUS: im</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>EXERTION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PEAK-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>PROSPECTIVE-STUDIES</TOPIC></MINORSUBJ>
<ABSTRACT>In a survey of cystic fibrosis (CF) in the Avon area, 48 children
with CF from 40 families together with 71 of their parents were
studied by spirometry, exercise tests, and pinch tests. A control
group of 42 young adults was similarly tested; control data for
children were taken from previously published work. The prevalence of
atopy (any positive prick test) in children with CF was 48%.
Sensitivity to grass pollens and house dust mite was no more common
in these children (29%) than in a normal population (34%).
Hypersensitivity to Aspergillus fumigatus was found in 35% of
children with CF and was associated with severe lung disease. The
parents had a normal pattern and prevalence of atopy. Exercise-
induced airways obstruction was present in only 22% of children with
CF; its association with severe lung disease rendered interpretation
difficult. The parents had a normal response to exercise. Both
hypersensitivity to A. fumigatus and exercise-induced airways
lability had the features of acquired characteristics. There was
nothing in the present study to support the hypothesis that the
possession of a CF gene predisposed to atopy.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ABBOTT V" publication="CAN MED ASSOC J" d1="64" d2="419" d3="951"/>
<CITE num="002" author="ALLAN JD" publication="CLIN ALLERGY" d1="5" d2="255" d3="975"/>
<CITE num="003" author="ANDERSON SD" publication="THESIS" d1="" d2="" d3="972"/>
<CITE num="004" author="ANDERSON SD" publication="THORAX" d1="26" d2="396" d3="971"/>
<CITE num="005" author="ASTRAND PO" publication="TEXTBOOK OF WORK PHYSIOLOGY" d1="" d2="" d3="970"/>
<CITE num="006" author="CHRISPIN AR" publication="PEDIATR RADIOL" d1="2" d2="101" d3="974"/>
<CITE num="007" author="COGSWELL JJ" publication="BR J DIS CHEST" d1="69" d2="177" d3="975"/>
<CITE num="008" author="COTES JE" publication="LUNG FUNCTION" d1="" d2="" d3="975"/>
<CITE num="009" author="COUNAHAN R" publication="ARCH DIS CHILD" d1="50" d2="477" d3="975"/>
<CITE num="010" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="011" author="FEATHERBY EA" publication="CAN MED ASSOC J" d1="102" d2="835" d3="970"/>
<CITE num="012" author="GODFREY RC" publication="CLIN ALLERGY" d1="6" d2="79" d3="976"/>
<CITE num="013" author="GODFREY S" publication="BR J DIS CHEST" d1="64" d2="15" d3="970"/>
<CITE num="014" author="JONES RS" publication="ARCH DIS CHILD" d1="50" d2="909" d3="975"/>
<CITE num="015" author="KULCZYCKI LL" publication="JAMA" d1="175" d2="358" d3="961"/>
<CITE num="016" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="017" author="MCFARLANE H" publication="LANCET" d1="1" d2="1241" d3="976"/>
<CITE num="018" author="PEPYS J" publication="BR J HOSP MED" d1="14" d2="412" d3="975"/>
<CITE num="019" author="RACHELEFSKY GS" publication="AM J DIS CHILD" d1="128" d2="355" d3="974"/>
<CITE num="020" author="SILVERMAN M" publication="THESIS" d1="" d2="" d3="973"/>
<CITE num="021" author="SILVERMAN M" publication="ARCH DIS CHILD" d1="47" d2="882" d3="972"/>
<CITE num="022" author="SWINSCOW TDV" publication="STATISTICS AT SQUARE ONE" d1="" d2="" d3="977"/>
<CITE num="023" author="VAN METRE TE JR" publication="J ALLERGY CLIN IMMUNOL" d1="31" d2="141" d3="960"/>
<CITE num="024" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="025" author="WARREN CPW" publication="CLIN ALLERGY" d1="5" d2="1" d3="975"/>
<CITE num="026" author="ZAPLETAL A" publication="PEDIATRICS" d1="48" d2="64" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78039</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ICE JF              CL" publication="IN ALLERGY" d1="9" d2="63 9" d3="9"/>
<CITE num="2" author="VANASPEREN PP" publication="AUST PAEDIATR J" d1="16" d2="53" d3="980"/>
<CITE num="3" author="ORMEROD LP" publication="THORAX" d1="35" d2="768" d3="980"/>
<CITE num="4" author="BRUETON MJ" publication="ARCH DIS CHILD" d1="55" d2="348" d3="980"/>
<CITE num="5" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="6" author="VANASPEREN P" publication="AM J DIS CHILD" d1="135" d2="815" d3="981"/>
<CITE num="7" author="HENRY RL" publication="AUST PAEDIATR J" d1="18" d2="110" d3="982"/>
<CITE num="8" author="PITCHERWILMOTT RW" publication="ARCH DIS CHILD" d1="57" d2="582" d3="982"/>
<CITE num="9" author="VOSS MJ" publication="J ALLERGY CLIN IMMUNOL" d1="69" d2="536" d3="982"/>
<CITE num="10" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="11" author="WILSON N" publication="J INT BIOMED INFOR DATA" d1="5" d2="37" d3="984"/>
<CITE num="12" author="WONNE R" publication="CLIN ALLERGY" d1="15" d2="455" d3="985"/>
<CITE num="13" author="LAUFER P" publication="CUTIS" d1="36" d2="245" d3="985"/>
<CITE num="14" author="SCHONHEYDER H" publication="ACTA PATH MICROB IMMU SCA (B)" d1="93" d2="105" d3="985"/>
<CITE num="15" author="WILMOTT RW" publication="AM J DIS CHILD" d1="139" d2="669" d3="985"/>
<CITE num="16" author="DARGA LL" publication="PEDIATR PULMONOL" d1="2" d2="82" d3="986"/>
<CITE num="17" author="LAROCHE D" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="404" d3="986"/>
</CITATIONS>
<RECORDNUM>00820 </RECORDNUM>
<MEDLINENUM>79164993</MEDLINENUM>
<AUTHORS><AUTHOR>Rudnik-J</AUTHOR><AUTHOR>Kurzawa-R</AUTHOR><AUTHOR>Gawel-J</AUTHOR><AUTHOR>Majewska-Zalewska-H</AUTHOR><AUTHOR>Zebrak-J</AUTHOR></AUTHORS>
<TITLE>Activity of serum inhibitory proteases in bronchial secretions from
children with various chronic non-specific respiratory diseases.</TITLE>
<SOURCE>Arch-Immunol-Ther-Exp (Warsz). 1978. 26(1-6). P 717-22.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-1-ANTITRYPSIN: me</TOPIC><TOPIC>BRONCHI: en</TOPIC><TOPIC>BRONCHIAL-DISEASES: en</TOPIC><TOPIC>PROTEASE-INHIBITORS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHI: se</TOPIC><TOPIC>BRONCHIECTASIS: en</TOPIC><TOPIC>BRONCHITIS: en</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: en, pa</TOPIC></MINORSUBJ>
<ABSTRACT>In a group of 223 children with various chronic, non-specific
respiratory diseases, the levels of serum inhibitory proteolytic
enzymes in bronchial secretions was measured. Activity of inhibitory
proteolytic enzymes was analyzed according to the nature of bronchial
lesions observed at bronchoscopy and character and cellular
composition of bronchial secretion. Statistically significant
increase of the mean inhibitory value in comparison to values in the
control group, was found in children with recurrent bronchitis (a-1-
AT), cystic fibrosis (a-1-AT and a-1-X), chronic bronchitis (a-1-X),
bronchiectases (a-1-X) and in children with obstructive bronchitis (a-
2-M).</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78040</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BERGMANN K" publication="Z ERKR ATMUNGSORGANE" d1="136" d2="3" d3="973"/>
<CITE num="002" author="BROGAN TD" publication="THORAX" d1="26" d2="418" d3="971"/>
<CITE num="003" author="BROGAN TD" publication="THORAX" d1="30" d2="72" d3="975"/>
<CITE num="004" author="COHEN AB" publication="J CLIN INVEST" d1="52" d2="2793" d3="973"/>
<CITE num="005" author="ERIKSSON S" publication="ACTA MED SCAND" d1="175" d2="197" d3="964"/>
<CITE num="006" author="FEIGELSON J" publication="ANN PEDIATR (PARIS)" d1="18" d2="704" d3="971"/>
<CITE num="008" author="HOCHSTRASSER K" publication="BAYER SYMPOSIUM V PROTEINASE" d1="" d2="111" d3="974"/>
<CITE num="009" author="HOCHSTRASSER K" publication="RESPIRATION" d1="31" d2="343" d3="974"/>
<CITE num="010" author="HOCHSTRASSER K" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="353" d2="221" d3="972"/>
<CITE num="011" author="GUNTHER W" publication="HUSTEN AND AUSWURF" d1="" d2="" d3="972"/>
<CITE num="012" author="HUTCHISON DCS" publication="BR J DIS CHEST" d1="67" d2="171" d3="973"/>
<CITE num="013" author="KIKINDJANIN V" publication="ALLERGIE IMMUNOL" d1="22" d2="17" d3="976"/>
<CITE num="014" author="KLEIBAUER JP" publication="REV FR MAL RESP" d1="1" d2="923" d3="973"/>
<CITE num="015" author="KOSMIDER ST" publication="PNEUM POL" d1="44" d2="937" d3="976"/>
<CITE num="016" author="KURZAWA R" publication="GRUZLICA" d1="743" d2="189" d3="975"/>
<CITE num="017" author="LAINE A" publication="CLIN CHIM ACTA" d1="67" d2="159" d3="976"/>
<CITE num="018" author="LINDH E" publication="ACTA UNIV UPSALM" d1="" d2="232" d3="975"/>
<CITE num="019" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="020" author="MANCINI G" publication="IMMUNOCHEMISTRY" d1="2" d2="235" d3="965"/>
<CITE num="021" author="MICHEL FB" publication="NOUV PRESSE MED" d1="3" d2="2245" d3="974"/>
<CITE num="022" author="MITTMAN C" publication="AM REV RESPIR DIS" d1="105" d2="430" d3="972"/>
<CITE num="023" author="MOSHER DF" publication="J CLIN INVEST" d1="60" d2="1036" d3="977"/>
<CITE num="024" author="NEIMANN N" publication="PEDIATRIE" d1="49" d2="351" d3="974"/>
<CITE num="025" author="RASCHE B" publication="KLIN WOCHENSCHR" d1="55" d2="795" d3="977"/>
<CITE num="026" author="RASCHE B" publication="PNEUMONOLOGIE" d1="149" d2="157" d3="973"/>
<CITE num="027" author="RASCHE B" publication="PNEUMONOLOGIE" d1="144" d2="10" d3="971"/>
<CITE num="028" author="RYLEY HC" publication="J CLIN PATHOL" d1="26" d2="852" d3="973"/>
<CITE num="029" author="RUDNIK J" publication="J PEDIATR POL" d1="51" d2="1279" d3="976"/>
<CITE num="030" author="STEINBUCH M" publication="BAYER SYMPOSIUM V PROTEINASE" d1="" d2="78" d3="974"/>
<CITE num="031" author="TALAMO RC" publication="ANN NY ACAD SCI" d1="221" d2="234" d3="974"/>
<CITE num="032" author="TOMASI TB JR" publication="J IMMUNOL" d1="112" d2="2274" d3="974"/>
</REFERENCES>
<RECORDNUM>00821 </RECORDNUM>
<MEDLINENUM>79061368</MEDLINENUM>
<AUTHORS><AUTHOR>Ranga-V</AUTHOR><AUTHOR>Kleinerman-J</AUTHOR></AUTHORS>
<TITLE>Structure and function of small airways in health and disease.</TITLE>
<SOURCE>Arch-Pathol-Lab-Med. 1978 Dec. 102(12). P 609-17. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AGING</TOPIC><TOPIC>AIRWAY-RESISTANCE</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>BRONCHI: pa, ph, pp</TOPIC><TOPIC>BRONCHIAL-DISEASES: di</TOPIC><TOPIC>BRONCHITIS: pa</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>DOGS</TOPIC><TOPIC>GRAVITATION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LUNG-COMPLIANCE</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC><TOPIC>MAXIMAL-EXPIRATORY-FLOW-RATE</TOPIC><TOPIC>PULMONARY-EMPHYSEMA: pa</TOPIC><TOPIC>RESPIRATORY-TRACT-DISEASES: pa</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SMOKING</TOPIC></MINORSUBJ>
<ABSTRACT>During the last two decades, great strides have been made in our
understanding of the functional aspects of airflow in the periphery
of the lung. It seems that the small airways are the important site
of obstruction in a variety of chronic respiratory disorders
associated with airflow obstruction. This review deals with the
anatomic and functional aspects of small airways in normal and
diseased lungs. In particular, the basis of obstruction or narrowing
that is not dependent on intrinsic airway lesion is reviewed. The
variety of pathologic changes in small airways observed in these
diseases are outlined along with physiologic tests that are currently
used to detect dysfunction at a stage long before they produce
symptoms or alter standard tests of lung function.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GOUGH J" publication="PROC R SOC MED" d1="45" d2="576" d3="952"/>
<CITE num="002" author="MATSUBA K" publication="AM REV RESPIR DIS" d1="104" d2="516" d3="971"/>
<CITE num="003" author="WEST JB" publication="J APPL PHYSIOL" d1="14" d2="753" d3="959"/>
<CITE num="004" author="PEDLEY TJ" publication="RESPIR PHYSIOL" d1="9" d2="387" d3="970"/>
<CITE num="005" author="AMBERSON JB" publication="TRANS ASSOC AM PHYSICIANS" d1="60" d2="92" d3="947"/>
<CITE num="006" author="SPAIN DM" publication="AM REV TUBERC" d1="68" d2="24" d3="953"/>
<CITE num="007" author="WEIBEL ER" publication="MORPHOMETRY OF THE HUMAN LUNG" d1="" d2="" d3="963"/>
<CITE num="008" author="HORSEFIELD K" publication="J APPL PHYSIOL" d1="24" d2="373" d3="968"/>
<CITE num="009" author="SMITH P" publication="THORAX" d1="29" d2="147" d3="974"/>
<CITE num="010" author="KUHN C" publication="IN: BOUHUYS A" d1="" d2="91" d3="976"/>
<CITE num="011" author="BREEZE RG" publication="AM REV RESPIR DIS" d1="116" d2="705" d3="977"/>
<CITE num="012" author="BASSET F" publication="Z ZELLFORSCH MIKROSK ANAT" d1="116" d2="45" d3="971"/>
<CITE num="013" author="EL-BERMANI AL-W" publication="AM J ANAT" d1="137" d2="12" d3="973"/>
<CITE num="014" author="HUNG K-S" publication="J ULTRASTRUCT RES" d1="43" d2="426" d3="973"/>
<CITE num="015" author="HUGHES JMB" publication="J APPL PHYSIOL" d1="32" d2="25" d3="972"/>
<CITE num="016" author="BRISCOE WA" publication="J CLIN INVEST" d1="37" d2="1279" d3="958"/>
<CITE num="017" author="MILIC-EMILI J" publication="J APPL PHYSIOL" d1="21" d2="749" d3="966"/>
<CITE num="018" author="GLAZIER JB" publication="J APPL PHYSIOL" d1="23" d2="694" d3="967"/>
<CITE num="019" author="WEST JB" publication="J APPL PHYSIOL" d1="32" d2="332" d3="972"/>
<CITE num="020" author="TURNER JM" publication="J APPL PHYSIOL" d1="25" d2="664" d3="968"/>
<CITE num="021" author="NIEWOEHNER DE" publication="J APPL PHYSIOL" d1="36" d2="412" d3="974"/>
<CITE num="022" author="MACKLEM PT" publication="RESPIR PHYSIOL" d1="8" d2="191" d3="970"/>
<CITE num="023" author="MACKLEM PT" publication="J APPL PHYSIOL" d1="22" d2="395" d3="967"/>
<CITE num="024" author="HOGG JC" publication="N ENGL J MED" d1="278" d2="1355" d3="968"/>
<CITE num="025" author="WOOLCOCK AJ" publication="J CLIN INVEST" d1="48" d2="1097" d3="969"/>
<CITE num="026" author="OLSON DE" publication="J APPL PHYSIOL" d1="28" d2="482" d3="970"/>
<CITE num="027" author="HOGG JC" publication="N ENGL J MED" d1="282" d2="1283" d3="970"/>
<CITE num="028" author="HIGH RH" publication="PEDIATR CLIN NORTH AM" d1="4" d2="183" d3="957"/>
<CITE num="029" author="KILBURN KH" publication="LAB INVEST" d1="28" d2="55" d3="973"/>
<CITE num="030" author="MAHVI D" publication="AM J PATHOL" d1="86" d2="559" d3="977"/>
<CITE num="031" author="LULLMANN-RAUCH R" publication="VIRCHOWS ARCH CELL PATHOL" d1="11" d2="167" d3="972"/>
<CITE num="032" author="SNIDER GL" publication="AM REV RESPIR DIS" d1="85" d2="666" d3="962"/>
<CITE num="033" author="BIGNON J" publication="AM REV RESPIR DIS" d1="99" d2="669" d3="969"/>
<CITE num="034" author="BIGNON J" publication="THORAX" d1="25" d2="556" d3="970"/>
<CITE num="035" author="MATSUBA K" publication="AM J PATHOL" d1="67" d2="265" d3="972"/>
<CITE num="036" author="DEPIERRE A" publication="CHEST" d1="62" d2="699" d3="972"/>
<CITE num="037" author="MATSUBA K" publication="AM REV RESPIR DIS" d1="107" d2="552" d3="973"/>
<CITE num="038" author="ZUELZER WW" publication="PEDIATRICS" d1="4" d2="53" d3="949"/>
<CITE num="039" author="WHITWELL F" publication="THORAX" d1="7" d2="213" d3="952"/>
<CITE num="040" author="ANON" publication="HEALTH CONSEQUENCES OF SM" d1="" d2="" d3="972"/>
<CITE num="041" author="ANDERSON AE JR" publication="ARCH ENVIRON HEALTH" d1="12" d2="569" d3="966"/>
<CITE num="042" author="SEELY JE" publication="SCIENCE" d1="172" d2="741" d3="971"/>
<CITE num="043" author="NIEWOEHNER DE" publication="N ENGL J MED" d1="291" d2="755" d3="974"/>
<CITE num="044" author="BODE FR" publication="AM J MED" d1="59" d2="43" d3="975"/>
<CITE num="045" author="INGRAM RH" publication="BULL PHYSIOPATH RESPIR NANCY" d1="7" d2="195" d3="971"/>
<CITE num="046" author="DAYMAN H" publication="J CLIN INVEST" d1="30" d2="1175" d3="951"/>
<CITE num="047" author="FRY DL" publication="AM J MED" d1="29" d2="672" d3="960"/>
<CITE num="048" author="MEAD J" publication="J APPL PHYSIOL" d1="22" d2="95" d3="967"/>
<CITE num="049" author="MACKLEM PT" publication="J APPL PHYSIOL" d1="20" d2="653" d3="965"/>
<CITE num="050" author="MARTIN RR" publication="AM REV RESPIR DIS" d1="111" d2="119" d3="975"/>
<CITE num="051" author="SCHILDER DP" publication="J CLIN INVEST" d1="42" d2="1705" d3="963"/>
<CITE num="052" author="HUTCHEON M" publication="AM REV RESPIR DIS" d1="110" d2="458" d3="974"/>
<CITE num="053" author="MACKLEM PT" publication="J CLIN INVEST" d1="44" d2="897" d3="965"/>
<CITE num="054" author="DESPAS PJ" publication="J CLIN INVEST" d1="51" d2="3235" d3="972"/>
<CITE num="055" author="MCCARTHY DS" publication="AM J MED" d1="52" d2="747" d3="972"/>
<CITE num="056" author="ANTHONISEN NR" publication="RESPIR PHYSIOL" d1="8" d2="58" d3="969"/>
<CITE num="057" author="OTIS AB" publication="J APPL PHYSIOL" d1="22" d2="395" d3="967"/>
<CITE num="058" author="HOWELL JBL" publication="IN: STRETTON TB" d1="" d2="157" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78041</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SKERVILLE A         NZ" publication="VET J" d1="29" d2="35 9" d3="1"/>
<CITE num="2" author="EBERT RV" publication="BR J DIS CHEST" d1="75" d2="277" d3="981"/>
<CITE num="3" author="LINHARTOVA A" publication="ARCH PATHOL LAB MED" d1="106" d2="499" d3="982"/>
<CITE num="4" author="MARIN ML" publication="LUNG" d1="160" d2="257" d3="982"/>
<CITE num="5" author="KILBURN KH" publication="ARCH ENVIRON HEALTH" d1="38" d2="277" d3="983"/>
</CITATIONS>
<RECORDNUM>00822 </RECORDNUM>
<MEDLINENUM>78186162</MEDLINENUM>
<AUTHORS><AUTHOR>Beckerman-R-C</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR></AUTHORS>
<TITLE>The spectrum of cystic fibrosis in children and adults.</TITLE>
<SOURCE>Ariz-Med. 1978 Apr. 35(4). P 246-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis, an autosomal recessive disorder, remains the most
common lethal genetic disease of Caucasian people.  The diagnosis of
CF is usually made based upon the clinical presentation of chronic
respiratory and/or gastrointestinal symptoms, a positive sweat
electrolyte test and, often, a family history of the disorder.  The
manifestations of chronic cough, recurrent pneumonias, bronchiectasis
with clubbing, pneumothorax, hemoptysis, and malabsorption secondary
to pancreatic insufficiency are so well associated with cystic
fibrosis that the diagnosis is usually not delayed.  However, it is
often not appreciated by physicians that CF may be associated with a
broad spectrum of less common manifestations as well as extreme
variability in severity of illness.  Lack of familiarity with these
manifestations may delay diagnosis until adolescence or adulthood.
First, there seems to be mild clinical expression of the disorder in
some patients (genetic variability).  Second, the subtle
manifestations of CF are not widely appreciated by physicians in
practice.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78042</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="004" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="005" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="006" author="TAUSSIG LM" publication="PRACTICE OF PEDIATRICS" d1="" d2="" d3="976"/>
<CITE num="007" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>
<RECORDNUM>00823 </RECORDNUM>
<MEDLINENUM>78256546</MEDLINENUM>
<AUTHORS><AUTHOR>Davidson-G-P</AUTHOR><AUTHOR>Phelan-P-D</AUTHOR><AUTHOR>Townley-R-R</AUTHOR></AUTHORS>
<TITLE>A controlled trial using intravenous infusion of soya oil emulsion
in the treatment of children with cystic fibrosis.</TITLE>
<SOURCE>Aust-Paediatr-J. 1978 Jun. 14(2). P 80-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>OILS: ad</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>EMULSIONS</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFUSIONS-PARENTERAL</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OILS: tu</TOPIC><TOPIC>SOY-BEANS</TOPIC></MINORSUBJ>
<ABSTRACT>Five children with cystic fibrosis were given repeated intravenous
infusions of soya oil emulsion (Intralipid) for 12 to 18 months and
the effects on growth, health, sweat chloride and pancreatic enzyme
activity compared with a control group.  No beneficial effect was
demonstrated and it is recommended that this form of therapy has no
place in the routine treatment of children with cystic fibrosis.  It
is possible that treatment may have modified the degree of weight
loss noted after 12 months of age.  The lack of other beneficial
effects and the problems involved in long-term Intralipid infusion
should preclude the use of this form of therapy in the routine
treatment of children with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="002" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="003" author="FAJANS SS" publication="HANDBOOK OF PHYSIOLOGY SECT 7" d1="1" d2="473" d3="972"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="WATSON EH" publication="GROWTH AND DEVELOPMENT OF CHI" d1="" d2="96" d3="967"/>
<CITE num="006" author="WILLIAMS HE" publication="RESPIRATORY ILLNESS IN CHILDR" d1="" d2="" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78043</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OYDSTILL JD         AM" publication="J CLIN NUTR" d1="34" d2="1 9" d3="1"/>
<CITE num="2" author="KUSOFFSKY E" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="434" d3="983"/>
<CITE num="3" author="ROGIERS V" publication="EUR J PEDIATR" d1="141" d2="39" d3="983"/>
<CITE num="4" author="GIBSON RA" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="408" d3="986"/>
</CITATIONS>
<RECORDNUM>00824 </RECORDNUM>
<MEDLINENUM>78256539</MEDLINENUM>
<AUTHORS><AUTHOR>Phelan-P-D</AUTHOR></AUTHORS>
<TITLE>Management of cystic fibrosis [editorial].</TITLE>
<SOURCE>Aust-Paediatr-J. 1978 Jun. 14(2). P 61-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PATIENT-CARE-TEAM</TOPIC></MINORSUBJ>
<EXTRACT>Controversy still surrounds the most appropriate method of management
of children with cystic fibrosis.  The reason for much of the
uncertainty about management of cystic fibrosis is that many
therapeutic approaches have been proposed without properly conducted
controlled trials.  With the current approaches to therapy, at least
80% of children with cystic fibrosis can expect to reach adult life,
most with minimal or no lung damage.  However, this dramatic
improvement in survival does not indicate that cystic fibrosis is now
an easy condition to manage and that it no longer requires
specialised care.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="002" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78044</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LAN G               J" publication="PEDIATR                      1" d1="01" d2="26 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00825 </RECORDNUM>
<MEDLINENUM>78256545</MEDLINENUM>
<AUTHORS><AUTHOR>Barnes-G-L</AUTHOR><AUTHOR>McNaught-S</AUTHOR></AUTHORS>
<TITLE>False negative sweat tests with apparently adequate sweat
collections.</TITLE>
<SOURCE>Aust-Paediatr-J. 1978 Jun. 14(2). P 78-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SODIUM: an</TOPIC></MINORSUBJ>
<ABSTRACT>Sweat tests collected on two or more occasions from normal children
and children with cystic fibrosis have been analysed according to
the weight of sweat collected.  In five cases collections of 50-99
mg of sweat gave false negative results.  Although 50-100 mg of
sweat is considered adequate by some authorities our results do not
support this.  The study confirms the view that at least 100 mg of
sweat must be collected to give reliable results.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRAY PT" publication="CLIN CHIM ACTA" d1="80" d2="333" d3="977"/>
<CITE num="002" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="003" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="004" author="GIBSON LE" publication="PROC FOR QUANTITATIVE ION" d1="" d2="" d3="975"/>
<CITE num="005" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="52" d2="870" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78045</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLINS JE            AC" publication="TA PAEDIATR SCAND" d1="74" d2="23 9" d3="5"/>
<CITE num="2" author="CHRISTOFFEL KS" publication="J PEDIATR" d1="107" d2="231" d3="985"/>
</CITATIONS>
<RECORDNUM>00826 </RECORDNUM>
<MEDLINENUM>78256549</MEDLINENUM>
<AUTHORS><AUTHOR>Field-P</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: a review of clinic patients.</TITLE>
<SOURCE>Aust-Paediatr-J. 1978 Jun. 14(2). P 91-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: pc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<ABSTRACT>The response of 72 patients to an intensive antimicrobial
prophylactic programme is presented in this review.  Treatment was
first commenced in 1968 and was evaluated during the last 4 months
of 1975.  The assessment confirmed a favourable clinical impression.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78046</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LAN G               J" publication="PEDIATR                      1" d1="01" d2="26 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00827 </RECORDNUM>
<MEDLINENUM>79021079</MEDLINENUM>
<AUTHORS><AUTHOR>Conover-J-H</AUTHOR><AUTHOR>Conod-E-J</AUTHOR></AUTHORS>
<TITLE>The influence of cystic fibrosis serum and calcium on secretion in
the rabbit tracheal mucociliary apparatus.</TITLE>
<SOURCE>Biochem-Biophys-Res-Commun. 1978 Aug 29. 83(4). P 1595-601.</SOURCE>
<MAJORSUBJ><TOPIC>CALCIUM: pd</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>IGG: ph</TOPIC><TOPIC>MUCUS: se</TOPIC><TOPIC>TRACHEA: se</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>A-23187: pd</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, pp</TOPIC><TOPIC>EPITHELIUM: se</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>TISSUE-CULTURE</TOPIC><TOPIC>TRACHEA: de</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic Fibrosis serum or its isolated component IgG fraction and
calcium ionophore A23187 all produced a quantitatively greater
increase of mucus glycoprotein secretion in the rabbit tracheal
epithelium than did control serum or its isolated component IgG
fraction.  These values were determined by dry weight secretion per
gram of tissue and on subsequent sialic acid content of secretions.
This demonstrable increase in mucus production represents a
measurable difference in the functioning of the cultured mucociliary
apparatus due to the influence of cystic fibrosis serum.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="002" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="143" d3="977"/>
<CITE num="003" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="004" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="005" author="CONOVER JH" publication="LANCET" d1="2" d2="1362" d3="976"/>
<CITE num="006" author="BOGART BI" publication="PEDIATR RES" d1="12" d2="15" d3="978"/>
<CITE num="007" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
<CITE num="008" author="SCHNEIDER WC" publication="METHODS ENZYMOL" d1="3" d2="680" d3="957"/>
<CITE num="009" author="CONOD EJ" publication="PEDIATR RES" d1="11" d2="45" d3="977"/>
<CITE num="010" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="011" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78047</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GART BI             BI" publication="OCHEM BIOPHYS RES COMMUN" d1="88" d2="98 9" d3="9"/>
<CITE num="2" author="DAVIS PB" publication="IRCS MED SCI BIOCHEM" d1="8" d2="413" d3="980"/>
<CITE num="3" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="4" author="KENNEDY JR" publication="PEDIATR RES" d1="14" d2="1173" d3="980"/>
<CITE num="5" author="PHIPPS RJ" publication="EUR J RESPIR DIS" d1="61" d2="33" d3="980"/>
<CITE num="6" author="WILSON GB" publication="J CLIN INVEST" d1="66" d2="1010" d3="980"/>
<CITE num="7" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="8" author="ADLER KB" publication="LAB INVEST" d1="45" d2="372" d3="981"/>
<CITE num="9" author="BOAT TF" publication="PEDIATR RES" d1="16" d2="792" d3="982"/>
<CITE num="10" author="BOGART BI" publication="PEDIATR RES" d1="16" d2="223" d3="982"/>
<CITE num="11" author="QUISSELL DO" publication="PEDIATR RES" d1="17" d2="899" d3="983"/>
<CITE num="12" author="MCPHERSON MA" publication="CLIN CHIM ACTA" d1="135" d2="181" d3="983"/>
<CITE num="13" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="14" author="BARBIERI EJ" publication="BR J PHARMACOL" d1="82" d2="199" d3="984"/>
<CITE num="15" author="RUSSI EW" publication="CHEST" d1="86" d2="475" d3="984"/>
<CITE num="16" author="WOOTEN MW" publication="J CELL PHYSIOL" d1="121" d2="490" d3="984"/>
<CITE num="17" author="NEAL JL" publication="EVOLUTIONARY THEORY" d1="7" d2="153" d3="985"/>
</CITATIONS>
<RECORDNUM>00828 </RECORDNUM>
<MEDLINENUM>79020917</MEDLINENUM>
<AUTHORS><AUTHOR>Choy-H</AUTHOR><AUTHOR>Applegarth-D-A</AUTHOR><AUTHOR>Davidson-A-G</AUTHOR><AUTHOR>Wong-L-T</AUTHOR></AUTHORS>
<TITLE>Anti-plasmin (alpha2-macroglobulin) activity of plasma from cystic
fibrosis patients.</TITLE>
<SOURCE>Biochem-Biophys-Res-Commun. 1978 Jun 29. 82(4). P 1325-8.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-MACROGLOBULINS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASEINS</TOPIC><TOPIC>FIBRINOLYSIN: ai</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>We have studied the plasim-alpha2-macroglobulin interaction using
plasma from cystic fibrosis patients.  In this system
alpha2-macroglobulin from cystic fibrosis plasma does not differ
from controls in its ability to bind with and inhibit plasmin.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="002" author="SHAPIRA E" publication="CLIN CHIM ACTA" d1="78" d2="359" d3="977"/>
<CITE num="003" author="CRAWFORD GPM" publication="CLIN SCI MOL MED" d1="51" d2="215" d3="976"/>
<CITE num="004" author="SGOURIS JT" publication="VOX SANG" d1="5" d2="357" d3="960"/>
<CITE num="005" author="ALKAERSIG N" publication="J BIOL CHEM" d1="234" d2="32" d3="959"/>
<CITE num="006" author="NORMAN PS" publication="J EXP MED" d1="106" d2="423" d3="957"/>
<CITE num="007" author="NORMAN PS" publication="J EXP MED" d1="108" d2="639" d3="958"/>
<CITE num="008" author="HARPEL PC" publication="PROC 5TH CONG INT SOC THROM H" d1="" d2="" d3="975"/>
<CITE num="009" author="BARRETT AJ" publication="BIOCHEM J" d1="133" d2="709" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78048</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              PE" publication="DIATR RES" d1="14" d2="83 9" d3="0"/>
<CITE num="2" author="ROMEO G" publication="J LAB CLIN MED" d1="95" d2="116" d3="980"/>
<CITE num="3" author="PARSONS M" publication="CLIN CHIM ACTA" d1="100" d2="215" d3="980"/>
<CITE num="4" author="RICHMAN JBY" publication="CAN J BIOCHEM" d1="59" d2="519" d3="981"/>
<CITE num="5" author="BURY AF" publication="IRCS MED SCI BIOCHEM" d1="10" d2="255" d3="982"/>
<CITE num="6" author="ROBERTS RC" publication="PEDIATR RES" d1="16" d2="416" d3="982"/>
<CITE num="7" author="BACK SA" publication="BIOCHEM MED" d1="30" d2="34" d3="983"/>
<CITE num="8" author="SHAPIRA E" publication="ANN NY ACAD SCI" d1="421" d2="352" d3="983"/>
<CITE num="9" author="BRUCE MC" publication="AM REV RESPIR DIS" d1="132" d2="529" d3="985"/>
</CITATIONS>
<RECORDNUM>00829 </RECORDNUM>
<MEDLINENUM>79082306</MEDLINENUM>
<AUTHORS><AUTHOR>Banschbach-M-W</AUTHOR><AUTHOR>Karam-A-G</AUTHOR><AUTHOR>Love-P-K</AUTHOR><AUTHOR>Hilman-B-C</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis serum promotes [45Ca] uptake by normal human
leukocytes.</TITLE>
<SOURCE>Biochem-Biophys-Res-Commun. 1978 Oct 30. 84(4). P 922-7.</SOURCE>
<MAJORSUBJ><TOPIC>CALCIUM: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LEUKOCYTES: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BIOLOGICAL-TRANSPORT-ACTIVE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>A two-fold increase in [45Ca] labeling was observed when normal
human leukocytes were incubated in the presence of serum obtained
from patients with cystic fibrosis.  The degree of [45Ca] labeling
of leukocytes isolated from patients with cystic fibrosis was also
significantly greater than that observed for leukocytes that had
been isolated from normal individuals.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="002" author="BOGART BI" publication="PEDIATR RES" d1="12" d2="15" d3="978"/>
<CITE num="003" author="OCHSMAN JL" publication="GAP CONF REP CALC ION CELL SE" d1="" d2="" d3="976"/>
<CITE num="004" author="DAVIS PB" publication="PEDIATR RES" d1="12" d2="703" d3="978"/>
<CITE num="005" author="RASMUSSEN H" publication="ADV CYCLIC NUCLEO RES" d1="5" d2="375" d3="975"/>
<CITE num="006" author="ANDERSON LE" publication="ANAL BIOCHEM" d1="51" d2="173" d3="973"/>
<CITE num="007" author="SCHREURS VVAM" publication="BIOCHIM BIOPHYS ACTA" d1="419" d2="320" d3="976"/>
<CITE num="008" author="CHANGUS JE" publication="ARCH PATHOL LAB MED" d1="100" d2="7" d3="976"/>
<CITE num="009" author="SHAPIRO BL" publication="CLIN CHIM ACTA" d1="82" d2="125" d3="978"/>
<CITE num="010" author="WILKOWSKE CJ" publication="MAYO CLIN PROC" d1="52" d2="616" d3="977"/>
<CITE num="011" author="NEU HC" publication="BULL NY ACAD MED" d1="54" d2="141" d3="978"/>
<CITE num="012" author="MAREN TH" publication="ANNU REV PHARMACOL TOXICOL" d1="16" d2="309" d3="976"/>
<CITE num="013" author="WILSON GB" publication="NATURE" d1="266" d2="463" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78049</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GART BI             BI" publication="OCHEM BIOPHYS RES COMMUN" d1="88" d2="98 9" d3="9"/>
<CITE num="2" author="DAVIS PB" publication="IRCS MED SCI BIOCHEM" d1="8" d2="413" d3="980"/>
<CITE num="3" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="4" author="DAVIS PB" publication="J LAB CLIN MED" d1="96" d2="75" d3="980"/>
<CITE num="5" author="BOGART BI" publication="PEDIATR RES" d1="16" d2="223" d3="982"/>
<CITE num="6" author="FEIGAL RJ" publication="LIFE SCI" d1="30" d2="93" d3="982"/>
<CITE num="7" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="8" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="9" author="BOUCHER RC" publication="PEDIATR RES" d1="18" d2="1336" d3="984"/>
<CITE num="10" author="VONRUECKER AA" publication="PEDIATR RES" d1="18" d2="594" d3="984"/>
<CITE num="11" author="HART DA" publication="IRCS MED SCI BIOCHEM" d1="14" d2="213" d3="986"/>
<CITE num="12" author="KEMP T" publication="PEDIATR RES" d1="20" d2="520" d3="986"/>
<CITE num="13" author="FEIGAL RJ" publication="ANN NY ACAD SCI" d1="488" d2="82" d3="986"/>
<CITE num="14" author="ZAKRZEWSKI JT" publication="BR J CLIN PHARMACOL" d1="23" d2="19" d3="987"/>
</CITATIONS>
<RECORDNUM>00830 </RECORDNUM>
<MEDLINENUM>78186681</MEDLINENUM>
<AUTHORS><AUTHOR>Gahl-W-A</AUTHOR><AUTHOR>Chesney-J</AUTHOR><AUTHOR>Pitot-H-C</AUTHOR></AUTHORS>
<TITLE>Serum ribonuclease levels in patients with cystic fibrosis.</TITLE>
<SOURCE>Biochem-Med. 1978 Apr. 19(2). P 294-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>RIBONUCLEASES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>PANCREAS: en</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is an autosomal recessive disease, usually fatal
before the third decade, characterized by chronic obstructive lung
disease, elevated sweat electrolyte concentrations, and pancreatic
insufficiency.  The present investigation was carried out to
determine if P-type serum RNase activity was reduced in CF patients 3
to 24 years of age.  No difference in serum RNase activity was found
among the groups of 17 normals, 21 CF patients, and 5 CF
heterozygotes.  It appears that observations of decreased RNase
activity in the serum of young children with pancreatic insufficiency
cannot be extended to older children, at least without withholding
pancreatic supplements.</EXTRACT>
<REFERENCES>
<CITE num="001" author="LEVY CC" publication="LIFE SCI" d1="17" d2="311" d3="975"/>
<CITE num="002" author="BARDON A" publication="CLIN CHIM ACTA" d1="67" d2="231" d3="976"/>
<CITE num="003" author="REDDI KK" publication="BIOCHEM BIOPHYS RES COMMUN" d1="67" d2="110" d3="975"/>
<CITE num="004" author="ALPERS DH" publication="J BIOL CHEM" d1="242" d2="5617" d3="967"/>
<CITE num="005" author="SCHMUKLER M" publication="J BIOL CHEM" d1="250" d2="2206" d3="975"/>
<CITE num="006" author="ZAN-KOWALCZEWSKA M" publication="BIOCHIM BIOPHYS ACTA" d1="341" d2="138" d3="974"/>
<CITE num="007" author="BARDON A" publication="BIOCHIM BIOPHYS ACTA" d1="438" d2="461" d3="976"/>
<CITE num="008" author="ZIMMERMAN SB" publication="ANAL BIOCHEM" d1="10" d2="444" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78050</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RSHAW AL            SU" publication="RGERY" d1="86" d2="27 9" d3="9"/>
<CITE num="2" author="ISAACS P" publication="DIGESTION" d1="22" d2="101" d3="981"/>
<CITE num="3" author="THOMAS JM" publication="CLIN CHIM ACTA" d1="111" d2="199" d3="981"/>
<CITE num="4" author="WEICKMANN JL" publication="J BIOL CHEM" d1="257" d2="8705" d3="982"/>
<CITE num="5" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
</CITATIONS>
<RECORDNUM>00831 </RECORDNUM>
<MEDLINENUM>79104083</MEDLINENUM>
<AUTHORS><AUTHOR>Antonowicz-I</AUTHOR><AUTHOR>Ishida-S</AUTHOR><AUTHOR>Shwachman-H</AUTHOR></AUTHORS>
<TITLE>Studies in meconium in cystic fibrosis: the activities of
alpha-D-mannosidase, beta-glucuronidase, beta-D-fucosidase, acid and
alkaline phosphatase.</TITLE>
<SOURCE>Biol-Neonate. 1978. 34(5-6). P 225-30.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLYCOSIDE-HYDROLASES: me</TOPIC><TOPIC>MECONIUM: en</TOPIC><TOPIC>PHOSPHATASES: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACID-PHOSPHATASE: me</TOPIC><TOPIC>ALKALINE-PHOSPHATASE: me</TOPIC><TOPIC>FUCOSIDASE: me</TOPIC><TOPIC>GLUCURONIDASE: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MANNOSIDASES: me</TOPIC></MINORSUBJ>
<ABSTRACT>The specific activities of alpha-D-mannosidase, beta-glucuronidase,
beta-D-fucosidase, acid and alkaline phosphatase were studied in
meconium from infants with cystic fibrosis (CF) and control subjects.
The study revealed significant variations in the specific activity of
the enzymes except for acid phosphatase. The variations were not
uniform. The activities of alpha-D-mannosidase, beta-glucuronidase
and alkaline phosphatase were markedly decreased (p less than 0.001,
p less than 0.002, p less than 0.001, respectively), while the
activity of beta-D-fucosidase was significantly increased (p less
than 0.001) in meconium from the infants with CF. It is suggested
that the decreased activity of alpha-D-mannosidase and beta-
glucuronidase might contribute to the accumulation of the abnormal
substances in CF meconium. The highly increased activity of beta-D-
fucosidase raises the possibility of an additional or alternative
method for screening newborns for CF using meconium as the test
material.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN H" publication="ACTA PATH MICROBIOL SCAND" d1="61" d2="377" d3="964"/>
<CITE num="002" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="72" d2="62" d3="946"/>
<CITE num="003" author="ANTONOWICZ I" publication="GASTROENTEROLOGY" d1="67" d2="51" d3="974"/>
<CITE num="004" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
<CITE num="005" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
<CITE num="006" author="BARRETT AJ" publication="IN: DINGLE JT" d1="" d2="116" d3="973"/>
<CITE num="007" author="BIERRING F" publication="ACTA PATH MICROBIOL SCAND" d1="61" d2="365" d3="964"/>
<CITE num="008" author="BUCHANAN DJ" publication="PEDIATRICS" d1="9" d2="304" d3="952"/>
<CITE num="009" author="CAIN ARR" publication="ARCH DIS CHILD" d1="47" d2="131" d3="972"/>
<CITE num="010" author="CHERNICK WS" publication="ANN NY ACAD SCI" d1="106" d2="698" d3="963"/>
<CITE num="011" author="CROW JF" publication="IN: NEEL JV" d1="" d2="23" d3="965"/>
<CITE num="012" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="013" author="DISCHE Z" publication="AM J DIS CHILD" d1="102" d2="733" d3="961"/>
<CITE num="014" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="015" author="EGGSTEIN M" publication="KLIN WOCHENSCHR" d1="33" d2="879" d3="955"/>
<CITE num="016" author="FRASER D" publication="CLIN CHIM ACTA" d1="59" d2="301" d3="975"/>
<CITE num="017" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="018" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="019" author="JOHANSEN PG" publication="ANN NY ACAD SCI" d1="106" d2="755" d3="963"/>
<CITE num="020" author="KNAUFF RE" publication="PROC SOC EXP BIOL MED" d1="127" d2="801" d3="968"/>
<CITE num="021" author="KOPITO L" publication="J PEDIATR" d1="68" d2="313" d3="966"/>
<CITE num="022" author="LEV R" publication="HISTOCHEMIE" d1="29" d2="103" d3="972"/>
<CITE num="023" author="LEVVY GA" publication="BIOCHEM J" d1="80" d2="433" d3="961"/>
<CITE num="024" author="LINHARDT K" publication="IN: BERGMEYER HU" d1="" d2="783" d3="965"/>
<CITE num="025" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="026" author="PALLAVICINI JC" publication="ANN NY ACAD SCI" d1="106" d2="330" d3="963"/>
<CITE num="027" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="028" author="ROMEO D" publication="BIOCHIM BIOPHYS ACTA" d1="159" d2="194" d3="968"/>
<CITE num="029" author="RULE AH" publication="PEDIATRICS" d1="45" d2="847" d3="970"/>
<CITE num="030" author="RULE AH" publication="PEDIATRICS" d1="48" d2="601" d3="971"/>
<CITE num="031" author="RYLEY HC" publication="ARCH DIS CHILD" d1="49" d2="901" d3="974"/>
<CITE num="032" author="SCHACHTER H" publication="CAN J BIOCHEM" d1="43" d2="381" d3="965"/>
<CITE num="033" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="034" author="SHWACHMAN H" publication="ANN NY ACAD SCI" d1="93" d2="600" d3="962"/>
<CITE num="035" author="SIEGAL S" publication="NONPARAMETRIC STATISTICS" d1="" d2="" d3="956"/>
<CITE num="036" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="037" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="038" author="TAPPEL AL" publication="J BIOL CHEM" d1="242" d2="2463" d3="967"/>
<CITE num="039" author="VAN HOOF F" publication="IN: HERS HG" d1="" d2="" d3="973"/>
<CITE num="040" author="WATZKA M" publication="VERH ANAT GES" d1="66" d2="" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78051</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IEH MC              CL" publication="IN CHEM" d1="27" d2="88 9" d3="1"/>
<CITE num="2" author="LAMBOTTE C" publication="J GENET HUM" d1="29" d2="85" d3="981"/>
<CITE num="3" author="CABEZAS JA" publication="INT J BIOCHEM" d1="15" d2="243" d3="983"/>
<CITE num="4" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="135" d2="49" d3="983"/>
</CITATIONS>
<RECORDNUM>00832 </RECORDNUM>
<MEDLINENUM>79083227</MEDLINENUM>
<AUTHORS><AUTHOR>Summitt-R-L</AUTHOR></AUTHORS>
<TITLE>Wolffian duct anomalies [editorial].</TITLE>
<SOURCE>Birth-Defects. 1978. 14(6C). P 54-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>VAS-DEFERENS: ab</TOPIC><TOPIC>WOLFFIAN-DUCT</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PHENOTYPE</TOPIC><TOPIC>INFERTILITY-MALE</TOPIC></MINORSUBJ>
<EXTRACT>The fact that a serum factor in cystic fibrosis patients inhibits
ciliary movement of cells of isolated tracheae, and the observation
that ciliary movement is associated with pinocytotic activity led
Ohno et al. to suggest that this defect is responsible for aplasia or
hypoplasia of the wolffian duct structures in males with cystic
fibrosis.  While Ohno's hypothesis lacks definitive proof, the
hypoplasia or aplasia of the vas in males with cystic fibrosis is
extremely common, producing sterility in affected males.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78052</PAPERNUM>
<REFERENCES>
<CITE num="001" author="KAPLAN E" publication="N ENGL J MED" d1="279" d2="65" d3="968"/>
<CITE num="002" author="VALMAN HB" publication="LANCET" d1="2" d2="566" d3="969"/>
<CITE num="003" author="OHNO S" publication="HEREDITAS" d1="69" d2="107" d3="971"/>
</REFERENCES>
<RECORDNUM>00833 </RECORDNUM>
<MEDLINENUM>78103772</MEDLINENUM>
<AUTHORS><AUTHOR>Mathieu-J-P</AUTHOR><AUTHOR>Stack-B-H</AUTHOR><AUTHOR>Dick-W-C</AUTHOR><AUTHOR>Buchanan-W-W</AUTHOR></AUTHORS>
<TITLE>Pulmonary infection and rheumatoid arthritis.</TITLE>
<SOURCE>Br-J-Dis-Chest. 1978 Jan. 72(1). P 57-61.</SOURCE>
<MAJORSUBJ><TOPIC>ARTHRITIS-RHEUMATOID: co</TOPIC><TOPIC>BRONCHIECTASIS: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ARTHRITIS-RHEUMATOID: im</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>RHEUMATOID-FACTOR: an</TOPIC></MINORSUBJ>
<ABSTRACT>Five of eleven patients with bronchiectasis and/or cystic fibrosis
developed a polyarthritis with positive tests for rheumatoid factor.
Possible mechanisms of this complication are discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALARCON-SEGOVIA D" publication="MEDICINE (BALTIMORE)" d1="46" d2="1" d3="967"/>
<CITE num="002" author="ARONOFF A" publication="BR MED J" d1="2" d2="228" d3="955"/>
<CITE num="003" author="BERKSON J" publication="PROC STAFF MTG MAYO CLIN" d1="30" d2="319" d3="955"/>
<CITE num="004" author="BRINKMAN GH" publication="AM REV TUBERC PULM DIS" d1="80" d2="732" d3="959"/>
<CITE num="005" author="GROSSMAN H" publication="AM J DIS CHILD" d1="107" d2="1" d3="964"/>
<CITE num="006" author="HARRIS J" publication="ARTHRITIS RHEUM" d1="4" d2="47" d3="961"/>
<CITE num="007" author="ISAACS AJ" publication="TUBERCLE" d1="55" d2="135" d3="974"/>
<CITE num="008" author="KELLGREN JH" publication="PRACTITIONER" d1="193" d2="257" d3="964"/>
<CITE num="009" author="KUNKEL HG" publication="ARTHRITIS RHEUM" d1="1" d2="289" d3="958"/>
<CITE num="010" author="LEE SL" publication="ARCH INTERN MED" d1="117" d2="620" d3="966"/>
<CITE num="011" author="MAINLAND D" publication="AM HEART J" d1="45" d2="644" d3="953"/>
<CITE num="012" author="MURRAY HW" publication="AM J MED" d1="58" d2="229" d3="975"/>
<CITE num="013" author="PONCET A" publication="POLYARTHRITE TUBERCULEU" d1="" d2="" d3="897"/>
<CITE num="014" author="SINGER JM" publication="ARTHRITIS RHEUM" d1="4" d2="124" d3="961"/>
<CITE num="015" author="VIRSHUP AM" publication="ARTHRITIS RHEUM" d1="16" d2="388" d3="973"/>
<CITE num="016" author="VOGL A" publication="AM J MED" d1="18" d2="51" d3="955"/>
<CITE num="017" author="WALKER WC" publication="Q J MED" d1="36" d2="239" d3="967"/>
<CITE num="018" author="WEINSTEIN MP" publication="AM J DIS CHILD" d1="127" d2="125" d3="974"/>
<CITE num="019" author="WHITE C" publication="BR MED J" d1="2" d2="1284" d3="953"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78053</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WIE AD              SC" publication="OTT MED J" d1="24" d2="93 9" d3="9"/>
<CITE num="2" author="SAGRANSKY DM" publication="AM J DIS CHILD" d1="134" d2="319" d3="980"/>
<CITE num="3" author="SUTTON PP" publication="ANN RHEUM DIS" d1="41" d2="47" d3="982"/>
<CITE num="4" author="DELUMLEY L" publication="ARCH FR PEDIATR" d1="40" d2="723" d3="983"/>
<CITE num="5" author="HILTON AM" publication="THORAX" d1="39" d2="185" d3="984"/>
<CITE num="6" author="SCHIDLOW DV" publication="ARCH DIS CHILD" d1="59" d2="377" d3="984"/>
<CITE num="7" author="BAMJI A" publication="SCAND J RHEUMATOL" d1="14" d2="15" d3="985"/>
<CITE num="8" author="BERKIN KE" publication="EUR J RESPIR DIS" d1="67" d2="103" d3="985"/>
<CITE num="9" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="10" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
</CITATIONS>
<RECORDNUM>00834 </RECORDNUM>
<MEDLINENUM>78145446</MEDLINENUM>
<AUTHORS><AUTHOR>Benghial-A</AUTHOR></AUTHORS>
<TITLE>Meconium ileus equivalent an adult: a case report.</TITLE>
<SOURCE>Br-J-Surg. 1978 Mar. 65(3). P 215.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: co</TOPIC><TOPIC>INTESTINE-SMALL</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLCYSTEINE: tu</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: dt</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>A case is described of meconium ileus equivalent presenting as a
small bowel obstruction in an adult patient with cystic fibrosis. The
importance of conservative management with acetylcysteine and
intravenous fluids is emphasized.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78054</PAPERNUM>
<REFERENCES>
<CITE num="001" author="FISHER OD" publication="ARCH DIS CHILD" d1="29" d2="262" d3="954"/>
<CITE num="002" author="GRACEY M" publication="ARCH DIS CHILD" d1="44" d2="404" d3="969"/>
<CITE num="003" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
<CITE num="004" author="HUNTON DB" publication="GASTROENTEROLOGY" d1="50" d2="99" d3="966"/>
<CITE num="005" author="LILLIBRIDGE CB" publication="J PEDIATR" d1="71" d2="887" d3="967"/>
</REFERENCES>
<RECORDNUM>00835 </RECORDNUM>
<MEDLINENUM>78104639</MEDLINENUM>
<AUTHORS><AUTHOR>Harries-J-T</AUTHOR></AUTHORS>
<TITLE>Meconium in health and disease.</TITLE>
<SOURCE>Br-Med-Bull. 1978 Jan. 34(1). P 75-8. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BILE-ACIDS-AND-SALTS: an</TOPIC><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>GLYCOPROTEINS: an</TOPIC><TOPIC>HEMOGLOBINS: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et, me</TOPIC><TOPIC>MECONIUM: en</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>STEROIDS: an</TOPIC></MINORSUBJ>
<EXTRACT>Meconium can be defined as the first stools passed by a newborn
infant, the first stool being passed within 24 hours of birth by more
than 90% of newborns.  This paper will review current knowledge on
the sources of meconium, and its composition in health and disease
states.  The precise origin of the components of meconium has not
been defined.  The qualitative and quantitative patterns of the
individual constituents of meconium in health are considered: water
and inorganic elements, enzymes, plasma proteins, glycoproteins,
lipids, haemoglobin metabolites, steroids and bile acids, and
sterols.  Meconium from infants with cystic fibrosis has been more
extensively studied than in any other disease and the paper
concentrates on this entity.  The composition of meconium in cystic
fibrosis, screening tests for cystic fibrosis, the diagnosis of
cystic fibrosis, and meconium ileus are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
<CITE num="002" author="BUCHANAN DJ" publication="J BIOL CHEM" d1="192" d2="251" d3="951"/>
<CITE num="003" author="BUCHANAN DJ" publication="PEDIATRICS" d1="9" d2="304" d3="952"/>
<CITE num="004" author="COTE RH" publication="IN: WOLLHEIM E" d1="1" d2="489" d3="962"/>
<CITE num="005" author="COTE RH" publication="IN: AMINOFF D" d1="" d2="249" d3="970"/>
<CITE num="006" author="COTE RH" publication="BIOCHEM J" d1="153" d2="63" d3="976"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="008" author="EGGERMONT E" publication="BIOL NEONATE" d1="10" d2="266" d3="966"/>
<CITE num="009" author="FARBER S" publication="J PEDIATR" d1="24" d2="387" d3="944"/>
<CITE num="010" author="FRASER D" publication="CLIN CHIM ACTA" d1="59" d2="301" d3="975"/>
<CITE num="011" author="FRENCH J" publication="BIOCHEM J" d1="120" d2="393" d3="970"/>
<CITE num="012" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="013" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="014" author="GUSTAFSSON JA" publication="EUR J BIOCHEM" d1="22" d2="246" d3="971"/>
<CITE num="015" author="HALL IC" publication="AM J DIS CHILD" d1="47" d2="1270" d3="934"/>
<CITE num="016" author="HURWITT ES" publication="AM J DIS CHILD" d1="64" d2="443" d3="942"/>
<CITE num="017" author="KARLSON P" publication="INTRODUCTION TO MODERN BIOCHE" d1="" d2="314" d3="968"/>
<CITE num="018" author="KINSELLA RA JR" publication="J CLIN ENDOCRINOL METAB" d1="32" d2="801" d3="971"/>
<CITE num="019" author="KNAUFF RE" publication="PROC SOC EXP BIOL MED" d1="127" d2="801" d3="968"/>
<CITE num="020" author="KOPITO L" publication="J PEDIATR" d1="68" d2="313" d3="966"/>
<CITE num="021" author="LIEBERMAN J" publication="GASTROENTEROLOGY" d1="50" d2="183" d3="966"/>
<CITE num="022" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
<CITE num="023" author="PRITCHARD JA" publication="OBSTET GYNECOL" d1="28" d2="606" d3="966"/>
<CITE num="024" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="025" author="RULE AH" publication="PEDIATRICS" d1="45" d2="847" d3="970"/>
<CITE num="026" author="RULE AH" publication="PEDIATRICS" d1="48" d2="601" d3="971"/>
<CITE num="027" author="RYLEY HC" publication="ARCH DIS CHILD" d1="49" d2="901" d3="974"/>
<CITE num="028" author="SCHACHTER H" publication="CAN J BIOCHEM" d1="43" d2="381" d3="965"/>
<CITE num="029" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="030" author="SCHWARZ E" publication="ANN PAEDIATR" d1="181" d2="306" d3="953"/>
<CITE num="031" author="ACHWIDT W" publication="VERH ANAT GES" d1="66" d2="55" d3="971"/>
<CITE num="032" author="SHARP HL" publication="PEDIATR RES" d1="5" d2="274" d3="971"/>
<CITE num="033" author="SMITH CA" publication="PHYSIOLOGY OF THE NEWBORN" d1="" d2="235" d3="959"/>
<CITE num="034" author="SPRINGER GF" publication="BIOCHEMISTRY" d1="5" d2="3254" d3="966"/>
<CITE num="035" author="YOUNG DM" publication="PROC SOC EXP BIOL MED" d1="99" d2="673" d3="958"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78055</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RLSSON KA           J" publication="BIOL CHEM                    2" d1="56" d2="12 9" d3="1"/>
<CITE num="2" author="KATZ S" publication="DIGESTION" d1="24" d2="98" d3="982"/>
<CITE num="3" author="FRANCOUAL J" publication="ANN BIOL CLIN" d1="40" d2="227" d3="982"/>
<CITE num="4" author="STPYREK J" publication="J STEROID BIOCHEM" d1="18" d2="341" d3="983"/>
<CITE num="5" author="FRANCOUAL J" publication="CLIN CHEM" d1="29" d2="2054" d3="983"/>
<CITE num="6" author="SLOMIANY A" publication="J BIOL CHEM" d1="258" d2="8535" d3="983"/>
<CITE num="7" author="HANLY JG" publication="BR MED J" d1="286" d2="1411" d3="983"/>
<CITE num="8" author="DEHNER LP" publication="HUM PATHOL" d1="17" d2="807" d3="986"/>
<CITE num="9" author="MELLANDER L" publication="CLIN EXP IMMUNOL" d1="63" d2="555" d3="986"/>
<CITE num="10" author="CLARK DA" publication="J PEDIATR" d1="110" d2="765" d3="987"/>
</CITATIONS>
<RECORDNUM>00836 </RECORDNUM>
<MEDLINENUM>78104725</MEDLINENUM>
<AUTHORS><AUTHOR>Dodge-J-A</AUTHOR><AUTHOR>Yassa-J-G</AUTHOR></AUTHORS>
<TITLE>Zinc deficiency syndrome in a British youth with cystic fibrosis.</TITLE>
<SOURCE>Br-Med-J. 1978 Feb 18. 1(6110). P 411.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>ZINC: df</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>GENITALIA-MALE</TOPIC><TOPIC>GROWTH-DISORDERS: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SEX-MATURATION</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<EXTRACT>A syndrome of dwarfism and retarded sexual development among Iranian
and Egyptian teenage boys has been shown to be due to zinc
deficiency.  A British patient with cystic fibrosis and nephrotic
syndrome showed growth retardation and hypogonadism, associated with
low plasma zinc concentrations.  The combination of cystic fibrosis
and nephrotic syndrome appears to be fortuitous, and undoubtedly
adverse effects on zinc homoeostasis were cumulative.  Nevertheless,
zinc deficiency should be considered when somatic and sexual growth
failure occur in patients with cystic fibrosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="PRASAD AS" publication="ARCH INTERN MED" d1="111" d2="407" d3="963"/>
<CITE num="002" author="HALSTED JA" publication="LANCET" d1="1" d2="322" d3="970"/>
<CITE num="003" author="EVANS GW" publication="IN: PRASAD AS" d1="" d2="" d3="976"/>
<CITE num="004" author="SANDSTEAD HH" publication="IN: PRASAD AS" d1="" d2="137" d3="976"/>
<CITE num="005" author="STEELE TH" publication="J LAB CLIN MED" d1="78" d2="1019" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78056</PAPERNUM>
<CITATIONS>
<CITE num="1" author="KINSON RL           AN" publication="N INTERN MED" d1="89" d2="91 9" d3="8"/>
<CITE num="2" author="AGGETT PJ" publication="MONOGR PAEDIATR" d1="10" d2="8" d3="979"/>
<CITE num="3" author="WALRAVENS PA" publication="WEST J MED" d1="130" d2="133" d3="979"/>
<CITE num="4" author="SHAW JCL" publication="AM J DIS CHILD" d1="133" d2="1260" d3="979"/>
<CITE num="5" author="KYNAST G" publication="J PERINATAL MED" d1="8" d2="171" d3="980"/>
<CITE num="6" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="33" d2="2031" d3="980"/>
<CITE num="7" author="PARSONS HG" publication="PEDIATRICS" d1="66" d2="812" d3="980"/>
<CITE num="8" author="MITCHELL EA" publication="NZ MED J" d1="92" d2="6" d3="980"/>
<CITE num="9" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="34" d2="462" d3="981"/>
<CITE num="10" author="BEDDOES V" publication="PRACTITIONER" d1="225" d2="557" d3="981"/>
<CITE num="11" author="HANSEN MA" publication="ANNU REV NUTRITION" d1="2" d2="151" d3="982"/>
<CITE num="12" author="SOLOMONS NW" publication="AM J CLIN NUTR" d1="35" d2="1048" d3="982"/>
<CITE num="13" author="SOLOMONS NW" publication="J AM DIET ASSOC" d1="80" d2="115" d3="982"/>
<CITE num="14" author="PATRICK J" publication="CRC CRIT REV CLIN LAB SCI" d1="20" d2="95" d3="984"/>
<CITE num="15" author="DODGE JA" publication="ACTA PAEDIATR SCAND SUPPL 317" d1="1985" d2="31" d3="985"/>
<CITE num="16" author="DODGE JA" publication="J ROY SOC MED" d1="79" d2="27" d3="986"/>
</CITATIONS>
<RECORDNUM>00837 </RECORDNUM>
<MEDLINENUM>78145601</MEDLINENUM>
<AUTHORS><AUTHOR>Hodson-M-E</AUTHOR></AUTHORS>
<TITLE>Diseases of the respiratory system: Bronchiectasis and cystic
fibrosis.</TITLE>
<SOURCE>Br-Med-J. 1978 Apr 15. 1(6118). P 971-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHIECTASIS: co, et, th</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di, th</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Bronchiectasis is characterised by dilatation of the bronchi.  This
dilation may be generalised or confined to a single segment or lobe
of the lung, and it may be tubular, fusiform (spindle shaped), or
saccular (cystic).  The aetiology, symptoms, diagnosis, treatment,
complications, and prevention of bronchiectasis are considered.
Cystic fibrosis affects many exocrine glands throughout the body.
Presentation and diagnosis, treatment, complications and their
treatment, management of associated social problems, and death due to
cystic fibrosis are discussed.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HODSON ME" publication="BR MED J" d1="2" d2="790" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78057</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DD JW               BR" publication="MED J" d1="1" d2="81 9" d3="8"/>
<CITE num="2" author="FLOWER KA" publication="BR MED J" d1="2" d2="630" d3="979"/>
<CITE num="3" author="FLOWER KA" publication="MONOGR PAEDIATR" d1="10" d2="54" d3="979"/>
<CITE num="4" author="REDDING GJ" publication="AM REV RESPIR DIS" d1="126" d2="31" d3="982"/>
<CITE num="5" author="ANON" publication="LANCET" d1="2" d2="257" d3="983"/>
<CITE num="6" author="HODSON ME" publication="BR J DIS CHEST" d1="77" d2="71" d3="983"/>
</CITATIONS>
<RECORDNUM>00838 </RECORDNUM>
<MEDLINENUM>78145788</MEDLINENUM>
<AUTHORS><AUTHOR>Norman-A-P</AUTHOR></AUTHORS>
<TITLE>Bronchiectasis and cystic fibrosis [letter].</TITLE>
<SOURCE>Br-Med-J. 1978 May 6. 1(6121). P 1217.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIECTASIS: th</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PROGNOSIS</TOPIC></MINORSUBJ>
<EXTRACT>The otherwise excellent article on bronchiectasis and cystic fibrosis
by Dr Margaret Hodson is seriously marred by the failure to emphasise
that the advice on management and drug dosage is directed throughout
to the adult and adolescent, and not to the child.  Firstly,
tetracycline should not be prescribed for young children for obvious
reasons; secondly, the dosage of all antibiotics recommended is high
for infants and small children.  The final paragraph gives a
pessimistic impression of an undoubtedly distressing condition by
stressing the early mortality of the past and of many of the older
patients of today, without noting the effect that early diagnosis -
perhaps as a result of neonatal screening - together with more
effective treatment may have in the future on the quality of life and
length of life.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78058</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HODSON ME" publication="BR MED J" d1="1" d2="971" d3="978"/>
</REFERENCES>
<RECORDNUM>00839 </RECORDNUM>
<MEDLINENUM>79043563</MEDLINENUM>
<AUTHORS><AUTHOR>Walker-L</AUTHOR></AUTHORS>
<TITLE>My fight for life.</TITLE>
<SOURCE>Can-Nurse. 1978 Nov. 74(10). P 28-9.</SOURCE>
<MAJORSUBJ><TOPIC>ATTITUDE-TO-DEATH</TOPIC><TOPIC>CYSTIC-FIBROSIS: px</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PNEUMONIA: co</TOPIC><TOPIC>PULMONARY-EMPHYSEMA: et, px</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78059</PAPERNUM>
<EXTRACT>A patient with cystic fibrosis discusses her experiences with the
disease.</EXTRACT>
<RECORDNUM>00840 </RECORDNUM>
<MEDLINENUM>78188959</MEDLINENUM>
<AUTHORS><AUTHOR>Breslow-J-L</AUTHOR><AUTHOR>Epstein-J</AUTHOR><AUTHOR>Fontaine-J-H</AUTHOR></AUTHORS>
<TITLE>Dexamethasone-resistant cystic fibrosis fibroblasts show
cross-resistance to sex steroids.</TITLE>
<SOURCE>Cell. 1978 Apr. 13(4). P 663-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>DEXAMETHASONE: pd</TOPIC><TOPIC>ESTRADIOL: pd</TOPIC><TOPIC>PROGESTERONE: pd</TOPIC><TOPIC>STANOLONE: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-SURVIVAL: de</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>DEXAMETHASONE: me</TOPIC><TOPIC>DRUG-RESISTANCE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FIBROBLASTS: de, me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Diploid skin fibroblasts derived from individuals with the autosomal
recessive disease, cystic fibrosis (CF), were shown previously to be
significantly  more resistant to the cytotoxicity of dexamethasone, a
glucocorticoid hormone, than were normal human fibroblasts. Here
cystic fibrosis fibroblasts are also shown to be more resistant than
normal human fibroblasts to the cytotoxic effects of the sex
hormones, 17 beta-estradiol, dihydrotestosterone and progesterone.
Since cells are believed to contain different receptors for each of
the steroid hormones, it is not probable than the resistance of CF
cells to these hormones results from a receptor deficiency. This was
shown by the fact that CF cells were found to exhibit the same
receptor activity as normal cells for 3-H-dexamethasone. Furthermore,
neither normal human nor CF fibroblasts could be demonstrated to
contain detectable receptor activity for 3H-17 beta-estradiol. In
addition, the studies of fibroblast killing by hormones led to the
further interesting observation that normal human diploid
fibroblasts, regardless of the sex of the tissue donor, are sensitive
to killing by each of the sex hormones. These findings suggest that
the cytotoxic effects of the steroid hormones may be observed
independently of the specific hormone receptors. The studies reported
here thus suggest that the resistance of CF cells to the different
steroid hormones is probably the result of a defect in a pathway in
cellular steroid hormone metabolism other than that involving
receptors.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAXTER JD" publication="SCIENCE" d1="171" d2="189" d3="971"/>
<CITE num="002" author="BOURGEOIS S" publication="CELL" d1="11" d2="423" d3="977"/>
<CITE num="003" author="BRESLOW JL" publication="EXP CELL RES" d1="110" d2="399" d3="977"/>
<CITE num="004" author="CHAN L" publication="N ENGL J MED" d1="294" d2="1322" d3="976"/>
<CITE num="005" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="006" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="007" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="008" author="FREUND JE" publication="MODERN ELEMENTARY STATISTICS" d1="" d2="" d3="967"/>
<CITE num="009" author="GORSKI J" publication="ANNU REV PHYSIOL" d1="38" d2="425" d3="976"/>
<CITE num="010" author="GRIFFIN JE" publication="J CLIN INVEST" d1="57" d2="1342" d3="976"/>
<CITE num="011" author="HORWITZ KB" publication="STEROID" d1="26" d2="785" d3="975"/>
<CITE num="012" author="KAUFMAN M" publication="J CLIN INVEST" d1="58" d2="345" d3="976"/>
<CITE num="013" author="KEENAN BS" publication="J CLIN ENDOCRINOL METAB" d1="38" d2="1143" d3="974"/>
<CITE num="014" author="LEUNG K" publication="ANNU REV PHYSIOL" d1="37" d2="245" d3="975"/>
<CITE num="015" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="016" author="MEYER WJ III" publication="PROC NAT ACAD SCI USA" d1="72" d2="1469" d3="975"/>
<CITE num="017" author="MIDDLEBROOK JL" publication="ENDOCRINOLOGY" d1="100" d2="271" d3="977"/>
<CITE num="018" author="NEIFELD JP" publication="J BIOL CHEM" d1="252" d2="2972" d3="977"/>
<CITE num="019" author="ROUSSEAU GG" publication="J STEROID BIOCHEM" d1="6" d2="75" d3="975"/>
<CITE num="020" author="SCATCHARD G" publication="ANN NY ACAD SCI" d1="51" d2="660" d3="949"/>
<CITE num="021" author="SIBLEY CH" publication="CELL" d1="2" d2="221" d3="974"/>
<CITE num="022" author="YAMAMOTO KR" publication="PROC NAT ACAD SCI USA" d1="71" d2="3901" d3="974"/>
<CITE num="023" author="YAMAMOTO KR" publication="IN: GREEP RO" d1="32" d2="3" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78060</PAPERNUM>
<CITATIONS>
<CITE num="1" author="STEIN J             SO" publication="MATIC CELL GENET" d1="4" d2="51 9" d3="8"/>
<CITE num="2" author="BRESLOW JL" publication="SCIENCE" d1="201" d2="180" d3="978"/>
<CITE num="3" author="HARRIS A" publication="DEVELOP MED CHILD NEUROL" d1="21" d2="675" d3="979"/>
<CITE num="4" author="BRESLOW JL" publication="J CELL PHYSIOL" d1="99" d2="343" d3="979"/>
<CITE num="5" author="KURZ JB" publication="SCIENCE" d1="206" d2="1317" d3="979"/>
<CITE num="6" author="THOMPSON EB" publication="J STEROID BIOCHEM" d1="12" d2="193" d3="980"/>
<CITE num="7" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="8" author="CHASE HP" publication="METABOLISM" d1="29" d2="365" d3="980"/>
<CITE num="9" author="KOEFFLER HP" publication="CANCER RES" d1="40" d2="563" d3="980"/>
<CITE num="10" author="DEMEYTS P" publication="CIRC RES" d1="46" d2="I  3" d3="980"/>
<CITE num="11" author="BRESLOW JL" publication="SCIENCE" d1="207" d2="1007" d3="980"/>
<CITE num="12" author="PEDERSEN PS" publication="ACTA PAEDIATR SCAND" d1="70" d2="507" d3="981"/>
<CITE num="13" author="KELLER GH" publication="ARCH BIOCHEM BIOPHYS" d1="211" d2="321" d3="981"/>
<CITE num="14" author="BRESLOW JL" publication="N ENGL J MED" d1="304" d2="1" d3="981"/>
<CITE num="15" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="16" author="MINGUELL JJ" publication="ARCH BIOL MED EXP" d1="15" d2="457" d3="982"/>
<CITE num="17" author="JUNEJA HS" publication="EXP HEMATOL" d1="12" d2="221" d3="984"/>
<CITE num="18" author="LANGHOFF E" publication="PEDIATR RES" d1="18" d2="488" d3="984"/>
<CITE num="19" author="GROSS NJ" publication="AM REV RESPIR DIS" d1="129" d2="805" d3="984"/>
<CITE num="20" author="PINSKY L" publication="ADV HUM GENET" d1="16" d2="299" d3="987"/>
</CITATIONS>
<RECORDNUM>00841 </RECORDNUM>
<MEDLINENUM>79126049</MEDLINENUM>
<AUTHORS><AUTHOR>Treton-J</AUTHOR><AUTHOR>Boucays-A</AUTHOR><AUTHOR>Dersakissian-H</AUTHOR><AUTHOR>Boue-A</AUTHOR><AUTHOR>Courtois-Y</AUTHOR></AUTHORS>
<TITLE>The repair of DNA single strand breaks in human cells with genetical
disorders.</TITLE>
<SOURCE>Cell-Biol-Int-Rep. 1978 Jul. 2(4). P 403-10.</SOURCE>
<MAJORSUBJ><TOPIC>DNA-REPAIR</TOPIC><TOPIC>DNA: re</TOPIC><TOPIC>DNA-SINGLE-STRANDED: bi</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CELL-LINE</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>FIBROBLASTS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LESCH-NYHAN-SYNDROME</TOPIC><TOPIC>RETINOBLASTOMA</TOPIC><TOPIC>TRISOMY</TOPIC><TOPIC>X-RAYS</TOPIC></MINORSUBJ>
<ABSTRACT>The aim of this work was to make a preliminary examination of some
hereditary diseases, related to precocious aging in order to
determine whether the defects involved resulted from an impairment of
the DNA repair capacity. To test for an impairment in DNA single
strand capacity, in cells from patients with different diseases, we
have followed the rate of the DNA after X-irradiation by
sedimentation on alkaline sucrose gradients. It was found that all
cells observed from Lesh Nyhan, cystic fibrosis, trisomy 15 et 21,
retinoblastoma, were able to repair the single strand breaks in their
DNA to the same extent and at the same initial rate.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOUE A" publication="IN VITRO" d1="11" d2="409" d3="975"/>
<CITE num="002" author="BRADLEY MO" publication="MUTATION RES" d1="37" d2="279" d3="976"/>
<CITE num="003" author="CLEAVER JE" publication="PROC NAT ACAD SCI USA" d1="63" d2="428" d3="969"/>
<CITE num="004" author="COUNIS MF" publication="DEVELOP BIOL" d1="57" d2="47" d3="977"/>
<CITE num="005" author="CURE S" publication="MOLEC CELLUL MECH AGING" d1="27" d2="47" d3="973"/>
<CITE num="006" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="70" d2="977" d3="973"/>
<CITE num="007" author="EPSTEIN J" publication="BIOCHEM BIOPHYS RES COMMUN" d1="59" d2="850" d3="974"/>
<CITE num="008" author="GIANNELLI F" publication="NATURE" d1="265" d2="446" d3="977"/>
<CITE num="009" author="HART RN" publication="IN: CUTLER RG" d1="9" d2="134" d3="976"/>
<CITE num="010" author="HIGURASHI M" publication="PEDIATR RES" d1="6" d2="514" d3="972"/>
<CITE num="011" author="KATO H" publication="NATURE" d1="260" d2="447" d3="976"/>
<CITE num="012" author="LAMBERT B" publication="ACTA MED SCAND" d1="200" d2="433" d3="976"/>
<CITE num="013" author="LINN S" publication="PROC NAT ACAD SCI USA" d1="73" d2="2818" d3="976"/>
<CITE num="014" author="LITTLE JB" publication="GERONTOLOGY" d1="22" d2="28" d3="976"/>
<CITE num="015" author="PATERSON MC" publication="NATURE" d1="260" d2="444" d3="976"/>
<CITE num="016" author="STRAUSS BS" publication="LIFE SCI" d1="15" d2="1685" d3="974"/>
<CITE num="017" author="TAYLOR AMR" publication="NATURE" d1="258" d2="427" d3="975"/>
<CITE num="018" author="TAYLOR AMR" publication="NATURE" d1="260" d2="441" d3="976"/>
<CITE num="019" author="TICE RR" publication="IN: CUTLER RG" d1="9" d2="60" d3="976"/>
<CITE num="020" author="TRETON JA" publication="EXP CELL RES" d1="102" d2="410" d3="976"/>
<CITE num="021" author="TRETON JA" publication="IN: COURTOIS Y" d1="60" d2="193" d3="976"/>
<CITE num="022" author="TROSKO JE" publication="IN: CUTLER RG" d1="9" d2="168" d3="976"/>
<CITE num="023" author="WEICHSELBAUM RR" publication="NATURE" d1="266" d2="726" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78061</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ONARD JC            MU" publication="TATION RES                   1" d1="05" d2="17 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00842 </RECORDNUM>
<MEDLINENUM>79106567</MEDLINENUM>
<AUTHORS><AUTHOR>Fink-R-J</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR><AUTHOR>Tucker-A-S</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Matthews-L-W</AUTHOR></AUTHORS>
<TITLE>Pulmonary function and morbidity in 40 adult patients with cystic
fibrosis.</TITLE>
<SOURCE>Chest. 1978 Dec. 74(6). P 643-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>LUNG: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HAEMOPHILUS-INFLUENZAE: ip</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: ip</TOPIC><TOPIC>RESIDUAL-VOLUME</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>SEX-FACTORS</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS: ip</TOPIC></MINORSUBJ>
<ABSTRACT>Pulmonary function and cardiopulmonary complications were studied in
a group of 40 patients with cystic fibrosis who reached the age of 25
years. Mean values for vital capacity (VC), functional residual
capacity, residual volume (RV), the ratio of RV over total lung
capacity (RV/TLC), conductance, and the ratio of the forced
expiratory volume in one second over VC were abnormal. There was a
variable pattern of progression from patient to patient. The men
differed from the women only in that they had a significantly larger
TLC and inspiratory capacity than the women. The resultant
preservation of VC may have an advantage for survival in those
patients in whom it is observed. Pseudomonas aeruginosa was
encountered with increasing frequency with age. Massive hemoptysis
did not result in early death. The occurrence of rightsided heart
failure secondary to cor pulmonale, with or without respiratory
failure, was a poor prognostic sign.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="CF FND 1976 REP SURVI STUD PA" d1="" d2="" d3="978"/>
<CITE num="002" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="003" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="004" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="005" author="COMROE JH JR" publication="LUNG CLINICAL PHYSIOLOGY AND" d1="" d2="" d3="962"/>
<CITE num="006" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="007" author="HELLIESEN PJ" publication="PEDIATRICS" d1="22" d2="80" d3="958"/>
<CITE num="008" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="009" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="615" d3="958"/>
<CITE num="010" author="STOWE SM" publication="AM REV RESPIR DIS" d1="111" d2="611" d3="975"/>
<CITE num="011" author="STERN RC" publication="AM REV RESPIR DIS" d1="117" d2="825" d3="978"/>
<CITE num="012" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="013" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78062</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSCLAW DS           CL" publication="IN CHEST MED" d1="1" d2="07 9" d3="0"/>
<CITE num="2" author="MATTHAY RA" publication="BR HEART J" d1="43" d2="474" d3="980"/>
<CITE num="3" author="FRANCIS PWJ" publication="AM J DIS CHILD" d1="134" d2="734" d3="980"/>
<CITE num="4" author="FICK RB" publication="CLIN CHEST MED" d1="2" d2="91" d3="981"/>
<CITE num="5" author="MATTHAY RA" publication="MED CLIN NORTH AM" d1="65" d2="489" d3="981"/>
<CITE num="6" author="GUIDOTTI TL" publication="RESPIRATION" d1="44" d2="351" d3="983"/>
<CITE num="7" author="HODGES P" publication="J AM DIET ASSOC" d1="84" d2="664" d3="984"/>
<CITE num="8" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="9" author="WIESEMANN HG" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="726" d3="985"/>
<CITE num="10" author="KRUHLAK RT" publication="WEST J MED" d1="145" d2="196" d3="986"/>
</CITATIONS>
<RECORDNUM>00843 </RECORDNUM>
<MEDLINENUM>78147498</MEDLINENUM>
<AUTHORS><AUTHOR>Ewing-C-W</AUTHOR></AUTHORS>
<TITLE>Role of the fiberoptic bronchoscope in lung lavage of patients with
cystic fibrosis.</TITLE>
<SOURCE>Chest. 1978 May. 73(5 Suppl). P 750-4.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHOSCOPY</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>IRRIGATION</TOPIC><TOPIC>LUNG</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: et</TOPIC></MINORSUBJ>
<EXTRACT>This study compared the use of the fiberoptic bronchoscope with
other lavage techniques under general anesthesia, and of techniques
using the rigid bronchoscope.  Seventy-seven procedures were
performed on 39 patients with cystic fibrosis.  Their vital
capacities were improved in 46 of the 75 valid measurements.
Arterial blood gas levels showed improvements in 14 of the 33 values
obtained.  A prospective study is needed which incorporates the
values of pre- and postoperative MMEV, RV/TLC, flow volume curves
and arterial blood gas values.  An evaluation of the complications
and ease of operation may be of greater value.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="002" author="KLINE BS" publication="J EXP MED" d1="21" d2="311" d3="915"/>
<CITE num="003" author="WINTERNITZ MC" publication="IN: CONTRIB MED BIOL RES" d1="" d2="1255" d3="919"/>
<CITE num="004" author="VICENTE G" publication="REV PROGR DE LA CLINICA" d1="" d2="" d3="928"/>
<CITE num="005" author="THOMPSON HT" publication="LANCET" d1="2" d2="8" d3="964"/>
<CITE num="006" author="LEFEMINE AA" publication="ANN THORAC SURG" d1="4" d2="308" d3="967"/>
<CITE num="007" author="HACKETT RR" publication="ANESTHESIOLOGY" d1="26" d2="248" d3="965"/>
<CITE num="008" author="RAMIREZ RJ" publication="ANN INTERN MED" d1="63" d2="819" d3="965"/>
<CITE num="009" author="RAMIREZ RJ" publication="DIS CHEST" d1="50" d2="581" d3="966"/>
<CITE num="010" author="CEZEAUX G JR" publication="JAMA" d1="199" d2="15" d3="967"/>
<CITE num="011" author="KYLSTRA JA" publication="AM REV RESPIR DIS" d1="103" d2="651" d3="971"/>
<CITE num="012" author="ALTMAN RP" publication="J PEDIATR SURG" d1="8" d2="809" d3="973"/>
<CITE num="013" author="MILLIS RM" publication="CHEST" d1="71" d2="508" d3="977"/>
<CITE num="014" author="SACKNER MA" publication="AM REV RESPIR DIS" d1="111" d2="62" d3="975"/>
<CITE num="015" author="SACKNER MA" publication="CHEST" d1="62" d2="705" d3="972"/>
<CITE num="016" author="DAHM LA" publication="CHEST" d1="12" d2="593" d3="977"/>
<CITE num="017" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="018" author="ALBERTINI RE" publication="JAMA" d1="230" d2="1666" d3="974"/>
<CITE num="019" author="BARRETT CR JR" publication="AM REV RESPIR DIS" d1="109" d2="429" d3="974"/>
<CITE num="020" author="KARETZKY MS" publication="NY STATE J MED" d1="74" d2="62" d3="974"/>
<CITE num="021" author="LOBER CW" publication="CHEST" d1="68" d2="382" d3="975"/>
<CITE num="022" author="BRAUNSTEIN MS" publication="CHEST" d1="66" d2="96" d3="974"/>
<CITE num="023" author="BEIER FR" publication="AM REV RESPIR DIS" d1="94" d2="430" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78063</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SLANDER HP          IN" publication="TERNIST" d1="21" d2="11 9" d3="0"/>
<CITE num="2" author="BURNS DM" publication="AM REV RESPIR DIS" d1="127" d2="695" d3="983"/>
<CITE num="3" author="SHERMAN JM" publication="PEDIATR PULMONOL" d1="2" d2="244" d3="986"/>
</CITATIONS>
<RECORDNUM>00844 </RECORDNUM>
<MEDLINENUM>78147499</MEDLINENUM>
<AUTHORS><AUTHOR>Quick-C-A</AUTHOR><AUTHOR>Warwick-W</AUTHOR></AUTHORS>
<TITLE>Bronchoscopy and lavage in management of pulmonary complications of
cystic fibrosis.</TITLE>
<SOURCE>Chest. 1978 May. 73(5 Suppl). P 755-8.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHOSCOPY</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>IRRIGATION</TOPIC><TOPIC>LUNG-DISEASES: th</TOPIC><TOPIC>LUNG</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC></MINORSUBJ>
<EXTRACT>This article presents our experience with bronchoscopy as a
therapeutic and diagnostic tool in the management of patients with
cystic fibrosis.  The results from therapeutic bronchoscopy and
bronchial irrigation in cystic fibrosis patients have been quite
impressive.  Levels of blood gas after the procedure have generally
shown improvement.  The vital capacity and FEF1 in general have shown
small but consistent improvements.  The most dramatic effect has been
the patient's own assessment of the operation.  These patients state
that their breathing is less labored in that it is less rapid and
much deeper.  Bronchoscopy offers an effective therapeutic tool in
the management of pulmonary complications of cystic fibrosis.
Unfortunately, the benefit is short-lived and repeated bronchoscopic
procedures are often necessary.  It must be accepted that there is a
point in time when the cardiopulmonary state of a patient's cystic
fibrosis may have progressed beyond salvageable limits.  It is our
conviction that earlier bronchoscopy and thorough bronchial
irrigation may prevent the critical pulmonary event which is followed
inevitably by progressive deterioration of the pulmonary status of
patients with cystic fibrosis.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78064</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SLANDER HP          IN" publication="TERNIST" d1="21" d2="11 9" d3="0"/>
<CITE num="2" author="ROTHMANN BF" publication="ANN OTOL RHINOL LARYNGOL" d1="91" d2="641" d3="982"/>
<CITE num="3" author="FITZPATRICK SB" publication="AM J DIS CHILD" d1="137" d2="595" d3="983"/>
<CITE num="4" author="MOAZAM F" publication="J PEDIATR SURG" d1="20" d2="398" d3="985"/>
<CITE num="5" author="SHERMAN JM" publication="PEDIATR PULMONOL" d1="2" d2="244" d3="986"/>
</CITATIONS>
<RECORDNUM>00845 </RECORDNUM>
<MEDLINENUM>79002962</MEDLINENUM>
<AUTHORS><AUTHOR>Mikkelsen-C</AUTHOR><AUTHOR>Waechter-E</AUTHOR><AUTHOR>Crittenden-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: a family challenge.</TITLE>
<SOURCE>Child-Today. 1978 Jul-Aug. 7(4). P 22-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: px</TOPIC><TOPIC>FAMILY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>To learn how families cope with cystic fibrosis, we interviewed 18
families who gave us vivid descriptions of the day-to-day process of
living with this devastating disease.  The families and the disease
are described.  Pre-diagnosis and diagnosis, home management and
treatment, family communication about CF, the reactions of siblings,
relationships with peers, hospitalization, and sources of support are
discussed.</EXTRACT>
<REFERENCES>
<CITE num="002" author="WAECHTER E" publication="IN: GODIN A" d1="" d2="" d3="972"/>
<CITE num="003" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="005" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78065</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WET B               S" publication="AFR MED J" d1="65" d2="26 9" d3="4"/>
<CITE num="2" author="DEWET B" publication="S AFR MED J" d1="67" d2="292" d3="985"/>
</CITATIONS>
<RECORDNUM>00846 </RECORDNUM>
<MEDLINENUM>79044102</MEDLINENUM>
<AUTHORS><AUTHOR>Warwick-W-J</AUTHOR><AUTHOR>Hansen-L</AUTHOR></AUTHORS>
<TITLE>Measurement of chloride in sweat with the chloride-selective
electrode.</TITLE>
<SOURCE>Clin-Chem. 1978 Nov. 24(11). P 2050-3.</SOURCE>
<MAJORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ELECTRODES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>PILOCARPINE: du</TOPIC></MINORSUBJ>
<EXTRACT>We describe here an improved method for the sweat test with the
chloride-selective electrode, after sweat production is stimulated
with pilocarpine, which gives results comparable to the more tedious
procedure of Gibson and Cooke.  Cystic fibrosis should never be
diagnosed solely on the results of any kind of sweat test; the
diagnosis must be consistent with the results of the physical
examination, history, and other studies, including a repeat of the
two sweat tests at another time.  Only by clinical examination and
repeated sweat tests can a physician confirm or rule out this
diagnosis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="167" d3="962"/>
<CITE num="002" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="003" author="GIBSON LE" publication="CLIN PEDIATR" d1="12" d2="450" d3="973"/>
<CITE num="004" author="HANSEN L" publication="MINN MED" d1="50" d2="1191" d3="967"/>
<CITE num="005" author="WARWICK WJ" publication="CF CLUB ABST" d1="" d2="5" d3="975"/>
<CITE num="006" author="WARWICK WJ" publication="PEDIATRICS" d1="36" d2="261" d3="965"/>
<CITE num="007" author="HANSEN L" publication="AM J CLIN PATHOL" d1="49" d2="834" d3="968"/>
<CITE num="008" author="KOPITO L" publication="PEDIATRICS" d1="43" d2="794" d3="969"/>
<CITE num="009" author="SZABO L" publication="CLIN CHEM" d1="19" d2="727" d3="973"/>
<CITE num="010" author="GURSON CT" publication="HELV PAEDIATR ACTA" d1="28" d2="165" d3="973"/>
<CITE num="011" author="STEINRUD J" publication="DAN MED BULL" d1="21" d2="251" d3="974"/>
<CITE num="012" author="WARWICK WJ" publication="JAMA" d1="198" d2="59" d3="966"/>
<CITE num="013" author="CHERIAN AG" publication="CLIN CHEM" d1="17" d2="652" d3="971"/>
<CITE num="014" author="BRAY PT" publication="CLIN CHIM ACTA" d1="77" d2="69" d3="977"/>
<CITE num="015" author="WARWICK WJ" publication="CLIN CHEM" d1="24" d2="381" d3="978"/>
<CITE num="016" author="BRAY PT" publication="CLIN CHIM ACTA" d1="80" d2="333" d3="977"/>
<CITE num="017" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="018" author="TOCCI PM" publication="CLIN CHEM" d1="22" d2="1841" d3="976"/>
<CITE num="019" author="MACLEAN WC JR" publication="J PEDIATR" d1="83" d2="86" d3="973"/>
<CITE num="020" author="VLACHOS P" publication="J PEDIATR" d1="84" d2="926" d3="974"/>
<CITE num="021" author="WARWICK WJ" publication="CF CLUB ABST" d1="12" d2="21" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78066</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BSTER HL            CL" publication="IN CHEM" d1="27" d2="85 9" d3="1"/>
<CITE num="2" author="WEBSTER HL" publication="CRC CRIT REV CLIN LAB SCI" d1="18" d2="313" d3="983"/>
<CITE num="3" author="COURY AJ" publication="CLIN CHEM" d1="29" d2="1593" d3="983"/>
<CITE num="4" author="MILLER ME" publication="CLIN CHEM" d1="31" d2="1715" d3="985"/>
</CITATIONS>
<RECORDNUM>00847 </RECORDNUM>
<MEDLINENUM>78213515</MEDLINENUM>
<AUTHORS><AUTHOR>Guy-G-J</AUTHOR><AUTHOR>Butterworth-J</AUTHOR></AUTHORS>
<TITLE>Carboxypeptidase A activity of cultured skin fibroblasts and
relationship to cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Jul 1. 87(1). P 63-9.</SOURCE>
<MAJORSUBJ><TOPIC>CARBOXYPEPTIDASES: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>SKIN: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBOXYPEPTIDASES: ai</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>ENZYME-ACTIVATION: de</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>LYSOSOMES: en</TOPIC></MINORSUBJ>
<ABSTRACT>Properties of carboxypeptidase A of cultured skin fibroblasts from
control and cystic fibrosis patients were studied using alpha-N-
carbobenzoxy-L-glutamyl-L-tyrosine as substrate. Carboxypeptidase A
was inhibited by thiomersal, cyanide, iodoacetate and N-
ethylmaleimide in a similar manner for control and cystic fibrosis
fibroblasts. Both trypsin and dithiothreitol treatment activated the
enzyme, but 1,10-phenanthroline inhibited only in the presence of
dithiothreitol. Both Zn2+ and Co2+ reversed this inhibition. Trypsin
treatment of carboxypeptidase A produced a form of the enzyme having
a higher KM value for both control and cystic fibrosis fibroblasts.
Dithiothreitol treatment of control fibroblasts resulted in a form
with similar properties to the trypsin activated form, but cystic
fibrosis fibroblasts yielded a variant form with even higher KM and
Vmax values. Since other properties were similar, it seems likely
that this difference reflected binding of a molecule to the enzyme
rather than of a defect in the enzyme.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="44" d2="295" d3="973"/>
<CITE num="002" author="BUTTERWORTH J" publication="CLIN GENET" d1="9" d2="505" d3="976"/>
<CITE num="003" author="BUTTERWORTH J" publication="CLIN GENET" d1="12" d2="297" d3="977"/>
<CITE num="004" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="005" author="TAYLOR SL" publication="BIOCHIM BIOPHYS ACTA" d1="341" d2="99" d3="974"/>
<CITE num="006" author="ROTH M" publication="ANAL CHEM" d1="43" d2="880" d3="971"/>
<CITE num="007" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="008" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="009" author="ERLANGER BF" publication="ARCH BIOCHEM BIOPHYS" d1="95" d2="271" d3="961"/>
<CITE num="010" author="RAO GJS" publication="J PEDIATR" d1="80" d2="573" d3="972"/>
<CITE num="011" author="BERGSTROM K" publication="SCIENCE TOOLS" d1="24" d2="8" d3="977"/>
<CITE num="012" author="BARRETT AJ" publication="BIOCHEM J" d1="133" d2="709" d3="973"/>
<CITE num="013" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78067</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TTERWORTH J         CL" publication="IN CHIM ACTA" d1="97" d2="39 9" d3="9"/>
<CITE num="2" author="BUTTERWORTH J" publication="ANAL BIOCHEM" d1="106" d2="156" d3="980"/>
<CITE num="3" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="143" d3="980"/>
<CITE num="4" author="BUTTERWORTH J" publication="J INHERIT METAB DIS" d1="5" d2="9" d3="982"/>
<CITE num="5" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="122" d2="51" d3="982"/>
</CITATIONS>
<RECORDNUM>00848 </RECORDNUM>
<MEDLINENUM>78189501</MEDLINENUM>
<AUTHORS><AUTHOR>Davis-P-B</AUTHOR></AUTHORS>
<TITLE>Urinary cyclic nucleotides in adult male cystic fibrosis patients.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Jul 15. 87(2). P 285-8.</SOURCE>
<MAJORSUBJ><TOPIC>ADENOSINE-CYCLIC-MONOPHOSPHATE: ur</TOPIC><TOPIC>CYSTIC-FIBROSIS: ur</TOPIC><TOPIC>GUANOSINE-CYCLIC-MONOPHOSPHATE: ur</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>BODY-SURFACE-AREA</TOPIC><TOPIC>CREATININE: ur</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>REFERENCE-VALUES</TOPIC></MINORSUBJ>
<ABSTRACT>Urinary adenosine 3':5' (cyclic) monophosphate and guanosine 3':5'
(cyclic)-monophosphate excretion are significantly elevated in adult
male cystic fibrosis patients compared to normal men when values are
expressed in ways which consider the smaller size of the cystic
fibrosis subjects of the same age. Cystic fibrosis patients excreted
3.22 +/- 1.16 nmol adenosine 3':5' (cyclic)monophosphate/g creatinine
per 24 h vs. 1.97 +/- 0.43 for normal men (p less than 0.02); and
cystic fibrosis patients excreted 0.50 +/- 0.16 nmol guanosine 3':k'
(cyclic)monophosphate/g creatinine per 24 h vs. 0.30 +/- 0.07 for
normal men (p less than 0.05). Subjects were all adults who had
completed linear growth and sexual development, thus eliminating any
possible effects of slower maturation of cystic fibrosis patients,
and all subjects were male, thus avoiding the fluctuation of urinary
cyclic nucleotides with the menstrual cycle, problems which had
complicated interpretation of previous studies.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SIMOPOULOS AP" publication="PROC AM PEDIATR SOC ANNU MTG" d1="" d2="201" d3="971"/>
<CITE num="002" author="MURAD F" publication="J CLIN ENDOCRINOL METAB" d1="40" d2="552" d3="975"/>
<CITE num="003" author="TAYLOR AL" publication="J CLIN ENDOCRINOL METAB" d1="30" d2="316" d3="970"/>
<CITE num="004" author="HAMADAH K" publication="BIOCHEM SOC TRANS" d1="2" d2="461" d3="974"/>
<CITE num="005" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="006" author="BROWN BL" publication="BIOCHEM J" d1="121" d2="561" d3="971"/>
<CITE num="007" author="STEINER AL" publication="ADV CYCLIC NUCLEO RES" d1="3" d2="89" d3="972"/>
<CITE num="008" author="MURAD F" publication="ADV CYCLIC NUCLEO RES" d1="3" d2="355" d3="973"/>
<CITE num="009" author="MURAD F" publication="N ENGL J MED" d1="286" d2="1382" d3="972"/>
<CITE num="010" author="STAHL M" publication="J PEDIATR" d1="84" d2="821" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78068</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RBACH GD            AD" publication="V CYCLIC NUCLEO RES" d1="12" d2="1 9" d3="0"/>
<CITE num="2" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="3" author="HUNT NH" publication="CLIN SCI" d1="58" d2="463" d3="980"/>
<CITE num="4" author="EBSTEIN RP" publication="ISR J MED SCI" d1="21" d2="302" d3="985"/>
</CITATIONS>
<RECORDNUM>00849 </RECORDNUM>
<MEDLINENUM>78082699</MEDLINENUM>
<AUTHORS><AUTHOR>Schuttringer-G</AUTHOR><AUTHOR>Zinterhofer-L</AUTHOR></AUTHORS>
<TITLE>Automated immunoprecipitation of meconium albumin for cystic
fibrosis screening in the newborn.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Feb 1. 83(1-2). P 109-16.</SOURCE>
<MAJORSUBJ><TOPIC>ALBUMINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: pc</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MASS-SCREENING</TOPIC><TOPIC>PRECIPITIN-TESTS: is, mt</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis is the most frequent substantially lethal inherited
disease in the United States. Newborn screening for cystic fibrosis
has been suggested because early diagnosis permits genetic
counselling of parents and improved treatment and prognosis for
cystic fibrosis patients. The fact that cystic fibrosis newborns have
abnormally high meconium albumin seems to offer the best screening
approach. Because we have had equivocal and false positive results
with meconium albumin test strips, we have developed a nephelometric
automated immunoprecipitation method for the quantitative and
specific analysis of meconium albumin. On a total of 3895 meconiums
so far examined, eleven albumin elevations of undetermined origin
have been detected. Nine of these were associated with prematurity.
There have been, so far, no detected true positives and no known
false negatives. The normal range for meconium albumin is in
agreement with previously published ranges determined using manual
immunochemical methods. This method is rapid and economic. The
question of sensitivity, specificity and predictive value of this and
other detection methods is discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="IN: DOWNEY JA" d1="" d2="25" d3="974"/>
<CITE num="002" author="THOMPSON JS" publication="GENETICS IN MEDICINE" d1="" d2="58" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="004" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="005" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="006" author="WARWICK WJ" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="320" d3="969"/>
<CITE num="007" author="BUCHANAN DJ" publication="PEDIATRICS" d1="9" d2="304" d3="952"/>
<CITE num="008" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="009" author="WISER WC" publication="PEDIATRICS" d1="33" d2="115" d3="964"/>
<CITE num="010" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="011" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="012" author="CAIN ARR" publication="ARCH DIS CHILD" d1="47" d2="131" d3="972"/>
<CITE num="013" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="014" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="015" author="BULL FE" publication="ARCH DIS CHILD" d1="49" d2="602" d3="974"/>
<CITE num="016" author="HELLSING K" publication="SCAND J CLIN LAB INVEST" d1="33" d2="333" d3="974"/>
<CITE num="017" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="64" d2="477" d3="975"/>
<CITE num="018" author="ANON" publication="MEDICAL LETTER ON DRU" d1="18" d2="35" d3="967"/>
<CITE num="019" author="HARDY JD" publication="ARCH DIS CHILD" d1="48" d2="316" d3="973"/>
<CITE num="020" author="GALEN RS" publication="BEYOND NORMALITY THE PREDICTI" d1="" d2="" d3="975"/>
<CITE num="021" author="KINGSBURY FB" publication="J LAB CLIN MED" d1="11" d2="981" d3="926"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78069</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LEY HC              AR" publication="CH DIS CHILD" d1="54" d2="92 9" d3="9"/>
<CITE num="2" author="MASTELLA G" publication="RIV ITAL PEDIATR" d1="7" d2="581" d3="981"/>
<CITE num="3" author="FORREST DC" publication="ARCH DIS CHILD" d1="56" d2="151" d3="981"/>
<CITE num="4" author="DODGE JA" publication="ARCH DIS CHILD" d1="57" d2="774" d3="982"/>
<CITE num="5" author="NAYLOR EW" publication="SEM PERINATOL" d1="9" d2="232" d3="985"/>
</CITATIONS>
<RECORDNUM>00850 </RECORDNUM>
<MEDLINENUM>78063089</MEDLINENUM>
<AUTHORS><AUTHOR>Shapiro-B-L</AUTHOR><AUTHOR>Feigal-R-J</AUTHOR><AUTHOR>Laible-N-J</AUTHOR><AUTHOR>Biros-M-H</AUTHOR><AUTHOR>Warwick-W-J</AUTHOR></AUTHORS>
<TITLE>Doubling time alpha-aminoisobutyrate transport and calcium exchange
in cultured fibroblasts from cystic fibrosis and control subjects.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Jan 2. 82(1-2). P 125-31.</SOURCE>
<MAJORSUBJ><TOPIC>AMINOISOBUTYRIC-ACIDS: me</TOPIC><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BIOLOGICAL-TRANSPORT</TOPIC><TOPIC>BIOLOGICAL-TRANSPORT-ACTIVE</TOPIC><TOPIC>CELL-DIVISION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FIBROBLASTS: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KINETICS</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Population doubling time, kinetics of transport of alpha-
aminoisobutyrate (AIB) and calcium (Ca) exchange were studied in skin
fibroblast monolayers obtained from 5 subjects with cystic fibrosis
(CF) and 5 age- and sex-matched controls. Population doubling time as
estimated from cell count, protein and DNA was no different in the
two groups. KM, Vmax, maximal uptake and time of half maximal uptake
of AIB were no different in the two groups. Intracellular Ca pool
size based on exchange of 45Ca with unlabelled Ca was significantly
greater in monolayers from CF subjects.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="OYAMA VI" publication="PROC SOC EXP BIOL MED" d1="91" d2="305" d3="956"/>
<CITE num="002" author="SWITZER BR" publication="CLIN CHIM ACTA" d1="32" d2="203" d3="971"/>
<CITE num="003" author="HOUCK JC" publication="PROC SOC EXP BIOL MED" d1="147" d2="167" d3="974"/>
<CITE num="004" author="FARRELL PM" publication="PROC SOC EXP BIOL MED" d1="149" d2="340" d3="975"/>
<CITE num="005" author="BOLTON WE" publication="AM J HUM GENET" d1="27" d2="394" d3="975"/>
<CITE num="006" author="FLETCHER DS" publication="CLIN CHIM ACTA" d1="44" d2="5" d3="973"/>
<CITE num="007" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="113" d3="976"/>
<CITE num="008" author="MANGOS JA" publication="PEDIATR RES ABST" d1="10" d2="357" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78070</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSCHBACH MW         BI" publication="OCHEM BIOPHYS RES COMMUN" d1="84" d2="22 9" d3="8"/>
<CITE num="2" author="FEIGAL RJ" publication="PEDIATR RES" d1="13" d2="764" d3="979"/>
<CITE num="3" author="LAM LFH" publication="LIFE SCI" d1="24" d2="2483" d3="979"/>
<CITE num="4" author="SHAPIRO BL" publication="PROC NAT ACAD SCI USA" d1="76" d2="2979" d3="979"/>
<CITE num="5" author="SWENEY LR" publication="J MICROSC" d1="115" d2="151" d3="979"/>
<CITE num="6" author="SHAPIRO BL" publication="SCIENCE" d1="203" d2="1251" d3="979"/>
<CITE num="7" author="FEIGAL RJ" publication="NATURE" d1="278" d2="276" d3="979"/>
<CITE num="8" author="OWEN K" publication="CANCER RES" d1="40" d2="3167" d3="980"/>
<CITE num="9" author="MALER T" publication="BIOCHIM BIOPHYS ACTA" d1="598" d2="1" d3="980"/>
<CITE num="10" author="GNEGY ME" publication="BIOCHEM MED" d1="26" d2="294" d3="981"/>
<CITE num="11" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="12" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="13" author="FEIGAL RJ" publication="LIFE SCI" d1="30" d2="93" d3="982"/>
<CITE num="14" author="SHAPIRO BL" publication="AM J HUM GENET" d1="34" d2="846" d3="982"/>
<CITE num="15" author="SHAPIRO BL" publication="SCIENCE" d1="216" d2="417" d3="982"/>
<CITE num="16" author="FONDACARO JD" publication="LIFE SCI" d1="32" d2="1449" d3="983"/>
<CITE num="17" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="18" author="WALLER RL" publication="LIFE SCI" d1="35" d2="775" d3="984"/>
<CITE num="19" author="WALLER RL" publication="CELL CALC" d1="6" d2="245" d3="985"/>
<CITE num="20" author="RUPP GM" publication="MED HYPOTHESES" d1="20" d2="245" d3="986"/>
<CITE num="21" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
<CITE num="22" author="FEIGAL RJ" publication="ANN NY ACAD SCI" d1="488" d2="82" d3="986"/>
</CITATIONS>
<RECORDNUM>00851 </RECORDNUM>
<MEDLINENUM>78063085</MEDLINENUM>
<AUTHORS><AUTHOR>Brock-D-J</AUTHOR><AUTHOR>Barron-L</AUTHOR><AUTHOR>Manson-J</AUTHOR><AUTHOR>McCrae-W-M</AUTHOR></AUTHORS>
<TITLE>Serum alphafetoprotein in cystic fibrosis of the pancreas.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Jan 2. 82(1-2). P 101-3.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-FETOPROTEINS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RADIOIMMUNOASSAY</TOPIC></MINORSUBJ>
<ABSTRACT>Serum alphafetoprotein concentrations were measured by three
different types of radioimmunoassay in 30 patients with cystic
fibrosis of the pancreas and in 55 controls. The highest value
obtained in cystic patient was 10.2 ng/ml and in a control 10.8
ng/ml. These are within published normal limits. Previously reported
large increases in serum AFP in patients with cystic fibrosis and in
heterozygote carriers have not been confirmed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CHANDRA RK" publication="BR MED J" d1="1" d2="714" d3="975"/>
<CITE num="002" author="BROCK DJH" publication="BR MED J" d1="2" d2="392" d3="975"/>
<CITE num="003" author="WALLWORK JC" publication="BR MED J" d1="2" d2="392" d3="975"/>
<CITE num="004" author="FITZSIMMONS JS" publication="BR MED J" d1="3" d2="544" d3="975"/>
<CITE num="005" author="BELANGER L" publication="BR MED J" d1="4" d2="759" d3="975"/>
<CITE num="006" author="BROCK DJH" publication="CLIN CHIM ACTA" d1="57" d2="315" d3="974"/>
<CITE num="007" author="BROCK DJH" publication="LANCET" d1="1" d2="745" d3="975"/>
<CITE num="008" author="VINCE JD" publication="BR J OBSTET GYNAECOL" d1="82" d2="718" d3="975"/>
<CITE num="009" author="FORRESTER PI" publication="CLIN CHIM ACTA" d1="64" d2="317" d3="975"/>
<CITE num="010" author="HUNTER WM" publication="IN: WEIR DM" d1="" d2="" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78071</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SDEN C              BR" publication="MED J" d1="2" d2="86 9" d3="8"/>
<CITE num="2" author="GOSDEN C" publication="J MED GENET" d1="15" d2="262" d3="978"/>
<CITE num="3" author="BROCK DJH" publication="BR J OBSTET GYNAECOL" d1="85" d2="575" d3="978"/>
<CITE num="4" author="RODECK CH" publication="LANCET" d1="1" d2="949" d3="980"/>
<CITE num="5" author="BROCK DJH" publication="BR J OBSTET GYNAECOL" d1="87" d2="582" d3="980"/>
<CITE num="6" author="BROCK DJH" publication="BR J OBSTET GYNAECOL" d1="89" d2="348" d3="982"/>
</CITATIONS>
<RECORDNUM>00852 </RECORDNUM>
<MEDLINENUM>79044172</MEDLINENUM>
<AUTHORS><AUTHOR>Kenny-D</AUTHOR><AUTHOR>Cooke-A</AUTHOR><AUTHOR>Tempany-E</AUTHOR><AUTHOR>McGeeney-K-F</AUTHOR></AUTHORS>
<TITLE>Activity of serum alpha-amylases in cystic fibrosis.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Nov 1. 89(3). P 429-33.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-AMYLASE: bl</TOPIC><TOPIC>AMYLASES: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MATHEMATICS</TOPIC><TOPIC>PANCREAS: en</TOPIC><TOPIC>SALIVA: en</TOPIC></MINORSUBJ>
<ABSTRACT>A new method which uses a differential inhibitor to measure
pancreatic and salivary type alpha-amylases (EC 3.2.1.1) was applied
to serum samples from 46 cystic fibrosis (CF) patients (age range 4-
14 years) and 50 controls of the same age group. The levels of
pancreatic type amylase were lower in the CF patients (median 26.5
I.U./1) than the controls (median 81.5) (P less than 0.001). The
results for salivary-type enzyme, however, did not support the
previously reported finding of higher than usual levels in CF
patients. This discrepancy is probably due to differences in
analytical methods. It is felt that this procedure will be of value
in the investigation of patients for cystic fibrosis and other
pancreatic disorders.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BURTON P" publication="GUT" d1="1" d2="111" d3="960"/>
<CITE num="002" author="LUNDH G" publication="GASTROENTEROLOGY" d1="42" d2="275" d3="962"/>
<CITE num="003" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="10" d2="577" d3="975"/>
<CITE num="004" author="OTSUKI M" publication="CLIN CHIM ACTA" d1="79" d2="1" d3="977"/>
<CITE num="005" author="TAKEUCHI T" publication="CLIN CHIM ACTA" d1="60" d2="207" d3="975"/>
<CITE num="006" author="BERK JE" publication="AM J GASTROENTEROL" d1="63" d2="457" d3="975"/>
<CITE num="007" author="ODONNELL MD" publication="BIOCHIM BIOPHYS ACTA" d1="422" d2="159" d3="976"/>
<CITE num="008" author="ODONNELL MD" publication="CLIN CHEM" d1="23" d2="560" d3="977"/>
<CITE num="009" author="CONOVER WG" publication="PRACTICAL NONPARAMETRIC STATI" d1="" d2="" d3="971"/>
<CITE num="010" author="SKUDE G" publication="ACTA PAEDIATR SCAND" d1="65" d2="145" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78072</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ONNELL MD           CL" publication="IN CHIM ACTA                 1" d1="04" d2="65 9" d3="0"/>
<CITE num="2" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="746" d3="980"/>
<CITE num="3" author="TOBIN MJ" publication="IR J MED SCI" d1="150" d2="325" d3="981"/>
<CITE num="4" author="BROWN RC" publication="J CLIN PATHOL" d1="35" d2="547" d3="982"/>
<CITE num="5" author="MORGENSTERN T" publication="MONATSSCHR KINDERHEILKD" d1="132" d2="661" d3="984"/>
<CITE num="6" author="GILLARD BK" publication="AM J DIS CHILD" d1="138" d2="577" d3="984"/>
<CITE num="7" author="MOLLERPETERSEN J" publication="CLIN CHIM ACTA" d1="157" d2="151" d3="986"/>
</CITATIONS>
<RECORDNUM>00853 </RECORDNUM>
<MEDLINENUM>79044177</MEDLINENUM>
<AUTHORS><AUTHOR>Alhadeff-J-A</AUTHOR></AUTHORS>
<TITLE>Lysosomal hydrolases in cystic fibrosis livers.</TITLE>
<SOURCE>Clin-Chim-Acta. 1978 Nov 1. 89(3). P 469-73.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HYDROLASES: me</TOPIC><TOPIC>LIVER: en</TOPIC><TOPIC>LYSOSOMES: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACETYLGLUCOSAMINIDASE: me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>MANNOSIDASES: me</TOPIC><TOPIC>NEURAMINIDASE: me</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The specific activity of several lysosomal hydrolases in normal and
cystic fibrosis (CF) livers has been investigated. Neuraminidase
activity with respect to two natural substrates (fetuin and bovine
submaxillary mucin) is normal in CF livers. No significant
differences were found between CF and normal livers in 4-
methylumbelliferyl-alpha-D-mannosidase specific activities determined
at three different pH values (4.3, 5.65 and 6.5) corresponding to
lysosomal, golgi and cytosolic components of the enzyme,
respectively. The specific activities of p-nitrophenyl-beta-D-
mannosidase and 4-methylumbelliferyl-beta-N-acetylglucosaminidase
were also both similar in CF and normal livers.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="002" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="003" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="004" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="417" d3="978"/>
<CITE num="005" author="OPHEIM DJ" publication="J BIOL CHEM" d1="253" d2="1017" d3="978"/>
<CITE num="006" author="PHILLIPS NC" publication="CLIN CHIM ACTA" d1="55" d2="11" d3="974"/>
<CITE num="007" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="008" author="WILSON RG" publication="CLIN CHIM ACTA" d1="36" d2="113" d3="972"/>
<CITE num="009" author="CALLAHAN JW" publication="PEDIATR RES" d1="11" d2="1166" d3="977"/>
<CITE num="010" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="011" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
<CITE num="012" author="PHILLIPS N" publication="BIOCHEM J" d1="151" d2="469" d3="975"/>
<CITE num="013" author="OKADA S" publication="AM J HUM GENET" d1="23" d2="55" d3="971"/>
<CITE num="014" author="TULSIANI DRP" publication="J BIOL CHEM" d1="245" d2="1821" d3="970"/>
<CITE num="015" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="016" author="ALHADEFF JA" publication="MOL CELL BIOCHEM" d1="18" d2="33" d3="977"/>
<CITE num="017" author="SPIRO RG" publication="ADV PROT CHEM" d1="27" d2="349" d3="973"/>
<CITE num="018" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="019" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78073</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NAMI R              CL" publication="IN CHIM ACTA" d1="96" d2="07 9" d3="9"/>
<CITE num="2" author="MEYER DM" publication="BIOCHEM BIOPHYS RES COMMUN" d1="103" d2="1302" d3="981"/>
<CITE num="3" author="ALHADEFF JA" publication="BIOCHEM J" d1="201" d2="95" d3="982"/>
<CITE num="4" author="DENTANDT WR" publication="BIOCHEM MED" d1="31" d2="287" d3="984"/>
<CITE num="5" author="HULTCRANTZ R" publication="HEPATOLOGY" d1="6" d2="881" d3="986"/>
<CITE num="6" author="PORTER WH" publication="CLIN CHEM" d1="32" d2="652" d3="986"/>
</CITATIONS>
<RECORDNUM>00854 </RECORDNUM>
<MEDLINENUM>78105815</MEDLINENUM>
<AUTHORS><AUTHOR>Alhadeff-J-A</AUTHOR><AUTHOR>Cimino-G</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis liver sialyltransferase.</TITLE>
<SOURCE>Clin-Genet. 1978 Feb. 13(2). P 207-12.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>LIVER: en</TOPIC><TOPIC>SIALYLTRANSFERASES: me</TOPIC><TOPIC>TRANSFERASES: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC><TOPIC>LIVER-DISEASES: en</TOPIC><TOPIC>TEMPERATURE</TOPIC></MINORSUBJ>
<ABSTRACT>The activity of sialytransferase with regard to the glycoprotein
substrates asialofetuin and asialo-ovine submaxillary mucin was
determined in normal, pathological control, and cystic fibrosis liver
homogenates. Cystic fibrosis and pathological livers have about 40%
of the average normal specific activity for sialytransferase. Several
properties of cystic fibrosis sialytransferase were investigated and
compared to those of the normal liver enzyme (Alhadeff et al. 1977).
The pH optima curves were similar, but cystic fibrosis
sialyltransferase appears to be more thermolabile than the normal
liver enzyme. Isoelectric focusing studies revealed that the three
most basic forms of sialyltransferase which are found in normal
livers are deficient or absent in most cystic fibrosis liver. The
data suggest that altered glycoprotein-sialyltransferases may be
present in cystic fibrosis livers, probably a secondary effect due to
general liver pathology.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="BIOCHIM BIOPHYS ACTA" d1="484" d2="307" d3="977"/>
<CITE num="002" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="57" d2="307" d3="974"/>
<CITE num="003" author="ALHADEFF JA" publication="DEVELOP BIOL" d1="47" d2="319" d3="975"/>
<CITE num="004" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="005" author="GOLDSTONE AP" publication="FEBS LETTERS" d1="13" d2="68" d3="971"/>
<CITE num="006" author="KATTWINKEL J" publication="J PEDIATR" d1="82" d2="234" d3="973"/>
<CITE num="007" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="008" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="009" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="010" author="MOOKERJEA S" publication="CAN J BIOCHEM" d1="50" d2="738" d3="972"/>
<CITE num="011" author="MURPHY WH" publication="BIOCHIM BIOPHYS ACTA" d1="52" d2="349" d3="961"/>
<CITE num="012" author="SCHACHTER H" publication="IN: FISHMAN WH" d1="3" d2="2" d3="973"/>
<CITE num="013" author="SPIRO RG" publication="J BIOL CHEM" d1="235" d2="2860" d3="960"/>
<CITE num="014" author="SPIRO RG" publication="ADV PROT CHEM" d1="27" d2="349" d3="973"/>
<CITE num="015" author="TETTAMANTI G" publication="ARCH BIOCHEM BIOPHYS" d1="124" d2="41" d3="968"/>
<CITE num="016" author="THORPE R" publication="FEBS LETTERS" d1="54" d2="89" d3="975"/>
<CITE num="017" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78074</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HADEFF JA           CL" publication="IN GENET" d1="13" d2="17 9" d3="8"/>
<CITE num="2" author="ALHADEFF JA" publication="CLIN GENET" d1="14" d2="189" d3="978"/>
<CITE num="3" author="LAPINA EB" publication="BIOORGAN KHIM" d1="5" d2="1720" d3="979"/>
<CITE num="4" author="ANFIMOVA ML" publication="BIOORGAN KHIM" d1="7" d2="1209" d3="981"/>
<CITE num="5" author="HULTBERG B" publication="CLIN CHIM ACTA" d1="112" d2="167" d3="981"/>
<CITE num="6" author="MARGOLIES R" publication="PEDIATR RES" d1="17" d2="931" d3="983"/>
<CITE num="7" author="PASCALI VL" publication="EUR J PEDIATR" d1="143" d2="133" d3="984"/>
</CITATIONS>
<RECORDNUM>00855 </RECORDNUM>
<MEDLINENUM>79002464</MEDLINENUM>
<AUTHORS><AUTHOR>Bois-E</AUTHOR><AUTHOR>Feingold-J</AUTHOR><AUTHOR>Demenais-F</AUTHOR><AUTHOR>Runavot-Y</AUTHOR><AUTHOR>Jehanne-M</AUTHOR><AUTHOR>Toudic-L</AUTHOR></AUTHORS>
<TITLE>Cluster of cystic fibrosis cases in a limited area of Brittany
(France).</TITLE>
<SOURCE>Clin-Genet. 1978 Aug. 14(2). P 73-76.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FRANCE</TOPIC><TOPIC>GENE-FREQUENCY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PEDIGREE</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis in the northern sector of the French "departement"
of Finistere is 1:1787 live births. Within this sector a
concentration of the disease was found in a small area. The minimal
frequency in this area, from 1946 to 1972, was calculated as 1 per
377 live births, the gene frequency being 0.0515. Genealogic
analysis, going back to the beginning of the 18th century, showed a
relationship between 8 of the 10 families to which the patients
belonged. The origin of the deleterious genes may be explained by a
least five primary ancestral couples living in the 18th century.
Random drift is the most probable explanation for the concentration
of cystic fibrosis in this region.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="MOD PROBL PEDIATR" d1="10" d2="381" d3="967"/>
<CITE num="002" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="004" author="FEINGOLD J" publication="ANN GENET (PARIS)" d1="17" d2="257" d3="974"/>
<CITE num="005" author="GOURVIL F" publication="NOMS DE FAMILLE BRETONS D-" d1="" d2="" d3="970"/>
<CITE num="006" author="HIRSCHHORN K" publication="IN: MANGOS JA" d1="" d2="275" d3="976"/>
<CITE num="007" author="KNUDSON AG JR" publication="AM J HUM GENET" d1="19" d2="388" d3="967"/>
<CITE num="008" author="RAO DC" publication="AM J HUM GENET" d1="25" d2="594" d3="973"/>
<CITE num="009" author="RUNAVOT Y" publication="THESIS" d1="" d2="" d3="975"/>
<CITE num="010" author="TEN KATE LP" publication="INT J EPIDEMIOL" d1="6" d2="23" d3="977"/>
<CITE num="011" author="WAGENER DK" publication="AM J HUM GENET" d1="27" d2="348" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78075</PAPERNUM>
<CITATIONS>
<CITE num="1" author="X DW                PE" publication="DIATR CLIN NORTH AM" d1="26" d2="67 9" d3="9"/>
<CITE num="2" author="DEMENAIS F" publication="REV EPIDEMIOL SANTE PUBLIQUE" d1="27" d2="5" d3="979"/>
<CITE num="3" author="KLINGER KW" publication="HUM GENET" d1="65" d2="94" d3="983"/>
<CITE num="4" author="PASCALETGUIDON MJ" publication="CLIN GENET" d1="26" d2="39" d3="984"/>
<CITE num="5" author="KLINGER KW" publication="SEM RESPIR MED" d1="6" d2="243" d3="985"/>
<CITE num="6" author="LIVINGSTONE FB" publication="HUM BIOL" d1="59" d2="59" d3="987"/>
</CITATIONS>
<RECORDNUM>00856 </RECORDNUM>
<MEDLINENUM>79023672</MEDLINENUM>
<AUTHORS><AUTHOR>Alhadeff-J-A</AUTHOR></AUTHORS>
<TITLE>Glycoproteins and cystic fibrosis: a review.</TITLE>
<SOURCE>Clin-Genet. 1978 Oct. 14(4). P 189-201. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>GLYCOPROTEINS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FUCOSE: me</TOPIC><TOPIC>FUCOSIDASE: me</TOPIC><TOPIC>GLYCOPROTEINS: ip</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>This article is a review of the major research of the last 20 years
on abnormal glycoproteins and abnormal glycoprotein metabolism in
cystic fibrosis.  Its purpose is to focus attention on an area
considered by the author to be of great importance for elucidating
the primary biochemical defect in CF.  The majority of the studies on
glycoproteins in CF have been done on crude mixtures of glycoproteins
from tissues or tissue fluids, secretions or excretions.  Very few
studies have compared the properties and composition of purified
glycoproteins from CF patients and controls.  Comparative studies on
the enzymes involved in the degradation and biosynthesis of the
carbohydrate portions of glycoproteins in CF patients and normal
controls are discussed.  Several studies have suggested abnormalities
in CF alpha-L-fucosidase and CF L-fucose metabolism.  There are
several studies which indirectly suggest that abnormalities in
glycoproteins or their metabolism may be involved in the pathogenesis
of cystic fibrosis.  Fruitful areas for future investigation are
comparison of the properties and composition of specific
glycoproteins purified to homogeneity from CF and control tissues,
particularly with regard to carbohydrate composition; comparison of
the activities and properties of the enzymes involved in both the
degradation and biosynthesis of glycoproteins in CF and control
tissues; and studies of the effects of increased electrolyte
concentration on the physical-chemical properties of glycoproteins.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="207" d3="978"/>
<CITE num="002" author="ALHADEFF JA" publication="BIOCHIM BIOPHYS ACTA" d1="484" d2="307" d3="977"/>
<CITE num="003" author="ALHADEFF JA" publication="MOL CELL BIOCHEM" d1="18" d2="33" d3="977"/>
<CITE num="004" author="ALHADEFF JA" publication="J BIOL CHEM" d1="250" d2="7106" d3="975"/>
<CITE num="005" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="006" author="ALHADEFF JA" publication="DEVELOP BIOL" d1="47" d2="319" d3="975"/>
<CITE num="007" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="417" d3="978"/>
<CITE num="008" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="009" author="ANTONOWICZ I" publication="PEDIATR RES" d1="6" d2="803" d3="972"/>
<CITE num="010" author="ASHWELL G" publication="ADV ENZYM MOLEC BIOL" d1="41" d2="99" d3="974"/>
<CITE num="011" author="BAKER AP" publication="FED PROC" d1="33" d2="1300" d3="974"/>
<CITE num="012" author="BAKER AP" publication="ARCH BIOCHEM BIOPHYS" d1="165" d2="597" d3="974"/>
<CITE num="013" author="BAUER U" publication="ANN PAEDIATR" d1="194" d2="236" d3="960"/>
<CITE num="014" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="015" author="BISWAS S" publication="CLIN CHIM ACTA" d1="69" d2="541" d3="976"/>
<CITE num="016" author="BLACKFAN KD" publication="J PEDIATR" d1="13" d2="627" d3="938"/>
<CITE num="017" author="BOAT TF" publication="ARCH BIOCHEM BIOPHYS" d1="177" d2="95" d3="976"/>
<CITE num="018" author="BOAT TF" publication="AM REV RESPIR DIS" d1="110" d2="428" d3="974"/>
<CITE num="019" author="BOAT TF" publication="PEDIATR RES" d1="8" d2="531" d3="974"/>
<CITE num="020" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="021" author="BROCK DJH" publication="BR MED J" d1="2" d2="392" d3="975"/>
<CITE num="022" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="56" d2="159" d3="974"/>
<CITE num="023" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="41" d2="367" d3="972"/>
<CITE num="024" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="40" d2="139" d3="972"/>
<CITE num="025" author="CHANDRA RK" publication="BR MED J" d1="1" d2="714" d3="975"/>
<CITE num="026" author="COHEN LF" publication="BLOOD" d1="48" d2="469" d3="976"/>
<CITE num="027" author="CROSBY P" publication="HISTOCHEM J" d1="3" d2="223" d3="971"/>
<CITE num="028" author="DAVIS PB" publication="CF CLUB ABST" d1="" d2="7" d3="976"/>
<CITE num="029" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="030" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="031" author="DISCHE Z" publication="ANN NY ACAD SCI" d1="93" d2="526" d3="962"/>
<CITE num="032" author="DISCHE Z" publication="AM J DIS CHILD" d1="102" d2="733" d3="961"/>
<CITE num="033" author="FILLIAT M" publication="PATHOL BIOL (PARIS)" d1="21" d2="13" d3="973"/>
<CITE num="034" author="FITZSIMMONS JS" publication="BR MED J" d1="3" d2="544" d3="975"/>
<CITE num="035" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="036" author="FORSTNER JF" publication="CF CLUB ABST" d1="" d2="10" d3="976"/>
<CITE num="037" author="FRIEDMANN T" publication="J LAB CLIN MED" d1="70" d2="404" d3="967"/>
<CITE num="038" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="039" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="040" author="GOLDSTONE AP" publication="LIFE SCI" d1="9" d2="1341" d3="970"/>
<CITE num="041" author="GRIFFIN GD" publication="PROC SOC EXP BIOL MED" d1="137" d2="438" d3="971"/>
<CITE num="042" author="GUGLER EC" publication="J PEDIATR" d1="71" d2="585" d3="967"/>
<CITE num="043" author="GUHA AK" publication="CLIN BIOCHEM" d1="10" d2="153" d3="977"/>
<CITE num="044" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="741" d3="977"/>
<CITE num="045" author="KIM YS" publication="J CLIN INVEST" d1="51" d2="2033" d3="972"/>
<CITE num="046" author="KNAUFF RE" publication="CLIN CHIM ACTA" d1="19" d2="245" d3="968"/>
<CITE num="047" author="KNOPFLE G" publication="BR MED J" d1="4" d2="459" d3="975"/>
<CITE num="048" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="62" d2="279" d3="973"/>
<CITE num="049" author="KOPITO L" publication="NATURE" d1="202" d2="501" d3="964"/>
<CITE num="050" author="KRAUS I" publication="PEDIATRICS" d1="47" d2="1010" d3="971"/>
<CITE num="051" author="KUTTY KM" publication="CF CLUB ABST" d1="" d2="45" d3="976"/>
<CITE num="052" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="053" author="LOUISOT P" publication="CLIN CHIM ACTA" d1="48" d2="373" d3="973"/>
<CITE num="054" author="LUNDGREN DW" publication="CLIN CHIM ACTA" d1="62" d2="357" d3="975"/>
<CITE num="055" author="MANDEL ID" publication="AM J DIS CHILD" d1="113" d2="431" d3="967"/>
<CITE num="056" author="MANDEL ID" publication="AM J DIS CHILD" d1="110" d2="646" d3="965"/>
<CITE num="057" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="058" author="MAXFIELD M" publication="J CLIN INVEST" d1="41" d2="455" d3="962"/>
<CITE num="059" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="060" author="MCEVOY FA" publication="PEDIATR RES" d1="9" d2="721" d3="975"/>
<CITE num="061" author="MCNEELY MC" publication="AM J HUM GENET" d1="29" d2="73A" d3="977"/>
<CITE num="062" author="MOOKERJEA S" publication="CAN J BIOCHEM" d1="50" d2="738" d3="972"/>
<CITE num="063" author="NADLER HL" publication="IN: STANBURY JB" d1="" d2="1683" d3="978"/>
<CITE num="064" author="NEUTRA MR" publication="LAB INVEST" d1="36" d2="535" d3="977"/>
<CITE num="065" author="NOVAK RA" publication="TEX REP BIOL MED" d1="34" d2="199" d3="976"/>
<CITE num="066" author="PALLAVICINI JC" publication="ANN NY ACAD SCI" d1="106" d2="330" d3="963"/>
<CITE num="067" author="PAPP Z" publication="CLIN GENET" d1="11" d2="431" d3="977"/>
<CITE num="068" author="PEARSON RD" publication="PEDIATR RES" d1="11" d2="462" d3="977"/>
<CITE num="069" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="070" author="RAO GJS" publication="CLIN RES" d1="24" d2="436A" d3="976"/>
<CITE num="071" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="072" author="RUSSELL SB" publication="J MED GENET" d1="8" d2="441" d3="971"/>
<CITE num="073" author="SCANLIN TF JR" publication="PEDIATR RES ABST 549" d1="11" d2="463" d3="977"/>
<CITE num="074" author="SCANLIN TF JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="79" d2="869" d3="977"/>
<CITE num="075" author="SCHACHTER H" publication="BIOCHEM SOC SYMP" d1="40" d2="57" d3="974"/>
<CITE num="076" author="SCHACHTER H" publication="IN: FISHMAN WH" d1="3" d2="2" d3="973"/>
<CITE num="077" author="SCHULTZE HE" publication="MOLECULAR BIOL OF HUMAN PROTE" d1="1" d2="" d3="966"/>
<CITE num="078" author="SCHWARTZ RH" publication="J LAB CLIN MED" d1="70" d2="725" d3="967"/>
<CITE num="079" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="080" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
<CITE num="081" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="082" author="SHARON N" publication="COMPLEX CARBOHYDRATES THEIR C" d1="" d2="" d3="975"/>
<CITE num="083" author="SHWACHMAN H" publication="MOD PROBL PEDIATR" d1="10" d2="158" d3="967"/>
<CITE num="084" author="SINGER L" publication="CLIN BIOCHEM" d1="7" d2="146" d3="974"/>
<CITE num="085" author="SMITH JA" publication="BR MED J" d1="2" d2="392" d3="975"/>
<CITE num="086" author="SPIRO RG" publication="ADV PROT CHEM" d1="27" d2="349" d3="973"/>
<CITE num="087" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="088" author="STEVENSON FK" publication="CLIN CHIM ACTA" d1="23" d2="441" d3="969"/>
<CITE num="089" author="TALAMO RC" publication="J PEDIATR" d1="65" d2="480" d3="964"/>
<CITE num="090" author="TOUSTER O" publication="MOL CELL BIOCHEM" d1="2" d2="169" d3="973"/>
<CITE num="091" author="WALLWORK JC" publication="BR MED J" d1="2" d2="392" d3="975"/>
<CITE num="092" author="WELCH DW" publication="PEDIATR RES" d1="9" d2="698" d3="975"/>
<CITE num="093" author="WILSON GB" publication="SCAND J IMMUNOL" d1="5" d2="829" d3="976"/>
<CITE num="094" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="095" author="WILSON RG" publication="CLIN CHIM ACTA" d1="36" d2="113" d3="972"/>
<CITE num="096" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="097" author="WU JT" publication="PEDIATR RES" d1="10" d2="235" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78076</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IER WT              ME" publication="D HYPOTHESES" d1="5" d2="61 9" d3="9"/>
<CITE num="2" author="BENYOSEPH Y" publication="CLIN CHIM ACTA" d1="99" d2="31" d3="979"/>
<CITE num="3" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="93" d2="50" d3="980"/>
<CITE num="4" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="108" d2="347" d3="980"/>
<CITE num="5" author="MALER T" publication="FEBS LETTERS" d1="121" d2="153" d3="980"/>
<CITE num="6" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="7" author="BENYOSEPH Y" publication="PEDIATR RES" d1="15" d2="839" d3="981"/>
<CITE num="8" author="BUTTERWORTH J" publication="CLIN CHIM ACTA" d1="110" d2="319" d3="981"/>
<CITE num="9" author="OWENSWILLIAMS L" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="567" d3="982"/>
<CITE num="10" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="11" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="938" d3="982"/>
<CITE num="12" author="MCNEELY MC" publication="PEDIATR RES" d1="16" d2="21" d3="982"/>
<CITE num="13" author="LITIN BS" publication="BIOL NEONATE" d1="42" d2="228" d3="982"/>
<CITE num="14" author="SNYDER CE" publication="CARBOHYD RES" d1="105" d2="87" d3="982"/>
<CITE num="15" author="LONGNECKER DS" publication="AM J PATHOL" d1="107" d2="103" d3="982"/>
<CITE num="16" author="BENYOSEPH Y" publication="BIOCHIM BIOPHYS ACTA" d1="718" d2="172" d3="982"/>
<CITE num="17" author="FRATES RC" publication="PEDIATR RES" d1="17" d2="30" d3="983"/>
<CITE num="18" author="SLOMIANY A" publication="J BIOL CHEM" d1="258" d2="8535" d3="983"/>
<CITE num="19" author="KARLSSON S" publication="J MED GENET" d1="21" d2="441" d3="984"/>
<CITE num="20" author="HART DA" publication="THROMB HAEMOST" d1="51" d2="212" d3="984"/>
<CITE num="21" author="GUEANT JL" publication="CLIN CHIM ACTA" d1="143" d2="217" d3="984"/>
<CITE num="22" author="PASCALI VL" publication="EUR J PEDIATR" d1="143" d2="133" d3="984"/>
<CITE num="23" author="PORTER WH" publication="CLIN CHEM" d1="32" d2="652" d3="986"/>
</CITATIONS>
<RECORDNUM>00857 </RECORDNUM>
<MEDLINENUM>78189549</MEDLINENUM>
<AUTHORS><AUTHOR>Alhadeff-J-A</AUTHOR><AUTHOR>Watkins-P</AUTHOR><AUTHOR>Freeze-H</AUTHOR></AUTHORS>
<TITLE>Purification and characterization of altered cystic fibrosis liver
alpha-L-fucosidase.</TITLE>
<SOURCE>Clin-Genet. 1978 May. 13(5). P 417-24.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>FUCOSIDASE: ip</TOPIC><TOPIC>LIVER: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARBOHYDRATES: an</TOPIC><TOPIC>ELECTROPHORESIS-POLYACRYLAMIDE-GEL</TOPIC><TOPIC>FUCOSIDASE: an, me</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>alpha-L-Fucosidase (E.C.3.2.4.51) from two cystic fibrosis livers has
been purified and characterized. Purification was accomplished by an
affinity chromatographic procedure previously used for normal liver
alpha-L-fucosidase. Characterization of the two cystic fibrosis alpha-
L-fucosidases indicated that they were very similar to normal liver
alpha-L-fucosidase with regard to pH optima profiles, Michaelis
constants (Km's), subunit structure and antigenicity. However, gas
liquid chromatographic analysis revealed altered carbohydrate
compositions for both the cystic fibrosis alpha-L-fucosidases. The
three major sugars found in normal purified liver alpha-L-fucosidase
(mannose, N-acetylglucosamine and sialic acid) were reduced in the
cystic fibrosis alpha-L-fucosidases, on average, to 51%, 44% and 32%,
respectively, of their normal amounts.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="CLIN GENET" d1="13" d2="207" d3="978"/>
<CITE num="002" author="ALHADEFF JA" publication="MOL CELL BIOCHEM" d1="18" d2="33" d3="977"/>
<CITE num="003" author="ALHADEFF JA" publication="J BIOL CHEM" d1="250" d2="7106" d3="975"/>
<CITE num="004" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="57" d2="307" d3="974"/>
<CITE num="005" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="006" author="ALHADEFF JA" publication="DEVELOP BIOL" d1="47" d2="319" d3="975"/>
<CITE num="007" author="CLAMP JR" publication="METHODS BIOCHEM ANAL" d1="19" d2="229" d3="971"/>
<CITE num="008" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="009" author="DISCHE Z" publication="ANN NY ACAD SCI" d1="93" d2="526" d3="962"/>
<CITE num="010" author="DISCHE Z" publication="AM J DIS CHILD" d1="102" d2="733" d3="961"/>
<CITE num="011" author="ETCHISON JR" publication="VIROLOGY" d1="60" d2="217" d3="974"/>
<CITE num="012" author="GUHA AK" publication="CLIN BIOCHEM" d1="10" d2="153" d3="977"/>
<CITE num="013" author="KNAUFF RE" publication="CLIN CHIM ACTA" d1="19" d2="245" d3="968"/>
<CITE num="014" author="LAEMMLI UK" publication="NATURE" d1="227" d2="680" d3="970"/>
<CITE num="015" author="LINEWEAVER H" publication="J AM CHEM SOC" d1="56" d2="658" d3="934"/>
<CITE num="016" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="017" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="018" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="019" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="020" author="SCANLIN TF JR" publication="PEDIATR RES ABST 549" d1="11" d2="463" d3="977"/>
<CITE num="021" author="SPIRO RG" publication="ADV PROT CHEM" d1="27" d2="349" d3="973"/>
<CITE num="022" author="THORPE R" publication="FEBS LETTERS" d1="54" d2="89" d3="975"/>
<CITE num="023" author="TURNER BM" publication="AM J HUM GENET" d1="27" d2="651" d3="975"/>
<CITE num="024" author="WARREN L" publication="J BIOL CHEM" d1="234" d2="1971" d3="959"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78077</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HADEFF JA           CL" publication="IN GENET" d1="14" d2="89 9" d3="8"/>
<CITE num="2" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="89" d2="469" d3="978"/>
<CITE num="3" author="ALHADEFF JA" publication="BIOCHEM BIOPHYS RES COMMUN" d1="86" d2="787" d3="979"/>
<CITE num="4" author="BENYOSEPH Y" publication="CLIN CHIM ACTA" d1="99" d2="31" d3="979"/>
<CITE num="5" author="FREEZE H" publication="BIOCHEM J" d1="177" d2="749" d3="979"/>
<CITE num="6" author="SCANLIN TF" publication="CLIN CHEST MED" d1="1" d2="424" d3="980"/>
<CITE num="7" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="105" d2="131" d3="980"/>
<CITE num="8" author="BENYOSEPH Y" publication="PEDIATR RES" d1="15" d2="839" d3="981"/>
<CITE num="9" author="JAKEL HP" publication="BIOL ZENTRALBL" d1="100" d2="273" d3="981"/>
<CITE num="10" author="HARRIS A" publication="CLIN CHIM ACTA" d1="116" d2="171" d3="981"/>
<CITE num="11" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="117" d2="227" d3="981"/>
<CITE num="12" author="MALER T" publication="J BIOL CHEM" d1="256" d2="1420" d3="981"/>
<CITE num="13" author="BLITZER MG" publication="PEDIATR RES" d1="16" d2="203" d3="982"/>
<CITE num="14" author="SCANLIN TF" publication="BIOCHEMISTRY" d1="21" d2="491" d3="982"/>
<CITE num="15" author="MARGOLIES R" publication="PEDIATR RES" d1="17" d2="931" d3="983"/>
<CITE num="16" author="RUDICK VL" publication="J CELL PHYSIOL" d1="115" d2="143" d3="983"/>
<CITE num="17" author="BOURASSA C" publication="CLIN CHIM ACTA" d1="129" d2="263" d3="983"/>
<CITE num="18" author="ALHADEFF JA" publication="CLIN CHIM ACTA" d1="134" d2="1" d3="983"/>
<CITE num="19" author="SCANLIN TF" publication="PEDIATR RES" d1="19" d2="368" d3="985"/>
<CITE num="20" author="HERMELIN B" publication="CELL MOL BIOL" d1="33" d2="83" d3="987"/>
</CITATIONS>
<RECORDNUM>00858 </RECORDNUM>
<MEDLINENUM>78189535</MEDLINENUM>
<AUTHORS><AUTHOR>Danes-B-S</AUTHOR><AUTHOR>Beck-B</AUTHOR><AUTHOR>Flensborg-E-W</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: cell culture classes in a Danish population.</TITLE>
<SOURCE>Clin-Genet. 1978 Apr. 13(4). P 327-34.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DENMARK</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<ABSTRACT>The cystic fibrosis (CF) culture phenotype of dermal fibroblasts
(metachromasia, metabolic cooperation) of a group of 131 Danish CF
patients and their families were studied to determine the
distribution of the two CF culture classes and their prognostic
significance. Of these, 62.6% (82) were Class I, 31.3% (41) Class II
and 61.1% (8) were proposed to be genetic compounds. The occurrence
of Class II was twice that found in a group of patients from New York
(13%) and Minnesota (18%). The prognosis for Class II CF patients was
considered to be poorer as: (1) The initial diagnosis was made
earlier in Class II than in Class I or the compounds (63% of Class II
were diagnosed in the first year of life, as compared to 35% in Class
I and 13% of the compounds). (2) Only 5% of the Class II patients
survived over the age of 15 years, both being deceased at the end of
the study in 1976, whereas 24% of Class I and 63% of the compounds
were over 15 years at the end of the study. This research added
further evidence for genetic heterogeneity within the clinical
syndrome, cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BERATIS NG" publication="PEDIATR RES" d1="7" d2="958" d3="973"/>
<CITE num="002" author="BOWMAN BH" publication="PROC NAT ACAD SCI USA" d1="70" d2="548" d3="973"/>
<CITE num="003" author="DANES BS" publication="BIRTH DEF ORIG ART SER" d1="8" d2="114" d3="972"/>
<CITE num="004" author="DANES BS" publication="LANCET" d1="2" d2="765" d3="973"/>
<CITE num="005" author="DANES BS" publication="CLIN GENET" d1="7" d2="128" d3="975"/>
<CITE num="006" author="DANES BS" publication="TEX REP BIOL MED" d1="34" d2="135" d3="976"/>
<CITE num="007" author="DANES BS" publication="AM J HUM GENET" d1="23" d2="297" d3="971"/>
<CITE num="008" author="DANES BS" publication="CLIN GENET" d1="9" d2="527" d3="976"/>
<CITE num="009" author="DANES BS" publication="CLIN GENET" d1="11" d2="83" d3="977"/>
<CITE num="011" author="LYKKEGAARD E" publication="DAN MED BULL" d1="22" d2="177" d3="975"/>
<CITE num="012" author="LYKKEGAARD E" publication="DAN MED BULL" d1="22" d2="169" d3="975"/>
<CITE num="013" author="LYKKEGAARD E" publication="DAN MED BULL" d1="22" d2="175" d3="975"/>
<CITE num="014" author="WOOD RE" publication="LANCET" d1="2" d2="1452" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78078</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NGE P               DA" publication="N MED BULL" d1="29" d2="58 9" d3="2"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
</CITATIONS>
<RECORDNUM>00859 </RECORDNUM>
<MEDLINENUM>78189631</MEDLINENUM>
<AUTHORS><AUTHOR>Erkkila-J-C</AUTHOR><AUTHOR>Warwick-W-J</AUTHOR><AUTHOR>Bradford-D-S</AUTHOR></AUTHORS>
<TITLE>Spine deformities and cystic fibrosis.</TITLE>
<SOURCE>Clin-Orthop. 1978 Mar-Apr. (131). P 146-50.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>SPINAL-DISEASES: co</TOPIC><TOPIC>SPINE: ab</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-DETERMINATION-BY-SKELETON</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>BLOOD-PROTEINS</TOPIC><TOPIC>BODY-WEIGHT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GROWTH-DISORDERS: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KYPHOSIS: cn</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SCOLIOSIS: cn</TOPIC></MINORSUBJ>
<ABSTRACT>Patients with cystic fibrosis have an increased risk for developing
kyphosis and scoliosis. The risk for both kyphosis and scoliosis
increases with age. The severity of kyphosis did not appear greater
in the older age groups. Patients with retarded bone age may be more
likely to have a significant spinal deformity. The presence of spine
deformity does not correlate with the severity of pulmonary
involvement, height, weight, serum protein and albumin in patients
with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="002" author="BRADFORD DS" publication="J BONE JOINT SURG" d1="56A" d2="740" d3="974"/>
<CITE num="003" author="BROOKS HL" publication="ORTHOP REV" d1="1" d2="17" d3="972"/>
<CITE num="004" author="BRUSZEWSKI J" publication="CHIR NARZAD RUCHU ORTOP POL" d1="22" d2="115" d3="972"/>
<CITE num="005" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="ANN INTERN MED" d1="50" d2="1321" d3="959"/>
<CITE num="007" author="GREULICH WW" publication="RADIOGRAPHIC ATLAS OF SKELETA" d1="" d2="" d3="959"/>
<CITE num="008" author="KANE WJ" publication="CLIN ORTHOP" d1="69" d2="216" d3="970"/>
<CITE num="009" author="KEMP FH" publication="BR J RADIOL" d1="21" d2="449" d3="948"/>
<CITE num="010" author="KEMP FH" publication="BR J SOC MED" d1="2" d2="66" d3="948"/>
<CITE num="011" author="MATTHEWS LW" publication="IN: MANGOS JA" d1="" d2="303" d3="973"/>
<CITE num="012" author="SCHEUERMANN HW" publication="UGESKR LAEGER" d1="82" d2="385" d3="920"/>
<CITE num="013" author="SHANDS AR JR" publication="J BONE JOINT SURG" d1="37A" d2="1243" d3="955"/>
<CITE num="014" author="SORENSEN KH" publication="SCHEUERMANN'S JUVENILE KYPHOS" d1="" d2="" d3="964"/>
<CITE num="015" author="WARWICK WJ" publication="MOD PROBL PEDIATR" d1="10" d2="353" d3="967"/>
<CITE num="016" author="WARWICK WJ" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="320" d3="969"/>
<CITE num="017" author="WYNNE-DAVIES R" publication="J BONE JOINT SURG" d1="50B" d2="24" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78079</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LING MR             SK" publication="ELETAL RADIOL" d1="8" d2="63 9" d3="2"/>
<CITE num="2" author="LOGVINOFF MM" publication="CLIN PEDIATR" d1="23" d2="389" d3="984"/>
<CITE num="3" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
</CITATIONS>
<RECORDNUM>00860 </RECORDNUM>
<MEDLINENUM>78168093</MEDLINENUM>
<AUTHORS><AUTHOR>McFarlene-H</AUTHOR><AUTHOR>Allan-J-D</AUTHOR><AUTHOR>Malhotra-A</AUTHOR><AUTHOR>Hozel-A</AUTHOR><AUTHOR>Wallwork-J-C</AUTHOR></AUTHORS>
<TITLE>The precipitins and hypersensitivity reactions in cystic fibrosis.</TITLE>
<SOURCE>Compr-Ther. 1978 Apr. 4(4). P 61-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>HYPERSENSITIVITY: im</TOPIC><TOPIC>PRECIPITINS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>COMPLEMENT-3</TOPIC><TOPIC>ELECTROPHORESIS-AGAR-GEL</TOPIC><TOPIC>FLUORESCENT-ANTIBODY-TECHNIC</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGA-SECRETORY</TOPIC><TOPIC>IGE</TOPIC><TOPIC>OVALBUMIN: im</TOPIC><TOPIC>SALIVA: im</TOPIC><TOPIC>SERUM-ALBUMIN-BOVINE: im</TOPIC><TOPIC>SPUTUM: im</TOPIC></MINORSUBJ>
<EXTRACT>The large number and wide variety of precipitins detected in the
sputum of cystic fibrosis patients suggest that the precipitins may
be nonprotective and even harmful to the patients.  These sputum
precipitins were directed principally against food, fungi, bacteria,
and human body tissue.  On the other hand, precipitins to
Staphylococcus alpha-hemolysin was the main type of immunoprecipitin
detected in CF serum and was found in 60% of the serum specimens
examined.  It seems likely that the precipitins in patients with CF
may be involved in the formation of immune complexes which, in
conjunction with complement, may be responsible for the respiratory
and gastrointestinal lesions that are common in patients with CF.
The immune complexes may be the result of excess food and bacterial
antigens escaping across the gut and lungs as a result of some
abnormality of the SIgA system.  Over 80% of the sputum specimens
tested gave positive precipitins in agar gel against human seminal
fluid and colostrum, suggesting that some of the antibodies formed in
CF patients could be directed against host tissue, and may account
for an autoimmune-type reaction in CF.  Crossreaction between the
high-titer antibody to Staphylococcus and basement membrane of lungs
and pancreas, with complement activation, may occur in CF and
required further study.  The high number of B-cells, as detected by
antibody, coated complement, activated sheep erythrocytes, and EAC
rosettes, may be partly responsible for the synthesis of the variety
of antibodies detected in CF patients.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78080</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DOGGETT RG" publication="J PEDIATR" d1="68" d2="215" d3="966"/>
<CITE num="002" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="003" author="SCHWARTZ RH" publication="CF CLUB ABST" d1="" d2="9" d3="965"/>
<CITE num="004" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="005" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="006" author="PEPYS J" publication="LANCET" d1="2" d2="134" d3="968"/>
<CITE num="007" author="URIEL J" publication="BULL SOC CHIM BIOL" d1="48" d2="969" d3="966"/>
<CITE num="008" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="009" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="010" author="MELLSTEDT H" publication="CLIN EXP IMMUNOL" d1="15" d2="309" d3="973"/>
<CITE num="011" author="JOHANSSEN SGO" publication="IMMUNOLOGY" d1="10" d2="265" d3="968"/>
</REFERENCES>
<RECORDNUM>00861 </RECORDNUM>
<MEDLINENUM>78149018</MEDLINENUM>
<AUTHORS><AUTHOR>Forstner-J-F</AUTHOR></AUTHORS>
<TITLE>Intestinal mucins in health and disease.</TITLE>
<SOURCE>Digestion. 1978. 17(3). P 234-63. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>INTESTINAL-MUCOSA</TOPIC><TOPIC>MUCINS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CARCINOMA: me</TOPIC><TOPIC>CHEMISTRY</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>GASTROINTESTINAL-DISEASES: me</TOPIC><TOPIC>HORMONES: ph</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-MUCOSA: cy, me, ph</TOPIC><TOPIC>MUCINS: bi, me, ph, se</TOPIC><TOPIC>NEUROREGULATORS: ph</TOPIC><TOPIC>REVIEW</TOPIC></MINORSUBJ>
<ABSTRACT>Intestinal mucins are complex glycoproteins which are secreted from
goblet cells, and form a gel-like covering over the mucosal surface.
They are assumed to provide lubrication and protection of the
underlying epithelium against potentially injurious chemicals,
enzymes, bacteria and dietary constituents. Recent advances in our
understanding of mucin structure, secretion and functional properties
are reviewed in this paper. Implications for diseases such as cystic
fibrosis, peptic ulcer, malignancy and inflammatory bowel disease are
briefly discussed.</ABSTRACT>
<REFERENCES>
001$  ABT AB                ARCH PATHOL                    100   301 976
002   ALLEN A               BIOCHEM J                      106   306 968
003   ALLEN A               FARADAY CHEM SOC                57   210 974
004   ALLEN A               GUT                             13   666 972
005   ALLEN A               BIOCHIM BIOPHYS ACTA           338   364 974
006   ALLEN A               BIOCHEM SOC TRANS                2   630 974
007   ALPERS DH             GASTROENTEROLOGY                64   471 973
008   ANDERSON CG           BR J EXP PATHOL                 20    25 939
009   ANDRE F               ACTA GASTROENTEROL BELG         37   469 974
010   ARONSON NN            IN: GOTTSCHALK A                    1211 972
011   BAUR PS               TEX REP BIOL MED                34   155 976
012   BELLA A JR            ARCH BIOCHEM BIOPHYS           150   679 972
013   BENNETT G             J CELL BIOL                     60   258 974
014   BHASKAR KR            BIOCHEM J                      143   669 974
015   BLOCH KJ              FED PROC FED AM SOC EXP BIOL    36  1054 977
016   BOAT TF               ARCH BIOCHEM BIOPHYS           177    95 976
017   BOAT TF               AM REV RESPIR DIS              110   428 974
018   BOGART BI             J ULTRASTRUCT RES               52   139 975
019   BOTTIN C              BIOL GASTROENTEROL               6   307 973
020   BRAIN MC              BR J HAEMATOL                   18   183 970
021   CALVER GA             CAN J MICROBIOL                 22   832 976
022   CAMARRI E             ARZNEIMITTEL FORSCH             22   768 972
023   CARLSON DM            J BIOL CHEM                    241  2984 966
024   CARLSON DM            J BIOL CHEM                    243   616 968
025   CHANG WWL             AM J ANAT                      144    39 975
026   CLAUSER H             IN: GOTTSCHALK A                    1151 972
027   CLAUSER H             IN: AMINOFF D                        479 970
028   CRAWFORD BJ           CAN J ZOOL                      52  1427 974
029   CREETH JM             MOD PROBL PEDIATR               19    34 977
030   CREETH JM             BIOCHEM J                      143   159 974
031   CULLING CFA           J CLIN PATHOL                   28   656 975
032   CZEGLEDY-NAGY E       LAB INVEST                      35   588 976
033   DEKANSKI JB           BR J PHARMACOL                  52   464 974
034   DEKANSKI JB           BR J PHARMACOL                  55   387 975
035   DI GIROLAMO R         APPL ENVIRON MICROBIOL          33    19 977
036   DI SANTAGNESE PA      N ENGL J MED                   277  1287 967
037   DUNSTONE JR           BIOCHIM BIOPHYS ACTA           101   300 965
038   EASTWOOD GL           GASTROENTEROLOGY                64   383 973
039   ELLIS DB              BIOCHIM BIOPHYS ACTA           276   105 972
040   FAILLARD H            IN: GOTTSCHALK A                    1246 972
041   FILIPE MI             BR J CANCER                     32    60 975
042   FLOREY H              PROC R SOC LOND BIOL           143   144 955
043   FLOREY HW             GASTROENTEROLOGY                43   326 962
044   FORD A                J BIOL STANDARDS                 4   353 976
045   FORSTNER GG           CAN J PHYSIOL PHARMACOL         51   122 973
046   FORSTNER JF           PEDIATR RES                     10   609 976
047   FORSTNER JF           MOD PROBL PEDIATR               19    54 977
048   FORSTNER JF           CAN J BIOCHEM                   51  1154 973
050   FREEMAN JA            ANAT REC                       154   121 966
051   FUKUDA M              BIOCHEM BIOPHYS RES COMMUN      64   465 975
052   GALLAGHER JT          PROC R SOC LOND BIOL           192    49 975
053   GELMAN RA             BIOCHIM BIOPHYS ACTA           427   627 976
054   GIBBONS RA            BIOCHEM J                       73   209 959
055   GIBBONS RA            NATURE                         200   665 963
056   GIBBONS RA            IN: AMINOFF D                        307 970
057   GIBBONS RJ            ADV EXP MED BIOL                45   315 974
058   GIBSON LE             PEDIATRICS                      48   695 971
059   GINSBURG V            ANNU REV BIOCHEM                38   371 969
060   GORALSKI A            CELL TISSUE RES                160   551 975
061   GORDON HA             EXPERIENTIA                     30   214 974
062   GOTTSCHALK A          IN: GOTTSCHALK A                    1082 972
063   GOTTSCHALK A          IN: GOTTSCHALK A                     529 972
064   HARTIALA K            J BIOL CHEM                    195   251 952
065   HEATLEY NG            GASTROENTEROLOGY                37   313 959
066   HERNANDEZ FJ          DIS COLON RECTUM                19    63 976
067   HOLLANDER F           ARCH INTERN MED                 93   107 954
068   HOROWITZ MI           IN: CODE CF                         1063 967
069   HOROWITZ MI           ANN NY ACAD SCI                140   784 967
070   HOSKINS LC            GASTROENTEROLOGY                54   218 968
071   HOSKINS LC            J CLIN INVEST                   57    63 976
072   HOSKINS LC            J CLIN INVEST                   57    63 976
073   HOSKINS LC            GASTROENTEROLOGY                54   210 968
074   JABBAL I              CAN J BIOCHEM                   54   707 976
075   JENNINGS MA           Q J EXP PHYSIOL                 41   131 956
076   KASHKET S             J BACTERIOL                    112  1127 972
077   KEEFER CS             J CLIN INVEST                   17    23 938
078   KELLAWAY IW           J PHARM PHARMACOL               27   281 975
079   KENT PW               BIOCHEM J                      106   645 968
080   KIM SK                J ULTRASTRUCT RES               38   371 972
081   KLAAS J               J PARASIT                       60   907 974
082   KLEINMAN HK           BIOCHIM BIOPHYS ACTA           354    17 974
083   KOGA A                Z ZELLFORSCH MIKROSK ANAT      139   463 973
084   KOKAS E               COMPAR BIOCHEM PHYSIOL          22    81 967
085   KORNFELD R            ANNU REV BIOCHEM                45   217 976
086   KRAMER MF             HISTOCHEM J                      7   511 975
087   KUPCHELLA CE          TRANS NY ACAD SCI               34   351 972
088   LAMBLIN G             BIOCHIM BIOPHYS ACTA           322   372 973
089   LAMBLIN G             BULL EUR PHYSIOPATH RESP        13   175 977
090   LAMBERT R             DIGESTION                        5   116 972
091   LAMONT JT             GASTROENTEROLOGY                72    82 977
092   LAWFORD GR            CAN J BIOCHEM                   45   507 967
093   LENT CM               SCIENCE                        179   693 973
094   LEWIS RW              LIPIDS                           5   947 970
095   LEWIS RW              LIPIDS                           8   321 973
096   LHERMITTE M           BIOCHIMIE                       58   367 976
097   LIAU YH               DIGESTION                       14   372 976
098   LINDSTEDT G           J EXP MED                      121   201 965
099   LLOYD KO              PROC NAT ACAD SCI USA           61  1470 968
100   LUKIE BE              BIOCHIM BIOPHYS ACTA           261   353 972
101   LUKIE BE              BIOCHIM BIOPHYS ACTA           261   353 972
102   LUKIE BE              BIOCHIM BIOPHYS ACTA           273   390 972
103   LUKIE BE              BIOCHIM BIOPHYS ACTA           338   345 974
104   MACDERMOTT RP         J CLIN INVEST                   54   545 974
105   MACHIN J              SCIENCE                        183   759 974
106   MACPHERSON B          DIGESTION                       14   424 976
107   MARTIN F              DIGESTION                        1   165 968
108   MARTINEZ JR           PEDIATR RES                      9   463 975
109   MCGUIRE EJ            IN: AMINOFF D                        461 970
110   MEDLINE A             HUM PATHOL                       7   693 976
111   MENGUY R              ANN NY ACAD SCI                140   797 967
112   MERZEL J              AM J ANAT                      124   281 969
113   MOON HW               LAB INVEST                      25   133 971
114   OATES MDG             CARBOHYD RES                    34   115 974
115   ODOHERTY PJA          INT J BIOCHEM                    6   435 975
116   OEMRAWSINGH I         ARCH ORAL BIOL                  19   753 974
117   OEMRAWSINGH I         ARCH ORAL BIOL                  21   755 976
118   NEGUS V               PROC R SOC MED                  60    75 967
119   NEMOTO T              BIOCHIM BIOPHYS ACTA           192    37 969
120   NEUTRA M              SCI AM                         220   100 969
121   NEUTRA M              J CELL BIOL                     30   119 966
122   NEUTRA M              J CELL BIOL                     30   137 966
123   NUNGESTER WJ          J INFECT DIS                    59    11 936
124   PALAY SL              IN: PALAY SL                         305 958
125   PIGMAN W              ANN ANAT PATHOL                 17   227 972
126   PIGMAN W              EUR J BIOCHEM                   32   148 973
127   PIGMAN W              IN: BLANAU                           143 973
128   PINEO GF              ANN NY ACAD SCI                230   262 974
129   PINEO GF              J LAB CLIN MED                  82   255 973
130   POTTER JL             ANN NY ACAD SCI                106   692 963
131   RAINSFORD KD          EXPERIENTIA                     15  1172 976
132   REES DA               BIOCHEM J                      126   257 972
133   ROBERTS GP            EUR J BIOCHEM                   50   265 974
134   ROBERTS GP            ARCH BIOCHEM BIOPHYS           173   528 976
135   ROBINSON DS           BIOCHEM J                      147    55 975
136   RODRIGUES MM          ARCH OPHTHALMOL                 89   493 973
137   ROSEMAN S             MOD PROBL PEDIATR               10   244 967
138   ROSSIGNOL B           FEBS LETTERS                    43   241 974
139   ROSSIGNOL B           FEBS LETTERS                    21   189 972
140   ROUSSEL P             J BIOL CHEM                    250  2114 975
141   SCHACHTER H           BIOCHEM SOC SYMP                40    57 974
142   SCHRAGER J            GUT                             12   559 971
143   SCHRAGER J            ARCH ORAL BIOL                  19  1215 974
144   SHACKLEFORD JM        IN: AMINOFF D                        223 970
145   SHARON N              REV BIOCHEM                     35   485 966
146   SHERR H               GASTROENTEROLOGY                72  1130 977
147   SHILLINGFORD JS       BIOCHEM SOC TRANS                2  1104 973
148   SHORA W               GASTROENTEROLOGY                68   480 975
149   SLAGLE GW             DIS COLON RECTUM                19   253 976
150   SOERGEL KH            GASTROENTEROLOGY                47   610 964
151   SPIRO RG              N ENGL J MED                   281   991 969
152   SPIRO RG              REV BIOCHEM                     39   559 970
153   STAHL GH              BIOCHEM J                      136   845 973
154   STARKEY BJ            BIOCHEM J                      141   633 974
155   STEINBERG SE          GASTROENTEROLOGY                68   309 975
156   STROMBECK DR          INFECT IMMUN                    10  1266 974
157   STURGESS JM           CLIN SCI                        43   533 972
158   SZULMAN AE            ANNU REV MED                    17   307 966
159   TAYLOR M              LARYNGOSCOPE                    84   612 974
160   TRIER JS              IN: CODE CF                      3  1125 968
161   TUPPY H               IN: GOTTSCHALK A                     403 972
162   WAECHTER CJ           REV BIOCHEM                     45    95 976
163   WALDRON-EDWARD D      PATHOL BIOL (PARIS)             24   521 976
164   WALDRON-EDWARD D      GASTROENTEROLOGY                59   671 970
165   WATKINS WM            IN: SMELLIE RMS                      125 974
166   WILLIAMS RC           INFECT IMMUN                    11   711 975
167$  WINDMUELLER HG        J BIOL CHEM                    249  5070 975
168   WINET H               J EXP BIOL                      64   283 976
169   WINSNES R             ACTA PATH MICROBIOL SCAND (C)   84    77 976
170   WOLD JK               ACTA CHEM SCAND (B)             29   703 975
171   WONG YC               EXP MOL PATH                    23   132 975
173   YOSIZAWA Z            IN: GOTTSCHALK A                 5  1000 972</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78081</PAPERNUM>
<CITATIONS>
<CITE num="1" author="D A                 SC" publication="AND J GASTROENTEROL" d1="14" d2="94 9" d3="9"/>
<CITE num="2" author="ZHEREV S" publication="AGRESSOLOGIE" d1="20" d2="107" d3="979"/>
<CITE num="3" author="QURESHI R" publication="J CLIN INVEST" d1="64" d2="1149" d3="979"/>
<CITE num="4" author="SPECIAN RD" publication="J CELL BIOL" d1="85" d2="626" d3="980"/>
<CITE num="5" author="NIMMERFALL F" publication="BIOCHEM BIOPHYS RES COMMUN" d1="94" d2="960" d3="980"/>
<CITE num="6" author="BONERANDI JJ" publication="ANN DERMATOL VENEREOL" d1="107" d2="51" d3="980"/>
<CITE num="7" author="BALAZS M" publication="VIRCHOWS ARCH PATHOL ANAT HIS" d1="387" d2="193" d3="980"/>
<CITE num="8" author="PRIZONT R" publication="J CLIN INVEST" d1="67" d2="336" d3="981"/>
<CITE num="9" author="SPECIAN RD" publication="AM J ANAT" d1="160" d2="461" d3="981"/>
<CITE num="10" author="TABAK LA" publication="J ORAL PATHOL" d1="11" d2="1" d3="982"/>
<CITE num="11" author="SPICER SS" publication="HUM PATHOL" d1="13" d2="343" d3="982"/>
<CITE num="12" author="ECKNAUER R" publication="Z GASTROENTEROL" d1="20" d2="150" d3="982"/>
<CITE num="13" author="SLOMIANY BL" publication="ARCH ORAL BIOL" d1="27" d2="803" d3="982"/>
<CITE num="14" author="GIBBONS RJ" publication="AM J CLIN NUTR" d1="36" d2="276" d3="982"/>
<CITE num="15" author="HOUNSELL EF" publication="MED BIOL" d1="60" d2="227" d3="982"/>
<CITE num="16" author="SLOMIANY BL" publication="J DENT RES" d1="61" d2="1163" d3="982"/>
<CITE num="17" author="NEUTRA MR" publication="CHEST" d1="81" d2="S 14" d3="982"/>
<CITE num="18" author="FERACCI H" publication="GASTROENTEROLOGY" d1="82" d2="317" d3="982"/>
<CITE num="19" author="BEYER EC" publication="J CELL BIOL" d1="92" d2="28" d3="982"/>
<CITE num="20" author="SCHACHTER H" publication="ADV EXP MED BIOL" d1="144" d2="3" d3="982"/>
<CITE num="21" author="TRAYNOR OJ" publication="ADV EXP MED BIOL" d1="144" d2="225" d3="982"/>
<CITE num="22" author="NEUTRA MR" publication="AM J PHYSIOL" d1="242" d2="G380" d3="982"/>
<CITE num="23" author="SPECIAN RD" publication="AM J PHYSIOL" d1="242" d2="G370" d3="982"/>
<CITE num="24" author="CASTRO GA" publication="AM J PHYSIOL" d1="243" d2="G321" d3="982"/>
<CITE num="25" author="SLOMIANY BL" publication="J BIOL CHEM" d1="257" d2="9561" d3="982"/>
<CITE num="26" author="PETERS MW" publication="BIOCHIM BIOPHYS ACTA" d1="693" d2="417" d3="982"/>
<CITE num="27" author="KURIHARA H" publication="BIOMED RES" d1="4" d2="549" d3="983"/>
<CITE num="28" author="ALLEN A" publication="TRENDS BIOCHEM SCI" d1="8" d2="169" d3="983"/>
<CITE num="29" author="DONALDSON JD" publication="EUR SURG RES" d1="15" d2="11" d3="983"/>
<CITE num="30" author="MA J" publication="PATHOLOGY" d1="15" d2="385" d3="983"/>
<CITE num="31" author="SLOMIANY BL" publication="ARCH ORAL BIOL" d1="28" d2="711" d3="983"/>
<CITE num="32" author="SCHULTE BA" publication="J HISTOCHEM CYTOCHEM" d1="31" d2="391" d3="983"/>
<CITE num="33" author="TRAYNOR OJ" publication="CANCER" d1="51" d2="1847" d3="983"/>
<CITE num="34" author="POON H" publication="CAN J BIOCHEM CELL BIOL" d1="61" d2="868" d3="983"/>
<CITE num="35" author="LAMONT JT" publication="GASTROENTEROLOGY" d1="84" d2="306" d3="983"/>
<CITE num="36" author="STEPHEN AM" publication="GASTROENTEROLOGY" d1="85" d2="589" d3="983"/>
<CITE num="37" author="MOUWEN JMVM" publication="DTSCH TIERARZ WSCHR" d1="90" d2="477" d3="983"/>
<CITE num="38" author="SAROSIEK J" publication="BIOCHEM BIOPHYS RES COMMUN" d1="115" d2="1053" d3="983"/>
<CITE num="39" author="WESLEY AW" publication="CARBOHYD RES" d1="115" d2="151" d3="983"/>
<CITE num="40" author="WITAS H" publication="CARBOHYD RES" d1="120" d2="67" d3="983"/>
<CITE num="41" author="ZENTLERMUNRO PL" publication="BR MED J" d1="287" d2="501" d3="983"/>
<CITE num="42" author="SHIMANO T" publication="ANN NY ACAD SCI" d1="417" d2="97" d3="983"/>
<CITE num="43" author="SLOMIANY A" publication="BIOCHIM BIOPHYS ACTA" d1="750" d2="253" d3="983"/>
<CITE num="44" author="YAMAMOTO A" publication="J PHARMACOBIO DYN" d1="7" d2="728" d3="984"/>
<CITE num="45" author="LINDAHL M" publication="VET MICROBIOL" d1="9" d2="249" d3="984"/>
<CITE num="46" author="REID PE" publication="HISTOCHEM J" d1="16" d2="235" d3="984"/>
<CITE num="47" author="ALLEN A" publication="SCAND J GASTROENTEROL" d1="19" d2="101" d3="984"/>
<CITE num="48" author="SAROSIEK J" publication="SCAND J GASTROENTEROL" d1="19" d2="150" d3="984"/>
<CITE num="49" author="BORSCH G" publication="KLIN WSCHR" d1="62" d2="699" d3="984"/>
<CITE num="50" author="OHARA S" publication="COMP BIOCHEM PHYSIOL (B)" d1="79" d2="325" d3="984"/>
<CITE num="51" author="FORSTNER J" publication="CIBA FOUND SYMP" d1="109" d2="61" d3="984"/>
<CITE num="52" author="NEUTRA MR" publication="CIBA FOUND SYMP" d1="109" d2="20" d3="984"/>
<CITE num="53" author="MURTY VLN" publication="BIOCHEM BIOPHYS RES COMMUN" d1="121" d2="521" d3="984"/>
<CITE num="54" author="SALMONOWITZ E" publication="AM J ROENTGENOL" d1="142" d2="721" d3="984"/>
<CITE num="55" author="KITADA M" publication="CLIN CHIM ACTA" d1="144" d2="173" d3="984"/>
<CITE num="56" author="STITH BJ" publication="J COMP PHYSIOL (B)" d1="155" d2="89" d3="984"/>
<CITE num="57" author="SLOMIANY A" publication="J BIOL CHEM" d1="259" d2="4743" d3="984"/>
<CITE num="58" author="SAROSIEK J" publication="ANN NY ACAD SCI" d1="435" d2="575" d3="984"/>
<CITE num="59" author="BASBAUM C" publication="GASTROENTEROL CLIN BIOL" d1="9" d2="45" d3="985"/>
<CITE num="60" author="GOLDERMAN L" publication="ISR J MED SCI" d1="21" d2="410" d3="985"/>
<CITE num="61" author="SEGAWA K" publication="JAP J MED" d1="24" d2="244" d3="985"/>
<CITE num="62" author="GONZALEZ EA" publication="FEMS MICROBIOL LETTERS" d1="29" d2="115" d3="985"/>
<CITE num="63" author="ALLEN A" publication="DIG DIS SCI" d1="30" d2="S 55" d3="985"/>
<CITE num="64" author="LASZEWICZ W" publication="DIGESTION" d1="31" d2="47" d3="985"/>
<CITE num="65" author="COHEN PS" publication="INFECT IMMUN" d1="48" d2="139" d3="985"/>
<CITE num="66" author="NEVOLA JJ" publication="INFECT IMMUN" d1="50" d2="152" d3="985"/>
<CITE num="67" author="CHNG HS" publication="J PHARM SCI" d1="74" d2="399" d3="985"/>
<CITE num="68" author="BELL AE" publication="GASTROENTEROLOGY" d1="88" d2="269" d3="985"/>
<CITE num="69" author="LOURENS JM" publication="TIJDSCHR DIERGENEESKD" d1="110" d2="755" d3="985"/>
<CITE num="70" author="SLOMIANY A" publication="BIOCHEM BIOPHYS RES COMMUN" d1="132" d2="299" d3="985"/>
<CITE num="71" author="ENE MD" publication="CLIN CHIM ACTA" d1="153" d2="165" d3="985"/>
<CITE num="72" author="BRADY RC" publication="AM J PHYSIOL" d1="248" d2="G 54" d3="985"/>
<CITE num="73" author="CARLSTEDTDUKE B" publication="EUR J CLIN MICROBIOL" d1="5" d2="634" d3="986"/>
<CITE num="74" author="SAITOH H" publication="J PHARMACOBIO DYN" d1="9" d2="1008" d3="986"/>
<CITE num="75" author="SALOMONOWITZ E" publication="GASTROINTEST RADIOL" d1="11" d2="93" d3="986"/>
<CITE num="76" author="TOOFANIAN F" publication="LAB ANIM SCI" d1="36" d2="157" d3="986"/>
<CITE num="77" author="HALAMA AK" publication="TIERARZ UMSCH" d1="41" d2="340" d3="986"/>
<CITE num="78" author="LAUX DC" publication="INFECT IMMUN" d1="52" d2="18" d3="986"/>
<CITE num="79" author="CARLSTEDTDUKE B" publication="ACTA PATH MICROB IMMU SCA (B)" d1="94" d2="293" d3="986"/>
<CITE num="80" author="SMITH PL" publication="AM J PHYSIOL" d1="250" d2="G432" d3="986"/>
<CITE num="81" author="MOURICOUT MA" publication="INFECT IMMUN" d1="55" d2="1216" d3="987"/>
<CITE num="82" author="SNYDER JD" publication="INT ARCH ALLERGY APPL IMMUNOL" d1="82" d2="351" d3="987"/>
<CITE num="83" author="SHERMAN P" publication="AM J PATHOL" d1="126" d2="527" d3="987"/>
</CITATIONS>
<RECORDNUM>00862 </RECORDNUM>
<MEDLINENUM>79045223</MEDLINENUM>
<AUTHORS><AUTHOR>Rao-G-J</AUTHOR><AUTHOR>Platt-M-W</AUTHOR><AUTHOR>Nadler-H-L</AUTHOR></AUTHORS>
<TITLE>Reaction of 4-methylumbelliferylguanidinobenzoate with proteases in
plasma of patients with cystic fibrosis.</TITLE>
<SOURCE>Enzyme. 1978. 23(5). P 314-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HYMECROMONE: du</TOPIC><TOPIC>PEPTIDE-HYDROLASES: df</TOPIC><TOPIC>UMBELLIFERONES: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ARGININE: aa, du</TOPIC><TOPIC>BINDING-SITES</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>GUANIDINES: du</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYMECROMONE: aa</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC><TOPIC>MOLECULAR-WEIGHT</TOPIC><TOPIC>PEPTIDE-HYDROLASES: bl</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Protease activity, assayed using 4-
methylumbelliferylguanidinobenzoate, an active site titrant of
certain proteases, is significantly deficient in plasma of patients
with cystic fibrosis. The deficiency can be demonstrated with both
chloroform-ellagic acid activated plasma in which the proteases can
hydrolyze esters of arginine and unactivated plasma in which the
proteases have negligible activity towards these esters. The
deficiency can also be demonstrated by separation of the proteases by
isoelectric focusing on polyacrylamide gels or by chromatography on
agarose columsn. Since protease deficiency can be demonstrated with
unactivated plasma, the deficiency in cystic fibrosis is probably due
to a reduced number of protease molecules rather than their decreased
catalytic efficiency.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BENDER ML" publication="J AM CHEM SOC" d1="88" d2="5890" d3="966"/>
<CITE num="002" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="003" author="CHASE T JR" publication="BIOCHEMISTRY" d1="8" d2="2212" d3="969"/>
<CITE num="004" author="COBURN MD" publication="AM REV RESPIR DIS" d1="110" d2="368" d3="974"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="006" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="007" author="KERR MA" publication="BIOCHEMISTRY" d1="14" d2="5088" d3="975"/>
<CITE num="008" author="OUCHTERLONY O" publication="ACTA PATH MICROBIOL SCAND" d1="25" d2="186" d3="948"/>
<CITE num="009" author="RAO GJS" publication="J PEDIATR" d1="80" d2="573" d3="972"/>
<CITE num="010" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="011" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="012" author="RAO GJS" publication="SCIENCE" d1="177" d2="610" d3="972"/>
<CITE num="013" author="SCHONI M" publication="EUR J CLIN INVEST" d1="5" d2="153" d3="975"/>
<CITE num="014" author="SEALE TW" publication="PEDIATR RES ABST 552" d1="11" d2="463" d3="977"/>
<CITE num="015" author="SHAPIRA E" publication="CLIN CHIM ACTA" d1="78" d2="359" d3="977"/>
<CITE num="016" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
<CITE num="017" author="BARRETT AJ" publication="BIOCHEM J" d1="133" d2="709" d3="973"/>
<CITE num="018" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78082</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OCK DJH             LA" publication="NCET" d1="1" d2="45 9" d3="9"/>
<CITE num="2" author="WALSH MM" publication="LANCET" d1="1" d2="622" d3="979"/>
<CITE num="3" author="HARRIS A" publication="DEVELOP MED CHILD NEUROL" d1="21" d2="675" d3="979"/>
<CITE num="4" author="RAO GJS" publication="ENZYME" d1="24" d2="280" d3="979"/>
<CITE num="5" author="WALSHPLATT M" publication="ENZYME" d1="24" d2="224" d3="979"/>
<CITE num="6" author="NADLER HL" publication="LANCET" d1="2" d2="96" d3="980"/>
<CITE num="7" author="WALSH MMJ" publication="PEDIATR RES" d1="14" d2="353" d3="980"/>
<CITE num="8" author="NADLER HL" publication="PEDIATRICS" d1="66" d2="690" d3="980"/>
<CITE num="9" author="PARSONS M" publication="CLIN CHIM ACTA" d1="100" d2="215" d3="980"/>
<CITE num="10" author="WALSH MMJ" publication="AM J OBSTET GYNECOL" d1="137" d2="978" d3="980"/>
<CITE num="11" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="12" author="LLOYDSTILL JD" publication="J PEDIATR" d1="99" d2="580" d3="981"/>
<CITE num="13" author="NADLER HL" publication="AM J OBSTET GYNECOL" d1="141" d2="885" d3="981"/>
<CITE num="14" author="BROCK DJH" publication="RIC CLIN LAB" d1="12" d2="231" d3="982"/>
<CITE num="15" author="SCHWARTZ M" publication="CLIN CHIM ACTA" d1="124" d2="213" d3="982"/>
<CITE num="16" author="TUMMLER B" publication="CLIN CHIM ACTA" d1="125" d2="219" d3="982"/>
<CITE num="17" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="18" author="BRANCHINI BR" publication="PEDIATR RES" d1="17" d2="850" d3="983"/>
<CITE num="19" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="20" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="21" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
<CITE num="22" author="MARYNEN P" publication="BIOCHIM BIOPHYS ACTA" d1="799" d2="187" d3="984"/>
<CITE num="23" author="PERINI JM" publication="BULL EUR PHYSIOPATH RESP" d1="21" d2="569" d3="985"/>
<CITE num="24" author="QURESHI AR" publication="J PEDIATR" d1="106" d2="913" d3="985"/>
</CITATIONS>
<RECORDNUM>00863 </RECORDNUM>
<MEDLINENUM>78238710</MEDLINENUM>
<AUTHORS><AUTHOR>Endres-W</AUTHOR><AUTHOR>Wuttge-B</AUTHOR></AUTHORS>
<TITLE>Occurrence of secondary cystathioninuria in children with inherited
metabolic disorders, liver diseases, neoplasms, cystic fibrosis and
celiac disease.</TITLE>
<SOURCE>Eur-J-Pediatr. 1978 Aug 17. 129(1). P 29-35.</SOURCE>
<MAJORSUBJ><TOPIC>CELIAC-DISEASE: ur</TOPIC><TOPIC>CYSTATHIONINE: ur</TOPIC><TOPIC>CYSTIC-FIBROSIS: ur</TOPIC><TOPIC>LIVER-DISEASES: ur</TOPIC><TOPIC>METABOLISM-INBORN-ERRORS: ur</TOPIC><TOPIC>NEOPLASMS: ur</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>BILE-DUCTS: ab</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYTOMEGALIC-INCLUSION-DISEASE: ur</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<ABSTRACT>Secondary cystathioninuria was found in two of 46 children suffering
from tumors, leukemia, liver disease, inherited metabolic disorders,
cystic fibrosis and celiac disease. Of these two patients, one had
congenital biliary atresia and the other cytomegalovirus infection.
Seven further children had only moderately elevated excretion of
cystathionine. It is suggested that secondary cystathioninuria is
uncommon in the disease investigated.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ENDRES W" publication="Z KINDERHEILK" d1="110" d2="46" d3="971"/>
<CITE num="003" author="FOURMAN P" publication="ARCH DIS CHILD" d1="41" d2="273" d3="966"/>
<CITE num="004" author="GEISER CF" publication="CANCER" d1="22" d2="856" d3="968"/>
<CITE num="005" author="GJESSING LR" publication="LANCET" d1="2" d2="1281" d3="963"/>
<CITE num="006" author="GJESSING LR" publication="SCAND J CLIN LAB INVEST" d1="17" d2="513" d3="965"/>
<CITE num="007" author="GJESSING LR" publication="RECENT RESULTS CANCER RES" d1="2" d2="26" d3="966"/>
<CITE num="008" author="LIEBERMAN E" publication="PEDIATRICS" d1="40" d2="828" d3="967"/>
<CITE num="009" author="SCRIVER CR" publication="PEDIATRICS" d1="31" d2="240" d3="963"/>
<CITE num="010" author="SHAW KNF" publication="AM J DIS CHILD" d1="113" d2="119" d3="967"/>
<CITE num="011" author="STUDNITZ W" publication="ACTA PAEDIATR SCAND" d1="58" d2="173" d3="969"/>
<CITE num="012" author="STUDNITZ W" publication="ACTA PAEDIATR SCAND" d1="59" d2="80" d3="970"/>
<CITE num="013" author="VOUTE PA JR" publication="CLIN CHIM ACTA" d1="22" d2="373" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78083</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IN YS               CL" publication="IN CHIM ACTA                 1" d1="27" d2="77 9" d3="3"/>
</CITATIONS>
<RECORDNUM>00864 </RECORDNUM>
<MEDLINENUM>78214700</MEDLINENUM>
<AUTHORS><AUTHOR>Schroder-C-P</AUTHOR><AUTHOR>Emrich-H-M</AUTHOR></AUTHORS>
<TITLE>Ultramicro-electrophoresis of protein in sweat from patients with
cystic fibrosis of the pancreas and controls.</TITLE>
<SOURCE>Eur-J-Pediatr. 1978 May 22. 128(1). P 49-56.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>PROTEINS: an</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BINDING-SITES</TOPIC><TOPIC>CELL-MEMBRANE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>ELECTROPHORESIS: mt</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>SALIVA</TOPIC><TOPIC>VISCOSITY</TOPIC></MINORSUBJ>
<ABSTRACT>46 sweat-samples from 32 children with cystic fibrosis of the
pancreas (C.F.) and 35 samples from 23 control-children were
collected with glass micro-capillaries. Protein was determined by
ultramicro-electrophoresis. Results: 1. Protein was detected in 48%
of the samples (C.F. and controls). 2. At pH 2.3, C.F.-sweat showed
at least one more band than control-sweat. 3. At pH 8.9, C.F.-sweat
occasionally showed one more band than the control-group. 4. At pH
2.3, more protein was found at the electrophoresis start point using
C.F.-sweat, whereas at pH 8.9 the opposite was found. 5. At pH 2.3,
protein was found in fewer samples than at pH 8.9. The "C.F.-factor"
is postulated to represent a basic polyelectrolyte which induces the
following pathogenic mechanisms: a) Aggregation of proteins giving
rise to a high viscosity of secretions, such as saliva. b) Binding to
the cell-membrane of the glandular epithelium, thus inducing a
disturbance of active NaCl-reabsorption (e.g. by reduction of luminal
passive Na+-influx).</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78084</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="002" author="BARNETT DR" publication="TEX REP BIOL MED" d1="31" d2="709" d3="973"/>
<CITE num="003" author="BOWMAN BH" publication="AM J HUM GENET" d1="25" d2="16A" d3="973"/>
<CITE num="004" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="250" d3="973"/>
<CITE num="005" author="EMRICH HM" publication="PFLUEGERS ARCH" d1="290" d2="298" d3="966"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="GROSSBACH U" publication="IN: GLICK D" d1="3" d2="" d3="975"/>
<CITE num="008" author="HEICK HMC" publication="CLIN RES" d1="21" d2="1037" d3="973"/>
<CITE num="009" author="JIRKA M" publication="NATURE" d1="199" d2="283" d3="963"/>
<CITE num="010" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
<CITE num="011" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="012" author="MCEVOY FA" publication="PEDIATR RES" d1="9" d2="721" d3="975"/>
<CITE num="013" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="014" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="015" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="016" author="MANGOS JA" publication="TEX REP BIOL MED" d1="31" d2="651" d3="973"/>
<CITE num="017" author="NIKOLAJEK WP" publication="EUR J PEDIATR" d1="122" d2="289" d3="976"/>
<CITE num="018" author="TAYLOR A" publication="PEDIATR RES" d1="8" d2="861" d3="974"/>
</REFERENCES>
<RECORDNUM>00865 </RECORDNUM>
<MEDLINENUM>78106794</MEDLINENUM>
<AUTHORS><AUTHOR>Gotz-M</AUTHOR><AUTHOR>Lubec-G</AUTHOR></AUTHORS>
<TITLE>Complement in cystic fibrosis.</TITLE>
<SOURCE>Eur-J-Pediatr. 1978 Jan 17. 127(2). P 133-9.</SOURCE>
<MAJORSUBJ><TOPIC>COMPLEMENT: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPLEMENT-3: an</TOPIC><TOPIC>COMPLEMENT-4: an</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA</TOPIC><TOPIC>SEX-FACTORS</TOPIC><TOPIC>SPUTUM: mi</TOPIC></MINORSUBJ>
<ABSTRACT>Complement components C3, C4, and C3A were estimated in 30 patients
with cystic fibrosis aged 1 to 21 years (M:F = 16:14) and were
compared with results in 40 healthy, age-matched subjects. The
influences of the clinical score, sputum microbiology, and the
patients' sex were also investigated. In contrast to most previous
communications, this paper shows that, compared to the control group,
a significant decrease of C3 (P less than 0.001) and C4 (P less than
0.02) was observed whereas C3A levels were not altered. There were no
increases in complement. Shwachman-scores above or below 70 did not
influence the complement levels, nor did exacerbations of the disease
change the levels. No influence of the patients' sex could be shown.
Pseudomonas aer. in the sputum was clearly associated with complement
defects (14/18). Alternative-pathway involvement of complement
activation could be demonstrated in 32%. The results make complement
activation due to pulmonary infection most likely. The defects
observed probably represent secondary changes.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALPER CA" publication="N ENGL J MED" d1="288" d2="601" d3="973"/>
<CITE num="002" author="ALPER CA" publication="IN: NETER E" d1="" d2="" d3="975"/>
<CITE num="003" author="BEDROSSIAN CWM" publication="HUM PATHOL" d1="7" d2="195" d3="976"/>
<CITE num="004" author="CHARLESWORTH JA" publication="J CLIN INVEST" d1="53" d2="1578" d3="974"/>
<CITE num="005" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="006" author="CONOVER JH" publication="LANCET" d1="1" d2="47" d3="975"/>
<CITE num="007" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="008" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="009" author="ESTERLY JR" publication="IN: MANGOS JA" d1="" d2="115" d3="976"/>
<CITE num="010" author="FEARON DT" publication="N ENGL J MED" d1="292" d2="937" d3="975"/>
<CITE num="011" author="FUST G" publication="CLIN IMMUNOL IMMUNOPATHOL" d1="5" d2="293" d3="976"/>
<CITE num="012" author="GIBBONS A" publication="BR MED J" d1="1" d2="120" d3="976"/>
<CITE num="013" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="014" author="GOETZ M" publication="PROC EWGCF 6TH ANNU MTG" d1="" d2="" d3="975"/>
<CITE num="015" author="HANN S" publication="LANCET" d1="2" d2="520" d3="974"/>
<CITE num="016" author="HANSSON LO" publication="LANCET" d1="2" d2="874" d3="975"/>
<CITE num="017" author="HARPER BL" publication="CF CLUB ABST" d1="17" d2="20" d3="976"/>
<CITE num="018" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="459" d3="975"/>
<CITE num="019" author="HOLZHAUER RJ" publication="CF CLUB ABST" d1="17" d2="22" d3="976"/>
<CITE num="020" author="JOHNSTON RB" publication="J PEDIATR" d1="90" d2="169" d3="977"/>
<CITE num="021" author="KAY AB" publication="LANCET" d1="2" d2="916" d3="974"/>
<CITE num="022" author="LEDERBERG S" publication="AM J HUM GENET" d1="28" d2="597" d3="976"/>
<CITE num="023" author="LEDERBERG S" publication="AM J HUM GENET" d1="28" d2="597" d3="976"/>
<CITE num="024" author="MCFARLANE H" publication="BR MED J" d1="1" d2="423" d3="975"/>
<CITE num="025" author="OSOFSKY SG" publication="J PEDIATR" d1="90" d2="180" d3="977"/>
<CITE num="026" author="PALMER DG" publication="AUST NZ J MED" d1="6" d2="349" d3="976"/>
<CITE num="027" author="POLMAR SH" publication="IN: KIRKPATRICK CH" d1="" d2="191" d3="976"/>
<CITE num="028" author="ROSSMAN CM" publication="J PEDIATR" d1="90" d2="579" d3="977"/>
<CITE num="028" author="ROY CC" publication="PEDIATR CLIN GASTROENTEROL" d1="" d2="" d3="975"/>
<CITE num="029" author="SCANLIN TF JR" publication="LANCET" d1="1" d2="1382" d3="974"/>
<CITE num="030" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="031" author="TAUSSIG LM" publication="CF CLUB ABST" d1="17" d2="21" d3="976"/>
<CITE num="032" author="WEEKE B" publication="DAN MED BULL" d1="23" d2="155" d3="976"/>
<CITE num="033" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="034" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78085</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HIOTZ PO            MO" publication="NOGR PAEDIATR" d1="10" d2="31 9" d3="9"/>
<CITE num="2" author="STRAUSS RG" publication="HELV PAEDIATR ACTA" d1="34" d2="429" d3="979"/>
<CITE num="3" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="4" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="5" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="6" author="FICK RB" publication="J CLIN INVEST" d1="68" d2="899" d3="981"/>
<CITE num="7" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="8" author="WISNIESKI JJ" publication="AM REV RESPIR DIS" d1="132" d2="770" d3="985"/>
<CITE num="9" author="FICK RB" publication="PEDIATR RES" d1="20" d2="1258" d3="986"/>
</CITATIONS>
<RECORDNUM>00866 </RECORDNUM>
<MEDLINENUM>78107013</MEDLINENUM>
<AUTHORS><AUTHOR>Watts-R-W</AUTHOR></AUTHORS>
<TITLE>Progress in screening for inborn errors of metabolism.</TITLE>
<SOURCE>Experientia. 1978 Feb 15. 34(2). P 143-52.</SOURCE>
<MAJORSUBJ><TOPIC>GENETIC-SCREENING</TOPIC><TOPIC>MASS-SCREENING</TOPIC><TOPIC>METABOLISM-INBORN-ERRORS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>LIPOIDOSIS: di</TOPIC><TOPIC>ANEMIA-SICKLE-CELL: di</TOPIC><TOPIC>CARBOXYLIC-ACIDS: ur</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>ENZYME-TESTS</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GALACTOSEMIA: di</TOPIC><TOPIC>GLYCOSIDES: bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPOTHYROIDISM: cn, di</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>JEWS</TOPIC><TOPIC>LYMPHOCYTES: me</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OLIGOSACCHARIDES: ur</TOPIC><TOPIC>PHENYLKETONURIA: di</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>THALASSEMIA: di</TOPIC></MINORSUBJ>
<ABSTRACT>The inborn errors of matabolism are a series of individually rare
biochemical anomalies some of which cause serious clinical
manifestations.  They are of great interest to biochemists and
geneticists, as well as to paediatricians and internist for whom
they often present special diagnostic and therapeutic problems.  The
study of the inborn errors of metabolism also has implications in
the fields of epidemiology and social medicine.  The number of known
inborn errors of metabolism has increased rapidly in recent years,
and others, as yet unidentified, presumably await recognition.  Only
a few of these conditions can be treated now, but the realisation
that early diagnosis is essential in order to achieve good results
has stimulated interest in the possibility of examining either whole
populations or selected predisposed groups of individuals for
biochemical differences which characterise particular inherited
metabolic diseases.  This article reviews some recent developments
with particular reference to the indications for such screening
programmes and progress in the identification of previously unknown
inborn errors of metabolism in otherwise homogeneous population
groups.  The inborn errors of metabolism are due to single gene
mutations.  Recognition of the asymptomatic individuals who are
heterozygous for the abnormal gene causing the disease may be
important clinically and the identification has to be considered as
one aspect of metabolic screening for the inborn errors of
metabolism.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WATTS RWE" publication="LANCET" d1="1" d2="368" d3="975"/>
<CITE num="002" author="PURKISS P" publication="PROC INT SYMP GLYCOCON 3RD" d1="" d2="19" d3="975"/>
<CITE num="005" author="BROWN E" publication="METABOLISM" d1="26" d2="1047" d3="977"/>
<CITE num="006" author="CHALMERS RA" publication="ANALYST" d1="97" d2="224" d3="972"/>
<CITE num="007" author="CHALMERS RA" publication="ANALYST" d1="97" d2="951" d3="972"/>
<CITE num="008" author="CHALMERS RA" publication="ANALYST" d1="97" d2="958" d3="972"/>
<CITE num="009" author="HEALY MJR" publication="J CHROMATOGR" d1="87" d2="365" d3="973"/>
<CITE num="010" author="LAWSON AM" publication="ADV MASS SPECTROMET" d1="6" d2="235" d3="974"/>
<CITE num="011" author="LAWSON AM" publication="BIOMED MASS SPECTROMET" d1="1" d2="199" d3="974"/>
<CITE num="012" author="CHALMERS RA" publication="CHEM BRIT" d1="11" d2="290" d3="975"/>
<CITE num="013" author="LEVY HL" publication="N ENGL J MED" d1="291" d2="1214" d3="974"/>
<CITE num="014" author="CLAYTON BE" publication="IN: RAINE DN" d1="1" d2="1" d3="974"/>
<CITE num="015" author="KOMROWER GM" publication="PEDIATRICS" d1="53" d2="182" d3="974"/>
<CITE num="016" author="SEEGMILLER JE" publication="IN: NATELSON S" d1="" d2="291" d3="974"/>
<CITE num="017" author="SCRIVER CR" publication="LANCET" d1="2" d2="230" d3="964"/>
<CITE num="018" author="SMITH DW" publication="PEDIATRICS" d1="19" d2="1011" d3="957"/>
<CITE num="019" author="MAN EB" publication="J PEDIATR" d1="63" d2="926" d3="963"/>
<CITE num="020" author="DUTAU G" publication="ANN PEDIATR (PARIS)" d1="22" d2="315" d3="975"/>
<CITE num="021" author="RAITI S" publication="ARCH DIS CHILD" d1="46" d2="692" d3="971"/>
<CITE num="022" author="KLEIN AH" publication="J PEDIATR" d1="81" d2="912" d3="972"/>
<CITE num="023" author="FISHER DA" publication="J PEDIATR" d1="89" d2="692" d3="976"/>
<CITE num="024" author="CHOPRA IJ" publication="N ENGL J MED" d1="293" d2="740" d3="975"/>
<CITE num="025" author="LAWSON D" publication="ARCH DIS CHILD" d1="44" d2="715" d3="969"/>
<CITE num="026" author="BRAY PT" publication="PERSPECTIVE OF SODIUM AND CHL" d1="" d2="" d3="975"/>
<CITE num="027" author="BRAY PT" publication="CLIN CHIM ACTA" d1="77" d2="69" d3="977"/>
<CITE num="028" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="029" author="RYLEY HC" publication="ARCH DIS CHILD" d1="49" d2="901" d3="974"/>
<CITE num="030" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="031" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="032" author="BOWMAN BH" publication="TEX REP BIOL MED" d1="31" d2="611" d3="973"/>
<CITE num="033" author="GLUECK CJ" publication="J LAB CLIN MED" d1="82" d2="467" d3="973"/>
<CITE num="034" author="KWITEROVICH PO JR" publication="LANCET" d1="1" d2="118" d3="973"/>
<CITE num="035" author="ADRIAENSSENS K" publication="PROTIDES BIOL FLUIDS" d1="19" d2="265" d3="971"/>
<CITE num="036" author="DARMADY J" publication="PROTIDES BIOL FLUIDS" d1="19" d2="26A" d3="971"/>
<CITE num="037" author="DARMADY JM" publication="BR MED J" d1="2" d2="685" d3="972"/>
<CITE num="038" author="OSE L" publication="LANCET" d1="2" d2="625" d3="975"/>
<CITE num="039" author="SAIFER A" publication="IN: NATELSON S" d1="" d2="353" d3="974"/>
<CITE num="040" author="KABACK MM" publication="PROG MED GENET" d1="10" d2="103" d3="974"/>
<CITE num="041" author="CHILDS B" publication="AM J HUM GENET" d1="28" d2="537" d3="976"/>
<CITE num="042" author="CHILDS B" publication="AM J HUM GENET" d1="28" d2="550" d3="976"/>
<CITE num="043" author="KABACK MM" publication="HUM HERED" d1="27" d2="186" d3="977"/>
<CITE num="044" author="PADEH B" publication="HUM HERED" d1="27" d2="200" d3="977"/>
<CITE num="045" author="EVANS PR" publication="IN: RAINE DN" d1="" d2="93" d3="977"/>
<CITE num="046" author="KAN YW" publication="LANCET" d1="1" d2="269" d3="977"/>
<CITE num="047" author="NATHAN DG" publication="BR J HAEMATOL SUPPL" d1="31" d2="143" d3="975"/>
<CITE num="048" author="CHALMERS RA" publication="ANN CLIN BIOCHEM" d1="14" d2="149" d3="977"/>
<CITE num="049" author="LAWSON AM" publication="CLIN CHEM" d1="22" d2="1283" d3="976"/>
<CITE num="050" author="CHALMERS RA" publication="CLIN CHEM" d1="22" d2="1288" d3="976"/>
<CITE num="051" author="CHALMERS RA" publication="CLIN CHEM" d1="22" d2="1292" d3="976"/>
<CITE num="052" author="ROBERTS GE" publication="BIOCHEM SOC SPEC PUBL" d1="1" d2="7" d3="973"/>
<CITE num="053" author="LA DU BN" publication="J BIOL CHEM" d1="230" d2="251" d3="958"/>
<CITE num="054" author="KAUFMAN S" publication="N ENGL J MED" d1="293" d2="785" d3="975"/>
<CITE num="055" author="BARTHOLOME K" publication="PEDIATR RES" d1="9" d2="899" d3="975"/>
<CITE num="056" author="WATTS RWE" publication="NATURE" d1="201" d2="396" d3="963"/>
<CITE num="057" author="POLLACK VE" publication="J LAB CLIN MED" d1="66" d2="564" d3="965"/>
<CITE num="058" author="LA DU BN" publication="BIOCHEM BIOPHYS RES COMMUN" d1="7" d2="398" d3="962"/>
<CITE num="059" author="RYMAN BE" publication="IN: WILKINSON JH" d1="" d2="" d3="976"/>
<CITE num="060" author="SCRIVER CR" publication="AMINO ACID METABOL DISORDERS" d1="" d2="" d3="973"/>
<CITE num="061" author="GIBBS DA" publication="ANN CLIN BIOCHEM" d1="14" d2="157" d3="977"/>
<CITE num="063" author="LYON MF" publication="AM J HUM GENET" d1="14" d2="135" d3="962"/>
<CITE num="064" author="WITKOP CJ JR" publication="AM J HUM GENET" d1="22" d2="55" d3="970"/>
<CITE num="065" author="GARTLER SM" publication="ANN HUM GENET" d1="33" d2="171" d3="969"/>
<CITE num="066" author="GARTLER SM" publication="SCIENCE" d1="172" d2="572" d3="971"/>
<CITE num="067" author="WATTS RWE" publication="IN: HOLTON J" d1="" d2="" d3="975"/>
<CITE num="068" author="SPENCE MW" publication="J MED GENET" d1="14" d2="91" d3="977"/>
<CITE num="070" author="RAINE DN" publication="J CLIN PATHOL SUPPL" d1="27" d2="8" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78086</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RKISS P             CL" publication="IN CHEM" d1="24" d2="69 9" d3="8"/>
<CITE num="2" author="LEHNERT W" publication="MONATSSCHR KINDERHEILKD" d1="127" d2="665" d3="979"/>
<CITE num="3" author="FARRIAUX JP" publication="ARCH FR PEDIATR" d1="37" d2="367" d3="980"/>
<CITE num="4" author="ISSAQ HJ" publication="J LIQUID CHROMATOGR" d1="4" d2="2233" d3="981"/>
<CITE num="5" author="BECKER K" publication="MONATSSCHR KINDERHEILKD" d1="129" d2="556" d3="981"/>
<CITE num="6" author="DHARESHWAR SS" publication="INDIAN J MED RES" d1="76" d2="716" d3="982"/>
</CITATIONS>
<RECORDNUM>00867 </RECORDNUM>
<MEDLINENUM>79046205</MEDLINENUM>
<AUTHORS><AUTHOR>Neutra-M-R</AUTHOR><AUTHOR>Trier-J-S</AUTHOR></AUTHORS>
<TITLE>Rectal mucosa in cystic fibrosis.  Morphological features before and
after short term organ culture.</TITLE>
<SOURCE>Gastroenterology. 1978 Oct. 75(4). P 701-10.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>INTESTINAL-MUCOSA: pa</TOPIC><TOPIC>RECTUM: pa</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AUTORADIOGRAPHY</TOPIC><TOPIC>BIOPSY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>EPITHELIUM: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>MUCUS: an</TOPIC><TOPIC>ORGAN-CULTURE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Histological changes observed in the large intestinal mucosa of
cystic fibrosis (CF) patients, including crypt enlargement as well as
intracellular and extracellular accumulation of mucus, have been
considered by some to be useful diagnostic signs of this disease. The
extent of these changes, however, has not been evaluated
quantitatively. In this study, quantitative stereological methods
were applied to biopsies of rectal mucosa from 5 CF patients, 5
sibling controls, and 2 normal adults, to measure goblet cell
numbers, crypt luminal volume, and volume of intracellular mucus. It
was found that CF crypt lumina were variably dilated, but that the
average relative volume of intracellular mucus and the numbers of
goblet cells in CF mucosae were comparable to those of sibling and
adult controls. In CF biopsies, however, surface columnar absorptive
cells consistently contained putative lipid droplets and rapidly
accumulated additional large lipid droplets during short term organ
culture. Lipid droplets were not observed in the same cell types of
control biopsies before or after short term organ culture.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="CHANGUS JE" publication="ARCH PATHOL LAB MED" d1="100" d2="7" d3="976"/>
<CITE num="004" author="NEUTRA MR" publication="LAB INVEST" d1="36" d2="535" d3="977"/>
<CITE num="005" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="006" author="DONNISON AB" publication="PEDIATRICS" d1="37" d2="833" d3="966"/>
<CITE num="007" author="EIDELMAN S" publication="CF CLUB ABST" d1="5" d2="" d3="964"/>
<CITE num="008" author="JABRO IH" publication="J LANCET" d1="86" d2="385" d3="966"/>
<CITE num="009" author="PARKINS RA" publication="LANCET" d1="2" d2="851" d3="963"/>
<CITE num="010" author="SHWACHMAN H" publication="N ENGL J MED" d1="286" d2="1300" d3="972"/>
<CITE num="011" author="HAGE E" publication="ACTA PATH MICROBIOL SCAND (A)" d1="80" d2="345" d3="972"/>
<CITE num="012" author="DALTON AJ" publication="ANAT REC" d1="121" d2="281" d3="955"/>
<CITE num="013" author="SHANTZ A" publication="STAIN TECHNOL" d1="40" d2="279" d3="965"/>
<CITE num="014" author="WEIBEL ER" publication="IN: HAYAT MA" d1="3" d2="239" d3="973"/>
<CITE num="015" author="BROWNING TH" publication="J CLIN INVEST" d1="48" d2="1423" d3="969"/>
<CITE num="016" author="EASTWOOD GL" publication="GASTROENTEROLOGY" d1="64" d2="375" d3="973"/>
<CITE num="017" author="JODL J" publication="ACTA PAEDIATR SCAND" d1="60" d2="367" d3="971"/>
<CITE num="018" author="GEAR EV JR" publication="GASTROENTEROLOGY" d1="55" d2="522" d3="968"/>
<CITE num="019" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="020" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="021" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="022" author="JOHANSEN PG" publication="LANCET" d1="1" d2="455" d3="968"/>
<CITE num="023" author="BENNETT G" publication="J CELL BIOL" d1="46" d2="409" d3="970"/>
<CITE num="024" author="FORSTNER GG" publication="J BIOL CHEM" d1="245" d2="3584" d3="970"/>
<CITE num="025" author="DOBBINS WO" publication="AM J CLIN NUTR" d1="22" d2="257" d3="969"/>
<CITE num="026" author="CARDELL RR" publication="J CELL BIOL" d1="34" d2="123" d3="967"/>
<CITE num="027" author="PALAY SL" publication="PROC INT SYMP LIPID TRANSPOR" d1="" d2="33" d3="964"/>
<CITE num="028" author="SABESIN SM" publication="LIPIDS" d1="10" d2="840" d3="975"/>
<CITE num="029" author="BINDER HJ" publication="PROC SOC EXP BIOL MED" d1="131" d2="1119" d3="969"/>
<CITE num="030" author="MELNICK CS" publication="GASTROENTEROLOGY" d1="52" d2="985" d3="967"/>
<CITE num="031" author="HOUCK JC" publication="PROC SOC EXP BIOL MED" d1="147" d2="167" d3="974"/>
<CITE num="032" author="KESSLER JI" publication="GASTROENTEROLOGY" d1="68" d2="1068" d3="975"/>
<CITE num="033" author="CLARK SB" publication="J LIPID RES" d1="14" d2="581" d3="973"/>
<CITE num="034" author="SNIPES R" publication="LAB INVEST" d1="18" d2="179" d3="968"/>
<CITE num="035" author="ODOHERTY PJA" publication="LIPIDS" d1="8" d2="249" d3="973"/>
<CITE num="036" author="GLICKMAN RM" publication="GASTROENTEROLOGY" d1="70" d2="347" d3="978"/>
<CITE num="037" author="JACOP JS" publication="J CELL BIOL" d1="70" d2="158A" d3="976"/>
<CITE num="038" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="039" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="040" author="BUTCHER FR" publication="IN: MANGOS JA" d1="" d2="243" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78087</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RK RW               GA" publication="STROENTEROLOGY" d1="81" d2="43 9" d3="1"/>
<CITE num="2" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="3" author="GOLDMAN H" publication="HUM PATHOL" d1="13" d2="981" d3="982"/>
<CITE num="4" author="HOWDLE PD" publication="CLIN SCI" d1="65" d2="105" d3="983"/>
<CITE num="5" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="6" author="BRADY RC" publication="EXP CELL RES" d1="150" d2="141" d3="984"/>
</CITATIONS>
<RECORDNUM>00868 </RECORDNUM>
<MEDLINENUM>78150401</MEDLINENUM>
<AUTHORS><AUTHOR>Pearson-R-D</AUTHOR><AUTHOR>Lubin-A-H</AUTHOR></AUTHORS>
<TITLE>A simple method for estimating a 'heparin binding capacity' of human
serum.</TITLE>
<SOURCE>Health-Lab-Sci. 1978 Jan. 15(1). P 32-7.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: me</TOPIC><TOPIC>HEPARIN: me</TOPIC><TOPIC>PROTEIN-BINDING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HEPARIN:  an, bl</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>MIDDLE-AGE</TOPIC></MINORSUBJ>
<ABSTRACT>A method for estimating a 'heparin binding capacity' of human serum
is described. When human serum is diluted with a low ionic strength,
heparin-containing buffer at pH 5.5, protein-heparin electrostatic
complexes form in solution with subsequent formation of insoluble
aggregates which can be collected by centrifugation. Quantitative
determination of the relative amounts by weight of protein and
heparin in the insoluble heparin-protein aggregates permits
estimation of a combining ratio at which serum proteins bind with
heparin to precipitate from solution. This weight combining ratio of
protein and heparin is a quantitative measure of the total affinity
for heparin of all proteins in serum which bind heparin at pH 5.57 to
form an insoluble complex. An unusually high affinity for heparin by
an abnormal serum protein or an increase in amount of a normally-
occuring, high heparin-affinity, serum protein would alter the
average protein: heparin combining ratio and increase the 'heparin-
binding capacity' of human serum. The converse would be true for
serum proteins having a low affinity for heparin, lowering the
'heparin-binding capacity' of human serum. The described method was
used to evaluate the 'heparin-binding capacity' of serum proteins in
normal individuals and in persons with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BITTER T" publication="ANAL BIOCHEM" d1="4" d2="330" d3="962"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="LANCET" d1="2" d2="765" d3="967"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="004" author="DISCHE Z" publication="J BIOL CHEM" d1="167" d2="189" d3="947"/>
<CITE num="005" author="DISCHE Z" publication="J BIOL CHEM" d1="175" d2="595" d3="948"/>
<CITE num="006" author="EHRLICH J" publication="J PHARM SCI" d1="62" d2="517" d3="973"/>
<CITE num="007" author="GOODMAN LS" publication="PHARMACOLOGIC BASIS OF THE TH" d1="" d2="1446" d3="970"/>
<CITE num="008" author="HOMAN JDH" publication="BIOCHIM BIOPHYS ACTA" d1="2" d2="333" d3="948"/>
<CITE num="009" author="JAKOVCIC S" publication="J PEDIATR" d1="62" d2="25" d3="963"/>
<CITE num="010" author="LASKER SE" publication="ARCH BIOCHEM BIOPHYS" d1="115" d2="360" d3="966"/>
<CITE num="011" author="LINDAHL U" publication="IN: BALAZS EA" d1="2" d2="943" d3="970"/>
<CITE num="012" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="013" author="MARCINIAK E" publication="J LAB CLIN MED" d1="84" d2="344" d3="974"/>
<CITE num="014" author="PEARSON RD" publication="CF CLUB ABST" d1="17" d2="" d3="976"/>
<CITE num="015" author="SLACK J" publication="J LAB CLIN MED" d1="59" d2="302" d3="962"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78088</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ARSON RD            PE" publication="DIATR RES" d1="13" d2="34 9" d3="9"/>
<CITE num="2" author="DUPOUY JP" publication="J PHYSIOL (PARIS)" d1="76" d2="631" d3="980"/>
<CITE num="3" author="VERPOORTE JA" publication="INT J BIOCHEM" d1="13" d2="1151" d3="981"/>
<CITE num="4" author="MARGOLIES R" publication="PEDIATR RES" d1="16" d2="181" d3="982"/>
<CITE num="5" author="MARGOLIES R" publication="PEDIATR RES" d1="17" d2="931" d3="983"/>
<CITE num="6" author="DUPOUY JP" publication="ANN ENDOCRINOL PARIS" d1="47" d2="429" d3="986"/>
</CITATIONS>
<RECORDNUM>00869 </RECORDNUM>
<MEDLINENUM>79109072</MEDLINENUM>
<AUTHORS><AUTHOR>Marchi-A-G</AUTHOR><AUTHOR>Marchi-M-A</AUTHOR><AUTHOR>Cigui-I</AUTHOR><AUTHOR>Uxa-F</AUTHOR><AUTHOR>Perticarari-S</AUTHOR><AUTHOR>Nordio-S</AUTHOR></AUTHORS>
<TITLE>Further studies on lymphocyte beta-glucuronidase abnormality in
cystic fibrosis.  Possible relations to carboxypeptidase B-like
activity.</TITLE>
<SOURCE>Helv-Paediatr-Acta. 1978 Dec. 33(6). P 517-25.</SOURCE>
<MAJORSUBJ><TOPIC>CARBOXYPEPTIDASES: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>GLUCURONIDASE: bl</TOPIC><TOPIC>LYMPHOCYTES: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LYMPHOCYTE-TRANSFORMATION</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHYTOHEMAGGLUTININS: pd</TOPIC></MINORSUBJ>
<ABSTRACT>The presence in the serum of both cystic fibrosis (CF) homozygotes
and heterozygotes of a factor inhibiting the response of lymphocyte
lysosome beta-glucuronidase activity to in vitro phytohaemagglutinin
(PHA) stimulation is confirmed. Studying lymphocyte beta-
glucuronidase activity on PHA stimulation represents a way to confirm
CF diagnosis and to screen CF heterozygotes. For technical
complexity, however, the method cannot be used for mass screening,
but it can be useful for confirming the diagnosis in suspected cases.
Relationships between serum factor inhibiting the effect of PHA on
beta-glucuronidase, ciliary dyskinesia factor and carboxypeptidase B-
like activity are discussed.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="002" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="003" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="224" d3="973"/>
<CITE num="004" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="006" author="ERDOS EG" publication="BIOCHEM PHARMACOL" d1="13" d2="893" d3="964"/>
<CITE num="007" author="FOLK JE" publication="J BIOL CHEM" d1="235" d2="2272" d3="960"/>
<CITE num="008" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="111" d2="100" d3="975"/>
<CITE num="009" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="116" d2="1047" d3="977"/>
<CITE num="010" author="MANGIAROTTI-MARCHI MA" publication="MINERVA PEDIATR" d1="23" d2="1847" d3="971"/>
<CITE num="011" author="MARCHI AG" publication="MINERVA PEDIATR" d1="23" d2="1842" d3="971"/>
<CITE num="012" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="013" author="MARCHI AG" publication="ACTA PAEDIATR BELG" d1="29" d2="67" d3="976"/>
<CITE num="014" author="NORDIO S" publication="ACTA PAEDIATR SCAND" d1="63" d2="664" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78089</PAPERNUM>
<CITATIONS>
<CITE num="1" author="KEL HP              BI" publication="OL ZENTRALBL                 1" d1="00" d2="73 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00870 </RECORDNUM>
<MEDLINENUM>79047858</MEDLINENUM>
<AUTHORS><AUTHOR>Schwarz-H-P</AUTHOR><AUTHOR>Kraemer-R</AUTHOR><AUTHOR>Thurnheer-U</AUTHOR><AUTHOR>Rossi-E</AUTHOR></AUTHORS>
<TITLE>Liver involvement in cystic fibrosis.  A report of 9 cases.</TITLE>
<SOURCE>Helv-Paediatr-Acta. 1978 Nov. 33(4-5). P 351-64.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>LIVER-DISEASES</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LIVER-CIRRHOSIS: pa</TOPIC><TOPIC>LIVER-CIRRHOSIS-BILIARY: pa</TOPIC><TOPIC>LIVER-DISEASES: pa</TOPIC><TOPIC>LIVER: pa</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>9 out of 204 unselected cystic fibrosis (CF) patients seen at the
Department of Pediatrics, University of Berne, Switzerland, over the
last 20 years had clinically overt liver disease. In 7 patients liver
cirrhosis was demonstrated (3.4%). Focal biliary cirrhosis was the
pertinent finding in 3 cases, whereas another 3 showed unspecific
nodular cirrhosis. One infant presented with prolonged obstructive
jaundice due to partial extrahepatic atresia and delayed passing of
meconium. Two other patients had steatosis. A review of the
literature dealing with clinical and laboratory findings in CF
patients with liver disease is given.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALHADEFF JA" publication="CLIN GENET" d1="10" d2="63" d3="976"/>
<CITE num="002" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="003" author="BERNSTEIN JG" publication="AM J DIS CHILD" d1="99" d2="804" d3="960"/>
<CITE num="004" author="BOAT TF" publication="CLIN PEDIATR" d1="13" d2="505" d3="974"/>
<CITE num="005" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="006" author="COOPER HS" publication="JOHNS HOPKINS MED J" d1="135" d2="268" d3="974"/>
<CITE num="007" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="009" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="010" author="DONATH A" publication="HELV PAEDIATR ACTA" d1="25" d2="634" d3="970"/>
<CITE num="011" author="DUBOIS RS" publication="GASTROENTEROLOGY" d1="72" d2="1052" d3="977"/>
<CITE num="012" author="EKLUND A" publication="IN: PAUMGARTNER G" d1="" d2="241" d3="977"/>
<CITE num="013" author="EXSS R" publication="DTSCH MED WSCHR" d1="97" d2="425" d3="972"/>
<CITE num="014" author="FEIGELSON J" publication="ACTA PAEDIATR SCAND" d1="59" d2="539" d3="970"/>
<CITE num="015" author="FEIGELSON J" publication="ACTA PAEDIATR SCAND" d1="61" d2="337" d3="972"/>
<CITE num="016" author="FEIGELSON J" publication="NOUV PRESSE MED" d1="1" d2="1899" d3="972"/>
<CITE num="017" author="FEIGELSON J" publication="ACTA PAEDIATR SCAND" d1="61" d2="337" d3="972"/>
<CITE num="018" author="GATZIMOS CD" publication="AM J DIS CHILD" d1="89" d2="182" d3="955"/>
<CITE num="019" author="GIEGLER I" publication="ANN ANAT PATHOL" d1="5" d2="115" d3="960"/>
<CITE num="020" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="021" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="813" d3="975"/>
<CITE num="022" author="ISENBERG JN" publication="GASTROENTEROLOGY" d1="66" d2="887" d3="974"/>
<CITE num="023" author="JEAN R" publication="ARCH FR PEDIATR" d1="27" d2="849" d3="970"/>
<CITE num="024" author="KATTWINKEL J" publication="J PEDIATR" d1="82" d2="234" d3="973"/>
<CITE num="025" author="KRAEMER R" publication="SCHWEIZ MED WOCHENSCHR" d1="107" d2="271" d3="977"/>
<CITE num="026" author="KRAEMER R" publication="HELV PAEDIATR ACTA" d1="32" d2="107" d3="977"/>
<CITE num="027" author="LITT IF" publication="PEDIATR CLIN NORTH AM" d1="20" d2="945" d3="973"/>
<CITE num="028" author="OPPENHEIMER EH" publication="LANCET" d1="2" d2="1031" d3="973"/>
<CITE num="029" author="OPPENHEIMER EH" publication="J PEDIATR" d1="86" d2="683" d3="975"/>
<CITE num="030" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="031" author="ROLLER RJ" publication="GASTROENTEROLOGY" d1="72" d2="661" d3="977"/>
<CITE num="032" author="ROSENSTEIN BJ" publication="J PEDIATR" d1="91" d2="1022" d3="977"/>
<CITE num="033" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="034" author="SCHWARZ HP" publication="CLIN CHIM ACTA" d1="50" d2="197" d3="974"/>
<CITE num="035" author="SHIER KJ" publication="CAN MED ASSOC J" d1="89" d2="645" d3="963"/>
<CITE num="036" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="037" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="038" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
<CITE num="039" author="SOLOWAY RD" publication="AM J DIG DIS" d1="16" d2="1082" d3="971"/>
<CITE num="040" author="STERN RC" publication="GASTROENTEROLOGY" d1="70" d2="645" d3="976"/>
<CITE num="041" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="042" author="STERN RC" publication="ANN INTERN MED" d1="87" d2="188" d3="977"/>
<CITE num="043" author="TALAMO RC" publication="AM J DIS CHILD" d1="115" d2="74" d3="968"/>
<CITE num="044" author="TANNER JM" publication="ARCH DIS CHILD" d1="41" d2="454" d3="966"/>
<CITE num="045" author="TAYLOR WF" publication="AM J DIS CHILD" d1="123" d2="161" d3="972"/>
<CITE num="046" author="VALMAN HB" publication="ARCH DIS CHILD" d1="46" d2="805" d3="971"/>
<CITE num="047" author="WARWICK WJ" publication="JAMA" d1="238" d2="2159" d3="977"/>
<CITE num="048" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="73" d2="1023" d3="977"/>
<CITE num="049" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="050" author="WEBER AM" publication="GUT" d1="17" d2="295" d3="976"/>
<CITE num="051" author="WILROY RS JR" publication="J PEDIATR" d1="68" d2="67" d3="966"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78090</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NNINGHAM DG         J" publication="COMPUT ASSIST TOMOGR" d1="4" d2="51 9" d3="0"/>
<CITE num="2" author="BALISTRERI WF" publication="J PEDIATR" d1="97" d2="689" d3="980"/>
<CITE num="3" author="MAGAZZU G" publication="RIV ITAL PEDIATR" d1="7" d2="73" d3="981"/>
<CITE num="4" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="5" author="MCCLURE HM" publication="ADV VET SCI COMP MED" d1="28" d2="267" d3="984"/>
<CITE num="6" author="BERNARD O" publication="CLIN GASTROENTEROL" d1="14" d2="33" d3="985"/>
<CITE num="7" author="FEIGELSON J" publication="ANN PEDIATR (PARIS)" d1="32" d2="218" d3="985"/>
<CITE num="8" author="SCHRODER R" publication="SCHWEIZ MED WOCHENSCHR" d1="115" d2="828" d3="985"/>
</CITATIONS>
<RECORDNUM>00871 </RECORDNUM>
<MEDLINENUM>78193578</MEDLINENUM>
<AUTHORS><AUTHOR>Warwick-W-J</AUTHOR></AUTHORS>
<TITLE>The incidence of cystic fibrosis in Caucasian populations.</TITLE>
<SOURCE>Helv-Paediatr-Acta. 1978 Jun. 33(2). P 117-25.</SOURCE>
<MAJORSUBJ><TOPIC>CAUCASOID-RACE</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>Estimates of the newborn frequency of cystic fibrosis in different
Caucasian groups range from 4 times more to 40 times less common than
the generally accepted figure of 1:2000. Current meconium screening
trials which may be effective in populations with the incidence equal
to or greater than 1:2000, may be useful for populations with an
incidence as low as 1:7000 only after maximum improvement of the
methods. Once the true incidence or the variable incidence is proven
for Caucasian populations, screening trails in Negro, Oriental and
Indian populations will be required.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANTONELLI M" publication="FRACASTORO (VERONA)" d1="63" d2="207" d3="970"/>
<CITE num="002" author="BECROFT DMO" publication="NZ MED J" d1="68" d2="113" d3="968"/>
<CITE num="003" author="BOCHKOVA DN" publication="PEDIATRIIA" d1="12" d2="24" d3="974"/>
<CITE num="004" author="BOZKOWA K" publication="PEDIATR POLSKA" d1="46" d2="677" d3="971"/>
<CITE num="005" author="BOZKOWA K" publication="PROC EWGCF 1ST ANNU MTG" d1="" d2="" d3="970"/>
<CITE num="006" author="BRUNECKY Z" publication="J MED GENET" d1="9" d2="33" d3="972"/>
<CITE num="007" author="BRUNECKY Z" publication="KINDERAERZTL PRAX" d1="38" d2="514" d3="970"/>
<CITE num="008" author="BRUNECKY Z" publication="CESK PEDIATR" d1="25" d2="74" d3="970"/>
<CITE num="009" author="CAIN ARR" publication="ARCH DIS CHILD" d1="47" d2="131" d3="972"/>
<CITE num="010" author="CARTER CO" publication="PHYSIOTHERAPY" d1="61" d2="240" d3="975"/>
<CITE num="011" author="CARTER CO" publication="MOD PROBL PEDIATR" d1="10" d2="372" d3="967"/>
<CITE num="012" author="CONNEALLY PM" publication="AMER SOC HUM GENET PROGRAM" d1="" d2="42" d3="966"/>
<CITE num="013" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="014" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="015" author="DIETZSCH HS" publication="PROC EWGCF 6TH ANNU MTG" d1="" d2="" d3="975"/>
<CITE num="016" author="FEINGOLD J" publication="CF Q ANNOTATED REFERENCES" d1="13" d2="15" d3="974"/>
<CITE num="017" author="FEINGOLD J" publication="ANN GENET (PARIS)" d1="17" d2="257" d3="974"/>
<CITE num="018" author="GALEN RS" publication="BEYOND NORMALITY THE PREDICTI" d1="" d2="" d3="975"/>
<CITE num="019" author="GILLY R" publication="ANN PEDIATR (PARIS)" d1="20" d2="5" d3="973"/>
<CITE num="020" author="GILLY R" publication="ARCH FR PEDIATR" d1="28" d2="49" d3="971"/>
<CITE num="021" author="GOTTSCHALK B" publication="PROC INT CF CONG 7TH" d1="" d2="38" d3="976"/>
<CITE num="022" author="GURSON CT" publication="HELV PAEDIATR ACTA" d1="28" d2="165" d3="973"/>
<CITE num="023" author="HALL BD" publication="J MED GENET" d1="5" d2="262" d3="968"/>
<CITE num="024" author="HALL BD" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="82" d3="969"/>
<CITE num="025" author="HANNA BL" publication="IN: US PUB HEAL SERV PUB1163" d1="" d2="7" d3="963"/>
<CITE num="026" author="HONEYMAN MS" publication="AM J HUM GENET" d1="17" d2="461" d3="965"/>
<CITE num="027" author="HONEYMAN MS" publication="CONN HLTH BULL" d1="75" d2="275" d3="961"/>
<CITE num="028" author="HOUSTEK J" publication="REV MED LIEGE" d1="22" d2="421" d3="967"/>
<CITE num="029" author="HOUSTEK J" publication="CESK PEDIATR" d1="17" d2="445" d3="962"/>
<CITE num="030" author="HOUSTEK J" publication="CAS LEK CES" d1="104" d2="201" d3="965"/>
<CITE num="031" author="KAISER D" publication="PROC INT CF CONG 7TH" d1="" d2="33" d3="976"/>
<CITE num="032" author="KOLLBERG H" publication="PROC EWGCF 1ST ANNU MTG" d1="" d2="" d3="970"/>
<CITE num="033" author="KOLLBERG H" publication="PROC INT CF CONG 7TH" d1="" d2="32" d3="976"/>
<CITE num="034" author="KRAMM ER" publication="AM J PUBLIC HEALTH" d1="52" d2="2041" d3="962"/>
<CITE num="035" author="KULCZYCKI LL" publication="AM J DIS CHILD" d1="100" d2="174" d3="960"/>
<CITE num="036" author="LEVIN S" publication="IN: GOLDSCHMIDT E" d1="" d2="294" d3="963"/>
<CITE num="037" author="MERRITT AD" publication="J LAB CLIN MED" d1="60" d2="998" d3="962"/>
<CITE num="038" author="MIGLIORI V" publication="MINERVA MED" d1="64" d2="4906" d3="973"/>
<CITE num="039" author="NEVANLINNA HR" publication="HEREDITAS" d1="71" d2="195" d3="972"/>
<CITE num="040" author="NIELSEN EL" publication="UGESKR LAEGER" d1="133" d2="1017" d3="971"/>
<CITE num="041" author="NIELSEN EL" publication="ACTA PAEDIATR SCAND" d1="61" d2="377" d3="972"/>
<CITE num="042" author="OREILLY D" publication="INT J EPIDEMIOL" d1="3" d2="247" d3="974"/>
<CITE num="043" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="044" author="PUGH RJ" publication="ARCH DIS CHILD" d1="42" d2="544" d3="967"/>
<CITE num="045" author="RACHINSKU SU" publication="PEDIATRIIA" d1="3" d2="60" d3="973"/>
<CITE num="046" author="REIDERMAN MI" publication="GENETIKA (SOV GENETICS)" d1="7" d2="148" d3="971"/>
<CITE num="047" author="RIGHETTI ABB" publication="PROC INT CF CONG 7TH" d1="" d2="36" d3="976"/>
<CITE num="048" author="ROBERTS GBS" publication="ANN HUM GENET" d1="24" d2="127" d3="960"/>
<CITE num="049" author="ROBINSON PG" publication="PROC INT CF CONG 7TH" d1="" d2="40" d3="976"/>
<CITE num="050" author="ROJO M" publication="PROC INT CF CONG 7TH" d1="" d2="36" d3="976"/>
<CITE num="051" author="SELANDER P" publication="ACTA PAEDIATR SCAND" d1="51" d2="65" d3="962"/>
<CITE num="052" author="SIMANKOVA N" publication="ANN GENET (PARIS)" d1="7" d2="84" d3="964"/>
<CITE num="053" author="STEINBERG AG" publication="IN: GOLDSCHMIDT E" d1="" d2="133" d3="963"/>
<CITE num="054" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="055" author="SULTZ HA" publication="AM J PUBLIC HEALTH" d1="56" d2="1461" d3="966"/>
<CITE num="056" author="SULTZ HA" publication="AM J PUBLIC HEALTH" d1="58" d2="491" d3="968"/>
<CITE num="057" author="SUPER M" publication="S AFR MED J" d1="49" d2="818" d3="975"/>
<CITE num="058" author="TEN KATE LP" publication="THESIS" d1="" d2="" d3="975"/>
<CITE num="059" author="TEN KATE LP" publication="INT J EPIDEMIOL" d1="6" d2="23" d3="977"/>
<CITE num="061" author="TODD RM" publication="MOD PROBL PEDIATR" d1="10" d2="387" d3="967"/>
<CITE num="062" author="TRIMBLE BK" publication="ANN HUM GENET" d1="38" d2="199" d3="974"/>
<CITE num="063" author="WRIGHT SW" publication="AM J HUM GENET" d1="20" d2="157" d3="968"/>
<CITE num="064" author="WRIGHT SW" publication="HAWAII MED J" d1="27" d2="229" d3="968"/>
<CITE num="065" author="ZYCHOWICZ C" publication="PEDIATR POLSKA" d1="40" d2="289" d3="965"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78091</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LAN JL              AU" publication="ST PAEDIATR J" d1="16" d2="70 9" d3="0"/>
<CITE num="2" author="JONES MB" publication="J CHRON DIS" d1="33" d2="697" d3="980"/>
<CITE num="3" author="ROMEO G" publication="RIV ITAL PEDIATR" d1="7" d2="201" d3="981"/>
<CITE num="4" author="WARWICK WJ" publication="MINN MED" d1="64" d2="553" d3="981"/>
<CITE num="5" author="KLINGER KW" publication="HUM GENET" d1="65" d2="94" d3="983"/>
<CITE num="6" author="MCCLURE HM" publication="ADV VET SCI COMP MED" d1="28" d2="267" d3="984"/>
<CITE num="7" author="KARJOO M" publication="J TROP PEDIATR" d1="30" d2="195" d3="984"/>
<CITE num="8" author="ALLAN JL" publication="ACTA PAEDIATR SCAND" d1="74" d2="286" d3="985"/>
<CITE num="9" author="KNOPFLE G" publication="KLIN PAEDIATR" d1="197" d2="481" d3="985"/>
<CITE num="10" author="KNOPFLE G" publication="KLIN PAEDIATR" d1="197" d2="13" d3="985"/>
<CITE num="11" author="GEDSCHOLD J" publication="HUM GENET" d1="75" d2="277" d3="987"/>
</CITATIONS>
<RECORDNUM>00872 </RECORDNUM>
<MEDLINENUM>78149805</MEDLINENUM>
<AUTHORS><AUTHOR>Seaman-W-B</AUTHOR></AUTHORS>
<TITLE>The case of the abnormal duodenum.</TITLE>
<SOURCE>Hosp-Pract. 1978 Mar. 13(3). P 80-1.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DUODENAL-DISEASES: ra</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DUODENAL-DISEASES: et</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<EXTRACT>Intermittent epigastric pain, partially relieved by food, was the
reason for examining the upper gastrointestinal tract in a
30-year-old man.  The second portion of the duodenum was strikingly
abnormal.  The patient had a history of daily, multiple loose stools
since birth.  At age 12 a diagnosis of small bowel malabsorption due
to fibrocystic disease of the pancreas was established.  In view of
this history, the duodenal changes were considered to be a
manifestation of fibrocystic disease of the pancreas.  At the present
time the cause of these duodenal abnormalities is unknown.</EXTRACT>
<REFERENCES>
<CITE num="001" author="TAUSSIG LM" publication="RADIOLOGY" d1="106" d2="369" d3="973"/>
<CITE num="002" author="BERK RN" publication="RADIOLOGY" d1="106" d2="377" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78092</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BOGUNJE OA          SU" publication="RGERY" d1="90" d2="14 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00873 </RECORDNUM>
<MEDLINENUM>78149840</MEDLINENUM>
<AUTHORS><AUTHOR>Hosli-P</AUTHOR><AUTHOR>Vogt-E</AUTHOR></AUTHORS>
<TITLE>Reliable detection of cystic fibrosis in skin-derived fibroblast
cultures.</TITLE>
<SOURCE>Hum-Genet. 1978 Mar 17. 41(2). P 169-73.</SOURCE>
<MAJORSUBJ><TOPIC>ALKALINE-PHOSPHATASE: bi</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>ENZYME-INDUCTION</TOPIC><TOPIC>GLYCOPROTEINS</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOPROTERENOL</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>PRENATAL-DIAGNOSIS</TOPIC><TOPIC>SKIN: cy</TOPIC><TOPIC>THEOPHYLLINE</TOPIC></MINORSUBJ>
<ABSTRACT>The specific induction of alkaline phosphatase with Tamm-Horsfall
glycoprotein, isoproterenol, and theophylline in skin-derived
fibroblast cultures from patients with cystic fibrosis permits one to
reliably discriminate between cystic fibrosis patients on the one
hand, and heterozygotes and normals on the other. It was found the
fibroblast-like and intermediary types of amniotic fluid-derived
cells behave essentially like skin-derived fibroblasts. These
findings imply that if different amniotic fluid cell types can be
reliably separated, prenatal diagnosis of cystic fibrosis should
become feasable in the near future.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOXER LA" publication="N ENGL J MED" d1="295" d2="1041" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="HOSLI P" publication="TISSUE CULTIVATION ON PLASTIC" d1="" d2="" d3="972"/>
<CITE num="004" author="HOSLI P" publication="IN: MOTULSKY AG" d1="" d2="226" d3="974"/>
<CITE num="005" author="HOSLI P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="73" d2="209" d3="976"/>
<CITE num="006" author="HOSLI P" publication="ADV EXP MED BIOL" d1="68" d2="1" d3="976"/>
<CITE num="007" author="HOSLI P" publication="CLIN CHEM" d1="23" d2="1476" d3="977"/>
<CITE num="008" author="HOSLI P" publication="HUM HERED" d1="27" d2="185" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78093</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SLI P               AC" publication="TA PAEDIATR SCAND" d1="67" d2="17 9" d3="8"/>
<CITE num="2" author="HOSLI P" publication="MONOGR PAEDIATR" d1="10" d2="90" d3="979"/>
<CITE num="3" author="HARRIS A" publication="DEVELOP MED CHILD NEUROL" d1="21" d2="675" d3="979"/>
<CITE num="4" author="CAREY WF" publication="AUST J EXP BIOL MED SCI" d1="57" d2="225" d3="979"/>
<CITE num="5" author="JAKEL HP" publication="BIOL ZENTRALBL" d1="98" d2="55" d3="979"/>
<CITE num="6" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="7" author="AITKEN DA" publication="J MED GENET" d1="17" d2="187" d3="980"/>
<CITE num="8" author="FASTH A" publication="ACTA PAEDIATR SCAND" d1="69" d2="189" d3="980"/>
<CITE num="9" author="STRATTON CJ" publication="J CLIN CHEM CLIN BIOCHEM" d1="19" d2="852" d3="981"/>
<CITE num="10" author="HARRIS A" publication="CLIN GENET" d1="20" d2="315" d3="981"/>
<CITE num="11" author="JAKEL HP" publication="BIOL ZENTRALBL" d1="100" d2="273" d3="981"/>
<CITE num="12" author="HOSLI P" publication="EUR J PEDIATR" d1="137" d2="116" d3="981"/>
<CITE num="13" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="14" author="LEGGE M" publication="CHIN MED J" d1="97" d2="671" d3="984"/>
<CITE num="15" author="AITKEN DA" publication="PRENAT DIAGN" d1="5" d2="119" d3="985"/>
<CITE num="16" author="PINO JA" publication="ANAL CHEM" d1="57" d2="295" d3="985"/>
</CITATIONS>
<RECORDNUM>00874 </RECORDNUM>
<MEDLINENUM>78192839</MEDLINENUM>
<AUTHORS><AUTHOR>Schiotz-P-O</AUTHOR><AUTHOR>Hoiby-N</AUTHOR><AUTHOR>Morling-N</AUTHOR><AUTHOR>Sorensen-H</AUTHOR></AUTHORS>
<TITLE>C3 polymorphism in a Danish cystic fibrosis population and its
possible association with antibody response.</TITLE>
<SOURCE>Hum-Hered. 1978. 28(4). P 293-300.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-BACTERIAL</TOPIC><TOPIC>COMPLEMENT-3: ge</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>POLYMORPHISM-GENETICS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBODIES-BACTERIAL: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>DENMARK</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENE-FREQUENCY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PHENOTYPE</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: im</TOPIC></MINORSUBJ>
<ABSTRACT>The C3 types of human serum are reported for a material of 113 Danish
cystic fibrosis patients, age 0-30 years. The frequency of the C3F
gene was 0.2832 which was significantly higher (p less than 0.0005)
than the frequency found in a control group of 224 healthy babies
(C3F = 0.1585). It also differed significantly (p less than 0.01)
from the C3F gene frequency of 0.1780 found in 177 blood donors, age
20-24 years. A significant association between any of the C3
phenotypes and the most serious infection in cystic fibrosis, chronic
mucoid P. aeruginosa infection, or the antibody response against
these bacteria was not found.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRONNESTAM R" publication="HUM HERED" d1="23" d2="206" d3="973"/>
<CITE num="002" author="BRONNESTAM R" publication="HUM HERED" d1="23" d2="214" d3="973"/>
<CITE num="003" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="004" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="" d3="962"/>
<CITE num="005" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="006" author="DOGGETT RG" publication="INFECT IMMUN" d1="6" d2="628" d3="972"/>
<CITE num="007" author="FARHUD DD" publication="HUMANGENETIK" d1="17" d2="57" d3="972"/>
<CITE num="008" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="009" author="HOFF GE" publication="SCAND J INFECT DIS" d1="6" d2="333" d3="974"/>
<CITE num="010" author="HOLZHAUER RJ" publication="AM J HUM GENET" d1="28" d2="602" d3="976"/>
<CITE num="011" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="81" d2="298" d3="973"/>
<CITE num="012" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="541" d3="974"/>
<CITE num="013" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="014" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="83" d2="549" d3="975"/>
<CITE num="015" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="58" d2="65" d3="977"/>
<CITE num="016" author="LEDERBERG S" publication="AM J HUM GENET" d1="28" d2="597" d3="976"/>
<CITE num="017" author="SHWACHMAN H" publication="CLIN PEDIATR" d1="14" d2="1115" d3="975"/>
<CITE num="018" author="SORENSEN H" publication="HUM HERED" d1="25" d2="279" d3="975"/>
<CITE num="019" author="SORENSEN H" publication="HUM HERED" d1="25" d2="284" d3="975"/>
<CITE num="020" author="TEISBERG P" publication="VOX SANG" d1="19" d2="47" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78094</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ACCHI R             HU" publication="M HERED" d1="31" d2="83 9" d3="1"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
<CITE num="3" author="BERNAL JE" publication="HUM HERED" d1="36" d2="97" d3="986"/>
<CITE num="4" author="SCHUR PH" publication="ANNU REV MED" d1="37" d2="333" d3="986"/>
</CITATIONS>
<RECORDNUM>00875 </RECORDNUM>
<MEDLINENUM>79217453</MEDLINENUM>
<AUTHORS><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Cheng-P</AUTHOR></AUTHORS>
<TITLE>Mucous glycoproteins in cystic fibrosis.  pp.  108-21.</TITLE>
<SOURCE>In: Walborg EF, ed. Glycoproteins and glycolipids in disease
processes. Washington, American Chemical Society, 1978. QU 55 S9801g
1978. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>GLYCOPROTEINS: me</TOPIC><TOPIC>MUCUS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CARBOHYDRATES: an</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MONOGRAPH</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>SULFURIC-ACIDS: me</TOPIC><TOPIC>TRACHEA: me</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis, the most common lethal genetic trait of Caucasians,
causes much of the chronic progressive lung disease in children and
young adults.  It is also responsible for intestinal obstruction at
birth (meconium ileus), pancreatic insufficiency with maldigestion
and failure to grow, and obstructive liver disease in this age group.
Furthermore, obliteration of the vas deferens causes aspermia and
infertility in most males with CF.  Individuals with CF secrete sweat
which contains excessive amounts of chloride and sodium.  Diagnostic
criteria include detection of elevated chloride levels in sweat of
individuals with typical pulmonary, gastrointestinal, or genital
manifestations of the disease.  There are several, well documented
alterations in the mucous secretions of individuals with cystic
fibrosis, any of which alone or in combination, may interfere with
mucous clearance from the lung or from passageways of other organs.
It seems clear that additional studies to define basic aspects of
normal mucous biochemistry, physiology and pharmacology must precede
or parallel studies of CF mucous secretions if data pertinent to CF
pathophysiology are to be generated.  Particular needs include an
understanding of the chemical determinants of physical and
rheological properties of these secretions, and elucidation of
mechanisms for control of sulfated glycoprotein biosynthesis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="MAYO BJ" publication="TEX REP BIOL MED" d1="34" d2="107" d3="976"/>
<CITE num="004" author="CONOD EJ" publication="PEDIATR RES" d1="11" d2="45" d3="977"/>
<CITE num="005" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="006" author="DEARBORN DG" publication="IN: MORRIS D" d1="" d2="273" d3="978"/>
<CITE num="007" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="008" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="009" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="010" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
<CITE num="011" author="DAVIS SS" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="47" d3="973"/>
<CITE num="012" author="POTTER JL" publication="AM REV RESPIR DIS" d1="99" d2="909" d3="969"/>
<CITE num="013" author="KHAN MA" publication="BIOCHIM BIOPHYS ACTA" d1="444" d2="369" d3="976"/>
<CITE num="014" author="REID L" publication="MOD PROBL PEDIATR" d1="10" d2="195" d3="967"/>
<CITE num="015" author="ZUELZER WW" publication="PEDIATRICS" d1="4" d2="53" d3="949"/>
<CITE num="016" author="REID L" publication="IN: PORTER R" d1="32" d2="45" d3="968"/>
<CITE num="017" author="OPPENHEIMER EH" publication="ARCH PATHOL" d1="96" d2="149" d3="973"/>
<CITE num="018" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="019" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="020" author="CZEGLEDY-NAGY E" publication="LAB INVEST" d1="35" d2="588" d3="976"/>
<CITE num="021" author="BOAT TF" publication="AM REV RESPIR DIS" d1="110" d2="428" d3="974"/>
<CITE num="022" author="BAKER AP" publication="GAP CONF REP" d1="" d2="" d3="976"/>
<CITE num="023" author="BOAT TF" publication="MOD PROBL PEDIATR" d1="19" d2="141" d3="977"/>
<CITE num="024" author="BAKER AP" publication="AM REV RESPIR DIS" d1="115" d2="811" d3="977"/>
<CITE num="025" author="BAKER AP" publication="ARCH BIOCHEM BIOPHYS" d1="165" d2="597" d3="974"/>
<CITE num="026" author="BOAT TF" publication="IN: MANGOS JA" d1="" d2="165" d3="976"/>
<CITE num="027" author="NEUTRA MR" publication="LAB INVEST" d1="36" d2="535" d3="977"/>
<CITE num="028" author="STURGESS JM" publication="CLIN SCI" d1="43" d2="533" d3="972"/>
<CITE num="029" author="DEARBORN DG" publication="IN: MANGOS JA" d1="" d2="179" d3="976"/>
<CITE num="030" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="031" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="032" author="GUGLER EC" publication="J PEDIATR" d1="71" d2="585" d3="967"/>
<CITE num="033" author="BOAT TF" publication="PEDIATR RES" d1="8" d2="531" d3="974"/>
<CITE num="034" author="BAILLEUL V" publication="CLIN CHIM ACTA" d1="74" d2="115" d3="977"/>
<CITE num="035" author="DEGAND P" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="199" d3="973"/>
<CITE num="036" author="ROBERTS GP" publication="ARCH BIOCHEM BIOPHYS" d1="173" d2="528" d3="976"/>
<CITE num="037" author="SHIH CK" publication="AM REV RESPIR DIS" d1="115" d2="989" d3="977"/>
<CITE num="038" author="SNARY D" publication="BIOCHEM BIOPHYS RES COMMUN" d1="40" d2="844" d3="970"/>
<CITE num="039" author="HILL HD" publication="J BIOL CHEM" d1="252" d2="3791" d3="977"/>
<CITE num="040" author="BOAT TF" publication="ARCH BIOCHEM BIOPHYS" d1="177" d2="95" d3="976"/>
<CITE num="041" author="ROUSSEL P" publication="J BIOL CHEM" d1="250" d2="2114" d3="975"/>
<CITE num="042" author="CHENG PW" publication="FED PROC" d1="35" d2="1444" d3="976"/>
<CITE num="043" author="LOPEZ-VIDRIERO MT" publication="IN: BRAIN JD" d1="" d2="289" d3="977"/>
<CITE num="044" author="GOTTSCHALK A" publication="BIOCHIM BIOPHYS ACTA" d1="46" d2="91" d3="961"/>
<CITE num="045" author="MEYER FA" publication="BIOCHIM BIOPHYS ACTA" d1="392" d2="223" d3="975"/>
<CITE num="046" author="DEMAN J" publication="BIOCHIM BIOPHYS ACTA" d1="297" d2="486" d3="973"/>
<CITE num="048" author="LAMBLIN G" publication="BULL EUR PHYSIOPATH RESP" d1="13" d2="175" d3="977"/>
<CITE num="050" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="051" author="ABLETT S" publication="IN: RESING H" d1="" d2="344" d3="976"/>
<CITE num="052" author="JEFFERY PK" publication="IN: BRAIN JD" d1="5" d2="193" d3="977"/>
<CITE num="053" author="BOAT TF" publication="IN: MANGOS JA" d1="" d2="165" d3="976"/>
<CITE num="055" author="CHENG PW" publication="ANAL BIOCHEM" d1="85" d2="276" d3="978"/>
<CITE num="056" author="BOAT TF" publication="CHEST" d1="67" d2="325" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78095</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RIARTY CM           J" publication="MED" d1="13" d2="57 9" d3="2"/>
<CITE num="2" author="LITIN BS" publication="BIOL NEONATE" d1="42" d2="228" d3="982"/>
<CITE num="3" author="BENYOSEPH Y" publication="BIOCHIM BIOPHYS ACTA" d1="718" d2="172" d3="982"/>
<CITE num="4" author="SLOMIANY A" publication="J BIOL CHEM" d1="258" d2="8535" d3="983"/>
<CITE num="5" author="RUDICK VL" publication="J CELL PHYSIOL" d1="118" d2="67" d3="984"/>
</CITATIONS>
<RECORDNUM>00876 </RECORDNUM>
<MEDLINENUM>78241012</MEDLINENUM>
<AUTHORS><AUTHOR>Sahu-S</AUTHOR><AUTHOR>Lynn-W-S</AUTHOR></AUTHORS>
<TITLE>Lipid composition of sputum from patients with asthma and patients
with cystic fibrosis.</TITLE>
<SOURCE>Inflammation. 1978 Mar. 3(1). P 27-36.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>LIPIDS: an</TOPIC><TOPIC>SPUTUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FATTY-ACIDS: an</TOPIC><TOPIC>GLYCOLIPIDS: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PHOSPHOLIPIDS: an</TOPIC><TOPIC>PULMONARY-SURFACTANT: an</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Lipids from the sputum of patients with asthma and with cystic
fibrosis were isolated and characterized. In both cases, lipids
constituted approximately 30% of the dry material.
Phosphatidlycholine was the most abundant lipid, Significant amounts
of phosphatidylethanolamine and phosphatidylglycerol were present.
Hexosyl ceramides, sphingomyelin, phosphatidylinositol,
lysophosphatidylcholine, and lysophosphatidylethanolamine were
present as minor lipid components. Apperciable quantities of neutral
lipids were present, of which triglycerides and cholesterol were the
main constituents. Phosphatidylcholine, sphingomyelin, and
phosphatidylgycerol were highly saturated. Large amounts of
phosphatidylcholine containing mostly palmitic acid, particularly in
the asthmatic sputum, suggest htat this highly saturated. Large
amounts of phosphatidylcholine containing mostly palmitic acid,
particularly in the asthmatic sputum, suggests that this highly
saturated phospholipid is synthesized in the upper airways for
reasons other than its beneficial surface-active properties in the
alveoli.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CHERNICK WS" publication="PEDIATRICS" d1="24" d2="739" d3="959"/>
<CITE num="002" author="MATTHEWS LW" publication="AM REV RESPIR DIS" d1="88" d2="199" d3="963"/>
<CITE num="003" author="RAMIREZ RJ" publication="AM J MED" d1="45" d2="502" d3="968"/>
<CITE num="004" author="LEWIS RW" publication="LIPIDS" d1="6" d2="859" d3="971"/>
<CITE num="005" author="SAHU S" publication="AM REV RESPIR DIS" d1="114" d2="177" d3="976"/>
<CITE num="006" author="SAHU S" publication="AM REV RESPIR DIS" d1="115" d2="233" d3="977"/>
<CITE num="007" author="GALLAI-HATCHARD JJ" publication="BIOCHIM BIOPHYS ACTA" d1="116" d2="532" d3="966"/>
<CITE num="008" author="ADAMS EP" publication="CHEM PHYS LIPIDS" d1="1" d2="368" d3="967"/>
<CITE num="009" author="FOLCH J" publication="J BIOL CHEM" d1="226" d2="497" d3="957"/>
<CITE num="010" author="ROUSER G" publication="IN: MARINETTI GV" d1="1" d2="99" d3="967"/>
<CITE num="011" author="ESSELMAN WJ" publication="METHODS ENZYMOL" d1="28" d2="140" d3="972"/>
<CITE num="012" author="VIOQUE E" publication="J AM OIL CHEM SOC" d1="39" d2="63" d3="962"/>
<CITE num="013" author="SKIPSKI VP" publication="METHODS ENZYMOL" d1="14" d2="530" d3="969"/>
<CITE num="014" author="DITMER JC" publication="METHODS ENZYMOL" d1="14" d2="482" d3="969"/>
<CITE num="015" author="ROONEY SA" publication="J LIPID RES" d1="16" d2="418" d3="975"/>
<CITE num="016" author="TARLOV AR" publication="J BIOL CHEM" d1="240" d2="49" d3="965"/>
<CITE num="017" author="BARTLETT GR" publication="J BIOL CHEM" d1="234" d2="466" d3="959"/>
<CITE num="018" author="FARKAS J" publication="J LIPID RES" d1="14" d2="344" d3="973"/>
<CITE num="019" author="VANHANDEL E" publication="J LAB CLIN MED" d1="50" d2="152" d3="957"/>
<CITE num="020" author="RUDEL LL" publication="J LIPID RES" d1="14" d2="364" d3="973"/>
<CITE num="021" author="LAUTER CJ" publication="J LIPID RES" d1="3" d2="136" d3="962"/>
<CITE num="022" author="TAO RVP" publication="J LIPID RES" d1="14" d2="16" d3="973"/>
<CITE num="023" author="BAXTER CF" publication="LIPIDS" d1="4" d2="243" d3="969"/>
<CITE num="024" author="HEPPLESTON AG" publication="BR J EXP PATHOL" d1="55" d2="384" d3="974"/>
<CITE num="025" author="BODY DR" publication="LIPIDS" d1="6" d2="625" d3="971"/>
<CITE num="026" author="HURST DJ" publication="RESPIR PHYSIOL" d1="17" d2="72" d3="973"/>
<CITE num="027" author="ROONEY SA" publication="BIOCHIM BIOPHYS ACTA" d1="360" d2="56" d3="974"/>
<CITE num="028" author="GRAY GM" publication="BIOCHIM BIOPHYS ACTA" d1="144" d2="519" d3="967"/>
<CITE num="029" author="HENDERSON RF" publication="LIPIDS" d1="7" d2="492" d3="972"/>
<CITE num="030" author="KING RJ" publication="AM J PHYSIOL" d1="224" d2="788" d3="973"/>
<CITE num="031" author="GODINEZ RI" publication="BIOCHEMISTRY" d1="14" d2="830" d3="975"/>
<CITE num="032" author="HALLMAN M" publication="J LIPID RES" d1="17" d2="257" d3="976"/>
<CITE num="033" author="KLAUS MH" publication="PROC NAT ACAD SCI USA" d1="47" d2="1858" d3="961"/>
<CITE num="034" author="CLEMENTS JA" publication="SCIENCE" d1="169" d2="603" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78096</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LABERT C            CL" publication="IN RESP PHYSIOL" d1="17" d2="97 9" d3="1"/>
<CITE num="2" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="3" author="SLAYTER HS" publication="EUR J BIOCHEM" d1="142" d2="209" d3="984"/>
</CITATIONS>
<RECORDNUM>00877 </RECORDNUM>
<MEDLINENUM>79129714</MEDLINENUM>
<AUTHORS><AUTHOR>Ten-Kate-L-P</AUTHOR><AUTHOR>Feenstra-de-Gooyer-I</AUTHOR><AUTHOR>Ploeg-de-Groot-G</AUTHOR><AUTHOR>Gouw-W-L</AUTHOR><AUTHOR>Anders-G-J</AUTHOR></AUTHORS>
<TITLE>Should we screen all newborns for cystic fibrosis?.</TITLE>
<SOURCE>Int-J-Epidemiol. 1978 Dec. 7(4). P 323-30.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>MASS-SCREENING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALBUMINS: an</TOPIC><TOPIC>ATTITUDE-OF-HEALTH-PERSONNEL</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MECONIUM: an</TOPIC><TOPIC>NETHERLANDS</TOPIC><TOPIC>PEDIATRICS</TOPIC><TOPIC>QUESTIONNAIRES</TOPIC></MINORSUBJ>
<ABSTRACT>To assess the value of detecting albumin in meconium as a screening
procedure for cystic fibrosis [CF] 68,000 meconium samples were
examined by BM Meconium Test, single radial immunodiffusion and
benzidine reaction. The specificity and sensitivity of this
combination of tests were 99.67% and 78.57% respectively. The
prevalence of CF at birth was confirmed as 1:3600 in this country.
This low prevalence resulted in a relatively high number of false
positives. Therefore, a positive test result has a low predictive
value [3.39%] and this is a serious drawback of the method. The
experiences and opinions of 37 local paediatricians about the
screening programme were evaluated by a simple questionnaire. Gold's
decision rule was applied. The least relative cost of
misclassification justifying a mass-screening programme was 3 times
higher than the actual relative cost as suggested by the aggregate
opinion of paediatricians in the region. These results support the
view that with the methods used screening may have more disadvantages
than not screening.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="TEN KATE LP" publication="INT J EPIDEMIOL" d1="6" d2="23" d3="977"/>
<CITE num="002" author="BRIMBLECOMBE FSW" publication="LANCET" d1="2" d2="1428" d3="973"/>
<CITE num="003" author="GOLD RJM" publication="ANN HUM GENET" d1="37" d2="315" d3="974"/>
<CITE num="004" author="STEPHAN U" publication="PADIATRISCHE PRAXIS" d1="12" d2="487" d3="973"/>
<CITE num="005" author="BULL FE" publication="ARCH DIS CHILD" d1="49" d2="602" d3="974"/>
<CITE num="006" author="HELLSING K" publication="SCAND J CLIN LAB INVEST" d1="33" d2="333" d3="974"/>
<CITE num="007" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="008" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="64" d2="477" d3="975"/>
<CITE num="009" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="010" author="GALEN RS" publication="BEYOND NORMALITY THE PREDICTI" d1="" d2="" d3="975"/>
<CITE num="011" author="TINSCHMANN P" publication="PROC EWGCF 5TH ANNU MTG" d1="" d2="" d3="974"/>
<CITE num="012" author="GRIFFITHS AD" publication="ARCH DIS CHILD" d1="51" d2="321" d3="976"/>
<CITE num="013" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="014" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="015" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="016" author="ORENSTEIN DM" publication="AM J DIS CHILD" d1="131" d2="973" d3="977"/>
<CITE num="017" author="RYLEY HC" publication="CLIN CHIM ACTA" d1="64" d2="117" d3="975"/>
<CITE num="018" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
<CITE num="019" author="ANTONOWICZ I" publication="LANCET" d1="1" d2="746" d3="976"/>
<CITE num="020" author="CROSSLEY JR" publication="LANCET" d1="2" d2="1093" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78097</PAPERNUM>
<CITATIONS>
<CITE num="1" author="DERS GJPA           J" publication="GENET HUM" d1="29" d2="23 9" d3="1"/>
<CITE num="2" author="SZIBOR R" publication="Z KLIN MED" d1="40" d2="313" d3="985"/>
<CITE num="3" author="DANKERTROELSE JE" publication="LANCET" d1="1" d2="326" d3="986"/>
<CITE num="4" author="DANKERTROELSE JE" publication="ACTA PAEDIATR SCAND" d1="76" d2="209" d3="987"/>
</CITATIONS>
<RECORDNUM>00878 </RECORDNUM>
<MEDLINENUM>79108929</MEDLINENUM>
<AUTHORS><AUTHOR>Ekvall-S</AUTHOR><AUTHOR>Mitchell-A</AUTHOR></AUTHORS>
<TITLE>The effect of supplemental vitamin E on vitamin A serum levels in
cystic fibrosis.</TITLE>
<SOURCE>Int-J-Vitam-Nutr-Res. 1978. 48(4). P 324-32.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>VITAMIN-A: bl</TOPIC><TOPIC>VITAMIN-E: tu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CREATINE: ur</TOPIC><TOPIC>CREATININE: ur</TOPIC><TOPIC>CYSTIC-FIBROSIS: me, ur</TOPIC><TOPIC>DRUG-THERAPY-COMBINATION</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>VITAMIN-A: tu</TOPIC><TOPIC>VITAMIN-E: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Effects of the ingestion of vitamin E with vitamin A on the serum
levels of these vitamins and the urinary creatine to creatinine
ratios of 18 children with cystic fibrosis disease of the pancreas
(CF) was studied. After the daily ingestion for two months of a
specially prepared capsule containing 5000 IU vitamin A palmitate and
100 mg d alpha-tocopherol acetate in aqueous dispersible form there
was a significant increase in vitamin A as well as vitamin E levels
of serum taken 3 1/2 hr postprandially. Creatine to creatinine ratios
in single voiding of urine decreased.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAKER H" publication="AM J CLIN NUTR" d1="20" d2="850" d3="967"/>
<CITE num="002" author="BAUERNFEIND JC" publication="AM J CLIN NUTR" d1="27" d2="234" d3="974"/>
<CITE num="003" author="BIERI JG" publication="PROC SOC EXP BIOL MED" d1="117" d2="131" d3="964"/>
<CITE num="004" author="BLANC WA" publication="PEDIATRICS" d1="22" d2="494" d3="958"/>
<CITE num="005" author="BONSNES RW" publication="J BIOL CHEM" d1="158" d2="581" d3="945"/>
<CITE num="006" author="CLARK LC JR" publication="AM J DIS CHILD" d1="81" d2="774" d3="951"/>
<CITE num="007" author="DAVIES AW" publication="NATURE" d1="147" d2="794" d3="941"/>
<CITE num="008" author="GOLDBLOOM RB" publication="PEDIATRICS" d1="32" d2="36" d3="963"/>
<CITE num="009" author="GORDON HH" publication="PEDIATRICS" d1="21" d2="673" d3="958"/>
<CITE num="010" author="GREEN J" publication="NUTR ABSTR REV" d1="38" d2="321" d3="969"/>
<CITE num="011" author="KATZ LN" publication="EXPERIMENTAL ATHEROSCLEROSIS" d1="" d2="" d3="953"/>
<CITE num="012" author="KERNER I" publication="AM J DIS CHILD" d1="99" d2="597" d3="960"/>
<CITE num="013" author="LEWIS JS" publication="AM J CLIN NUTR" d1="26" d2="136" d3="973"/>
<CITE num="014" author="MAJAJ AS" publication="AM J CLIN NUTR" d1="12" d2="374" d3="963"/>
<CITE num="015" author="MEDWADOWSKI B" publication="THESIS" d1="" d2="" d3="964"/>
<CITE num="016" author="NEELD JB" publication="J NUTR" d1="79" d2="454" d3="963"/>
<CITE num="017" author="NITOWSKY HM" publication="AM J CLIN NUTR" d1="10" d2="368" d3="962"/>
<CITE num="018" author="RIVERS JPW" publication="LANCET" d1="2" d2="642" d3="975"/>
<CITE num="019" author="RODRIQUEZ MS" publication="J NUTR" d1="102" d2="908" d3="972"/>
<CITE num="020" author="UNDERWOOD BA" publication="BULL NY ACAD MED" d1="47" d2="34" d3="971"/>
<CITE num="021" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="022" author="WO CKW" publication="AM J CLIN NUTR" d1="28" d2="808" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78098</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ODRUFF CW           AM" publication="J CLIN NUTR" d1="44" d2="84 9" d3="6"/>
</CITATIONS>
<RECORDNUM>00879 </RECORDNUM>
<MEDLINENUM>78170950</MEDLINENUM>
<AUTHORS><AUTHOR>OHalloran-E-T</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis--an eleven year survey.</TITLE>
<SOURCE>Ir-Med-J. 1978 Apr 21. 71(6). P 184-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, oc, th</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>IRELAND</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<EXTRACT>The purpose of this communication is to review our experiences with
children with cystic fibrosis seen from January 1964 to January 1975
and to analyse the factors which have contributed to the improved
prognosis which has occurred in this period.  The numbers of new
patients have increased from six in 1964 to 12 in 1974.  Both sexes
have been equally affected.  Respiratory infections, failure to
thrive and diarrhoea were the predominant presenting features in that
order, and thus any one of these presenting features should indicate
that cystic fibrosis should at least be considered and excluded.
Each patient was assessed monthly at the clinic during which
attendance formal physiotherapy was carried out and the parents were
instructed in the techniques of percussion and drainage.  Forty-two
of our sixty-four patients are still alive and thirty-three of those
fall into the excellent category, seven into the good and one each
into the fair and poor.  During the period of this review there has
been an obvious improvement with a fall in morbidity and mortality
and with the increasing proportion of patients now in the "excellent"
group.  We attribute these facts to earlier diagnosis, regular and
careful follow-up and a supervised therapeutic programme including
parent education and participation.  It would seem, therefore, that
early diagnosis and active treatment prolong life and give better
health.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78099</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="002" author="ANDERSEN DH" publication="PEDIATRICS" d1="3" d2="406" d3="949"/>
<CITE num="003" author="DODGE JA" publication="BR MED J" d1="2" d2="192" d3="975"/>
<CITE num="004" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="005" author="MITCHELL-HEGGS PF" publication="Q J MED" d1="45" d2="479" d3="976"/>
<CITE num="006" author="MEARNS MB" publication="ARCH DIS CHILD" d1="46" d2="139" d3="972"/>
<CITE num="007" author="ROBINSON MJ" publication="ARCH DIS CHILD" d1="50" d2="962" d3="975"/>
<CITE num="008" author="SHWACHMAN H" publication="ADV PEDIATR" d1="7" d2="249" d3="955"/>
<CITE num="009" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="010" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="011" author="WARWICK WJ" publication="MOD PROBL PEDIATR" d1="10" d2="353" d3="967"/>
</REFERENCES>
<RECORDNUM>00880 </RECORDNUM>
<MEDLINENUM>78170976</MEDLINENUM>
<AUTHORS><AUTHOR>Katznelson-D</AUTHOR><AUTHOR>Ben-Yishay-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in Israel: clinical and genetic aspects.</TITLE>
<SOURCE>Isr-J-Med-Sci. 1978 Feb. 14(2). P 204-11.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AUTOPSY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, fg, oc</TOPIC><TOPIC>ETHNIC-GROUPS</TOPIC><TOPIC>FAMILY-PLANNING</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>ISRAEL</TOPIC></MINORSUBJ>
<ABSTRACT>A total of 140 cases of cystic fibrosis in 110 families was
identified in Israel during the years 1946--75, and there was reason
to suspect inadequate ascertainment. Cystic fibrosis is frequent
among the Ashkenazic and Arab populations with an incidence
approximating that for Caucasians of European ancestry (1:1,800 to
1:4,000 live births). It is about half as frequent in the Sephardim,
rare in the Iraqi or Yemenite Jews and perhaps absent in Iranian
Jews. The clinical picture of cystic fibrosis in Israel in all the
ethnic groups was found to be the same as elsewhere in the world. In-
depth.interviews of 50 families were conducted to assess their
understanding of the genetics of the disease and their attitude
toward family planning.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LEVIN S" publication="IN: GOLDSCHMIDT E" d1="" d2="294" d3="963"/>
<CITE num="002" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="003" author="PUGH RJ" publication="ARCH DIS CHILD" d1="42" d2="544" d3="967"/>
<CITE num="004" author="ANON" publication="FACTS ABOUT ISRAEL 1975" d1="" d2="" d3="975"/>
<CITE num="005" author="ANON" publication="STATISTICAL ABST OF ISRAEL" d1="" d2="" d3="975"/>
<CITE num="006" author="GOLDSCHMIDT AE" publication="ANN HUM GENET" d1="24" d2="191" d3="960"/>
<CITE num="007" author="BEARN AG" publication="CLIN RES" d1="17" d2="462" d3="969"/>
<CITE num="008" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="009" author="WING JP" publication="HUM HERED" d1="24" d2="323" d3="974"/>
<CITE num="010" author="ADAM A" publication="ISR J MED SCI" d1="9" d2="1383" d3="973"/>
<CITE num="011" author="CARTER CO" publication="LANCET" d1="1" d2="281" d3="971"/>
<CITE num="012" author="LEONARD CO" publication="N ENGL J MED" d1="287" d2="433" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78100</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HAAP T              IS" publication="R J MED SCI" d1="14" d2="01 9" d3="8"/>
<CITE num="2" author="KATZNELSON D" publication="ISR J MED SCI" d1="17" d2="687" d3="981"/>
<CITE num="3" author="KATZNELSON D" publication="LANCET" d1="1" d2="112" d3="982"/>
<CITE num="4" author="HOLLANDER DH" publication="MED HYPOTHESES" d1="8" d2="191" d3="982"/>
<CITE num="5" author="STURGESS JM" publication="AM J MED GENET" d1="22" d2="383" d3="985"/>
<CITE num="6" author="KOLLBERG H" publication="J TROP PEDIATR" d1="32" d2="293" d3="986"/>
<CITE num="7" author="NAZER H" publication="TRANS R SOC TROP MED HYG" d1="80" d2="348" d3="986"/>
</CITATIONS>
<RECORDNUM>00881 </RECORDNUM>
<MEDLINENUM>78170975</MEDLINENUM>
<AUTHORS><AUTHOR>Schaap-T</AUTHOR><AUTHOR>Hodes-M-E</AUTHOR><AUTHOR>Cohen-M-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis--problems and prospects [editorial].</TITLE>
<SOURCE>Isr-J-Med-Sci. 1978 Feb. 14(2). P 201-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LINKAGE-GENETICS</TOPIC><TOPIC>RESEARCH</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis, an autosomal recessive trait, is the most common
hereditary lethal condition among Caucasians, approximating a
prevalence of 1 per 2500 births with a carrier frequency of 1:25 in
populations originating from West Europe.  The markedly elevated
frequency of CF in a considerable proportion of the human race
presents a genetic enigma for which several solutions have been
proposed.  Genetic heterogeneity, heterozygote advantage, reduced
penetrance, genetic drift, and linkage or epistasis are discussed.
The basic defect in CF and its fundamental biochemical and
physiological ramifications are unknown.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78101</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="BEARN AG" publication="CLIN GASTROENTEROL" d1="2" d2="515" d3="973"/>
<CITE num="003" author="CONNEALLY PM" publication="TEX REP BIOL MED" d1="31" d2="639" d3="973"/>
<CITE num="004" author="KATZNELSON D" publication="ISR J MED SCI" d1="14" d2="204" d3="978"/>
<CITE num="005" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="006" author="DANES BS" publication="BIRTH DEF ORIG ART SER" d1="8" d2="114" d3="972"/>
<CITE num="007" author="SHWACHMAN H" publication="BIRTH DEF ORIG ART SER" d1="8" d2="102" d3="972"/>
<CITE num="008" author="FEINGOLD J" publication="ANN GENET (PARIS)" d1="17" d2="257" d3="974"/>
<CITE num="009" author="CROW JF" publication="IN: NEEL JV" d1="" d2="23" d3="965"/>
<CITE num="010" author="STUART AB" publication="LANCET" d1="2" d2="1521" d3="974"/>
<CITE num="011" author="SUPER M" publication="S AFR MED J" d1="49" d2="818" d3="975"/>
<CITE num="012" author="RAO DC" publication="AM J HUM GENET" d1="25" d2="594" d3="973"/>
<CITE num="013" author="WAGENER DK" publication="AM J HUM GENET" d1="27" d2="348" d3="975"/>
<CITE num="014" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="015" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="016" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="017" author="WOOD RE" publication="LANCET" d1="2" d2="1452" d3="973"/>
<CITE num="018" author="BENKE PJ" publication="IN: MANGOS JA" d1="" d2="157" d3="976"/>
<CITE num="019" author="WILSON GB" publication="CLIN CHIM ACTA" d1="49" d2="79" d3="973"/>
<CITE num="020" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="1148" d3="977"/>
<CITE num="021" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="022" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="023" author="SHAPIRA E" publication="PEDIATR RES" d1="10" d2="812" d3="976"/>
</REFERENCES>
<RECORDNUM>00882 </RECORDNUM>
<MEDLINENUM>79067429</MEDLINENUM>
<AUTHORS><AUTHOR>Pinney-M-A</AUTHOR></AUTHORS>
<TITLE>Review of cystic fibrosis.</TITLE>
<SOURCE>Issues-Compr-Pediatr-Nurs. 1978 Aug. 3(2). P 54-65.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PARENTS</TOPIC><TOPIC>PEDIATRIC-NURSING</TOPIC><TOPIC>RESPIRATORY-THERAPY</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is an inherited disease affecting mainly Caucasians.
All exocrine glands are obstructed, causing multiple manifestations.
The most lethal aspect is the pulmonary involvement.  Early diagnosis
and treatment influence prognosis.  The sweat test is the diagnostic
tool; it must be done in a center where it is performed frequently
and where quality control is available.  Specific therapy varies from
center to center, but all agree on a consistent, comprehensive
approach to management.  One must be acutely aware of the
psychosocial aspects when caring for children with cystic fibrosis.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78102</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="LEVISON H" publication="IN: MANGOS JA" d1="" d2="3" d3="976"/>
<CITE num="004" author="WAGGET J" publication="J PEDIATR" d1="77" d2="407" d3="970"/>
<CITE num="006" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="007" author="MELLINS RB" publication="AM REV RESPIR DIS SUPPL" d1="110" d2="137" d3="974"/>
<CITE num="009" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="976"/>
<CITE num="010" author="ROTHSTEIN RJ" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="100" d3="974"/>
<CITE num="011" author="DROTUR DA" publication="PEDIATRICS" d1="56" d2="710" d3="975"/>
<CITE num="013" author="MATTSSON A" publication="PEDIATRICS" d1="50" d2="801" d3="972"/>
<CITE num="014" author="DI SANTAGNESE PA" publication="AM FAM PHYSICIAN" d1="7" d2="102" d3="973"/>
<CITE num="015" author="DOOLEY RR" publication="AM J OBSTET GYNECOL" d1="118" d2="971" d3="974"/>
</REFERENCES>
<RECORDNUM>00883 </RECORDNUM>
<MEDLINENUM>78067357</MEDLINENUM>
<AUTHORS><AUTHOR>Reitman-A-A</AUTHOR><AUTHOR>Faber-R-D</AUTHOR></AUTHORS>
<TITLE>A cephalometric study of patients with cystic fibrosis.</TITLE>
<SOURCE>J-Am-Dent-Assoc. 1978 Jan. 96(1). P 83-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>MAXILLOFACIAL-DEVELOPMENT</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CEPHALOMETRY</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SKULL: gd</TOPIC></MINORSUBJ>
<ABSTRACT>Children with cystic fibrosis have skeletal maturation and epiphyseal
anomalies similar to those in children with nutritional problems.
However, these patients have been found to have normal somatic
development if treatment is begun early. In a group of children with
cystic fibrosis undergoing medical treatment, cephalometric
measurements compared favorably with those established by normal
standards.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78103</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HUANG NN" publication="AM J DIS CHILD" d1="120" d2="289" d3="970"/>
<CITE num="002" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="003" author="GORLIN RJ" publication="THOMAS ORAL PATHOLOGY" d1="" d2="995" d3="970"/>
<CITE num="004" author="SPROUL A" publication="J PEDIATR" d1="65" d2="664" d3="964"/>
<CITE num="005" author="KREISSL T" publication="Z KINDERHEILK" d1="113" d2="93" d3="972"/>
<CITE num="006" author="GREEN OC" publication="ENDOCRINOL METAB J CLIN" d1="27" d2="1059" d3="967"/>
<CITE num="007" author="MILUNSKY A" publication="AM J DIS CHILD" d1="121" d2="15" d3="971"/>
<CITE num="008" author="DENNIS JL" publication="JAMA" d1="94" d2="855" d3="965"/>
<CITE num="009" author="SNODGRASS RM" publication="AM J ROENTG RAD THER NUCL MED" d1="74" d2="6" d3="955"/>
<CITE num="010" author="TAUSSIG LM" publication="AM J DIS CHILD" d1="125" d2="495" d3="973"/>
</REFERENCES>
<RECORDNUM>00884 </RECORDNUM>
<MEDLINENUM>78217979</MEDLINENUM>
<AUTHORS><AUTHOR>Govan-J-R</AUTHOR><AUTHOR>Fyfe-J-A</AUTHOR></AUTHORS>
<TITLE>Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the
mucoid from to carbenicillin, flucloxacillin and tobramycin and the
isolation of mucoid variants in vitro.</TITLE>
<SOURCE>J-Antimicrob-Chemother. 1978 May. 4(3). P 233-40.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: pd</TOPIC><TOPIC>CARBENICILLIN: pd</TOPIC><TOPIC>CLOXACILLIN: aa</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>FLOXACILLIN: pd</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: ip</TOPIC><TOPIC>TOBRAMYCIN: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHEMISTRY-PHYSICAL</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>POLYSACCHARIDES-BACTERIAL: an</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: de</TOPIC></MINORSUBJ>
<ABSTRACT>Mucoid strains of Pseudomonas aeruginosa isolated from the sputa of
patients with cystic fibrosis or in vitro through selection with
phage were more resistant to carbenicillin, flucloxacillin and
tobramycin and more sensitive to tetracycline than related
non-mucoid strains.  The observations led to the development of a
technique for the isolation of mucoid variants in vitro based on
enhanced resistance to carbenicillin.  Mucoid variants were isolated
from various strains of Ps. aeruginosa and the exopolysaccharide
found to be similar to that obtained from mucoid Ps. aeruginosa
isolated from patients with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRUMFITT W" publication="J ANTIMICROB CHEMOTHER" d1="1" d2="163" d3="975"/>
<CITE num="002" author="DOGGETT RG" publication="APPL MICROBIOL" d1="18" d2="936" d3="969"/>
<CITE num="003" author="DOGGETT RG" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="175" d3="969"/>
<CITE num="004" author="DOGGETT RG" publication="J PEDIATR" d1="68" d2="215" d3="966"/>
<CITE num="005" author="EVANS LR" publication="J BACTERIOL" d1="116" d2="915" d3="973"/>
<CITE num="006" author="GOVAN JRW" publication="J MED MICROBIOL" d1="8" d2="513" d3="975"/>
<CITE num="007" author="GOVAN JRW" publication="J ANTIMICROB CHEMOTHER" d1="2" d2="215" d3="976"/>
<CITE num="008" author="GOVAN JRW" publication="IN: NORRIS JR" d1="10" d2="59" d3="978"/>
<CITE num="009" author="HOLLOWAY BW" publication="BACT REV" d1="33" d2="419" d3="969"/>
<CITE num="010" author="IACOCCA VF" publication="AM J DIS CHILD" d1="106" d2="315" d3="963"/>
<CITE num="011" author="LAWSON D" publication="IN: WATT PJ" d1="" d2="69" d3="970"/>
<CITE num="012" author="MCCRAE WM" publication="J INFECT DIS SUPPL" d1="134" d2="191" d3="976"/>
<CITE num="013" author="MARKS MI" publication="J PEDIATR" d1="79" d2="822" d3="971"/>
<CITE num="014" author="MARTIN DR" publication="J MED MICROBIOL" d1="6" d2="111" d3="973"/>
<CITE num="015" author="MAY JR" publication="J MED MICROBIOL" d1="6" d2="77" d3="973"/>
<CITE num="016" author="PHILLIPS I" publication="J MED MICROBIOL" d1="2" d2="9" d3="969"/>
<CITE num="017" author="RAEBURN JA" publication="J ANTIMICROB CHEMOTHER" d1="2" d2="107" d3="976"/>
<CITE num="018" author="SONNENSCHEIN C" publication="ZENTRALBL BAKTERIOL" d1="104" d2="365" d3="927"/>
<CITE num="019" author="STANISICH V" publication="GENETICS" d1="61" d2="327" d3="969"/>
<CITE num="020" author="WILLIAMS RJ" publication="J MED MICROBIOL" d1="6" d2="409" d3="973"/>
<CITE num="021" author="ZIERDT CH" publication="J BACTERIOL" d1="87" d2="1003" d3="964"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78104</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLOWAY BW           MI" publication="CROBIOL REV" d1="43" d2="73 9" d3="9"/>
<CITE num="2" author="GOVAN JRW" publication="J GEN MICROBIOL" d1="110" d2="229" d3="979"/>
<CITE num="3" author="THOMASSEN MJ" publication="J INFECT DIS" d1="140" d2="873" d3="979"/>
<CITE num="4" author="DEMKO CA" publication="CURRENT MICROBIOL" d1="4" d2="69" d3="980"/>
<CITE num="5" author="MARKOWITZ SM" publication="J ANTIMICROB CHEMOTHER" d1="6" d2="251" d3="980"/>
<CITE num="6" author="CHENG KJ" publication="CAN J MICROBIOL" d1="26" d2="1104" d3="980"/>
<CITE num="7" author="LAM J" publication="INFECT IMMUN" d1="28" d2="546" d3="980"/>
<CITE num="8" author="LIEBERMAN MM" publication="INFECT IMMUN" d1="29" d2="489" d3="980"/>
<CITE num="9" author="FYFE JAM" publication="J GEN MICROBIOL" d1="119" d2="443" d3="980"/>
<CITE num="10" author="BRISOU JF" publication="C R ACAD SCI (D)(PARIS)" d1="290" d2="1421" d3="980"/>
<CITE num="11" author="FICK RB" publication="CLIN CHEST MED" d1="2" d2="91" d3="981"/>
<CITE num="12" author="SLACK MPE" publication="LANCET" d1="2" d2="502" d3="981"/>
<CITE num="13" author="COSTERTON JW" publication="CRC CRIT REV MICROBIOL" d1="8" d2="303" d3="981"/>
<CITE num="14" author="IRVIN RT" publication="ANTIMICROB AGENTS CHEMOTHER" d1="19" d2="1056" d3="981"/>
<CITE num="15" author="CHENG KJ" publication="CAN J MICROBIOL" d1="27" d2="461" d3="981"/>
<CITE num="16" author="BLACKWOOD LL" publication="INFECT IMMUN" d1="32" d2="443" d3="981"/>
<CITE num="17" author="COSTERTON JW" publication="ANNU REV MICROBIOL" d1="35" d2="299" d3="981"/>
<CITE num="18" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="19" author="GOVAN JRW" publication="J GEN MICROBIOL" d1="125" d2="217" d3="981"/>
<CITE num="20" author="BERGAN T" publication="SCAND J INFECT DIS" d1="1981" d2="7" d3="981"/>
<CITE num="21" author="BAKER NR" publication="CURRENT MICROBIOL" d1="7" d2="35" d3="982"/>
<CITE num="22" author="SLACK MPE" publication="J ANTIMICROB CHEMOTHER" d1="10" d2="368" d3="982"/>
<CITE num="23" author="PIGGOTT NH" publication="EUR J APP MICROBIO BIOTECHNOL" d1="16" d2="131" d3="982"/>
<CITE num="24" author="SUTHERLAND IW" publication="ADV MICROB PHYSIOL" d1="23" d2="79" d3="982"/>
<CITE num="25" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="840" d3="982"/>
<CITE num="26" author="OHMAN DE" publication="INFECT IMMUN" d1="37" d2="662" d3="982"/>
<CITE num="27" author="HOOKE AM" publication="INFECT IMMUN" d1="38" d2="136" d3="982"/>
<CITE num="28" author="MONTIE TC" publication="INFECT IMMUN" d1="38" d2="1296" d3="982"/>
<CITE num="29" author="EXNER M" publication="ZENTRALBL BAKT MIKROB HYG (B)" d1="176" d2="425" d3="982"/>
<CITE num="30" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="31" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="32" author="COSTERTON JW" publication="REV INFECT DIS" d1="5" d2="S867" d3="983"/>
<CITE num="33" author="GOVAN JRW" publication="REV INFECT DIS" d1="5" d2="S874" d3="983"/>
<CITE num="34" author="OMBAKA EA" publication="REV INFECT DIS" d1="5" d2="S880" d3="983"/>
<CITE num="35" author="COSTERTON JW" publication="PROG FOOD NUTR SCI" d1="7" d2="91" d3="983"/>
<CITE num="36" author="OLIVER AM" publication="J CLIN LAB IMMUNOL" d1="10" d2="221" d3="983"/>
<CITE num="37" author="TURNOWSKY F" publication="FEMS MICROBIOL LETTERS" d1="17" d2="243" d3="983"/>
<CITE num="38" author="HACKING AJ" publication="J GEN MICROBIOL" d1="129" d2="3473" d3="983"/>
<CITE num="39" author="DALHOFF A" publication="ZENTRALBL BAKT MIKROB HYG (A)" d1="254" d2="379" d3="983"/>
<CITE num="40" author="COSTERTON JW" publication="REV INFECT DIS" d1="6" d2="S608" d3="984"/>
<CITE num="41" author="GRISTINA AG" publication="ORTHOP CLIN NORTH AM" d1="15" d2="517" d3="984"/>
<CITE num="42" author="KELLY HW" publication="DRUG INTEL CLIN PHARM" d1="18" d2="772" d3="984"/>
<CITE num="43" author="NACUCCHIO MC" publication="PEDIATR RES" d1="18" d2="295" d3="984"/>
<CITE num="44" author="CHAN R" publication="J CLIN MICROBIOL" d1="19" d2="8" d3="984"/>
<CITE num="45" author="WINGENDER J" publication="FEMS MICROBIOL LETTERS" d1="21" d2="63" d3="984"/>
<CITE num="46" author="COSTERTON JW" publication="DEVELOP IND MICROBIOL" d1="25" d2="363" d3="984"/>
<CITE num="47" author="TANNENBAUM CS" publication="ANTIMICROB AGENTS CHEMOTHER" d1="25" d2="673" d3="984"/>
<CITE num="48" author="LAMBE DW" publication="CAN J MICROBIOL" d1="30" d2="809" d3="984"/>
<CITE num="49" author="MILLS J" publication="INFECT IMMUN" d1="43" d2="359" d3="984"/>
<CITE num="50" author="HANSEN JB" publication="APPL ENVIRON MICROBIOL" d1="47" d2="704" d3="984"/>
<CITE num="51" author="VOGEL F" publication="DTSCH MED WSCHR" d1="109" d2="1148" d3="984"/>
<CITE num="52" author="FYFE JAM" publication="J GEN MICROBIOL" d1="130" d2="825" d3="984"/>
<CITE num="53" author="JARMAN TR" publication="ARCH MICROBIOL" d1="137" d2="231" d3="984"/>
<CITE num="54" author="GOLDBERG JB" publication="J BACTERIOL" d1="158" d2="1115" d3="984"/>
<CITE num="55" author="DARZINS A" publication="J BACTERIOL" d1="159" d2="9" d3="984"/>
<CITE num="56" author="LINKER A" publication="J BACTERIOL" d1="159" d2="958" d3="984"/>
<CITE num="57" author="LIEBERMAN MM" publication="SURV SYNTH PATHOL RES" d1="4" d2="312" d3="985"/>
<CITE num="58" author="MARTY N" publication="MED MALAD INFECT" d1="15" d2="604" d3="985"/>
<CITE num="59" author="SHABTAI J" publication="DEVELOP IND MICROBIOL" d1="26" d2="291" d3="985"/>
<CITE num="60" author="IRVIN RT" publication="CAN J MICROBIOL" d1="31" d2="268" d3="985"/>
<CITE num="61" author="MARESZBABCZYSZYN J" publication="ARCH IMMUNOL THER EXP" d1="33" d2="515" d3="985"/>
<CITE num="62" author="SUTHERLAND IW" publication="ANNU REV MICROBIOL" d1="39" d2="243" d3="985"/>
<CITE num="63" author="MARCUS H" publication="INFECT IMMUN" d1="47" d2="723" d3="985"/>
<CITE num="64" author="SHABTAI Y" publication="APPL ENVIRON MICROBIOL" d1="49" d2="192" d3="985"/>
<CITE num="65" author="LUZAR MA" publication="INFECT IMMUN" d1="50" d2="577" d3="985"/>
<CITE num="66" author="KOMIYAMA K" publication="ORAL SURG" d1="59" d2="590" d3="985"/>
<CITE num="67" author="WINKLER U" publication="KLIN WSCHR" d1="63" d2="490" d3="985"/>
<CITE num="68" author="GRISTINA AG" publication="J BONE JOINT SURG" d1="67A" d2="264" d3="985"/>
<CITE num="69" author="DUMA RJ" publication="AM J MED" d1="78" d2="154" d3="985"/>
<CITE num="70" author="GRISTINA AG" publication="SURGERY" d1="98" d2="12" d3="985"/>
<CITE num="71" author="LORY S" publication="CURR TOP MICROBIOL IMMUNOL" d1="118" d2="53" d3="985"/>
<CITE num="72" author="PULLIAM L" publication="J INFECT DIS" d1="151" d2="153" d3="985"/>
<CITE num="73" author="DARZINS A" publication="J BACTERIOL" d1="161" d2="249" d3="985"/>
<CITE num="74" author="OHMAN DE" publication="J BACTERIOL" d1="162" d2="1068" d3="985"/>
<CITE num="75" author="GOVAN JRW" publication="MICROBIOL SCI" d1="3" d2="302" d3="986"/>
<CITE num="76" author="SCHMITT DD" publication="J VASC SURG" d1="3" d2="732" d3="986"/>
<CITE num="77" author="WEBB LX" publication="J VASC SURG" d1="4" d2="16" d3="986"/>
<CITE num="78" author="MCEACHRAN DW" publication="J MICROBIOL METH" d1="5" d2="99" d3="986"/>
<CITE num="79" author="FLOURNOY DJ" publication="METH FIND EXP CLIN PHARMACOL" d1="8" d2="391" d3="986"/>
<CITE num="80" author="FRIEND PA" publication="J INFECT" d1="13" d2="55" d3="986"/>
<CITE num="81" author="MACGEORGE J" publication="J MED MICROBIOL" d1="21" d2="331" d3="986"/>
<CITE num="82" author="KRIEG DP" publication="J CLIN MICROBIOL" d1="24" d2="986" d3="986"/>
<CITE num="83" author="PITT TL" publication="J ROY SOC MED" d1="79" d2="13" d3="986"/>
<CITE num="84" author="DERETIC V" publication="J BACTERIOL" d1="165" d2="510" d3="986"/>
<CITE num="85" author="DERETIC V" publication="BIO TECHNOL" d1="5" d2="469" d3="987"/>
<CITE num="86" author="GROSS M" publication="J PHYTOPATH" d1="118" d2="276" d3="987"/>
</CITATIONS>
<RECORDNUM>00885 </RECORDNUM>
<MEDLINENUM>78129864</MEDLINENUM>
<AUTHORS><AUTHOR>Lewis-S-M</AUTHOR><AUTHOR>Evans-J-W</AUTHOR><AUTHOR>Jalowayski-A-A</AUTHOR></AUTHORS>
<TITLE>Continuous distributions of specific ventilation recovered from
inert gas washout.</TITLE>
<SOURCE>J-Appl-Physiol. 1978 Mar. 44(3). P 416-23.</SOURCE>
<MAJORSUBJ><TOPIC>NITROGEN</TOPIC><TOPIC>RESPIRATION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>AGING</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: pp</TOPIC><TOPIC>LUNG: ph</TOPIC><TOPIC>MATHEMATICS</TOPIC><TOPIC>RESPIRATORY-DEAD-SPACE</TOPIC><TOPIC>TIDAL-VOLUME</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>We describe a new technique for recovering continuous distributions
of ventilation (V) as a function of tidal ventilation/volume ratio
(V/V0) from the nitrogen washout. The analysis yields a continuous
distribution of V as a function of V/V0 represented as fractional
ventilations of 50 compartments plus dead space. The procedure was
verified by recovering known distributions from data to which noise
had been added. Using an apparatus to control the subject's tidal
volume and FRC, mixed expired N2 data gave the following results: a)
the distributions of young, normal subjects were narrow and unimodal
with a mean ln standard deviation of 0.56 plus or minus 0.13; b)
those of subjects over age 40 were broader (ln SD 0.86 plus or minus
0.19) with more poorly ventilated units; c) patients with pulmonary
disease of all descriptions showed enlarged dead space; d) patients
with cystic fibrosis showed multimodal distributions with the bulk of
the ventilation going to overventilated units; and e) patients with
obstructive lung diseases fell into several classes, three of which
are illustrated. These results suggest that our approach is well
suited for clinical investigation.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BECKLAKE MR" publication="THORAX" d1="7" d2="111" d3="952"/>
<CITE num="002" author="BOUHUYS A" publication="PHYSIOL REV" d1="39" d2="731" d3="959"/>
<CITE num="003" author="EVANS JW" publication="BULL MATH BIOPHYS" d1="32" d2="59" d3="970"/>
<CITE num="004" author="EVANS JW" publication="BULL MATH BIOPHYS" d1="29" d2="711" d3="967"/>
<CITE num="005" author="EVANS JW" publication="J APPL PHYSIOL" d1="42" d2="889" d3="977"/>
<CITE num="006" author="FOWLER WS" publication="J APPL PHYSIOL" d1="2" d2="283" d3="949"/>
<CITE num="007" author="GOMEZ DM" publication="PROC NAT ACAD SCI USA" d1="49" d2="312" d3="963"/>
<CITE num="008" author="GOMEZ DM" publication="J APPL PHYSIOL" d1="19" d2="683" d3="964"/>
<CITE num="009" author="GOMEZ DM" publication="J EXP MED" d1="193" d2="514" d3="965"/>
<CITE num="010" author="GOMEZ DM" publication="AM REV RESPIR DIS" d1="93" d2="1" d3="966"/>
<CITE num="011" author="HASHIMOTO T" publication="J APPL PHYSIOL" d1="23" d2="203" d3="967"/>
<CITE num="012" author="HEISE M" publication="RESPIRATION" d1="31" d2="310" d3="974"/>
<CITE num="013" author="JALAWALA SA" publication="J CLIN INVEST" d1="53" d2="188" d3="975"/>
<CITE num="014" author="LAWSON CL" publication="SOLVING LEAST SQUARES PROBLEM" d1="" d2="" d3="974"/>
<CITE num="015" author="MARTIN CJ" publication="RESPIR PHYSIOL" d1="21" d2="157" d3="974"/>
<CITE num="016" author="NAKAMURA T" publication="J APPL PHYSIOL" d1="21" d2="227" d3="966"/>
<CITE num="017" author="NYE RE" publication="J APPL PHYSIOL" d1="16" d2="115" d3="961"/>
<CITE num="018" author="OKUBO T" publication="J APPL PHYSIOL" d1="24" d2="658" d3="968"/>
<CITE num="019" author="OLSZOWKA AJ" publication="RESPIR PHYSIOL" d1="25" d2="191" d3="975"/>
<CITE num="020" author="PESLIN R" publication="J APPL PHYSIOL" d1="30" d2="462" d3="971"/>
<CITE num="021" author="ROSSING RG" publication="J APPL PHYSIOL" d1="21" d2="1907" d3="966"/>
<CITE num="022" author="SCHWARZL F" publication="PHYSICA" d1="18" d2="791" d3="952"/>
<CITE num="023" author="TSUNODA S" publication="J APPL PHYSIOL" d1="32" d2="644" d3="972"/>
<CITE num="024" author="WAGNER PD" publication="J APPL PHYSIOL" d1="36" d2="588" d3="974"/>
<CITE num="025" author="YOUNG AC" publication="J CLIN INVEST" d1="53" d2="1178" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78105</PAPERNUM>
<CITATIONS>
<CITE num="1" author="WIS SM              J" publication="APPL PHYSIOL" d1="44" d2="24 9" d3="8"/>
<CITE num="2" author="BUTLER JP" publication="J APPL PHYSIOL" d1="46" d2="47" d3="979"/>
<CITE num="3" author="EVANS JW" publication="MATH BIOSCI" d1="46" d2="233" d3="979"/>
<CITE num="4" author="WAGNER PD" publication="J APPL PHYSIOL" d1="46" d2="579" d3="979"/>
<CITE num="5" author="MARTIN CJ" publication="J APPL PHYSIOL" d1="47" d2="319" d3="979"/>
<CITE num="6" author="LAMEDICA G" publication="RESPIRATION" d1="39" d2="333" d3="980"/>
<CITE num="7" author="WAGNER PD" publication="ANNU REV PHYSIOL" d1="42" d2="235" d3="980"/>
<CITE num="8" author="AZZARO SH" publication="IEEE TRANS BIOMED ENG" d1="28" d2="755" d3="981"/>
<CITE num="9" author="DEVRIES WR" publication="J APPL PHYSIOL" d1="51" d2="1122" d3="981"/>
<CITE num="10" author="LEWIS SM" publication="J APPL PHYSIOL" d1="51" d2="1463" d3="981"/>
<CITE num="11" author="PIMMEL RL" publication="J APPL PHYSIOL" d1="51" d2="1581" d3="981"/>
<CITE num="12" author="OZANNE GM" publication="ANESTHESIOLOGY" d1="54" d2="413" d3="981"/>
<CITE num="13" author="WAGNER PD" publication="BULL EUR PHYSIOPATH RESP" d1="18" d2="361" d3="982"/>
<CITE num="14" author="JALOWAYSKI AA" publication="RESPIRATION" d1="43" d2="249" d3="982"/>
<CITE num="15" author="LEWIS SM" publication="RESPIR PHYSIOL" d1="50" d2="111" d3="982"/>
<CITE num="16" author="HUTCHISON AA" publication="AM REV RESPIR DIS" d1="125" d2="28" d3="982"/>
<CITE num="17" author="BRONIKOWSKI TA" publication="INT J BIOMEDICAL COMPUT" d1="14" d2="411" d3="983"/>
<CITE num="18" author="MULLER E" publication="BULL EUR PHYSIOPATH RESP" d1="19" d2="P100" d3="983"/>
<CITE num="19" author="RUBIN DZ" publication="J APPL PHYSIOL" d1="56" d2="708" d3="984"/>
<CITE num="20" author="BATES JHT" publication="IEEE TRANS BIOMED ENG" d1="32" d2="478" d3="985"/>
<CITE num="21" author="BRUNNER JX" publication="J APPL PHYSIOL" d1="59" d2="1008" d3="985"/>
<CITE num="22" author="HARF A" publication="AM REV RESPIR DIS" d1="132" d2="350" d3="985"/>
<CITE num="23" author="BUCHANAN PR" publication="CLIN PHYS PHYSIOL MEASURE" d1="7" d2="237" d3="986"/>
<CITE num="24" author="CRAWFORD ABH" publication="J APPL PHYSIOL" d1="61" d2="2108" d3="986"/>
<CITE num="25" author="BATES JHT" publication="RADIAT RES" d1="107" d2="307" d3="986"/>
<CITE num="26" author="BUCHANAN PR" publication="AM REV RESPIR DIS" d1="133" d2="A384" d3="986"/>
<CITE num="27" author="BATES JHT" publication="MED BIOL ENG COMPUT" d1="25" d2="131" d3="987"/>
</CITATIONS>
<RECORDNUM>00886 </RECORDNUM>
<MEDLINENUM>78129865</MEDLINENUM>
<AUTHORS><AUTHOR>Lewis-S-M</AUTHOR></AUTHORS>
<TITLE>Emptying patterns of the lung studied by multiple-breath N2 washout.</TITLE>
<SOURCE>J-Appl-Physiol. 1978 Mar. 44(3). P 424-30.</SOURCE>
<MAJORSUBJ><TOPIC>MODELS-BIOLOGICAL</TOPIC><TOPIC>RESPIRATION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>AGING</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: pp</TOPIC><TOPIC>LUNG-VOLUME-MEASUREMENTS</TOPIC><TOPIC>LUNG: ph, pp</TOPIC><TOPIC>NITROGEN</TOPIC><TOPIC>RESPIRATORY-DEAD-SPACE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Changes in the nitrogen concentration seen during the single-breath
nitrogen washout reflect changes in relative flow (V) from units with
differing ventilation/volume ratios (V/V0). The multiple-breath
washout provides sufficient data for the V for units with varying
V/V0 to be plotted as a function of the volume expired. Flow from the
dead space may also be determined. In young normals the emptying
patterns are narrow and unimodal throughout the alveolar plateau with
little or no flow from the dead space at the end of the breath. Older
normals show more flow from the dead space, particularly toward the
end of the breath, and some show a high V/V0 mode early in the
breath. Patients with obstructive lung disease have a high flow from
the dead space which is present throughout the breath. A well
ventilated mode at the end of the breath is seen in some obstructed
subjects. Patients with cystic fibrosis showed a poorly ventilated
mode appearing at the end of the breath as well as a very high dead
space.</ABSTRACT>
<REFERENCES>001$  BAKER LG              RESPIR PHYSIOL                  21   119 974
002   BALL WC JR            J CLIN INVEST                   41   519 962
003   DOLLFUSS RE           RESPIR PHYSIOL                   2   234 967
004   ENGEL LA              J APPL PHYSIOL                  35     9 973
005   EVANS JW              BULL MATH BIOPHYS               32    59 970
006   EVANS JW              BULL MATH BIOPHYS               29   711 967
007   EVANS JW              J APPL PHYSIOL                  42   889 977
008   FOWLER WS             AM J PHYSIOL                   154   405 948
009   FOWLER WS             J APPL PHYSIOL                   2   283 949
010   FOWLER WS             J CLIN INVEST                   31    40 952
011   LEWIS SM              J APPL PHYSIOL                  44   416 978
012   MCCARTHY DS           AM J MED                        52   747 972
013   MARTIN CJ             RESPIR PHYSIOL                  21   157 974
014   MILLETTE B            J APPL PHYSIOL                  27   587 969
015   PAIVA M               J APPL PHYSIOL                  35   401 973
016   POWER G               J APPL PHYSIOL                  27   701 969
017   SCHERER PW            BULL MATH BIOPHYS               34   393 972
018   SIKAND R              J APPL PHYSIOL                  21  1331 966
019   SUDA Y                J APPL PHYSIOL                  29   480 970
020   TSUNODA S             J APPL PHYSIOL                  32   644 972
021   WAGNER PD             J APPL PHYSIOL                  36   588 974
022   YOUNG AC              J CLIN INVEST                   53  1178 974</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78107</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MEDICA G            RE" publication="SPIRATION" d1="39" d2="33 9" d3="0"/>
<CITE num="2" author="JALOWAYSKI AA" publication="RESPIRATION" d1="43" d2="249" d3="982"/>
<CITE num="3" author="RUBIN DZ" publication="J APPL PHYSIOL" d1="56" d2="708" d3="984"/>
<CITE num="4" author="CUMMING G" publication="CLIN PHYSIOL" d1="5" d2="33" d3="985"/>
<CITE num="5" author="BUCHANAN PR" publication="CLIN PHYS PHYSIOL MEASURE" d1="7" d2="237" d3="986"/>
</CITATIONS>
<RECORDNUM>00887 </RECORDNUM>
<MEDLINENUM>79048678</MEDLINENUM>
<AUTHORS><AUTHOR>Sparham-P-D</AUTHOR><AUTHOR>Lobban-D-I</AUTHOR><AUTHOR>Speller-D-C</AUTHOR></AUTHORS>
<TITLE>Isolation of Staphylococcus aureus from sputum in cystic fibrosis.</TITLE>
<SOURCE>J-Clin-Pathol. 1978 Oct. 31(10). P 913-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>SPUTUM: mi</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS: ip</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BACTERIOLOGICAL-TECHNICS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CULTURE-MEDIA</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: ip</TOPIC><TOPIC>SONICATION</TOPIC></MINORSUBJ>
<ABSTRACT>The success in the isolation of Staphylococcus aureus of different
methods of sputum processing was investigated in 60 specimens
collected from 14 patients with cystic fibrosis during a seven-month
period. Fifty specimens (83%) from 11 patients yielded Staph. aureus
by one or more methods. Direct plating of purulent portions of sputum
on to media designed for general use in respiratory infections gave
unsatisfactory results (35% yield of Staph. aureus). Some increase in
isolations was obtained with preliminary liquefaction of sputum; but
the best results were given by the addition of a medium selective for
staphylococci (mannitol salt agar, BBL) or by initial sonication of
sputum (each 83% yield). Seven of the 11 strains of Staph. aureus
were thymidine-dependent and otherwise atypical in laboratory
characteristics; these were isolated from patients who had received
co-trimoxazole.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ALDER VG" publication="J APPL BACT" d1="25" d2="436" d3="962"/>
<CITE num="002" author="BABER KG" publication="J MED LAB TECH" d1="26" d2="391" d3="969"/>
<CITE num="003" author="CHRISTIE R" publication="J PATHOL BACTERIOL" d1="51" d2="189" d3="940"/>
<CITE num="004" author="CRUICKSHANK R" publication="MEDICAL MICROBIOLOGY" d1="2" d2="" d3="975"/>
<CITE num="005" author="GEORGE RH" publication="LANCET" d1="2" d2="1081" d3="977"/>
<CITE num="006" author="HUHTANEN CN" publication="J DAIRY SCI" d1="49" d2="1008" d3="966"/>
<CITE num="007" author="MCINTOSH AF" publication="PROCESS BIOCHEM" d1="6" d2="22" d3="971"/>
<CITE num="008" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="009" author="MEAD GR" publication="TUBERCLE" d1="45" d2="370" d3="964"/>
<CITE num="010" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="011" author="MILES AA" publication="J HYGIENE" d1="38" d2="732" d3="938"/>
<CITE num="012" author="PHILLIPS I" publication="J MED MICROBIOL" d1="2" d2="9" d3="969"/>
<CITE num="013" author="RAWLINS GA" publication="LANCET" d1="2" d2="538" d3="953"/>
<CITE num="014" author="WILKINSON PJ" publication="J CLIN PATHOL" d1="30" d2="417" d3="977"/>
<CITE num="015" author="WILLIAMS RF" publication="IN: WILLIAMS RF" d1="" d2="20" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78108</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLIAMS RF           CU" publication="RR MED RES OPIN" d1="6" d2="43 9" d3="9"/>
<CITE num="2" author="HOWDEN R" publication="MED LAB SCI" d1="38" d2="29" d3="981"/>
<CITE num="3" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="4" author="FRIEND PA" publication="J INFECT" d1="13" d2="55" d3="986"/>
</CITATIONS>
<RECORDNUM>00888 </RECORDNUM>
<MEDLINENUM>78152669</MEDLINENUM>
<AUTHORS><AUTHOR>Morris-L-J</AUTHOR><AUTHOR>Mascia-A-V</AUTHOR><AUTHOR>Farnsworth-P-B</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: making a correct and early diagnosis.</TITLE>
<SOURCE>J-Fam-Pract. 1978 Apr. 6(4). P 749-56.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, fg</TOPIC><TOPIC>DIABETES-MELLITUS: co</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: di</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RECTAL-PROLAPSE: et</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis is detected with increasing frequency in older
children, adolescents, and even young adults. The quality of life and
longevity in patients with cystic fibrosis is more favorable the
earlier a diagnosis is made and a therapeutic regimen begun. This
report presents and reviews five cases in chich the diagnosis of
cystic fibrosis was made after the age of six years. Emphasis is
placed on the variability of presenting signs and symptoms and the
problems that can arise in confirming a suspected diagnosis of cystic
fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DOERSHUK CF" publication="PEDIATRICS" d1="36" d2="675" d3="965"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="003" author="STEINBERG AG" publication="AM J HUM GENET" d1="12" d2="416" d3="960"/>
<CITE num="004" author="DI SANTAGNESE PA" publication="JAMA" d1="172" d2="2065" d3="960"/>
<CITE num="005" author="ANDERSON CM" publication="ARCH DIS CHILD" d1="35" d2="581" d3="960"/>
<CITE num="006" author="DARLING RC" publication="AM J MED SCI" d1="225" d2="67" d3="953"/>
<CITE num="007" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="008" author="ESTERLY JR" publication="JOHNS HOPKINS MED J" d1="122" d2="94" d3="968"/>
<CITE num="009" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="389" d3="962"/>
<CITE num="010" author="MCCOLLUM AT" publication="J PEDIATR" d1="77" d2="571" d3="970"/>
<CITE num="011" author="GIBSON LE" publication="J PEDIATR" d1="81" d2="193" d3="972"/>
<CITE num="012" author="ELIAN E" publication="N ENGL J MED" d1="264" d2="13" d3="961"/>
<CITE num="013" author="SHWACHMAN H" publication="ANN NY ACAD SCI" d1="93" d2="600" d3="962"/>
<CITE num="014" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="015" author="KULCZYCKI LL" publication="N ENGL J MED" d1="259" d2="409" d3="958"/>
<CITE num="016" author="TOMASHEFSKI JF" publication="CHEST" d1="57" d2="28" d3="970"/>
<CITE num="017" author="MILUNSKY A" publication="PEDIATRICS" d1="42" d2="501" d3="968"/>
<CITE num="018" author="HIDE DW" publication="ARCH DIS CHILD" d1="44" d2="533" d3="969"/>
<CITE num="019" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="48" d2="684" d3="973"/>
<CITE num="020" author="TAYLOR BW" publication="ARCH DIS CHILD" d1="48" d2="692" d3="973"/>
<CITE num="021" author="SHWACHMAN H" publication="PEDIATR CLIN NORTH AM" d1="22" d2="787" d3="975"/>
<CITE num="022" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="023" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="024" author="ROSAN RC" publication="AM J DIS CHILD" d1="104" d2="625" d3="962"/>
<CITE num="025" author="GEORGE L" publication="ARCH DIS CHILD" d1="46" d2="139" d3="971"/>
<CITE num="026" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="027" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="028" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="167" d3="962"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78109</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RWICK WJ            J" publication="CHRON DIS" d1="33" d2="85 9" d3="0"/>
<CITE num="2" author="CHINO ES" publication="AM SURGEON" d1="50" d2="70" d3="984"/>
</CITATIONS>
<RECORDNUM>00889 </RECORDNUM>
<MEDLINENUM>78152730</MEDLINENUM>
<AUTHORS><AUTHOR>Cloutier-M-M</AUTHOR><AUTHOR>Mangos-J-A</AUTHOR></AUTHORS>
<TITLE>The challenges of cystic fibrosis.</TITLE>
<SOURCE>J-Fla-Med-Assoc. 1978 Apr. 65(4). P 259-63.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di, fg, th</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<ABSTRACT>Cystic fibrosis is an autosomal recessive genetic disorder of the
exocrine glands which has a frequency of approximately 1:1,500 live
births.  This disease presents challenges to the physician and the
health care team.  The Pediatric Pulmonary Center of the University
of Florida in Gainesville, in coordination with Cystic Fibrosis
Centers and clinics throughout the state, is helping physicians and
patients to recognize and manage this chronic disease.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78110</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="FANCONI G" publication="WIEN MED WOCHENSCHR" d1="86" d2="753" d3="936"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="AM J MED" d1="15" d2="777" d3="953"/>
<CITE num="004" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="005" author="BAU SK" publication="PEDIATRICS" d1="48" d2="605" d3="971"/>
<CITE num="006" author="DUDLEY JP" publication="CF CLUB ABST" d1="" d2="" d3="976"/>
<CITE num="007" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="008" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="009" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="010" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
</REFERENCES>
<RECORDNUM>00890 </RECORDNUM>
<MEDLINENUM>78243783</MEDLINENUM>
<AUTHORS><AUTHOR>Klinger-J-D</AUTHOR><AUTHOR>Straus-D-C</AUTHOR><AUTHOR>Hilton-C-B</AUTHOR><AUTHOR>Bass-J-A</AUTHOR></AUTHORS>
<TITLE>Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in
patients with cystic fibrosis: Demonstration by radioimmunoassay.</TITLE>
<SOURCE>J-Infect-Dis. 1978 Jul. 138(1). P 49-8.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES-BACTERIAL: ip</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>EXOTOXINS: im</TOPIC><TOPIC>PEPTIDE-HYDROLASES: im</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: en, py</TOPIC><TOPIC>RADIOIMMUNOASSAY</TOPIC><TOPIC>VIRULENCE</TOPIC></MINORSUBJ>
<ABSTRACT>Sera from 33 patients with cystic fibrosis and two pediatric patients
being treated for chronic pulmonary infections not related to cystic
fibrosis and six sera or serum pools from uninfected individuals were
tested with a microtiter radioimmunoassay for reactivity against
exotoxin A and two proteases from Pseudomonas aeruginosa. Exotoxin A
was purified from a low-protease strain of P. aeruginosa and shown to
have adenosine diphosphate-ribose transferase activity and mouse
lethality. Proteases were purified from an isolate of P. aeruginosa
from a patient with cystic fibrosis and had proteolytic activity
against elastin and collagen in an assay employing dimethylated
protein substrates. The antibody responses of the patients detected
using 125I-labeled antibody to human immunoglobulin were correlated
with clinical evaluations expressed as a composite score based on
pulmonary findings, case histories, growth and nutrition, and chest X
rays. Values in the radioimmunoassay for patients' sera were compared
with those of a control serum pool and expressed as the ratio of
counts per minute (cpm) in patient serum to the cpm in the control
pool. Inverse correlations were found between these ratios for each
of the pseudomonas exoproducts and clinical scores; highest ratios
occurred in patients showing the lowest clinical scores. These
results confirm that proteases and exotoxin A of P. aeruginosa are
produced in cystic fibrosis pulmonary infections due to P. aeruginosa
and suggest that they may serve as significant virulence factors in
these chronic infectious states.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="IACOCCA VF" publication="AM J DIS CHILD" d1="106" d2="315" d3="963"/>
<CITE num="003" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="004" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="902" d3="972"/>
<CITE num="005" author="HOIBY N" publication="ACTA PAEDIATR SCAND" d1="63" d2="843" d3="974"/>
<CITE num="006" author="MARKS MI" publication="J PEDIATR" d1="79" d2="822" d3="971"/>
<CITE num="007" author="ELLER JJ" publication="AM J MED SUPPL" d1="62" d2="179" d3="977"/>
<CITE num="008" author="KREGER AS" publication="INFECT IMMUN" d1="9" d2="828" d3="974"/>
<CITE num="009" author="SCHULTZ DR" publication="INFECT IMMUN" d1="10" d2="128" d3="974"/>
<CITE num="010" author="PAVLOVSKIS OR" publication="IN: SCHLESSINGER D" d1="" d2="252" d3="975"/>
<CITE num="011" author="PAVLOVSKIS OR" publication="J INFECT DIS" d1="133" d2="253" d3="976"/>
<CITE num="012" author="MIDDLEBROOK JL" publication="CAN J MICROBIOL" d1="23" d2="183" d3="977"/>
<CITE num="013" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="014" author="DIAZ F" publication="J INFECT DIS" d1="121" d2="269" d3="970"/>
<CITE num="015" author="HABBOUSHE C" publication="PEDIATRICS" d1="48" d2="973" d3="971"/>
<CITE num="016" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (C)" d1="83" d2="459" d3="975"/>
<CITE num="017" author="SEIDMON EJ" publication="J PEDIATR" d1="87" d2="528" d3="975"/>
<CITE num="018" author="POLLACK M" publication="INFECT IMMUN" d1="14" d2="942" d3="976"/>
<CITE num="019" author="POLLACK M" publication="J CLIN MICROBIOL" d1="6" d2="58" d3="977"/>
<CITE num="020" author="LIU PV" publication="J INFECT DIS" d1="128" d2="514" d3="973"/>
<CITE num="021" author="IGLEWSKI BH" publication="INFECT IMMUN" d1="15" d2="138" d3="977"/>
<CITE num="022" author="MORIHARA K" publication="J BIOL CHEM" d1="240" d2="3295" d3="965"/>
<CITE num="023" author="PURCELL RH" publication="APPL MICROBIOL" d1="26" d2="478" d3="973"/>
<CITE num="024" author="ROSENTHAL JD" publication="J IMMUNOL" d1="109" d2="171" d3="972"/>
<CITE num="025" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
<CITE num="026" author="DOWNIE NM" publication="BASIC STATISTICAL METHODS" d1="" d2="" d3="970"/>
<CITE num="027" author="COLLIER RJ" publication="J BIOL CHEM" d1="246" d2="1496" d3="971"/>
<CITE num="028" author="VASIL ML" publication="INFECT IMMUN" d1="16" d2="353" d3="977"/>
<CITE num="029" author="FREDRICK JF" publication="ANN NY ACAD SCI" d1="121" d2="305" d3="964"/>
<CITE num="030" author="LIN Y" publication="J BIOL CHEM" d1="244" d2="789" d3="969"/>
<CITE num="031" author="LIU PV" publication="J INFECT DIS" d1="116" d2="481" d3="966"/>
<CITE num="032" author="IGLEWSKI BH" publication="PROC NAT ACAD SCI USA" d1="72" d2="2284" d3="975"/>
<CITE num="033" author="MORIHARA K" publication="INFECT IMMUN" d1="15" d2="679" d3="977"/>
<CITE num="034" author="CARRICK L JR" publication="BIOCHIM BIOPHYS ACTA" d1="391" d2="422" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78111</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AY L                IN" publication="FECT IMMUN" d1="23" d2="50 9" d3="9"/>
<CITE num="2" author="MORIHARA K" publication="INFECT IMMUN" d1="24" d2="188" d3="979"/>
<CITE num="3" author="CASH HA" publication="AM REV RESPIR DIS" d1="119" d2="453" d3="979"/>
<CITE num="4" author="KOSTIALA AAI" publication="J MED MICROBIOL" d1="13" d2="201" d3="980"/>
<CITE num="5" author="BERDISCHEWSKY M" publication="PEDIATR RES" d1="14" d2="830" d3="980"/>
<CITE num="6" author="JENSEN SE" publication="CAN J MICROBIOL" d1="26" d2="77" d3="980"/>
<CITE num="7" author="JENSEN SE" publication="CAN J MICROBIOL" d1="26" d2="87" d3="980"/>
<CITE num="8" author="HOMMA JY" publication="JAP J EXP MED" d1="50" d2="149" d3="980"/>
<CITE num="9" author="BEAUDRY PH" publication="J PEDIATR" d1="97" d2="144" d3="980"/>
<CITE num="10" author="SANAI Y" publication="FEBS LETTERS" d1="120" d2="131" d3="980"/>
<CITE num="11" author="CROSS AS" publication="J INFECT DIS" d1="142" d2="538" d3="980"/>
<CITE num="12" author="JENSEN SE" publication="J BACTERIOL" d1="144" d2="844" d3="980"/>
<CITE num="13" author="FICK RB" publication="CLIN CHEST MED" d1="2" d2="91" d3="981"/>
<CITE num="14" author="BLACKWOOD LL" publication="INFECT IMMUN" d1="32" d2="443" d3="981"/>
<CITE num="15" author="CRYZ SJ" publication="INFECT IMMUN" d1="32" d2="759" d3="981"/>
<CITE num="16" author="PENNINGTON JE" publication="J CLIN INVEST" d1="68" d2="1140" d3="981"/>
<CITE num="17" author="WOODS DE" publication="J CLIN INVEST" d1="68" d2="1435" d3="981"/>
<CITE num="18" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="19" author="WOODS DE" publication="J INFECT DIS" d1="143" d2="784" d3="981"/>
<CITE num="20" author="DORING G" publication="ZENTRALBL BAKT MIKROB HYG (A)" d1="249" d2="89" d3="981"/>
<CITE num="21" author="OBERNESSER HJ" publication="ZENTRALBL BAKT MIKROB HYG (A)" d1="249" d2="76" d3="981"/>
<CITE num="22" author="WRETLIND B" publication="SCAND J INFECT DIS" d1="1981" d2="13" d3="981"/>
<CITE num="23" author="CROWE KE" publication="J CLIN MICROBIOL" d1="15" d2="115" d3="982"/>
<CITE num="24" author="JAGGER KS" publication="J CLIN MICROBIOL" d1="15" d2="1054" d3="982"/>
<CITE num="25" author="BAKER NR" publication="IN VITRO" d1="18" d2="369" d3="982"/>
<CITE num="26" author="BAKER NR" publication="CAN J MICROBIOL" d1="28" d2="248" d3="982"/>
<CITE num="27" author="WOODS DE" publication="INFECT IMMUN" d1="36" d2="1223" d3="982"/>
<CITE num="28" author="WEINER RN" publication="EXP MOL PATH" d1="37" d2="249" d3="982"/>
<CITE num="29" author="DORING G" publication="ZENTRALBL BAKT MIKROB HYG (A)" d1="252" d2="239" d3="982"/>
<CITE num="30" author="OBERNESSER HJ" publication="ZENTRALBL BAKT MIKROB HYG (A)" d1="252" d2="248" d3="982"/>
<CITE num="31" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="32" author="POLLACK M" publication="REV INFECT DIS" d1="5" d2="S979" d3="983"/>
<CITE num="33" author="WOODS DE" publication="REV INFECT DIS" d1="5" d2="S715" d3="983"/>
<CITE num="34" author="WRETLIND B" publication="REV INFECT DIS" d1="5" d2="S998" d3="983"/>
<CITE num="35" author="JAGGER KN" publication="J CLIN MICROBIOL" d1="17" d2="55" d3="983"/>
<CITE num="36" author="BRYAN LE" publication="J CLIN MICROBIOL" d1="18" d2="276" d3="983"/>
<CITE num="37" author="CUKOR G" publication="J CLIN MICROBIOL" d1="18" d2="457" d3="983"/>
<CITE num="38" author="CASH HA" publication="CAN J MICROBIOL" d1="29" d2="448" d3="983"/>
<CITE num="39" author="KLINGER JD" publication="INFECT IMMUN" d1="39" d2="1377" d3="983"/>
<CITE num="40" author="LYERLY DM" publication="INFECT IMMUN" d1="40" d2="113" d3="983"/>
<CITE num="41" author="DORING G" publication="INFECT IMMUN" d1="42" d2="197" d3="983"/>
<CITE num="42" author="DORING G" publication="J INFECT DIS" d1="147" d2="744" d3="983"/>
<CITE num="43" author="CAPLAN DB" publication="REV INFECT DIS" d1="6" d2="S705" d3="984"/>
<CITE num="44" author="SPEERT DP" publication="PEDIATR RES" d1="18" d2="431" d3="984"/>
<CITE num="45" author="BOROWSKI RS" publication="J CLIN MICROBIOL" d1="19" d2="736" d3="984"/>
<CITE num="46" author="LONDON CJ" publication="APPL ENVIRON MICROBIOL" d1="47" d2="75" d3="984"/>
<CITE num="47" author="GRANSTROM M" publication="ACTA PAEDIATR SCAND" d1="73" d2="772" d3="984"/>
<CITE num="48" author="DORING G" publication="ACTA PATH MICROB IMMU SCA (C)" d1="92" d2="307" d3="984"/>
<CITE num="49" author="WOOTEN MW" publication="J CELL PHYSIOL" d1="121" d2="490" d3="984"/>
<CITE num="50" author="HANCOCK REW" publication="J INFECT DIS" d1="149" d2="220" d3="984"/>
<CITE num="51" author="PARMELY MJ" publication="J EXP MED" d1="160" d2="1338" d3="984"/>
<CITE num="52" author="GRANSTROM M" publication="EUR J CLIN MICROBIOL" d1="4" d2="197" d3="985"/>
<CITE num="53" author="KLINGER KW" publication="EUR J CLIN MICROBIOL" d1="4" d2="201" d3="985"/>
<CITE num="54" author="PITT TL" publication="EUR J CLIN MICROBIOL" d1="4" d2="190" d3="985"/>
<CITE num="55" author="SAELINGER CB" publication="EUR J CLIN MICROBIOL" d1="4" d2="170" d3="985"/>
<CITE num="56" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="57" author="DORING G" publication="INFECT IMMUN" d1="49" d2="557" d3="985"/>
<CITE num="58" author="LUZAR MA" publication="INFECT IMMUN" d1="50" d2="577" d3="985"/>
<CITE num="59" author="WINKLER U" publication="KLIN WSCHR" d1="63" d2="490" d3="985"/>
<CITE num="60" author="LORY S" publication="CURR TOP MICROBIOL IMMUNOL" d1="118" d2="53" d3="985"/>
<CITE num="61" author="BRUCE MC" publication="AM REV RESPIR DIS" d1="132" d2="529" d3="985"/>
<CITE num="62" author="GOTZ M" publication="MONATSSCHR KINDERHEILKD" d1="133" d2="718" d3="985"/>
<CITE num="63" author="WOODS DE" publication="CLIN INVEST MED" d1="9" d2="108" d3="986"/>
<CITE num="64" author="BALTIMORE RS" publication="PEDIATR RES" d1="20" d2="1085" d3="986"/>
<CITE num="65" author="WOODS DE" publication="J CLIN MICROBIOL" d1="24" d2="260" d3="986"/>
<CITE num="66" author="HINGLEY ST" publication="INFECT IMMUN" d1="54" d2="379" d3="986"/>
<CITE num="67" author="PITT TL" publication="J ROY SOC MED" d1="79" d2="13" d3="986"/>
<CITE num="68" author="VASIL ML" publication="J PEDIATR" d1="108" d2="800" d3="986"/>
<CITE num="69" author="MOSS RB" publication="AM REV RESPIR DIS" d1="133" d2="648" d3="986"/>
<CITE num="70" author="PARMELY MJ" publication="J IMMUNOL" d1="137" d2="988" d3="986"/>
<CITE num="71" author="DASGUPTA MK" publication="J CLIN IMMUNOL" d1="7" d2="51" d3="987"/>
<CITE num="72" author="DORING G" publication="INFECTION" d1="15" d2="47" d3="987"/>
</CITATIONS>
<RECORDNUM>00891 </RECORDNUM>
<MEDLINENUM>80076215</MEDLINENUM>
<AUTHORS><AUTHOR>Dann-L-G</AUTHOR><AUTHOR>Blau-K</AUTHOR></AUTHORS>
<TITLE>Studies on the basic defect in cystic fibrosis: the kinin hypothesis.</TITLE>
<SOURCE>J-Inherited-Metab-Dis. 1978. 1(4). P 179-81.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>KININS: ph</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>EXOCRINE-GLANDS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MODELS-BIOLOGICAL</TOPIC></MINORSUBJ>
<EXTRACT>It is our hypothesis that in cystic fibrosis there is a genetically
determined specific deficiency in the activity of either the
glandular kallikrein or in its activating enzyme, and that this
defect is the primary defect in the disease.  The immediate
consequence of either of these defects is the absence of kallidin and
the resulting failure of reabsorption.  The fact that there may be
mutations affecting distinct enzymes could account for the genetic
heterogeneity of cystic fibrosis.  A consequence of a defective
kallikrein system would be accumulation of a precursor related to the
low molecular weight kininogen and we propose that this compound is
the ciliary-dyskinesia factor.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78112</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BENKE PJ" publication="IN: MANGOS JA" d1="" d2="157" d3="976"/>
<CITE num="002" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="003" author="DANN LG" publication="LANCET" d1="2" d2="405" d3="978"/>
<CITE num="004" author="DIETL T" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="359" d2="499" d3="978"/>
<CITE num="005" author="EMRICH HM" publication="PEDIATR RES" d1="2" d2="464" d3="968"/>
<CITE num="006" author="GARRETT JR" publication="ARCH ORAL BIOL" d1="12" d2="1417" d3="967"/>
<CITE num="007" author="KAISER D" publication="LANCET" d1="1" d2="1003" d3="970"/>
<CITE num="008" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="009" author="MCKUSICK VA" publication="MENDELIAN INHERIT IN MAN" d1="" d2="468" d3="978"/>
<CITE num="010" author="MANGOS JA" publication="AM J PHYSIOL" d1="224" d2="1235" d3="973"/>
<CITE num="011" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="012" author="MANGOS JA" publication="IN: MANGOS JA" d1="" d2="311" d3="976"/>
<CITE num="013" author="MUNGER BL" publication="J BIOPHYS BIOCHEM CYTOL" d1="11" d2="385" d3="961"/>
<CITE num="014" author="NUSTAD K" publication="GEN PHARMAC" d1="9" d2="1" d3="978"/>
<CITE num="015" author="ORSTAVIK TB" publication="ACTA HISTOCHEM" d1="54" d2="183" d3="975"/>
<CITE num="016" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="017" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="018" author="SELINGER Z" publication="IN: CARAFOLI E" d1="" d2="139" d3="975"/>
<CITE num="019" author="SCHRAMM M" publication="J CYCLIC NUCLEOTIDES RES" d1="1" d2="181" d3="975"/>
<CITE num="020" author="SUTCLIFFE CH" publication="PROC R SOC MED" d1="61" d2="297" d3="968"/>
<CITE num="021" author="ULLRICH KJ" publication="IN: THORN NA" d1="" d2="423" d3="974"/>
<CITE num="022" author="WEBSTER ME" publication="BIOCHEM PHARMACOL" d1="12" d2="511" d3="963"/>
</REFERENCES>
<RECORDNUM>00892 </RECORDNUM>
<MEDLINENUM>78243862</MEDLINENUM>
<AUTHORS><AUTHOR>Wilson-G-B</AUTHOR><AUTHOR>Fudenberg-H-H</AUTHOR></AUTHORS>
<TITLE>Separation of ciliary dyskinesia substances found in serum and
secreted by cystic fibrosis leukocytes and lymphoid cell lines,
using protein A--Sepharose CL-4B.</TITLE>
<SOURCE>J-Lab-Clin-Med. 1978 Sep. 92(3). P 463-82.</SOURCE>
<MAJORSUBJ><TOPIC>BACTERIAL-PROTEINS</TOPIC><TOPIC>CILIA: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LEUKOCYTES: se</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-LINE</TOPIC><TOPIC>CELL-MOVEMENT</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CILIA: ph</TOPIC><TOPIC>GENOTYPE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>IGG: me</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>PROTEIN-BINDING</TOPIC><TOPIC>SERUM-ALBUMIN</TOPIC><TOPIC>SERUM-ALBUMIN-BOVINE</TOPIC><TOPIC>STAPHYLOCOCCUS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Cell-free culture medium from PHA-stimulated PBL cultures or
long-term lymphoid cell lines from CF homozygotes or obligate
heterozygotes, as well as serum from such individuals, can produce
three distinct changes in the ciliary beat of rabbit tracheal
ciliated epithelium: (1) increased beat frequency, (2) CD, and (3)
ciliostasis.  The ability to produce both 1 and 2 seems to be
characteristic for leukocyte cultures from CF genotypes: 46 of 49 CF
cultures produced both effects, as compared with none of 16 cultures
from normal controls and 1 of 10 from non-CF patient controls with
bronchial asthma.  CTA was not specific for CF PBL cultures, since
13% of normal control and 60% of the non-CF patient control cultures
produced ciliostasis.  Similar findings were obtained when serum from
the same individuals or culture medium from long-term lymphoid cell
lines was tested.  Using protein A from Staphylococcus aureus
covalently coupled to Sepharose CL-4B as a reagent, we separated the
CDAs present in serum and in culture medium from PBL and lymphoid
cultures.  Protein A specifically adsorbs IgG and binds it under mild
conditions at physiological pH.  The CDAs are noncovalently bound to
IgG at physiological pH and can be co-purified with IgG.  The IgG-CDA
complexes can be readily desorbed from protein A-Sepharose CL-4B at
pH 3.0, and under these conditions the CDAs are dissociated from IgG,
retain all their activity, and can be separated by chromatography on
Bio-Gel P-10 or Sephadex G-200.  Three distinct activities were
removed from serum or PBL cultures which showed both CDA and CTA, and
two were obtained from samples which showed only CDA.  One CDA
believed to be specific for CF (CF-CDA) was separated from CF serum
and PBL or lymphoid cell culture medium.  This CF-CDA was complexed
noncovalently to IgG (not subclass IgG3), had a molecular weight of
4000 to 6000, was stable as acid pH, was found in biological fluids
from both homozygotes and heterozygotes for CF, was shown not to be
C3a (anaphylatoxin), did not require IgG for activity, and was
positively charged at pH values more acidic than 8.0.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="004" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="005" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="006" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="007" author="BERATIS NG" publication="PEDIATR RES" d1="7" d2="958" d3="973"/>
<CITE num="008" author="BOWMAN BH" publication="PROC NAT ACAD SCI USA" d1="70" d2="548" d3="973"/>
<CITE num="009" author="DANES BS" publication="J EXP MED" d1="136" d2="1313" d3="972"/>
<CITE num="010" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="224" d3="973"/>
<CITE num="011" author="DANES BS" publication="CLIN GENET" d1="7" d2="128" d3="975"/>
<CITE num="012" author="WILSON GB" publication="CLIN RES" d1="25" d2="34" d3="977"/>
<CITE num="014" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="64" d2="1310" d3="975"/>
<CITE num="015" author="DANES BS" publication="J EXP MED" d1="137" d2="1538" d3="973"/>
<CITE num="016" author="DANES BS" publication="TEX REP BIOL MED" d1="34" d2="135" d3="976"/>
<CITE num="017" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="317" d3="977"/>
<CITE num="018" author="CONOD EJ" publication="PEDIATR RES" d1="11" d2="45" d3="977"/>
<CITE num="019" author="GLADE PR" publication="AM J PATHOL" d1="60" d2="483" d3="970"/>
<CITE num="020" author="CONOVER JH" publication="LANCET" d1="2" d2="1501" d3="973"/>
<CITE num="021" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="022" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="143" d3="977"/>
<CITE num="023" author="WILSON GB" publication="IN: RADOLA BJ" d1="" d2="337" d3="977"/>
<CITE num="024" author="WILSON GB" publication="NATURE" d1="266" d2="463" d3="977"/>
<CITE num="025" author="HJELM H" publication="FEBS LETTERS" d1="28" d2="73" d3="972"/>
<CITE num="026" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
<CITE num="027" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="139" d3="977"/>
<CITE num="028" author="POLET H" publication="J EXP MED" d1="142" d2="949" d3="975"/>
<CITE num="029" author="BOYUM A" publication="SCAND J CLIN LAB INVEST SUPPL" d1="97" d2="77" d3="968"/>
<CITE num="030" author="BRODER SW" publication="BLOOD" d1="35" d2="539" d3="970"/>
<CITE num="032" author="GRABAR P" publication="BIOCHIM BIOPHYS ACTA" d1="10" d2="193" d3="953"/>
<CITE num="033" author="LAURELL CB" publication="ANAL BIOCHEM" d1="15" d2="45" d3="966"/>
<CITE num="034" author="FUDENBERG HH" publication="BASIC IMMUNOGENETICS" d1="" d2="" d3="977"/>
<CITE num="035" author="VYAS GN" publication="J IMMUNOL" d1="100" d2="274" d3="968"/>
<CITE num="036" author="PANDEY JP" publication="J IMMUNOGENET" d1="5" d2="122" d3="978"/>
<CITE num="037" author="BOHLEN P" publication="ARCH BIOCHEM BIOPHYS" d1="155" d2="213" d3="973"/>
<CITE num="038" author="KRONVALL G" publication="J IMMUNOL" d1="103" d2="828" d3="969"/>
<CITE num="040" author="SPRAGG J" publication="ANN NY ACAD SCI" d1="209" d2="372" d3="973"/>
<CITE num="041" author="AMAUD P" publication="TRANS ASSOC AM PHYSICIANS" d1="39" d2="205" d3="976"/>
<CITE num="042" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
<CITE num="043" author="CONOD EJ" publication="PEDIATR RES" d1="9" d2="724" d3="975"/>
<CITE num="044" author="VALLOTA EH" publication="J EXP MED" d1="137" d2="1109" d3="973"/>
<CITE num="045" author="BARNETT DR" publication="TEX REP BIOL MED" d1="31" d2="709" d3="973"/>
<CITE num="046" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="047" author="SHAPIRA E" publication="J BIOL CHEM" d1="252" d2="7923" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78113</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LSON GB             PE" publication="DIATR RES" d1="13" d2="79 9" d3="9"/>
<CITE num="2" author="STRAUSS RG" publication="HELV PAEDIATR ACTA" d1="34" d2="429" d3="979"/>
<CITE num="3" author="WILSON GB" publication="J CLIN INVEST" d1="66" d2="1010" d3="980"/>
<CITE num="4" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="5" author="WILSON GB" publication="PROC SOC EXP BIOL MED" d1="164" d2="105" d3="980"/>
<CITE num="6" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="53" d3="981"/>
<CITE num="7" author="WILSON GB" publication="J CLIN INVEST" d1="68" d2="171" d3="981"/>
<CITE num="8" author="WILSON GB" publication="CLIN GENET" d1="26" d2="331" d3="984"/>
</CITATIONS>
<RECORDNUM>00893 </RECORDNUM>
<MEDLINENUM>79049543</MEDLINENUM>
<AUTHORS><AUTHOR>Moller-N-E</AUTHOR><AUTHOR>Thomsen-J</AUTHOR></AUTHORS>
<TITLE>Mucocele of the paranasal sinuses in cystic fibrosis.</TITLE>
<SOURCE>J-Laryngol-Otol. 1978 Nov. 92(11). P 1025-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>MUCOCELE: et</TOPIC><TOPIC>PARANASAL-SINUS-DISEASES: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Two children below 9 years of age with mucocele and cystic fibrosis
are reported. Mucocele in this age-group is very rare and is probably
pathognomonic of cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CARDESA" publication="CITED IN: ACTA OTO RINO LARIN" d1="3" d2="251" d3="970"/>
<CITE num="002" author="DAWES JDK" publication="IN: SCOTT-BROWN" d1="3" d2="266" d3="971"/>
<CITE num="003" author="MENDELSOHN RS" publication="ARCH OTOLARYNGOL" d1="79" d2="312" d3="964"/>
<CITE num="004" author="NEELY JG" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="76" d2="313" d3="972"/>
<CITE num="005" author="RITTER FN" publication="IN: COATES GM" d1="3" d2="15" d3="955"/>
<CITE num="006" author="ROBERTSON DM" publication="AM J OPHTHALMOL" d1="68" d2="845" d3="969"/>
<CITE num="007" author="RULON JT" publication="ARCH OTOLARYNGOL" d1="78" d2="192" d3="963"/>
<CITE num="008" author="STOOL S" publication="TRANS AM ACAD OPHTHALMOL OTOL" d1="70" d2="811" d3="966"/>
<CITE num="009" author="TALLENT A" publication="CAHIERS OTO RHINO LARYNGOL" d1="5" d2="7" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78114</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BACHNIK NF          SU" publication="RG GYNECOL OBSTET            1" d1="52" d2="37 9" d3="1"/>
<CITE num="2" author="BECK B" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="125" d3="982"/>
</CITATIONS>
<RECORDNUM>00894 </RECORDNUM>
<MEDLINENUM>78201635</MEDLINENUM>
<AUTHORS><AUTHOR>Calbreath-D-F</AUTHOR></AUTHORS>
<TITLE>Screening for cystic fibrosis.</TITLE>
<SOURCE>J-Nurs-Care. 1978 Jul. 11(7). P 8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78115</PAPERNUM>
<EXTRACT>Cystic fibrosis is a great unknown.  There is a lot of information
about the disease, but no common denominator, nothing to pull all the
pieces together.  It represents both a diagnostic and a therapeutic
challenge.  Progress is being made and perhaps someday we will be
able to understand this complex entity.</EXTRACT>
<RECORDNUM>00895 </RECORDNUM>
<MEDLINENUM>79153473</MEDLINENUM>
<AUTHORS><AUTHOR>Morrissey-S-M</AUTHOR><AUTHOR>Tymvios-M-C</AUTHOR></AUTHORS>
<TITLE>Acid mucins in human intestinal goblet cells.</TITLE>
<SOURCE>J-Pathol. 1978 Dec. 126(4). P 197-208.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: me</TOPIC><TOPIC>INTESTINE-SMALL: me</TOPIC><TOPIC>MUCINS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-COUNT</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>DUODENUM: me</TOPIC><TOPIC>HISTOCYTOCHEMISTRY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ILEUM: me</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: pa</TOPIC><TOPIC>INTESTINE-SMALL: pa</TOPIC><TOPIC>JEJUNUM: me</TOPIC></MINORSUBJ>
<ABSTRACT>Acid mucins in goblet cells of the duodenum, jejunum and ileum of
neonates and infants with cystic fibrosis (CF) and without CF were
measured by scanning microdensitometry after alcian blue staining
according to the protocol of McCarthy and Reid (1963) which
characterises four groups of acidic mucins. In CF infants over 6 mth
of age, but not in controls, there was an increase along the gut from
duodenum to ileum of both weakly acidic and strongly acidic
sulphomucins. In the ileum the increase was in total mucins from 6
mth previously in the same CF patients and this difference could be
accounted for by an increase of sialidase-resistant mucins. The
increase in sulphomucins was more marked at the tip than at the base
of the villi. In CF neonates there was significant difference in the
quantities of acidic mucins. The question whether the mucins of CF
are chemically abnormal or merely accumulated to an abnormal extent
is probably best investigated by analysis of sialidase-resistant
mucins and sulphomucins of the ileum and strongly acidic sulphomucins
of the duodenum and jejunum in CF infants over 6 mth of age.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="ANN NY ACAD SCI" d1="93" d2="500" d3="962"/>
<CITE num="002" author="BAUER U" publication="ANN PAEDIATR" d1="194" d2="236" d3="960"/>
<CITE num="003" author="BELANGER L" publication="ANN NY ACAD SCI" d1="106" d2="364" d3="963"/>
<CITE num="004" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="005" author="FARBER S" publication="J MICH MED SOC" d1="44" d2="587" d3="945"/>
<CITE num="006" author="FREYE HB" publication="J PEDIATR" d1="64" d2="575" d3="964"/>
<CITE num="007" author="GIBBONS RA" publication="EXCERPTA MED INT CONG SERIES" d1="133" d2="695" d3="966"/>
<CITE num="008" author="GOTTSCHALK A" publication="CHEM BIOL SIALIC ACID REL" d1="" d2="" d3="960"/>
<CITE num="009" author="GRAIG JM" publication="IN: RESEARCH ON CF" d1="" d2="25" d3="959"/>
<CITE num="010" author="GRECO V" publication="GUT" d1="8" d2="491" d3="967"/>
<CITE num="011" author="JOHANSEN PG" publication="ANN NY ACAD SCI" d1="106" d2="755" d3="963"/>
<CITE num="012" author="JOHANSEN PG" publication="J PATHOL" d1="99" d2="299" d3="969"/>
<CITE num="013" author="JONES R" publication="HISTOCHEM J" d1="5" d2="19" d3="973"/>
<CITE num="014" author="KENT PW" publication="BIOCHEM J" d1="87" d2="38" d3="963"/>
<CITE num="015" author="LAMB D" publication="THESIS" d1="" d2="" d3="969"/>
<CITE num="016" author="LAMB D" publication="J PATHOL" d1="98" d2="213" d3="969"/>
<CITE num="017" author="LAMB D" publication="HISTOCHEM J" d1="4" d2="91" d3="972"/>
<CITE num="018" author="LANDING BH" publication="ROSS PAEDIATR RES CONF 18TH" d1="" d2="63" d3="956"/>
<CITE num="019" author="LEV R" publication="LAB INVEST" d1="14" d2="2080" d3="966"/>
<CITE num="020" author="LEV R" publication="AM J PATHOL" d1="46" d2="23" d3="965"/>
<CITE num="021" author="MCCARTHY C" publication="Q J EXP PHYSIOL" d1="49" d2="81" d3="964"/>
<CITE num="022" author="PALLAVICINI JC" publication="ANN NY ACAD SCI" d1="106" d2="330" d3="963"/>
<CITE num="023" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="024" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="025" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="026" author="SCHRAGER J" publication="NATURE" d1="201" d2="702" d3="964"/>
<CITE num="027" author="SHACKLEFORD JM" publication="J HISTOCHEM CYTOCHEM" d1="12" d2="512" d3="964"/>
<CITE num="028" author="SPICER SS" publication="AM J CLIN PATHOL" d1="33" d2="453" d3="970"/>
<CITE num="029" author="THOMAIDIS TS" publication="J PEDIATR" d1="63" d2="444" d3="963"/>
<CITE num="030" author="WAGNER BM" publication="AM J DIS CHILD" d1="99" d2="61" d3="960"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78116</PAPERNUM>
<CITATIONS>
<CITE num="1" author="UGH L               J" publication="PHYSIOL (LOND)               2" d1="91" d2="9 9" d3="9"/>
<CITE num="2" author="MORRISSEY SM" publication="GUT" d1="22" d2="788" d3="981"/>
<CITE num="3" author="ADLER KB" publication="LAB INVEST" d1="45" d2="372" d3="981"/>
<CITE num="4" author="FORSTNER G" publication="ADV EXP MED BIOL" d1="144" d2="199" d3="982"/>
<CITE num="5" author="WESLEY A" publication="PEDIATR RES" d1="17" d2="65" d3="983"/>
<CITE num="6" author="MORRISSEY SM" publication="GUT" d1="24" d2="909" d3="983"/>
<CITE num="7" author="REID L" publication="INT REV EXP PATHOL" d1="24" d2="335" d3="983"/>
<CITE num="8" author="JACOBS LR" publication="DIG DIS SCI" d1="28" d2="422" d3="983"/>
<CITE num="9" author="JEFFREY I" publication="J CLIN PATHOL" d1="36" d2="1292" d3="983"/>
<CITE num="10" author="HOLLANDERS D" publication="BR J CLIN PRACT" d1="37" d2="112" d3="983"/>
<CITE num="11" author="SLOMIANY A" publication="BIOCHIM BIOPHYS ACTA" d1="750" d2="253" d3="983"/>
<CITE num="12" author="REID PE" publication="HISTOCHEM J" d1="16" d2="253" d3="984"/>
<CITE num="13" author="JEFFREY I" publication="J CLIN PATHOL" d1="37" d2="957" d3="984"/>
<CITE num="14" author="HOLLANDERS D" publication="J PHYSIOL (LOND)" d1="348" d2="P  8" d3="984"/>
<CITE num="15" author="CLEGHORN GJ" publication="LANCET" d1="1" d2="8" d3="986"/>
<CITE num="16" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
<CITE num="17" author="HOLLANDERS D" publication="BR J CLIN PRACT" d1="40" d2="74" d3="986"/>
</CITATIONS>
<RECORDNUM>00896 </RECORDNUM>
<MEDLINENUM>78153026</MEDLINENUM>
<AUTHORS><AUTHOR>Buts-J-P</AUTHOR><AUTHOR>Morin-C-L</AUTHOR><AUTHOR>Roy-C-C</AUTHOR><AUTHOR>Weber-A</AUTHOR><AUTHOR>Bonin-A</AUTHOR></AUTHORS>
<TITLE>One-hour blood xylose test: a reliable index of small bowel function.</TITLE>
<SOURCE>J-Pediatr. 1978 May. 92(5). P 729-33.</SOURCE>
<MAJORSUBJ><TOPIC>INTESTINAL-MUCOSA: pp</TOPIC><TOPIC>INTESTINE-SMALL: pp</TOPIC><TOPIC>XYLOSE: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELIAC-DISEASE: di</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FECES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-DISEASES: di</TOPIC><TOPIC>LIPIDS: an</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: di</TOPIC><TOPIC>RETROSPECTIVE-STUDIES</TOPIC><TOPIC>TIME-FACTORS</TOPIC><TOPIC>XYLOSE: bl</TOPIC></MINORSUBJ>
<ABSTRACT>A retrospective analysis of oral D-xylose tolerance tests in 435
pediatric patients was performed. A significant difference was found
between 126 normal subjects and 47 untreated children with celiac
disease one hour after load. The one-hour value was found to be more
reliable than was fecal fat analysis in screening children for celiac
disease. Sex, age, weight, and body surface did not influence the
results of the one-hour value in the control subjects. Forty-eight
children with cystic fibrosis had one-hour xylose levels within the
normal range, but the means at 90, 120, and 180 minutes after load
exceeded significantly (P less than 0.01) those of the controls. In a
nonceliac group of 63 children with abnormally low xylose levels,
almost all were found to have clinical conditions compatible with
upper small bowel mucosal impairment. This study shows that a single
estimation of xylose in blood one hour after load is a reliable index
of small bowel mucosal function. It is a good screening test for
celiac disease and small bowel disorders producing malabsorption in
children.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="HAWKINS KI" publication="CLIN CHEM" d1="16" d2="749" d3="970"/>
<CITE num="002" author="JONES WO" publication="J PEDIATR" d1="62" d2="50" d3="963"/>
<CITE num="003" author="MEEUWISSE GW" publication="ACTA PAEDIATR SCAND" d1="54" d2="33" d3="965"/>
<CITE num="004" author="MCCRAE WM" publication="ARCH DIS CHILD" d1="38" d2="571" d3="963"/>
<CITE num="005" author="SAMMONS HG" publication="GUT" d1="8" d2="348" d3="967"/>
<CITE num="006" author="FINLAY JM" publication="ANN INTERN MED" d1="61" d2="411" d3="964"/>
<CITE num="007" author="BENSON JA JR" publication="N ENGL J MED" d1="256" d2="335" d3="957"/>
<CITE num="008" author="ROLLES CJ" publication="LANCET" d1="2" d2="1043" d3="973"/>
<CITE num="009" author="ROLLES CJ" publication="ARCH DIS CHILD" d1="50" d2="359" d3="975"/>
<CITE num="010" author="SLADEN GE" publication="BR MED J" d1="3" d2="223" d3="973"/>
<CITE num="011" author="LAMABADUSURIYA SP" publication="ARCH DIS CHILD" d1="50" d2="34" d3="975"/>
<CITE num="012" author="GOLDMAN AS" publication="PEDIATRICS" d1="32" d2="425" d3="963"/>
<CITE num="013" author="DAVIDSON M" publication="J PEDIATR" d1="69" d2="1027" d3="966"/>
<CITE num="014" author="ROE JH" publication="J BIOL CHEM" d1="173" d2="507" d3="948"/>
<CITE num="015" author="LANZKOWSKY P" publication="JAMA" d1="186" d2="517" d3="963"/>
<CITE num="016" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="017" author="SHMERLING DH" publication="PEDIATRICS" d1="46" d2="690" d3="970"/>
<CITE num="018" author="FORDTRAN JS" publication="N ENGL J MED" d1="267" d2="274" d3="962"/>
<CITE num="019" author="BUTTERWORTH CE JR" publication="N ENGL J MED" d1="261" d2="157" d3="959"/>
<CITE num="020" author="SEGAL S" publication="J CLIN INVEST" d1="38" d2="407" d3="959"/>
<CITE num="021" author="CASPARY WF" publication="GASTROENTEROLOGY" d1="63" d2="531" d3="972"/>
<CITE num="022" author="GLUCKMAN RF" publication="GASTROENTEROLOGY" d1="44" d2="828" d3="963"/>
<CITE num="023" author="KENDALL MJ" publication="BR MED J" d1="1" d2="533" d3="971"/>
<CITE num="024" author="JACOBSON ED" publication="AM J MED" d1="28" d2="524" d3="960"/>
<CITE num="025" author="EGAN-MITCHELL B" publication="ARCH DIS CHILD" d1="47" d2="238" d3="972"/>
<CITE num="026" author="OPPENHEIMER EH" publication="J PEDIATR" d1="86" d2="683" d3="975"/>
<CITE num="027" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="18" d2="387" d3="956"/>
<CITE num="028" author="WYNGAARDEN JB" publication="J CLIN INVEST" d1="36" d2="1395" d3="957"/>
<CITE num="029" author="BRIEN FS" publication="GASTROENTEROLOGY" d1="20" d2="287" d3="952"/>
<CITE num="030" author="SANTIAGO-BORRERO PJ" publication="PEDIATRICS" d1="48" d2="59" d3="971"/>
<CITE num="031" author="GOLDSTEIN F" publication="GASTROENTEROLOGY" d1="59" d2="380" d3="970"/>
<CITE num="032" author="ROBILLARD JE" publication="UNION MED CAN" d1="102" d2="1496" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78117</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RIN CL              LA" publication="NCET" d1="1" d2="02 9" d3="9"/>
<CITE num="2" author="CHRISTIE DL" publication="J PEDIATR" d1="94" d2="509" d3="979"/>
<CITE num="3" author="LIEBMAN WM" publication="J PEDIATR" d1="94" d2="508" d3="979"/>
<CITE num="4" author="MORIN CL" publication="J PEDIATR" d1="94" d2="509" d3="979"/>
<CITE num="5" author="COBDEN I" publication="GUT" d1="21" d2="512" d3="980"/>
<CITE num="6" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="7" author="LEBENTHAL E" publication="J PEDIATR" d1="98" d2="681" d3="981"/>
<CITE num="8" author="KEKOMAKI M" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="369" d3="982"/>
<CITE num="9" author="MONTGOMERY RD" publication="TRANS R SOC TROP MED HYG" d1="76" d2="25" d3="982"/>
<CITE num="10" author="RYAN ME" publication="CLIN GASTROENTEROL" d1="12" d2="533" d3="983"/>
<CITE num="11" author="SAVILAHTI E" publication="ARCH DIS CHILD" d1="58" d2="246" d3="983"/>
<CITE num="12" author="PERKKIO M" publication="ACTA PAEDIATR SCAND" d1="73" d2="680" d3="984"/>
<CITE num="13" author="FITZGERALD JF" publication="PEDIATR INFECT DIS" d1="4" d2="6" d3="985"/>
<CITE num="14" author="BONAMICO M" publication="RIV ITAL PEDIATR" d1="11" d2="172" d3="985"/>
<CITE num="15" author="CHATTI N" publication="UNION MED CAN" d1="114" d2="60" d3="985"/>
<CITE num="16" author="LOMBARD KA" publication="PEDIATRICS" d1="77" d2="396" d3="986"/>
<CITE num="17" author="LEVINE JJ" publication="AM J DIS CHILD" d1="141" d2="435" d3="987"/>
</CITATIONS>
<RECORDNUM>00897 </RECORDNUM>
<MEDLINENUM>79069434</MEDLINENUM>
<AUTHORS><AUTHOR>Davidson-G-P</AUTHOR><AUTHOR>Hassel-F-M</AUTHOR><AUTHOR>Crozier-D</AUTHOR><AUTHOR>Corey-M</AUTHOR><AUTHOR>Forstner-G-G</AUTHOR></AUTHORS>
<TITLE>Iatrogenic hyperuricemia in children with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1978 Dec. 93(6). P 976-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>URIC-ACID: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREAS: en</TOPIC><TOPIC>PANCREATIC-EXTRACTS: ae, tu</TOPIC><TOPIC>PURINES: ae</TOPIC></MINORSUBJ>
<EXTRACT>We report the frequent presence of hyperuricemia in a group of
children with cystic fibrosis who were known to be consuming large
dosages of pancreatic extract as part of their therapy.
Hyperuricemia was more common in older patients who had been treated
for a longer period of time.  Clarification of the role of renal
function and other factors in the production of hyperuricemia awaits
a careful study of the relationship of purine load to urate excretion
at various ages in these patients.</EXTRACT>
<REFERENCES>
<CITE num="001" author="STAPLETON FB" publication="N ENGL J MED" d1="295" d2="246" d3="976"/>
<CITE num="002" author="NOUSIA-ARVANITAKIS S" publication="J PEDIATR" d1="90" d2="302" d3="977"/>
<CITE num="003" author="COREY M" publication="AM REV RESPIR DIS" d1="114" d2="1085" d3="976"/>
<CITE num="004" author="HARKNESS RA" publication="ARCH DIS CHILD" d1="44" d2="773" d3="969"/>
<CITE num="005" author="ENDOZIEN JC" publication="NATURE" d1="228" d2="180" d3="970"/>
<CITE num="006" author="STAPLETON FB" publication="PEDIATR RES" d1="11" d2="558" d3="977"/>
<CITE num="007" author="KAUFMAN JM" publication="J PEDIATR" d1="73" d2="583" d3="968"/>
<CITE num="008" author="WINBERG J" publication="ACTA PAEDIATR SCAND" d1="48" d2="443" d3="959"/>
<CITE num="009" author="GUTMAN AB" publication="TRANS ASSOC AM PHYSICIANS" d1="74" d2="353" d3="961"/>
<CITE num="010" author="KLINENBERG J" publication="NEPHRON" d1="14" d2="88" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78118</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HL WA               J" publication="PEDIATR" d1="95" d2="30 9" d3="9"/>
<CITE num="2" author="ROBB TA" publication="LANCET" d1="2" d2="544" d3="980"/>
<CITE num="3" author="BELL L" publication="J CAN DIET ASSOC" d1="42" d2="62" d3="981"/>
<CITE num="4" author="BOHLES H" publication="HELV PAEDIATR ACTA" d1="37" d2="267" d3="982"/>
<CITE num="5" author="MISCHLER EH" publication="AM J DIS CHILD" d1="136" d2="1060" d3="982"/>
<CITE num="6" author="CHEN YT" publication="N ENGL J MED" d1="311" d2="128" d3="984"/>
<CITE num="7" author="PERRY RS" publication="CLIN PHARMACY" d1="4" d2="161" d3="985"/>
<CITE num="8" author="ZENTLERMUNRO PL" publication="GUT" d1="26" d2="892" d3="985"/>
<CITE num="9" author="SPINO M" publication="J PEDIATR" d1="107" d2="64" d3="985"/>
<CITE num="10" author="RUSH PJ" publication="SEM ARTHRITIS RHEUM" d1="15" d2="213" d3="986"/>
<CITE num="11" author="GOODCHILD MC" publication="J ROY SOC MED" d1="79" d2="32" d3="986"/>
<CITE num="12" author="PHILLIPS BM" publication="J ROY SOC MED" d1="79" d2="44" d3="986"/>
</CITATIONS>
<RECORDNUM>00898 </RECORDNUM>
<MEDLINENUM>78153070</MEDLINENUM>
<AUTHORS><AUTHOR>Kulczycki-L-L</AUTHOR><AUTHOR>Schauf-V</AUTHOR></AUTHORS>
<TITLE>Incidence of cystic fibrosis in black children--revisited [letter].</TITLE>
<SOURCE>J-Pediatr. 1978 May. 92(5). P 855.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BLACKS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>DISTRICT-OF-COLUMBIA</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: oc</TOPIC><TOPIC>NEW-YORK-CITY</TOPIC></MINORSUBJ>
<EXTRACT>In the February, 1977, issue of The Journal, Dr. Heffer comments on
publications concerning the occurrence of cystic fibrosis (CF) in
black children.  He "feels" that CF occurs more frequently than we
have reported.  Our ten-year search in the Washington, D.C., area
shows a minimum incidence of cystic fibrosis among black newborn
infants as one per 17,000.  Since 1972, we have identified an
additional four black patients with cystic fibrosis in black
children.  This is consistent with the previously reported incidence
of one in 17,000.  Therefore, we disagree with Heffer, that this is a
common disease among blacks.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78119</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HEFFER ET" publication="J PEDIATR" d1="90" d2="324" d3="977"/>
<CITE num="002" author="HEFFER ET" publication="NY STATE J MED" d1="74" d2="2355" d3="974"/>
<CITE num="003" author="KULCZYCKI LL" publication="AM J DIS CHILD" d1="127" d2="64" d3="974"/>
<CITE num="004" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="3" d2="692" d3="964"/>
<CITE num="005" author="STERN RC" publication="J PEDIATR" d1="89" d2="412" d3="976"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="ANN INTERN MED" d1="54" d2="482" d3="961"/>
</REFERENCES>
<RECORDNUM>00899 </RECORDNUM>
<MEDLINENUM>78153027</MEDLINENUM>
<AUTHORS><AUTHOR>Nousia-Arvanitakis-S</AUTHOR><AUTHOR>Arvanitakis-C</AUTHOR><AUTHOR>Desai-N</AUTHOR><AUTHOR>Greenberger-N-J</AUTHOR></AUTHORS>
<TITLE>Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by
the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.</TITLE>
<SOURCE>J-Pediatr. 1978 May. 92(5). P 734-7.</SOURCE>
<MAJORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: du</TOPIC><TOPIC>AMINOBENZOIC-ACIDS: du</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PANCREATIC-DISEASES: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>P-AMINOBENZOIC-ACID: aa, ur</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHYMOTRYPSIN: me</TOPIC><TOPIC>FECES: an, en</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIPIDS: an</TOPIC><TOPIC>PANCREATIC-DISEASES: et, ur</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid is
specifically cleaved by chymotrypsin to Bz-Ty and PABA. The liberated
PABA is absorbed and excreted in the urine. Accordingly, PABA
recovery reflects intraluminal chymotrypsin activity and is an index
of exocrine pancreatic function. This test was evaluated in 24
patients with cystic fibrosis to determine its role in the diagnosis
of exocrine pancreatic insufficiency. Cumulative percent PABA
recovery in six hours was significantly lower in CF patients compared
with the control group. No overlap was noted between the two groups.
There was good correlation between PABA recovery, fecal chymotrypsin
activity, and coefficient of fat absorption. These findings indicate
that PABA recovery is significantly reduced in patients with CF and
steatorrhea and may prove a practical and reliable test of pancreatic
insufficiency.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KOPEL FB" publication="GASTROENTEROLOGY" d1="62" d2="483" d3="972"/>
<CITE num="002" author="STAPLETON FB" publication="N ENGL J MED" d1="295" d2="246" d3="976"/>
<CITE num="003" author="IMONDI AR" publication="GUT" d1="13" d2="726" d3="972"/>
<CITE num="004" author="ARVANITAKIS C" publication="LANCET" d1="1" d2="663" d3="976"/>
<CITE num="005" author="GYR K" publication="GUT" d1="17" d2="27" d3="976"/>
<CITE num="006" author="BORNSCHEIN W" publication="CLIN CHIM ACTA" d1="67" d2="21" d3="976"/>
<CITE num="007" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="008" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="009" author="IMONDI AR" publication="ANAL BIOCHEM" d1="54" d2="199" d3="973"/>
<CITE num="010" author="BRATTON AC" publication="J BIOL CHEM" d1="128" d2="537" d3="939"/>
<CITE num="011" author="SMITH HW" publication="J CLIN INVEST" d1="24" d2="388" d3="945"/>
<CITE num="012" author="BARBERO GJ" publication="AM J DIS CHILD" d1="112" d2="536" d3="966"/>
<CITE num="013" author="DYCK WP" publication="AM J DIG DIS" d1="12" d2="310" d3="967"/>
<CITE num="014" author="GREENGARD P" publication="IN: GOODMAN LS" d1="" d2="1661" d3="970"/>
<CITE num="015" author="ZAROFONETIS CJD" publication="J INVEST DERMATOL" d1="11" d2="359" d3="948"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78120</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ONDI AR             DI" publication="G DIS SCI" d1="24" d2="14 9" d3="9"/>
<CITE num="2" author="MALIS F" publication="J PEDIATR" d1="94" d2="942" d3="979"/>
<CITE num="3" author="SACHER M" publication="J PEDIATR" d1="94" d2="159" d3="979"/>
<CITE num="4" author="LANKISCH PG" publication="DTSCH MED WSCHR" d1="105" d2="1418" d3="980"/>
<CITE num="5" author="LANG C" publication="SCHWEIZ MED WOCHENSCHR" d1="110" d2="522" d3="980"/>
<CITE num="6" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="746" d3="980"/>
<CITE num="7" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="301" d3="980"/>
<CITE num="8" author="OSSWALD P" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="340" d3="980"/>
<CITE num="9" author="SCHONBERGER W" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="195" d3="980"/>
<CITE num="10" author="HOEK FJ" publication="GUT" d1="22" d2="8" d3="981"/>
<CITE num="11" author="LANKISCH PG" publication="HEPATOGASTROENTEROLOGY" d1="28" d2="333" d3="981"/>
<CITE num="12" author="LANG C" publication="BR J SURG" d1="68" d2="771" d3="981"/>
<CITE num="13" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="14" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="15" author="WOLF C" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="343" d3="981"/>
<CITE num="16" author="LIBEER JC" publication="CLIN CHIM ACTA" d1="115" d2="119" d3="981"/>
<CITE num="17" author="KAI H" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="445" d3="982"/>
<CITE num="18" author="LANKISCH PG" publication="GUT" d1="23" d2="777" d3="982"/>
<CITE num="19" author="RYAN ME" publication="CLIN GASTROENTEROL" d1="12" d2="533" d3="983"/>
<CITE num="20" author="DELCHIER JC" publication="GUT" d1="24" d2="318" d3="983"/>
<CITE num="21" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="22" author="TOSKES PP" publication="GASTROENTEROLOGY" d1="85" d2="565" d3="983"/>
<CITE num="23" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="2" d2="249" d3="984"/>
<CITE num="24" author="TOSKES PP" publication="PHARMACOTHERAPY" d1="4" d2="74" d3="984"/>
<CITE num="25" author="LANKISCH PG" publication="CLIN GASTROENTEROL" d1="13" d2="717" d3="984"/>
<CITE num="26" author="HUBBARD VS" publication="DIG DIS SCI" d1="29" d2="881" d3="984"/>
<CITE num="27" author="GILLARD BK" publication="AM J DIS CHILD" d1="138" d2="577" d3="984"/>
<CITE num="28" author="BELLENTANI S" publication="EUR J PEDIATR" d1="143" d2="145" d3="984"/>
<CITE num="29" author="ORENSTEIN DM" publication="SEM RESPIR MED" d1="6" d2="252" d3="985"/>
<CITE num="30" author="SCOTTA MS" publication="CLIN BIOCHEM" d1="18" d2="233" d3="985"/>
<CITE num="31" author="BORNSCHEIN W" publication="Z GASTROENTEROL" d1="23" d2="247" d3="985"/>
<CITE num="32" author="KOREN G" publication="DIG DIS SCI" d1="30" d2="928" d3="985"/>
<CITE num="33" author="RIEU D" publication="ANN PEDIATR (PARIS)" d1="32" d2="205" d3="985"/>
<CITE num="34" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND" d1="74" d2="460" d3="985"/>
<CITE num="35" author="NIEDERAU C" publication="GASTROENTEROLOGY" d1="88" d2="1973" d3="985"/>
<CITE num="36" author="HEYMAN MB" publication="GASTROENTEROLOGY" d1="89" d2="685" d3="985"/>
<CITE num="37" author="WEIZMAN Z" publication="GASTROENTEROLOGY" d1="89" d2="596" d3="985"/>
<CITE num="38" author="SCHARPE S" publication="CLIN CHEM" d1="33" d2="5" d3="987"/>
<CITE num="39" author="SARLES J" publication="ARCH FR PEDIATR" d1="44" d2="311" d3="987"/>
</CITATIONS>
<RECORDNUM>00900 </RECORDNUM>
<MEDLINENUM>79069407</MEDLINENUM>
<AUTHORS><AUTHOR>Vitullo-B-B</AUTHOR><AUTHOR>Rochon-L</AUTHOR><AUTHOR>Seemayer-T-A</AUTHOR><AUTHOR>Beardmore-H</AUTHOR><AUTHOR>de-Belle-R-C</AUTHOR></AUTHORS>
<TITLE>Intrapancreatic compression of the common bile duct in cystic
fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1978 Dec. 93(6). P 1060-1.</SOURCE>
<MAJORSUBJ><TOPIC>COMMON-BILE-DUCT</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AUTOPSY</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CHOLESTASIS: et</TOPIC><TOPIC>COMMON-BILE-DUCT: pa</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PRESSURE</TOPIC></MINORSUBJ>
<ABSTRACT>We report an infant with cystic fibrosis presenting at birth with
meconium ileus who developed prolonged cholestatic jaundice from
compression of the common bile duct and the pancreatic duct by
advanced pancreatic fibrosis.  Extrahepatic biliary obstruction of
this nature has not been previously described in cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="002" author="OPPENHEIMER EH" publication="J PEDIATR" d1="86" d2="683" d3="975"/>
<CITE num="003" author="TALAMO RC" publication="AM J DIS CHILD" d1="115" d2="74" d3="968"/>
<CITE num="004" author="JEAN R" publication="ARCH FR PEDIATR" d1="27" d2="849" d3="970"/>
<CITE num="005" author="VALMAN HB" publication="ARCH DIS CHILD" d1="46" d2="805" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78121</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MBERT JR            GA" publication="STROENTEROLOGY" d1="80" d2="69 9" d3="1"/>
<CITE num="2" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="3" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="4" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="5" author="TEDESCO FJ" publication="GASTROINTEST ENDOSC" d1="32" d2="25" d3="986"/>
<CITE num="6" author="PATRICK MK" publication="J PEDIATR" d1="108" d2="101" d3="986"/>
</CITATIONS>
<RECORDNUM>00901 </RECORDNUM>
<MEDLINENUM>78088954</MEDLINENUM>
<AUTHORS><AUTHOR>Antonowicz-I</AUTHOR><AUTHOR>Lebenthal-E</AUTHOR><AUTHOR>Schwachman-H</AUTHOR></AUTHORS>
<TITLE>Disaccharidase activities in small intestinal mucosa in patients
with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1978 Feb. 92(2). P 214-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>DISACCHARIDASES: me</TOPIC><TOPIC>INTESTINAL-MUCOSA: en</TOPIC><TOPIC>INTESTINE-SMALL: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALPHA-GLUCOSIDASES: me</TOPIC><TOPIC>ATROPHY</TOPIC><TOPIC>BETA-GALACTOSIDASES: me</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTESTINAL-MUCOSA: pa</TOPIC><TOPIC>INTESTINE-SMALL: pa</TOPIC></MINORSUBJ>
<ABSTRACT>The disaccharidase activities in small intestinal biopsies were
related to the morphology of the mucosa and the ages of 63 patients
with cystic fibrosis and 177 healthy control subjects of Caucasian
origin. In patients with CF and in the healthy control subjects under
5 years of age with normal intestinal mucosa, no low lactase activity
was found. In those patients with CF who were over 5 years of age,
one group had high and one group had low lactase activity, as occurs
in healthy Caucasian control subjects of the same age. This finding
supports the view that in patients with CF, lactase deficiency is not
related to the disease entity. In patients with or without CF who had
the same degree of mucosal atrophy, the decrease of disaccharidase
activities followed the same pattern, indicating that enzyme
activities are affected to the same extent by the damage of the
mucosa. In patients with CF with pancreatic insufficiency, the
disaccharidase activities were significantly (P less than 0.001)
higher when compared to those in control subjects of the same age and
ethnic group, although the increase was not uniform in all patients
with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="AURICCHIO S" publication="LANCET" d1="2" d2="324" d3="963"/>
<CITE num="002" author="WESER E" publication="N ENGL J MED" d1="273" d2="1070" d3="965"/>
<CITE num="003" author="ANDERSON AFR" publication="AM J DIG DIS" d1="9" d2="91" d3="942"/>
<CITE num="004" author="CHALFIN D" publication="AM J DIG DIS" d1="12" d2="81" d3="967"/>
<CITE num="005" author="SHEEHY TW" publication="LANCET" d1="2" d2="1" d3="965"/>
<CITE num="006" author="BINDER HJ" publication="AM J DIG DIS" d1="11" d2="858" d3="966"/>
<CITE num="007" author="FRAZER AC" publication="LANCET" d1="1" d2="503" d3="966"/>
<CITE num="008" author="LITMAN A" publication="ISR J MED SCI" d1="4" d2="110" d3="968"/>
<CITE num="009" author="KOJECKY Z" publication="AM J PROCTOL" d1="19" d2="204" d3="968"/>
<CITE num="010" author="NORDIO S" publication="ANN PAEDIATR" d1="206" d2="287" d3="966"/>
<CITE num="011" author="PETERNAL WW" publication="GASTROENTEROLOGY" d1="48" d2="299" d3="965"/>
<CITE num="012" author="COZZETTO FJ" publication="PEDIATRICS" d1="32" d2="228" d3="963"/>
<CITE num="013" author="GRYBOSKI JD" publication="GASTROENTEROLOGY" d1="45" d2="633" d3="963"/>
<CITE num="014" author="JONES RHT" publication="LANCET" d1="2" d2="120" d3="964"/>
<CITE num="015" author="ANTONOWICZ I" publication="PEDIATRICS" d1="42" d2="492" d3="968"/>
<CITE num="016" author="CUATRECASAS P" publication="LANCET" d1="1" d2="14" d3="965"/>
<CITE num="017" author="COOK GC" publication="LANCET" d1="1" d2="725" d3="966"/>
<CITE num="018" author="GILAT T" publication="AM J DIG DIS" d1="15" d2="895" d3="970"/>
<CITE num="019" author="KRETCHMER N" publication="LANCET" d1="2" d2="392" d3="971"/>
<CITE num="020" author="HUANG SS" publication="SCIENCE" d1="160" d2="83" d3="966"/>
<CITE num="021" author="BAYLESS TM" publication="JAMA" d1="197" d2="968" d3="966"/>
<CITE num="022" author="BAYLESS TM" publication="JOHNS HOPKINS MED J" d1="121" d2="54" d3="967"/>
<CITE num="023" author="ALZATE H" publication="AM J CLIN NUTR" d1="22" d2="122" d3="969"/>
<CITE num="024" author="REDDY V" publication="AM J CLIN NUTR" d1="25" d2="114" d3="972"/>
<CITE num="025" author="LEBENTHAL E" publication="GASTROENTEROLOGY" d1="67" d2="807" d3="974"/>
<CITE num="026" author="WELSH JD" publication="MEDICINE (BALTIMORE)" d1="49" d2="257" d3="970"/>
<CITE num="027" author="SIMMONS FJ" publication="AM J DIG DIS" d1="18" d2="595" d3="973"/>
<CITE num="028" author="JOHNSON JD" publication="ADV PEDIATR" d1="22" d2="197" d3="975"/>
<CITE num="029" author="DAHLQVIST A" publication="BIOL SOC TRANS" d1="3" d2="227" d3="975"/>
<CITE num="030" author="LEBENTHAL E" publication="AM J CLIN NUTR" d1="28" d2="595" d3="975"/>
<CITE num="031" author="ALPERS DH" publication="BIOCHIM BIOPHYS ACTA" d1="401" d2="28" d3="975"/>
<CITE num="032" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="033" author="DAHLQVIST A" publication="ANAL BIOCHEM" d1="7" d2="18" d3="964"/>
<CITE num="034" author="TOWNLEY RRW" publication="PEDIATRICS" d1="36" d2="911" d3="965"/>
<CITE num="035" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="036" author="EGGSTEIN M" publication="KLIN WOCHENSCHR" d1="33" d2="879" d3="955"/>
<CITE num="037" author="PENA AS" publication="GUT" d1="10" d2="1052" d3="969"/>
<CITE num="038" author="GUDMAND-HOYER E" publication="GUT" d1="11" d2="338" d3="970"/>
<CITE num="039" author="TANDON R" publication="AM J DIG DIS" d1="16" d2="845" d3="971"/>
<CITE num="040" author="PENA AS" publication="GASTROENTEROLOGY" d1="64" d2="400" d3="973"/>
<CITE num="041" author="GUDMAND-HOYER E" publication="SCAND J GASTROENTEROL" d1="10" d2="209" d3="975"/>
<CITE num="042" author="ARVANITAKIS C" publication="AM J DIG DIS" d1="19" d2="417" d3="974"/>
<CITE num="043" author="SEETHARAM B" publication="LIFE SCI" d1="18" d2="89" d3="976"/>
<CITE num="044" author="ANTONOWICZ I" publication="PEDIATRICS" d1="56" d2="782" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78122</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HMIDT E             CL" publication="IN BIOCHEM" d1="12" d2="47 9" d3="9"/>
<CITE num="2" author="SCHMIDT E" publication="J CLIN CHEM CLIN BIOCHEM" d1="17" d2="693" d3="979"/>
<CITE num="3" author="KEDINGER M" publication="ENZYME" d1="24" d2="96" d3="979"/>
<CITE num="4" author="COX KL" publication="J PEDIATR" d1="94" d2="488" d3="979"/>
<CITE num="5" author="LEBENTHAL E" publication="AM J DIS CHILD" d1="133" d2="21" d3="979"/>
<CITE num="6" author="BROWN KH" publication="AM J CLIN NUTR" d1="33" d2="1054" d3="980"/>
<CITE num="7" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="17" d2="89" d3="981"/>
<CITE num="8" author="BRANSKI D" publication="DIGESTION" d1="22" d2="8" d3="981"/>
<CITE num="9" author="MCNAMARA D" publication="BIOMEDICINE EXPRESS" d1="35" d2="122" d3="981"/>
<CITE num="10" author="LEBENTHAL E" publication="PEDIATRICS" d1="67" d2="828" d3="981"/>
<CITE num="11" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="12" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="13" author="CATALA J" publication="DIGESTION" d1="24" d2="234" d3="982"/>
<CITE num="14" author="BOUNOUS G" publication="GASTROENTEROLOGY" d1="82" d2="1457" d3="982"/>
<CITE num="15" author="GUTSCHMIDT S" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="677" d3="983"/>
<CITE num="16" author="ROSSI E" publication="ANN ALLERGY" d1="53" d2="649" d3="984"/>
<CITE num="17" author="SCHWARTZ M" publication="PRENAT DIAGN" d1="5" d2="145" d3="985"/>
<CITE num="18" author="CREUTZFELDT W" publication="SCAND J GASTROENTEROL" d1="20" d2="45" d3="985"/>
<CITE num="19" author="FRASE LL" publication="GASTROENTEROLOGY" d1="88" d2="478" d3="985"/>
<CITE num="20" author="RUBINSTEIN S" publication="PEDIATRICS" d1="78" d2="473" d3="986"/>
</CITATIONS>
<RECORDNUM>00902 </RECORDNUM>
<MEDLINENUM>78132308</MEDLINENUM>
<TITLE>Pancreatitis in children [letter].</TITLE>
<SOURCE>J-Pediatr. 1978 Apr. 92(4). P 685-6.</SOURCE>
<MAJORSUBJ><TOPIC>PANCREATITIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMYLASES: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PANCREATITIS: et</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<EXTRACT>"Hereditary pancreatitis" is important for at least three reasons:
(1) It is probably not an uncommon form of pancreatitis in children
and young adults; (2) the course of the disorder may be chronic, with
substantial long-term morbidity, including an apparently increased
risk for pancreatic cancer; and (3) once having made the correct
diagnosis, occurrence among siblings and/or offspring (and perhaps
other relatives) of the proband may be expected.  Hereditary
pancreatitis is an autosomal dominant trait with apparently complete
penetrance, though markedly variable expressivity.  It would be
reasonable to point out that hereditary pancreatitis should be
entertained whenever an alternative diagnosis is not documented, even
without a positive family history. - We agree with the statement by
Jordan and Ament in a recent article that "acute pancreatitis is one
of the rarer causes of abdominal pain in children and is among the
least reported and characterized."  However, their discussion of this
problem is surprisingly incomplete.  Familial pancreatitis, one of
the most important causes of pancreatitis in childhood, is not even
mentioned; cystic fibrosis is barely acknowledged.  These two
conditions as well as hypolipoproteinemia and ascariasis (also not
mentioned) should be included in the differential diagnosis of
pancreatitis in children and of otherwise unexplained abdominal pain
in this age group. - We appreciate the concern that we did not
diagnose hereditary pancreatitis in any of our patients.  None of the
ten patients with "idiopathic pancreatitis" had a family history of
pancreatitis documented in their charts.  Cystic fibrosis (CF) is not
a common cause of pancreatitis in our center.  We chose to omit
ascariasis from our differential diagnosis because in the developed
countries it is unlikely to be a common cause of pancreatitis.</EXTRACT>
<REFERENCES>
<CITE num="001" author="JORDAN SC" publication="J PEDIATR" d1="91" d2="211" d3="977"/>
<CITE num="002" author="RICCARDI VM" publication="ARCH INTERN MED" d1="135" d2="822" d3="975"/>
<CITE num="003" author="KATTWINKEL J" publication="PEDIATRICS" d1="51" d2="55" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="IN: VAUGHAN VC III" d1="" d2="903" d3="975"/>
<CITE num="004" author="SCRIVER CR" publication="AMINO ACID METABOL DISORDERS" d1="" d2="" d3="973"/>
<CITE num="004" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="005" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="10" d2="577" d3="975"/>
<CITE num="006" author="TYE JG" publication="J MED GENET" d1="13" d2="96" d3="976"/>
<CITE num="007" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
<CITE num="008" author="SKUDE G" publication="ACTA PAEDIATR SCAND" d1="65" d2="145" d3="976"/>
<CITE num="009" author="SCHIOTZ PO" publication="CLIN GENET" d1="11" d2="43" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78123</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LF RO               PE" publication="DIATR RES" d1="13" d2="76 9" d3="9"/>
<CITE num="2" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="3" author="MASARYK TJ" publication="DIG DIS SCI" d1="28" d2="874" d3="983"/>
</CITATIONS>
<RECORDNUM>00903 </RECORDNUM>
<MEDLINENUM>79007007</MEDLINENUM>
<AUTHORS><AUTHOR>Buescher-E-S</AUTHOR><AUTHOR>Winkelstein-J-A</AUTHOR></AUTHORS>
<TITLE>The ability of bacteria to activate the terminal complement
components in serum of patients with cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1978 Sep. 93(3). P 530-1.</SOURCE>
<MAJORSUBJ><TOPIC>BACTERIA</TOPIC><TOPIC>COMPLEMENT</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: co, mi</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>LUNG-DISEASES: et</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA</TOPIC><TOPIC>RECURRENCE</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>The terminal complement components, C3 to C9, contribute to the
host's defense against infection.  This study was performed to
determine if defective activation of C3 to C9 by bacteria contributes
to the pathogenesis of the recurrent pulmonary infections in cystic
fibrosis.  When each of the bacteria was incubated in the serum of
patients with cystic fibrosis for 30 minutes, the consumption of
available C3 was the same as in the sera of the control patients and
of the two patients with chronic, severe bronchiectasis.  Based on
the results of the present study, it is unlikely that defective
activation of C3 to C9 contributes to the pathogenesis of the
increased susceptibility to pulmonary infections of these patients.</EXTRACT>
<REFERENCES>
<CITE num="001" author="TALAMO RC" publication="IN: MANGOS JA" d1="" d2="195" d3="976"/>
<CITE num="002" author="POLLEY MJ" publication="J MED GENET" d1="11" d2="249" d3="974"/>
<CITE num="003" author="LYRENE RK" publication="J PEDIATR" d1="91" d2="681" d3="977"/>
<CITE num="004" author="WINKELSTEIN JA" publication="J IMMUNOL" d1="108" d2="1681" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78124</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RAUSS RG            HE" publication="LV PAEDIATR ACTA" d1="34" d2="29 9" d3="9"/>
<CITE num="2" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="3" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="63" d3="982"/>
<CITE num="4" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
</CITATIONS>
<RECORDNUM>00904 </RECORDNUM>
<MEDLINENUM>79049980</MEDLINENUM>
<AUTHORS><AUTHOR>Mitchell-I</AUTHOR><AUTHOR>Corey-M</AUTHOR><AUTHOR>Woenne-R</AUTHOR><AUTHOR>Krastins-I-R</AUTHOR><AUTHOR>Levison-H</AUTHOR></AUTHORS>
<TITLE>Bronchial hyperreactivity in cystic fibrosis and asthma.</TITLE>
<SOURCE>J-Pediatr. 1978 Nov. 93(5). P 744-8.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: pp</TOPIC><TOPIC>BRONCHI: de</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>METHACHOLINE-COMPOUNDS: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ASTHMA: im</TOPIC><TOPIC>BRONCHI: im, pp</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg, im</TOPIC><TOPIC>DOSE-RESPONSE-RELATIONSHIP-DRUG</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>HISTAMINE: pd</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>We studied 113 patients with CF and compared their responsiveness to
inhaled methacholine to that of 50 asthmatic children and 26 normal
children. Positive responses to MCh occurred in 51% of the patients
with CF and 98% of those with asthma. There was a significant
correlation between a positive response to MCh in CF and poor
pulmonary function. There was no relationship between allergic
rhinitis or positive allergen skin tests and a positive MCh response.
Dose-response curves and time course to MCh challenge differed in CF
and asthma. Bronchial hyperreactivity is thus common in CF but is
different from that in asthma.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="COUNAHAN R" publication="ARCH DIS CHILD" d1="50" d2="477" d3="975"/>
<CITE num="002" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="003" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="004" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="005" author="CHAI H" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="323" d3="975"/>
<CITE num="006" author="ROTHSTEIN RJ" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="100" d3="974"/>
<CITE num="007" author="MELLIS CM" publication="PEDIATRICS" d1="61" d2="446" d3="978"/>
<CITE num="008" author="MERCER TT" publication="ANN ALLERGY" d1="23" d2="314" d3="965"/>
<CITE num="009" author="WENG TR" publication="AM REV RESPIR DIS" d1="99" d2="879" d3="969"/>
<CITE num="010" author="NIE NH" publication="STAT PACKAGE FOR THE SOCIAL S" d1="" d2="" d3="975"/>
<CITE num="011" author="SNEDECOR GW" publication="STATISTICAL METHODS" d1="" d2="" d3="967"/>
<CITE num="012" author="HALUSZKA J" publication="RESPIRATION" d1="32" d2="217" d3="975"/>
<CITE num="013" author="EMPEY DW" publication="AM REV RESPIR DIS" d1="113" d2="131" d3="976"/>
<CITE num="014" author="RUBINFELD AR" publication="AM REV RESPIR DIS" d1="115" d2="381" d3="977"/>
<CITE num="015" author="SWIFT DL" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="" d3="969"/>
<CITE num="016" author="DOLOVICH MB" publication="J APPL PHYSIOL" d1="40" d2="468" d3="976"/>
<CITE num="017" author="NELSON LA" publication="CF CLUB ABST" d1="18" d2="" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78125</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="1" d2="08 9" d3="9"/>
<CITE num="2" author="MIHALAS LS" publication="J PEDIATR" d1="94" d2="1013" d3="979"/>
<CITE num="3" author="MILLIGAN DWA" publication="J PEDIATR" d1="95" d2="24" d3="979"/>
<CITE num="4" author="KATTAN M" publication="N ENGL J MED" d1="301" d2="664" d3="979"/>
<CITE num="5" author="BURDON JGW" publication="MED J AUST" d1="2" d2="77" d3="980"/>
<CITE num="6" author="SLY PD" publication="AUST PAEDIATR J" d1="16" d2="205" d3="980"/>
<CITE num="7" author="KATTAN M" publication="THORAX" d1="35" d2="531" d3="980"/>
<CITE num="8" author="ORMEROD LP" publication="THORAX" d1="35" d2="768" d3="980"/>
<CITE num="9" author="TOBIN MJ" publication="THORAX" d1="35" d2="807" d3="980"/>
<CITE num="10" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="11" author="GURWITZ D" publication="AM REV RESPIR DIS" d1="122" d2="95" d3="980"/>
<CITE num="12" author="LARSEN GL" publication="AM J DIS CHILD" d1="134" d2="1143" d3="980"/>
<CITE num="13" author="DAVIS PB" publication="N ENGL J MED" d1="302" d2="1453" d3="980"/>
<CITE num="14" author="FANTA CH" publication="MED CLIN NORTH AM" d1="65" d2="473" d3="981"/>
<CITE num="15" author="GALANT SP" publication="J CLIN INVEST" d1="68" d2="253" d3="981"/>
<CITE num="16" author="GURWITZ D" publication="J PEDIATR" d1="98" d2="551" d3="981"/>
<CITE num="17" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="18" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="19" author="VANASPEREN P" publication="AM J DIS CHILD" d1="135" d2="815" d3="981"/>
<CITE num="20" author="RUSSELL NJ" publication="BR J DIS CHEST" d1="76" d2="35" d3="982"/>
<CITE num="21" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="22" author="WONNE R" publication="ATEMWEGS LUNGENKRANKH" d1="9" d2="104" d3="983"/>
<CITE num="23" author="NEIJENS HJ" publication="PEDIATR CLIN NORTH AM" d1="30" d2="829" d3="983"/>
<CITE num="24" author="DAVIS PB" publication="J CHRON DIS" d1="36" d2="269" d3="983"/>
<CITE num="25" author="SCHEINMANN P" publication="SEM HOP PARIS" d1="59" d2="2969" d3="983"/>
<CITE num="26" author="LEWIS MI" publication="S AFR MED J" d1="65" d2="641" d3="984"/>
<CITE num="27" author="MCFADDEN ER" publication="J ALLERGY CLIN IMMUNOL" d1="73" d2="413" d3="984"/>
<CITE num="28" author="DAVIS PB" publication="AM REV RESPIR DIS" d1="129" d2="911" d3="984"/>
<CITE num="29" author="SELTZER J" publication="AM REV RESPIR DIS" d1="129" d2="790" d3="984"/>
<CITE num="30" author="MISCHLER EH" publication="SEM RESPIR MED" d1="6" d2="271" d3="985"/>
<CITE num="31" author="WONNE R" publication="CLIN ALLERGY" d1="15" d2="455" d3="985"/>
<CITE num="32" author="MITCHELL I" publication="ANN ALLERGY" d1="54" d2="233" d3="985"/>
<CITE num="33" author="HORDVIK NL" publication="AM REV RESPIR DIS" d1="131" d2="889" d3="985"/>
<CITE num="34" author="DARGA LL" publication="PEDIATR PULMONOL" d1="2" d2="82" d3="986"/>
<CITE num="35" author="MACLUSKY IB" publication="PEDIATR PULMONOL" d1="2" d2="94" d3="986"/>
<CITE num="36" author="DAVIS PB" publication="HORM METAB RES" d1="18" d2="217" d3="986"/>
<CITE num="37" author="DAVIES RJ" publication="J ALLERGY CLIN IMMUNOL" d1="78" d2="1031" d3="986"/>
<CITE num="38" author="SULLIVAN MM" publication="CHEST" d1="90" d2="239" d3="986"/>
<CITE num="39" author="BARNES PJ" publication="AM REV RESPIR DIS" d1="134" d2="1289" d3="986"/>
<CITE num="40" author="STEAD RJ" publication="PROSTAGLANDINS LEUKOTR MED" d1="26" d2="91" d3="987"/>
<CITE num="41" author="GALVEZ RA" publication="J ALLERGY CLIN IMMUNOL" d1="79" d2="331" d3="987"/>
</CITATIONS>
<RECORDNUM>00905 </RECORDNUM>
<MEDLINENUM>78220043</MEDLINENUM>
<AUTHORS><AUTHOR>Sorensen-R-U</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Polmar-S-H</AUTHOR></AUTHORS>
<TITLE>Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic
fibrosis: Relationship to status of pulmonary disease in sibling
pairs.</TITLE>
<SOURCE>J-Pediatr. 1978 Aug. 93(2). P 201-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>LYMPHOCYTES: im</TOPIC><TOPIC>LYMPHOPENIA: et</TOPIC><TOPIC>PNEUMONIA: im</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGGLUTINATION-TESTS</TOPIC><TOPIC>ANTIGENS-BACTERIAL</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IMMUNITY-CELLULAR</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>LYMPHOPENIA: im</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PNEUMONIA-STAPHYLOCOCCAL: im</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC><TOPIC>STAPHYLOCOCCAL-INFECTIONS: im</TOPIC><TOPIC>STAPHYLOCOCCUS-AUREUS: im</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Lymphocyte proliferative responses to Pseudomonas aeruginosa and
Staphylococcus aureus were evaluated in six sibling pairs with cystic
fibrosis. In each pair, one sibling had advanced clinical disease,
whereas the other sibling was in good clinical condition. Three in
this latter group had no clinically apparent Pseudomonas bronchitis.
In all cases, the average responses to Pseudomonas isolated from each
sibling pair were lower in the sibling with advanced clinical
disease. This difference was not observed in the responses to
Staphylococcus. Normal plasma or plasma from patients with CF in good
clinical condition does not restore the responses in patients with
advanced clinical disease. However, plasma from patients with low or
no responses to Pseudomonas inhibits the responses of responding
siblings. A progressive specific lymphocyte unresponsiveness to
Pseudomonas may play an important role in the increasing
destructiveness of chronic pulmonary Pseudomonas infection in cystic
fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="TALAMO RC" publication="IN: MANGOS JA" d1="" d2="195" d3="976"/>
<CITE num="002" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="003" author="BIGGAR WD" publication="PROC NAT ACAD SCI USA" d1="68" d2="1716" d3="971"/>
<CITE num="004" author="BOXERBAUM B" publication="AM REV RESPIR DIS" d1="108" d2="777" d3="973"/>
<CITE num="005" author="THOMASSEN MJ" publication="J RETICULOENDOTHEL SOC" d1="22" d2="38A" d3="977"/>
<CITE num="006" author="HANN S" publication="INFECT IMMUN" d1="14" d2="114" d3="976"/>
<CITE num="007" author="HOIBY N" publication="SCAND J RESPIR DIS" d1="56" d2="38" d3="975"/>
<CITE num="008" author="SCHWARTZ RH" publication="AM J DIS CHILD" d1="111" d2="408" d3="966"/>
<CITE num="009" author="SOUTH MA" publication="J PEDIATR" d1="71" d2="645" d3="967"/>
<CITE num="010" author="WALLWORK JC" publication="CLIN EXP IMMUNOL" d1="18" d2="303" d3="974"/>
<CITE num="011" author="GREEN GM" publication="AM REV RESPIR DIS" d1="102" d2="691" d3="970"/>
<CITE num="012" author="GREEN GM" publication="J EXP MED" d1="119" d2="167" d3="964"/>
<CITE num="013" author="KALTREIDER HB" publication="AM REV RESPIR DIS" d1="113" d2="347" d3="976"/>
<CITE num="014" author="WARR GA" publication="AM REV RESPIR DIS" d1="108" d2="371" d3="973"/>
<CITE num="015" author="SORENSEN RU" publication="INFECT IMMUN" d1="18" d2="735" d3="977"/>
<CITE num="016" author="THORSBY E" publication="HISTOCOMPATIBILITY TESTING" d1="" d2="655" d3="970"/>
<CITE num="017" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="018" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78126</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OMASSEN MJ          PE" publication="DIATR RES" d1="13" d2="85 9" d3="9"/>
<CITE num="2" author="CHURCH JA" publication="J PEDIATR" d1="95" d2="272" d3="979"/>
<CITE num="3" author="MCCARTHY MM" publication="CLIN PEDIATR" d1="19" d2="746" d3="980"/>
<CITE num="4" author="HODSON ME" publication="THORAX" d1="35" d2="801" d3="980"/>
<CITE num="5" author="CHURCH JA" publication="ANN ALLERGY" d1="45" d2="217" d3="980"/>
<CITE num="6" author="BEAUDRY PH" publication="J PEDIATR" d1="97" d2="144" d3="980"/>
<CITE num="7" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="8" author="BALTIMORE RS" publication="J INFECT DIS" d1="141" d2="238" d3="980"/>
<CITE num="9" author="HARPER TB" publication="LUNG" d1="157" d2="219" d3="980"/>
<CITE num="10" author="SCHIOTZ PO" publication="ACTA PATH MICROBIOL SCAND (C)" d1="S276" d2="1" d3="981"/>
<CITE num="11" author="SORENSEN RU" publication="PEDIATR RES" d1="15" d2="14" d3="981"/>
<CITE num="12" author="RUBIN HR" publication="CELL IMMUNOL" d1="57" d2="307" d3="981"/>
<CITE num="13" author="MARKS MI" publication="J PEDIATR" d1="98" d2="173" d3="981"/>
<CITE num="14" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="15" author="SORENSEN RU" publication="AM REV RESPIR DIS" d1="123" d2="37" d3="981"/>
<CITE num="16" author="FROLAND SS" publication="SCAND J INFECT DIS" d1="1981" d2="72" d3="981"/>
<CITE num="17" author="VANGEFFEL R" publication="ANN IMMUNOL (PARIS)" d1="D133" d2="293" d3="982"/>
<CITE num="18" author="VANGEFFEL R" publication="IMMUNOL LETTERS" d1="5" d2="155" d3="982"/>
<CITE num="19" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="20" author="GOTZ M" publication="CLIN EXP IMMUNOL" d1="50" d2="178" d3="982"/>
<CITE num="21" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="22" author="PORWOLL JM" publication="INFECT IMMUN" d1="40" d2="670" d3="983"/>
<CITE num="23" author="CAPLAN DB" publication="REV INFECT DIS" d1="6" d2="S705" d3="984"/>
<CITE num="24" author="PARMELY MJ" publication="J EXP MED" d1="160" d2="1338" d3="984"/>
<CITE num="25" author="LIEBERMAN MM" publication="SURV SYNTH PATHOL RES" d1="4" d2="312" d3="985"/>
<CITE num="26" author="SPEERT DP" publication="SURV SYNTH PATHOL RES" d1="4" d2="14" d3="985"/>
<CITE num="27" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="28" author="KURLAND G" publication="PEDIATRICS" d1="78" d2="1097" d3="986"/>
<CITE num="29" author="PIEDRA P" publication="J PEDIATR" d1="108" d2="817" d3="986"/>
</CITATIONS>
<RECORDNUM>00906 </RECORDNUM>
<MEDLINENUM>78220060</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenstein-B-J</AUTHOR><AUTHOR>Plotnick-L-P</AUTHOR><AUTHOR>Blasco-P-A</AUTHOR></AUTHORS>
<TITLE>Iodide-induced hypothyroidism without a goiter in an infant with
cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr. 1978 Aug. 93(2). P 261-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HYPOTHYROIDISM: ci</TOPIC><TOPIC>POTASSIUM-IODIDE: ae</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>POTASSIUM-IODIDE: tu</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>It has been suggested that patients with cystic fibrosis may have an
intrinsic abnormality of thyroid function that may be enhanced by
the administration of iodides.  We wish to report an infant with CF
in whom hyperthyroidism developed, in the absence of a goiter,
following short-term iodide therapy.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DOLAN TF JR" publication="J PEDIATR" d1="79" d2="684" d3="971"/>
<CITE num="002" author="AZIZI F" publication="TRANS ASSOC AM PHYSICIANS" d1="87" d2="111" d3="974"/>
<CITE num="003" author="BEGG TB" publication="Q J MED" d1="32" d2="351" d3="963"/>
<CITE num="004" author="SEGALL-BLANK M" publication="CF CLUB ABST" d1="" d2="21" d3="977"/>
<CITE num="005" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78127</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ABROLLE JP          AR" publication="CH FR PEDIATR" d1="36" d2="80 9" d3="9"/>
</CITATIONS>
<RECORDNUM>00907 </RECORDNUM>
<MEDLINENUM>78220113</MEDLINENUM>
<AUTHORS><AUTHOR>Rich-R-H</AUTHOR><AUTHOR>Warwick-W-J</AUTHOR><AUTHOR>Leonard-A-S</AUTHOR></AUTHORS>
<TITLE>Open thoracotomy and pleural abrasion in the treatment of
spontaneous pneumothorax in cystic fibrosis.</TITLE>
<SOURCE>J-Pediatr-Surg. 1978 Jun. 13(3). P 237-42.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PLEURA: su</TOPIC><TOPIC>PNEUMOTHORAX: su</TOPIC><TOPIC>THORAX: su</TOPIC><TOPIC>THORACIC-SURGERY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTUBATION</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>PNEUMOTHORAX: dt, et</TOPIC><TOPIC>QUINACRINE: tu</TOPIC><TOPIC>RETROSPECTIVE-STUDIES</TOPIC></MINORSUBJ>
<ABSTRACT>The various treatments of spontaneous pneumothorax in cystic fibrosis
are examined over a 15-yr period. Open thoracotomy with pleural
abrasion is compared to observation, tube thoracostomy, and tube
thoracostomy with instillation of quinacrine. Open thoracotomy with
pleural abrasion has been performed 31 times in 20 patients.
Discussion centers around selection of patients, preoperative
preparation, operative technique, and postoperative care and follow-
up, including analysis of pulmonary function studies. In our
experience, open thoracotomy with pleural abrasion is a safe and
effective method that should be utilized in the management of
pneumothorax in patients with cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GRAHAM WP 3RD" publication="SURG GYNECOL OBSTET" d1="122" d2="373" d3="966"/>
<CITE num="002" author="SCHUSTER SR" publication="J THORAC CARDIOVASC SURG" d1="48" d2="750" d3="964"/>
<CITE num="003" author="HOLSCLAW DS" publication="CLIN PEDIATR" d1="9" d2="346" d3="970"/>
<CITE num="004" author="HOLSCLAW DS" publication="MINN MED" d1="52" d2="1547" d3="969"/>
<CITE num="005" author="MEARNS MB" publication="ARCH DIS CHILD" d1="47" d2="499" d3="972"/>
<CITE num="006" author="GIBBS GE" publication="MINN MED" d1="52" d2="1433" d3="969"/>
<CITE num="007" author="WYLIE RH" publication="J THORAC CARDIOVASC SURG" d1="48" d2="770" d3="964"/>
<CITE num="008" author="LIFSCHITZ MI" publication="AM J DIS CHILD" d1="116" d2="633" d3="968"/>
<CITE num="009" author="BOAT TF" publication="JAMA" d1="209" d2="1498" d3="969"/>
<CITE num="010" author="SHWACHMAN H" publication="MINN MED" d1="52" d2="1521" d3="969"/>
<CITE num="011" author="JONES RE" publication="AM J DIS CHILD" d1="130" d2="777" d3="976"/>
<CITE num="012" author="KATTWINKEL J" publication="JAMA" d1="226" d2="557" d3="973"/>
<CITE num="013" author="BROOKS JW" publication="ANN SURG" d1="177" d2="798" d3="973"/>
<CITE num="014" author="SAHA SP" publication="ANN THORAC SURG" d1="19" d2="561" d3="975"/>
<CITE num="015" author="MITCHELL-HEGGS PF" publication="THORAX" d1="25" d2="165" d3="970"/>
<CITE num="016" author="STOWE SM" publication="AM REV RESPIR DIS" d1="111" d2="611" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78128</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HUSTER SR           J" publication="PEDIATR SURG" d1="18" d2="92 9" d3="3"/>
<CITE num="2" author="WEEDEN D" publication="THORAX" d1="38" d2="737" d3="983"/>
<CITE num="3" author="ROBB KL" publication="J ECON ENTOMOL" d1="77" d2="1288" d3="984"/>
<CITE num="4" author="MISRA M" publication="BULL INST ZOOL ACAD SINICA" d1="24" d2="85" d3="985"/>
</CITATIONS>
<RECORDNUM>00908 </RECORDNUM>
<MEDLINENUM>78244407</MEDLINENUM>
<AUTHORS><AUTHOR>Flanigan-R-C</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Izant-R-J-Jr</AUTHOR><AUTHOR>Filston-H-C</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in a black infant: presentation with meconium ileus
and volvulus.</TITLE>
<SOURCE>J-Pediatr-Surg. 1978 Aug. 13(4). P 435-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: su</TOPIC><TOPIC>INTESTINE-SMALL: su</TOPIC><TOPIC>MECONIUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>COLON: ab</TOPIC><TOPIC>DUCTUS-ARTERIOSUS-PATENT: co</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ILEOSTOMY</TOPIC><TOPIC>ILEUM: su</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: co</TOPIC><TOPIC>JEJUNUM: su</TOPIC><TOPIC>NEGROID-RACE</TOPIC><TOPIC>PREGNANCY</TOPIC></MINORSUBJ>
<ABSTRACT>This is a case report of meconium ileus complicated by intestinal
volvulus and infarction in a black infant.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="STERN RC" publication="J PEDIATR" d1="89" d2="412" d3="976"/>
<CITE num="002" author="KULCZYCKI LL" publication="CLIN PEDIATR" d1="3" d2="692" d3="964"/>
<CITE num="003" author="KULCZYCKI LL" publication="AM J DIS CHILD" d1="127" d2="64" d3="974"/>
<CITE num="004" author="WAGGET J" publication="J PEDIATR SURG" d1="5" d2="649" d3="970"/>
<CITE num="005" author="KALAYOGLU M" publication="J PEDIATR SURG" d1="6" d2="290" d3="971"/>
<CITE num="006" author="BISHOP HC" publication="ANN SURG" d1="145" d2="410" d3="957"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78129</PAPERNUM>
<CITATIONS>
<CITE num="1" author="BACHNIK NF          SU" publication="RG GYNECOL OBSTET            1" d1="52" d2="37 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00909 </RECORDNUM>
<MEDLINENUM>79050049</MEDLINENUM>
<AUTHORS><AUTHOR>Shigemoto-H</AUTHOR><AUTHOR>Endo-S</AUTHOR><AUTHOR>Isomoto-T</AUTHOR><AUTHOR>Sano-K</AUTHOR><AUTHOR>Taguchi-K</AUTHOR></AUTHORS>
<TITLE>Neonatal meconium obstruction in the ileum without mucoviscidosis.</TITLE>
<SOURCE>J-Pediatr-Surg. 1978 Oct. 13(6). P 475-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>ILEUM</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: th</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: th</TOPIC><TOPIC>MECONIUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CONTRAST-MEDIA: tu</TOPIC><TOPIC>ENEMA</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYPERTONIC-SOLUTIONS</TOPIC><TOPIC>HYPERTROPHY: et</TOPIC><TOPIC>ILEUM: pa</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INFANT-NEWBORN-DISEASES: et, pa</TOPIC><TOPIC>INTESTINAL-MUCOSA: se</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et, pa</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MUCUS: se</TOPIC></MINORSUBJ>
<ABSTRACT>Two newborns with intestinal obstruction of the terminal ileum
without mucoviscidosis were cured by Gastrografin enema. A further
case of a premature infant showed, at autopsy, a large intestine
containing normal meconium, but an ileum which was plugged with
tenacious meconium containing PAS-positive and alcian blue-negative
mucus. Our 3 cases were similar to cases of "meconium disease"
reported by Rickham and of "meconium plug in the small intestine"
reported by Emery. The primary cause of this disease lies in the
large amount of PAS-positive mucus secreted from goblet cells of the
ileal mucosa and the hypertrophy of lymph nodules in the ileal
submucosa.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="LEUBNER H" publication="PEDIATRICS" d1="15" d2="135" d3="955"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="22" d2="507" d3="958"/>
<CITE num="003" author="BERTI G" publication="ARCH KINDERHEILK" d1="24" d2="463" d3="898"/>
<CITE num="004" author="CLATWORTHY HW" publication="SURGERY" d1="39" d2="131" d3="956"/>
<CITE num="005" author="RICKHAM PP" publication="AM J SURG" d1="109" d2="173" d3="965"/>
<CITE num="006" author="KORNBLITH BA" publication="AM J PATHOL" d1="5" d2="249" d3="929"/>
<CITE num="007" author="HURWITT ES" publication="AM J DIS CHILD" d1="64" d2="443" d3="942"/>
<CITE num="008" author="EMERY JL" publication="ARCH DIS CHILD" d1="32" d2="17" d3="957"/>
<CITE num="009" author="ZACHARY RB" publication="ARCH DIS CHILD" d1="32" d2="22" d3="957"/>
<CITE num="010" author="DOLAN TF JR" publication="J PEDIATR SURG" d1="9" d2="821" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78130</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EGEL MJ             RA" publication="DIOLOGY                      1" d1="32" d2="79 9" d3="9"/>
<CITE num="2" author="YOSHIKAWA Y" publication="ACTA PATHOL JAP" d1="31" d2="845" d3="981"/>
<CITE num="3" author="HILLEMEIER AC" publication="PEDIATRICS" d1="69" d2="325" d3="982"/>
<CITE num="4" author="TAL A" publication="CLIN PEDIATR" d1="24" d2="460" d3="985"/>
<CITE num="5" author="SAMUEL N" publication="J ULTRASOUND MED" d1="5" d2="425" d3="986"/>
<CITE num="6" author="KING A" publication="PEDIATR RES" d1="20" d2="536" d3="986"/>
</CITATIONS>
<RECORDNUM>00910 </RECORDNUM>
<MEDLINENUM>78221008</MEDLINENUM>
<AUTHORS><AUTHOR>Lloyd-Still-J-D</AUTHOR></AUTHORS>
<TITLE>Assisted ventilation in cystic fibrosis [letter].</TITLE>
<SOURCE>JAMA. 1978 Aug 25. 240(8). P 739.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>RESPIRATION-ARTIFICIAL</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: th</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>RESPIRATORY-DISTRESS-SYNDROME: th</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: et</TOPIC></MINORSUBJ>
<EXTRACT>My colleagues and I reviewed the diagnosis, management, and prognosis
in 17 cases of infants with cystic fibrosis and severe respiratory
distress who were admitted to the Children's Hospital Medical Center,
Boston, between 1968 and 1972.  There was a 60% mortality overall.
Six of the 17 infants were treated with assisted ventilation, of whom
only one survived.  Our subsequent experience with assisted
ventilation has shown no improvement in the survival of these
infants.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78131</PAPERNUM>
<REFERENCES>
<CITE num="000" author="DAVIS PB" publication="JAMA" d1="239" d2="1851" d3="978"/>
<CITE num="001" author="LLOYD-STILL JD" publication="PEDIATRICS" d1="53" d2="678" d3="974"/>
</REFERENCES>
<RECORDNUM>00911 </RECORDNUM>
<MEDLINENUM>79050797</MEDLINENUM>
<AUTHORS><AUTHOR>Garrison-D-W</AUTHOR></AUTHORS>
<TITLE>Parents' understanding of genetic risk data in genetic counseling
[letter].</TITLE>
<SOURCE>JAMA. 1978 Dec 8. 240(24). P 2631-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>RISK</TOPIC></MINORSUBJ>
<EXTRACT>Relatively little has been published on the parents' ability to grasp
the importance of empirical risk data and Mendelian-type
probabilities.  The basic problem is that for many reasons, consumers
do not know what the recurrent risks are for the various genetic
diseases, not only cystic fibrosis.  As is so often the problem in
health care, the most effective means to communicate health care
information is not used or even known.  Until the problem of
communication of probability can be worked out, I would like to make
some suggestions in trying to help those who are provided with
probability data.  Always record probability values discussed in the
genetic counseling session.  If dealing with a family physician, the
information should become a part of the medical history for future
reference.  When providing documentation of probabilities, always
include the interpretation of such probabilities through diagrams,
charts, and other simple means.  Use available pamphlets and
brochures provided by various organizations such as foundations and
departments of health.</EXTRACT>
<REFERENCES>
<CITE num="000" author="CHECK W" publication="JAMA" d1="240" d2="819" d3="978"/>
<CITE num="001" author="LEONARD CO" publication="N ENGL J MED" d1="287" d2="433" d3="972"/>
<CITE num="002" author="CARTER CO" publication="LANCET" d1="1" d2="281" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78132</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ITTEN CF            AM" publication="J HUM GENET" d1="33" d2="02 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00912 </RECORDNUM>
<MEDLINENUM>78197203</MEDLINENUM>
<AUTHORS><AUTHOR>Kulczycki-L-L</AUTHOR><AUTHOR>Murphy-T-M</AUTHOR><AUTHOR>Bellanti-J-A</AUTHOR></AUTHORS>
<TITLE>Pseudomonas colonization in cystic fibrosis.  A study of 160
patients.</TITLE>
<SOURCE>JAMA. 1978 Jul 7. 240(1). P 30-4.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHI: mi</TOPIC><TOPIC>CARRIER-STATE: mi</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: ip</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBIOTICS: pd, tu</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>DISEASE-SUSCEPTIBILITY</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>FOLLOW-UP-STUDIES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: de, gd</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: dt</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>We investigated the role of Pseudomonas aeruginosa colonization in
the respiratory tracts of cystic fibrosis (CF) patients to relate the
effect of this colonization to progression of bronchial airway
pathologic conditions and to the patients' clinical progress, and to
identify predisposing factors to persistence of P aeruginosa
colonization and bronchial tree damage. Half of 160 CF patients
studied had persistent P aeruginosa respiratory tract colonization;
the other half had none. Pseudomonas aeruginosa seems to have an
exclusive propensity for the respiratory tract and may appear at any
age. Treatment with antibiotics, including aminoglycosides, failed to
eradicate P aeruginosa. The continuous use of antibiotics seemed to
contribute to the persistence of P aeruginosa and the appearance of
mucoid strains of P aeruginosa.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="REYNOLDS HY" publication="JAMA" d1="236" d2="2190" d3="976"/>
<CITE num="002" author="ELSTON HR" publication="AM J CLIN PATHOL" d1="48" d2="519" d3="967"/>
<CITE num="003" author="HARRISON GM" publication="CF CLUB ABST" d1="16" d2="42" d3="975"/>
<CITE num="004" author="LARAYA-CUASAY LR" publication="J PEDIATR" d1="89" d2="23" d3="976"/>
<CITE num="005" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="006" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="007" author="ALTMAN RP" publication="J PEDIATR SURG" d1="8" d2="809" d3="973"/>
<CITE num="008" author="WARING WW" publication="PEDIATRICS" d1="39" d2="166" d3="967"/>
<CITE num="009" author="DOGGETT RG" publication="LANCET" d1="1" d2="236" d3="971"/>
<CITE num="010" author="REYNOLDS HY" publication="ANN INTERN MED" d1="82" d2="819" d3="975"/>
<CITE num="011" author="HOIBY N" publication="ACTA PATH MICROBIOL SCAND (B)" d1="82" d2="551" d3="974"/>
<CITE num="012" author="ZIERDT CH" publication="J CLIN MICROBIOL" d1="1" d2="521" d3="975"/>
<CITE num="013" author="BELLANTI JA" publication="PROC INT CF CONG 7TH" d1="" d2="20" d3="976"/>
<CITE num="014" author="PENNINGTON JE" publication="J INFECT DIS" d1="131" d2="158" d3="975"/>
<CITE num="015" author="MILLIS RM" publication="CHEST" d1="71" d2="508" d3="977"/>
<CITE num="016" author="DI SANTAGNESE PA" publication="AM J DIS CHILD" d1="72" d2="17" d3="946"/>
<CITE num="017" author="HUANG NN" publication="J PEDIATR" d1="59" d2="512" d3="961"/>
<CITE num="018" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="968"/>
<CITE num="019" author="DOERSHUK CF" publication="IN: MANGOS JA" d1="" d2="" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78133</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LCZYCKI LL          MO" publication="NOGR PAEDIATR" d1="10" d2="27 9" d3="9"/>
<CITE num="2" author="LOENINGBAUCKE VA" publication="J PEDIATR" d1="95" d2="630" d3="979"/>
<CITE num="3" author="MCCARTHY MM" publication="CLIN PEDIATR" d1="19" d2="746" d3="980"/>
<CITE num="4" author="LAM J" publication="INFECT IMMUN" d1="28" d2="546" d3="980"/>
<CITE num="5" author="BEAUDRY PH" publication="J PEDIATR" d1="97" d2="144" d3="980"/>
<CITE num="6" author="WIENTZEN R" publication="AM J DIS CHILD" d1="134" d2="1134" d3="980"/>
<CITE num="7" author="BALTIMORE RS" publication="J INFECT DIS" d1="141" d2="238" d3="980"/>
<CITE num="8" author="CARLONE S" publication="MICROBIOLOGICA" d1="4" d2="215" d3="981"/>
<CITE num="9" author="KOEPP LH" publication="CURRENT MICROBIOL" d1="6" d2="383" d3="981"/>
<CITE num="10" author="MOSS RB" publication="J PEDIATR" d1="99" d2="215" d3="981"/>
<CITE num="11" author="BAKER NR" publication="CURRENT MICROBIOL" d1="7" d2="35" d3="982"/>
<CITE num="12" author="BAKER NR" publication="IN VITRO" d1="18" d2="369" d3="982"/>
<CITE num="13" author="SORDELLI DO" publication="CLIN IMMUNOL IMMUNOPATHOL" d1="22" d2="153" d3="982"/>
<CITE num="14" author="BAKER NR" publication="CAN J MICROBIOL" d1="28" d2="248" d3="982"/>
<CITE num="15" author="BALTIMORE RS" publication="HELV PAEDIATR ACTA" d1="37" d2="547" d3="982"/>
<CITE num="16" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="695" d3="982"/>
<CITE num="17" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="840" d3="982"/>
<CITE num="18" author="OHMAN DE" publication="INFECT IMMUN" d1="37" d2="662" d3="982"/>
<CITE num="19" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="33" d3="982"/>
<CITE num="20" author="HOIBY N" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="75" d3="982"/>
<CITE num="21" author="BODEY GP" publication="REV INFECT DIS" d1="5" d2="279" d3="983"/>
<CITE num="22" author="CROSS A" publication="REV INFECT DIS" d1="5" d2="S837" d3="983"/>
<CITE num="23" author="GOVAN JRW" publication="REV INFECT DIS" d1="5" d2="S874" d3="983"/>
<CITE num="24" author="BALTIMORE RS" publication="PEDIATR RES" d1="17" d2="952" d3="983"/>
<CITE num="25" author="CUKOR G" publication="J CLIN MICROBIOL" d1="18" d2="457" d3="983"/>
<CITE num="26" author="BOYD RL" publication="INFECT IMMUN" d1="39" d2="1403" d3="983"/>
<CITE num="27" author="HASTIE AT" publication="INFECT IMMUN" d1="40" d2="506" d3="983"/>
<CITE num="28" author="DORING G" publication="INFECT IMMUN" d1="42" d2="197" d3="983"/>
<CITE num="29" author="PENKETH A" publication="AM REV RESPIR DIS" d1="127" d2="605" d3="983"/>
<CITE num="30" author="HACKING AJ" publication="J GEN MICROBIOL" d1="129" d2="3473" d3="983"/>
<CITE num="31" author="BOUCHER RC" publication="LUNG" d1="161" d2="1" d3="983"/>
<CITE num="32" author="ADLER KB" publication="JAMA" d1="249" d2="1615" d3="983"/>
<CITE num="33" author="CHAN R" publication="J CLIN MICROBIOL" d1="19" d2="8" d3="984"/>
<CITE num="34" author="PENKETH A" publication="THORAX" d1="39" d2="299" d3="984"/>
<CITE num="35" author="BUCKMIRE FLA" publication="MICROBIOS" d1="41" d2="49" d3="984"/>
<CITE num="36" author="KUHN RJ" publication="CLIN PHARMACY" d1="4" d2="555" d3="985"/>
<CITE num="37" author="EFTIMIADI C" publication="DRUGS UNDER EXP CLIN RES" d1="11" d2="241" d3="985"/>
<CITE num="38" author="OLIVER AM" publication="J CLIN LAB IMMUNOL" d1="17" d2="85" d3="985"/>
<CITE num="39" author="IRVIN RT" publication="CAN J MICROBIOL" d1="31" d2="268" d3="985"/>
<CITE num="40" author="STACK BHR" publication="THORAX" d1="40" d2="358" d3="985"/>
<CITE num="41" author="JACQUOT J" publication="INFECT IMMUN" d1="47" d2="555" d3="985"/>
<CITE num="42" author="MARCUS H" publication="INFECT IMMUN" d1="47" d2="723" d3="985"/>
<CITE num="43" author="SORDELLI DO" publication="INFECT IMMUN" d1="49" d2="265" d3="985"/>
<CITE num="44" author="WINKLER U" publication="KLIN WSCHR" d1="63" d2="490" d3="985"/>
<CITE num="45" author="LINDEMANN RA" publication="J DENT RES" d1="64" d2="54" d3="985"/>
<CITE num="46" author="SORDELLI DO" publication="EUR J RESPIR DIS" d1="67" d2="118" d3="985"/>
<CITE num="47" author="TABLAN OC" publication="J PEDIATR" d1="107" d2="382" d3="985"/>
<CITE num="48" author="BROWN J" publication="AM J DIS CHILD" d1="139" d2="836" d3="985"/>
<CITE num="49" author="GOVAN JRW" publication="MICROBIOL SCI" d1="3" d2="302" d3="986"/>
<CITE num="50" author="FRIEND PA" publication="J INFECT" d1="13" d2="55" d3="986"/>
<CITE num="51" author="PADGETT PJ" publication="CURRENT MICROBIOL" d1="14" d2="187" d3="986"/>
<CITE num="52" author="PEDERSEN SS" publication="J ANTIMICROB CHEMOTHER" d1="17" d2="505" d3="986"/>
<CITE num="53" author="PEDERSEN SS" publication="ACTA PAEDIATR SCAND" d1="75" d2="840" d3="986"/>
<CITE num="54" author="ADLER KB" publication="AM J PATHOL" d1="125" d2="501" d3="986"/>
<CITE num="55" author="STUTTS MJ" publication="AM REV RESPIR DIS" d1="134" d2="17" d3="986"/>
<CITE num="56" author="LONNQVIST B" publication="J INFECT DIS" d1="153" d2="175" d3="986"/>
<CITE num="57" author="DUNNE WM" publication="DIAGN MICROBIOL INFECT DIS" d1="6" d2="165" d3="987"/>
<CITE num="58" author="BOUCHER RC" publication="TOXICOL APPL PHARMACOL" d1="87" d2="264" d3="987"/>
<CITE num="59" author="GOLDBERG JB" publication="J BACTERIOL" d1="169" d2="1349" d3="987"/>
</CITATIONS>
<RECORDNUM>00913 </RECORDNUM>
<MEDLINENUM>78174206</MEDLINENUM>
<AUTHORS><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Abramowsky-C-R</AUTHOR><AUTHOR>Matthews-L-W</AUTHOR><AUTHOR>Wood-R-E</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR></AUTHORS>
<TITLE>Intermediate-range sweat chloride concentration and Pseudomonas
bronchitis.  A cystic fibrosis variant with preservation of exocrine
pancreatic function.</TITLE>
<SOURCE>JAMA. 1978 Jun 23. 239(25). P 2676-80.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHITIS: co</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: co</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>BRONCHITIS: et</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PEDIGREE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>We studied the clinical and laboratory characteristics of seven
patients with sweat chloride concentration consistently between 40
and 60 mEq/liter. Each has chronic Pseudomonas bronchitis, and all
lack digestive symptoms. Laboratory findings indicate the
preservation of exocrine pancreatic function. The patients include
two of five children in one family and two of four in another. In a
third family, one of five siblings has an intermediate sweat chloride
concentration, but another has a typical fibrosis value (105
mEq/liter). One patient died of respiratory failure; results of an
autopsy showed bronchiolectasis typical of cystic fibrosis, but
minimal pancreatic changes. The data suggest a genetic basis for this
variant of cystic fibrosis. These patients may be homozygous for a
portion of a closely linked multigene cystic fibrosis locus or may
have modifier genes that ameliorate the pancreatic and sweat lesions.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="002" author="SHWACHMAN H" publication="ADV PEDIATR" d1="7" d2="249" d3="955"/>
<CITE num="003" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="004" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="005" author="COGSWELL JJ" publication="ARCH DIS CHILD" d1="49" d2="520" d3="974"/>
<CITE num="006" author="SARSFIELD JK" publication="ARCH DIS CHILD" d1="50" d2="463" d3="975"/>
<CITE num="007" author="OTSUKI M" publication="CLIN CHIM ACTA" d1="22" d2="439" d3="976"/>
<CITE num="008" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="92" d2="347" d3="956"/>
<CITE num="009" author="SHWACHMAN H" publication="BIRTH DEF ORIG ART SER" d1="8" d2="102" d3="972"/>
<CITE num="010" author="LOBECK CC" publication="PEDIATRICS" d1="30" d2="172" d3="962"/>
<CITE num="011" author="SHWACHMAN H" publication="PEDIATRICS" d1="36" d2="689" d3="965"/>
<CITE num="012" author="TAUSSIG LM" publication="PEDIATRICS" d1="54" d2="229" d3="974"/>
<CITE num="013" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="014" author="DENNING CR" publication="PEDIATRICS" d1="41" d2="7" d3="968"/>
<CITE num="015" author="ANDERSON CM" publication="ARCH DIS CHILD" d1="35" d2="581" d3="960"/>
<CITE num="016" author="GHARIB R" publication="AM J DIS CHILD" d1="108" d2="499" d3="964"/>
<CITE num="017" author="LARAYA-CUASAY LR" publication="J PEDIATR" d1="89" d2="23" d3="976"/>
<CITE num="018" author="KISSMEYER-NIELSEN F" publication="NATURE" d1="224" d2="75" d3="969"/>
<CITE num="019" author="FAGERHOL MK" publication="PROG MED GENET" d1="7" d2="96" d3="970"/>
<CITE num="020" author="GALDSTON M" publication="AM REV RESPIR DIS" d1="107" d2="718" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78134</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="2" d2="32 9" d3="8"/>
<CITE num="2" author="GURWITZ D" publication="PEDIATR CLIN NORTH AM" d1="26" d2="603" d3="979"/>
<CITE num="3" author="DAVIS PB" publication="AM J MED" d1="69" d2="643" d3="980"/>
<CITE num="4" author="SHWACHMAN H" publication="ARCH DIS CHILD" d1="56" d2="137" d3="981"/>
<CITE num="5" author="COLTEN HR" publication="N ENGL J MED" d1="304" d2="831" d3="981"/>
<CITE num="6" author="STERN RC" publication="LANCET" d1="1" d2="1401" d3="982"/>
<CITE num="7" author="BARBERO GJ" publication="J PEDIATR" d1="100" d2="914" d3="982"/>
<CITE num="8" author="GASKIN K" publication="J PEDIATR" d1="100" d2="857" d3="982"/>
<CITE num="9" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="10" author="GUIDOTTI TL" publication="RESPIRATION" d1="44" d2="351" d3="983"/>
<CITE num="11" author="BLYTHE SA" publication="CLIN BIOCHEM" d1="17" d2="277" d3="984"/>
<CITE num="12" author="MATTHEWS LW" publication="PEDIATR CLIN NORTH AM" d1="31" d2="133" d3="984"/>
<CITE num="13" author="FISHER JH" publication="AM REV RESPIR DIS" d1="132" d2="1149" d3="985"/>
<CITE num="14" author="MCCARTHY VP" publication="PEDIATR INFECT DIS" d1="5" d2="256" d3="986"/>
<CITE num="15" author="BROWN RF" publication="SOUTH MED J" d1="79" d2="1430" d3="986"/>
<CITE num="16" author="ROSENSTEIN BJ" publication="SOUTH MED J" d1="79" d2="319" d3="986"/>
<CITE num="17" author="FERNALD GW" publication="SEM ROENTGENOL" d1="22" d2="87" d3="987"/>
</CITATIONS>
<RECORDNUM>00914 </RECORDNUM>
<MEDLINENUM>78153979</MEDLINENUM>
<AUTHORS><AUTHOR>Davis-P-B</AUTHOR><AUTHOR>di-SantAgnese-P-A</AUTHOR></AUTHORS>
<TITLE>Assisted ventilation for patients with cystic fibrosis.</TITLE>
<SOURCE>JAMA. 1978 May 5. 239(18). P 1851-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>RESPIRATION-ARTIFICIAL</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACUTE-DISEASE</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: th</TOPIC><TOPIC>REMISSION-SPONTANEOUS</TOPIC><TOPIC>RESPIRATORY-INSUFFICIENCY: th</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>Forty-six patients with cystic fibrosis (CF), 1 month to 32 years of
age, had 51 episodes of assisted ventilation. Thirty-five (69%) died
after 1 to 395 days of mechanical ventilation and six others (12%)
died in the hospital 1 to 42 days after assisted ventilation therapy
was discontinued. Only three patients survived longer than one year
after discharge. These results are much poorer than those reported
for patients with chronic obstructive pulmonary disease of other
causes probably because of the different natural history and response
to therapy in CF. Patients with CF whose conditions progressively
deteriorated despite optimal therapy and no longer respond to
antibiotic and physical therapy are not good candidates for
mechanical ventilation. The occasional patient with good baseline
status in whom acute respiratory failure develops should be
considered for assisted ventilation.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ZWILLICH CW" publication="AM J MED" d1="57" d2="161" d3="974"/>
<CITE num="002" author="PETTY TL" publication="JAMA" d1="233" d2="34" d3="975"/>
<CITE num="003" author="ROGERS RM" publication="CHEST SUPPL" d1="62" d2="95" d3="972"/>
<CITE num="004" author="ODONOHUE WJ" publication="CHEST" d1="58" d2="603" d3="970"/>
<CITE num="005" author="JESSEN O" publication="LANCET" d1="2" d2="9" d3="967"/>
<CITE num="006" author="WEISS EB" publication="ANN INTERN MED" d1="67" d2="556" d3="967"/>
<CITE num="007" author="BRADLEY RD" publication="LANCET" d1="1" d2="854" d3="964"/>
<CITE num="008" author="ANON" publication="GAP CONF REP PULMONARY COMPLI" d1="" d2="10" d3="972"/>
<CITE num="009" author="ANON" publication="GAP CONF REP CHRON BRONC CF" d1="" d2="17" d3="977"/>
<CITE num="010" author="SHWACHMAN H" publication="N ENGL J MED" d1="296" d2="1519" d3="977"/>
<CITE num="011" author="BIGELOW DB" publication="IN: PETTY TL" d1="" d2="240" d3="974"/>
<CITE num="012" author="DI SANTAGNESE PA" publication="IN: DOWNEY JA" d1="" d2="25" d3="974"/>
<CITE num="013" author="DAVIS PB" publication="AM REV RESPIR DIS SUPPL" d1="115" d2="278" d3="977"/>
<CITE num="014" author="DI SANTAGNESE PA" publication="IN: VAUGHAN VC III" d1="" d2="903" d3="975"/>
<CITE num="015" author="ALBERTINI RE" publication="CHEST" d1="67" d2="134" d3="975"/>
<CITE num="016" author="SALISBURY BG" publication="THORAX" d1="30" d2="441" d3="975"/>
<CITE num="017" author="ROGERS RM" publication="N ENGL J MED" d1="286" d2="1230" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78135</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NTAGNESE PAD        AM" publication="J MED" d1="66" d2="21 9" d3="9"/>
<CITE num="2" author="WOOD RE" publication="SOUTH MED J" d1="72" d2="189" d3="979"/>
<CITE num="3" author="PETTY TL" publication="SEM RESPIR MED" d1="3" d2="263" d3="982"/>
<CITE num="4" author="KNAUS WA" publication="JAMA" d1="249" d2="1059" d3="983"/>
<CITE num="5" author="NUSSBAUM E" publication="CLIN PEDIATR" d1="24" d2="379" d3="985"/>
<CITE num="6" author="SCOGGIN CH" publication="POSTGRAD MED" d1="77" d2="243" d3="985"/>
<CITE num="7" author="MAKE BJ" publication="CLIN CHEST MED" d1="7" d2="679" d3="986"/>
<CITE num="8" author="ODONOHUE WJ" publication="CHEST" d1="90" d2="S  1" d3="986"/>
</CITATIONS>
<RECORDNUM>00915 </RECORDNUM>
<MEDLINENUM>79007746</MEDLINENUM>
<AUTHORS><AUTHOR>Bonforte-R-J</AUTHOR></AUTHORS>
<TITLE>Variability in cystic fibrosis [letter].</TITLE>
<SOURCE>JAMA. 1978 Oct 20. 240(17). P 1855.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>All of us who care for patients with cystic fibrosis (CF) are well
aware of the varying degrees of clinical involvement they have.  It
has long been known that whereas the most patients have pulmonary
involvement of one degree or another, approximately 15% to 20% of
patients will not have any pancreatic involvement.  In the 80% to 85%
of patients with pancreatic involvement, the degree of involvement
can vary greatly.  If we can accept the concept of clinical
heterogeneity for the pulmonary and gastrointestinal systems, there
is no reason why we should doubt the existence of clinical
variability for the other major organ system affected by this
disease, the sweat glands.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78136</PAPERNUM>
<REFERENCES>
<CITE num="000" author="STERN RC" publication="JAMA" d1="239" d2="2676" d3="978"/>
</REFERENCES>
<RECORDNUM>00916 </RECORDNUM>
<MEDLINENUM>79007795</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenstein-B-J</AUTHOR><AUTHOR>Langbaum-T-S</AUTHOR><AUTHOR>Gordes-E</AUTHOR><AUTHOR>Brusilow-S-W</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis.  Problems encountered with sweat testing.</TITLE>
<SOURCE>JAMA. 1978 Oct 27. 240(18). P 1987-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHLORIDES: an</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IONTOPHORESIS</TOPIC><TOPIC>PILOCARPINE: du</TOPIC><TOPIC>SPECIMEN-HANDLING: st</TOPIC></MINORSUBJ>
<ABSTRACT>The sweat test is the only practical and reliable laboratory test for
confirmation of the diagnosis of cystic fibrosis. Among 234 patients
referred to The Johns Hopkins Hospital for sweat testing, 62 had had
a previous test; 29 tests had been reported as negative, and 33 tests
had been reported as positive. Results of quantitative pilocarpine-
iontophoresis sweat tests at this center led to a change in diagnosis
in 27 (43.5%) of these 62 patients. Most of the errors were false-
positive.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="DARLING RC" publication="AM J MED SCI" d1="225" d2="67" d3="953"/>
<CITE num="003" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="004" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="005" author="KOPITO L" publication="PEDIATRICS" d1="43" d2="794" d3="969"/>
<CITE num="006" author="SHWACHMAN H" publication="J PEDIATR" d1="66" d2="432" d3="965"/>
<CITE num="007" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="008" author="MACLEAN WC JR" publication="J PEDIATR" d1="83" d2="86" d3="973"/>
<CITE num="009" author="GIBSON LE" publication="CLIN PEDIATR" d1="12" d2="450" d3="973"/>
<CITE num="010" author="BRAY PT" publication="CLIN CHIM ACTA" d1="80" d2="333" d3="977"/>
<CITE num="011" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78137</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IEST JB             JA" publication="MA                           2" d1="42" d2="70 9" d3="9"/>
<CITE num="2" author="SCHWACHMAN H" publication="J PEDIATR" d1="98" d2="576" d3="981"/>
<CITE num="3" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="4" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="5" author="WEBSTER HL" publication="CRC CRIT REV CLIN LAB SCI" d1="18" d2="313" d3="983"/>
<CITE num="6" author="KIRK JM" publication="ANN CLIN BIOCHEM" d1="20" d2="369" d3="983"/>
<CITE num="7" author="ORENSTEIN DM" publication="SEM RESPIR MED" d1="6" d2="252" d3="985"/>
<CITE num="8" author="CHRISTOFFEL KS" publication="J PEDIATR" d1="107" d2="231" d3="985"/>
<CITE num="9" author="TAGLE S" publication="REV MED CHIL" d1="113" d2="758" d3="985"/>
<CITE num="10" author="ROSENSTEIN BJ" publication="CLIN PEDIATR" d1="26" d2="78" d3="987"/>
</CITATIONS>
<RECORDNUM>00917 </RECORDNUM>
<MEDLINENUM>79175879</MEDLINENUM>
<AUTHORS><AUTHOR>Cho-Y-J</AUTHOR><AUTHOR>Oh-Y-H</AUTHOR><AUTHOR>Abe-C</AUTHOR><AUTHOR>Homma-J-Y</AUTHOR><AUTHOR>Usui-M</AUTHOR><AUTHOR>Matuhasi-T</AUTHOR></AUTHORS>
<TITLE>IgE antibody production to exoenzymes and common antigen (OEP) of
Pseudomonas aeruginosa in mice.</TITLE>
<SOURCE>Jpn-J-Exp-Med. 1978 Dec. 48(6). P 491-6.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODY-FORMATION</TOPIC><TOPIC>IGE: bi</TOPIC><TOPIC>PANCREATOPEPTIDASE: im</TOPIC><TOPIC>PEPTIDE-HYDROLASES: im</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>ANTIBODIES-BACTERIAL: im</TOPIC><TOPIC>ANTIGENS-BACTERIAL: im</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>ENDOTOXINS: an</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MICE</TOPIC><TOPIC>PSEUDOMONAS-AERUGINOSA: en</TOPIC><TOPIC>TOXOIDS: im</TOPIC></MINORSUBJ>
<ABSTRACT>IgE antibody production to exoenzymes and common antigen (OEP) of P.
aeruginosa was studied in mice that were injected with the antigens
incorporated into water-in-oil-in-water (w/o/w) emulsion or Al(OH)3
gel. OEP and protease toxoid (PT) elicited IgE antibody response but
elastase toxoid (ET) did not. Capacity of the OEP to produce IgE
antibody was reduced remarkably by it's protease treatment, which
suggested that the capacity lies in the protein portion of OEP. The
w/o/w emulsion was less effective than Al(OH)3 gel in adjuvanticity
to elicit IgE antibody response, but the emulsion enhanced the IgM
and/or IgG antibody response to PT and maintained a constant level
for a long period. These findings may suggest that IgE antibody
response to some components of P. aeruginosa could be induced in man.
High serum level of IgE was observed in some cases of cystic fibrosis
caused by P. aeruginosa infection, although the IgE antibody activity
has not yet been determined.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SORENSEN RU" publication="INFECT IMMUN" d1="18" d2="735" d3="977"/>
<CITE num="002" author="HOMMA JY" publication="JAPAN J EXP MED" d1="45" d2="361" d3="975"/>
<CITE num="003" author="DANNEMAN PJ" publication="INFECT IMMUN" d1="14" d2="694" d3="976"/>
<CITE num="004" author="MATUHASI T" publication="NATURE NEW BIOL" d1="245" d2="213" d3="973"/>
<CITE num="005" author="HOMMA JY" publication="ANIMAL PLANT MICROBIOL TOXINS" d1="1" d2="499" d3="976"/>
<CITE num="006" author="ABE C" publication="JAPAN J EXP MED" d1="47" d2="393" d3="977"/>
<CITE num="007" author="TANAMOTO K" publication="J BIOCHEM (TOKYO)" d1="83" d2="711" d3="978"/>
<CITE num="008" author="MORIHARA K" publication="BIOCHIM BIOPHYS ACTA" d1="73" d2="113" d3="963"/>
<CITE num="009" author="MORIHARA K" publication="J BIOL CHEM" d1="240" d2="3295" d3="965"/>
<CITE num="010" author="MORIHARA K" publication="AGRIC BIOL CHEM" d1="39" d2="1123" d3="975"/>
<CITE num="011" author="HOMMA JY" publication="JAPAN J EXP MED" d1="48" d2="111" d3="978"/>
<CITE num="012" author="MOTA I" publication="LIFE SCI" d1="8" d2="813" d3="969"/>
<CITE num="013" author="TOMIYAMA T" publication="JAPAN J EXP MED" d1="43" d2="185" d3="973"/>
<CITE num="014" author="KIMURA J" publication="JAPAN J EXP MED" d1="48" d2="149" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78138</PAPERNUM>
<CITATIONS>
<CITE num="1" author="E C                 JA" publication="P J EXP MED" d1="51" d2="71 9" d3="1"/>
<CITE num="2" author="PAUWELS R" publication="ALLERGY" d1="38" d2="239" d3="983"/>
<CITE num="3" author="HOMMA JY" publication="J CLIN MICROBIOL" d1="20" d2="855" d3="984"/>
</CITATIONS>
<RECORDNUM>00918 </RECORDNUM>
<MEDLINENUM>79155504</MEDLINENUM>
<AUTHORS><AUTHOR>Araki-H</AUTHOR><AUTHOR>Nakamura-K</AUTHOR></AUTHORS>
<TITLE>Effect of sera from cystic fibrosis homozygotes and heterozygotes on
glucose metabolism in Vero cells.</TITLE>
<SOURCE>Lancet. 1978 Apr 15. 1(8068). P 793-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>GLUCOSE: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CARBON-DIOXIDE</TOPIC><TOPIC>CELL-LINE</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KIDNEY</TOPIC><TOPIC>ANTHROPOIDEA</TOPIC></MINORSUBJ>
<ABSTRACT>The effect on intracellular production of carbon dioxide from glucose
of sera from cystic fibrosis (C.F.) homozygotes and heterozygotes was
determined in an established cell line (Vero cell) by a double-blind
assay. CO2 production was reduced when cells were incubated with an
ammonium-sulphate-precipitated fraction of sera from C.F. homozygotes
and heterozygotes but not by a similar fraction from sera of healthy
donors.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BALFE JW" publication="SCIENCE" d1="162" d2="689" d3="968"/>
<CITE num="002" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="003" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="004" author="LAPEY A" publication="PEDIATR RES" d1="5" d2="446" d3="971"/>
<CITE num="005" author="FEIG SA" publication="PEDIATR RES" d1="8" d2="594" d3="974"/>
<CITE num="006" author="FITZPATRICK DF" publication="NATURE NEW BIOL" d1="235" d2="173" d3="972"/>
<CITE num="007" author="DUFFY MJ" publication="NATURE NEW BIOL" d1="246" d2="151" d3="973"/>
<CITE num="008" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="009" author="YASUMURA T" publication="NIPPON RINSHO" d1="21" d2="1201" d3="963"/>
<CITE num="010" author="WARSHAW JB" publication="CELL BIOL" d1="52" d2="283" d3="972"/>
<CITE num="011" author="GOLDNER AM" publication="J GEN PHYSIOL" d1="53" d2="362" d3="969"/>
<CITE num="012" author="ARAKI H" publication="PROC INT CF CONG 7TH" d1="" d2="28" d3="976"/>
<CITE num="013" author="BOWMAN BH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="14" d2="253" d3="975"/>
<CITE num="014" author="DANES BS" publication="J EXP MED" d1="137" d2="1538" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78139</PAPERNUM>
<CITATIONS>
<CITE num="1" author="KAMURA K            J" publication="NATL CANCER INST" d1="77" d2="35 9" d3="6"/>
</CITATIONS>
<RECORDNUM>00919 </RECORDNUM>
<MEDLINENUM>78245770</MEDLINENUM>
<AUTHORS><AUTHOR>Dodge-J-A</AUTHOR><AUTHOR>Hamdi-I</AUTHOR></AUTHORS>
<TITLE>Abnormal levels of prostaglandins and fatty acids in cystic fibrosis
[letter].</TITLE>
<SOURCE>Lancet. 1978 Aug 26. 2(8087). P 475.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>LINOLEIC-ACIDS: df</TOPIC><TOPIC>PROSTAGLANDINS-E: bi</TOPIC><TOPIC>PROSTAGLANDINS-F: bi</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Like Dr Chase and Dr Dupont we have found essential fatty-acid
deficiency, usually subclinical, in cystic fibrosis patients.
However, we feel that their data on prostaglandin synthesis may have
other interpretations.  In patients with deficiency of linoleic
acid, oleic acid is used an alternative substrate; and instead of
dihomogammalinoleic acid, an alternative 20:3 fatty acid is produced.
We have found increased amounts of this substance in the plasma of
patients with cystic fibrosis.  We agree with the authors' conclusion
that levels of linoleic acid are specifically related to P.G.
production in children with cystic fibrosis.  It remains to be shown
whether children with cystic fibrosis have a primary abnormality of
fatty-acid metabolism or whether the observed disturbances of
prostaglandin metabolism are secondary to malabsorption of dietary
essential fatty acids.  In either case, certain clinical features of
the disease may well be explained by prostaglandin disturbances.</EXTRACT>
<REFERENCES>
<CITE num="000" author="CHASE HP" publication="LANCET" d1="2" d2="236" d3="978"/>
<CITE num="001" author="YASSA JG" publication="PROC INT CF CONG 7TH" d1="" d2="323" d3="976"/>
<CITE num="002" author="ROBINSON PG" publication="PROC INT CF CONG 7TH" d1="" d2="107" d3="976"/>
<CITE num="003" author="VAN EVERT WE" publication="PROSTAGLANDINS" d1="15" d2="268" d3="978"/>
<CITE num="004" author="LEMEN RJ" publication="AM REV RESPIR DIS" d1="117" d2="639" d3="978"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78140</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AIGSCHMIDT MC       AM" publication="J CLIN NUTR" d1="44" d2="16 9" d3="6"/>
</CITATIONS>
<RECORDNUM>00920 </RECORDNUM>
<MEDLINENUM>78245706</MEDLINENUM>
<AUTHORS><AUTHOR>Smalley-C-A</AUTHOR><AUTHOR>Addy-D-P</AUTHOR><AUTHOR>Anderson-C-M</AUTHOR></AUTHORS>
<TITLE>Does that child really have cystic fibrosis?.</TITLE>
<SOURCE>Lancet. 1978 Aug 19. 2(8086). P 415-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMYLASES: an</TOPIC><TOPIC>BICARBONATES: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CHOLECYSTOKININ: du</TOPIC><TOPIC>EVALUATION-STUDIES</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIPASE: an</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>SECRETIN: du</TOPIC><TOPIC>SODIUM: an</TOPIC><TOPIC>SWEAT: an</TOPIC><TOPIC>TRYPSIN: an</TOPIC></MINORSUBJ>
<ABSTRACT>A diagnosis of cystic fibrosis was incorrectly made after false-
positive sweat tests in 14 children. 13 of these children had been
tested at hospitals where it seems likely that sweat tests were not
done very often. All the children had normal sweat-electrolyte values
when the test was repeated at a regional paediatric centre where
approximately 250 sweat tests are done each year. In 5 cases,
detailed testing of pancreatic function was normal. None of the
children had typical chest disease and only 2 had gastrointestinal
symptoms. In the absence of the typical clinical features of the
disease a diagnosis of cystic fibrosis should be made with extreme
caution and only after meticulous testing of both sweat electrolytes
and pancreatic function.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="002" author="SCHWARZ V" publication="IN: DAVIS JA" d1="" d2="545" d3="974"/>
<CITE num="003" author="GIBSON LE" publication="J PEDIATR" d1="81" d2="193" d3="972"/>
<CITE num="004" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="52" d2="870" d3="977"/>
<CITE num="005" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="006" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="007" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="008" author="SCHALES O" publication="J BIOL CHEM" d1="140" d2="879" d3="941"/>
<CITE num="009" author="HADORN B" publication="J PEDIATR" d1="73" d2="39" d3="968"/>
<CITE num="010" author="SCHWERT GW" publication="J BIOL CHEM" d1="172" d2="221" d3="948"/>
<CITE num="011" author="VAN DE KAMER JH" publication="J BIOL CHEM" d1="177" d2="347" d3="949"/>
<CITE num="012" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
<CITE num="013" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78141</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ON                  LA" publication="NCET" d1="2" d2="32 9" d3="8"/>
<CITE num="2" author="STAGG BH" publication="ANN CLIN BIOCHEM" d1="16" d2="147" d3="979"/>
<CITE num="3" author="DANDONA P" publication="THORAX" d1="36" d2="60" d3="981"/>
<CITE num="4" author="ANON" publication="LANCET" d1="2" d2="1196" d3="982"/>
<CITE num="5" author="DAVID TJ" publication="LANCET" d1="2" d2="1204" d3="982"/>
<CITE num="6" author="GASKIN KJ" publication="PEDIATR RES" d1="16" d2="554" d3="982"/>
<CITE num="7" author="WONG LTK" publication="GUT" d1="23" d2="744" d3="982"/>
<CITE num="8" author="BROWN RC" publication="J CLIN PATHOL" d1="35" d2="547" d3="982"/>
<CITE num="9" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="10" author="LITTLEWOOD JM" publication="BR MED J" d1="287" d2="501" d3="983"/>
<CITE num="11" author="CARTER EP" publication="ARCH DIS CHILD" d1="59" d2="919" d3="984"/>
<CITE num="12" author="PERINI JM" publication="BULL EUR PHYSIOPATH RESP" d1="21" d2="569" d3="985"/>
<CITE num="13" author="GREEN A" publication="ANN CLIN BIOCHEM" d1="22" d2="171" d3="985"/>
<CITE num="14" author="CUMMING JGR" publication="ARCH DIS CHILD" d1="61" d2="573" d3="986"/>
<CITE num="15" author="LITTLEWOOD JM" publication="ARCH DIS CHILD" d1="61" d2="1041" d3="986"/>
<CITE num="16" author="DAVIDSON GP" publication="ACTA PAEDIATR SCAND" d1="75" d2="145" d3="986"/>
<CITE num="17" author="ROSENSTEIN BJ" publication="CLIN PEDIATR" d1="26" d2="78" d3="987"/>
</CITATIONS>
<RECORDNUM>00921 </RECORDNUM>
<MEDLINENUM>78245699</MEDLINENUM>
<AUTHORS><AUTHOR>Dann-L-G</AUTHOR><AUTHOR>Blau-K</AUTHOR></AUTHORS>
<TITLE>Exocrine-gland function and the basic biochemical defect in cystic
fibrosis.</TITLE>
<SOURCE>Lancet. 1978 Aug 19. 2(8086). P 405-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: et</TOPIC><TOPIC>SALIVARY-GLANDS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ABSORPTION</TOPIC><TOPIC>ARGININE</TOPIC><TOPIC>CALCIUM: me</TOPIC><TOPIC>CELL-MEMBRANE: me</TOPIC><TOPIC>CHLORINE: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en, me</TOPIC><TOPIC>ESTERASES: df</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>KININS: bi</TOPIC><TOPIC>MODELS-BIOLOGICAL</TOPIC><TOPIC>SALIVARY-GLANDS: pa, se</TOPIC><TOPIC>SODIUM: me</TOPIC></MINORSUBJ>
<ABSTRACT>A biochemical link is proposed between secretion and reabsorption in
exocrine glands, in the form of a factor (kinin E) which initiates
ion reabsorption. Activation of this factor involves arginine
esterases, and in cystic fibrosis these may be defective, preventing
the formation of kinin E. In cystic fibrosis stimulation of exocrine
glands produces abnormal reabsorption of ions, leading to the
physiological abnormalities and clinical manifestations of the
disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="PETERSEN OH" publication="PHIL TRANS R SOC LOND BIOL" d1="262" d2="307" d3="971"/>
<CITE num="002" author="GARRETT JR" publication="ARCH ORAL BIOL" d1="12" d2="1417" d3="967"/>
<CITE num="003" author="FOX RH" publication="J PHYSIOL (LOND)" d1="142" d2="2119" d3="958"/>
<CITE num="004" author="ULLRICH KJ" publication="IN: THORN NA" d1="" d2="423" d3="974"/>
<CITE num="005" author="MANGOS JA" publication="AM J PHYSIOL" d1="224" d2="1235" d3="973"/>
<CITE num="006" author="SUTCLIFFE CH" publication="PROC R SOC MED" d1="61" d2="297" d3="968"/>
<CITE num="007" author="MANGOS JA" publication="IN: MANGOS JA" d1="" d2="311" d3="976"/>
<CITE num="008" author="RAO GJS" publication="SCIENCE" d1="177" d2="610" d3="972"/>
<CITE num="009" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="010" author="COBURN MD" publication="AM REV RESPIR DIS" d1="110" d2="368" d3="974"/>
<CITE num="011" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="012" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
<CITE num="013" author="NUSTAD K" publication="GEN PHARMAC" d1="9" d2="1" d3="978"/>
<CITE num="014" author="FRAKI JE" publication="ACTA DERM VENEREOL (STOCKH)" d1="50" d2="321" d3="970"/>
<CITE num="015" author="BEILENSON S" publication="J PHYSIOL (LOND)" d1="199" d2="303" d3="968"/>
<CITE num="016" author="GARRETT JR" publication="IN: THORN NA" d1="" d2="487" d3="974"/>
<CITE num="017" author="FINK E" publication="ANAL CHEM" d1="290" d2="183" d3="978"/>
<CITE num="018" author="BOWMAN BH" publication="CLIN GENET" d1="12" d2="333" d3="977"/>
<CITE num="019" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="020" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="021" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="022" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="470" d3="975"/>
<CITE num="023" author="WHITELAW A" publication="LANCET" d1="2" d2="1288" d3="977"/>
<CITE num="024" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="025" author="GUGLER EC" publication="J PEDIATR" d1="71" d2="585" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78142</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OCK DJH             LA" publication="NCET" d1="1" d2="45 9" d3="9"/>
<CITE num="2" author="DANN LG" publication="LANCET" d1="2" d2="907" d3="979"/>
<CITE num="3" author="WILSON GB" publication="PEDIATR RES" d1="13" d2="1079" d3="979"/>
<CITE num="4" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="5" author="DUFFY MJ" publication="CLIN CHIM ACTA" d1="103" d2="233" d3="980"/>
<CITE num="6" author="STEGMAYR B" publication="ULTRASTRUCTURAL PATHOL" d1="2" d2="357" d3="981"/>
<CITE num="7" author="HALLINAN F" publication="MED HYPOTHESES" d1="7" d2="793" d3="981"/>
<CITE num="8" author="BURY AF" publication="PEDIATR RES" d1="16" d2="613" d3="982"/>
<CITE num="9" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="10" author="HEELEY AF" publication="CLIN CHEM" d1="29" d2="2011" d3="983"/>
<CITE num="11" author="HARE ER" publication="PEDIATR RES" d1="19" d2="938" d3="985"/>
<CITE num="12" author="RUPP GM" publication="MED HYPOTHESES" d1="20" d2="245" d3="986"/>
</CITATIONS>
<RECORDNUM>00922 </RECORDNUM>
<MEDLINENUM>78112941</MEDLINENUM>
<AUTHORS><AUTHOR>Kilbourn-J-P</AUTHOR></AUTHORS>
<TITLE>Bacterial content and ionic composition of sputum in cystic fibrosis
[letter].</TITLE>
<SOURCE>Lancet. 1978 Feb 11. 1(8059). P 334.</SOURCE>
<MAJORSUBJ><TOPIC>BACTERIA</TOPIC><TOPIC>CYSTIC-FIBROSIS</TOPIC><TOPIC>ELECTROLYTES</TOPIC><TOPIC>SPUTUM</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BACTERIA: ip</TOPIC><TOPIC>CALCIUM: an</TOPIC><TOPIC>CANDIDA-ALBICANS: ip</TOPIC><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>ELECTROLYTES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>POTASSIUM: an</TOPIC><TOPIC>SODIUM: an</TOPIC><TOPIC>SPUTUM: an, mi</TOPIC></MINORSUBJ>
<EXTRACT>Burns and May proposed the following pattern for the bacteriology of
cystic fibrosis: (1) Staphylococcus aureus is the initial bacterial
pathogen, and damage caused by it renders the lungs susceptible to
infection by other species.  (2) Control of S. aureus by antibiotics
allows the influx of Haemophilus influenzae.  (3) Pseudomonas
aeruginosa is introduced and continued chemotherapy encourages its
establishment.  (4) P. aeruginosa supplants S. aureus and H.
influenzae, becoming the sole pathogen.  I have examined these ideas
by quantitative culture of sputum from 20 patients seen at the Cystic
Fibrosis Treatment and Research Center, University of Oregon Health
Sciences Center from 1965 to 1977.  The results accord with the
original hypothesis of Burns and May.  In 13 of 20 patients the
sputum bacterial flora changed as the hypothesis of Burns and May
predicted.  This preliminary data suggests that one of the primary
sputum abnormalities in cystic fibrosis may be increased Ca++ which
makes the sputum susceptible to colonisation by S. aureus.  After
infection the Ca++ concentration is reduced and the lung becomes
susceptible to colonisation by other microorganisms including H.
influenzae, P. aeruginosa, and Escherichia coli.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BURNS MW" publication="LANCET" d1="1" d2="270" d3="958"/>
<CITE num="002" author="MAY JR" publication="ARCH DIS CHILD" d1="47" d2="908" d3="972"/>
<CITE num="003" author="KILBOURN JP" publication="AM REV RESPIR DIS" d1="98" d2="810" d3="968"/>
<CITE num="004" author="KILBOURN JP" publication="LANCET" d1="2" d2="878" d3="970"/>
<CITE num="005" author="KILBOURN JP" publication="LANCET" d1="1" d2="405" d3="974"/>
<CITE num="006" author="MATTHEWS LW" publication="AM REV RESPIR DIS" d1="88" d2="199" d3="963"/>
<CITE num="007" author="POTTER JL" publication="AM REV RESPIR DIS" d1="96" d2="83" d3="967"/>
<CITE num="008" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="009" author="CHERNICK WS" publication="PEDIATRICS" d1="24" d2="739" d3="959"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78143</PAPERNUM>
<CITATIONS>
<CITE num="1" author="YCE JR              LA" publication="NCET" d1="2" d2="68 9" d3="0"/>
<CITE num="2" author="KILBOURN JP" publication="PEDIATR RES" d1="14" d2="259" d3="980"/>
<CITE num="3" author="LINKE HAB" publication="MICROBIOS" d1="27" d2="107" d3="980"/>
<CITE num="4" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="695" d3="982"/>
<CITE num="5" author="BOYCE JR" publication="INFECT IMMUN" d1="37" d2="840" d3="982"/>
<CITE num="6" author="PIER GB" publication="J INFECT DIS" d1="147" d2="494" d3="983"/>
<CITE num="7" author="KILBOURN JP" publication="CURRENT MICROBIOL" d1="11" d2="19" d3="984"/>
<CITE num="8" author="MULLER RM" publication="SCANN ELECTRON MICROSC" d1="1985" d2="1583" d3="985"/>
</CITATIONS>
<RECORDNUM>00923 </RECORDNUM>
<MEDLINENUM>78091015</MEDLINENUM>
<AUTHORS><AUTHOR>Sparham-P-D</AUTHOR><AUTHOR>Lobban-D-I</AUTHOR><AUTHOR>Speller-D-C</AUTHOR></AUTHORS>
<TITLE>Thymidine-requiring Staphylococcus aureus [letter].</TITLE>
<SOURCE>Lancet. 1978 Jan 14. 1(8055). P 104-5.</SOURCE>
<MAJORSUBJ><TOPIC>STAPHYLOCOCCUS-AUREUS: gd</TOPIC><TOPIC>THYMIDINE</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: mi</TOPIC><TOPIC>DRUG-RESISTANCE-MICROBIAL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>TRIMETHOPRIM: ad</TOPIC></MINORSUBJ>
<EXTRACT>We confirm that thymidine-requiring (thy-) Staphylococcus aureus
strains are common in patients with cystic fibrosis.  In 7 months, we
isolated Staph. aureus from 11 of 14 patients with C.F.  Despite
long-term co-trimoxazole Staph. aureus tends to persist in the sputum
even though isolates do not require thymidine at first and are
trimethoprim-sensitive in vitro.  Staph. aureus is less commonly
isolated, and of less significance, in most other chest conditions
for which co-trimoxazole is given.  These factors may explain why
thy- staphylococci are recognised more frequently in C.F. than in
other diseases.</EXTRACT>
<REFERENCES>
<CITE num="000" author="GEORGE RH" publication="LANCET" d1="2" d2="1081" d3="977"/>
<CITE num="002" author="WILLIAMS RF" publication="PROC EWGCF 6TH ANNU MTG" d1="" d2="4" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78144</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLIAMS RF           CU" publication="RR MED RES OPIN" d1="6" d2="43 9" d3="9"/>
<CITE num="2" author="STURM AW" publication="ANT V LEEUW J MICROBIOL SEROL" d1="47" d2="92" d3="981"/>
<CITE num="3" author="LACEY RW" publication="J MED MICROBIOL" d1="15" d2="403" d3="982"/>
<CITE num="4" author="KING CH" publication="J CLIN MICROBIOL" d1="18" d2="79" d3="983"/>
</CITATIONS>
<RECORDNUM>00924 </RECORDNUM>
<MEDLINENUM>78222230</MEDLINENUM>
<AUTHORS><AUTHOR>Chase-H-P</AUTHOR><AUTHOR>Dupont-J</AUTHOR></AUTHORS>
<TITLE>Abnormal levels of prostaglandins and fatty acids in blood of
children with cystic fibrosis.</TITLE>
<SOURCE>Lancet. 1978 Jul 29. 2(8083). P 236-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LINOLEIC-ACIDS: bl</TOPIC><TOPIC>PROSTAGLANDINS-E: bl</TOPIC><TOPIC>PROSTAGLANDINS-F: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>CYSTIC-FIBROSIS: dt, pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LINOLEIC-ACIDS: pd, tu</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PROSTAGLANDINS-E: bi</TOPIC><TOPIC>PROSTAGLANDINS-F: bi</TOPIC><TOPIC>STIMULATION-CHEMICAL</TOPIC></MINORSUBJ>
<ABSTRACT>12 children with cystic fibrosis (C.F.) had lower levels of the
essential fatty acid, linoleic acid, in plasma and in red blood
cells, than did control children, and production of prostaglandin
F2alpha (P.G.F2alpha) was higher than in controls. After 10 months of
oral linoleic-acid supplementation in 6 of the children with C.F.,
the linoleic-acid levels in plasma, red cells, and platelets were
higher and P.G.F2alpha production was lower than in the 6 children
with C.F. who received a placebo lipid. Prostaglandin F2alpha is
associated with bronchoconstriction and its increased production in
children with C.F. might be causally related to their chronic
pulmonary disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="002" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="003" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="004" author="RIVERS JPW" publication="LANCET" d1="2" d2="642" d3="975"/>
<CITE num="005" author="HUBBARD VS" publication="LANCET" d1="2" d2="1302" d3="977"/>
<CITE num="006" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="007" author="SILVER MJ" publication="J PROSTAGLANDINS" d1="1" d2="429" d3="972"/>
<CITE num="009" author="PASARGIKLIAN M" publication="IN: SAMUELSSON B" d1="1" d2="461" d3="976"/>
<CITE num="010" author="NELSON GJ" publication="IN: NELSON GJ" d1="" d2="10" d3="972"/>
<CITE num="012" author="MCCOSH FJ" publication="J PROSTAGLANDINS" d1="12" d2="471" d3="976"/>
<CITE num="013" author="DUPONT J" publication="FED PROC" d1="37" d2="445" d3="978"/>
<CITE num="014" author="PACE-ASCIAK C" publication="BIOCHIM BIOPHYS ACTA" d1="152" d2="784" d3="968"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78145</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RROBIN DF           ME" publication="D HYPOTHESES" d1="5" d2="99 9" d3="9"/>
<CITE num="2" author="HORROBIN DF" publication="MED HYPOTHESES" d1="5" d2="365" d3="979"/>
<CITE num="3" author="CHASE HP" publication="PEDIATRICS" d1="64" d2="207" d3="979"/>
<CITE num="4" author="CHASE HP" publication="J PEDIATR" d1="95" d2="337" d3="979"/>
<CITE num="5" author="HORROBIN DF" publication="MED HYPOTHESES" d1="6" d2="277" d3="980"/>
<CITE num="6" author="GALEY WR" publication="PEDIATR RES" d1="14" d2="1269" d3="980"/>
<CITE num="7" author="CHASE HP" publication="METABOLISM" d1="29" d2="365" d3="980"/>
<CITE num="8" author="HUBBARD VS" publication="J PEDIATR" d1="96" d2="421" d3="980"/>
<CITE num="9" author="SHEPHERD R" publication="J PEDIATR" d1="97" d2="351" d3="980"/>
<CITE num="10" author="HUBBARD VS" publication="CLIN CHIM ACTA" d1="102" d2="115" d3="980"/>
<CITE num="11" author="ROGIERS V" publication="CLIN CHIM ACTA" d1="105" d2="105" d3="980"/>
<CITE num="12" author="OLLEY PM" publication="AM J DIS CHILD" d1="134" d2="688" d3="980"/>
<CITE num="13" author="LLOYDSTILL JD" publication="AM J CLIN NUTR" d1="34" d2="1" d3="981"/>
<CITE num="14" author="RIVERS JPW" publication="BR MED BULL" d1="37" d2="59" d3="981"/>
<CITE num="15" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="16" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="17" author="ALLING C" publication="EUR J PEDIATR" d1="137" d2="197" d3="981"/>
<CITE num="18" author="CHASE HP" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="49" d3="982"/>
<CITE num="19" author="LEVI N" publication="RIV ITAL PEDIATR" d1="8" d2="695" d3="982"/>
<CITE num="20" author="STAFFORD RJ" publication="CLIN GASTROENTEROL" d1="11" d2="141" d3="982"/>
<CITE num="21" author="ROGIERS V" publication="PEDIATR RES" d1="16" d2="761" d3="982"/>
<CITE num="22" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="23" author="HUBBARD VS" publication="EUR J PEDIATR" d1="141" d2="68" d3="983"/>
<CITE num="24" author="ROGIERS V" publication="EUR J PEDIATR" d1="141" d2="39" d3="983"/>
<CITE num="25" author="HUANG YS" publication="PROSTAGLANDINS LEUKOTR MED" d1="15" d2="223" d3="984"/>
<CITE num="26" author="ROGIERS V" publication="PEDIATR RES" d1="18" d2="704" d3="984"/>
<CITE num="27" author="HORROBIN DF" publication="BIOMED BIOCHIM ACTA" d1="43" d2="S114" d3="984"/>
<CITE num="28" author="MANSELL AL" publication="J PEDIATR" d1="104" d2="700" d3="984"/>
<CITE num="29" author="MCKENNA MC" publication="J PEDIATR GASTROENTEROL NUTR" d1="4" d2="45" d3="985"/>
<CITE num="30" author="HUBBARD VS" publication="SEM RESPIR MED" d1="6" d2="308" d3="985"/>
<CITE num="31" author="FARRELL PM" publication="PEDIATR RES" d1="19" d2="104" d3="985"/>
<CITE num="32" author="CHRISTOPHE A" publication="ANN NUTR METAB" d1="29" d2="239" d3="985"/>
<CITE num="33" author="MAAK B" publication="Z KLIN MED" d1="40" d2="1115" d3="985"/>
<CITE num="34" author="WILSON DO" publication="AM REV RESPIR DIS" d1="132" d2="1347" d3="985"/>
<CITE num="35" author="GALLAND L" publication="J AM COLL NUTR" d1="5" d2="213" d3="986"/>
<CITE num="36" author="LESTER LA" publication="J PARENT ENTERAL NUTR" d1="10" d2="289" d3="986"/>
<CITE num="37" author="MISCHLER EH" publication="PEDIATR RES" d1="20" d2="36" d3="986"/>
<CITE num="38" author="DUHAMEL JF" publication="ARCH FR PEDIATR" d1="43" d2="229" d3="986"/>
<CITE num="39" author="CRAIGSCHMIDT MC" publication="AM J CLIN NUTR" d1="44" d2="816" d3="986"/>
<CITE num="40" author="CARLSTEDTDUKE J" publication="PROC NAT ACAD SCI USA" d1="83" d2="9202" d3="986"/>
<CITE num="41" author="DUPONT J" publication="N ENGL J MED" d1="314" d2="718" d3="986"/>
<CITE num="42" author="HARE WR" publication="BIOCHEM SOC TRANS" d1="15" d2="497" d3="987"/>
<CITE num="43" author="HUBBARD VS" publication="LIPIDS" d1="22" d2="424" d3="987"/>
<CITE num="44" author="STEAD RJ" publication="PROSTAGLANDINS LEUKOTR MED" d1="26" d2="91" d3="987"/>
<CITE num="45" author="YOUNGBERG  CA" publication="DIG DIS SCI" d1="32" d2="472" d3="987"/>
</CITATIONS>
<RECORDNUM>00925 </RECORDNUM>
<MEDLINENUM>78155356</MEDLINENUM>
<AUTHORS><AUTHOR>Lieberman-J</AUTHOR></AUTHORS>
<TITLE>Lectins and cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1978 May 6. 1(8071). P 985-6.</SOURCE>
<MAJORSUBJ><TOPIC>CONCANAVALIN-A</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CYSTIC-FIBROSIS: et</TOPIC><TOPIC>EXOCRINE-GLANDS: se</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MUCUS: se</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<EXTRACT>Dr Freed and Dr Buckley have shown that a lectin, concanavalin A (Con
A), causes severe rhinitis, sinusitis, and increased mucus secretion
when inhaled by man or small-intestinal colic, foul-smelling flatus,
and mucus-coated stools if ingested.  It is somewhat surprising that
the authors suggest that a suitable inhaled or ingested lectin may be
useful in treating patients with cystic fibrosis, since the very
symptoms produced by the ingested lectin resemble those associated
with the disease.  A more attractive recommendation would be for
patients with cystic fibrosis to avoid substances containing lectins
such as Con A to avoid stimulating additional mucus release.  The
underlying pathogenetic defect in cystic fibrosis may be
inappropriate, excessive stimuli by lectin-like substances.  These
observations suggest that the increase in the protein content of
lymphocytes is stimulated by a plasma factor present in patients with
cystic fibrosis and in carriers of the cystic fibrosis gene.  These
observations, plus those of Freed and Buckley, might suggest that
cystic fibrosis is a disease involving a plasma factor with lectin or
Con A-like activity which stimulates the secretion of mucus and
increases the enzyme content of circulating or cultured lymphocytes.
- Professor Lieberman confuses cause with effect.  If there is
excessive mucus production in cystic fibrosis we suggest that this is
because the secretion is so difficult to remove from the mucosal
surface.  Goblet cells and mucus glands become clogged with
hyperviscid mucus which, not being removed, stimulates further mucus
production.  To deprive the patient of the mucotractive value of his
dietary lectins would be a therapeutic mischief equivalent to
prescribing a cough-suppresant for a productive cough.</EXTRACT>
<REFERENCES>
<CITE num="000" author="FREED DLJ" publication="LANCET" d1="1" d2="585" d3="978"/>
<CITE num="001" author="MARCHI AG" publication="HELV PAEDIATR ACTA" d1="28" d2="427" d3="973"/>
<CITE num="002" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="116" d2="1047" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78146</PAPERNUM>
<CITATIONS>
<CITE num="1" author="EBERMAN J           J" publication="LAB CLIN MED" d1="97" d2="46 9" d3="1"/>
</CITATIONS>
<RECORDNUM>00926 </RECORDNUM>
<MEDLINENUM>79052016</MEDLINENUM>
<TITLE>Cystic-fibrosis variants--or variations?  [editorial].</TITLE>
<SOURCE>Lancet. 1978 Nov 11. 2(8098). P 1032-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BRONCHITIS: di</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PANCREAS: pp</TOPIC><TOPIC>PSEUDOMONAS-INFECTIONS: di</TOPIC><TOPIC>STAPHYLOCOCCAL-INFECTIONS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is inherited by single autosomal transmission.  That,
at least, is the general view; but from time to time other
suggestions are offered.  Stern et al. describe what they believe may
be a genetic variant.  The affected patients, they suggest, are
homozygous for a portion of a closely linked multigenic cystic
fibrosis locus, or have modifier genes ameliorating the pancreatic
and sweat lesions.  Do these patients really have CF?  And, if so,
are Stern et al. justified in suggesting that they differ genetically
from the "classic" CF patient?  This hypothesis may not be correct
but, until we understand the basic fundamental defect, it may be
unwise to divide CF into different genetic types on the basis of
clinical variations.</EXTRACT>
<REFERENCES>
<CITE num="001" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="004" author="STERN RC" publication="JAMA" d1="239" d2="2676" d3="978"/>
<CITE num="005" author="HADORN B" publication="CAN MED ASSOC J" d1="98" d2="377" d3="968"/>
<CITE num="006" author="ZOPPI G" publication="ACTA PAEDIATR SCAND" d1="59" d2="692" d3="970"/>
<CITE num="007" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="ANN NY ACAD SCI" d1="93" d2="555" d3="962"/>
<CITE num="009" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="52" d2="870" d3="977"/>
<CITE num="010" author="SMALLEY CA" publication="LANCET" d1="2" d2="415" d3="978"/>
<CITE num="011" author="MANGOS JA" publication="CF PROJECTIONS INTO THE FUTUR" d1="" d2="" d3="976"/>
<CITE num="012" author="HIRSCHHORN K" publication="IN: MANGOS JA" d1="" d2="305" d3="976"/>
<CITE num="013" author="CONOVER JH" publication="LIFE SCI" d1="14" d2="253" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78147</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIS PB              AM" publication="J MED" d1="69" d2="43 9" d3="0"/>
<CITE num="2" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
</CITATIONS>
<RECORDNUM>00927 </RECORDNUM>
<MEDLINENUM>79052040</MEDLINENUM>
<AUTHORS><AUTHOR>Kibel-M-A</AUTHOR></AUTHORS>
<TITLE>Sweat tests in cystic fibrosis [letter].</TITLE>
<SOURCE>Lancet. 1978 Nov 11. 2(8098). P 1050.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHLORIDES: an</TOPIC><TOPIC>ECZEMA: di</TOPIC><TOPIC>FALSE-POSITIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>SODIUM: an</TOPIC></MINORSUBJ>
<EXTRACT>Dr Smalley and her colleagues rightly stress that the commonest
reason for abnormally high sweat-electrolyte levels, apart from
cystic fibrosis, is faulty technique.  A further cause of
false-positive results, and potentially more important than the list
of rare disorders usually cited, is atopic dermatitis.  Dr M. Ampola
and I investigated ten children with eczema at the Tufts New England
Medical Center, Boston, and found higher sodium and/or chloride
levels in sweat obtained from affected skin than in sweat from normal
skin in the same individuals.  In four of these atopic children,
levels within the diagnostic range for cystic fibrosis were obtained
(above 60 mmol/l).</EXTRACT>
<REFERENCES>
<CITE num="000" author="SMALLEY CA" publication="LANCET" d1="2" d2="415" d3="978"/>
<CITE num="001" author="SHWACHMAN H" publication="MOD PROBL PEDIATR" d1="10" d2="158" d3="967"/>
<CITE num="002" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="003" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78148</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VID TJ              LA" publication="NCET" d1="2" d2="04 9" d3="2"/>
<CITE num="2" author="RUDDY RM" publication="CLIN PEDIATR" d1="26" d2="83" d3="987"/>
</CITATIONS>
<RECORDNUM>00928 </RECORDNUM>
<MEDLINENUM>79031281</MEDLINENUM>
<AUTHORS><AUTHOR>Galabert-C</AUTHOR><AUTHOR>Filliat-M</AUTHOR><AUTHOR>Chazalette-J-P</AUTHOR></AUTHORS>
<TITLE>Fatty-acid composition of serum-lecithins in cystic-fibrosis
patients without steatorrhoea [letter].</TITLE>
<SOURCE>Lancet. 1978 Oct 21. 2(8095). P 903.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>FATTY-ACIDS-UNSATURATED: an</TOPIC><TOPIC>PHOSPHATIDYLCHOLINES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>PANCREAS: me</TOPIC></MINORSUBJ>
<EXTRACT>We have investigated the fatty-acid composition of serum-lecithins
from four groups of C.F. patients, defined by their pancreatic
function evaluated by 72-h quantitative stool fat and determination
of the coefficient of fat absorption.  C.F. patients without
pancreatic insufficiency and not on pancreatic extract had
significantly higher percentages of linoleic acid than did patients
of any other group.  The altered fatty-acid composition of
serum-lipid fractions seems to be a secondary consequence of the
pancreatic insufficiency commonly associated with C.F. disease and
not a direct metabolic defect as some have suggested.</EXTRACT>
<REFERENCES>
<CITE num="001" author="HUBBARD VS" publication="LANCET" d1="2" d2="1302" d3="977"/>
<CITE num="002" author="KUO PT" publication="J PEDIATR" d1="60" d2="394" d3="962"/>
<CITE num="003" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="004" author="UNDERWOOD BA" publication="ANN NY ACAD SCI" d1="203" d2="237" d3="972"/>
<CITE num="005" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78149</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GIERS V             CL" publication="IN CHIM ACTA                 1" d1="05" d2="05 9" d3="0"/>
<CITE num="2" author="ROGIERS V" publication="PEDIATR RES" d1="16" d2="761" d3="982"/>
<CITE num="3" author="HARPER TB" publication="AM REV RESPIR DIS" d1="126" d2="540" d3="982"/>
<CITE num="4" author="KUSOFFSKY E" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="434" d3="983"/>
<CITE num="5" author="HUBBARD VS" publication="EUR J PEDIATR" d1="141" d2="68" d3="983"/>
<CITE num="6" author="ROGIERS V" publication="EUR J PEDIATR" d1="141" d2="39" d3="983"/>
<CITE num="7" author="ROGIERS V" publication="PEDIATR RES" d1="18" d2="704" d3="984"/>
<CITE num="8" author="FARRELL PM" publication="PEDIATR RES" d1="19" d2="104" d3="985"/>
<CITE num="9" author="CRAIGSCHMIDT MC" publication="AM J CLIN NUTR" d1="44" d2="816" d3="986"/>
<CITE num="10" author="STEAD RJ" publication="PROSTAGLANDINS LEUKOTR MED" d1="26" d2="91" d3="987"/>
</CITATIONS>
<RECORDNUM>00929 </RECORDNUM>
<MEDLINENUM>79071612</MEDLINENUM>
<AUTHORS><AUTHOR>Ellam-S-V</AUTHOR></AUTHORS>
<TITLE>Improvement on the safety of sweat-test equipment.</TITLE>
<SOURCE>Med-Biol-Eng-Comput. 1978 Sep. 16(5). P 595-6.</SOURCE>
<MAJORSUBJ><TOPIC>ACCIDENT-PREVENTION</TOPIC><TOPIC>IONTOPHORESIS: is</TOPIC><TOPIC>SAFETY</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BURNS-ELECTRIC: pc</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Patients with cystic fibrosis have a higher concentration of sodium
and chloride in their sweat than normals.  This observation led to
the introduction of an iontophoresis technique for stimulating the
sweat glands with pilocarpine.  Occasionally, electrical burns result
from defective equipment or from an incorrect or badly applied test
procedure.  A new design of equipment is presented which eliminates
the possibility of a burn during the test.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78150</PAPERNUM>
<REFERENCES>
<CITE num="001" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="002" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="003" author="SCHWARZ V" publication="ARCH DIS CHILD" d1="43" d2="695" d3="968"/>
</REFERENCES>
<RECORDNUM>00930 </RECORDNUM>
<MEDLINENUM>79052693</MEDLINENUM>
<AUTHORS><AUTHOR>Elliott-R-B</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis screening in the newborn [editorial].</TITLE>
<SOURCE>Med-J-Aust. 1978 Jul 29. 2(3). P 95.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pc</TOPIC><TOPIC>MASS-SCREENING: mt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC></MINORSUBJ>
<EXTRACT>Many attempts have been made to establish a suitable screening test
for cystic fibrosis for newborns.  Recently, a new method has been
described by Crossley and her associates.  It is based on measuring
pancreatic trypsin in a sample of faeces collected on to filter paper
on the 4th or 5th day of life.  The false-negative rate of the new
test has not yet been determined, but older children with CF and
pancreatic achylia all gave abnormal results when tested.  The
disadvantage of the test, as with the meconium albumin test, is that
about 10% of children with CF are said not to have pancreatic
achylia.  Whilst the method needs more extensive evaluation, it
appears technically more satisfactory than others so far described.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78151</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="REC ADELAIDE CHILD HOSP" d1="1" d2="359" d3="977"/>
<CITE num="002" author="PROSSER R" publication="ARCH DIS CHILD" d1="49" d2="597" d3="974"/>
<CITE num="003" author="CROSSLEY JR" publication="LANCET" d1="2" d2="1093" d3="977"/>
</REFERENCES>
<RECORDNUM>00931 </RECORDNUM>
<MEDLINENUM>79072550</MEDLINENUM>
<AUTHORS><AUTHOR>Moses-R-G</AUTHOR><AUTHOR>Bowen-T</AUTHOR><AUTHOR>Edwards-R</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis and fast moving haemoglobin [letter].</TITLE>
<SOURCE>Med-J-Aust. 1978 Aug 12. 2(4). P 160-1.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HEMOGLOBINS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC></MINORSUBJ>
<EXTRACT>We have measured fast moving components of haemoglobin (FMH) in nine
children with cystic fibrosis without any clinical evidence of
diabetes mellitus.  The nine patients with cystic fibrosis had a mean
FMH of 9.3 which differed significantly from 97 controls with a mean
FMH of 7.6.  There was no correlation between FMH and age or FMH and
duration of disease.  The above results raise the question as to what
extent the FMH is a reflection of hyperglycaemia or insulinopenia.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78152</PAPERNUM>
<REFERENCES>
<CITE num="001" author="PAULSEN EP" publication="DIABETES" d1="25" d2="890" d3="976"/>
<CITE num="002" author="KOENIG RJ" publication="N ENGL J MED" d1="295" d2="417" d3="976"/>
<CITE num="003" author="MILNER AD" publication="ARCH DIS CHILD" d1="44" d2="351" d3="969"/>
</REFERENCES>
<RECORDNUM>00932 </RECORDNUM>
<MEDLINENUM>78113434</MEDLINENUM>
<AUTHORS><AUTHOR>Holzel-A</AUTHOR></AUTHORS>
<TITLE>Malabsorption.</TITLE>
<SOURCE>Midwife-Health-Visit-Community-Nurse. 1978 Mar. 14(3). P 79-81.</SOURCE>
<MAJORSUBJ><TOPIC>MALABSORPTION-SYNDROMES: pp</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELIAC-DISEASE: pp</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>DIETARY-CARBOHYDRATES</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LACTOSE-INTOLERANCE: pp</TOPIC><TOPIC>SUCROSE</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78153</PAPERNUM>
<EXTRACT>Malabsorption in infancy and childhood can roughly be defined as a
condition of inadequate growth in spite of seemingly adequate
nutrition and is accompanied by excessive excretion of food
components in the stools.  Acquired lactase deficiency, the
introduction of sugar in the diet, coeliac disease, and cystic
fibrosis are discussed.</EXTRACT>
<RECORDNUM>00933 </RECORDNUM>
<MEDLINENUM>79093734</MEDLINENUM>
<AUTHORS><AUTHOR>Watts-R-W</AUTHOR></AUTHORS>
<TITLE>Recent advances in screening for inborn errors of metabolism.</TITLE>
<SOURCE>Monogr-Hum-Genet. 1978. 9. P 204-11.</SOURCE>
<MAJORSUBJ><TOPIC>METABOLISM-INBORN-ERRORS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANEMIA-SICKLE-CELL: oc</TOPIC><TOPIC>CRETINISM: oc</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>METABOLISM-INBORN-ERRORS: fg</TOPIC><TOPIC>PHENYLKETONURIA: oc</TOPIC><TOPIC>TAY-SACHS-DISEASE: oc</TOPIC></MINORSUBJ>
<EXTRACT>A screening test is any diagnostic procedure which we apply without
a specific clinical indication from the point of view of the
individual patient concerned.  Non-selective (whole population)
screening for inborn errors of metabolism, selective screening for
inborn errors of metabolism, screening for nonamino organic
acidurias, and selective screening for inborn errors of metabolism
because of genetic indications are discussed.  The main points which
emerge for the future from this review are the need to develop
multidisease screening programmes to detect the very rare diseases;
that postnatal, prenatal and carrier screening should be considered
and developed collectively; and there us an urgent needs to develop
screening for thallasaemia, sickle cell disease, cystic fibrosis and
congenital hypothyroidism.</EXTRACT>
<REFERENCES>
<CITE num="001" author="BROWN E" publication="METABOLISM" d1="26" d2="1047" d3="977"/>
<CITE num="002" author="CHALMERS RA" publication="CLIN CHEM" d1="22" d2="1292" d3="976"/>
<CITE num="003" author="CHALMERS RA" publication="CLIN CHEM" d1="22" d2="1288" d3="976"/>
<CITE num="004" author="CHALMERS RA" publication="ANN CLIN BIOCHEM" d1="14" d2="149" d3="977"/>
<CITE num="005" author="CHILDS B" publication="AM J HUM GENET" d1="28" d2="537" d3="976"/>
<CITE num="006" author="CHILDS B" publication="AM J HUM GENET" d1="28" d2="550" d3="976"/>
<CITE num="007" author="EVANS PR" publication="IN: RAINE DN" d1="" d2="93" d3="977"/>
<CITE num="008" author="FISHER DA" publication="J PEDIATR" d1="89" d2="692" d3="976"/>
<CITE num="009" author="GIBBS DA" publication="ANN CLIN BIOCHEM" d1="14" d2="157" d3="977"/>
<CITE num="011" author="KABACK MM" publication="HUM HERED" d1="27" d2="186" d3="977"/>
<CITE num="012" author="KABACK MM" publication="PROG MED GENET" d1="10" d2="103" d3="974"/>
<CITE num="013" author="KAN YW" publication="LANCET" d1="1" d2="269" d3="977"/>
<CITE num="014" author="KOMROWER GM" publication="PEDIATRICS" d1="53" d2="182" d3="974"/>
<CITE num="015" author="LAWSON AM" publication="CLIN CHEM" d1="22" d2="1283" d3="976"/>
<CITE num="016" author="NATHAN DG" publication="BR J HAEMATOL SUPPL" d1="31" d2="143" d3="975"/>
<CITE num="017" author="PADEH B" publication="HUM HERED" d1="27" d2="200" d3="977"/>
<CITE num="018" author="PURKISS P" publication="PROC INT SYMP GLYCOCON 3RD" d1="" d2="19" d3="975"/>
<CITE num="019" author="SEEGMILLER JE" publication="IN: NATELSON S" d1="" d2="291" d3="974"/>
<CITE num="020" author="WATTS RWE" publication="LANCET" d1="1" d2="368" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78154</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IDER M              CL" publication="IN BIOCHEM CONTEM THEO TECH" d1="2" d2="45 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00934 </RECORDNUM>
<MEDLINENUM>79032102</MEDLINENUM>
<AUTHORS><AUTHOR>Gordeuk-V</AUTHOR><AUTHOR>Keeports-R</AUTHOR><AUTHOR>Rexrode-W</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in adults [letter].</TITLE>
<SOURCE>N-Engl-J-Med. 1978 Nov 16. 299(20). P 1137.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>
<EXTRACT>Long considered a childhood disease, cystic fibrosis has been
recognized with increasing frequency in adults.  In the case reported
below the diagnosis was made in an adult.  The initial diagnosis of
cystic fibrosis in patients over 30 years of age has rarely been
reported.  Our patient, in whom the diagnosis of cystic fibrosis was
first made at 48 years if age, serves to emphasize the point that
physicians should consider cystic fibrosis in the differential
diagnosis of adults with unexplained chronic obstructive lung
disease.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WARWICK WJ" publication="JAMA" d1="238" d2="2159" d3="977"/>
<CITE num="002" author="SHWACHMAN H" publication="N ENGL J MED" d1="296" d2="1519" d3="977"/>
<CITE num="003" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78155</PAPERNUM>
<CITATIONS>
<CITE num="1" author="VIDSON AGF          N" publication="ENGL J MED                   3" d1="00" d2="64 9" d3="9"/>
</CITATIONS>
<RECORDNUM>00935 </RECORDNUM>
<MEDLINENUM>79053053</MEDLINENUM>
<AUTHORS><AUTHOR>Bennion-L-J</AUTHOR><AUTHOR>Grundy-S-M</AUTHOR></AUTHORS>
<TITLE>Risk factors for the development of cholelithiasis in man (second of
two parts).</TITLE>
<SOURCE>N-Engl-J-Med. 1978 Nov 30. 299(22). P 1221-7. (REVIEW).</SOURCE>
<MAJORSUBJ><TOPIC>CHOLELITHIASIS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ANEMIA-HEMOLYTIC: co</TOPIC><TOPIC>BILE: mi</TOPIC><TOPIC>CHOLELITHIASIS: ci, fg, oc</TOPIC><TOPIC>CLOFIBRATE: ae</TOPIC><TOPIC>CONTRACEPTIVES-ORAL: ae</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DIET: ae</TOPIC><TOPIC>ESTROGENS: ae</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GASTROINTESTINAL-DISEASES: co</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFECTION: co</TOPIC><TOPIC>LIVER-CIRRHOSIS-ALCOHOLIC: co</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OBESITY: co</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>REVIEW</TOPIC><TOPIC>RISK</TOPIC></MINORSUBJ>
<EXTRACT>The demographic characteristics of persons at high risk for pigment
gallstones differ from those is whom cholesterol stones are likely to
develop.  Conditions associated with pigment gallstones include
hemolytic anemia, alcoholic cirrhosis, and infected bile.  Conditions
associated with cholesterol gallstones include obesity, diet,
blood-cholesterol-lowering drugs, disorders of the gastrointestinal
tract, female sex hormones, and genetic and ethnic influences.
Problem areas such as case finding and common disorders and pregnancy
are discussed, along with clinical implications (diagnosis,
prevention, and therapy).</EXTRACT>
<REFERENCES>
<CITE num="049" author="SAMPLINER RE" publication="N ENGL J MED" d1="283" d2="1358" d3="970"/>
<CITE num="050" author="SIEVERS ML" publication="JAMA" d1="182" d2="570" d3="962"/>
<CITE num="051" author="THISTLE JL" publication="MAYO CLIN PROC" d1="46" d2="603" d3="971"/>
<CITE num="052" author="SUTOR DJ" publication="GUT" d1="12" d2="55" d3="971"/>
<CITE num="053" author="GROSS DMB" publication="J PATHOL BACTERIOL" d1="32" d2="503" d3="929"/>
<CITE num="054" author="TROTMAN BW" publication="AM J DIG DIS" d1="20" d2="735" d3="975"/>
<CITE num="055" author="MARINOVIC J" publication="REV MED CHIL" d1="100" d2="1320" d3="972"/>
<CITE num="056" author="MIYAKE H" publication="DIGESTION" d1="1" d2="219" d3="968"/>
<CITE num="057" author="YAGI T" publication="TOHOKU J EXP MED" d1="72" d2="117" d3="960"/>
<CITE num="058" author="NAKAYAMA F" publication="AM J SURG" d1="120" d2="794" d3="970"/>
<CITE num="059" author="KAMEDA H" publication="GASTROENTEROLOGY" d1="46" d2="109" d3="964"/>
<CITE num="060" author="MATSUSHIRO T" publication="GASTROENTEROLOGY" d1="72" d2="630" d3="977"/>
<CITE num="061" author="GLENN F" publication="ANN SURG" d1="153" d2="411" d3="961"/>
<CITE num="062" author="CAMERON JL" publication="ANN SURG" d1="174" d2="702" d3="971"/>
<CITE num="063" author="MERENDINO KA" publication="ANN SURG" d1="177" d2="694" d3="973"/>
<CITE num="064" author="TAMALET E" publication="J MED FR" d1="21" d2="159" d3="932"/>
<CITE num="065" author="JORDAN RA" publication="GASTROENTEROLOGY" d1="33" d2="952" d3="957"/>
<CITE num="066" author="DEWEY KW" publication="RADIOLOGY" d1="96" d2="385" d3="970"/>
<CITE num="067" author="BATES GC" publication="GASTROENTEROLOGY" d1="21" d2="104" d3="952"/>
<CITE num="068" author="BOUCHIER IAD" publication="GUT" d1="10" d2="705" d3="969"/>
<CITE num="069" author="NICHOLAS P" publication="GASTROENTEROLOGY" d1="63" d2="112" d3="972"/>
<CITE num="070" author="VAN DER LINDEN W" publication="ACTA CHIR SCAND SUPPL" d1="269" d2="1" d3="961"/>
<CITE num="071" author="FRIEDMAN GD" publication="J CHRON DIS" d1="19" d2="273" d3="966"/>
<CITE num="072" author="STURDEVANT RAL" publication="N ENGL J MED" d1="288" d2="24" d3="973"/>
<CITE num="073" author="MABEE TM" publication="SURGERY" d1="79" d2="460" d3="976"/>
<CITE num="074" author="SARLES H" publication="SEM HOP PARIS" d1="33" d2="3424" d3="957"/>
<CITE num="075" author="SARLES H" publication="AM J DIG DIS" d1="14" d2="531" d3="969"/>
<CITE num="076" author="SARLES H" publication="AM J DIG DIS" d1="15" d2="251" d3="970"/>
<CITE num="077" author="SARLES H" publication="SCAND J GASTROENTEROL" d1="6" d2="189" d3="971"/>
<CITE num="078" author="SCHREIBMAN PH" publication="AM SOC CLIN INVE 66TH ANN MTG" d1="" d2="72A" d3="974"/>
<CITE num="079" author="QUINTAO E" publication="J LIPID RES" d1="12" d2="233" d3="971"/>
<CITE num="080" author="SARLES H" publication="SCAND J GASTROENTEROL" d1="5" d2="603" d3="970"/>
<CITE num="081" author="DAM H" publication="Z ERNAEHRUNGSWISS" d1="10" d2="178" d3="971"/>
<CITE num="082" author="DENBESTEN L" publication="SURGERY" d1="73" d2="266" d3="973"/>
<CITE num="083" author="MIETTINEN M" publication="ANN CLIN RES" d1="8" d2="111" d3="976"/>
<CITE num="084" author="DAM H" publication="SCAND J CLIN LAB INVEST" d1="19" d2="367" d3="967"/>
<CITE num="085" author="WATANABE N" publication="ARCH SURG" d1="85" d2="136" d3="962"/>
<CITE num="086" author="GRUNDY SM" publication="J CLIN INVEST" d1="55" d2="269" d3="975"/>
<CITE num="087" author="HEATON KW" publication="CLIN GASTROENTEROL" d1="2" d2="67" d3="973"/>
<CITE num="088" author="BURKITT DP" publication="BR MED J" d1="1" d2="274" d3="973"/>
<CITE num="089" author="POMARE EW" publication="AM J DIG DIS" d1="21" d2="521" d3="976"/>
<CITE num="091" author="RAYMOND TL" publication="J CLIN INVEST" d1="60" d2="1429" d3="977"/>
<CITE num="092" author="ANON" publication="N ENGL J MED" d1="296" d2="1185" d3="977"/>
<CITE num="093" author="COOPER J" publication="LANCET" d1="1" d2="1083" d3="975"/>
<CITE num="094" author="PERTSEMLIDIS D" publication="GASTROENTEROLOGY" d1="66" d2="565" d3="974"/>
<CITE num="095" author="THISTLE JL" publication="GASTROENTEROLOGY" d1="61" d2="488" d3="971"/>
<CITE num="096" author="HORLICK L" publication="CIRCULATION" d1="43" d2="299" d3="971"/>
<CITE num="097" author="GRUNDY SM" publication="J LIPID RES" d1="13" d2="531" d3="972"/>
<CITE num="098" author="WOOD PD" publication="METABOLISM" d1="21" d2="107" d3="972"/>
<CITE num="099" author="DAM H" publication="Z ERNAEHRUNGSWISS" d1="10" d2="188" d3="971"/>
<CITE num="100" author="MEIHOFF WE" publication="J CLIN INVEST" d1="47" d2="261" d3="968"/>
<CITE num="101" author="HEATON KW" publication="GASTROENTEROLOGY" d1="55" d2="5" d3="968"/>
<CITE num="102" author="DOWLING RH" publication="GUT" d1="13" d2="415" d3="972"/>
<CITE num="103" author="COHEN S" publication="GASTROENTEROLOGY" d1="60" d2="237" d3="971"/>
<CITE num="104" author="BAKER AL" publication="AM J DIG DIS" d1="19" d2="109" d3="975"/>
<CITE num="105" author="MARKS JW" publication="AM J DIG DIS" d1="22" d2="1097" d3="977"/>
<CITE num="106" author="HEATON KW" publication="BR MED J" d1="3" d2="494" d3="969"/>
<CITE num="107" author="PELLERIN D" publication="J PEDIATR SURG" d1="10" d2="35" d3="975"/>
<CITE num="108" author="ROVSING H" publication="ACTA RADIOL DIAGN STOCKH" d1="14" d2="588" d3="973"/>
<CITE num="109" author="ROY CC" publication="N ENGL J MED" d1="297" d2="1301" d3="977"/>
<CITE num="110" author="WEBER AM" publication="N ENGL J MED" d1="289" d2="1001" d3="973"/>
<CITE num="111" author="GOODCHILD MC" publication="ARCH DIS CHILD" d1="50" d2="769" d3="975"/>
<CITE num="112" author="WATKINS JB" publication="GASTROENTEROLOGY" d1="67" d2="835" d3="974"/>
<CITE num="113" author="ANON" publication="LANCET" d1="1" d2="1399" d3="973"/>
<CITE num="114" author="ANON" publication="ORAL CONTRACEPTIVES AND HEALT" d1="" d2="57" d3="974"/>
<CITE num="115" author="STOLLEY PD" publication="AM J EPIDEMIOL" d1="102" d2="197" d3="975"/>
<CITE num="116" author="ANON" publication="N ENGL J MED" d1="290" d2="15" d3="974"/>
<CITE num="117" author="BENNION LJ" publication="N ENGL J MED" d1="294" d2="189" d3="976"/>
<CITE num="118" author="TRITAPEPE R" publication="N ENGL J MED" d1="295" d2="961" d3="976"/>
<CITE num="119" author="ANON" publication="FDA DRUG BULL" d1="8" d2="12" d3="978"/>
<CITE num="120" author="NILSSON S" publication="ACTA CHIR SCAND" d1="132" d2="275" d3="966"/>
<CITE num="121" author="HORN G" publication="BR MED J" d1="2" d2="732" d3="956"/>
<CITE num="122" author="BENNION LJ" publication="METABOLISM" d1="27" d2="961" d3="978"/>
<CITE num="123" author="BENNION LJ" publication="CLIN RES" d1="26" d2="496A" d3="978"/>
<CITE num="124" author="BENNION LJ" publication="N ENGL J MED" d1="297" d2="709" d3="977"/>
<CITE num="125" author="NILSSON S" publication="ACTA CHIR SCAND" d1="133" d2="648" d3="967"/>
<CITE num="126" author="WILCOX LL" publication="CLIN RES" d1="20" d2="223" d3="972"/>
<CITE num="127" author="ZAHOR Z" publication="SCAND J GASTROENTEROL" d1="9" d2="3" d3="974"/>
<CITE num="128" author="BILL K" publication="N ENGL J MED" d1="284" d2="694" d3="971"/>
<CITE num="129" author="REDINGER RN" publication="ARCH INTERN MED" d1="130" d2="618" d3="972"/>
<CITE num="130" author="THISTLE JL" publication="N ENGL J MED" d1="284" d2="144" d3="971"/>
<CITE num="131" author="JACKSON CD" publication="SURGERY" d1="46" d2="853" d3="959"/>
<CITE num="132" author="VAN DER LINDEN W" publication="ACTA GENET STATIST MED" d1="15" d2="159" d3="965"/>
<CITE num="133" author="DANZINGER RG" publication="MAYO CLIN PROC" d1="47" d2="762" d3="972"/>
<CITE num="134" author="BAINTON D" publication="N ENGL J MED" d1="294" d2="1147" d3="976"/>
<CITE num="135" author="WILLIAMS CN" publication="CAN MED ASSOC J" d1="117" d2="758" d3="977"/>
<CITE num="136" author="BENNION LJ" publication="N ENGL J MED" d1="296" d2="1365" d3="977"/>
<CITE num="137" author="KAYE MD" publication="LANCET" d1="1" d2="1228" d3="971"/>
<CITE num="138" author="RIEGEL C" publication="JAMA" d1="105" d2="1343" d3="935"/>
<CITE num="139" author="POTTER MG" publication="JAMA" d1="106" d2="1070" d3="937"/>
<CITE num="140" author="LARGE AM" publication="AM J MED SCI" d1="239" d2="713" d3="960"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78156</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RKER DJP            BR" publication="MED J" d1="2" d2="89 9" d3="9"/>
<CITE num="2" author="GRUNDY SM" publication="EUR J CLIN INVEST" d1="9" d2="179" d3="979"/>
<CITE num="3" author="AYUB A" publication="SURG CLIN NORTH AM" d1="59" d2="1095" d3="979"/>
<CITE num="4" author="REDINGER RN" publication="POSTGRAD MED" d1="65" d2="56" d3="979"/>
<CITE num="5" author="ANDERSEN JM" publication="GASTROENTEROLOGY" d1="77" d2="1146" d3="979"/>
<CITE num="6" author="INGELFINGER FJ" publication="N ENGL J MED" d1="300" d2="917" d3="979"/>
<CITE num="7" author="PADOVA CD" publication="METH FIND EXP CLIN PHARMACOL" d1="2" d2="177" d3="980"/>
<CITE num="8" author="CAPRON JP" publication="GASTROENTEROL CLIN BIOL" d1="4" d2="63" d3="980"/>
<CITE num="9" author="DEVORE GR" publication="CLIN PERINATOL" d1="7" d2="349" d3="980"/>
<CITE num="10" author="HUIJBREGTS AWM" publication="EUR J CLIN INVEST" d1="10" d2="443" d3="980"/>
<CITE num="11" author="DIPADOVA C" publication="EUR SURG RES" d1="12" d2="57" d3="980"/>
<CITE num="12" author="ANGELIN B" publication="SCAND J GASTROENTEROL" d1="15" d2="849" d3="980"/>
<CITE num="13" author="HONORE LH" publication="J CLIN PHARMACOL" d1="20" d2="338" d3="980"/>
<CITE num="14" author="DEMARQUEZ JL" publication="AGRESSOLOGIE" d1="21" d2="137" d3="980"/>
<CITE num="15" author="PETERS H" publication="INTERNIST" d1="21" d2="559" d3="980"/>
<CITE num="16" author="CADIER L" publication="ANN RADIOL (PARIS)" d1="23" d2="428" d3="980"/>
<CITE num="17" author="SHAFFER EA" publication="CAN J SURG" d1="23" d2="517" d3="980"/>
<CITE num="18" author="HONORE LH" publication="J REPROD MED" d1="25" d2="187" d3="980"/>
<CITE num="19" author="HONORE LH" publication="J CHRON DIS" d1="33" d2="465" d3="980"/>
<CITE num="20" author="SCHLIERF G" publication="ATHEROSCLEROSIS" d1="36" d2="323" d3="980"/>
<CITE num="21" author="DIEHL AK" publication="J NATL CANCER INST" d1="65" d2="1209" d3="980"/>
<CITE num="22" author="MCMICHAEL AJ" publication="J NATL CANCER INST" d1="65" d2="1201" d3="980"/>
<CITE num="23" author="DIEHL AK" publication="SOUTH MED J" d1="73" d2="438" d3="980"/>
<CITE num="24" author="AHLBERG J" publication="GASTROENTEROLOGY" d1="79" d2="90" d3="980"/>
<CITE num="25" author="MOCK DM" publication="J PEDIATR" d1="96" d2="878" d3="980"/>
<CITE num="26" author="HONORE LH" publication="ARCH SURG" d1="115" d2="62" d3="980"/>
<CITE num="27" author="PAUMGARTNER G" publication="MUNCH MED WOCHENSCHR" d1="122" d2="1223" d3="980"/>
<CITE num="28" author="PAUMGARTNER G" publication="MUNCH MED WOCHENSCHR" d1="122" d2="1001" d3="980"/>
<CITE num="29" author="WILLIAMS CN" publication="CAN MED ASSOC J" d1="122" d2="664" d3="980"/>
<CITE num="30" author="NIESSEN KH" publication="MONATSSCHR KINDERHEILKD" d1="128" d2="551" d3="980"/>
<CITE num="31" author="SCHWEIGHOFER S" publication="AM J DIS CHILD" d1="134" d2="622" d3="980"/>
<CITE num="32" author="BRAVERMAN DZ" publication="N ENGL J MED" d1="302" d2="362" d3="980"/>
<CITE num="33" author="COHEN S" publication="N ENGL J MED" d1="302" d2="397" d3="980"/>
<CITE num="34" author="DIEHL AK" publication="LANCET" d1="2" d2="187" d3="981"/>
<CITE num="35" author="DIPADOVA C" publication="METH FIND EXP CLIN PHARMACOL" d1="3" d2="155" d3="981"/>
<CITE num="36" author="ANGELIN B" publication="SCAND J GASTROENTEROL" d1="16" d2="1015" d3="981"/>
<CITE num="37" author="SCHLIERF G" publication="DIGESTION" d1="21" d2="44" d3="981"/>
<CITE num="38" author="AHLBERG J" publication="J LIPID RES" d1="22" d2="404" d3="981"/>
<CITE num="39" author="STEVEN MM" publication="GUT" d1="22" d2="592" d3="981"/>
<CITE num="40" author="CAPRON JP" publication="DIG DIS SCI" d1="26" d2="523" d3="981"/>
<CITE num="41" author="DIPADOVA C" publication="DIG DIS SCI" d1="26" d2="1095" d3="981"/>
<CITE num="42" author="SOUSTEK Z" publication="ACTA MORPHOL ACAD SCI HUNG" d1="29" d2="127" d3="981"/>
<CITE num="43" author="RUDERMAN NB" publication="AM J CLIN NUTR" d1="34" d2="1617" d3="981"/>
<CITE num="44" author="PIMSTONE NR" publication="SURG CLIN NORTH AM" d1="61" d2="865" d3="981"/>
<CITE num="45" author="KLATSKY AL" publication="CIRCULATION" d1="64" d2="32" d3="981"/>
<CITE num="46" author="MOK HYI" publication="GASTROENTEROLOGY" d1="81" d2="340" d3="981"/>
<CITE num="47" author="LEE SP" publication="SCIENCE" d1="211" d2="1429" d3="981"/>
<CITE num="48" author="TURLEY SD" publication="J BIOL CHEM" d1="256" d2="2438" d3="981"/>
<CITE num="49" author="RUDERMAN NB" publication="INT J OBES" d1="6" d2="151" d3="982"/>
<CITE num="50" author="TUCKER LE" publication="INT J OBES" d1="6" d2="247" d3="982"/>
<CITE num="51" author="CHILDS B" publication="AM J MED GENET" d1="13" d2="319" d3="982"/>
<CITE num="52" author="ZSIGMOND G" publication="EUR SURG RES" d1="14" d2="344" d3="982"/>
<CITE num="53" author="LEISS O" publication="SCAND J GASTROENTEROL" d1="17" d2="587" d3="982"/>
<CITE num="54" author="HENEGOUWEN GPV" publication="NETH J MED" d1="25" d2="89" d3="982"/>
<CITE num="55" author="USCANGA L" publication="REV INVEST CLIN" d1="34" d2="341" d3="982"/>
<CITE num="56" author="TAKEUCHI N" publication="ATHEROSCLEROSIS" d1="42" d2="129" d3="982"/>
<CITE num="57" author="PODDA M" publication="ARCH DIS CHILD" d1="57" d2="956" d3="982"/>
<CITE num="58" author="BRAUN B" publication="KLIN WSCHR" d1="60" d2="1357" d3="982"/>
<CITE num="59" author="EVERSON GT" publication="GASTROENTEROLOGY" d1="82" d2="711" d3="982"/>
<CITE num="60" author="HEUBI JE" publication="GASTROENTEROLOGY" d1="82" d2="1295" d3="982"/>
<CITE num="61" author="LOWENFELS AB" publication="GASTROENTEROLOGY" d1="83" d2="672" d3="982"/>
<CITE num="62" author="KRISHNAMURTHY GT" publication="WEST J MED" d1="137" d2="87" d3="982"/>
<CITE num="63" author="SHUMAN WP" publication="AM J ROENTGENOL" d1="138" d2="1" d3="982"/>
<CITE num="64" author="KORENMAN SG" publication="ARCH INTERN MED" d1="142" d2="1131" d3="982"/>
<CITE num="65" author="SASTIC JW" publication="SURG GYNECOL OBSTET" d1="155" d2="209" d3="982"/>
<CITE num="66" author="KERN F" publication="SEM LIVER DIS" d1="3" d2="87" d3="983"/>
<CITE num="67" author="ZAK RA" publication="SEM LIVER DIS" d1="3" d2="132" d3="983"/>
<CITE num="68" author="BOUCHIER IAD" publication="CLIN GASTROENTEROL" d1="12" d2="25" d3="983"/>
<CITE num="69" author="DOWLING RH" publication="CLIN GASTROENTEROL" d1="12" d2="125" d3="983"/>
<CITE num="70" author="BORGNAPIGNATTI C" publication="ITAL J GASTROENTEROL" d1="15" d2="228" d3="983"/>
<CITE num="71" author="KESANIEMI YA" publication="SCAND J GASTROENTEROL" d1="18" d2="897" d3="983"/>
<CITE num="72" author="WHITING MJ" publication="GUT" d1="24" d2="11" d3="983"/>
<CITE num="73" author="LEISS O" publication="KLIN WSCHR" d1="61" d2="579" d3="983"/>
<CITE num="74" author="GILAT T" publication="GASTROENTEROLOGY" d1="84" d2="242" d3="983"/>
<CITE num="75" author="MESSING B" publication="GASTROENTEROLOGY" d1="84" d2="1012" d3="983"/>
<CITE num="76" author="TURLEY SD" publication="GASTROENTEROLOGY" d1="84" d2="253" d3="983"/>
<CITE num="77" author="LEISS O" publication="FETTE SEIFEN ANSTRICHM" d1="85" d2="447" d3="983"/>
<CITE num="78" author="MEDINA E" publication="REV MED CHIL" d1="111" d2="668" d3="983"/>
<CITE num="79" author="MCMICHAEL AJ" publication="AM J EPIDEMIOL" d1="118" d2="620" d3="983"/>
<CITE num="80" author="ADYE B" publication="WEST J MED" d1="139" d2="471" d3="983"/>
<CITE num="81" author="BOUCHIER IAD" publication="BR MED J" d1="286" d2="415" d3="983"/>
<CITE num="82" author="DOTY JE" publication="J PARENT ENTERAL NUTR" d1="8" d2="263" d3="984"/>
<CITE num="83" author="WHITING MJ" publication="INT J OBES" d1="8" d2="681" d3="984"/>
<CITE num="84" author="ANGELIN B" publication="EUR J CLIN INVEST" d1="14" d2="73" d3="984"/>
<CITE num="85" author="FAED EM" publication="DRUG METAB REV" d1="15" d2="1213" d3="984"/>
<CITE num="86" author="DIPADOVA C" publication="SCAND J GASTROENTEROL" d1="19" d2="820" d3="984"/>
<CITE num="87" author="BOUCHIER JAD" publication="GUT" d1="25" d2="1021" d3="984"/>
<CITE num="88" author="WERNER D" publication="GUT" d1="25" d2="269" d3="984"/>
<CITE num="89" author="ACALOVSCHI M" publication="ACTA GASTROENTEROL BELG" d1="47" d2="381" d3="984"/>
<CITE num="90" author="ADAMI HO" publication="BR J CANCER" d1="49" d2="235" d3="984"/>
<CITE num="91" author="DEDERER YM" publication="KLIN MED" d1="62" d2="14" d3="984"/>
<CITE num="92" author="ADAMTHWAITE DN" publication="S AFR MED J" d1="65" d2="572" d3="984"/>
<CITE num="93" author="WHITING MJ" publication="GASTROENTEROLOGY" d1="86" d2="243" d3="984"/>
<CITE num="94" author="TURLEY SD" publication="GASTROENTEROLOGY" d1="87" d2="284" d3="984"/>
<CITE num="95" author="FRIED GM" publication="SURGERY" d1="95" d2="284" d3="984"/>
<CITE num="96" author="VOGELBERG KH" publication="DTSCH MED WSCHR" d1="109" d2="1712" d3="984"/>
<CITE num="97" author="MULLIGAN SC" publication="IR J MED SCI" d1="153" d2="106" d3="984"/>
<CITE num="98" author="SCRAGG RKR" publication="BR MED J" d1="288" d2="1113" d3="984"/>
<CITE num="99" author="RHOMBERG HP" publication="BR MED J" d1="289" d2="1002" d3="984"/>
<CITE num="100" author="MORRISON WB" publication="VET PATHOL" d1="22" d2="285" d3="985"/>
<CITE num="101" author="BOLONDI L" publication="GUT" d1="26" d2="734" d3="985"/>
<CITE num="102" author="SPITZ MR" publication="J SURG ONCOL" d1="30" d2="6" d3="985"/>
<CITE num="103" author="DIEHL AK" publication="J CHRON DIS" d1="38" d2="1019" d3="985"/>
<CITE num="104" author="LEISS O" publication="KLIN WSCHR" d1="63" d2="1163" d3="985"/>
<CITE num="105" author="NILSELL K" publication="GASTROENTEROLOGY" d1="89" d2="287" d3="985"/>
<CITE num="106" author="BORTNICHAK EA" publication="AM J EPIDEMIOL" d1="121" d2="19" d3="985"/>
<CITE num="107" author="PIXLEY F" publication="BR MED J" d1="291" d2="11" d3="985"/>
<CITE num="108" author="EINARSSON K" publication="N ENGL J MED" d1="313" d2="277" d3="985"/>
<CITE num="109" author="ABATE MA" publication="DRUG INTEL CLIN PHARM" d1="20" d2="106" d3="986"/>
<CITE num="110" author="DIDONATO P" publication="GUT" d1="27" d2="23" d3="986"/>
<CITE num="111" author="TURLEY SD" publication="J LIPID RES" d1="27" d2="486" d3="986"/>
<CITE num="112" author="OKOLICSANYI L" publication="DRUGS" d1="31" d2="430" d3="986"/>
<CITE num="113" author="MARMON L" publication="POSTGRAD MED" d1="79" d2="181" d3="986"/>
<CITE num="114" author="SANDLER RS" publication="GASTROENTEROLOGY" d1="91" d2="157" d3="986"/>
<CITE num="115" author="WYSOWSKI DK" publication="AM J EPIDEMIOL" d1="123" d2="532" d3="986"/>
<CITE num="116" author="KEANE P" publication="SURG GYNECOL OBSTET" d1="163" d2="555" d3="986"/>
<CITE num="117" author="TURLEY SD" publication="BIOCHIM BIOPHYS ACTA" d1="879" d2="28" d3="986"/>
<CITE num="118" author="WINSHIP KA" publication="ADVER DRUG REAC ACUT POIS REV" d1="6" d2="37" d3="987"/>
<CITE num="119" author="HEATON KW" publication="MOL ASP MED" d1="9" d2="89" d3="987"/>
<CITE num="120" author="LEE SS" publication="J CLIN GASTROENTEROL" d1="9" d2="65" d3="987"/>
<CITE num="121" author="PITT HA" publication="AM J SURG" d1="153" d2="233" d3="987"/>
<CITE num="122" author="SCHULMAN A" publication="RADIOLOGY" d1="162" d2="425" d3="987"/>
</CITATIONS>
<RECORDNUM>00936 </RECORDNUM>
<MEDLINENUM>78247032</MEDLINENUM>
<AUTHORS><AUTHOR>Romeo-G</AUTHOR><AUTHOR>Parsons-M</AUTHOR><AUTHOR>Bossen-A</AUTHOR><AUTHOR>Blessing-Moore-J</AUTHOR><AUTHOR>Cavalli-Sforza-L</AUTHOR></AUTHORS>
<TITLE>Trypsin-binding IgG in cystic fibrosis.</TITLE>
<SOURCE>Nature. 1978 Aug 31. 274(5674). P 909-11.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBODIES: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: im</TOPIC><TOPIC>TRYPSIN: im</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IGG</TOPIC><TOPIC>IMMUNOGLOBULINS-FAB</TOPIC><TOPIC>PANCREATIC-EXTRACTS: im, tu</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>It has been observed that most cystic fibrosis patients lack an
alpha2 macroglobulin-protease complex and that binding of trypsin and
other proteases to alpha2 macroglobulin is lower in plasma of CF
patients than in that of normal controls.  We therefore decided to
study the interaction of trypsin with plasma proteins of CF patients.
Here we report that trypsin-binding IgG (TbIgG) is present in 80% of
CF patients and in 30% of their mothers, but not in 97% of normal
controls or in other relatives of CF patients.  Experimental evidence
supports the antibody nature of TbIgG, which is presumably produced
against the porcine trypsin ingested by CF patients as pancreatic
extracts for substitutive enzyme therapy.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="002" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="003" author="HUNTER WM" publication="NATURE" d1="194" d2="495" d3="962"/>
<CITE num="004" author="DAIGER S" publication="PROC NAT ACAD SCI USA" d1="72" d2="2076" d3="975"/>
<CITE num="005" author="STANWORTH DR" publication="IN: WEIR DM" d1="10" d2="1" d3="973"/>
<CITE num="006" author="KOPITO LE" publication="PEDIATR RES" d1="10" d2="742" d3="976"/>
<CITE num="007" author="TWAROG FJ" publication="J ALLERGY CLIN IMMUNOL" d1="59" d2="35" d3="977"/>
<CITE num="008" author="DOLAN TF JR" publication="AM REV RESPIR DIS" d1="110" d2="812" d3="974"/>
<CITE num="010" author="GENELL S" publication="HOPPE SEYLERS Z PHYSIOL CHEM" d1="358" d2="115" d3="977"/>
<CITE num="011" author="LIEBOW C" publication="SCIENCE" d1="189" d2="472" d3="975"/>
<CITE num="012" author="ELIAS E" publication="LANCET" d1="2" d2="66" d3="977"/>
<CITE num="013" author="AARON R" publication="IMMUNOCHEMISTRY" d1="3" d2="451" d3="966"/>
<CITE num="014" author="ERICKSON RP" publication="IMMUNOCHEMISTRY" d1="11" d2="41" d3="974"/>
<CITE num="015" author="RAO GJS" publication="SCIENCE" d1="177" d2="610" d3="972"/>
<CITE num="016" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="017" author="CHAN KYH" publication="CLIN CHIM ACTA" d1="74" d2="71" d3="977"/>
<CITE num="018" author="TALAMO RC" publication="PEDIATR RES" d1="6" d2="430" d3="972"/>
<CITE num="019" author="LIEBERMAN J" publication="AM REV RESPIR DIS" d1="109" d2="399" d3="974"/>
<CITE num="020" author="GOLDSMITH GH" publication="J LAB CLIN MED" d1="89" d2="131" d3="977"/>
<CITE num="021" author="ROMEO G" publication="AM J HUM GENET" d1="29" d2="92A" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78157</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NLEUVEN F           PE" publication="DIATR RES" d1="13" d2="84 9" d3="9"/>
<CITE num="2" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="3" author="DENARO M" publication="PEDIATR RES" d1="14" d2="1086" d3="980"/>
<CITE num="4" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="5" author="ROMEO G" publication="J LAB CLIN MED" d1="95" d2="116" d3="980"/>
<CITE num="6" author="PARSONS M" publication="CLIN CHIM ACTA" d1="100" d2="215" d3="980"/>
<CITE num="7" author="MOSS RB" publication="AM REV RESPIR DIS" d1="121" d2="23" d3="980"/>
<CITE num="8" author="SCHIDLOW DV" publication="AM REV RESPIR DIS" d1="121" d2="31" d3="980"/>
<CITE num="9" author="BLITZER MG" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="289" d3="982"/>
<CITE num="10" author="COX KL" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="345" d3="982"/>
<CITE num="11" author="DURIE PR" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="337" d3="982"/>
<CITE num="12" author="ROBERTS RC" publication="PEDIATR RES" d1="16" d2="416" d3="982"/>
<CITE num="13" author="MOSS RB" publication="CLIN EXP IMMUNOL" d1="47" d2="301" d3="982"/>
<CITE num="14" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="15" author="LAROCHE D" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="404" d3="986"/>
<CITE num="16" author="MOORE DJ" publication="CLIN BIOCHEM" d1="19" d2="303" d3="986"/>
<CITE num="17" author="GOLDSTEIN W" publication="AM REV RESPIR DIS" d1="134" d2="49" d3="986"/>
<CITE num="18" author="BLANDIN C" publication="J BIOPHYS BIOMECAN" d1="11" d2="5" d3="987"/>
</CITATIONS>
<RECORDNUM>00937 </RECORDNUM>
<MEDLINENUM>78248435</MEDLINENUM>
<AUTHORS><AUTHOR>Phillips-B-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: the challenge in research and management.</TITLE>
<SOURCE>Nurs-Mirror. 1978 Aug 24. 147(8). P 13-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: nu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, px</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESEARCH</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is a common and serious disease, and presents a
challenge in management to the paediatrician, nurse, dietitian,
physiotherapist, and all other members of the caring team.  The
outstanding research challenge is to discover the basic defect, and
if this is not treatable to find a method of identifying carriers
and affected infants in utero.  In this task, the work of the Cystic
Fibrosis Research Trust, both in raising money for research and for
supporting and advising patients, is much appreciated.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78158</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="003" author="WOLFSDORF J" publication="PEDIATRICS" d1="43" d2="799" d3="969"/>
<CITE num="004" author="PARKS CR" publication="AM REV RESPIR DIS" d1="108" d2="513" d3="973"/>
</REFERENCES>
<RECORDNUM>00938 </RECORDNUM>
<MEDLINENUM>78248436</MEDLINENUM>
<AUTHORS><AUTHOR>Duberley-J-D</AUTHOR><AUTHOR>King-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: the nurse-teacher and carer for mother and child.</TITLE>
<SOURCE>Nurs-Mirror. 1978 Aug 24. 147(8). P 15-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: nu</TOPIC><TOPIC>PARENT-CHILD-RELATIONS</TOPIC><TOPIC>PATIENTS: ed</TOPIC><TOPIC>PATIENT-EDUCATION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HOME-NURSING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INTERPERSONAL-RELATIONS</TOPIC><TOPIC>NURSE-PATIENT-RELATIONS</TOPIC><TOPIC>TERMINAL-CARE</TOPIC></MINORSUBJ>
<EXTRACT>The authors explain the importance of nursing care being directed to
all members of the family involved in the care of the cystic fibrosis
child and, in particular, the mother.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78159</PAPERNUM>
<REFERENCES>
<CITE num="001" author="BIVALEC LM" publication="NURS CLIN NORTH AM" d1="2" d2="109" d3="976"/>
<CITE num="002" author="BURTON L" publication="FAMILY LIFE OF SICK CHILDREN" d1="" d2="" d3="975"/>
<CITE num="003" author="HARRISSON SP" publication="FAMILIES IN STRESS" d1="" d2="" d3="977"/>
<CITE num="004" author="TURK J" publication="PEDIATRICS" d1="34" d2="67" d3="964"/>
<CITE num="005" author="QUINT JC" publication="NURSE AND THE DYING PATIE" d1="" d2="" d3="967"/>
</REFERENCES>
<RECORDNUM>00939 </RECORDNUM>
<MEDLINENUM>78248437</MEDLINENUM>
<AUTHORS><AUTHOR>Mallinson-B-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: 7 rules for physiotherapy.</TITLE>
<SOURCE>Nurs-Mirror. 1978 Aug 24. 147(8). P 18-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: nu</TOPIC><TOPIC>PHYSICAL-THERAPY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>POSTURE</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78160</PAPERNUM>
<EXTRACT>The author explains why treatment, although time-consuming, must be
carried out every day.</EXTRACT>
<RECORDNUM>00940 </RECORDNUM>
<MEDLINENUM>78248433</MEDLINENUM>
<TITLE>A positive approach to cystic fibrosis [editorial].</TITLE>
<SOURCE>Nurs-Mirror. 1978 Aug 24. 147(8). P 1.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: nu</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>FAMILY</TOPIC><TOPIC>HOME-NURSING</TOPIC><TOPIC>HUMAN</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78161</PAPERNUM>
<EXTRACT>The child with cystic fibrosis presents a heart-breaking problem to
parents, since the disease is inherited equally from both mother and
father, and there is the possibility that other children will be
similarly afflicted.  Perhaps the most valuable advice the nurse can
give to parents is to adopt at all times a positive approach to their
problem.</EXTRACT>
<RECORDNUM>00941 </RECORDNUM>
<MEDLINENUM>78136652</MEDLINENUM>
<AUTHORS><AUTHOR>Russell-G</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis--1.  Clinical aspects.</TITLE>
<SOURCE>Nurs-Times. 1978 Mar 23. 74(12). P 486-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PROGNOSIS</TOPIC></MINORSUBJ>

</RECORD><RECORD>
<PAPERNUM>PN78162</PAPERNUM>
<EXTRACT>Cystic fibrosis is a fatal inherited disease involving many different
organs.  At one time most affected children died within a few years
of birth but modern management has led to a marked improvement in
prognosis and, of course, to an increase in the number of affected
older children and young adults.  Cystic fibrosis is, therefore, no
longer a disease encountered only in paediatric units, but with
increasing survival into teens and twenties affected patients are now
appearing in adult units.  The aetiology and pathology, the clinical
picture, diagnosis, treatment, and prognosis are discussed.</EXTRACT>
<RECORDNUM>00942 </RECORDNUM>
<MEDLINENUM>78115481</MEDLINENUM>
<AUTHORS><AUTHOR>Russell-G</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis--2: genetic and social aspects.</TITLE>
<SOURCE>Nurs-Times. 1978 Mar 30. 74(13). P 538-41.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENETIC-COUNSELING</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>PARENTS: ed</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>PRENATAL-DIAGNOSIS</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>RESEARCH</TOPIC></MINORSUBJ>
<EXTRACT>The inheritance of cystic fibrosis and its impact on the patient and
on the community are examined.  Inheritance, genetic counseling,
antenatal diagnosis, screening for cystic fibrosis, psychosocial
aspects, employment prospects, and the Cystic Fibrosis Research Trust
are discussed.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78163</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="CF A MANUAL OF DIAGNOSIS AND" d1="" d2="" d3="976"/>
<CITE num="002" author="BURTON L" publication="PRACTITIONER" d1="210" d2="247" d3="973"/>
<CITE num="003" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="004" author="GIBBS GE" publication="PAEDIATRICIAN" d1="1" d2="133" d3="972"/>
<CITE num="005" author="MCCRAE WM" publication="IN: APLEY J" d1="4" d2="157" d3="974"/>
<CITE num="006" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
</REFERENCES>
<RECORDNUM>00943 </RECORDNUM>
<MEDLINENUM>79115400</MEDLINENUM>
<AUTHORS><AUTHOR>Lavy-U</AUTHOR><AUTHOR>Bauer-C-H</AUTHOR></AUTHORS>
<TITLE>Pathophysiology of failure to thrive in gastrointestinal disorders.</TITLE>
<SOURCE>Pediatr-Ann. 1978 Nov. 7(11). P 743-9.</SOURCE>
<MAJORSUBJ><TOPIC>GASTROINTESTINAL-DISEASES: co</TOPIC><TOPIC>GROWTH-DISORDERS: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CELIAC-DISEASE: co</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COLITIS-ULCERATIVE: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>ENTERITIS: co</TOPIC><TOPIC>ESOPHAGEAL-DISEASES: co</TOPIC><TOPIC>ESOPHAGUS: ab</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>LIVER-DISEASES: co</TOPIC><TOPIC>MALABSORPTION-SYNDROMES: co</TOPIC><TOPIC>MEGACOLON: co</TOPIC><TOPIC>MOUTH-ABNORMALITIES: co</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<ABSTRACT>What will be our GI approach to a child with FTT syndrome? Detailed
history and physical examination will give us the clue and often the
probable diagnosis. Several laboratory tests are helpful in
establishing the fact that there is malabsorption. Among them are a
complete blood count with smear, quantitative stool fat excretion,
serum protein and chemistry screen panel, prothrombin time, and oral
tolerance and absorption--i.e., of glucose, iron, vitamin A, and
xylose. Specialized procedures may be used to nail down the
diagnosis: radiology, biopsy, duodenal intubation, etc. These should
never be employed as routine screening tests, however. In outlining a
comprehensive and successful therapy, the attending physician will
find it helpful to consider the particular pathophysiologic
mechanisms of a specific disease. Exact diagnosis makes the therapy
both rational and effective.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78164</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANDERSON CM" publication="IN: ANDERSON CM" d1="" d2="" d3="975"/>
<CITE num="002" author="BEEKEN WL" publication="PEDIATRICS" d1="52" d2="69" d3="973"/>
<CITE num="003" author="CARRE IJ" publication="CLIN PROC CHILD HOSP DC" d1="25" d2="123" d3="969"/>
<CITE num="004" author="CASTLEMAN B" publication="N ENGL J MED" d1="289" d2="147" d3="973"/>
<CITE num="005" author="DAVIDSON M" publication="J PEDIATR" d1="69" d2="1027" d3="966"/>
<CITE num="006" author="DAVIDSON M" publication="IN: BARNETT HL" d1="" d2="" d3="972"/>
<CITE num="007" author="DAVIDSON M" publication="IN: SLEISENGER MH" d1="" d2="" d3="973"/>
<CITE num="008" author="KATTWINKEL J" publication="PEDIATRICS" d1="51" d2="55" d3="973"/>
<CITE num="009" author="OLSEN WA" publication="N ENGL J MED" d1="285" d2="1358" d3="971"/>
<CITE num="010" author="PRINSEN JE" publication="J PEDIATR SURG" d1="10" d2="97" d3="975"/>
<CITE num="011" author="SHWACHMAN H" publication="PEDIATRICS" d1="46" d2="335" d3="970"/>
<CITE num="012" author="SILVERBERG M" publication="IN: BARNETT HL" d1="" d2="" d3="972"/>
<CITE num="013" author="SILVERBERG M" publication="PEDIATR ANN" d1="6" d2="" d3="977"/>
<CITE num="014" author="SMITH DW" publication="RECOGNIZABLE PATTERNS OF HUMA" d1="" d2="" d3="970"/>
<CITE num="015" author="TRIER JS" publication="N ENGL J MED" d1="285" d2="1470" d3="971"/>
</REFERENCES>
<RECORDNUM>00944 </RECORDNUM>
<MEDLINENUM>78072649</MEDLINENUM>
<AUTHORS><AUTHOR>Holsclaw-D-S-Jr</AUTHOR></AUTHORS>
<TITLE>Recognition and management of patients with cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Ann. 1978 Jan. 7(1). P 9-10, 12-6, 21-2 passim.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AIRWAY-OBSTRUCTION: th</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: co, di, pa, th</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>INTESTINAL-OBSTRUCTION: et</TOPIC><TOPIC>LIVER: pa</TOPIC><TOPIC>LUNG: pa</TOPIC><TOPIC>MECONIUM</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PANCREAS: pa</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC><TOPIC>INFERTILITY: et</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>Cystic fibrosis is the most common lethal genetic disease in
childhood, and the broad range of its clinical expression can involve
practically every specialty of medicine.  The pathology of cystic
fibrosis, its clinical features, diagnosis, and treatment are
discussed.  The pediatrician will not want to attempt to provide
exclusive care for the CF patient.  These patients require the many
supports that only a specialized center will have.  Chest surgeons,
pediatric surgeons, otolaryngologists, cardiologists,
gastroenterologists - in fact, all fields of medicine and all medical
specialties - may be needed for the various clinical problems
associated with the disease.</EXTRACT>
<REFERENCES>
<CITE num="001" author="MCKUSICK VA" publication="MENDELIAN INHERIT IN MAN" d1="" d2="" d3="975"/>
<CITE num="002" author="ANON" publication="GUIDE TO DIAGNOSIS AND MANAGE" d1="" d2="" d3="971"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="004" author="HOLSCLAW DS" publication="CLIN PEDIATR" d1="9" d2="346" d3="970"/>
<CITE num="005" author="SHWACHMAN H" publication="PEDIATRICS" d1="30" d2="389" d3="962"/>
<CITE num="006" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="007" author="CRAIG JM" publication="AM J DIS CHILD" d1="93" d2="357" d3="957"/>
<CITE num="008" author="HOLSCLAW DS" publication="AM J DIS CHILD" d1="109" d2="101" d3="965"/>
<CITE num="009" author="SHWACHMAN H" publication="N ENGL J MED" d1="286" d2="1300" d3="972"/>
<CITE num="010" author="HOLSCLAW DS" publication="J UROL" d1="106" d2="568" d3="971"/>
<CITE num="011" author="HOLSCLAW DS" publication="PEDIATRICS" d1="48" d2="442" d3="971"/>
<CITE num="012" author="KOPITO LE" publication="FERTIL STERIL" d1="24" d2="512" d3="973"/>
<CITE num="013" author="OPPENHEIMER EH" publication="J PEDIATR" d1="77" d2="991" d3="970"/>
<CITE num="014" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="015" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="016" author="DOGGETT RG" publication="J PEDIATR" d1="68" d2="215" d3="966"/>
<CITE num="017" author="KULCZYCKI LL" publication="N ENGL J MED" d1="259" d2="409" d3="958"/>
<CITE num="018" author="VALMAN HB" publication="ARCH DIS CHILD" d1="46" d2="805" d3="971"/>
<CITE num="019" author="KESSLER WR" publication="PEDIATRICS" d1="8" d2="648" d3="951"/>
<CITE num="020" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="021" author="GIBSON LE" publication="PROC FOR QUANTITATIVE ION" d1="" d2="" d3="975"/>
<CITE num="022" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="023" author="WARING WW" publication="ADV PEDIATR" d1="23" d2="401" d3="976"/>
<CITE num="024" author="HUANG NN" publication="GUIDE TO DRUG THERAPY IN PATI" d1="" d2="" d3="974"/>
<CITE num="025" author="TECKLIN JS" publication="PHYS THER" d1="55" d2="1081" d3="975"/>
<CITE num="026" author="STERN RC" publication="CLIN PEDIATR" d1="11" d2="521" d3="972"/>
<CITE num="027" author="HANDWERGER S" publication="N ENGL J MED" d1="281" d2="451" d3="969"/>
<CITE num="028" author="HOLSCLAW DS" publication="J PEDIATR" d1="76" d2="829" d3="970"/>
<CITE num="029" author="HOLSCLAW DS" publication="PEDIATRICS" d1="48" d2="51" d3="971"/>
<CITE num="030" author="SIASSI B" publication="J PEDIATR" d1="78" d2="794" d3="971"/>
<CITE num="031" author="KELMINSON LL" publication="PEDIATRICS" d1="39" d2="24" d3="967"/>
<CITE num="032" author="GAYTON WF" publication="AM J DIS CHILD" d1="126" d2="856" d3="973"/>
<CITE num="033" author="GAYTON WF" publication="PEDIATRICS" d1="59" d2="888" d3="977"/>
<CITE num="034" author="BOYLE IR" publication="J PEDIATR" d1="88" d2="318" d3="976"/>
<CITE num="035" author="SHWACHMAN H" publication="MEDICINE (BALTIMORE)" d1="56" d2="129" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78165</PAPERNUM>
<CITATIONS>
<CITE num="1" author="O YW                J" publication="CLIN PHARMACOL" d1="21" d2="24 9" d3="1"/>
<CITE num="2" author="STANGHELLE JK" publication="ACTA PAEDIATR SCAND" d1="72" d2="935" d3="983"/>
</CITATIONS>
<RECORDNUM>00945 </RECORDNUM>
<MEDLINENUM>78072646</MEDLINENUM>
<AUTHORS><AUTHOR>Huang-N-N</AUTHOR></AUTHORS>
<TITLE>The use of new antibiotic agents for chronic pulmonary disease.</TITLE>
<SOURCE>Pediatr-Ann. 1978 Jan. 7(1). P 56, 58-60, 62 passim.</SOURCE>
<MAJORSUBJ><TOPIC>ANTIBIOTICS: tu</TOPIC><TOPIC>BACTERIAL-INFECTIONS: dt</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: dt</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AGAMMAGLOBULINEMIA: co</TOPIC><TOPIC>AMINOGLYCOSIDES: tu</TOPIC><TOPIC>ASTHMA: co</TOPIC><TOPIC>CEPHALOSPORINS: tu</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>IMMUNOLOGIC-DEFICIENCY-SYNDROMES: co</TOPIC><TOPIC>PENICILLINS: tu</TOPIC><TOPIC>PNEUMONIA-ASPIRATION: co</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: et</TOPIC><TOPIC>SULFAMETHOXAZOLE: tu</TOPIC><TOPIC>TETRACYCLINES: tu</TOPIC><TOPIC>TRIMETHOPRIM: tu</TOPIC></MINORSUBJ>
<ABSTRACT>Modern advances in the development of antimicrobial agents and in
chemotherapy have made available potent aminoglycoside antibiotics,
with more effective ones to come. Their effectiveness against P.
aeruginosa is a great contribution to patients with cystic fibrosis
and other chronic disorders. The development of carbenicillin has
augmented the effectiveness of the aminoglycoside antibiotics.
Ticarcillin is similar to carbenicillin and will play a similar role
in antibiotic therapy. The cephalosporins serve as alternative agents
principally for their antistaphylococcal activity. We are urgently in
need of a potent antibiotic agent against P. aeruginosa that can be
given by the oral route. The TMP-SMX combination is a potent
chemotherapeutic agent that can be administered by the oral route. It
is effective in the treatment of P. carinii pneumonia, which is very
common owing to the extended survival of patients with leukemia and
other malignancies or with allografts who are prone to develop
infections with immunosuppressive therapy.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78166</PAPERNUM>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
<CITE num="002" author="CUMMING WA" publication="RADIOLOGY" d1="105" d2="387" d3="972"/>
<CITE num="003" author="BARTLETT JG" publication="CHEST" d1="68" d2="560" d3="975"/>
<CITE num="004" author="KIM IG" publication="LARYNGOSCOPE" d1="83" d2="347" d3="973"/>
<CITE num="005" author="GOSINK BB" publication="AM J ROENTG RAD THER NUCL MED" d1="117" d2="816" d3="973"/>
<CITE num="006" author="LARAYA-CUASAY LR" publication="AM REV RESPIR DIS" d1="109" d2="703" d3="974"/>
<CITE num="007" author="BAUER AW" publication="AM J CLIN PATHOL" d1="45" d2="493" d3="966"/>
<CITE num="008" author="STRATFORD BC" publication="LANCET" d1="1" d2="378" d3="974"/>
<CITE num="009" author="MENDELSON J" publication="ANTIMICROB AGENTS CHEMOTHER" d1="9" d2="633" d3="976"/>
<CITE num="010" author="MEYERS RM" publication="ARCH OTOLARYNGOL" d1="92" d2="160" d3="970"/>
<CITE num="011" author="KOSSEK JC" publication="J LAB INVEST" d1="30" d2="48" d3="974"/>
<CITE num="012" author="BOBROW SN" publication="JAMA" d1="222" d2="1546" d3="972"/>
<CITE num="013" author="HOLMES RK" publication="ANTIMICROB AGENTS CHEMOTHER" d1="6" d2="253" d3="974"/>
<CITE num="014" author="HOUANG ET" publication="LANCET" d1="1" d2="423" d3="976"/>
<CITE num="015" author="NEU HC" publication="J INFECT DIS SUPPL" d1="134" d2="3" d3="976"/>
<CITE num="016" author="HUANG NN" publication="INFECTION SUPPL" d1="4" d2="465" d3="976"/>
<CITE num="017" author="MARKS MI" publication="J CLIN PHARMACOL" d1="15" d2="246" d3="975"/>
<CITE num="018" author="HUANG NN" publication="CLINICAL EXPERIENCE WITH AMIK" d1="" d2="" d3="976"/>
<CITE num="019" author="KHAN AJ" publication="CURR THER RES" d1="19" d2="479" d3="976"/>
<CITE num="020" author="KLASTERSKY J" publication="J MED MICROBIOL" d1="7" d2="465" d3="974"/>
<CITE num="021" author="LEVISON ME" publication="ANTIMICROB AGENTS CHEMOTHER" d1="5" d2="667" d3="974"/>
<CITE num="022" author="MCLAUGHLIN JE" publication="LANCET" d1="1" d2="261" d3="971"/>
<CITE num="023" author="RIFF LJ" publication="ARCH INTERN MED" d1="130" d2="887" d3="972"/>
<CITE num="024" author="LEVINE BB" publication="J INFECT DIS SUPPL" d1="128" d2="364" d3="973"/>
<CITE num="025" author="TUANO SB" publication="ANTIMICROB AGENTS CHEMOTHER" d1="6" d2="101" d3="966"/>
<CITE num="026" author="BURTON JR" publication="JAMA" d1="229" d2="679" d3="974"/>
<CITE num="027" author="THORNHILL TS" publication="APPL MICROBIOL" d1="17" d2="457" d3="969"/>
<CITE num="028" author="STORE SD" publication="J POSTGRAD MED" d1="21" d2="121" d3="975"/>
<CITE num="029" author="KIRBY WMM" publication="J INFECT DIS SUPPL" d1="128" d2="341" d3="973"/>
<CITE num="030" author="STANFORD HC" publication="J INFECT DIS SUPPL" d1="122" d2="9" d3="970"/>
<CITE num="031" author="HUANG NN" publication="J PEDIATR" d1="78" d2="338" d3="971"/>
<CITE num="032" author="BROWN CH 3RD" publication="N ENGL J MED" d1="291" d2="265" d3="974"/>
<CITE num="033" author="ERVIN ER" publication="ANTIMICROB AGENTS CHEMOTHER" d1="9" d2="94" d3="976"/>
<CITE num="034" author="PARRY MF" publication="J PEDIATR" d1="90" d2="144" d3="977"/>
<CITE num="035" author="PARRY MF" publication="J INFECT DIS SUPPL" d1="134" d2="194" d3="976"/>
<CITE num="036" author="NEU HC" publication="ANTIMICROB AGENTS CHEMOTHER" d1="8" d2="457" d3="975"/>
<CITE num="037" author="HUANG NN" publication="ANTIMICROB AGENTS CHEMOTHER" d1="6" d2="127" d3="966"/>
<CITE num="038" author="PINES A" publication="PRACTITIONER" d1="213" d2="727" d3="974"/>
<CITE num="039" author="BROGDEN RN" publication="DRUGS" d1="9" d2="251" d3="975"/>
<CITE num="040" author="GROSSMAN ER" publication="PEDIATRICS" d1="47" d2="567" d3="971"/>
<CITE num="041" author="FRIMPTER GW" publication="JAMA" d1="184" d2="111" d3="963"/>
<CITE num="042" author="KABU SB" publication="CLIN PHARMACOL THER" d1="9" d2="550" d3="968"/>
<CITE num="043" author="BERGAN T" publication="ACTA MED SCAND" d1="192" d2="483" d3="972"/>
<CITE num="044" author="LEWIN EB" publication="J INFECT DIS SUPPL" d1="128" d2="618" d3="973"/>
<CITE num="045" author="STORE SD" publication="J POSTGRAD MED" d1="21" d2="114" d3="975"/>
<CITE num="046" author="KNIGHT D" publication="LANCET" d1="2" d2="717" d3="975"/>
<CITE num="047" author="HUGHES WT" publication="CANCER" d1="36" d2="2004" d3="975"/>
<CITE num="048" author="HUGHES WT" publication="N ENGL J MED" d1="295" d2="726" d3="976"/>
</REFERENCES>
<RECORDNUM>00946 </RECORDNUM>
<MEDLINENUM>78072644</MEDLINENUM>
<AUTHORS><AUTHOR>Holsclaw-D-S-Jr</AUTHOR><AUTHOR>Keith-H-H</AUTHOR><AUTHOR>Palmer-J</AUTHOR></AUTHORS>
<TITLE>Meconium screening for cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Ann. 1978 Jan. 7(1). P 29-30, 35, 38-40.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>MASS-SCREENING</TOPIC><TOPIC>MECONIUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALBUMINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC><TOPIC>FALSE-NEGATIVE-REACTIONS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>REAGENT-STRIPS</TOPIC><TOPIC>SWEAT: an</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC><TOPIC>UNITED-STATES</TOPIC></MINORSUBJ>
<ABSTRACT>In our hands, the BMC-Test Meconium has been a significant step
towards the goal of developing an ideal newborn screening test for
CF. It is easily performed, is highly specific, has reasonably high
sensitivity, and--given its limitation of identifying only patients
with CF who have intrauterine pancreatic insufficiency--is the best
method of screening newborns for CF that has been devised to date.
Many technical problems remain to be solved before the test can be
endorsed without reservation. Because the test, as currently
constituted, does not identify all potential subjects for further
testing who might have CF, it should not be made mandatory. It is,
however, better than other available screening methods for CF and can
be praised for that benefit. The concept has indicated a valuable new
direction for mass-screening possibilities and perhaps can, by future
modification, be made sensitive enough to warrant universal usage.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78167</PAPERNUM>
<REFERENCES>
<CITE num="001" author="ANON" publication="GAP CONF REP PROB SWEAT TESTI" d1="" d2="" d3="975"/>
<CITE num="002" author="STEPHAN U" publication="NEONATAL MASS SCREENING FOR C" d1="" d2="" d3="976"/>
<CITE num="003" author="LANDSTEINER K" publication="ZENTRALBL ALLG PATHOL" d1="16" d2="903" d3="905"/>
<CITE num="004" author="KORNBLITH BA" publication="AM J PATHOL" d1="5" d2="249" d3="929"/>
<CITE num="005" author="FARBER S" publication="AM J DIS CHILD" d1="64" d2="953" d3="942"/>
<CITE num="006" author="FARBER S" publication="J PEDIATR" d1="24" d2="387" d3="944"/>
<CITE num="007" author="RAPOPORT S" publication="SCIENCE" d1="112" d2="150" d3="950"/>
<CITE num="008" author="BUCHANAN DJ" publication="PEDIATRICS" d1="9" d2="304" d3="952"/>
<CITE num="009" author="GREEN MN" publication="PEDIATRICS" d1="21" d2="635" d3="958"/>
<CITE num="010" author="WISER WC" publication="PEDIATRICS" d1="33" d2="115" d3="964"/>
<CITE num="011" author="SCHUTT WH" publication="ARCH DIS CHILD" d1="43" d2="178" d3="968"/>
<CITE num="012" author="GREEN MN" publication="PEDIATRICS" d1="41" d2="989" d3="968"/>
<CITE num="013" author="DAVIDSON AG" publication="BR MED J" d1="4" d2="362" d3="971"/>
<CITE num="014" author="CAIN ARR" publication="ARCH DIS CHILD" d1="47" d2="131" d3="972"/>
<CITE num="015" author="STEPHAN U" publication="PADIATRISCHE PRAXIS" d1="12" d2="487" d3="973"/>
<CITE num="016" author="SZIBOR R" publication="HELV PAEDIATR ACTA" d1="28" d2="359" d3="973"/>
<CITE num="017" author="SZIBOR R" publication="DTSCH GESUNDHEITSW" d1="28" d2="2252" d3="973"/>
<CITE num="018" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND" d1="64" d2="477" d3="975"/>
<CITE num="019" author="BRUNS WT" publication="AM J DIS CHILD" d1="131" d2="71" d3="977"/>
<CITE num="020" author="ANON" publication="PROC EWGCF 5TH ANNU MTG" d1="" d2="" d3="974"/>
<CITE num="021" author="STEPHAN U" publication="PEDIATRICS" d1="55" d2="35" d3="975"/>
<CITE num="022" author="MCKUSICK VA" publication="MENDELIAN INHERIT IN MAN" d1="" d2="167" d3="968"/>
<CITE num="023" author="ANON" publication="CF FND 1974 REP SURVI STUD PA" d1="" d2="" d3="976"/>
<CITE num="024" author="SCRIVER CR" publication="PEDIATRICS" d1="58" d2="757" d3="976"/>
<CITE num="025" author="HOLTZMAN NA" publication="JAMA" d1="229" d2="667" d3="974"/>
<CITE num="026" author="FISHER DA" publication="J PEDIATR" d1="89" d2="692" d3="976"/>
</REFERENCES>
<RECORDNUM>00947 </RECORDNUM>
<MEDLINENUM>78157263</MEDLINENUM>
<AUTHORS><AUTHOR>Savoca-C-J</AUTHOR><AUTHOR>Brasch-R-C</AUTHOR><AUTHOR>Gooding-C-A</AUTHOR><AUTHOR>Gamsu-G</AUTHOR></AUTHORS>
<TITLE>The right paratracheal stripe in children.</TITLE>
<SOURCE>Pediatr-Radiol. 1978 Feb 28. 6(4). P 203-7.</SOURCE>
<MAJORSUBJ><TOPIC>THORACIC-RADIOGRAPHY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: ra</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>LYMPHOSARCOMA: ra</TOPIC><TOPIC>MALE</TOPIC><TOPIC>NEOPLASM-RECURRENCE-LOCAL: ra</TOPIC><TOPIC>REFERENCE-VALUES</TOPIC><TOPIC>PLEURAL-EFFUSION: ra</TOPIC><TOPIC>SALIVARY-GLAND-NEOPLASMS: ra</TOPIC><TOPIC>SUBMANDIBULAR-GLAND: ra</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>The width of the right paratracheal stripe (RPS) has been established
in normal adults but not in normal children. The thymus and great
vessels are relatively larger in children than in adults and could
obscure or widen the RPS. We found that obscuration does occur and,
therefore, the RPS is less often measurable in children than in
adults. Widening by the thymus and great vessels, however, does not
occur. The width of the RPS in normal children, 0.5 to 3.0 mm, is
slightly less than in adults. From this study of normal children and
our subsequent experience with pediatric patients, we conclude that
in a child an RPS 4 mm or wider is reliable evidence of disease
affecting the trachea, mediastinum, or pleura.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="SAVOCA CJ" publication="RADIOLOGY" d1="122" d2="295" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78168</PAPERNUM>
<CITATIONS>
<CITE num="1" author="UFANG KFR           LY" publication="MPHOLOGY" d1="15" d2="32 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00948 </RECORDNUM>
<MEDLINENUM>79054260</MEDLINENUM>
<AUTHORS><AUTHOR>Moffat-R-E</AUTHOR><AUTHOR>Sobonya-R-E</AUTHOR><AUTHOR>Chang-C-H</AUTHOR></AUTHORS>
<TITLE>Childhood sarcoidosis with fatal cor pulmonale.</TITLE>
<SOURCE>Pediatr-Radiol. 1978 Sep 26. 7(3). P 180-2.</SOURCE>
<MAJORSUBJ><TOPIC>LUNG-DISEASES: di</TOPIC><TOPIC>PULMONARY-HEART-DISEASE: di</TOPIC><TOPIC>SARCOIDOSIS: di</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DIAGNOSIS-DIFFERENTIAL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES: ra</TOPIC><TOPIC>LUNG: ra</TOPIC><TOPIC>PULMONARY-HEART-DISEASE: ra</TOPIC><TOPIC>SARCOIDOSIS: ra</TOPIC></MINORSUBJ>
<ABSTRACT>A 14 year-old white girl who developed fatal cor pulmonale from
severe pulmonary sarcoidosis had a previous clinical diagnosis of
cystic fibrosis. Chest radiographs demonstrated marked pulmonary
fibrosis without the changes of severe bronchiectasis that would be
anticipated with cystic fibrosis.</ABSTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78169</PAPERNUM>
<REFERENCES>
<CITE num="001" author="HAUSER H" publication="OKLA STATE MED ASSOC" d1="39" d2="395" d3="946"/>
<CITE num="002" author="KENDIG EL JR" publication="CHEST" d1="70" d2="351" d3="976"/>
<CITE num="003" author="KIRKS DR" publication="AM J ROENTG RAD THER NUCL MED" d1="117" d2="777" d3="973"/>
<CITE num="004" author="KOERNER SK" publication="N ENGL J MED" d1="293" d2="268" d3="975"/>
<CITE num="005" author="MCGOVERN JP" publication="ADV PEDIATR" d1="8" d2="97" d3="956"/>
</REFERENCES>
<RECORDNUM>00949 </RECORDNUM>
<MEDLINENUM>79011613</MEDLINENUM>
<AUTHORS><AUTHOR>Wilson-G-B</AUTHOR><AUTHOR>Fudenberg-H-H</AUTHOR></AUTHORS>
<TITLE>Is cystic fibrosis protein a diagnostic marker for individuals who
harbor the defective gene?  [letter].</TITLE>
<SOURCE>Pediatr-Res. 1978 Jul. 12(7). P 801-4.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>HETEROZYGOTE-DETECTION</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<EXTRACT>It has been almost 5 years since the publication of our original
report describing a "cystic fibrosis factor" (now designated "cystic
fibrosis protein" or CFP) detected in the serum of most homozygotes
and heterozygotes for cystic fibrosis when analyzed using isoelectric
focusing in thin layer polyacrylamide gels.  The recent report by
Scholey et al. confirms that CFP is present in the majority of CF
sera and that it can be detected by our methods.  Before discussing
whether the CFP can be used as a diagnostic marker for cystic
fibrosis, we would like to examine more closely some of the
requirements of the method which seemed to have been critical for the
detection of CFP by Scholey et al.  We would like to point out that
Scholey and his coworkers adhered closely to most of our guidelines
during their attempts to detect CFP.  The exact nature of CFP and the
other ciliary dyskinesia factors is only partially known, and all
aspects of their metabolism are not yet understood.  Therefore, it
may be some time before we comprehend the incomplete concordance
found between CFP and the pathogenesis of CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ALTLAND K" publication="HUMANGENETIK" d1="28" d2="207" d3="975"/>
<CITE num="002" author="AWDEH ZL" publication="NATURE" d1="219" d2="66" d3="968"/>
<CITE num="003" author="DANES BS" publication="CLIN GENET" d1="11" d2="83" d3="977"/>
<CITE num="004" author="SCHOLEY J" publication="PEDIATR RES" d1="12" d2="800" d3="978"/>
<CITE num="005" author="SHAPIRA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="71" d2="864" d3="976"/>
<CITE num="006" author="SMITH QT" publication="PEDIATR RES" d1="10" d2="999" d3="976"/>
<CITE num="007" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="138" d3="977"/>
<CITE num="008" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="1148" d3="977"/>
<CITE num="009" author="WARNER JO" publication="LANCET" d1="1" d2="990" d3="976"/>
<CITE num="010" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="986" d3="977"/>
<CITE num="011" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="1001" d3="976"/>
<CITE num="014" author="WILSON GB" publication="SCAND J IMMUNOL" d1="5" d2="829" d3="976"/>
<CITE num="015" author="WILSON GB" publication="CLIN RES" d1="26" d2="501" d3="978"/>
<CITE num="016" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="87" d3="976"/>
<CITE num="017" author="WILSON GB" publication="TEX REP BIOL MED" d1="34" d2="51" d3="976"/>
<CITE num="018" author="WILSON GB" publication="ADV POLYMINE RES" d1="2" d2="281" d3="978"/>
<CITE num="019" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
<CITE num="020" author="WILSON GB" publication="CLIN CHIM ACTA" d1="49" d2="79" d3="973"/>
<CITE num="021" author="WILSON GB" publication="IN: RADOLA BJ" d1="" d2="337" d3="977"/>
<CITE num="022" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="139" d3="977"/>
<CITE num="023" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78170</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLY GW              PE" publication="DIATR RES" d1="13" d2="78 9" d3="9"/>
<CITE num="2" author="WILSON GB" publication="PEDIATR RES" d1="13" d2="1079" d3="979"/>
<CITE num="3" author="MANSON JC" publication="LANCET" d1="1" d2="330" d3="980"/>
<CITE num="4" author="NEVIN GB" publication="HUM GENET" d1="56" d2="387" d3="981"/>
<CITE num="5" author="HALLINAN FM" publication="CLIN CHIM ACTA" d1="117" d2="103" d3="981"/>
<CITE num="6" author="BULLOCK S" publication="CLIN GENET" d1="21" d2="336" d3="982"/>
<CITE num="7" author="BROCK DJH" publication="HUM GENET" d1="60" d2="30" d3="982"/>
<CITE num="8" author="ROSENSTEIN BJ" publication="JOHNS HOPKINS MED J" d1="150" d2="113" d3="982"/>
<CITE num="9" author="WILSON GB" publication="CLIN GENET" d1="26" d2="331" d3="984"/>
<CITE num="10" author="HODSON ME" publication="POSTGRAD MED J" d1="60" d2="225" d3="984"/>
<CITE num="11" author="KLINGER KW" publication="SEM RESPIR MED" d1="6" d2="243" d3="985"/>
<CITE num="12" author="KIRKPATRICK C" publication="PEDIATR RES" d1="19" d2="1341" d3="985"/>
<CITE num="13" author="JAMIESON A" publication="HUM GENET" d1="70" d2="168" d3="985"/>
<CITE num="14" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
</CITATIONS>
<RECORDNUM>00950 </RECORDNUM>
<MEDLINENUM>78157307</MEDLINENUM>
<AUTHORS><AUTHOR>Impero-J-E</AUTHOR><AUTHOR>Harrison-G-M</AUTHOR><AUTHOR>Nelson-T-E</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: isolation and physical properties of a salivary
cystic fibrosis factor.</TITLE>
<SOURCE>Pediatr-Res. 1978 Feb. 12(2). P 108-14.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>SALIVA: an</TOPIC><TOPIC>SALIVARY-PROTEINS: ip</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ALPHA-AMYLASE: ip, pd</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>CILIA: de</TOPIC><TOPIC>GLYCOGEN-DEBRANCHING-ENZYME: ai</TOPIC><TOPIC>GLYCOGEN</TOPIC><TOPIC>HEPARIN</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>OYSTERS</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>SALIVARY-PROTEINS: pd</TOPIC><TOPIC>TEMPERATURE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>A ciliostatic factor has been isolated from cystic fibrosis (CF)
saliva by dialyzing it from purified alpha-amylase prepared by a
glycogen-complex method. This method of isolating the CF factor is an
improvement over the previously employed heparin procedure. The
activity of the isolated factor is proportional with concentration
using the oyster gill ciliostatic assay and in its inhibition of
mammalian glycogen debranching enzyme. The ciliostatic action of the
factor can be reversed by heparin under certain conditions. The type
of inhibition of the debranching enzyme by the isolated CF factor
indicates that its chemical structure is similar to that observed
with hydroxyalkylamines and polyamine metabolites. Physical
properties of the isolated factor indicate that it is of low
molecular weight and is labile as a function of pH and temperature.
At neutral pH the conditions under which it is maintained have a
direct effect on the length of time that it is stable.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="002" author="ASANO T" publication="AM J PHYSIOL" d1="207" d2="415" d3="964"/>
<CITE num="003" author="BERNFELD P" publication="METHODS ENZYMOL" d1="1" d2="149" d3="955"/>
<CITE num="004" author="BESLEY GTN" publication="J MED GENET" d1="6" d2="278" d3="969"/>
<CITE num="005" author="BISHOP SH" publication="CF CLUB ABST" d1="14" d2="25" d3="973"/>
<CITE num="006" author="BOWMAN BH" publication="IN: MANGOS JA" d1="" d2="277" d3="976"/>
<CITE num="007" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="008" author="ANON" publication="GAP CONF REP CILIARY INHIBITO" d1="" d2="2" d3="973"/>
<CITE num="009" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="010" author="DANES BS" publication="CLIN GENET" d1="7" d2="128" d3="975"/>
<CITE num="011" author="DANES BS" publication="J EXP MED" d1="136" d2="1313" d3="972"/>
<CITE num="012" author="DANES BS" publication="CLIN GENET" d1="8" d2="85" d3="975"/>
<CITE num="013" author="DEARBORN DG" publication="GAP CONF REP POLYAMINES" d1="" d2="19" d3="976"/>
<CITE num="014" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="015" author="DOGGETT RG" publication="TEX REP BIOL MED" d1="31" d2="685" d3="973"/>
<CITE num="016" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="250" d3="973"/>
<CITE num="018" author="DUBOIS M" publication="ANAL CHEM" d1="28" d2="350" d3="956"/>
<CITE num="019" author="FISHER EH" publication="BIOCHEM PREP" d1="8" d2="27" d3="961"/>
<CITE num="020" author="GILLARD BK" publication="PEDIATR RES" d1="10" d2="907" d3="976"/>
<CITE num="021" author="GILLARD BK" publication="BIOCHEMISTRY" d1="16" d2="3978" d3="977"/>
<CITE num="022" author="KAISER D" publication="LANCET" d1="1" d2="1003" d3="970"/>
<CITE num="023" author="KIMES BW" publication="BIOCHIM BIOPHYS ACTA" d1="228" d2="223" d3="971"/>
<CITE num="024" author="LEVITZKI A" publication="BIOCHIM BIOPHYS ACTA" d1="81" d2="101" d3="964"/>
<CITE num="025" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="026" author="LOCKHART LH" publication="TEX REP BIOL MED" d1="31" d2="631" d3="973"/>
<CITE num="027" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="028" author="LOYTER A" publication="BIOCHIM BIOPHYS ACTA" d1="65" d2="200" d3="962"/>
<CITE num="029" author="MANGOS JA" publication="SCIENCE" d1="158" d2="135" d3="967"/>
<CITE num="030" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="031" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="032" author="MCCOMBS ML" publication="TEX REP BIOL MED" d1="31" d2="615" d3="973"/>
<CITE num="033" author="MCNEELY CM" publication="CF CLUB ABST" d1="16" d2="6" d3="975"/>
<CITE num="034" author="MILLER GL" publication="ANAL CHEM" d1="31" d2="964" d3="959"/>
<CITE num="035" author="NELSON TE" publication="CF CLUB ABST" d1="" d2="7" d3="974"/>
<CITE num="036" author="NELSON TE" publication="FED PROC" d1="33" d2="1311" d3="974"/>
<CITE num="037" author="NELSON TE" publication="BIOCHEMISTRY" d1="8" d2="1419" d3="969"/>
<CITE num="038" author="NELSON TE" publication="FED PROC" d1="32" d2="627" d3="973"/>
<CITE num="039" author="SCHMOYER IR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="46" d2="1923" d3="972"/>
<CITE num="040" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="041" author="TAYLOR A" publication="PEDIATR RES" d1="8" d2="861" d3="974"/>
<CITE num="042" author="WATTS TE" publication="ANAL BIOCHEM" d1="49" d2="479" d3="972"/>
<CITE num="043" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
<CITE num="044" author="WOOD RE" publication="LANCET" d1="2" d2="1452" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78171</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PERO JE             PE" publication="DIATR RES" d1="15" d2="40 9" d3="1"/>
<CITE num="2" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="3" author="BOGART BI" publication="J CHROMATOGR" d1="381" d2="29" d3="986"/>
</CITATIONS>
<RECORDNUM>00951 </RECORDNUM>
<MEDLINENUM>78248077</MEDLINENUM>
<AUTHORS><AUTHOR>Platt-M-W</AUTHOR><AUTHOR>Rao-G-J</AUTHOR><AUTHOR>Nadler-H-L</AUTHOR></AUTHORS>
<TITLE>Reaction of 4-methylumbelliferylguanidinobenzoate with cultivated
human skin fibroblasts derived from patients with cystic fibrosis.</TITLE>
<SOURCE>Pediatr-Res. 1978 Aug. 12(8). P 874-7.</SOURCE>
<MAJORSUBJ><TOPIC>BIOLOGICAL-ASSAY</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>HYMECROMONE: du</TOPIC><TOPIC>PEPTIDE-HYDROLASES: me</TOPIC><TOPIC>UMBELLIFERONES: du</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>FIBROBLASTS: en</TOPIC><TOPIC>GUANIDINES: du</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYMECROMONE: aa</TOPIC><TOPIC>SKIN: en</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Protease activity in cultivated human skin fibroblasts has been
quantitated using 4-methylumbelliferylguanidinobenzoate (MUGB), an
active site titrant of trypsin-like proteases (7). The reaction of
the proteases with MUGB was complete in 1 hr, inhibited both by
benzamidine and (p-nitrophenyl)-p'-guanidinobenzoate, but not by p-
hydroxymercuribenzoate. The extent of reaction was proportional to
protein concentration and independent of MUGB concentration. This
activity was present in the particulate fraction of the cell. The
mean "titre" values (nanomoles of 4-methylumbelliferone released per
mg protein) of the proteases in fibroblasts from eight controls (N),
8 obligate heterozygotes (H), and 14 patients with cystic fibrosis
(CF) were: N, 1.27 +/- 0.11; H, 0.82 +/- 0.12; CF, 0.66 +/- 0.10. The
differences in the "titre" values for N:CF and N:H were significant
(p less than 0.001) as were those for H:CF (p less than 0.01). The
mean "titre" value obtained for cultivated control amniotic fluid
cells was 1.29 +/- 0.17. These data indicate a reduction in the MUGB-
reactive proteases in skin fibroblasts derived from patients with CF
when compared either to control or to obligate heterozygotes. These
data are consistent with our earlier suggestion (11, 15) that
decreased proteolytic levels in the tissues and fluids of patients
with CF may be a generalized phenomenon.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARRETT AJ" publication="BIOCHEM J" d1="131" d2="809" d3="973"/>
<CITE num="002" author="BROWN CR" publication="BIOCHEM J" d1="149" d2="147" d3="975"/>
<CITE num="003" author="CALLAHAN JW" publication="PEDIATR RES" d1="11" d2="1166" d3="977"/>
<CITE num="004" author="CHASE T JR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="29" d2="508" d3="967"/>
<CITE num="005" author="CHASE T JR" publication="BIOCHEMISTRY" d1="8" d2="2212" d3="969"/>
<CITE num="006" author="HATCHER VB" publication="BIOCHEM BIOPHYS RES COMMUN" d1="76" d2="602" d3="977"/>
<CITE num="007" author="JAMESON GW" publication="BIOCHEM J" d1="131" d2="107" d3="973"/>
<CITE num="008" author="KERR MA" publication="BIOCHEMISTRY" d1="14" d2="5088" d3="975"/>
<CITE num="009" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="010" author="NADLER HL" publication="NATURE" d1="213" d2="1261" d3="967"/>
<CITE num="011" author="WALSH-PLATT M" publication="AM J HUM GENET" d1="29" d2="111A" d3="977"/>
<CITE num="012" author="RAO GJS" publication="J PEDIATR" d1="80" d2="573" d3="972"/>
<CITE num="013" author="RAO GJS" publication="PEDIATR RES" d1="8" d2="684" d3="974"/>
<CITE num="014" author="RAO GJS" publication="PEDIATR RES" d1="9" d2="739" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78172</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OCK DJH             LA" publication="NCET" d1="1" d2="45 9" d3="9"/>
<CITE num="2" author="WALSH MM" publication="LANCET" d1="1" d2="622" d3="979"/>
<CITE num="3" author="HARRIS A" publication="DEVELOP MED CHILD NEUROL" d1="21" d2="675" d3="979"/>
<CITE num="4" author="WALSHPLATT M" publication="ENZYME" d1="24" d2="224" d3="979"/>
<CITE num="5" author="NADLER HL" publication="LANCET" d1="2" d2="96" d3="980"/>
<CITE num="6" author="NADLER HL" publication="PEDIATRICS" d1="66" d2="690" d3="980"/>
<CITE num="7" author="WALSH MMJ" publication="AM J OBSTET GYNECOL" d1="137" d2="978" d3="980"/>
<CITE num="8" author="TUMMLER B" publication="CLIN CHIM ACTA" d1="125" d2="219" d3="982"/>
<CITE num="9" author="GREEN JR" publication="EUR J PEDIATR" d1="139" d2="35" d3="982"/>
<CITE num="10" author="BROCK DJH" publication="PRENAT DIAGN" d1="3" d2="1" d3="983"/>
<CITE num="11" author="BRIDGES MA" publication="ANN NY ACAD SCI" d1="421" d2="360" d3="983"/>
<CITE num="12" author="CEDER O" publication="ACTA PAEDIATR SCAND" d1="1983" d2="1" d3="983"/>
<CITE num="13" author="BUYS CHCM" publication="CLIN CHIM ACTA" d1="136" d2="229" d3="984"/>
</CITATIONS>
<RECORDNUM>00952 </RECORDNUM>
<MEDLINENUM>78201164</MEDLINENUM>
<AUTHORS><AUTHOR>Knoke-J-D</AUTHOR><AUTHOR>Stern-R-C</AUTHOR><AUTHOR>Doershuk-C-F</AUTHOR><AUTHOR>Boat-T-F</AUTHOR><AUTHOR>Matthews-L-W</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: the prognosis for five-year survival.</TITLE>
<SOURCE>Pediatr-Res. 1978 May. 12(5). P 676-9.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: mo</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>PROBABILITY</TOPIC><TOPIC>PROGNOSIS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Statistical discriminant analysis is applied to 41 concomitant
variables obtained during the first year of study of 226 patients
with cystic fibrosis. A discriminant function based on six variables
is developed which can be used as a predictive index. This index
estimates the probability of 5-year survival for an individual
patient and can also be used to classify patients into one of two
groups: (1) will live for 5 years or (2) will die within 5 years.
Speculation A classification rule for cystic fibrosis is presented
which correctly assigns 90% of the 5-year survivors and 84% of those
who expire. Such a classification scheme is useful for clinical and
research purposes.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="AFIFI AA" publication="AM J CARDIOL" d1="33" d2="826" d3="974"/>
<CITE num="002" author="AFIFI AA" publication="N ENGL J MED" d1="285" d2="1497" d3="971"/>
<CITE num="003" author="CHANG PC" publication="J AM STATIST ASSOC" d1="69" d2="336" d3="974"/>
<CITE num="004" author="DIXON WJ" publication="BMDP: BIOMEDICAL COMPUTER PRO" d1="" d2="" d3="975"/>
<CITE num="005" author="DOERSHUK CF" publication="J PEDIATR" d1="65" d2="677" d3="964"/>
<CITE num="006" author="LACHENBRUCH PA" publication="DISCRIMINANT ANALYSIS" d1="" d2="" d3="975"/>
<CITE num="007" author="LACHENBRUCH PA" publication="TECHNOMETRICS" d1="10" d2="1" d3="968"/>
<CITE num="008" author="LURIA MH" publication="ANN INTERN MED" d1="85" d2="561" d3="976"/>
<CITE num="009" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="010" author="MCCABE GP JR" publication="TECHNOMETRICS" d1="17" d2="103" d3="975"/>
<CITE num="011" author="MOORE DH" publication="J AM STATIST ASSOC" d1="68" d2="399" d3="973"/>
<CITE num="012" author="SHUBIN H" publication="CARDIOVASC RES" d1="2" d2="329" d3="968"/>
<CITE num="013" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="014" author="STERN RC" publication="J PEDIATR" d1="89" d2="406" d3="976"/>
<CITE num="015" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78173</PAPERNUM>
<CITATIONS>
<CITE num="1" author="AEMER R             HE" publication="LV PAEDIATR ACTA" d1="34" d2="17 9" d3="9"/>
<CITE num="2" author="TUMMLER B" publication="MONATSSCHR KINDERHEILKD" d1="130" d2="157" d3="982"/>
<CITE num="3" author="PARSONS HG" publication="J PEDIATR GASTROENTEROL NUTR" d1="2" d2="44" d3="983"/>
<CITE num="4" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
</CITATIONS>
<RECORDNUM>00953 </RECORDNUM>
<MEDLINENUM>78248067</MEDLINENUM>
<AUTHORS><AUTHOR>Wright-R-K</AUTHOR><AUTHOR>Buehler-B-A</AUTHOR><AUTHOR>Schott-S-N</AUTHOR><AUTHOR>Rennert-O-M</AUTHOR></AUTHORS>
<TITLE>Spermine and spermidine, modulators of the cell surface enzyme
adenylate cyclase.</TITLE>
<SOURCE>Pediatr-Res. 1978 Aug. 12(8). P 830-3.</SOURCE>
<MAJORSUBJ><TOPIC>ADENYL-CYCLASE: ai</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>SPERMIDINE: pd</TOPIC><TOPIC>SPERMINE: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>CELL-MEMBRANE: de, en</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>FIBROBLASTS: de</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>IN-VITRO</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Adenylate cyclase activity was measured in membrane preparations of
cultured fibroblasts from controls and patients with cystic fibrosis.
Enzyme activity increased as the transition from exponential growth
to confluence occurred; sodium fluoride-stimulated activity more
markedly displayed this relationship than basal cyclase activity. The
in vitro addition of spermine (1 X 10(-6) to 2 X 10(-3) M) to
membrane preparations caused inhibition of basal and sodium fluoride-
stimulated enzyme activity, with 50% inhibition of basal activity
occurring at 10(-6) M spermine. Spermidine (10(-4) M) caused 15--25%
inhibition of adenylate cyclase activity. The increase in fibroblast
adenylate cyclase activity during the transition from exponential
growth was comparable in cells obtained from cystic fibrosis patients
and control subjects. Basal and sodium-fluoride stimulated adenylate
cyclase activity as well as inhibition of this enzyme activity by
spermidine and spermine were undistinguishable between the different
cell genotypes. A potential modulation of cellular proliferative
activity through polyamine interaction with the adenylate cyclase
system is postulated.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSON WB" publication="ADV CYCLIC NUCLEO RES" d1="5" d2="681" d3="975"/>
<CITE num="002" author="AMATRUDA J" publication="BIOCHIM BIOPHYS ACTA" d1="373" d2="266" d3="974"/>
<CITE num="003" author="ARVANITAKIS S" publication="TEX REP BIOL MED" d1="34" d2="175" d3="976"/>
<CITE num="004" author="BUEHLER B" publication="PEDIATR RES" d1="11" d2="186" d3="977"/>
<CITE num="005" author="BUCHWALD M" publication="PROC NAT ACAD SCI USA" d1="73" d2="2899" d3="976"/>
<CITE num="006" author="CHUN P" publication="BIOCHEM BIOPHYS RES COMMUN" d1="69" d2="1095" d3="976"/>
<CITE num="007" author="COHEN LF" publication="PEDIATR RES" d1="9" d2="334" d3="975"/>
<CITE num="008" author="CUETRECASAS P" publication="ADV CYCLIC NUCLEO RES" d1="5" d2="79" d3="975"/>
<CITE num="009" author="DYKSTRA WG" publication="SCIENCE" d1="149" d2="428" d3="965"/>
<CITE num="010" author="FRANKS DJ" publication="FEBS LETTERS" d1="42" d2="267" d3="974"/>
<CITE num="011" author="HOLTTA E" publication="BIOCHEM BIOPHYS RES COMMUN" d1="54" d2="350" d3="973"/>
<CITE num="012" author="JOHNSON RA" publication="J BIOL CHEM" d1="250" d2="6599" d3="975"/>
<CITE num="013" author="KOSSOROTOW A" publication="BIOCHEM J" d1="144" d2="21" d3="974"/>
<CITE num="014" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="015" author="MANGOS JA" publication="IN: MANGOS JA" d1="" d2="311" d3="976"/>
<CITE num="016" author="ONEILL J" publication="BIOCHIM BIOPHYS ACTA" d1="404" d2="243" d3="975"/>
<CITE num="017" author="OTTEN J" publication="J BIOL CHEM" d1="247" d2="7082" d3="972"/>
<CITE num="018" author="PROCTOR MS" publication="J INVEST DERMATOL" d1="65" d2="409" d3="975"/>
<CITE num="019" author="RAINA A" publication="MED BIOL" d1="53" d2="121" d3="975"/>
<CITE num="020" author="RENNERT OM" publication="TEX REP BIOL MED" d1="34" d2="187" d3="976"/>
<CITE num="021" author="RICHARDS GM" publication="ANAL BIOCHEM" d1="57" d2="369" d3="974"/>
<CITE num="022" author="ROSENTHAL S" publication="BIOCHIM BIOPHYS ACTA" d1="363" d2="141" d3="974"/>
<CITE num="023" author="RUSSELL DH" publication="PROC NAT ACAD SCI USA" d1="60" d2="1420" d3="968"/>
<CITE num="024" author="SALOMON Y" publication="ANAL BIOCHEM" d1="58" d2="541" d3="974"/>
<CITE num="025" author="TASHIMA Y" publication="BIOCHEM BIOPHYS RES COMMUN" d1="66" d2="1344" d3="975"/>
<CITE num="026" author="WOLFF J" publication="J BIOL CHEM" d1="250" d2="6897" d3="975"/>
<CITE num="027" author="WRIGHT RK" publication="ARCH DERMATOL" d1="107" d2="47" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78174</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LIANO G             BU" publication="LL MOL BIOL MED" d1="4" d2="55 9" d3="9"/>
<CITE num="2" author="CANELLAKIS ES" publication="CURR TOP CELL REGUL" d1="15" d2="155" d3="979"/>
<CITE num="3" author="TINTNER R" publication="J NEUROCHEM" d1="33" d2="1067" d3="979"/>
<CITE num="4" author="ALLEN JC" publication="EUR J BIOCHEM" d1="102" d2="153" d3="979"/>
<CITE num="5" author="GAHL WA" publication="PEDIATR RES" d1="14" d2="118" d3="980"/>
<CITE num="6" author="KUROSHIMA A" publication="JAP J PHYSIOL" d1="30" d2="935" d3="980"/>
<CITE num="7" author="KIMBERLY MM" publication="ANAL CHEM" d1="53" d2="789" d3="981"/>
</CITATIONS>
<RECORDNUM>00954 </RECORDNUM>
<MEDLINENUM>79011612</MEDLINENUM>
<AUTHORS><AUTHOR>Scholey-J</AUTHOR><AUTHOR>Applegarth-D-A</AUTHOR><AUTHOR>Davidson-A-G</AUTHOR><AUTHOR>Wong-L-T</AUTHOR></AUTHORS>
<TITLE>Detection of cystic fibrosis protein by electrofocusing [letter].</TITLE>
<SOURCE>Pediatr-Res. 1978 Jul. 12(7). P 800.</SOURCE>
<MAJORSUBJ><TOPIC>BLOOD-PROTEINS: an</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>ISOELECTRIC-FOCUSING</TOPIC></MINORSUBJ>
<EXTRACT>Wilson et al. reported a biophysical assay for cystic fibrosis that
employed isoelectric focusing of serum proteins.  Their work appeared
to establish the presence of a definitive marker for CF serum in the
form of a protein band that was not present in normal serum.  We
tried to repeat their work and found that the background color of the
fresh electropherograms made it rather difficult to detect
unequivocally the presence or absence of bands in the appropriate pH
region in CF vs. control serum.  However, when the gels were
photographed using Kodak Panatomic X film and a Wratten 25 A red
filter, the color response and contrast of the film eliminated this
interference to a great extent and it was much easier to detect the
putative band.  We agree partially with the observations of Wilson
and Fudenberg, but would like to stress that the technique is not a
diagnostic test.</EXTRACT>
<REFERENCES>
<CITE num="001" author="SMITH QT" publication="PEDIATR RES" d1="10" d2="999" d3="976"/>
<CITE num="002" author="THOMAS JM" publication="PEDIATR RES" d1="11" d2="1148" d3="977"/>
<CITE num="003" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="986" d3="977"/>
<CITE num="004" author="WILSON GB" publication="PEDIATR RES" d1="10" d2="1001" d3="976"/>
<CITE num="005" author="WILSON GB" publication="PEDIATR RES" d1="9" d2="635" d3="975"/>
<CITE num="006" author="WILSON GB" publication="PEDIATR RES" d1="11" d2="139" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78175</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLY GW              PE" publication="DIATR RES" d1="13" d2="78 9" d3="9"/>
<CITE num="2" author="WILSON GB" publication="PEDIATR RES" d1="13" d2="1079" d3="979"/>
<CITE num="3" author="MANSON JC" publication="LANCET" d1="1" d2="330" d3="980"/>
<CITE num="4" author="WILSON GB" publication="LANCET" d1="2" d2="313" d3="980"/>
<CITE num="5" author="NEVIN GB" publication="HUM GENET" d1="56" d2="387" d3="981"/>
<CITE num="6" author="HALLINAN FM" publication="CLIN CHIM ACTA" d1="117" d2="103" d3="981"/>
<CITE num="7" author="BULLOCK S" publication="CLIN GENET" d1="21" d2="336" d3="982"/>
<CITE num="8" author="BROCK DJH" publication="HUM GENET" d1="60" d2="30" d3="982"/>
<CITE num="9" author="BURY AF" publication="CLIN CHIM ACTA" d1="118" d2="45" d3="982"/>
<CITE num="10" author="GRATAROLI R" publication="PEDIATR RES" d1="18" d2="130" d3="984"/>
<CITE num="11" author="ANON" publication="LANCET" d1="2" d2="249" d3="985"/>
<CITE num="12" author="JAMIESON A" publication="HUM GENET" d1="70" d2="168" d3="985"/>
<CITE num="13" author="QURESHI AR" publication="J PEDIATR" d1="106" d2="913" d3="985"/>
<CITE num="14" author="HAYWARD C" publication="J IMMUNOL METH" d1="91" d2="117" d3="986"/>
</CITATIONS>
<RECORDNUM>00955 </RECORDNUM>
<MEDLINENUM>78157324</MEDLINENUM>
<AUTHORS><AUTHOR>Perlmutter-J</AUTHOR><AUTHOR>Martinez-J-R</AUTHOR></AUTHORS>
<TITLE>The chronically reserpinized rat as a possible model for cystic
fibrosis.  VII.  Alterations in the secretory response to
cholecystokinin and to secretin from the pancreas in vivo.</TITLE>
<SOURCE>Pediatr-Res. 1978 Mar. 12(3). P 188-94.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>DISEASE-MODELS-ANIMAL</TOPIC><TOPIC>PANCREATIC-JUICE: se</TOPIC><TOPIC>RESERPINE: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMYLASES: se</TOPIC><TOPIC>ANIMAL</TOPIC><TOPIC>CHOLECYSTOKININ: pd</TOPIC><TOPIC>ELECTROLYTES: se</TOPIC><TOPIC>MALE</TOPIC><TOPIC>ORGAN-WEIGHT: de</TOPIC><TOPIC>PANCREATIC-JUICE: de</TOPIC><TOPIC>PROTEINS: se</TOPIC><TOPIC>RATS</TOPIC><TOPIC>SECRETIN: pd</TOPIC><TOPIC>TIME-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>The chronically reserpinized rat has been proposed as an animal
model for cystic fibrosis on the basis of morphologic and secretory
alterations in the submaxillary gland and of abnormalities in
pulmonary secretions.  In this investigation, the volume and
composition of pancreatic juice from reserpine treated rats (0.5
mg/kg/day) have been compared to those of untreated controls after
stimulation with purified cholecystokinin (0.1 microgram/kg body
weight) and with crude and purified preparations of secretin (6
microns/100 g body weight) infused iv for 30-min periods.  The
results demonstrate that the treated animals secreted a
significantly lower volume of pancreatic juice after stimulation
with these secretagogues.  Flow rates were also significantly
reduced after stimulation with cholecystokinin and crude secretin.
Protein and amylase outputs in response to cholecystokinin were
smaller than in control animals after unrestritced feedings, but
greater after a 24-hr fast.  Total bicarbonate output was also
reduced after stimulation with either crude or purified secretin and
the normal excretion patterns for bicarbonate and chloride were
either absent of reversed in the secretin-stimulated pancreatic
juice of the treated animals.  Whole pancreas homogenates from the
treated animals showed significant increases in Ca++ and protein
content.  These results indicate that chronic administration of
reserpine alters the secretion of water, protein, and bicarbonate
from the rat pancreas and that it affects several of the exocrine
glands involved in cystic fibrosis.  These findings lend support to
the concept of an animal model for the human disease.  The chronic
administration of reserpine to rats has been shown to induce
alterations in salivary and pulmonary secretions which resemble
those seen in patients with cystic fibrosis.  The concept of an
animal model has been proposed on the basis of these observations.
The pancreas is another exocrine gland prominently involved in
cystic fibrosis and if it can be demonstrated that reserpine
administration also induces alterations in pancreatic secretion, the
concept of the animal model would be strengthened considerably.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BOGART BI" publication="PEDIATR RES" d1="11" d2="131" d3="977"/>
<CITE num="002" author="CASE RM" publication="J PHYSIOL (LOND)" d1="235" d2="75" d3="973"/>
<CITE num="003" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="004" author="EIMERL S" publication="J BIOL CHEM" d1="249" d2="3991" d3="974"/>
<CITE num="005" author="HADORN B" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="56" d3="969"/>
<CITE num="006" author="IMMKEN L" publication="CF CLUB ABST" d1="16" d2="9" d3="975"/>
<CITE num="007" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="008" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="009" author="MANGOS JA" publication="AM J PHYSIOL" d1="221" d2="496" d3="971"/>
<CITE num="010" author="MANGOS JA" publication="PROC SOC EXP BIOL MED" d1="146" d2="321" d3="974"/>
<CITE num="011" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="012" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="470" d3="975"/>
<CITE num="013" author="SEWELL WA" publication="J PHYSIOL (LOND)" d1="252" d2="379" d3="975"/>
<CITE num="014" author="SHAW HM" publication="AUST J BIOL SCI" d1="25" d2="147" d3="972"/>
<CITE num="015" author="SHAW HM" publication="J EXP PHYSIOL" d1="58" d2="229" d3="973"/>
<CITE num="016" author="THOMPSON FE" publication="PEDIATR RES" d1="10" d2="632" d3="976"/>
<CITE num="017" author="WILLIAMS JA" publication="BIOCHEM BIOPHYS RES COMMUN" d1="60" d2="542" d3="974"/>
<CITE num="018" author="WOOD DL" publication="PEDIATR RES" d1="11" d2="827" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78176</PAPERNUM>
<CITATIONS>
<CITE num="1" author="MSON JAV            LA" publication="B INVEST" d1="39" d2="57 9" d3="8"/>
<CITE num="2" author="MARTINEZ JR" publication="PEDIATR RES" d1="13" d2="1156" d3="979"/>
<CITE num="3" author="MAWHINNEY TP" publication="PEDIATR RES" d1="13" d2="760" d3="979"/>
<CITE num="4" author="SETSER ME" publication="LAB INVEST" d1="41" d2="256" d3="979"/>
<CITE num="5" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="6" author="MAWHINNEY TP" publication="PEDIATR RES" d1="14" d2="872" d3="980"/>
<CITE num="7" author="MORTON D" publication="PEDIATR RES" d1="14" d2="18" d3="980"/>
<CITE num="8" author="MCCURDY RE" publication="PEDIATR RES" d1="15" d2="1308" d3="981"/>
<CITE num="9" author="CUTLER LS" publication="VIRCHOWS ARCH PATHOL ANAT HIS" d1="392" d2="185" d3="981"/>
<CITE num="10" author="ROOMANS GM" publication="ULTRASTRUCTURAL PATHOL" d1="3" d2="285" d3="982"/>
<CITE num="11" author="SHIFFMAN ML" publication="PEDIATR RES" d1="16" d2="104" d3="982"/>
<CITE num="12" author="MACLEOD RM" publication="DEVELOP NEUROSCI" d1="16" d2="271" d3="983"/>
<CITE num="13" author="MARTINEZ JR" publication="PEDIATR RES" d1="17" d2="523" d3="983"/>
<CITE num="14" author="SHIFFMAN ML" publication="PEDIATR RES" d1="17" d2="486" d3="983"/>
<CITE num="15" author="MODRZAKOWSKI MC" publication="CAN J MICROBIOL" d1="29" d2="1339" d3="983"/>
<CITE num="16" author="LINGARD JM" publication="AM J PHYSIOL" d1="245" d2="G690" d3="983"/>
<CITE num="17" author="LOGIN IS" publication="BRAIN RES" d1="260" d2="99" d3="983"/>
<CITE num="18" author="CASTEELS R" publication="J PHYSIOL (LOND)" d1="340" d2="403" d3="983"/>
<CITE num="19" author="BOYD RL" publication="PEDIATR RES" d1="18" d2="1028" d3="984"/>
<CITE num="20" author="CHUNG KS" publication="PEDIATR RES" d1="18" d2="1300" d3="984"/>
<CITE num="21" author="SPICER SS" publication="ENVIRON HEALTH PERSPECT" d1="55" d2="193" d3="984"/>
<CITE num="22" author="MARTINEZ JR" publication="PEDIATR RES" d1="19" d2="711" d3="985"/>
<CITE num="23" author="HAZLETT D" publication="PEDIATR RES" d1="20" d2="1236" d3="986"/>
</CITATIONS>
<RECORDNUM>00956 </RECORDNUM>
<MEDLINENUM>78248075</MEDLINENUM>
<AUTHORS><AUTHOR>Gillard-B-K</AUTHOR><AUTHOR>Markman-H-C</AUTHOR><AUTHOR>Feig-S-A</AUTHOR></AUTHORS>
<TITLE>Differences between cystic fibrosis and normal saliva alpha-amylase
as a function of age and sex.</TITLE>
<SOURCE>Pediatr-Res. 1978 Aug. 12(8). P 868-72.</SOURCE>
<MAJORSUBJ><TOPIC>ALPHA-AMYLASE: me</TOPIC><TOPIC>AMYLASES: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>SALIVA: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>ALPHA-AMYLASE: an</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PARENTS</TOPIC><TOPIC>SALIVA: an</TOPIC><TOPIC>SALIVARY-PROTEINS: an</TOPIC><TOPIC>SEX-FACTORS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Alpha-amylase activity and protein concentration of cystic fibrosis
(CF), obligate heterozygote (H), and normal (N) saliva have been
evaluated with respect to genotype, age, sex and clinical status.
"Factors" present in CF saliva had no detectable effect on salivary
amylase activity under reaction conditions optimized for both
competitive and noncompetitive inhibition.  Tris
[tris-(hydoxy-methyl)aminomethane] inhibited amylase activity with a
Ki = 59 plus or minus 10 mM, but CF "factors" had no detectable
effect on either substrate or Tris binding to alpha-amylase.
Alpha-amylase concentrationand protein content of CF saliva had
bimodal distributions.  Thirty-six percent of the CF patients were
found to be amylase hypersecretors, with amylase concentration 3 or
more SD above the N mean.  Amylase hypersecretion was marginally
correlated with both genetic factors (with parent values, P = 0.075)
and clinical status (with Scwachman scores, P = 0.068).  All the
hypersecretors were in the 14-24 year age group.  Amylase
concentration for this age was significant higher in CF samples
(mean plus or minus SD), 82 plus or minus 37 starch units/ml (n = 
12), than in N samples, 33 plus or minus 17 starch unites/ml (n =
13), as measured by the Student t-test (P &lt; 0.001).  Salivary
protein content of 14- to 24-year-old CF males was elevated compared
to all other groups [1.57 plus or minus 0.76 (n = 5) vs. 0.63 plus
or minus  0.47 (n = 20); Student t-test, P &lt; 0.005].  Mean specific
activity of male saliva dropped sharply as age increased from 10-15
years, from over 200 to less than 75 starch units/mg protein.  Mean
normal female specific activity values were essentially constant [97
plus or minus 50 (n = 18) starch units/mg protein] from 5-30 years
of age.  CF male specific activity values decreased similarly to the
N male values from preadolescence to adolescence, but the mean CF
female values peaked later, at 17 years, with a maximum of 171 plus
or minus 58 (n = 4).  This is significantly higher than all the
other groups in the 16- to 20-year age range: 63 plus or minus 30 (n
= 9), P &lt; 0.005.  These data emphasize the need for age- and
sex-matched controls in all studies of salivary composition.  We
were unable to detect any effect of a salivary CF factor on the
enzymatic activity of alpha-amylase.  Hypersecretion of salivary
alpha-amylase was observed in 36% of CF patients.  This may reflect
alterations in secretory function basic to CF, or be secondary to
the disease process and result from decreased secretion from the
mucous salivary glands or deterioration of pancreatic function.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BISHOP SH" publication="CF CLUB ABST" d1="14" d2="25" d3="973"/>
<CITE num="002" author="BLOMFIELD J" publication="AUST PAEDIATR J" d1="10" d2="75" d3="974"/>
<CITE num="003" author="BLOMFIELD J" publication="PEDIATR RES" d1="10" d2="574" d3="976"/>
<CITE num="004" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="005" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1344" d3="967"/>
<CITE num="006" author="DIXON M" publication="BIOCHEM J" d1="55" d2="170" d3="953"/>
<CITE num="007" author="DIXON WJ" publication="BMDP: BIOMEDICAL COMPUTER PRO" d1="" d2="" d3="975"/>
<CITE num="008" author="DOGGETT RG" publication="NATURE NEW BIOL" d1="243" d2="250" d3="973"/>
<CITE num="009" author="DOGGETT RG" publication="TEX REP BIOL MED" d1="31" d2="685" d3="973"/>
<CITE num="010" author="FISHER EH" publication="BIOCHEM PREP" d1="8" d2="27" d3="961"/>
<CITE num="011" author="GILLARD BK" publication="PEDIATR RES" d1="10" d2="907" d3="976"/>
<CITE num="012" author="GILLARD BK" publication="CLIN CHEM" d1="23" d2="2279" d3="977"/>
<CITE num="013" author="GILLARD BK" publication="BIOCHEMISTRY" d1="16" d2="3978" d3="977"/>
<CITE num="014" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="015" author="LEHNINGER AL" publication="BIOCHEMISTRY" d1="14" d2="197" d3="975"/>
<CITE num="016" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="017" author="MANDEL ID" publication="AM J DIS CHILD" d1="113" d2="431" d3="967"/>
<CITE num="018" author="MAYO JW" publication="ARCH BIOCHEM BIOPHYS" d1="175" d2="507" d3="976"/>
<CITE num="019" author="MCNEELY CM" publication="CF CLUB ABST" d1="16" d2="6" d3="975"/>
<CITE num="020" author="MILLER GL" publication="ANAL CHEM" d1="31" d2="964" d3="959"/>
<CITE num="021" author="NELSON TE" publication="CF CLUB ABST" d1="15" d2="7" d3="974"/>
<CITE num="022" author="POULSEN JH" publication="J PHYSIOL (LOND)" d1="264" d2="323" d3="977"/>
<CITE num="023" author="ROBYT JF" publication="IN: RADLEY JA" d1="" d2="431" d3="968"/>
<CITE num="024" author="SHWACHMAN H" publication="CF CLUB ABST" d1="16" d2="19" d3="975"/>
<CITE num="025" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="026" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="10" d2="577" d3="975"/>
<CITE num="027" author="SMITH QT" publication="PROC SOC EXP BIOL MED" d1="153" d2="241" d3="976"/>
<CITE num="028" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="029" author="TOWNES PL" publication="AM J HUM GENET" d1="28" d2="378" d3="976"/>
<CITE num="030" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
<CITE num="031" author="WOOD RE" publication="AM REV RESPIR DIS" d1="113" d2="833" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78177</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LLARD BK            PE" publication="DIATR RES" d1="14" d2="68 9" d3="0"/>
<CITE num="2" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="3" author="GILLARD BK" publication="CLIN CHEM" d1="29" d2="1119" d3="983"/>
</CITATIONS>
<RECORDNUM>00957 </RECORDNUM>
<MEDLINENUM>78157291</MEDLINENUM>
<AUTHORS><AUTHOR>Bogart-B-I</AUTHOR><AUTHOR>Conod-E-J</AUTHOR><AUTHOR>Gaerlan-P-F</AUTHOR><AUTHOR>Conover-J</AUTHOR></AUTHORS>
<TITLE>The biologic activities of cystic fibrosis serum.  II.
Ultrastructural aspects of the effect of cystic fibrosis sera and
calcium ionophore A23187 on rabbit tracheal explants.</TITLE>
<SOURCE>Pediatr-Res. 1978 Jan. 12(1). P 15-24.</SOURCE>
<MAJORSUBJ><TOPIC>A-23187: pd</TOPIC><TOPIC>ANTIBIOTICS: pd</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>TRACHEA: de</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ANIMAL</TOPIC><TOPIC>CALCIUM: me, ph</TOPIC><TOPIC>CILIA: ul</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>EPITHELIUM: ul</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RABBITS</TOPIC><TOPIC>TRACHEA: ul</TOPIC></MINORSUBJ>
<ABSTRACT>Ultrastructural and cytochemical observations indicate that both
cystic fibrosis (CF) sera and calcium ionophore A23187 induce a
swelling or an increase in the size and possibly the number of
secondary lysosomes and an increase in mucus secretion in epithelium
of the rabbit tracheal bioassay system. Extended incubation of the
rabbit tracheal explants with either CF or control sera produces a
cytotoxic effect on the tracheal epithelium, but only after the
termination of the normal bioassay time period. Comparative
ultrastructural study of the effect of both CF sera and calcium
ionophore A23187 on the rabbit tracheal bioassay system indicates
that increased membrane permeability to calcium may be important in
the production of the ciliary dyskinesia response by CF serum
factor(s) in the rabbit tracheal bioassay system.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ADSHEAD PC" publication="ANN NY ACAD SCI" d1="253" d2="192" d3="975"/>
<CITE num="002" author="BARRETT LA" publication="CANCER RES" d1="36" d2="1003" d3="976"/>
<CITE num="003" author="BAUR PS" publication="TEX REP BIOL MED" d1="34" d2="155" d3="976"/>
<CITE num="004" author="BOGART BI" publication="J HISTOCHEM CYTOCHEM" d1="16" d2="572" d3="968"/>
<CITE num="005" author="BOGART BI" publication="J ULTRASTRUCT RES" d1="52" d2="139" d3="975"/>
<CITE num="007" author="CHERRY JD" publication="J PEDIATR" d1="79" d2="937" d3="971"/>
<CITE num="008" author="CHEUNG ATW" publication="PEDIATR RES" d1="10" d2="144" d3="976"/>
<CITE num="009" author="COCHRANE DE" publication="PROC NAT ACAD SCI USA" d1="71" d2="408" d3="974"/>
<CITE num="010" author="CONOVER JH" publication="PEDIATR RES" d1="7" d2="220" d3="973"/>
<CITE num="011" author="CONOVER JH" publication="TEX REP BIOL MED" d1="34" d2="45" d3="976"/>
<CITE num="012" author="DAEMS WT" publication="IN: DINGLE JT" d1="1" d2="64" d3="969"/>
<CITE num="013" author="DETER RL" publication="J CELL BIOL" d1="33" d2="437" d3="967"/>
<CITE num="014" author="DIRKSEN ER" publication="CANCER RES" d1="28" d2="906" d3="968"/>
<CITE num="015" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="016" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="017" author="EIMERL S" publication="J BIOL CHEM" d1="249" d2="3991" d3="974"/>
<CITE num="018" author="ERRICSSON JLE" publication="IN: DINGLE JT" d1="2" d2="345" d3="969"/>
<CITE num="019" author="FARQUHAR MG" publication="IN: DINGLE JT" d1="2" d2="462" d3="969"/>
<CITE num="020" author="FARRELL PM" publication="PEDIATR RES" d1="10" d2="127" d3="976"/>
<CITE num="021" author="GALLIN JI" publication="J CELL BIOL" d1="62" d2="594" d3="974"/>
<CITE num="022" author="GILLESPIE E" publication="J CELL BIOL" d1="50" d2="544" d3="971"/>
<CITE num="023" author="GINN FL" publication="AM J PATHOL" d1="53" d2="1041" d3="968"/>
<CITE num="024" author="JACQUES PJ" publication="IN: DINGLE JT" d1="2" d2="395" d3="969"/>
<CITE num="025" author="KAGAYAMA M" publication="J CELL BIOL" d1="62" d2="519" d3="974"/>
<CITE num="026" author="KIRSCHNA MW" publication="J SUPRAMOL STRUCT" d1="2" d2="412" d3="974"/>
<CITE num="027" author="KURIYAMA R" publication="J BIOCHEM (TOKYO)" d1="75" d2="463" d3="975"/>
<CITE num="028" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="029" author="LUFT JH" publication="J BIOPHYS BIOCHEM CYTOL" d1="9" d2="409" d3="961"/>
<CITE num="030" author="MIRA-MOSER F" publication="EUR J CLIN INVEST" d1="6" d2="103" d3="976"/>
<CITE num="031" author="MOTOKAWA T" publication="J CELL BIOL" d1="66" d2="377" d3="975"/>
<CITE num="032" author="NEUTRA M" publication="J CELL BIOL" d1="30" d2="119" d3="966"/>
<CITE num="033" author="PALADE GE" publication="IN: HAYASHI T" d1="" d2="64" d3="959"/>
<CITE num="034" author="PRESSMAN BC" publication="FED PROC" d1="32" d2="1698" d3="973"/>
<CITE num="035" author="RAVAZZOLA M" publication="LAB INVEST" d1="35" d2="425" d3="976"/>
<CITE num="036" author="REED PW" publication="J BIOL CHEM" d1="247" d2="6970" d3="972"/>
<CITE num="037" author="SATIR P" publication="SCIENCE" d1="190" d2="586" d3="975"/>
<CITE num="038" author="SELINGER Z" publication="PROC NAT ACAD SCI USA" d1="71" d2="128" d3="974"/>
<CITE num="039" author="SHELANSKI ML" publication="PROC NAT ACAD SCI USA" d1="70" d2="765" d3="973"/>
<CITE num="040" author="SOMLYO AP" publication="J CELL BIOL" d1="66" d2="425" d3="975"/>
<CITE num="041" author="SPOCK A" publication="PEDIATR RES" d1="1" d2="173" d3="967"/>
<CITE num="042" author="TRUMP BF" publication="IN: TRUMP BF" d1="" d2="1" d3="975"/>
<CITE num="043" author="TRUMP BF" publication="IN: RICHTER GW" d1="" d2="84" d3="971"/>
<CITE num="044" author="TRUMP BF" publication="IN: KARBE F" d1="" d2="548" d3="974"/>
<CITE num="045" author="WEISENBERG RC" publication="SCIENCE" d1="177" d2="1104" d3="972"/>
<CITE num="046" author="WONG DT" publication="ARCH BIOCHEM BIOPHYS" d1="156" d2="578" d3="973"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78178</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSCHBACH MW         BI" publication="OCHEM BIOPHYS RES COMMUN" d1="84" d2="22 9" d3="8"/>
<CITE num="2" author="BOGART BI" publication="BIOCHEM BIOPHYS RES COMMUN" d1="88" d2="1398" d3="979"/>
<CITE num="3" author="KENNEDY JR" publication="PEDIATR RES" d1="14" d2="1173" d3="980"/>
<CITE num="4" author="SANDERSON MJ" publication="PEDIATR RES" d1="15" d2="219" d3="981"/>
<CITE num="5" author="SCHONI M" publication="SCHWEIZ MED WOCHENSCHR" d1="111" d2="658" d3="981"/>
<CITE num="6" author="CEDER O" publication="SCANN ELECTRON MICROSC" d1="1982" d2="723" d3="982"/>
<CITE num="7" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1982" d2="229" d3="982"/>
<CITE num="8" author="CEDER O" publication="ULTRASTRUCTURAL PATHOL" d1="4" d2="305" d3="983"/>
<CITE num="9" author="CEDER O" publication="ACTA PAEDIATR SCAND SUPPL 309" d1="1983" d2="1" d3="983"/>
<CITE num="10" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="11" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="12" author="NEAL JL" publication="EVOLUTIONARY THEORY" d1="7" d2="153" d3="985"/>
<CITE num="13" author="VONEULER AM" publication="EXP MOL PATH" d1="43" d2="142" d3="985"/>
<CITE num="14" author="BOGART BI" publication="J CHROMATOGR" d1="381" d2="29" d3="986"/>
<CITE num="15" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1986" d2="165" d3="986"/>
</CITATIONS>
<RECORDNUM>00958 </RECORDNUM>
<MEDLINENUM>78157289</MEDLINENUM>
<AUTHORS><AUTHOR>Grinwald-P-M</AUTHOR><AUTHOR>Segal-M-B</AUTHOR></AUTHORS>
<TITLE>Effect of saliva from cystic fibrosis patients and from normal
subjects on red blood cell sodium transport.</TITLE>
<SOURCE>Pediatr-Res. 1978 Jan. 12(1). P 1-3.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>ERYTHROCYTES: me</TOPIC><TOPIC>SALIVA: ph</TOPIC><TOPIC>SODIUM: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>BIOLOGICAL-TRANSPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>OUABAIN: pd</TOPIC><TOPIC>SODIUM: bl</TOPIC></MINORSUBJ>
<ABSTRACT>Saliva, whether taken from patients with cystic fibrosis or from
normal subjects, caused an increase in red blood cell Na+ efflux (in
the presence or absence of ouabain) of 19-29% as compared with non-
saliva controls. However, there was no significant difference between
the effects of cystic fibrosis saliva and normal saliva.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BALFE JW" publication="SCIENCE" d1="162" d2="689" d3="968"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1344" d3="967"/>
<CITE num="003" author="DUFFY MJ" publication="LANCET" d1="2" d2="136" d3="972"/>
<CITE num="004" author="HOFFMAN JF" publication="ANN NY ACAD SCI" d1="137" d2="566" d3="966"/>
<CITE num="005" author="KAISER D" publication="LANCET" d1="1" d2="1003" d3="970"/>
<CITE num="006" author="LAPEY A" publication="PEDIATR RES" d1="5" d2="446" d3="971"/>
<CITE num="007" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="008" author="SACHS JR" publication="J CLIN INVEST" d1="46" d2="65" d3="967"/>
<CITE num="009" author="TAUSSIG LM" publication="LANCET" d1="1" d2="1367" d3="972"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78179</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ALE TW              PE" publication="DIATR RES" d1="14" d2="98 9" d3="0"/>
<CITE num="2" author="BERGHOUT AGRV" publication="PEDIATR RES" d1="18" d2="1017" d3="984"/>
</CITATIONS>
<RECORDNUM>00959 </RECORDNUM>
<MEDLINENUM>79073912</MEDLINENUM>
<AUTHORS><AUTHOR>Davidson-G-P</AUTHOR><AUTHOR>Koheil-A</AUTHOR><AUTHOR>Forstner-G-G</AUTHOR></AUTHORS>
<TITLE>Salivary amylase in cystic fibrosis: a marker of disordered
autonomic function.</TITLE>
<SOURCE>Pediatr-Res. 1978 Oct. 12(10). P 967-70.</SOURCE>
<MAJORSUBJ><TOPIC>AMYLASES: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>SALIVA: en</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>EATING</TOPIC><TOPIC>FECES: an</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>ISOENZYMES: bl</TOPIC><TOPIC>LIPIDS: an</TOPIC><TOPIC>PANCREAS: en</TOPIC><TOPIC>PANCREATIC-DISEASES: en</TOPIC><TOPIC>SYNDROME</TOPIC></MINORSUBJ>
<ABSTRACT>Total serum amylase was determined in 83 patients with cystic
fibrosis (CF) (14 of whom had no steatorrhea), 21 control patients,
and 6 patients with Shwachman's syndrome. Patients with CF who had
steatorrhea and therefore lacked pancreatic function had the same
serum levels pre- and postprandially as the control subjects, whereas
patients without steatorrhea and, therefore, with evidence of
pancreatic function, had significantly higher levels. The patients
with Shwachman's syndrome had significantly lower total serum amylase
than the three other patient groups. Only the patients with
Shwachman's syndrome demonstrated a significant postprandial rise in
activity. Only the salivary isoenzyme was detected in patients with
Shwachman's syndrome or CF and apparently absent pancreatic function,
whereas CF patients without steatorrhea had both salivary and
pancreatic isoenzymes. These results demonstrate that patients with
CF have an increase in circulating salivary amylase isoenzyme whereas
patients with Shwachman's syndrome do not. The increase probably
reflects an autonomic hyperstimulation of salivary secretion which is
primary to CF, and unrelated to the state of pancreatic activity.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARBERO GJ" publication="PEDIATRICS" d1="29" d2="788" d3="962"/>
<CITE num="002" author="BARBERO GJ" publication="CF CLUB ABST" d1="" d2="4" d3="967"/>
<CITE num="003" author="BLOMFIELD J" publication="AUST PAEDIATR J" d1="10" d2="75" d3="974"/>
<CITE num="004" author="BLOMFIELD J" publication="PEDIATR RES" d1="10" d2="574" d3="976"/>
<CITE num="005" author="BONGIOVANNI AM" publication="LAB INVEST" d1="10" d2="956" d3="961"/>
<CITE num="006" author="CARAWAY WT" publication="AM J CLIN PATHOL" d1="32" d2="97" d3="959"/>
<CITE num="007" author="GIBBS GE" publication="PROC SOC EXP BIOL MED" d1="77" d2="251" d3="951"/>
<CITE num="008" author="HAGLUND H" publication="METHODS BIOCHEM ANAL" d1="19" d2="1" d3="971"/>
<CITE num="009" author="JANOWITZ HD" publication="AM J MED" d1="27" d2="924" d3="959"/>
<CITE num="010" author="MANDEL ID" publication="AM J DIS CHILD" d1="113" d2="431" d3="967"/>
<CITE num="011" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="012" author="MARMAR J" publication="GASTROENTEROLOGY" d1="50" d2="551" d3="966"/>
<CITE num="013" author="NIKOLAJEK WP" publication="EUR J PEDIATR" d1="122" d2="289" d3="976"/>
<CITE num="014" author="ODONNELL MD" publication="CLIN CHEM" d1="23" d2="560" d3="977"/>
<CITE num="015" author="ROY CC" publication="PEDIATR CLIN GASTROENTEROL" d1="" d2="" d3="975"/>
<CITE num="016" author="RUBIN LS" publication="PEDIATRICS" d1="38" d2="865" d3="966"/>
<CITE num="017" author="SHWACHMAN H" publication="J PEDIATR" d1="65" d2="645" d3="964"/>
<CITE num="018" author="SHWACHMAN H" publication="PEDIATRICS" d1="55" d2="86" d3="975"/>
<CITE num="019" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="10" d2="577" d3="975"/>
<CITE num="020" author="SKUDE G" publication="SCAND J GASTROENTEROL" d1="11" d2="525" d3="976"/>
<CITE num="021" author="SUN DCH" publication="GASTROENTEROLOGY" d1="45" d2="203" d3="963"/>
<CITE num="022" author="TAUSSIG LM" publication="PEDIATRICS" d1="54" d2="229" d3="974"/>
<CITE num="023" author="VESTERBERG O" publication="ACTA CHEM SCAND" d1="20" d2="820" d3="966"/>
<CITE num="024" author="WOLF RO" publication="J LAB CLIN MED" d1="87" d2="164" d3="976"/>
<CITE num="025" author="WORMSLEY KG" publication="SCAND J GASTROENTEROL" d1="4" d2="623" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78180</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LF RO               PE" publication="DIATR RES" d1="13" d2="76 9" d3="9"/>
<CITE num="2" author="QUINTON PM" publication="NATURE" d1="279" d2="551" d3="979"/>
<CITE num="3" author="GILLARD BK" publication="PEDIATR RES" d1="14" d2="1168" d3="980"/>
<CITE num="4" author="ROULET M" publication="PEDIATR RES" d1="14" d2="1360" d3="980"/>
<CITE num="5" author="WOLF RO" publication="PEDIATR RES" d1="14" d2="968" d3="980"/>
<CITE num="6" author="DAVIDSON GP" publication="J CLIN PATHOL" d1="33" d2="390" d3="980"/>
<CITE num="7" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="8" author="ROSCHER AA" publication="J PHARMACOL EXP THER" d1="216" d2="419" d3="981"/>
<CITE num="9" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="18" d2="118" d3="982"/>
<CITE num="10" author="GOLDBERG DM" publication="CLIN PHYSIOL BIOCHEM" d1="2" d2="249" d3="984"/>
<CITE num="11" author="MORGENSTERN T" publication="MONATSSCHR KINDERHEILKD" d1="132" d2="661" d3="984"/>
<CITE num="12" author="MAILLIE AJ" publication="SCAND J GASTROENTEROL" d1="21" d2="941" d3="986"/>
<CITE num="13" author="LIU P" publication="J CAN ASSOC RADIOL" d1="37" d2="279" d3="986"/>
</CITATIONS>
<RECORDNUM>00960 </RECORDNUM>
<MEDLINENUM>79073920</MEDLINENUM>
<AUTHORS><AUTHOR>Katz-S</AUTHOR></AUTHORS>
<TITLE>Calcium and sodium transport processes in patients with cystic
fibrosis.  I. A specific decrease in Mg2+-dependent, Ca2+-adenosine
triphosphatase activity in erythrocyte membranes from cystic
fibrosis patients.</TITLE>
<SOURCE>Pediatr-Res. 1978 Nov. 12(11). P 1033-8.</SOURCE>
<MAJORSUBJ><TOPIC>ADENOSINE-TRIPHOSPHATASE-CALCIUM: me</TOPIC><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: en</TOPIC><TOPIC>ERYTHROCYTE-MEMBRANE: en</TOPIC><TOPIC>ERYTHROCYTES: en</TOPIC><TOPIC>MAGNESIUM: me</TOPIC><TOPIC>SODIUM: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADENOSINE-TRIPHOSPHATASE-SODIUM-POTASSIUM: me</TOPIC><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>Calcium-ATPase activity (Mg2+-dependent Ca2+-ATPase, ATP
phosphohydrolase, EC 3.6.1.3) in erythrocyte membrane preparations
from cystic fibrosis (CF) patients was greatly reduced compared to
erythrocyte membranes from control subjects. The Km for calcium was
found to be similar in the two groups; however, the Vmax, the maximal
rate of activation of the Ca2+-ATPase, is reduced by 50% in the
erythrocyte membrane preparations of the CF patients (P less than
0.001). In contrast, the Mg2+-ATPase activity of erythrocyte
membranes from CF patients was unchanged compared to the control
subjects. No difference in the Na+,K+-ATPase activity in erythrocyte
membranes from CF patients compared to control patients could be
observed. This indicates that the Ca2+-ATPase activity noted in CF
erythrocytes is not part of a generalized membrane or membrane-bound
enzyme alteration. It remains to be determined whether this
alteration in Ca2+-ATPase activity is directly related to a defect in
calcium transport in these cells and is a generalized phenomenon in
CF present in cell types more directly involved in secretion.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAKER PF" publication="IN: BUTLER JAV" d1="" d2="179" d3="972"/>
<CITE num="002" author="BETTELHEIM FA" publication="BIOCHIM BIOPHYS ACTA" d1="236" d2="702" d3="971"/>
<CITE num="003" author="BLOMFIELD J" publication="ARCH DIS CHILD" d1="48" d2="267" d3="973"/>
<CITE num="004" author="BLOSTEIN R" publication="J BIOL CHEM" d1="243" d2="1957" d3="968"/>
<CITE num="005" author="BLOSTEIN R" publication="J BIOL CHEM" d1="245" d2="270" d3="970"/>
<CITE num="006" author="BOAT TF" publication="PEDIATR RES" d1="8" d2="531" d3="974"/>
<CITE num="007" author="BOND GH" publication="BIOCHIM BIOPHYS ACTA" d1="323" d2="592" d3="973"/>
<CITE num="008" author="CALDWELL PG" publication="IN: CUTHBERT AW" d1="" d2="10" d3="973"/>
<CITE num="009" author="CHERNICK WS" publication="J PEDIATR" d1="59" d2="890" d3="961"/>
<CITE num="010" author="COLE CH" publication="PEDIATR RES" d1="6" d2="616" d3="972"/>
<CITE num="011" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1344" d3="967"/>
<CITE num="012" author="DOUGLAS WW" publication="BR J PHARMACOL" d1="34" d2="451" d3="968"/>
<CITE num="013" author="FEIG SA" publication="PEDIATR RES" d1="8" d2="594" d3="974"/>
<CITE num="014" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="015" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="016" author="GLYNN IM" publication="BIOCHEM J" d1="90" d2="147" d3="964"/>
<CITE num="017" author="HORTON CR" publication="BIOCHEM BIOPHYS RES COMMUN" d1="40" d2="505" d3="970"/>
<CITE num="018" author="KATZ S" publication="CF CLUB ABST" d1="18" d2="9" d3="977"/>
<CITE num="019" author="KATZ S" publication="BIOCHIM BIOPHYS ACTA" d1="389" d2="314" d3="975"/>
<CITE num="020" author="KATZ AM" publication="ADV CYCLIC NUCLEO RES" d1="5" d2="453" d3="975"/>
<CITE num="021" author="LEE KS" publication="J GEN PHYSIOL" d1="54" d2="713" d3="969"/>
<CITE num="022" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="023" author="MANDEL ID" publication="CLIN PEDIATR" d1="8" d2="161" d3="969"/>
<CITE num="024" author="MCEVOY FA" publication="CLIN CHIM ACTA" d1="54" d2="195" d3="974"/>
<CITE num="025" author="POST RL" publication="METHODS ENZYMOL" d1="10" d2="762" d3="967"/>
<CITE num="026" author="RUSSELL JM" publication="J GEN PHYSIOL" d1="63" d2="144" d3="974"/>
<CITE num="027" author="SCHATZMANN HJ" publication="J PHYSIOL (LOND)" d1="235" d2="551" d3="973"/>
<CITE num="028" author="WIESMANN UN" publication="CF CLUB ABST" d1="9" d2="12" d3="968"/>
<CITE num="029" author="WINS P" publication="BIOCHIM BIOPHYS ACTA" d1="120" d2="341" d3="966"/>
<CITE num="030" author="ZIPKIN I" publication="CF CLUB ABST" d1="11" d2="57" d3="970"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78181</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PINATH RM           AM" publication="J HEMATOL" d1="7" d2="03 9" d3="9"/>
<CITE num="2" author="ANSAH TA" publication="CELL CALC" d1="1" d2="195" d3="980"/>
<CITE num="3" author="SCANLIN TF" publication="CLIN CHEST MED" d1="1" d2="424" d3="980"/>
<CITE num="4" author="RAESS BU" publication="J PHARMACOL METHODS" d1="4" d2="273" d3="980"/>
<CITE num="5" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="6" author="ANSAH TA" publication="PROC WEST PHARMACOL SOC" d1="23" d2="389" d3="980"/>
<CITE num="7" author="KATZ S" publication="CLIN CHIM ACTA" d1="100" d2="245" d3="980"/>
<CITE num="8" author="FODER B" publication="CLIN CHIM ACTA" d1="104" d2="187" d3="980"/>
<CITE num="9" author="KATZ S" publication="CELL CALC" d1="2" d2="545" d3="981"/>
<CITE num="10" author="LARSEN FL" publication="NATURE" d1="294" d2="667" d3="981"/>
<CITE num="11" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="12" author="WARWICK WJ" publication="AM J MED TECHNOLOGY" d1="48" d2="539" d3="982"/>
<CITE num="13" author="REINILA M" publication="ANAL BIOCHEM" d1="124" d2="19" d3="982"/>
<CITE num="14" author="APPLEGARTH DA" publication="MED HYPOTHESES" d1="11" d2="277" d3="983"/>
<CITE num="15" author="FONDACARO JD" publication="LIFE SCI" d1="32" d2="1449" d3="983"/>
<CITE num="16" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="17" author="MINER C" publication="J PHYSIOL (LOND)" d1="338" d2="P 63" d3="983"/>
<CITE num="18" author="NORDT FJ" publication="ANN NY ACAD SCI" d1="416" d2="651" d3="983"/>
<CITE num="19" author="SEYMOUR CA" publication="BIOESSAYS" d1="1" d2="38" d3="984"/>
<CITE num="20" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="21" author="BERGHOUT AGRV" publication="PEDIATR RES" d1="18" d2="1017" d3="984"/>
<CITE num="22" author="DEARBORN DG" publication="PEDIATR RES" d1="18" d2="890" d3="984"/>
<CITE num="23" author="VONRUECKER AA" publication="PEDIATR RES" d1="18" d2="594" d3="984"/>
<CITE num="24" author="WALLER RL" publication="LIFE SCI" d1="35" d2="775" d3="984"/>
<CITE num="25" author="PETTEGREW JW" publication="J MAGNET RESON" d1="57" d2="185" d3="984"/>
<CITE num="26" author="CLOUGH DL" publication="CLIN CHIM ACTA" d1="138" d2="259" d3="984"/>
<CITE num="27" author="WALLER RL" publication="CELL CALC" d1="6" d2="245" d3="985"/>
<CITE num="28" author="SUTER S" publication="PEDIATR RES" d1="19" d2="346" d3="985"/>
<CITE num="29" author="ALBAZZAZ FJ" publication="J APPL PHYSIOL" d1="59" d2="1191" d3="985"/>
<CITE num="30" author="MUALLEM S" publication="BIOCHIM BIOPHYS ACTA" d1="819" d2="143" d3="985"/>
<CITE num="31" author="ALLEN BG" publication="CELL CALC" d1="7" d2="161" d3="986"/>
<CITE num="32" author="BRIDGES MA" publication="PEDIATR RES" d1="20" d2="356" d3="986"/>
<CITE num="33" author="DAVIS PB" publication="PEDIATR RES" d1="20" d2="1290" d3="986"/>
<CITE num="34" author="RUPP GM" publication="MED HYPOTHESES" d1="20" d2="245" d3="986"/>
<CITE num="35" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
<CITE num="36" author="HUNSINGER RN" publication="CLIN CHIM ACTA" d1="156" d2="165" d3="986"/>
<CITE num="37" author="SCHONI MH" publication="CELL CALC" d1="8" d2="53" d3="987"/>
</CITATIONS>
<RECORDNUM>00961 </RECORDNUM>
<MEDLINENUM>78225004</MEDLINENUM>
<AUTHORS><AUTHOR>Davis-P-B</AUTHOR><AUTHOR>Braunstein-M</AUTHOR><AUTHOR>Jay-C</AUTHOR></AUTHORS>
<TITLE>Decreased adenosine 3':5'-monophosphate response to isoproterenol in
cystic fibrosis leukocytes.</TITLE>
<SOURCE>Pediatr-Res. 1978 Jun. 12(6). P 703-7.</SOURCE>
<MAJORSUBJ><TOPIC>ADENOSINE-CYCLIC-MONOPHOSPHATE: bl</TOPIC><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>ISOPROTERENOL: pd</TOPIC><TOPIC>LEUKOCYTES: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ANTIBIOTICS</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>DIGOXIN</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GRANULOCYTES: me</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LEUKOCYTES: de</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PANCREATIC-EXTRACTS</TOPIC><TOPIC>PROSTAGLANDINS-E: pd</TOPIC><TOPIC>RECEPTORS-ADRENERGIC-BETA: ph</TOPIC></MINORSUBJ>
<ABSTRACT>Leukocyte preparations from cystic fibrosis (CF) patients produced
markedly less adenosine 3':5'-monophosphate (cAMP) in response to
isoproterenol than normal cells.  Both stimulation ratio and net
isoproterenol-stimulated accumulation of cAMP were significantly (P
&lt; 0.001) lower in mixed leukocyte preparations from 20 CF patients
(29 trials) compared to 21 normal subjects (49 trials).  There was
no significant correlation of results with clinical score, and no
differences in the CF group attributable to medications or presence
of pancreatic insufficiency.  CF heterozygotes had mean stimulation
ratio and mean net isoproterenol-stimulated cAMP intermediate
betweem normal and CF.  There were no statistically significant
differences among normal subjects, CF patients, and CF heterozygotes
in basal cAMP or prostaglandin E1-stimulated cAMP.  Purified
mononuclear cells from five normal persons and seven CF homozygotes
had the same basal and prostaglandin E1-stimulated cAMP, but
isoproterenol-stimulated cAMP was markedly depressed (P &lt; 0.01) in
the CF cells.  Granulocytes from six normal persons and nine CF
patients also had the same basal and prostaglandin E1-stimulated
cAMP, but isoproterenol-stimulated cAMP was decreased (P &lt; 0.05) in
the CF samples.  These results clearly demonstrate a difference
between normal and CF leukocytes in cAMP response to beta-adrenergic
stimulation.  The diminised cAMP response to beta-adrenergic
stimulation in CF is probably related to the presence of a CF gene,
and may interact with other genetic abnormalities to produce the
clinical syndrome of CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ATKINSON JP" publication="J CYCLIC NUCLEOTIDES RES" d1="2" d2="297" d3="976"/>
<CITE num="002" author="BOLANDE RP" publication="ARCH PATHOL" d1="95" d2="172" d3="973"/>
<CITE num="003" author="BOURNE HR" publication="J PHARMACOL EXP THER" d1="178" d2="1" d3="971"/>
<CITE num="004" author="BOYD EM" publication="CAN MED ASSOC J" d1="82" d2="821" d3="960"/>
<CITE num="005" author="BOYUM A" publication="SCAND J CLIN LAB INVEST SUPPL" d1="97" d2="77" d3="968"/>
<CITE num="006" author="BRAUNSTEIN M" publication="CF CLUB ABST" d1="" d2="28" d3="975"/>
<CITE num="007" author="BROWN BL" publication="ADV CYCLIC NUCLEO RES" d1="2" d2="25" d3="972"/>
<CITE num="008" author="BUCHWALD M" publication="PROC NAT ACAD SCI USA" d1="73" d2="2899" d3="976"/>
<CITE num="009" author="BUSSE WW" publication="J ALLERGY CLIN IMMUNOL" d1="58" d2="586" d3="976"/>
<CITE num="010" author="CAMPBELL IM" publication="PEDIATRICS" d1="57" d2="480" d3="976"/>
<CITE num="011" author="CHERNICK WS" publication="MOD PROBL PEDIATR" d1="10" d2="125" d3="967"/>
<CITE num="012" author="CHERNICK WS" publication="J PEDIATR" d1="59" d2="890" d3="961"/>
<CITE num="013" author="CONOLLY ME" publication="J CLIN INVEST" d1="58" d2="1307" d3="976"/>
<CITE num="015" author="DAVIS PB" publication="FED PROC" d1="36" d2="409" d3="977"/>
<CITE num="016" author="DIEM K" publication="DOCUMENTA GEIGY SCIENTIFIC TA" d1="" d2="156" d3="970"/>
<CITE num="017" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="018" author="ENGELHARD VH" publication="PROC NAT ACAD SCI USA" d1="73" d2="4482" d3="976"/>
<CITE num="019" author="FARBER S" publication="AM J DIS CHILD" d1="64" d2="953" d3="942"/>
<CITE num="021" author="LEFKOWITZ RJ" publication="N ENGL J MED" d1="295" d2="323" d3="976"/>
<CITE num="022" author="MANGOS JA" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="25" d3="969"/>
<CITE num="023" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="463" d3="975"/>
<CITE num="024" author="MARTINEZ JR" publication="PEDIATR RES" d1="9" d2="470" d3="975"/>
<CITE num="025" author="MCEVOY FA" publication="LANCET" d1="2" d2="236" d3="975"/>
<CITE num="026" author="MICKEY J" publication="J BIOL CHEM" d1="250" d2="5727" d3="975"/>
<CITE num="027" author="MURAD F" publication="J CLIN ENDOCRINOL METAB" d1="40" d2="552" d3="975"/>
<CITE num="028" author="PARKER DW" publication="J CLIN INVEST" d1="52" d2="48" d3="973"/>
<CITE num="029" author="PATEL KR" publication="CLIN ALLERGY" d1="4" d2="311" d3="974"/>
<CITE num="030" author="RUBIN LS" publication="PEDIATRICS" d1="38" d2="865" d3="966"/>
<CITE num="031" author="SCHAAP T" publication="IN: MANGOS JA" d1="" d2="291" d3="976"/>
<CITE num="032" author="SIMOPOULOS AP" publication="PEDIATR RES" d1="6" d2="355" d3="972"/>
<CITE num="033" author="SNIDER DE" publication="J CLIN INVEST" d1="58" d2="524" d3="976"/>
<CITE num="034" author="STURGESS JM" publication="BR J EXP PATHOL" d1="54" d2="388" d3="973"/>
<CITE num="035" author="TALLMAN JF" publication="PROC NAT ACAD SCI USA" d1="74" d2="873" d3="977"/>
<CITE num="036" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="037" author="THOMPSON FE" publication="PEDIATR RES" d1="10" d2="632" d3="976"/>
<CITE num="038" author="WILLIAMS LT" publication="J CLIN INVEST" d1="57" d2="149" d3="976"/>
<CITE num="039" author="WRIGHT R" publication="PEDIATR RES" d1="10" d2="373" d3="976"/>
<CITE num="040" author="ZENSER TV" publication="J BIOL CHEM" d1="251" d2="7431" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78182</PAPERNUM>
<CITATIONS>
<CITE num="1" author="NSCHBACH MW         BI" publication="OCHEM BIOPHYS RES COMMUN" d1="84" d2="22 9" d3="8"/>
<CITE num="2" author="DISANTAGNESE PA" publication="MONOGR PAEDIATR" d1="10" d2="66" d3="979"/>
<CITE num="3" author="LAKE CR" publication="CLIN CHIM ACTA" d1="92" d2="141" d3="979"/>
<CITE num="4" author="DAVIS PB" publication="IRCS MED SCI BIOCHEM" d1="8" d2="413" d3="980"/>
<CITE num="5" author="AURBACH GD" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="1" d3="980"/>
<CITE num="6" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="7" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="8" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="863" d3="980"/>
<CITE num="9" author="ROSCHER AA" publication="PEDIATR RES" d1="14" d2="261" d3="980"/>
<CITE num="10" author="AITKEN DA" publication="J MED GENET" d1="17" d2="187" d3="980"/>
<CITE num="11" author="DAVIS PB" publication="J LAB CLIN MED" d1="96" d2="75" d3="980"/>
<CITE num="12" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="122" d2="213" d3="980"/>
<CITE num="13" author="DAVIS PB" publication="N ENGL J MED" d1="302" d2="1453" d3="980"/>
<CITE num="14" author="MARKOVAC J" publication="BIOCHEM MED" d1="26" d2="299" d3="981"/>
<CITE num="15" author="JOHNSON DL" publication="RES COMMUN CHEM PATH PHARM" d1="32" d2="377" d3="981"/>
<CITE num="16" author="GALANT SP" publication="J CLIN INVEST" d1="68" d2="253" d3="981"/>
<CITE num="17" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="18" author="BYLUND DB" publication="J PHARMACOL EXP THER" d1="218" d2="134" d3="981"/>
<CITE num="19" author="FRASER CM" publication="N ENGL J MED" d1="305" d2="1165" d3="981"/>
<CITE num="20" author="ROAN Y" publication="PEDIATR RES" d1="16" d2="591" d3="982"/>
<CITE num="21" author="MOTULSKY HJ" publication="N ENGL J MED" d1="307" d2="18" d3="982"/>
<CITE num="22" author="ZAMMARCHI E" publication="RIV ITAL PEDIATR" d1="9" d2="505" d3="983"/>
<CITE num="23" author="DAVIS PB" publication="J CHRON DIS" d1="36" d2="269" d3="983"/>
<CITE num="24" author="DAVIS PB" publication="J CLIN INVEST" d1="71" d2="1787" d3="983"/>
<CITE num="25" author="CABRINI G" publication="RIV ITAL PEDIATR" d1="10" d2="405" d3="984"/>
<CITE num="26" author="STESSMAN J" publication="J GERONTOL" d1="39" d2="667" d3="984"/>
<CITE num="27" author="SATO K" publication="J CLIN INVEST" d1="73" d2="1763" d3="984"/>
<CITE num="28" author="EBSTEIN RP" publication="ISR J MED SCI" d1="21" d2="302" d3="985"/>
<CITE num="29" author="MITCHELL EA" publication="AUST PAEDIATR J" d1="21" d2="127" d3="985"/>
<CITE num="30" author="ERICKSON RP" publication="AM J HUM GENET" d1="37" d2="124" d3="985"/>
<CITE num="31" author="KOPELMAN H" publication="N ENGL J MED" d1="312" d2="329" d3="985"/>
<CITE num="32" author="DAVIS PB" publication="HORM METAB RES" d1="18" d2="217" d3="986"/>
<CITE num="33" author="DAVIS PB" publication="PEDIATR RES" d1="20" d2="1290" d3="986"/>
<CITE num="34" author="BOUCHER RC" publication="J CLIN INVEST" d1="78" d2="1245" d3="986"/>
<CITE num="35" author="SCHONI MH" publication="EUR J PEDIATR" d1="145" d2="80" d3="986"/>
<CITE num="36" author="SPAIDE RF" publication="AM J OPHTHALMOL" d1="103" d2="204" d3="987"/>
</CITATIONS>
<RECORDNUM>00962 </RECORDNUM>
<MEDLINENUM>78225040</MEDLINENUM>
<AUTHORS><AUTHOR>Allue-X</AUTHOR><AUTHOR>Sanjurjo-P</AUTHOR></AUTHORS>
<TITLE>Triglyceride levels after Intralipid infusion in children with
cystic fibrosis.</TITLE>
<SOURCE>Pediatrics. 1978 Jun. 61(6). P 924-5.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>DIETARY-FATS: ad</TOPIC><TOPIC>GLYCERIN: ad</TOPIC><TOPIC>PHOSPHATIDYLCHOLINES: ad</TOPIC><TOPIC>TRIGLYCERIDES: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>CYSTIC-FIBROSIS: th</TOPIC><TOPIC>DRUG-COMBINATIONS</TOPIC><TOPIC>FATTY-ACIDS-ESSENTIAL: bl</TOPIC><TOPIC>FATTY-ACIDS-NONESTERIFIED: bl</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PARENTERAL-FEEDING</TOPIC></MINORSUBJ>
<EXTRACT>Infusions of soybean oil emulsion (Intralipid) have been reported to
correct essential fatty acid (EFA) deficiency in patients with cystic
fibrosis of the pancreas.  This article reports the immediate effects
of Intralipid infusion in patients with CF in an attempt to ascertain
through biochemical data whether the use of Intralipid at the
reported dose is free of untoward effects.  Six patients with CF were
placed in a protocol that called for periodic infusions with soybean
oil emulsion containing EFAs.  The first three patients received 2
gm/kg of body weight of Intralipid over a four-hour period.  The
other three patients received half that dose over the same period.
The first three patients developed symptoms of paleness, nausea and
mild discomfort two to three hours after the infusion.  Further
information is needed to determine the best method of correction of
EFA deficiency in children with CF.</EXTRACT>
<REFERENCES>
<CITE num="001" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="002" author="TAUSSIG LM" publication="J PEDIATR" d1="82" d2="380" d3="973"/>
<CITE num="003" author="SANJURJO P" publication="LANCET" d1="1" d2="752" d3="977"/>
<CITE num="004" author="EGGSTEIN M" publication="KLIN WOCHENSCHR" d1="44" d2="267" d3="966"/>
<CITE num="005" author="CALDWELL MD" publication="J PEDIATR" d1="81" d2="894" d3="972"/>
<CITE num="006" author="SHENNAN AT" publication="J PEDIATR" d1="91" d2="134" d3="977"/>
<CITE num="007" author="PRESS M" publication="LANCET" d1="1" d2="597" d3="974"/>
<CITE num="008" author="TASHIRO T" publication="J PEDIATR SURG" d1="10" d2="203" d3="975"/>
<CITE num="009" author="FRIEDMAN Z" publication="PEDIATRICS" d1="58" d2="650" d3="976"/>
<CITE num="010" author="CHASE HP" publication="PEDIATRICS" d1="57" d2="441" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78183</PAPERNUM>
<CITATIONS>
<CITE num="1" author="OYDSTILL JD         AM" publication="J CLIN NUTR" d1="34" d2="1 9" d3="1"/>
<CITE num="2" author="MERRITT RJ" publication="ADV NUTR RES" d1="5" d2="77" d3="983"/>
</CITATIONS>
<RECORDNUM>00963 </RECORDNUM>
<MEDLINENUM>78225020</MEDLINENUM>
<AUTHORS><AUTHOR>Bureau-M-A</AUTHOR><AUTHOR>McDougall-D-M</AUTHOR><AUTHOR>Beaudry-P-H</AUTHOR><AUTHOR>Belmonte-M-M</AUTHOR></AUTHORS>
<TITLE>Late effect of nocturnal mist tent therapy related to the severity
of airway obstruction in children with cystic fibrosis.</TITLE>
<SOURCE>Pediatrics. 1978 Jun. 61(6). P 842-6.</SOURCE>
<MAJORSUBJ><TOPIC>AIRWAY-OBSTRUCTION: th</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>RESPIRATORY-THERAPY</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>AIRWAY-OBSTRUCTION: et</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MAXIMAL-MIDEXPIRATORY-FLOW-RATE</TOPIC></MINORSUBJ>
<ABSTRACT>To evaluate the long-term effect of nocturnal mist tent therapy on
the progression of airway obstruction in children with cystic
fibrosis (CF) of varying severity, two matched groups each consisting
of 24 children with CF were studied during 18 months on mist tent
therapy and 18 months of therapy. The progression in airway
obstruction was measured by change in serial measurements of maximal
midexpiratory flow (MMEF), from which a regression equation of MMEF
against time was obtained for each individual. Changes in MMEF value
with or without therapy were compared in patients matched for
severity of disease as indicated by initial MMEF values. For the
group as a whole no differences were found in the progression of the
airway obstruction whether the patients received mist tent therapy or
not. This therapy failed to benefit any of the groups of children
with CF who had early, moderate, or advanced airway obstruction as
judged from their initial MMEF value. It is concluded that nocturnal
mist tent therapy neither decreases airway obstruction nor prevents
its progression in children with CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CROZIER DN" publication="PEDIATR CLIN NORTH AM" d1="21" d2="935" d3="974"/>
<CITE num="002" author="CHANG N" publication="AM REV RESPIR DIS" d1="107" d2="672" d3="973"/>
<CITE num="003" author="TAUSSIG LM" publication="J PEDIATR" d1="84" d2="619" d3="974"/>
<CITE num="004" author="JEHANNE M" publication="ANN PEDIATR (PARIS)" d1="21" d2="595" d3="974"/>
<CITE num="005" author="NORMAN AP" publication="PRACTITIONER" d1="206" d2="786" d3="971"/>
<CITE num="006" author="MATTHEWS LW" publication="J PEDIATR" d1="65" d2="558" d3="964"/>
<CITE num="007" author="MATTHEWS LW" publication="PEDIATRICS" d1="39" d2="176" d3="967"/>
<CITE num="008" author="AVERY ME" publication="PEDIATRICS" d1="39" d2="160" d3="967"/>
<CITE num="009" author="WOLFSDORF J" publication="PEDIATRICS" d1="43" d2="799" d3="969"/>
<CITE num="010" author="ALDERSON PO" publication="J PEDIATR" d1="84" d2="479" d3="974"/>
<CITE num="011" author="FEATHERBY EA" publication="AM REV RESPIR DIS" d1="102" d2="737" d3="970"/>
<CITE num="012" author="BEAUDRY PH" publication="AM REV RESPIR DIS" d1="95" d2="248" d3="967"/>
<CITE num="013" author="FOX WW" publication="PEDIATRICS" d1="54" d2="293" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78184</PAPERNUM>
<CITATIONS>
<CITE num="1" author="URENCO RV           AR" publication="CH INTERN MED                1" d1="42" d2="99 9" d3="2"/>
</CITATIONS>
<RECORDNUM>00964 </RECORDNUM>
<MEDLINENUM>78157375</MEDLINENUM>
<AUTHORS><AUTHOR>Mellis-C-M</AUTHOR><AUTHOR>Levison-H</AUTHOR></AUTHORS>
<TITLE>Bronchial reactivity in cystic fibrosis.</TITLE>
<SOURCE>Pediatrics. 1978 Mar. 61(3). P 446-50.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: co</TOPIC><TOPIC>BRONCHI: de</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>HISTAMINE: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AEROSOLS</TOPIC><TOPIC>AIRWAY-RESISTANCE</TOPIC><TOPIC>BRONCHI: pp</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>FORCED-EXPIRATORY-VOLUME</TOPIC><TOPIC>HISTAMINE: ad</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MAXIMAL-MIDEXPIRATORY-FLOW-RATE</TOPIC><TOPIC>SKIN-TESTS</TOPIC><TOPIC>SPIROMETRY</TOPIC></MINORSUBJ>
<ABSTRACT>There is considerable dispute regarding the prevalence of asthma in
patients with cystic fibrosis (CF). We studied 50 patients with CF
and compared their responsiveness to inhaled histamine with that of
asthmatic children. The incidence of positive responses to inhaled
histamine was 24% in the patients with CF and more than 90% in the
asthmatic patients. We found no correlation, in the patients with CF,
between the histamine response and several indexes of atopy (clinical
allergic disease and positive allergen skin tests). Positive
responders to histamine were not evenly distributed over the disease
spectrum of CF. Instead, positive responses occurred only in those
patients whose prechallenge pulmonary function was abnormal. We
conclude that the heightened bronchial reactivity in patients with CF
reflects the severity of their underlying lung disease rather than
the presence of coexistent asthma.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="COUNAHAN R" publication="ARCH DIS CHILD" d1="50" d2="477" d3="975"/>
<CITE num="002" author="MCCARTHY DS" publication="IN: LAWSON D PROC 5TH INT CF" d1="" d2="194" d3="969"/>
<CITE num="003" author="WARNER JO" publication="ARCH DIS CHILD" d1="51" d2="507" d3="976"/>
<CITE num="004" author="ABBOTT V" publication="CAN MED ASSOC J" d1="64" d2="419" d3="951"/>
<CITE num="005" author="DERBES VJ" publication="J ALLERGY" d1="28" d2="287" d3="957"/>
<CITE num="006" author="LANDAU LI" publication="J PEDIATR" d1="82" d2="863" d3="973"/>
<CITE num="007" author="HEIMLICH EM" publication="J ALLERGY CLIN IMMUNOL" d1="37" d2="103" d3="966"/>
<CITE num="008" author="DAY G" publication="ARCH DIS CHILD" d1="48" d2="355" d3="973"/>
<CITE num="009" author="SKORECKI K" publication="ACTA PAEDIATR SCAND" d1="65" d2="39" d3="976"/>
<CITE num="010" author="ITKIN IH" publication="J ALLERGY CLIN IMMUNOL" d1="40" d2="245" d3="967"/>
<CITE num="011" author="PARKER CD" publication="ARCH INTERN MED" d1="115" d2="452" d3="965"/>
<CITE num="012" author="DEKOCK MA" publication="J APPL PHYSIOL" d1="21" d2="185" d3="966"/>
<CITE num="013" author="ANON" publication="LANCET" d1="2" d2="691" d3="975"/>
<CITE num="014" author="CHAI H" publication="J ALLERGY CLIN IMMUNOL" d1="56" d2="323" d3="975"/>
<CITE num="015" author="MERCER TT" publication="ANN ALLERGY" d1="23" d2="314" d3="965"/>
<CITE num="016" author="DUBOIS AB" publication="J CLIN INVEST" d1="35" d2="322" d3="956"/>
<CITE num="017" author="WENG TR" publication="AM REV RESPIR DIS" d1="99" d2="879" d3="969"/>
<CITE num="018" author="HALUSZKA J" publication="RESPIRATION" d1="32" d2="217" d3="975"/>
<CITE num="019" author="ROTHSTEIN RJ" publication="J ALLERGY CLIN IMMUNOL" d1="53" d2="100" d3="974"/>
<CITE num="020" author="RUBINFELD AR" publication="AM REV RESPIR DIS" d1="115" d2="381" d3="977"/>
<CITE num="021" author="DOLOVICH MB" publication="J APPL PHYSIOL" d1="40" d2="468" d3="976"/>
<CITE num="022" author="HOGG JC" publication="N ENGL J MED" d1="278" d2="1355" d3="968"/>
<CITE num="023" author="EMPEY DW" publication="AM REV RESPIR DIS" d1="113" d2="131" d3="976"/>
<CITE num="024" author="GIMENO F" publication="THORAX" d1="29" d2="16" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78185</PAPERNUM>
<CITATIONS>
<CITE num="1" author="TCHELL I            J" publication="PEDIATR" d1="93" d2="44 9" d3="8"/>
<CITE num="2" author="LEUPOLD W" publication="MONOGR PAEDIATR" d1="10" d2="119" d3="979"/>
<CITE num="3" author="ZAMBIE MF" publication="ANN ALLERGY" d1="42" d2="290" d3="979"/>
<CITE num="4" author="LARSEN GL" publication="AM REV RESPIR DIS" d1="119" d2="399" d3="979"/>
<CITE num="5" author="NELSON LA" publication="AM REV RESPIR DIS" d1="120" d2="863" d3="979"/>
<CITE num="6" author="BURDON JGW" publication="MED J AUST" d1="2" d2="77" d3="980"/>
<CITE num="7" author="SLY PD" publication="AUST PAEDIATR J" d1="16" d2="205" d3="980"/>
<CITE num="8" author="VANASPEREN PP" publication="AUST PAEDIATR J" d1="16" d2="53" d3="980"/>
<CITE num="9" author="TOBIN MJ" publication="THORAX" d1="35" d2="807" d3="980"/>
<CITE num="10" author="TABACHNIK E" publication="AM REV RESPIR DIS" d1="122" d2="97" d3="980"/>
<CITE num="11" author="LARSEN GL" publication="AM J DIS CHILD" d1="134" d2="1143" d3="980"/>
<CITE num="12" author="PULLAN CR" publication="BR MED J" d1="280" d2="364" d3="980"/>
<CITE num="13" author="DOLOVICH J" publication="THORAX" d1="36" d2="641" d3="981"/>
<CITE num="14" author="HOLZER FJ" publication="ARCH DIS CHILD" d1="56" d2="455" d3="981"/>
<CITE num="15" author="FANTA CH" publication="MED CLIN NORTH AM" d1="65" d2="473" d3="981"/>
<CITE num="16" author="FREEDMAN PM" publication="J ALLERGY CLIN IMMUNOL" d1="67" d2="59" d3="981"/>
<CITE num="17" author="SMYTH JA" publication="PEDIATRICS" d1="68" d2="336" d3="981"/>
<CITE num="18" author="LEMANSKE RF" publication="AM REV RESPIR DIS" d1="123" d2="622" d3="981"/>
<CITE num="19" author="BECHTEL JJ" publication="AM REV RESPIR DIS" d1="124" d2="759" d3="981"/>
<CITE num="20" author="VANASPEREN P" publication="AM J DIS CHILD" d1="135" d2="815" d3="981"/>
<CITE num="21" author="MYERS JR" publication="JAMA" d1="246" d2="225" d3="981"/>
<CITE num="22" author="GEORGITIS JW" publication="ANN ALLERGY" d1="48" d2="175" d3="982"/>
<CITE num="23" author="EIGEN H" publication="PEDIATRICS" d1="70" d2="698" d3="982"/>
<CITE num="24" author="PULLAN CR" publication="BR MED J" d1="284" d2="1665" d3="982"/>
<CITE num="25" author="NADEL JA" publication="ADV INTERN MED" d1="28" d2="207" d3="983"/>
<CITE num="26" author="EASTON JG" publication="ANN ALLERGY" d1="50" d2="171" d3="983"/>
<CITE num="27" author="NELSON HS" publication="ANN ALLERGY" d1="51" d2="488" d3="983"/>
<CITE num="28" author="PRATTER MR" publication="CHEST" d1="84" d2="42" d3="983"/>
<CITE num="29" author="LEE DA" publication="BR MED J" d1="286" d2="1256" d3="983"/>
<CITE num="30" author="MOK JYQ" publication="ARCH DIS CHILD" d1="59" d2="299" d3="984"/>
<CITE num="31" author="PEARLMAN DS" publication="AM J DIS CHILD" d1="138" d2="459" d3="984"/>
<CITE num="32" author="HAIDER SA" publication="BR MED J" d1="289" d2="109" d3="984"/>
<CITE num="33" author="RUBIN BK" publication="PEDIATR INFECT DIS" d1="4" d2="88" d3="985"/>
<CITE num="34" author="DAVIS PB" publication="SEM RESPIR MED" d1="6" d2="261" d3="985"/>
<CITE num="35" author="WONNE R" publication="CLIN ALLERGY" d1="15" d2="455" d3="985"/>
<CITE num="36" author="MAPP CE" publication="ANN ALLERGY" d1="54" d2="424" d3="985"/>
<CITE num="37" author="MITCHELL I" publication="ANN ALLERGY" d1="54" d2="233" d3="985"/>
<CITE num="38" author="KONIG P" publication="ANN ALLERGY" d1="55" d2="95" d3="985"/>
<CITE num="39" author="RIVLIN J" publication="EUR J RESPIR DIS" d1="67" d2="286" d3="985"/>
<CITE num="40" author="CROPP GJA" publication="CHEST" d1="87" d2="S 55" d3="985"/>
<CITE num="41" author="ENARSON DA" publication="CHEST" d1="87" d2="452" d3="985"/>
<CITE num="42" author="HORDVIK NL" publication="AM REV RESPIR DIS" d1="131" d2="889" d3="985"/>
<CITE num="43" author="DARGA LL" publication="PEDIATR PULMONOL" d1="2" d2="82" d3="986"/>
<CITE num="44" author="CHAY OM" publication="AUST NZ J MED" d1="16" d2="644" d3="986"/>
<CITE num="45" author="MELILLO G" publication="EUR J RESPIR DIS" d1="69" d2="282" d3="986"/>
<CITE num="46" author="PIEDRA P" publication="J PEDIATR" d1="108" d2="817" d3="986"/>
</CITATIONS>
<RECORDNUM>00965 </RECORDNUM>
<MEDLINENUM>79032974</MEDLINENUM>
<AUTHORS><AUTHOR>Rimsza-M-E</AUTHOR><AUTHOR>Hernried-L-S</AUTHOR><AUTHOR>Kaplan-A-M</AUTHOR></AUTHORS>
<TITLE>Hemorrhagic retinopathy in a patient with cystic fibrosis.</TITLE>
<SOURCE>Pediatrics. 1978 Sep. 62(3). P 336-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>RETINAL-HEMORRHAGE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ACUTE-DISEASE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>ALTITUDE</TOPIC><TOPIC>ANOXIA: co</TOPIC><TOPIC>CASE-REPORT</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>RISK</TOPIC><TOPIC>VISION-DISORDERS: et</TOPIC></MINORSUBJ>
<ABSTRACT>A 21-year-old woman with a history of chronic lung disease secondary
to cystic fibrosis (CF) developed an acute hemorrhagic retinopathy
during exposure to moderately high altitude. Although retinal
hemorrhages are known to occur in patients with CF, we speculate that
the retinopathy in this case was partially related to altitudinal
change and that patients with chronic hypoxemia may be predisposed to
high-altitude retinopathy at much lower altitudes.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRUCE GM" publication="ARCH OPHTHALMOL" d1="63" d2="391" d3="960"/>
<CITE num="002" author="SPALTER HF" publication="J PEDIATR OPHTHALMOL" d1="8" d2="6" d3="971"/>
<CITE num="003" author="CHAZAN BI" publication="J PEDIATR" d1="77" d2="86" d3="970"/>
<CITE num="004" author="WONG VG" publication="AM J OPHTHALMOL" d1="59" d2="763" d3="965"/>
<CITE num="005" author="LIETMAN PA" publication="JAMA" d1="189" d2="924" d3="964"/>
<CITE num="006" author="COCKE JG JR" publication="J PEDIATR" d1="68" d2="27" d3="966"/>
<CITE num="007" author="STRAUSS RG" publication="PEDIATRICS" d1="43" d2="297" d3="969"/>
<CITE num="008" author="HOUSTON CS" publication="LANCET" d1="2" d2="758" d3="975"/>
<CITE num="009" author="SINGH I" publication="N ENGL J MED" d1="280" d2="175" d3="969"/>
<CITE num="010" author="FRAYSER R" publication="N ENGL J MED" d1="282" d2="1183" d3="970"/>
<CITE num="011" author="SHULTS WT" publication="ARCH OPHTHALMOL" d1="93" d2="404" d3="975"/>
<CITE num="012" author="RENNIE D" publication="ARCH OPHTHALMOL" d1="93" d2="395" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78186</PAPERNUM>
<CITATIONS>
<CITE num="1" author="LDER PM             AN" publication="ESTHESIOLOGY" d1="61" d2="95 9" d3="4"/>
<CITE num="2" author="SPAIDE RF" publication="AM J OPHTHALMOL" d1="103" d2="204" d3="987"/>
</CITATIONS>
<RECORDNUM>00966 </RECORDNUM>
<MEDLINENUM>78094640</MEDLINENUM>
<AUTHORS><AUTHOR>Gilmore-J-P</AUTHOR><AUTHOR>Davis-M</AUTHOR><AUTHOR>Gibbs-G-E</AUTHOR></AUTHORS>
<TITLE>Influence of cystic fibrotic and heterozygous serum on rat jejunum.</TITLE>
<SOURCE>Proc-Soc-Exp-Biol-Med. 1978 Jan. 157(1). P 70-4.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>SODIUM: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>BIOLOGICAL-TRANSPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, fg</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>JEJUNUM: me</TOPIC><TOPIC>MEMBRANE-POTENTIALS</TOPIC><TOPIC>RATS</TOPIC></MINORSUBJ>
<EXTRACT>The rat jejunum bioassay has been shown to be capable of identifying
both the cystic fibrotic homozygote and heterozygote and therefore
would appear to have great potential as a screening test for the
latter.  It is suggested that the cystic fibrosis factor does not
influence sodium reabsorption by inhibiting an active sodium
reabsorption mechanism but rather by inhibiting passive sodium entry
into the cell.</EXTRACT>
<REFERENCES>
<CITE num="001" author="WOOD RE" publication="LANCET" d1="2" d2="1452" d3="973"/>
<CITE num="002" author="MANGOS JA" publication="PEDIATR RES" d1="1" d2="436" d3="967"/>
<CITE num="003" author="ARAKI H" publication="PEDIATR RES" d1="9" d2="932" d3="975"/>
<CITE num="004" author="ARAKI H" publication="PROC INT CF CONG 7TH" d1="" d2="28" d3="976"/>
<CITE num="005" author="USSING HH" publication="ACTA PHYSIOL SCAND" d1="61" d2="484" d3="964"/>
<CITE num="006" author="ARMITAGE P" publication="STATISTICAL METHODS IN MEDICA" d1="" d2="" d3="971"/>
<CITE num="007" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78187</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CKER RD             PE" publication="DIATR RES" d1="13" d2="71 9" d3="9"/>
<CITE num="2" author="WILL PC" publication="PEDIATR RES" d1="13" d2="1129" d3="979"/>
<CITE num="3" author="TUCKER RD" publication="IEEE TRANS BIOMED ENG" d1="26" d2="607" d3="979"/>
</CITATIONS>
<RECORDNUM>00967 </RECORDNUM>
<MEDLINENUM>78179933</MEDLINENUM>
<AUTHORS><AUTHOR>Katz-S</AUTHOR></AUTHORS>
<TITLE>Calcium and sodium transport processes in patients with cystic
fibrosis 2. Mg2+- dependent, Ca2+ ATPase activity in fibroblast
membrane preparations from cystic fibrosis patients and controls.</TITLE>
<SOURCE>Res-Commun-Chem-Pathol-Pharmacol. 1978 Mar. 19(3). P 491-503.</SOURCE>
<MAJORSUBJ><TOPIC>ADENOSINE-TRIPHOSPHATASE: me</TOPIC><TOPIC>CALCIUM: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>SODIUM: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CELL-MEMBRANE: en</TOPIC><TOPIC>CELLS-CULTURED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>FIBROBLASTS: en, ul</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MAGNESIUM: me, pd</TOPIC></MINORSUBJ>
<ABSTRACT>Mg2+-dependent Ca2+-ATPase activity was determined in membrane
preparations of fibroblasts grown from skin biopsies of cystic
fibrosis patients and age-matched controls. This enzyme was
stimulated by increasing free calcium concentrations with an apparent
Kdiss for calcium of approximately 45 micron. Although there was a
great deal of variation in Ca2+-ATPase activity observed between
individual strains, there was a significant decrease in the maximal
activation of the Ca2+-ATPase in membrane preparations of fibroblasts
obtained from cystic fibrosis patients compared to the controls (P
less than 0.05). This observation indicates that decreased Ca2+-
ATPase activity is a generalized phenomenon in cystic fibrosis found
in more than one cell-type. This decrease in Ca2+-ATPase activity may
have a number of implications that may explain some of the
manifestations of the disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BAKER PF" publication="IN: BUTLER JAV" d1="" d2="179" d3="972"/>
<CITE num="002" author="BARRANCO SC" publication="J CELL PHYSIOL" d1="88" d2="33" d3="976"/>
<CITE num="003" author="BETTELHEIM FA" publication="BIOCHIM BIOPHYS ACTA" d1="236" d2="702" d3="971"/>
<CITE num="004" author="BLOMFIELD J" publication="ARCH DIS CHILD" d1="48" d2="267" d3="973"/>
<CITE num="005" author="BLOSTEIN R" publication="J BIOL CHEM" d1="243" d2="1957" d3="968"/>
<CITE num="006" author="BOAT TF" publication="PEDIATR RES" d1="8" d2="531" d3="974"/>
<CITE num="007" author="BOND GH" publication="BIOCHIM BIOPHYS ACTA" d1="323" d2="592" d3="973"/>
<CITE num="008" author="CALDWELL PG" publication="IN: CUTHBERT AW" d1="" d2="10" d3="973"/>
<CITE num="009" author="CHERNICK WS" publication="J PEDIATR" d1="59" d2="890" d3="961"/>
<CITE num="010" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="011" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1344" d3="967"/>
<CITE num="012" author="DOUGLAS WW" publication="BR J PHARMACOL" d1="34" d2="451" d3="968"/>
<CITE num="013" author="FLETCHER DS" publication="CLIN CHIM ACTA" d1="44" d2="5" d3="973"/>
<CITE num="014" author="FORSTNER JF" publication="PEDIATR RES" d1="10" d2="609" d3="976"/>
<CITE num="015" author="GIBSON LE" publication="PEDIATRICS" d1="48" d2="695" d3="971"/>
<CITE num="016" author="GLYNN IM" publication="BIOCHEM J" d1="90" d2="147" d3="964"/>
<CITE num="017" author="KATZ S" publication="CF CLUB ABST" d1="18" d2="9" d3="977"/>
<CITE num="018" author="KATZ S" publication="BIOCHIM BIOPHYS ACTA" d1="389" d2="314" d3="975"/>
<CITE num="019" author="KROOTH RS" publication="MED CLIN NORTH AM" d1="53" d2="795" d3="969"/>
<CITE num="020" author="LEWIS AE" publication="BIOSTATISTICS" d1="" d2="" d3="966"/>
<CITE num="021" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="022" author="MANDEL ID" publication="CLIN PEDIATR" d1="8" d2="161" d3="969"/>
<CITE num="023" author="MATALON R" publication="BIOCHEM BIOPHYS RES COMMUN" d1="33" d2="954" d3="968"/>
<CITE num="024" author="POST RL" publication="METHODS ENZYMOL" d1="10" d2="762" d3="967"/>
<CITE num="025" author="QUISSELL DO" publication="NATURE" d1="247" d2="115" d3="974"/>
<CITE num="026" author="ROUFOGALIS BD" publication="BIOCHIM BIOPHYS ACTA" d1="318" d2="360" d3="973"/>
<CITE num="027" author="RUSSELL JM" publication="J GEN PHYSIOL" d1="63" d2="144" d3="974"/>
<CITE num="028" author="SCHATZMANN HJ" publication="J PHYSIOL (LOND)" d1="235" d2="551" d3="973"/>
<CITE num="029" author="SHIGEKAWA M" publication="J BIOL CHEM" d1="251" d2="6984" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78188</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SAH TA              CE" publication="LL CALC" d1="1" d2="95 9" d3="0"/>
<CITE num="2" author="ANSAH TA" publication="PROC WEST PHARMACOL SOC" d1="23" d2="389" d3="980"/>
<CITE num="3" author="THEOHARIDES TC" publication="LIFE SCI" d1="27" d2="703" d3="980"/>
<CITE num="4" author="KATZ S" publication="CLIN CHIM ACTA" d1="100" d2="245" d3="980"/>
<CITE num="5" author="FODER B" publication="CLIN CHIM ACTA" d1="104" d2="187" d3="980"/>
<CITE num="6" author="MALER T" publication="BIOCHIM BIOPHYS ACTA" d1="598" d2="1" d3="980"/>
<CITE num="7" author="GNEGY ME" publication="BIOCHEM MED" d1="26" d2="294" d3="981"/>
<CITE num="8" author="SORSCHER EJ" publication="LANCET" d1="1" d2="368" d3="982"/>
<CITE num="9" author="HARRIS A" publication="CLIN CHIM ACTA" d1="128" d2="41" d3="983"/>
<CITE num="10" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="11" author="ALLEN BG" publication="CELL CALC" d1="7" d2="161" d3="986"/>
<CITE num="12" author="BRIDGES MA" publication="PEDIATR RES" d1="20" d2="356" d3="986"/>
<CITE num="13" author="MORRISSEY SM" publication="DIGESTION" d1="34" d2="28" d3="986"/>
</CITATIONS>
<RECORDNUM>00968 </RECORDNUM>
<MEDLINENUM>79014649</MEDLINENUM>
<AUTHORS><AUTHOR>Super-M</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis in Southern Africa.  Including the preparation of a
register of carriers and potential carriers.</TITLE>
<SOURCE>S-Afr-Med-J. 1978 Jul 1. 54(1). P 18-21.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: oc</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MEDICAL-RECORDS-PROBLEM-ORIENTED</TOPIC><TOPIC>NAMIBIA</TOPIC><TOPIC>ZIMBABWE</TOPIC><TOPIC>SOUTH-AFRICA</TOPIC><TOPIC>WHITES</TOPIC></MINORSUBJ>
<ABSTRACT>Little has been published on cystic fibrosis (CF) in Whites in
southern Africa, and no figures as to incidence exist. A register of
CF patients, their parents (obligatory carriers), siblings, uncles,
aunts and first cousins (potential carriers) has been compiled for
southern Africa. The degree of co-operation shown by colleagues and
by families whose addresses have been provided by them, and possible
reasons for non-co-operation are discussed. From the numbers and
birth dates of patients a rough estimate of the incidence in the
Republic of South Africa, South West Africa and Rhodesia has been
made. In all three regions, but especially in South Africa, incidence
is likely to have been underestimated. Details available from the
register include the number of CF patients alive and dead, those who
presented with meconium ileus, the number of affected patients per
family, consanguinity among the parents or grandparents, the
frequency with which identical surnames were encountered, and the
sibship sizes of all those on the register. Towns and districts with
a population rich in the CF gene are mentioned. The number of
potential carriers has been determined, so that they can be screened
when a practicable detection test is devised. The register has
answered a number of questions about CF in southern Africa. It has
focused attention on the disease in the region and played a major
catalytic role in the formation of the Southern African Cystic
Fibrosis Association.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="GROVE SS" publication="S AFR J LAB CLIN MED" d1="5" d2="113" d3="959"/>
<CITE num="002" author="LEVIN SE" publication="S AFR MED J" d1="41" d2="482" d3="967"/>
<CITE num="003" author="SUPER M" publication="S AFR MED J" d1="49" d2="818" d3="975"/>
<CITE num="004" author="SUPER M" publication="S AFR MED J" d1="50" d2="238" d3="976"/>
<CITE num="005" author="BARBERO GJ" publication="IN: MANGOS JA" d1="" d2="83" d3="976"/>
<CITE num="006" author="MACKENZIE DJM" publication="S AFR MED J" d1="50" d2="2083" d3="975"/>
<CITE num="007" author="CARTER CO" publication="ABC OF MEDICAL GENETICS" d1="" d2="" d3="969"/>
<CITE num="008" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="009" author="BOTHA MC" publication="S AFR MED J SUPPL 1" d1="46" d2="22" d3="972"/>
<CITE num="010" author="SUPER M" publication="LANCET" d1="2" d2="1288" d3="977"/>
<CITE num="011" author="SUPER M" publication="THESIS" d1="" d2="" d3="978"/>
<CITE num="012" author="OLIVIER SP" publication="PIONIERTREKKE NA GAZALAND" d1="" d2="59" d3="943"/>
<CITE num="013" author="MEYER ET" publication="IN: GEDENKBOEK VAN DIE DORSLA" d1="" d2="5" d3="974"/>
<CITE num="014" author="EMERY AEH" publication="ELEMENTS OF MEDICAL GENET" d1="" d2="103" d3="975"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78189</PAPERNUM>
<CITATIONS>
<CITE num="1" author="PER M               MO" publication="NOGR PAEDIATR" d1="10" d2="06 9" d3="9"/>
<CITE num="2" author="SUPER M" publication="LANCET" d1="2" d2="1200" d3="983"/>
<CITE num="3" author="BOTHA MC" publication="S AFR MED J" d1="64" d2="609" d3="983"/>
</CITATIONS>
<RECORDNUM>00969 </RECORDNUM>
<MEDLINENUM>79159331</MEDLINENUM>
<AUTHORS><AUTHOR>Kollberg-H</AUTHOR><AUTHOR>Mossberg-B</AUTHOR><AUTHOR>Afzelius-B-A</AUTHOR><AUTHOR>Philipson-K</AUTHOR><AUTHOR>Camner-P</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis compared with the immotile-cilia syndrome.  A study
of mucociliary clearance, ciliary ultrastructure, clinical picture
and ventilatory function.</TITLE>
<SOURCE>Scand-J-Respir-Dis. 1978. 59(6). P 297-306.</SOURCE>
<MAJORSUBJ><TOPIC>BRONCHIAL-DISEASES: di</TOPIC><TOPIC>CILIA</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: et</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADULT</TOPIC><TOPIC>BRONCHI: pp</TOPIC><TOPIC>BRONCHIAL-DISEASES: pa, pp</TOPIC><TOPIC>CILIA: ph, ul</TOPIC><TOPIC>CLINICAL-TRIALS</TOPIC><TOPIC>COMPARATIVE-STUDY</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa, pp</TOPIC><TOPIC>DOUBLE-BLIND-METHOD</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LUNG-DISEASES-OBSTRUCTIVE: pa, pp</TOPIC><TOPIC>MALE</TOPIC><TOPIC>RESPIRATORY-FUNCTION-TESTS</TOPIC><TOPIC>RESPIRATORY-TRACT-INFECTIONS: pa, pp</TOPIC><TOPIC>SPIROMETRY</TOPIC><TOPIC>SYNDROME</TOPIC><TOPIC>TERBUTALINE: tu</TOPIC></MINORSUBJ>
<ABSTRACT>Patients with cystic fibrosis (CF) were investigated for mucociliary
clearance (with and without stimulation by terbutaline), clinical
picture, ventilatory function and ultrastructure of cilia. The
results were compared with those of patients with congenitally
immotile cilia (immotile-cilia syndrome). Mucociliary clearance could
be demonstrated in all the seven CF patients who succeeded in
inhaling the test aerosol. Ciliary ultrastructure from a deceased CF
patient was normal. Patients with the immotile cilia syndrome had no
substantial clearance and defective cilia. The CF patients coughed
more during the clearance measurements than any other group studied
earlier, and their coughing was effective. One patient succeeded in
avoiding coughing in both measurements and had faster clearance when
he got terbutaline than when he got the vehicle. Although younger,
the CF patients tended to be more obstructed in their lungs and more
handicapped than the patients suffering from the immotile-cilia
syndrome. The latter patients had more discomfort from rhinitis,
sinusitis and otitis than had the CF patients. An impairment of the
mucociliary transport rate is hence unlikely to be a primary
pathogenic factor for the respiratory tract disease in CF patients.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="AFZELIUS BA" publication="SCIENCE" d1="193" d2="317" d3="976"/>
<CITE num="002" author="BERGLUND E" publication="ACTA MED SCAND" d1="173" d2="185" d3="963"/>
<CITE num="003" author="CAMNER P" publication="ENVIRON PHYSIOL" d1="1" d2="137" d3="971"/>
<CITE num="004" author="CAMNER P" publication="SCAND J RESPIR DIS" d1="54" d2="272" d3="973"/>
<CITE num="005" author="CAMNER P" publication="AM REV RESPIR DIS" d1="108" d2="131" d3="973"/>
<CITE num="006" author="CAMNER P" publication="AM REV RESPIR DIS" d1="112" d2="807" d3="975"/>
<CITE num="007" author="CAMNER P" publication="ARCH ENVIRON HEALTH" d1="31" d2="79" d3="976"/>
<CITE num="008" author="ELIASSON R" publication="N ENGL J MED" d1="297" d2="1" d3="977"/>
<CITE num="009" author="ESTERLY JR" publication="JOHNS HOPKINS MED J" d1="122" d2="94" d3="968"/>
<CITE num="010" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="011" author="JARSTRAND C" publication="AM REV RESPIR DIS" d1="110" d2="415" d3="974"/>
<CITE num="012" author="KARTAGENER M" publication="BEITR KLIN TUBERK" d1="83" d2="489" d3="933"/>
<CITE num="013" author="KOLLBERG H" publication="THESIS" d1="" d2="" d3="974"/>
<CITE num="014" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="57" d2="281" d3="976"/>
<CITE num="015" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="57" d2="119" d3="976"/>
<CITE num="016" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="59" d2="1" d3="978"/>
<CITE num="017" author="MOSSBERG B" publication="SCAND J RESPIR DIS" d1="59" d2="55" d3="978"/>
<CITE num="018" author="PEDERSEN H" publication="NATURE" d1="262" d2="494" d3="976"/>
<CITE num="019" author="PHILIPSON K" publication="J AEROLOL SCI" d1="4" d2="51" d3="977"/>
<CITE num="021" author="SANCHIS J" publication="N ENGL J MED" d1="288" d2="651" d3="973"/>
<CITE num="022" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="023" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="024" author="SHWACHMAN H" publication="AM J DIS CHILD" d1="96" d2="6" d3="958"/>
<CITE num="025" author="THOMSON ML" publication="N ENGL J MED" d1="289" d2="749" d3="973"/>
<CITE num="026" author="WOOD RE" publication="AM REV RESPIR DIS" d1="111" d2="733" d3="975"/>
<CITE num="027" author="YEATES DB" publication="ARCH DIS CHILD" d1="51" d2="28" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78190</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ZELIUS B            BR" publication="MED J" d1="2" d2="74 9" d3="9"/>
<CITE num="2" author="PAVIA D" publication="CLIN RESP PHYSIOL" d1="16" d2="335" d3="980"/>
<CITE num="3" author="AFZELIUS BA" publication="THORAX" d1="35" d2="401" d3="980"/>
<CITE num="4" author="CAMNER P" publication="CLIN SCI" d1="59" d2="79" d3="980"/>
<CITE num="5" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="61" d2="8" d3="980"/>
<CITE num="6" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="61" d2="51" d3="980"/>
<CITE num="7" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="61" d2="18" d3="980"/>
<CITE num="8" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="61" d2="47" d3="980"/>
<CITE num="9" author="RUTLAND J" publication="THORAX" d1="36" d2="654" d3="981"/>
<CITE num="10" author="TEGNER H" publication="ACTA PAEDIATR SCAND" d1="70" d2="629" d3="981"/>
<CITE num="11" author="AFZELIUS BA" publication="AM REV RESPIR DIS" d1="124" d2="107" d3="981"/>
<CITE num="12" author="CORKEY CWB" publication="AM REV RESPIR DIS" d1="124" d2="544" d3="981"/>
<CITE num="13" author="KONRADOVA V" publication="EUR J RESPIR DIS" d1="63" d2="516" d3="982"/>
<CITE num="14" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="63" d2="111" d3="982"/>
<CITE num="15" author="YARNAL JR" publication="POSTGRAD MED" d1="71" d2="195" d3="982"/>
<CITE num="16" author="KOLLBERG H" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="15" d3="982"/>
<CITE num="17" author="SCHIOTZ PO" publication="ACTA PAEDIATR SCAND SUPPL 301" d1="1982" d2="55" d3="982"/>
<CITE num="18" author="FERGUSON JA" publication="AM PHARM" d1="23" d2="48" d3="983"/>
<CITE num="19" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="64" d2="129" d3="983"/>
<CITE num="20" author="NEWHOUSE MT" publication="EUR J RESPIR DIS" d1="64" d2="151" d3="983"/>
<CITE num="21" author="RUTLAND J" publication="AM REV RESPIR DIS" d1="128" d2="1030" d3="983"/>
<CITE num="22" author="ROOMANS GM" publication="SCANN ELECTRON MICROSC" d1="1983" d2="697" d3="983"/>
<CITE num="23" author="KATZ S" publication="CELL CALC" d1="5" d2="421" d3="984"/>
<CITE num="24" author="NEWHOUSE MT" publication="SEM RESPIR MED" d1="5" d2="341" d3="984"/>
<CITE num="25" author="WOOD RE" publication="SEM RESPIR MED" d1="5" d2="336" d3="984"/>
<CITE num="26" author="CAMNER P" publication="ATEMWEGS LUNGENKRANKH" d1="10" d2="237" d3="984"/>
<CITE num="27" author="CANET E" publication="PRESSE MED" d1="13" d2="1607" d3="984"/>
<CITE num="28" author="BECKER B" publication="RESPIRATION" d1="46" d2="180" d3="984"/>
<CITE num="29" author="ROSSMAN CM" publication="AM REV RESPIR DIS" d1="129" d2="161" d3="984"/>
<CITE num="30" author="HANDELSMAN DJ" publication="N ENGL J MED" d1="310" d2="3" d3="984"/>
<CITE num="31" author="AFZELIUS BA" publication="CRC CRIT REV BIOCHEM" d1="19" d2="63" d3="985"/>
<CITE num="32" author="SATO T" publication="EXP MOL PATH" d1="43" d2="13" d3="985"/>
<CITE num="33" author="KOHLER D" publication="ATEMWEGS LUNGENKRANKH" d1="12" d2="358" d3="986"/>
<CITE num="34" author="WILSON R" publication="THORAX" d1="41" d2="453" d3="986"/>
<CITE num="35" author="SVARTENGREN M" publication="EUR J RESPIR DIS" d1="68" d2="267" d3="986"/>
<CITE num="36" author="KOHLER D" publication="EUR J RESPIR DIS" d1="69" d2="319" d3="986"/>
<CITE num="37" author="MOSSBERG B" publication="EUR J RESPIR DIS" d1="69" d2="295" d3="986"/>
<CITE num="38" author="WILSON R" publication="J INFECT DIS" d1="153" d2="376" d3="986"/>
<CITE num="39" author="ZWAS ST" publication="J NUCL MED" d1="28" d2="161" d3="987"/>
<CITE num="40" author="SYKES DA" publication="THORAX" d1="42" d2="256" d3="987"/>
</CITATIONS>
<RECORDNUM>00970 </RECORDNUM>
<MEDLINENUM>78096506</MEDLINENUM>
<AUTHORS><AUTHOR>Vaughan-W-J</AUTHOR><AUTHOR>Lindgren-F-T</AUTHOR><AUTHOR>Whalen-J-B</AUTHOR><AUTHOR>Abraham-S</AUTHOR></AUTHORS>
<TITLE>Serum lipoprotein concentrations in cystic fibrosis.</TITLE>
<SOURCE>Science. 1978 Feb 17. 199(4330). P 783-6.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: bl</TOPIC><TOPIC>LIPOPROTEINS: bl</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>CARRIER-STATE: bl</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>ELECTROPHORESIS-AGAR-GEL</TOPIC><TOPIC>ELECTROPHORESIS-POLYACRYLAMIDE-GEL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>LIPOPROTEINS-HDL: bl</TOPIC><TOPIC>LIPOPROTEINS-LDL: bl</TOPIC><TOPIC>LIPOPROTEINS-VLDL: bl</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>SUPPORT-U-S-GOVT-NON-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Two major classes of lipoproteins, low density and high density, are
decreased in the serum of patients with cystic fibrosis; major
apoproteins are also decreased. Since essential fatty acids and
certain fat-soluble vitamins depend on lipoproteins for transport in
the serum, knowledge of lipoprotein levels in cystic fibrosis
patients could prove valuable in understanding (i) the basis for the
abnormally low serum levels of these fatty acids and vitamins and
(ii) the effects of therapies involving these molecules.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="DANKS DM" publication="ANN HUM GENET" d1="28" d2="323" d3="965"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="597" d3="976"/>
<CITE num="003" author="WIESE HF" publication="AM J CLIN NUTR" d1="18" d2="155" d3="966"/>
<CITE num="003" author="KUO PT" publication="J CLIN INVEST" d1="44" d2="1924" d3="965"/>
<CITE num="004" author="CAREN R" publication="J CLIN ENDOCRINOL METAB" d1="26" d2="470" d3="966"/>
<CITE num="004" author="ROSENLUND ML" publication="NATURE" d1="251" d2="719" d3="974"/>
<CITE num="005" author="LOBECK CC" publication="IN: STANBURY JB" d1="" d2="1605" d3="972"/>
<CITE num="006" author="MCCORMICK EC" publication="J LIPID RES" d1="1" d2="221" d3="960"/>
<CITE num="006" author="KRINSKY NI" publication="ARCH BIOCHEM BIOPHYS" d1="73" d2="233" d3="958"/>
<CITE num="006" author="KUTSKY RJ" publication="HANDBOOK OF VITAMINS AND HORM" d1="" d2="36" d3="973"/>
<CITE num="006" author="SKIPSKI VP" publication="IN: NELSON GJ" d1="" d2="471" d3="972"/>
<CITE num="009" author="FERRO-LUZZI AMES G" publication="J BIOL CHEM" d1="249" d2="634" d3="974"/>
<CITE num="009" author="VAUGHAN WJ" publication="GERONTOLOGY" d1="23" d2="110" d3="977"/>
<CITE num="010" author="WEBER K" publication="J BIOL CHEM" d1="244" d2="4406" d3="969"/>
<CITE num="011" author="MORRISETT JD" publication="ANNU REV BIOCHEM" d1="44" d2="879" d3="975"/>
<CITE num="012" author="LINDGREN FT" publication="IN: NELSON GJ" d1="" d2="181" d3="972"/>
<CITE num="014" author="HATCH FT" publication="J LAB CLIN MED" d1="81" d2="946" d3="973"/>
<CITE num="017" author="DYERBERY J" publication="SCAND J CLIN LAB INVEST" d1="31" d2="473" d3="973"/>
<CITE num="017" author="SRINIVASAN SR" publication="CIRCULATION" d1="54" d2="309" d3="976"/>
<CITE num="018" author="LOPEZ-S A" publication="AM J CLIN NUTR" d1="20" d2="808" d3="967"/>
<CITE num="018" author="JOHNSON BC" publication="J CHRON DIS" d1="18" d2="147" d3="965"/>
<CITE num="019" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="021" author="WILSON DE" publication="J CLIN INVEST" d1="51" d2="1051" d3="972"/>
<CITE num="022" author="THOMPSON GR" publication="CLIN SCI MOL MED" d1="45" d2="583" d3="973"/>
<CITE num="024" author="SMITH FR" publication="J LAB CLIN MED" d1="80" d2="423" d3="972"/>
<CITE num="025" author="HOLVEY DN" publication="MERCK MANUAL OF DIAGNOSIS" d1="" d2="739" d3="972"/>
<CITE num="026" author="KESSLER JI" publication="J BIOL CHEM" d1="245" d2="5281" d3="970"/>
<CITE num="026" author="GLICKMAN RM" publication="J CLIN INVEST" d1="52" d2="2910" d3="973"/>
<CITE num="026" author="GLICKMAN RM" publication="SCIENCE" d1="193" d2="1254" d3="976"/>
<CITE num="027" author="ELLIOTT RB" publication="PEDIATRICS" d1="57" d2="474" d3="976"/>
<CITE num="027" author="ELLIOTT RB" publication="ARCH DIS CHILD" d1="50" d2="76" d3="975"/>
<CITE num="027" author="ROSENLUND ML" publication="PEDIATRICS" d1="59" d2="428" d3="977"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78191</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ASE HP              J" publication="PEDIATR" d1="95" d2="37 9" d3="9"/>
<CITE num="2" author="YI PI" publication="BLOOD" d1="57" d2="1055" d3="981"/>
<CITE num="3" author="PARK RW" publication="GASTROENTEROLOGY" d1="81" d2="1143" d3="981"/>
<CITE num="4" author="ROY CC" publication="J PEDIATR GASTROENTEROL NUTR" d1="1" d2="469" d3="982"/>
<CITE num="5" author="KRAUSS RM" publication="MED CLIN NORTH AM" d1="66" d2="403" d3="982"/>
<CITE num="6" author="SCHONI M" publication="PEDIATR RES" d1="18" d2="66" d3="984"/>
<CITE num="7" author="ABMAN SH" publication="J PEDIATR GASTROENTEROL NUTR" d1="5" d2="393" d3="986"/>
</CITATIONS>
<RECORDNUM>00971 </RECORDNUM>
<MEDLINENUM>78204217</MEDLINENUM>
<AUTHORS><AUTHOR>Breslow-J-L</AUTHOR><AUTHOR>Epstein-J</AUTHOR><AUTHOR>Fontaine-J-H</AUTHOR><AUTHOR>Forbes-G-B</AUTHOR></AUTHORS>
<TITLE>Enhanced dexamethasone resistance in cystic fibrosis cells:
potential use for heterozygote detection and prenatal diagnosis.</TITLE>
<SOURCE>Science. 1978 Jul 14. 201(4351). P 180-2.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>DEXAMETHASONE: to</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>AMNIOTIC-FLUID: cy</TOPIC><TOPIC>CELL-SURVIVAL: de</TOPIC><TOPIC>CYSTIC-FIBROSIS: di, fg</TOPIC><TOPIC>DRUG-RESISTANCE</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HETEROZYGOTE</TOPIC><TOPIC>HOMOZYGOTE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>PREGNANCY</TOPIC><TOPIC>PRENATAL-DIAGNOSIS</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Cultured skin fibroblasts from patients with cystic fibrosis (CF) are
more resistant to dexamethasone toxicity than are normal cells. We
now report that, when fibroblasts cultured from obligate CF
heterozygotes are exposed to dexamethasone, they have an intermediate
survival compared to normal and homozygous CF cells. When
dexamethasone survival was tested on cells from four patients
undergoing amniocentesis, cells from a woman at risk of producing a
child with CF showed significant dexamethasone resistance, similar to
that of fibroblasts derived from lnown CF homozygotes; the other
amniotic cell specimens showed dexamethasone sensitivity similar to
that of normal skin fibroblasts. These data suggest that the
dexamethasone resistance previously observed in skin fibroblasts may
also be useful in the prenatal diagnosis of CF.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANON" publication="J PEDIATR" d1="88" d2="711" d3="976"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="003" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="004" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="005" author="BRESLOW JL" publication="CELL" d1="13" d2="663" d3="978"/>
<CITE num="006" author="BRESLOW JL" publication="EXP CELL RES" d1="110" d2="399" d3="977"/>
<CITE num="008" author="FREUND JE" publication="MODERN ELEMENTARY STATISTICS" d1="" d2="" d3="967"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78192</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SLI P               LA" publication="NCET" d1="2" d2="43 9" d3="9"/>
<CITE num="2" author="MAHONEY MJ" publication="CLIN PERINATOL" d1="6" d2="255" d3="979"/>
<CITE num="3" author="KURNIT DM" publication="ANNU REV GENET" d1="13" d2="235" d3="979"/>
<CITE num="4" author="HARRIS A" publication="DEVELOP MED CHILD NEUROL" d1="21" d2="675" d3="979"/>
<CITE num="5" author="SHWACHMAN H" publication="J PEDIATR" d1="95" d2="661" d3="979"/>
<CITE num="6" author="HOSLI P" publication="FEBS LETTERS" d1="104" d2="271" d3="979"/>
<CITE num="7" author="KURZ JB" publication="SCIENCE" d1="206" d2="1317" d3="979"/>
<CITE num="8" author="SCANLIN TF" publication="CLIN CHEST MED" d1="1" d2="424" d3="980"/>
<CITE num="9" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="10" author="TARNOKY AL" publication="J ROY SOC MED" d1="73" d2="73" d3="980"/>
<CITE num="11" author="BARDON A" publication="CLIN CHIM ACTA" d1="101" d2="17" d3="980"/>
<CITE num="12" author="BRESLOW JL" publication="SCIENCE" d1="207" d2="1007" d3="980"/>
<CITE num="13" author="DANIEL A" publication="HUM GENET" d1="57" d2="96" d3="981"/>
<CITE num="14" author="KELLER GH" publication="ARCH BIOCHEM BIOPHYS" d1="211" d2="321" d3="981"/>
<CITE num="15" author="BRESLOW JL" publication="N ENGL J MED" d1="304" d2="1" d3="981"/>
<CITE num="16" author="LITTLEFIELD JW" publication="N ENGL J MED" d1="304" d2="44" d3="981"/>
<CITE num="17" author="SEALE TW" publication="ANN CLIN LAB SCI" d1="12" d2="415" d3="982"/>
<CITE num="18" author="KHALID BAK" publication="CLIN ENDOCRINOL" d1="18" d2="407" d3="983"/>
<CITE num="19" author="KHALID BAK" publication="MOL CELL ENDOCRINOL" d1="30" d2="303" d3="983"/>
<CITE num="20" author="LANGHOFF E" publication="PEDIATR RES" d1="18" d2="488" d3="984"/>
<CITE num="21" author="NELSON MM" publication="S AFR MED J" d1="66" d2="688" d3="984"/>
<CITE num="22" author="GROSS NJ" publication="AM REV RESPIR DIS" d1="129" d2="805" d3="984"/>
<CITE num="23" author="BOUE A" publication="PRESSE MED" d1="14" d2="575" d3="985"/>
<CITE num="24" author="POLANSKY J" publication="INVEST OPHTHALMOL VIS SCI" d1="26" d2="805" d3="985"/>
<CITE num="25" author="RAVIA Y" publication="HUM GENET" d1="71" d2="294" d3="985"/>
<CITE num="26" author="BOUE A" publication="HUM GENET" d1="74" d2="288" d3="986"/>
<CITE num="27" author="KUZEMKO JA" publication="J ROY SOC MED" d1="79" d2="2" d3="986"/>
</CITATIONS>
<RECORDNUM>00972 </RECORDNUM>
<MEDLINENUM>78204186</MEDLINENUM>
<AUTHORS><AUTHOR>Rosenblum-M-G</AUTHOR><AUTHOR>Durie-B-G</AUTHOR><AUTHOR>Beckerman-R-C</AUTHOR><AUTHOR>Taussig-L-M</AUTHOR><AUTHOR>Russell-D-H</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis: decreased conjugation and excretion of
[14C]spermidine.</TITLE>
<SOURCE>Science. 1978 Jun 30. 200(4349). P 1496-7.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>SPERMIDINE: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>HUMAN</TOPIC><TOPIC>SPERMIDINE: bl, ur</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC></MINORSUBJ>
<ABSTRACT>Free and conjugated [14C]spermidine were measured in plasma samples
from normal individuals and cystic fibrosis patients. Within 4
minutes, the 14C-labeled material in the plasma from normal
individuals was 70 percent conjugated compared to no detectable
conjugation by cystic fibrosis patients. Further, the patients
excreted only 11 to 13 percent of the [14C]spermidine in their urine
within 72 hours whereas normal excretion was 60 to 76 percent. In
both cases, the labeled material was in a conjugated form.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ANDERSEN DH" publication="AM J DIS CHILD" d1="56" d2="344" d3="938"/>
<CITE num="001" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="277" d2="1287" d3="967"/>
<CITE num="002" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="003" author="BOWMAN BH" publication="SCIENCE" d1="164" d2="325" d3="969"/>
<CITE num="003" author="TAUSSIG LM" publication="IN: KELLEY VC" d1="4" d2="1" d3="976"/>
<CITE num="004" author="LUNDGREN DW" publication="CLIN CHIM ACTA" d1="62" d2="357" d3="975"/>
<CITE num="005" author="COHEN LF" publication="BLOOD" d1="48" d2="469" d3="976"/>
<CITE num="007" author="RUSSELL DH" publication="CLIN CHEM" d1="23" d2="22" d3="977"/>
<CITE num="008" author="ROSENBLUM MG" publication="CANCER RES" d1="37" d2="47" d3="977"/>
<CITE num="009" author="ROSENBLUM MG" publication="PROC AM ASSOC CANCER RES" d1="17" d2="15" d3="976"/>
<CITE num="010" author="SEILER N" publication="NEUROCHEM RES" d1="1" d2="469" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78193</PAPERNUM>
<CITATIONS>
<CITE num="1" author="SENBLUM MG          CA" publication="NCER RES" d1="38" d2="61 9" d3="8"/>
<CITE num="2" author="CAMPBELL RA" publication="LANCET" d1="1" d2="724" d3="979"/>
<CITE num="3" author="RUSSELL DH" publication="PEDIATR RES" d1="13" d2="1137" d3="979"/>
<CITE num="4" author="CANELLAKIS ES" publication="CURR TOP CELL REGUL" d1="15" d2="155" d3="979"/>
<CITE num="5" author="AIGNERHELD R" publication="PROC NAT ACAD SCI USA" d1="76" d2="6652" d3="979"/>
<CITE num="6" author="AIGNERHELD R" publication="PHYSIOL CHEM PHYS" d1="12" d2="389" d3="980"/>
<CITE num="7" author="MELVIN MAL" publication="PHYSIOL CHEM PHYS" d1="12" d2="431" d3="980"/>
<CITE num="8" author="BAYLIN SB" publication="PEDIATR RES" d1="14" d2="921" d3="980"/>
<CITE num="9" author="SWENDSEID ME" publication="LIFE SCI" d1="26" d2="533" d3="980"/>
<CITE num="10" author="THEOHARIDES TC" publication="LIFE SCI" d1="27" d2="703" d3="980"/>
<CITE num="11" author="BARDON A" publication="CLIN CHIM ACTA" d1="101" d2="17" d3="980"/>
<CITE num="12" author="SHIPE JR" publication="CRC CRIT REV CLIN LAB SCI" d1="16" d2="1" d3="981"/>
<CITE num="13" author="FAN MZ" publication="PHYSIOL CHEM PHYS MED NMR" d1="15" d2="57" d3="983"/>
<CITE num="14" author="FAN MZ" publication="PHYSIOL CHEM PHYS MED NMR" d1="15" d2="69" d3="983"/>
<CITE num="15" author="TAKAGI T" publication="J CHROMATOGR" d1="272" d2="279" d3="983"/>
<CITE num="16" author="NORDLANDER JE" publication="J ORGANIC CHEM" d1="49" d2="133" d3="984"/>
</CITATIONS>
<RECORDNUM>00973 </RECORDNUM>
<MEDLINENUM>78250613</MEDLINENUM>
<AUTHORS><AUTHOR>Epstein-J</AUTHOR><AUTHOR>Breslow-J-L</AUTHOR><AUTHOR>Fitzsimmons-M-J</AUTHOR><AUTHOR>Vayo-M-M</AUTHOR></AUTHORS>
<TITLE>Pleiotropic drug resistance in cystic fibrosis fibroblasts:
increased resistance to cyclic AMP.</TITLE>
<SOURCE>Somatic-Cell-Genet. 1978 Jul. 4(4). P 451-64.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>DIBUTYRYL-CYCLIC-AMP: pd</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CELL-LINE</TOPIC><TOPIC>CELL-SURVIVAL: de</TOPIC><TOPIC>DRUG-RESISTANCE</TOPIC><TOPIC>ISOPROTERENOL: pd</TOPIC><TOPIC>SUPPORT-U-S-GOVT-P-H-S</TOPIC><TOPIC>3-5-CYCLIC-AMP-PHOSPHODIESTERASE: me</TOPIC></MINORSUBJ>
<ABSTRACT>In previous studies, cystic fibrosis (CF) fibroblasts were
demonstrated to be resistant to the cytotoxic effects of ouabain,
dexamethasone, and the sex hormones, dihydrotestosterone, 17beta-
estradiol, and progesterone. We now show that CF fibroblasts also
exhibit greatly increased resistance to the cytotoxic effects of
exogenous dibutyryl cyclic AMP (cAMP), as well as to isoproterenol
and theophylline, drugs which are known to increase endogenous levels
of cAMP. CF cells were also shown to have normal amounts of (3H)cAMP
binding to protein kinase as well as normal amounts of cAMP-
stimulated protein kinase activity. Phosphodiesterase in CF cells was
also found to be stimulated by cAMP to the same degree as in normal
cells. These findings suggest that there is no detectable protein
kinase deficiency in CF cells. cf cells thus appear to be unlike some
cAMP-resistant mutants described by others which are defective in
protein kinase activity and cAMP regulation of phosphodiesterase
levels. The cross-resistance of CF fibroblasts to ouabain, steroid
hormones, and cAMP may provide a unique opportunity to study the
biochemical events involved in the metabolism of these drugs as well
as the basic biochemical defect in a common human genetic disease.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="1676" d3="977"/>
<CITE num="002" author="EPSTEIN JL" publication="PROC NAT ACAD SCI USA" d1="74" d2="5642" d3="977"/>
<CITE num="003" author="BRESLOW JL" publication="CELL" d1="13" d2="663" d3="978"/>
<CITE num="004" author="BRESLOW JL" publication="EXP CELL RES" d1="110" d2="399" d3="977"/>
<CITE num="005" author="LELIEVRE L" publication="EXP CELL RES" d1="104" d2="191" d3="977"/>
<CITE num="006" author="LOWRY OH" publication="J BIOL CHEM" d1="193" d2="265" d3="951"/>
<CITE num="007" author="INSEL PA" publication="SCIENCE" d1="190" d2="896" d3="975"/>
<CITE num="008" author="GILMAN AG" publication="PROC NAT ACAD SCI USA" d1="67" d2="305" d3="970"/>
<CITE num="009" author="BEAVO JA" publication="J BIOL CHEM" d1="245" d2="5649" d3="970"/>
<CITE num="010" author="MANGANIELLO VC" publication="BIOCHIM BIOPHYS ACTA" d1="362" d2="509" d3="974"/>
<CITE num="011" author="APPLEMAN MM" publication="ADV CYCLIC NUCLEO RES" d1="3" d2="65" d3="973"/>
<CITE num="012" author="KUO JF" publication="PROC NAT ACAD SCI USA" d1="64" d2="1349" d3="969"/>
<CITE num="013" author="ERLICHMAN J" publication="J BIOL CHEM" d1="248" d2="7607" d3="973"/>
<CITE num="014" author="BEAVO JA" publication="IN: DRUMMOND P" d1="5" d2="241" d3="975"/>
<CITE num="015" author="DANIEL V" publication="PROC NAT ACAD SCI USA" d1="70" d2="76" d3="973"/>
<CITE num="016" author="COFFINO P" publication="J CELL PHYSIOL" d1="85" d2="603" d3="975"/>
<CITE num="017" author="BOURNE HR" publication="J CELL PHYSIOL" d1="85" d2="611" d3="975"/>
<CITE num="018" author="BUCHWALD M" publication="PROC NAT ACAD SCI USA" d1="73" d2="2899" d3="976"/>
<CITE num="019" author="BOURNE HR" publication="SCIENCE" d1="181" d2="952" d3="973"/>
<CITE num="020" author="D ARMIENTO M" publication="PROC NAT ACAD SCI USA" d1="69" d2="459" d3="972"/>
<CITE num="021" author="MAGANIELLO V" publication="PROC NAT ACAD SCI USA" d1="69" d2="269" d3="972"/>
<CITE num="022" author="THOMPSON EB" publication="METABOLISM" d1="23" d2="159" d3="974"/>
<CITE num="023" author="MANKOVITZ R" publication="CELL" d1="3" d2="221" d3="974"/>
<CITE num="024" author="LEVER JE" publication="J CELL PHYSIOL" d1="88" d2="343" d3="976"/>
<CITE num="025" author="BAXTER JD" publication="SCIENCE" d1="171" d2="189" d3="971"/>
<CITE num="026" author="SIBLEY CH" publication="CELL" d1="2" d2="221" d3="974"/>
<CITE num="027" author="YAMAMOTO KR" publication="IN: GREEP RO" d1="32" d2="3" d3="976"/>
<CITE num="028" author="BOURGEOIS S" publication="CELL" d1="11" d2="423" d3="977"/>
<CITE num="029" author="BOURNE HR" publication="SCIENCE" d1="187" d2="750" d3="975"/>
<CITE num="030" author="GRANNER DK" publication="NATURE" d1="259" d2="572" d3="974"/>
<CITE num="031" author="SCHAFFER LD" publication="BIOCHIM BIOPHYS ACTA" d1="192" d2="304" d3="969"/>
<CITE num="032" author="MILLER TB" publication="J BIOL CHEM" d1="246" d2="3672" d3="971"/>
<CITE num="033" author="AXTON JH" publication="J BIOL CHEM" d1="247" d2="3579" d3="972"/>
<CITE num="034" author="STELLWAGEN RH" publication="BIOCHEM BIOPHYS RES COMMUN" d1="47" d2="1144" d3="972"/>
<CITE num="035" author="VAN RIJN H" publication="J BIOL CHEM" d1="60" d2="181" d3="974"/>
<CITE num="036" author="LEMAIRE I" publication="CELL" d1="11" d2="149" d3="977"/>
<CITE num="037" author="MOMMAERTS WFHM" publication="PROC NAT ACAD SCI USA" d1="45" d2="791" d3="959"/>
<CITE num="038" author="HUG G" publication="J CLIN INVEST" d1="48" d2="704" d3="969"/>
<CITE num="039" author="HUIJING F" publication="AM J HUM GENET" d1="21" d2="275" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78194</PAPERNUM>
<CITATIONS>
<CITE num="1" author="RZ JB               SC" publication="IENCE                        2" d1="06" d2="17 9" d3="9"/>
<CITE num="2" author="BUCHWALD M" publication="ADV CYCLIC NUCLEO RES" d1="12" d2="243" d3="980"/>
<CITE num="3" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="83" d3="980"/>
<CITE num="4" author="DAVIS PB" publication="PEDIATR RES" d1="14" d2="863" d3="980"/>
<CITE num="5" author="BRESLOW JL" publication="SCIENCE" d1="207" d2="1007" d3="980"/>
<CITE num="6" author="GNEGY ME" publication="BIOCHEM MED" d1="26" d2="294" d3="981"/>
<CITE num="7" author="MARKOVAC J" publication="BIOCHEM MED" d1="26" d2="299" d3="981"/>
<CITE num="8" author="BRESLOW JL" publication="N ENGL J MED" d1="304" d2="1" d3="981"/>
<CITE num="9" author="UNSICKER K" publication="CELL TISSUE RES" d1="223" d2="73" d3="982"/>
<CITE num="10" author="LANGHOFF E" publication="PEDIATR RES" d1="18" d2="488" d3="984"/>
<CITE num="11" author="PINSKY L" publication="ADV HUM GENET" d1="16" d2="299" d3="987"/>
</CITATIONS>
<RECORDNUM>00974 </RECORDNUM>
<MEDLINENUM>78204429</MEDLINENUM>
<AUTHORS><AUTHOR>Carpentieri-U</AUTHOR><AUTHOR>Gustavson-L-P</AUTHOR><AUTHOR>Haggard-M-E</AUTHOR></AUTHORS>
<TITLE>Misdiagnosis of neglect in a child with bleeding disorder and cystic
fibrosis.</TITLE>
<SOURCE>South-Med-J. 1978 Jul. 71(7). P 854-5.</SOURCE>
<MAJORSUBJ><TOPIC>CHILD-ABUSE</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>DISSEMINATED-INTRAVASCULAR-COAGULATION: et</TOPIC><TOPIC>VITAMIN-K-DEFICIENCY: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CYSTIC-FIBROSIS: di</TOPIC><TOPIC>DIAGNOSTIC-ERRORS</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC></MINORSUBJ>
<ABSTRACT>This report describes a child in whom a bleeding disorder secondary
to vitamin K deficiency led to a mistaken diagnosis of child
neglect, which was eventually corrected to that of cystic fibrosis.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="WALTERS TR" publication="AM J DIS CHILD" d1="124" d2="641" d3="972"/>
<CITE num="002" author="TORSTENSON OL" publication="PEDIATRICS" d1="45" d2="857" d3="970"/>
<CITE num="003" author="OPPENHEIMER EH" publication="J PEDIATR" d1="88" d2="1079" d3="976"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78195</PAPERNUM>
<CITATIONS>
<CITE num="1" author="ARE AE              AR" publication="CH DIS CHILD" d1="59" d2="60 9" d3="4"/>
<CITE num="2" author="PAYNE NR" publication="PEDIATRICS" d1="73" d2="712" d3="984"/>
<CITE num="3" author="LANE PA" publication="J PEDIATR" d1="106" d2="351" d3="985"/>
</CITATIONS>
<RECORDNUM>00975 </RECORDNUM>
<MEDLINENUM>79077519</MEDLINENUM>
<AUTHORS><AUTHOR>Lewis-R-W</AUTHOR></AUTHORS>
<TITLE>The biochemical basis of cystic fibrosis: an hypothesis based upon
the polyelectrolytes of mucus.</TITLE>
<SOURCE>Tex-Rep-Biol-Med. 1978. 36. P 33-8.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>ELECTROLYTES: me</TOPIC><TOPIC>MUCUS: me</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CYSTIC-FIBROSIS: pp</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MEMBRANE-PROTEINS: me</TOPIC><TOPIC>MEMBRANES: me</TOPIC><TOPIC>MUCUS: se</TOPIC><TOPIC>VISCOSITY</TOPIC></MINORSUBJ>
<ABSTRACT>The evidence shows that the pathology of cystic fibrosis (CF) is
related to mucoid secretions. Consequently, the question of what
governs the viscosity of mucus is examined in detail. It is generally
agreed that the mucin gel consists of polyanionic glycoproteins and a
hitherto unidentified poly cationic cross-linking protein. It is
proposed that larger amounts of polycations increase viscosity and,
in excess, cause mucus to become a polycation. As these compounds are
known to inhibit the ductal reabsorption of sodium, the two principal
aspects of the pathology of CF can be related to the same mechanism.
The mucus globule membrane (MGM) has been proposed as the cross-
linking protein.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BARBERO GJ" publication="PEDIATRICS" d1="22" d2="945" d3="958"/>
<CITE num="002" author="BODIAN M" publication="FIBROCYSTIC DIS OF THE PANCRE" d1="" d2="" d3="952"/>
<CITE num="003" author="BOTELHO SY" publication="J PEDIATR" d1="83" d2="601" d3="973"/>
<CITE num="004" author="CARLBORG L" publication="ACTA ENDOCRINOL" d1="62" d2="721" d3="969"/>
<CITE num="005" author="COOK GMW" publication="SURFACE CARBOHYDRATES OF THE" d1="" d2="58" d3="973"/>
<CITE num="006" author="DI SANTAGNESE PA" publication="PEDIATRICS" d1="12" d2="549" d3="953"/>
<CITE num="007" author="DISCHE Z" publication="FED PROC" d1="19" d2="904" d3="960"/>
<CITE num="008" author="DISCHE Z" publication="PEDIATRICS" d1="24" d2="74" d3="959"/>
<CITE num="009" author="ELSTEIN M" publication="J OBSTET GYNAECOL BR COMMONW" d1="77" d2="443" d3="970"/>
<CITE num="010" author="FARBER S" publication="J MICH MED SOC" d1="44" d2="587" d3="945"/>
<CITE num="011" author="GIBBONS RA" publication="BIOCHEM J" d1="73" d2="209" d3="959"/>
<CITE num="012" author="GIBBONS RA" publication="PROTIDES BIOL FLUIDS" d1="16" d2="299" d3="968"/>
<CITE num="013" author="IACOBELLI S" publication="FERTIL STERIL" d1="22" d2="727" d3="971"/>
<CITE num="014" author="JIRKA M" publication="CLIN CHIM ACTA" d1="2" d2="292" d3="957"/>
<CITE num="015" author="JOHNSTON WH" publication="ARCH DIS CHILD" d1="31" d2="477" d3="956"/>
<CITE num="016" author="KAISER D" publication="PEDIATR RES" d1="5" d2="167" d3="971"/>
<CITE num="017" author="KIM SK" publication="J ULTRASTRUCT RES" d1="38" d2="371" d3="972"/>
<CITE num="018" author="KORNGUTH SE" publication="EXP CELL RES" d1="24" d2="484" d3="961"/>
<CITE num="020" author="LEWIS RW" publication="LIPIDS" d1="8" d2="321" d3="973"/>
<CITE num="021" author="MANDEL ID" publication="AM J DIS CHILD" d1="110" d2="646" d3="965"/>
<CITE num="022" author="MANGOS JA" publication="PEDIATR RES" d1="2" d2="378" d3="968"/>
<CITE num="023" author="MAMELAK M" publication="J MEMBR BIOL" d1="1" d2="144" d3="969"/>
<CITE num="024" author="MASSON PL" publication="IN: ELSTEIN M" d1="" d2="82" d3="973"/>
<CITE num="025" author="NEUTRA M" publication="J CELL BIOL" d1="30" d2="119" d3="966"/>
<CITE num="026" author="PALLAVICINI JC" publication="ANN NY ACAD SCI" d1="106" d2="330" d3="963"/>
<CITE num="027" author="POTTER JL" publication="ANN NY ACAD SCI" d1="106" d2="692" d3="963"/>
<CITE num="028" author="SCHUMACHER GFB" publication="PROTIDES BIOL FLUIDS" d1="16" d2="525" d3="968"/>
<CITE num="029" author="SHWACHMAN H" publication="PEDIATRICS" d1="7" d2="153" d3="951"/>
<CITE num="030" author="ROELFS RE" publication="AM J DIS CHILD" d1="113" d2="419" d3="967"/>
<CITE num="031" author="TANDLER B" publication="J MORPHOL" d1="127" d2="383" d3="969"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78196</PAPERNUM>
<CITATIONS>
<CITE num="1" author="CHELLE E            EU" publication="R J CLIN INVEST" d1="15" d2="89 9" d3="5"/>
</CITATIONS>
<RECORDNUM>00976 </RECORDNUM>
<MEDLINENUM>78204754</MEDLINENUM>
<AUTHORS><AUTHOR>Picot-R</AUTHOR><AUTHOR>Das-I</AUTHOR><AUTHOR>Reid-L</AUTHOR></AUTHORS>
<TITLE>Pus, deoxyribonucleic acid, and sputum viscosity.</TITLE>
<SOURCE>Thorax. 1978 Apr. 33(2). P 235-42.</SOURCE>
<MAJORSUBJ><TOPIC>DNA: an</TOPIC><TOPIC>SPUTUM: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGED</TOPIC><TOPIC>ASTHMA: me</TOPIC><TOPIC>BRONCHIECTASIS: me</TOPIC><TOPIC>BRONCHITIS: me</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HYDROGEN-ION-CONCENTRATION</TOPIC><TOPIC>MALE</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>SPUTUM: ph</TOPIC><TOPIC>SUPPURATION</TOPIC><TOPIC>VISCOSITY</TOPIC></MINORSUBJ>
<ABSTRACT>On 100 sputum specimens selected from patients suffering  from
chronic bronchitis, bronchiectasis, asthma, and cystic fibrosis total
deoxyribonucleic acid (DNA) content has been related to macroscopic
type, to total dry weight yield, and to the apparent viscosity of the
secretion at 1350 s-1: since DNA may be present, either as fibres or
within cells, in one-third of the specimens the contribution of each
form to the apparent viscosity was assessed. The effect on sputum
viscosity of the addition of DNA in vitro has also been studied.
Whereas between mucoid, mucopurulent, and purulent macroscopic types
a significant difference in total DNA and dry weight yield has been
found, viscosity was not significantly correlated with purulence.
Similarly, the concentration of either cells or fibres correlated
significantly with total DNA but not with viscosity. The in vitro
addition of DNA to sputum caused a significant increase in its
viscosity, and reasons for the differences between the iv vivo and in
vitro effect are discussed. Certain constituents of purulent sputum
tend to increase viscosity and others to reduce it, and the influence
of these varies in the several diseases studied.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="ADLER K" publication="AM REV RESPIR DIS" d1="106" d2="86" d3="972"/>
<CITE num="002" author="BRUCE RA" publication="BR MED J" d1="1" d2="282" d3="962"/>
<CITE num="003" author="BURGI H" publication="MED THORAC" d1="21" d2="156" d3="964"/>
<CITE num="004" author="BURGI H" publication="MED HYGIENE" d1="23" d2="1169" d3="965"/>
<CITE num="005" author="BURTON K" publication="BIOCHEM J" d1="62" d2="315" d3="956"/>
<CITE num="006" author="CHARMAN J" publication="BIORHEOLOGY" d1="9" d2="185" d3="972"/>
<CITE num="007" author="CONWAY BE" publication="J POLYM SCI" d1="12" d2="199" d3="954"/>
<CITE num="008" author="CROFT DN" publication="BIOCHEM J" d1="95" d2="612" d3="965"/>
<CITE num="009" author="DAVIS SS" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="47" d3="973"/>
<CITE num="010" author="DAVIS SS" publication="BIORHEOLOGY" d1="6" d2="11" d3="969"/>
<CITE num="011" author="FEATHER EA" publication="BR J DIS CHEST" d1="64" d2="192" d3="970"/>
<CITE num="012" author="FEULGEN R" publication="QUOTED IN: DRURY RAB" d1="" d2="158" d3="967"/>
<CITE num="013" author="GUERRIN F" publication="IN: POINSOT R" d1="" d2="249" d3="969"/>
<CITE num="014" author="KEAL EE" publication="POSTGRAD MED J" d1="47" d2="171" d3="971"/>
<CITE num="015" author="LEACH SA" publication="NATURE" d1="199" d2="486" d3="963"/>
<CITE num="016" author="LIEBERMAN J" publication="J LAB CLIN MED" d1="70" d2="595" d3="967"/>
<CITE num="017" author="LIEBERMAN J" publication="PEDIATRICS" d1="31" d2="1028" d3="963"/>
<CITE num="018" author="LIEBERMAN J" publication="LAB INVEST" d1="14" d2="249" d3="965"/>
<CITE num="019" author="LITT M" publication="BIORHEOLOGY" d1="11" d2="111" d3="974"/>
<CITE num="020" author="LITT M" publication="BIORHEOLOGY" d1="13" d2="37" d3="976"/>
<CITE num="021" author="LOPEZ-VIDRIERO MT" publication="THORAX" d1="28" d2="401" d3="973"/>
<CITE num="022" author="LOPEZ-VIDRIERO MT" publication="THESIS" d1="" d2="" d3="976"/>
<CITE num="023" author="LOPEZ-VIDRIERO MT" publication="THORAX" d1="" d2="734" d3="977"/>
<CITE num="024" author="MILLER DL" publication="AM REV RESPIR DIS" d1="88" d2="473" d3="963"/>
<CITE num="025" author="MOLINA C" publication="J FRANC MED CHIR THORAC" d1="23" d2="734" d3="969"/>
<CITE num="026" author="PALMER KNV" publication="BR J DIS CHEST" d1="64" d2="185" d3="970"/>
<CITE num="027" author="PUCHELLE E" publication="BULL PHYSIOPATH RESPIR NANCY" d1="9" d2="237" d3="973"/>
<CITE num="028" author="ROSENBLUTH M" publication="ARCH DIS CHILD" d1="49" d2="606" d3="974"/>
<CITE num="029" author="STURGESS J" publication="RHEOL ACTA" d1="10" d2="36" d3="971"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78197</PAPERNUM>
<CITATIONS>
<CITE num="1" author="IMURA S             BI" publication="ORHEOLOGY" d1="17" d2="63 9" d3="0"/>
<CITE num="2" author="KING M" publication="FED PROC" d1="39" d2="3080" d3="980"/>
<CITE num="3" author="MIRRAKHIMOV MM" publication="TER ARKH" d1="52" d2="22" d3="980"/>
<CITE num="4" author="TAKISHIMA T" publication="TOHOKU J EXP MED" d1="131" d2="103" d3="980"/>
<CITE num="5" author="KING M" publication="PEDIATR RES" d1="15" d2="120" d3="981"/>
<CITE num="6" author="MIRRAKHIMOV MM" publication="TER ARKH" d1="53" d2="110" d3="981"/>
<CITE num="7" author="SNYDER CE" publication="CARBOHYD RES" d1="105" d2="87" d3="982"/>
<CITE num="8" author="PUCHELLE E" publication="EUR J CLIN INVEST" d1="15" d2="389" d3="985"/>
</CITATIONS>
<RECORDNUM>00977 </RECORDNUM>
<MEDLINENUM>79077659</MEDLINENUM>
<AUTHORS><AUTHOR>Hennequet-A</AUTHOR><AUTHOR>Jehanne-M</AUTHOR><AUTHOR>Betuel-H</AUTHOR><AUTHOR>Gilly-R</AUTHOR><AUTHOR>Schmid-M</AUTHOR><AUTHOR>Hors-J</AUTHOR></AUTHORS>
<TITLE>Cystic fibrosis and HLA.</TITLE>
<SOURCE>Tissue-Antigens. 1978 Sep. 12(3). P 159-62.</SOURCE>
<MAJORSUBJ><TOPIC>CYSTIC-FIBROSIS: fg</TOPIC><TOPIC>HLA-ANTIGENS</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHILD-PRESCHOOL</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>GENE-FREQUENCY</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>HLA-ANTIGENS: an</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MALE</TOPIC><TOPIC>PEDIGREE</TOPIC></MINORSUBJ>
<ABSTRACT>In 94 children suffering from cystic fibrosis, no abnormal
frequencies of HLA markers of the A and B locus were observed in
comparison with the distribution of these antigens in control series.
Furthermore, the HLA genotypes of seven pairs of diseased sibs are
incompatible with the hypothesis of a closed linkage between CF--an
autosomal recessive transmitted disease--and HLA.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="BRIMBLECOMBE FSW" publication="LANCET" d1="2" d2="1428" d3="973"/>
<CITE num="002" author="CONOVER JH" publication="LANCET" d1="1" d2="1122" d3="973"/>
<CITE num="003" author="DANES BS" publication="J EXP MED" d1="129" d2="775" d3="969"/>
<CITE num="005" author="ANON" publication="TRANSPLANT REV" d1="22" d2="" d3="975"/>
<CITE num="006" author="KAISER GI" publication="HLA AND DISEASE" d1="" d2="252" d3="976"/>
<CITE num="007" author="LAMM LU" publication="ANN HUM GENET" d1="38" d2="383" d3="975"/>
<CITE num="008" author="LOWE CU" publication="AM J DIS CHILD" d1="78" d2="349" d3="949"/>
<CITE num="009" author="MITTAL KK" publication="TRANSPLANTATION" d1="6" d2="913" d3="968"/>
<CITE num="010" author="MORTON NE" publication="AM J HUM GENET" d1="7" d2="277" d3="955"/>
<CITE num="011" author="POLYMENIDIS Z" publication="LANCET" d1="2" d2="1452" d3="973"/>
<CITE num="012" author="RYDER LP" publication="HUMANGENETIK" d1="25" d2="251" d3="974"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78198</PAPERNUM>
<CITATIONS>
<CITE num="1" author="HWARZ HP            J" publication="PEDIATR                      1" d1="04" d2="99 9" d3="4"/>
<CITE num="2" author="KNOPFLE G" publication="KLIN PAEDIATR" d1="197" d2="13" d3="985"/>
</CITATIONS>
<RECORDNUM>00978 </RECORDNUM>
<MEDLINENUM>78229466</MEDLINENUM>
<AUTHORS><AUTHOR>Hanawa-M</AUTHOR><AUTHOR>Takebe-T</AUTHOR><AUTHOR>Takahashi-S</AUTHOR><AUTHOR>Koizumi-M</AUTHOR><AUTHOR>Endo-K</AUTHOR></AUTHORS>
<TITLE>The significance of the sweat test in chronic pancreatitis.</TITLE>
<SOURCE>Tohoku-J-Exp-Med. 1978 May. 125(1). P 59-69.</SOURCE>
<MAJORSUBJ><TOPIC>PANCREATITIS: me</TOPIC><TOPIC>SODIUM-CHLORIDE: an</TOPIC><TOPIC>SWEAT: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>ADOLESCENCE</TOPIC><TOPIC>ADULT</TOPIC><TOPIC>AGE-FACTORS</TOPIC><TOPIC>AGED</TOPIC><TOPIC>CHILD</TOPIC><TOPIC>CHRONIC-DISEASE</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>EATING</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>METHODS</TOPIC><TOPIC>MIDDLE-AGE</TOPIC><TOPIC>PILOCARPINE: pd</TOPIC><TOPIC>SEX-FACTORS</TOPIC></MINORSUBJ>
<ABSTRACT>In order to study the disposition which is thought to be latent in
chronic pancreatitis, we investigated the sweat chloride
concentration of 95 normal subjects, 43 cases of chronic
pancreatitis, 12 cases of cholelithiasis, 15 cases of peptic ulcers,
16 cases of hepatic diseases and 23 cases of diabetes mellitus with
the sweat test, using the method of pilocarpine iontophoresis. We
obtained the following results. (1) In normal subjects, the sweat
chloride concentration was inclined to rise gradually with age from
childhood to adulthood; the mean value of sweat chloride
concentration was 30.0 mEq/liter in adults from 20 years old, and the
upper limit was about 60 mEq/liter. (2) The mean value of sweat
chloride concentration was 60.0 mEq/liter in chronic calcifying
pancreatitis; this value was markedly higher than that of control
subjects of the same age (p is less than 0.001). (3) The mean value
of sweat chloride concentration in cholelithiasis, peptic ulcer and
hepatic diseases did not differ significantly from control subjects.
The mean value of sweat chloride concentration in diabetes mellitus
was significantly higher than that of control subjects (p is less
than 0.01), but was significantly lower than that in chronic
pancreatitis (p is less than 0.01). (4) It was supposed that some
cases of chronic pancreatitis have a congenital disposition toward
abnormal secretion of sweat glands and epithelium in the pancreatic
duct, resembling cystic fibrosis, and this disposition leads easily
to pancreatic disorders when the individual is exposed to various
external factors.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CAREY MC" publication="GUT" d1="9" d2="700" d3="968"/>
<CITE num="002" author="GIBSON LE" publication="PEDIATRICS" d1="23" d2="545" d3="959"/>
<CITE num="003" author="GROSS JB" publication="IN: DE REUCK AVS" d1="" d2="278" d3="962"/>
<CITE num="004" author="KLATSKIN G" publication="AM J MED" d1="12" d2="3" d3="952"/>
<CITE num="005" author="KOCH E" publication="IN: HEINKEL K" d1="" d2="261" d3="964"/>
<CITE num="006" author="NOVIS MH" publication="LANCET" d1="1" d2="748" d3="975"/>
<CITE num="007" author="DI SANTAGNESE PA" publication="N ENGL J MED" d1="295" d2="481" d3="976"/>
<CITE num="010" author="SARLES H" publication="BIBL GASTROENT BASEL" d1="7" d2="75" d3="965"/>
<CITE num="011" author="TAKEBE T" publication="SAISHIN IGAKU" d1="27" d2="1757" d3="972"/>
<CITE num="012" author="VINK CLJ" publication="IN: DE REUCK AVS" d1="" d2="310" d3="962"/>
</REFERENCES>

</RECORD><RECORD>
<PAPERNUM>PN78199</PAPERNUM>
<CITATIONS>
<CITE num="1" author="GARELLA C           EU" publication="R J CLIN INVEST" d1="12" d2="45 9" d3="2"/>
<CITE num="2" author="QUINTON PM" publication="ANNU REV MED" d1="34" d2="429" d3="983"/>
</CITATIONS>
<RECORDNUM>00979 </RECORDNUM>
<MEDLINENUM>80082663</MEDLINENUM>
<AUTHORS><AUTHOR>Gogus-S</AUTHOR><AUTHOR>Caglar-M</AUTHOR><AUTHOR>Yilgor-E</AUTHOR><AUTHOR>Altay-C</AUTHOR></AUTHORS>
<TITLE>Coexistence of sickle cell trait and cystic fibrosis.</TITLE>
<SOURCE>Turk-J-Pediatr. 1978 Jan-Apr. 20(1-2). P 58-62.</SOURCE>
<MAJORSUBJ><TOPIC>ANEMIA-SICKLE-CELL: co</TOPIC><TOPIC>CYSTIC-FIBROSIS: co</TOPIC><TOPIC>SICKLE-CELL-TRAIT: co</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CASE-REPORT</TOPIC><TOPIC>CONSANGUINITY</TOPIC><TOPIC>CYSTIC-FIBROSIS: pa</TOPIC><TOPIC>FEMALE</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>INFANT-NEWBORN</TOPIC><TOPIC>MALE</TOPIC><TOPIC>SICKLE-CELL-TRAIT: pa</TOPIC></MINORSUBJ>
<EXTRACT>The aim of this paper is to report in detail the clinical and
pathological observations in a case of cystic fibrosis showing widely
disseminated intravascular sickling.  To the best of our knowledge no
case of cystic fibrosis associated with sickle cell trait has been
reported in the literature.  A six month old infant who was diagnosed
to have cystic fibrosis and sickle cell trait was presented and the
literature was reviewed for this coexistence.</EXTRACT>

</RECORD><RECORD>
<PAPERNUM>PN78200</PAPERNUM>
<REFERENCES>
<CITE num="001" author="MYERSON RM" publication="AM J MED" d1="26" d2="543" d3="959"/>
<CITE num="002" author="ALTAY C" publication="HUM HERED" d1="28" d2="56" d3="978"/>
<CITE num="003" author="OPPENHEIMER EH" publication="PERSPECT PEDIATR PATHOL" d1="2" d2="241" d3="975"/>
<CITE num="004" author="GURSON CT" publication="HELV PAEDIATR ACTA" d1="28" d2="165" d3="973"/>
<CITE num="005" author="OBER WB" publication="N ENGL J MED" d1="263" d2="947" d3="960"/>
<CITE num="006" author="JONES SR" publication="N ENGL J MED" d1="282" d2="323" d3="970"/>
<CITE num="007" author="MCCORMICK WF" publication="AM J MED SCI" d1="241" d2="329" d3="961"/>
<CITE num="008" author="MULLICK FG" publication="ARCH ENVIRON HEALTH" d1="26" d2="221" d3="973"/>
</REFERENCES>
<RECORDNUM>00980 </RECORDNUM>
<MEDLINENUM>79161280</MEDLINENUM>
<AUTHORS><AUTHOR>Foltinova-J</AUTHOR><AUTHOR>Mikulikova-K</AUTHOR><AUTHOR>Soltes-L</AUTHOR></AUTHORS>
<TITLE>Mucopolysaccharides in bronchial secretion of children.</TITLE>
<SOURCE>Z-Mikrosk-Anat-Forsch. 1978. 92(2). P 409-15.</SOURCE>
<MAJORSUBJ><TOPIC>ASTHMA: me</TOPIC><TOPIC>BRONCHI: se</TOPIC><TOPIC>BRONCHITIS: me</TOPIC><TOPIC>CYSTIC-FIBROSIS: me</TOPIC><TOPIC>MUCOPOLYSACCHARIDES: an</TOPIC><TOPIC>MUCUS: an</TOPIC></MAJORSUBJ>
<MINORSUBJ><TOPIC>CHILD</TOPIC><TOPIC>HUMAN</TOPIC><TOPIC>INFANT</TOPIC><TOPIC>MUCUS: cy, se</TOPIC></MINORSUBJ>
<ABSTRACT>The diseases of respiratory system are nowadays one of the important
medical, economical and social problems of modern civilization. A
common symptom of these diseases regardless of their etiology,
character, klinical manifestation and morphological findings is
hypersecretion of bronchial sputum. Tracheobronchial mucus is
produced by mucous bronchial glands and goblet cells. This mucus
represents at physiological condition about 5 micrometer thick cover
on mucous of nasopharynx, larynx, trachea, bronchi up to terminal
bronchioles. Protective function of mucus cover resposes in
mechanical and humoral barrier and also in removing the inhaled
particles and their transport to the upper part of the respiratory
system. In spite of the fact, that bronchial secretion has an
important role in protective mechanism and in thermal and water
exchange of respiratory tract, this secretion is not sufficiently
scrutinized mainly of children yet.</ABSTRACT>
<REFERENCES>
<CITE num="001" author="CHLAP Z" publication="ACTA MED POL" d1="10" d2="209" d3="959"/>
<CITE num="002" author="GERTH B" publication="Z ERKR ATMUNGSORGANE" d1="132" d2="223" d3="970"/>
<CITE num="003" author="JONES R" publication="HISTOCHEM J" d1="5" d2="19" d3="973"/>
<CITE num="004" author="KISZELI G" publication="MIKROTECHNISCHE UND HISTOCHEM" d1="" d2="" d3="964"/>
<CITE num="005" author="PEARSE AGE" publication="HISTOCHEM THEORET AND APPLIED" d1="" d2="" d3="974"/>
<CITE num="006" author="POGODIN BIV" publication="VOPR CASNOJ PAT ANAT VORNA" d1="" d2="81" d3="973"/>
<CITE num="007" author="RAVETTO C" publication="J HISTOCHEM CYTOCHEM" d1="12" d2="44" d3="964"/>
<CITE num="008" author="LAMB D" publication="HISTOCHEM J" d1="4" d2="91" d3="972"/>
<CITE num="009" author="SALVATO G" publication="THORAX" d1="23" d2="168" d3="968"/>
<CITE num="010" author="SCOTT DE" publication="HISTOCHEMIE" d1="5" d2="221" d3="965"/>
<CITE num="011" author="SPICER SS" publication="J HISTOCHEM CYTOCHEM" d1="8" d2="18" d3="960"/>
<CITE num="012" author="SPICER SS" publication="J HISTOCHEM CYTOCHEM" d1="13" d2="211" d3="965"/>
<CITE num="013" author="SPICER SS" publication="TECH BULL REG MED TECHNOL" d1="30" d2="53" d3="960"/>
<CITE num="014" author="SORVARI TE" publication="J HISTOCHEM CYTOCHEM" d1="17" d2="291" d3="969"/>
</REFERENCES>
</RECORD>
</FILE>
